{"relation": "INHIBITOR", "token": ["Experimental cystathioninuria was induced in rats by administration of the ", "cystathionine gamma-lyase", " inhibitor, ", "D,L-propargylglycine", "."], "h": {"pos": [1, 2], "type": null, "name": "cystathionine gamma-lyase  inhibitor, "}, "t": {"pos": [3, 4], "type": null, "name": "D,L-propargylglycine ."}}
{"relation": "INHIBITOR", "token": ["A series of xanthine derivatives in which a methylene was inserted at position 8 of ", "xanthine", " scaffold was synthesized and evaluated as inhibitors of dipeptidyl peptidase 4 (", "DPP-4", ") for the treatment of type 2 diabetes."], "h": {"pos": [1, 2], "type": null, "name": "xanthine  scaffold was synthesized and evaluated as inhibitors of dipeptidyl peptidase 4 ("}, "t": {"pos": [3, 4], "type": null, "name": "DPP-4 ) for the treatment of type 2 diabetes."}}
{"relation": "INHIBITOR", "token": ["In this study, we demonstrate significant inhibitory activity of ", "dasatinib", " against both wild-type KIT and the KIT", "D816V", " mutation in the nanomolar range in in vitro and cell-based kinase assays."], "h": {"pos": [1, 2], "type": null, "name": "dasatinib  against both wild-type KIT and the KIT"}, "t": {"pos": [3, 4], "type": null, "name": "D816V  mutation in the nanomolar range in in vitro and cell-based kinase assays."}}
{"relation": "INHIBITOR", "token": ["Four prenylflavonoids, ", "kurarinone", " ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on ", "diacylglycerol acyltransferase", " (DGAT)."], "h": {"pos": [1, 2], "type": null, "name": "kurarinone  ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on "}, "t": {"pos": [3, 4], "type": null, "name": "diacylglycerol acyltransferase  (DGAT)."}}
{"relation": "INHIBITOR", "token": ["5-(N,N-dimethyl)-amiloride (50 microM; ", "DMA", "), a concentration that selectively inhibits the NHE isoforms NHE1 and ", "NHE2", ", but not NHE3, did not affect DBS."], "h": {"pos": [1, 2], "type": null, "name": "DMA ), a concentration that selectively inhibits the NHE isoforms NHE1 and "}, "t": {"pos": [3, 4], "type": null, "name": "NHE2 , but not NHE3, did not affect DBS."}}
{"relation": "INHIBITOR", "token": ["These five ", "CGPs", " also inhibited [(3)H]E217\u03b2G uptake by ", "MRP4", "."], "h": {"pos": [1, 2], "type": null, "name": "CGPs  also inhibited [(3)H]E217\u03b2G uptake by "}, "t": {"pos": [3, 4], "type": null, "name": "MRP4 ."}}
{"relation": "INHIBITOR", "token": ["", "Rapamycin", " inhibits proteinase and selected ", "peptidase", " activities of the catalytic core proteasome at low micromolar concentrations."], "h": {"pos": [1, 2], "type": null, "name": "Rapamycin  inhibits proteinase and selected "}, "t": {"pos": [3, 4], "type": null, "name": "peptidase  activities of the catalytic core proteasome at low micromolar concentrations."}}
{"relation": "INHIBITOR", "token": ["When ", "amiloride", " was dropped on the eye surface on the first day of irradiation and subsequently daily until the end of the experiment, ", "u-PA", " activity in both cornea and tear fluid was strongly inhibited."], "h": {"pos": [1, 2], "type": null, "name": "amiloride  was dropped on the eye surface on the first day of irradiation and subsequently daily until the end of the experiment, "}, "t": {"pos": [3, 4], "type": null, "name": "u-PA  activity in both cornea and tear fluid was strongly inhibited."}}
{"relation": "INHIBITOR", "token": ["A significant decrease of aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase (", "LDH", ") activities and glutathione (GSH) levels and an increase of malondialdehyde (MDA) quantity was observed after ", "CCl4", " and PC administration alone."], "h": {"pos": [1, 2], "type": null, "name": "LDH ) activities and glutathione (GSH) levels and an increase of malondialdehyde (MDA) quantity was observed after "}, "t": {"pos": [3, 4], "type": null, "name": "CCl4  and PC administration alone."}}
{"relation": "INHIBITOR", "token": ["Blockade of NMDA receptors by ", "memantine", " could theoretically confer disease-modifying activity in AD by inhibiting the \"weak\" ", "NMDA receptor", "-dependent excitotoxicity that has been hypothesized to play a role in the progressive neuronal loss that underlies the evolving dementia."], "h": {"pos": [1, 2], "type": null, "name": "memantine  could theoretically confer disease-modifying activity in AD by inhibiting the \"weak\" "}, "t": {"pos": [3, 4], "type": null, "name": "NMDA receptor -dependent excitotoxicity that has been hypothesized to play a role in the progressive neuronal loss that underlies the evolving dementia."}}
{"relation": "INHIBITOR", "token": ["", "HSYA", " treatment also decreased NF-\u03baB p65 nuclear translocation and inhibited the phosphorylation of p38 mitogen-activated protein kinase (", "p38", " MAPK)."], "h": {"pos": [1, 2], "type": null, "name": "HSYA  treatment also decreased NF-\u03baB p65 nuclear translocation and inhibited the phosphorylation of p38 mitogen-activated protein kinase ("}, "t": {"pos": [3, 4], "type": null, "name": "p38  MAPK)."}}
{"relation": "INHIBITOR", "token": ["Four prenylflavonoids, kurarinone ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and ", "kushenol K", " ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on ", "diacylglycerol acyltransferase", " (DGAT)."], "h": {"pos": [1, 2], "type": null, "name": "kushenol K  ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on "}, "t": {"pos": [3, 4], "type": null, "name": "diacylglycerol acyltransferase  (DGAT)."}}
{"relation": "INHIBITOR", "token": ["We studied mouse osteoblasts alone or in a co-culture with HGC to determine whether ", "TZD", " inhibition of ", "aromatase", " plays a role in their effects on bone metabolism."], "h": {"pos": [1, 2], "type": null, "name": "TZD  inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "aromatase  plays a role in their effects on bone metabolism."}}
{"relation": "INHIBITOR", "token": ["Repression of ", "farnesyltransferase", " (FNTA) by siRNA and the enzyme inhibitor ", "manumycin A", " caused elevation of ApoA-I secretion from hepatocytes and from transgenic mice expressing hApoA-I and cholesterol ester transfer protein transgenes."], "h": {"pos": [1, 2], "type": null, "name": "farnesyltransferase  (FNTA) by siRNA and the enzyme inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "manumycin A  caused elevation of ApoA-I secretion from hepatocytes and from transgenic mice expressing hApoA-I and cholesterol ester transfer protein transgenes."}}
{"relation": "INHIBITOR", "token": ["", "Rasagiline", " [N-propargyl-1R(+)-aminoindan; TVP1012] is a potent irreversible ", "monoamine oxidase", " (MAO) inhibitor with selectivity for type B of the enzyme, which is being developed for treatment of Parkinson's disease."], "h": {"pos": [1, 2], "type": null, "name": "Rasagiline  [N-propargyl-1R(+)-aminoindan; TVP1012] is a potent irreversible "}, "t": {"pos": [3, 4], "type": null, "name": "monoamine oxidase  (MAO) inhibitor with selectivity for type B of the enzyme, which is being developed for treatment of Parkinson's disease."}}
{"relation": "INHIBITOR", "token": ["On the other hand, high doses of okadaic acid (10 ng/mouse, i.c.v.) and cantharidin (1 microg/mouse, i.c.v.), which also block PP1, and ", "calyculin-A", " (0.1 fg/mouse-1 ng/mouse, i.c.v.), which inhibits equally both PP1 and ", "PP2A", ", did not modify the morphine-induced antinociception."], "h": {"pos": [1, 2], "type": null, "name": "calyculin-A  (0.1 fg/mouse-1 ng/mouse, i.c.v.), which inhibits equally both PP1 and "}, "t": {"pos": [3, 4], "type": null, "name": "PP2A , did not modify the morphine-induced antinociception."}}
{"relation": "INHIBITOR", "token": ["TREK-1 currents are insensitive to pharmacological agents that block ", "TWIK-1", " activity such as quinine and ", "quinidine", "."], "h": {"pos": [1, 2], "type": null, "name": "TWIK-1  activity such as quinine and "}, "t": {"pos": [3, 4], "type": null, "name": "quinidine ."}}
{"relation": "INHIBITOR", "token": ["This hypothesis was tested by investigating whether, in subjects with essential hypertension, the natriuretic response to specific ", "renin", "-angiotensin-aldosterone system (RAAS) blockade by renin-inhibitor ", "remikiren", " could be predicted from pretreatment renal vascular tone."], "h": {"pos": [1, 2], "type": null, "name": "renin -angiotensin-aldosterone system (RAAS) blockade by renin-inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "remikiren  could be predicted from pretreatment renal vascular tone."}}
{"relation": "INHIBITOR", "token": ["(-)-6-(7-Methoxy-2-(trifluoromethyl)pyrazolo[1,5-a]pyridin-4-yl)-5-methyl-4,5-dihydropyridazin-3(2H)-one (", "KCA-1490", ") exhibits moderate dual ", "PDE3/4", "-inhibitory activity and promises as a combined bronchodilatory/anti-inflammatory agent."], "h": {"pos": [1, 2], "type": null, "name": "KCA-1490 ) exhibits moderate dual "}, "t": {"pos": [3, 4], "type": null, "name": "PDE3/4 -inhibitory activity and promises as a combined bronchodilatory/anti-inflammatory agent."}}
{"relation": "INHIBITOR", "token": ["", "Sorafenib", " inhibited the kinase activity of both ", "C-RAF", " and B-RAF (wild type and V600E mutant)."], "h": {"pos": [1, 2], "type": null, "name": "Sorafenib  inhibited the kinase activity of both "}, "t": {"pos": [3, 4], "type": null, "name": "C-RAF  and B-RAF (wild type and V600E mutant)."}}
{"relation": "INHIBITOR", "token": ["Gelatin zymography showed that ", "DMBT", " inhibited secretion and activity of ", "MMP-9", "."], "h": {"pos": [1, 2], "type": null, "name": "DMBT  inhibited secretion and activity of "}, "t": {"pos": [3, 4], "type": null, "name": "MMP-9 ."}}
{"relation": "INHIBITOR", "token": ["In this report, we show that the hypolipidemic agent ", "atorvastatin", " is a competitive inhibitor of ", "porcine DPP-IV", " in vitro, with K(i)=57.8+/-2.3 microM."], "h": {"pos": [1, 2], "type": null, "name": "atorvastatin  is a competitive inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "porcine DPP-IV  in vitro, with K(i)=57.8+/-2.3 microM."}}
{"relation": "INHIBITOR", "token": ["", "Rasagiline", " inhibits ", "MAO-B", " more potently than selegiline and has the advantage of once-daily dosing."], "h": {"pos": [1, 2], "type": null, "name": "Rasagiline  inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "MAO-B  more potently than selegiline and has the advantage of once-daily dosing."}}
{"relation": "INHIBITOR", "token": ["It was also antagonized by the non-specific ", "cyclooxygenase", " (COX) inhibitor, ", "indomethacin", ", and by the selective COX-2 inhibitor, NS-398, but not by the specific COX-1 inhibitor, valeryl salicylate."], "h": {"pos": [1, 2], "type": null, "name": "cyclooxygenase  (COX) inhibitor, "}, "t": {"pos": [3, 4], "type": null, "name": "indomethacin , and by the selective COX-2 inhibitor, NS-398, but not by the specific COX-1 inhibitor, valeryl salicylate."}}
{"relation": "INHIBITOR", "token": ["Development and validation of a non-radioactive ", "DNA polymerase", " assay for studying cytomegalovirus resistance to ", "foscarnet", "."], "h": {"pos": [1, 2], "type": null, "name": "DNA polymerase  assay for studying cytomegalovirus resistance to "}, "t": {"pos": [3, 4], "type": null, "name": "foscarnet ."}}
{"relation": "INHIBITOR", "token": ["Blockade of PDE1 (8-methoxymethyl-3-isobutyl-1-methylxanthine, 100 microM), PDE2 [erythro-9-(2-hydroxy-3-nonyl)adenine, 30 microM], PDE3 (milrinone, 10 microM; cGMP, 10 microM), PDE4 (Ro 20-1724 [4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one], 100 microM), ", "PDE5", " and PDE6 (", "zaprinast", ", 30 microM), and PDE7 [BRL-50481 (5-nitro-2,N,N-trimethylbenzenesulfonamide), 10 microM] did not alter renal ecto-phosphodiesterase activity."], "h": {"pos": [1, 2], "type": null, "name": "PDE5  and PDE6 ("}, "t": {"pos": [3, 4], "type": null, "name": "zaprinast , 30 microM), and PDE7 [BRL-50481 (5-nitro-2,N,N-trimethylbenzenesulfonamide), 10 microM] did not alter renal ecto-phosphodiesterase activity."}}
{"relation": "INHIBITOR", "token": ["Synthesis and in vitro evaluation of ", "N-Aryl pyrido-quinazolines", " derivatives as potent ", "EGFR", " inhibitors."], "h": {"pos": [1, 2], "type": null, "name": "N-Aryl pyrido-quinazolines  derivatives as potent "}, "t": {"pos": [3, 4], "type": null, "name": "EGFR  inhibitors."}}
{"relation": "INHIBITOR", "token": ["Based on recent reports that the small molecules, isatin and phthalimide, are suitable scaffolds for the design of high potency monoamine oxidase (MAO) inhibitors, the present study examines the ", "MAO", " inhibitory properties of a series of phthalide ", " 2-benzofuran-1(3H)-one", "] analogues."], "h": {"pos": [1, 2], "type": null, "name": "MAO  inhibitory properties of a series of phthalide "}, "t": {"pos": [3, 4], "type": null, "name": " 2-benzofuran-1(3H)-one ] analogues."}}
{"relation": "INHIBITOR", "token": ["In this study, we assessed the effects of ", "clopidogrel", " and clarithromycin, known ", "CYP2B6", " and CYP3A inhibitors, respectively, on the enantioselective disposition of racemic sibutramine in conjunction with CYP2B6 polymorphisms in humans."], "h": {"pos": [1, 2], "type": null, "name": "clopidogrel  and clarithromycin, known "}, "t": {"pos": [3, 4], "type": null, "name": "CYP2B6  and CYP3A inhibitors, respectively, on the enantioselective disposition of racemic sibutramine in conjunction with CYP2B6 polymorphisms in humans."}}
{"relation": "INHIBITOR", "token": ["Aspirin (", "ASA", ") and other non-steroidal anti-inflammatory drugs, which are cyclooxygenase (", "COX", ") inhibitors, precipitate asthmatic attacks in ASA-intolerant patients, while sodium salicylate, hardly active on COX by itself, is well tolerated by these patients."], "h": {"pos": [1, 2], "type": null, "name": "ASA ) and other non-steroidal anti-inflammatory drugs, which are cyclooxygenase ("}, "t": {"pos": [3, 4], "type": null, "name": "COX ) inhibitors, precipitate asthmatic attacks in ASA-intolerant patients, while sodium salicylate, hardly active on COX by itself, is well tolerated by these patients."}}
{"relation": "INHIBITOR", "token": ["The i.c.v. administration of very low doses of ", "okadaic acid", " (0.001-1 pg/mouse) and cantharidin (0.001-1 ng/mouse), which inhibit ", "PP2A", ", produced a dose-dependent antagonism of the antinociception induced by morphine (s.c.)."], "h": {"pos": [1, 2], "type": null, "name": "okadaic acid  (0.001-1 pg/mouse) and cantharidin (0.001-1 ng/mouse), which inhibit "}, "t": {"pos": [3, 4], "type": null, "name": "PP2A , produced a dose-dependent antagonism of the antinociception induced by morphine (s.c.)."}}
{"relation": "INHIBITOR", "token": ["Further characterization of ", "sorafenib", " revealed that this molecule was a multikinase inhibitor that targeted the vascular endothelial growth factor receptor family (", "VEGFR-2", " and VEGFR-3) and platelet-derived growth factor receptor family (PDGFR-beta and Kit), which play key roles in tumor progression and angiogenesis."], "h": {"pos": [1, 2], "type": null, "name": "sorafenib  revealed that this molecule was a multikinase inhibitor that targeted the vascular endothelial growth factor receptor family ("}, "t": {"pos": [3, 4], "type": null, "name": "VEGFR-2  and VEGFR-3) and platelet-derived growth factor receptor family (PDGFR-beta and Kit), which play key roles in tumor progression and angiogenesis."}}
{"relation": "INHIBITOR", "token": ["Apolipoprotein E3 (apoE3) safeguards pig proximal tubular LLC-PK1 cells against reduction in ", "SGLT1", " activity induced by ", "gentamicin C", "."], "h": {"pos": [1, 2], "type": null, "name": "SGLT1  activity induced by "}, "t": {"pos": [3, 4], "type": null, "name": "gentamicin C ."}}
{"relation": "INHIBITOR", "token": ["The ROS scavenger N-acetyl l-cysteine and the mitochondrial antioxidant Mito-TEMPO rescued the inhibitory effect of ", "cucurbitacin I", " on ", "Rac1", " activation."], "h": {"pos": [1, 2], "type": null, "name": "cucurbitacin I  on "}, "t": {"pos": [3, 4], "type": null, "name": "Rac1  activation."}}
{"relation": "INHIBITOR", "token": ["Moreover, S1611 and ", "S3226", ", both specific inhibitors of ", "NHE3", " only, or perfusion with Na+-free solutions, dose dependently increased DBS, as measured by pH-stat and CO2-sensitive electrode, without affecting intracellular pH."], "h": {"pos": [1, 2], "type": null, "name": "S3226 , both specific inhibitors of "}, "t": {"pos": [3, 4], "type": null, "name": "NHE3  only, or perfusion with Na+-free solutions, dose dependently increased DBS, as measured by pH-stat and CO2-sensitive electrode, without affecting intracellular pH."}}
{"relation": "INHIBITOR", "token": ["Agents that have only begun to undergo clinical evaluation include CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, and ", "PKI166", " and GW572016, both examples of dual kinase inhibitors (inhibiting epidermal growth factor receptor and ", "Her2", ")."], "h": {"pos": [1, 2], "type": null, "name": "PKI166  and GW572016, both examples of dual kinase inhibitors (inhibiting epidermal growth factor receptor and "}, "t": {"pos": [3, 4], "type": null, "name": "Her2 )."}}
{"relation": "INHIBITOR", "token": ["In vitro, ", "minocycline", ", but not doxycycline, inhibits ", "MMP-9", ", at least in part, via the extracellular signaling-related kinase 1/2 (ERK1/2)-mediated pathway."], "h": {"pos": [1, 2], "type": null, "name": "minocycline , but not doxycycline, inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "MMP-9 , at least in part, via the extracellular signaling-related kinase 1/2 (ERK1/2)-mediated pathway."}}
{"relation": "INHIBITOR", "token": ["Indomethacin abolished the inhibitory effect of ", "acetazolamide", " on CA I and ", "CA II", "."], "h": {"pos": [1, 2], "type": null, "name": "acetazolamide  on CA I and "}, "t": {"pos": [3, 4], "type": null, "name": "CA II ."}}
{"relation": "INHIBITOR", "token": ["Together these studies support a unique mode of inhibition in which ", "phenothiazines", " disrupt the ", "S100A4", "/myosin-IIA interaction by sequestering S100A4 via small molecule-induced oligomerization."], "h": {"pos": [1, 2], "type": null, "name": "phenothiazines  disrupt the "}, "t": {"pos": [3, 4], "type": null, "name": "S100A4 /myosin-IIA interaction by sequestering S100A4 via small molecule-induced oligomerization."}}
{"relation": "INHIBITOR", "token": ["Inhibition of ", "mammalian isoforms I-XIV", " with a series of natural product ", "polyphenols", " and phenolic acids."], "h": {"pos": [1, 2], "type": null, "name": "mammalian isoforms I-XIV  with a series of natural product "}, "t": {"pos": [3, 4], "type": null, "name": "polyphenols  and phenolic acids."}}
{"relation": "INHIBITOR", "token": ["In this article, the action of dasatinib (BMS-354825) is contrasted with that of ", "imatinib", ", a ", "kinase", " inhibitor that is currently being used to treat chronic myelogenous leukemia and other disorders."], "h": {"pos": [1, 2], "type": null, "name": "imatinib , a "}, "t": {"pos": [3, 4], "type": null, "name": "kinase  inhibitor that is currently being used to treat chronic myelogenous leukemia and other disorders."}}
{"relation": "INHIBITOR", "token": ["These data suggest that inhibition of ", "JAK2", "/STAT3 signaling is a novel mechanism of action for ", "PTE", " during therapeutic intervention in osteosarcoma cancers."], "h": {"pos": [1, 2], "type": null, "name": "JAK2 /STAT3 signaling is a novel mechanism of action for "}, "t": {"pos": [3, 4], "type": null, "name": "PTE  during therapeutic intervention in osteosarcoma cancers."}}
{"relation": "INHIBITOR", "token": ["The inhibitory effects of iloprost on ", "tissue factor", " expression were also potentiated by isobutylmethylxanthine and mimicked by forskolin and d", "ibutyryl cyclic AMP", " but not dibutyryl cyclic GMP."], "h": {"pos": [1, 2], "type": null, "name": "tissue factor  expression were also potentiated by isobutylmethylxanthine and mimicked by forskolin and d"}, "t": {"pos": [3, 4], "type": null, "name": "ibutyryl cyclic AMP  but not dibutyryl cyclic GMP."}}
{"relation": "INHIBITOR", "token": ["Sorafenib (BAY 43-9006, ", "Nexavar", "), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/", "PDGFR", " in tumor vasculature."], "h": {"pos": [1, 2], "type": null, "name": "Nexavar ), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/"}, "t": {"pos": [3, 4], "type": null, "name": "PDGFR  in tumor vasculature."}}
{"relation": "INHIBITOR", "token": ["(S)-3-(Aminomethyl)-7-(3-hydroxypropoxy)-1-hydroxy-1,3-dihydro-2,1-benzoxaborole (", "GSK2251052", ") is a novel boron-containing antibiotic that inhibits ", "bacterial leucyl tRNA synthetase", ", and that has been in development for the treatment of serious Gram-negative infections."], "h": {"pos": [1, 2], "type": null, "name": "GSK2251052 ) is a novel boron-containing antibiotic that inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "bacterial leucyl tRNA synthetase , and that has been in development for the treatment of serious Gram-negative infections."}}
{"relation": "INHIBITOR", "token": ["OBJECTIVE: Celecoxib and ", "rofecoxib", " are two relatively new nonsteroidal anti-inflammatory drugs (NSAIDs) that selectively inhibit the cyclo-oxygenase-2 (", "COX-2", ") isoenzyme at therapeutic concentrations."], "h": {"pos": [1, 2], "type": null, "name": "rofecoxib  are two relatively new nonsteroidal anti-inflammatory drugs (NSAIDs) that selectively inhibit the cyclo-oxygenase-2 ("}, "t": {"pos": [3, 4], "type": null, "name": "COX-2 ) isoenzyme at therapeutic concentrations."}}
{"relation": "INHIBITOR", "token": ["Although the precise mechanism of the protective action of trilisate is unknown, our data support the possibility of interaction between salicylate and ", "ASA", " on ", "cyclo-oxygenase", " locus in the respiratory tract in ASA-intolerant patients."], "h": {"pos": [1, 2], "type": null, "name": "ASA  on "}, "t": {"pos": [3, 4], "type": null, "name": "cyclo-oxygenase  locus in the respiratory tract in ASA-intolerant patients."}}
{"relation": "INHIBITOR", "token": ["Furthermore, the ", "Panx1", " channel blockers carbenoxolone and ", "Probenecid", " were less effective in inhibiting Panx1 currents when Kvbeta3 was co-expressed."], "h": {"pos": [1, 2], "type": null, "name": "Panx1  channel blockers carbenoxolone and "}, "t": {"pos": [3, 4], "type": null, "name": "Probenecid  were less effective in inhibiting Panx1 currents when Kvbeta3 was co-expressed."}}
{"relation": "INHIBITOR", "token": ["Preclinical pharmacokinetics and in vitro metabolism of dasatinib (", "BMS-354825", "): a potent oral multi-targeted kinase inhibitor against ", "SRC", " and BCR-ABL."], "h": {"pos": [1, 2], "type": null, "name": "BMS-354825 ): a potent oral multi-targeted kinase inhibitor against "}, "t": {"pos": [3, 4], "type": null, "name": "SRC  and BCR-ABL."}}
{"relation": "INHIBITOR", "token": ["Addition of a 6-aryl-4,5-dihydropyridazin-3(2H)-one extension to the ", "N", "-alkyl group facilitates both enhancement of ", "PDE4", "-inhibitory activity and restoration of potent PDE3 inhibition."], "h": {"pos": [1, 2], "type": null, "name": "N -alkyl group facilitates both enhancement of "}, "t": {"pos": [3, 4], "type": null, "name": "PDE4 -inhibitory activity and restoration of potent PDE3 inhibition."}}
{"relation": "INHIBITOR", "token": ["Using standard assays, ", "lumiracoxib", " was found to be a poor inhibitor of purified ", "ovine COX-1", " and a relatively weak inhibitor of purified human COX-2."], "h": {"pos": [1, 2], "type": null, "name": "lumiracoxib  was found to be a poor inhibitor of purified "}, "t": {"pos": [3, 4], "type": null, "name": "ovine COX-1  and a relatively weak inhibitor of purified human COX-2."}}
{"relation": "INHIBITOR", "token": ["To explore for the existence of an auxiliary hydrophobic binding register remote from the active site of PSMA a series of phenylalkylphosphonamidate derivatives of ", "glutamic acid", " were synthesized and evaluated for their inhibitory potencies against ", "PSMA", "."], "h": {"pos": [1, 2], "type": null, "name": "glutamic acid  were synthesized and evaluated for their inhibitory potencies against "}, "t": {"pos": [3, 4], "type": null, "name": "PSMA ."}}
{"relation": "INHIBITOR", "token": ["Endogenously produced asymmetrically methylated ", "arginine", " residues are competitive inhibitors of all three isoforms of nitric oxide synthase (", "NOS", ")."], "h": {"pos": [1, 2], "type": null, "name": "arginine  residues are competitive inhibitors of all three isoforms of nitric oxide synthase ("}, "t": {"pos": [3, 4], "type": null, "name": "NOS )."}}
{"relation": "INHIBITOR", "token": ["The acetylcholinesterase (", "AChE", ") and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ ", "4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine", " (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."], "h": {"pos": [1, 2], "type": null, "name": "AChE ) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ "}, "t": {"pos": [3, 4], "type": null, "name": "4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine  (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."}}
{"relation": "INHIBITOR", "token": ["Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=", "galanthamine", " >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of ", "acetylcholinesterase", " also displaced [3H]-oxotremorine-M to the greatest extent."], "h": {"pos": [1, 2], "type": null, "name": "galanthamine  >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of "}, "t": {"pos": [3, 4], "type": null, "name": "acetylcholinesterase  also displaced [3H]-oxotremorine-M to the greatest extent."}}
{"relation": "INHIBITOR", "token": ["Chronic insulin (24 h) activates NHE3 through the classic phosphatidylinositol 3-kinase-serum- and glucocorticoid-dependent kinase 1 (PI3K-SGK1) pathway as insulin stimulates SGK1 phosphorylation and the insulin effect can be blocked by the ", "PI3K", " inhibitor ", "wortmannin", " or a dominant-negative SGK1."], "h": {"pos": [1, 2], "type": null, "name": "PI3K  inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "wortmannin  or a dominant-negative SGK1."}}
{"relation": "INHIBITOR", "token": ["", "Indomethacin", " and SC-236, a selective cyclooxygenase-2 (", "COX-2", ") inhibitor, exerted a similar effect as sulindac."], "h": {"pos": [1, 2], "type": null, "name": "Indomethacin  and SC-236, a selective cyclooxygenase-2 ("}, "t": {"pos": [3, 4], "type": null, "name": "COX-2 ) inhibitor, exerted a similar effect as sulindac."}}
{"relation": "INHIBITOR", "token": ["One exception is ", "tranexamic acid", " (TXA), which, as a lysine mimetic, inhibits binding of plasminogen to ", "fibrin", "."], "h": {"pos": [1, 2], "type": null, "name": "tranexamic acid  (TXA), which, as a lysine mimetic, inhibits binding of plasminogen to "}, "t": {"pos": [3, 4], "type": null, "name": "fibrin ."}}
{"relation": "INHIBITOR", "token": ["First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, ", "TOP2", "-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, ", "mitoxantrone", ", and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected."], "h": {"pos": [1, 2], "type": null, "name": "TOP2 -mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, "}, "t": {"pos": [3, 4], "type": null, "name": "mitoxantrone , and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected."}}
{"relation": "INHIBITOR", "token": ["Preclinical pharmacokinetics and in vitro metabolism of ", "dasatinib", " (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and ", "BCR", "-ABL."], "h": {"pos": [1, 2], "type": null, "name": "dasatinib  (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and "}, "t": {"pos": [3, 4], "type": null, "name": "BCR -ABL."}}
{"relation": "INHIBITOR", "token": ["We also observed that ", "fisetin", " efficiently suppressed the phosphorylation of Akt, ", "S6K1", " and mTORC1 in adipose tissue."], "h": {"pos": [1, 2], "type": null, "name": "fisetin  efficiently suppressed the phosphorylation of Akt, "}, "t": {"pos": [3, 4], "type": null, "name": "S6K1  and mTORC1 in adipose tissue."}}
{"relation": "INHIBITOR", "token": ["", "Catecholamines", " (adrenaline, noradrenaline and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase (phenylalanine hydroxylase, ", "EC 1.14.16.1", ")."], "h": {"pos": [1, 2], "type": null, "name": "Catecholamines  (adrenaline, noradrenaline and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase (phenylalanine hydroxylase, "}, "t": {"pos": [3, 4], "type": null, "name": "EC 1.14.16.1 )."}}
{"relation": "INHIBITOR", "token": ["We used mutagenesis of these residues, combined with an investigation of ", "hERG", " block by close analogs of clofilium and ", "ibutilide", ", to assess how specific alterations in drug structure affected potency and binding interactions."], "h": {"pos": [1, 2], "type": null, "name": "hERG  block by close analogs of clofilium and "}, "t": {"pos": [3, 4], "type": null, "name": "ibutilide , to assess how specific alterations in drug structure affected potency and binding interactions."}}
{"relation": "INHIBITOR", "token": ["In addition, the new compound perviridicin B (2), three known rocaglate derivatives (9, 11, 12), and a known ", "sesquiterpene", ", 2-oxaisodauc-5-en-12-al (17), showed significant NF-\u03baB (", "p65", ") inhibitory activity in an ELISA assay."], "h": {"pos": [1, 2], "type": null, "name": "sesquiterpene , 2-oxaisodauc-5-en-12-al (17), showed significant NF-\u03baB ("}, "t": {"pos": [3, 4], "type": null, "name": "p65 ) inhibitory activity in an ELISA assay."}}
{"relation": "INHIBITOR", "token": ["Enalkiren (", "A-64662", "), a potent, dipeptide renin inhibitor, mimics the transition state of the ", "human renin", " substrate, angiotensinogen."], "h": {"pos": [1, 2], "type": null, "name": "A-64662 ), a potent, dipeptide renin inhibitor, mimics the transition state of the "}, "t": {"pos": [3, 4], "type": null, "name": "human renin  substrate, angiotensinogen."}}
{"relation": "INHIBITOR", "token": ["The chemical identity and position of the substituents on the lower ", "aniline", " ring were important in determining the potency and extent of ", "COX", " inhibition as well as COX-2 selectivity."], "h": {"pos": [1, 2], "type": null, "name": "aniline  ring were important in determining the potency and extent of "}, "t": {"pos": [3, 4], "type": null, "name": "COX  inhibition as well as COX-2 selectivity."}}
{"relation": "INHIBITOR", "token": ["In the presence of the system L inhibitor BCH, Na(+)-dependent l-alanine uptake in WKY and SHR PTE cells was inhibited by ", "alanine", ", serine, and cysteine, which is consistent with amino acid transport through ", "ASCT2", "."], "h": {"pos": [1, 2], "type": null, "name": "alanine , serine, and cysteine, which is consistent with amino acid transport through "}, "t": {"pos": [3, 4], "type": null, "name": "ASCT2 ."}}
{"relation": "INHIBITOR", "token": ["Mechanisms of Glucose Lowering of ", "Dipeptidyl Peptidase-4", " Inhibitor ", "Sitagliptin", " When Used Alone or With Metformin in Type 2 Diabetes: A double-tracer study."], "h": {"pos": [1, 2], "type": null, "name": "Dipeptidyl Peptidase-4  Inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "Sitagliptin  When Used Alone or With Metformin in Type 2 Diabetes: A double-tracer study."}}
{"relation": "INHIBITOR", "token": ["The selective ", "norepinephrine (NE) transporter", " inhibitor ", "atomoxetine", " (formerly called tomoxetine or LY139603) has been shown to alleviate symptoms in Attention Deficit/Hyperactivity Disorder (ADHD)."], "h": {"pos": [1, 2], "type": null, "name": "norepinephrine (NE) transporter  inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "atomoxetine  (formerly called tomoxetine or LY139603) has been shown to alleviate symptoms in Attention Deficit/Hyperactivity Disorder (ADHD)."}}
{"relation": "INHIBITOR", "token": ["Inhibition of gelatinase A (", "MMP-2", ") by batimastat and ", "captopril", " reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma."], "h": {"pos": [1, 2], "type": null, "name": "MMP-2 ) by batimastat and "}, "t": {"pos": [3, 4], "type": null, "name": "captopril  reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma."}}
{"relation": "INHIBITOR", "token": ["Moreover, the rank order for potency in inhibiting ", "acetylcholinesterase", " (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>", "gramine", ") indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent."], "h": {"pos": [1, 2], "type": null, "name": "acetylcholinesterase  (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>"}, "t": {"pos": [3, 4], "type": null, "name": "gramine ) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent."}}
{"relation": "INHIBITOR", "token": ["In catalytic properties, mouse CA V is closest to CA I; however, in inhibition by ", "acetazolamide", ", ethoxzolamide, and cyanate, ", "CA V", " is very similar to CA II."], "h": {"pos": [1, 2], "type": null, "name": "acetazolamide , ethoxzolamide, and cyanate, "}, "t": {"pos": [3, 4], "type": null, "name": "CA V  is very similar to CA II."}}
{"relation": "INHIBITOR", "token": ["OBJECTIVE: To evaluate the extent of ", "human cyclooxygenase-1", " (COX-1) inhibition by ", "meloxicam", ", which has been reported to preferentially inhibit cyclooxygenase-2 (COX-2)."], "h": {"pos": [1, 2], "type": null, "name": "human cyclooxygenase-1  (COX-1) inhibition by "}, "t": {"pos": [3, 4], "type": null, "name": "meloxicam , which has been reported to preferentially inhibit cyclooxygenase-2 (COX-2)."}}
{"relation": "INHIBITOR", "token": ["The inhibitory effect of PGE1 or sulprostone was prevented by pretreatment with pertussis toxin [islet activating protein (IAP)] or phorbol-12-myristate-13-acetate (PMA), and the ", "protein kinase C", " (PKC) inhibitor ", "chelerythrine", " blocked the action of PMA."], "h": {"pos": [1, 2], "type": null, "name": "protein kinase C  (PKC) inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "chelerythrine  blocked the action of PMA."}}
{"relation": "INHIBITOR", "token": ["Collectively, these results suggest that inhibition of ", "mTORC1", " signaling by ", "fisetin", " prevents adipocyte differentiation of 3T3-L1 preadipocytes and obesity in HFD-fed mice."], "h": {"pos": [1, 2], "type": null, "name": "mTORC1  signaling by "}, "t": {"pos": [3, 4], "type": null, "name": "fisetin  prevents adipocyte differentiation of 3T3-L1 preadipocytes and obesity in HFD-fed mice."}}
{"relation": "INHIBITOR", "token": ["They included the COX-1 inhibitor indomethacin; the COX-2 inhibitor NS-398; the mixed COX-1/COX-2 inhibitor ibuprofen; the nitric oxide (NO) derivatives of indomethacin, ibuprofen and flurbiprofen; the 5-LOX inhibitor REV 5901; and the 5-LOX activating protein (", "FLAP", ") inhibitor ", "MK-886", "."], "h": {"pos": [1, 2], "type": null, "name": "FLAP ) inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "MK-886 ."}}
{"relation": "INHIBITOR", "token": ["Guided by the ", "acetylcholinesterase", " inhibiting activity, the bisindole alkaloid ", "3'-R/S-hydroxyvoacamine", " was isolated from a stem extract of Tabernaemontana divaricata, a plant used in Thailand in traditional rejuvenation remedies for improving the memory."], "h": {"pos": [1, 2], "type": null, "name": "acetylcholinesterase  inhibiting activity, the bisindole alkaloid "}, "t": {"pos": [3, 4], "type": null, "name": "3'-R/S-hydroxyvoacamine  was isolated from a stem extract of Tabernaemontana divaricata, a plant used in Thailand in traditional rejuvenation remedies for improving the memory."}}
{"relation": "INHIBITOR", "token": ["DHODH inhibition occurs at lower concentrations of ", "A77 1726", " than that of ", "tyrosine kinases", " and is currently considered the major mode of action."], "h": {"pos": [1, 2], "type": null, "name": "A77 1726  than that of "}, "t": {"pos": [3, 4], "type": null, "name": "tyrosine kinases  and is currently considered the major mode of action."}}
{"relation": "INHIBITOR", "token": ["", "Pterostilbene", " exerts antitumor activity against human osteosarcoma cells by inhibiting the ", "JAK2", "/STAT3 signaling pathway."], "h": {"pos": [1, 2], "type": null, "name": "Pterostilbene  exerts antitumor activity against human osteosarcoma cells by inhibiting the "}, "t": {"pos": [3, 4], "type": null, "name": "JAK2 /STAT3 signaling pathway."}}
{"relation": "INHIBITOR", "token": ["Chelation of calcium ions by BAPTA-AM or blockade of ", "ERK1/2", " activation by ", "UO126", " also prevented the NMDA effects."], "h": {"pos": [1, 2], "type": null, "name": "ERK1/2  activation by "}, "t": {"pos": [3, 4], "type": null, "name": "UO126  also prevented the NMDA effects."}}
{"relation": "INHIBITOR", "token": ["MXF or ", "VP-16", " slightly affected cellular topo II activity in nuclear extracts derived from drug-treated cells while the combination enhanced inhibitory activity and the reduction in band depletion of ", "topo II", "."], "h": {"pos": [1, 2], "type": null, "name": "VP-16  slightly affected cellular topo II activity in nuclear extracts derived from drug-treated cells while the combination enhanced inhibitory activity and the reduction in band depletion of "}, "t": {"pos": [3, 4], "type": null, "name": "topo II ."}}
{"relation": "INHIBITOR", "token": ["Interestingly, a Val-349 to Ile mutant was inhibited with equal potency to ", "human COX-2", " with 2,6-dichloro-, 2,6-dimethyl-, or ", "2-chloro-6-methyl", "-substituted inhibitors and, in the case of lumiracoxib, actually showed an increase in potency."], "h": {"pos": [1, 2], "type": null, "name": "human COX-2  with 2,6-dichloro-, 2,6-dimethyl-, or "}, "t": {"pos": [3, 4], "type": null, "name": "2-chloro-6-methyl -substituted inhibitors and, in the case of lumiracoxib, actually showed an increase in potency."}}
{"relation": "INHIBITOR", "token": ["We have examined the effect of dihydropyridine ", "Ca2+-channel", " blockers felodipine and ", "nicardipine", " on CaMPDE."], "h": {"pos": [1, 2], "type": null, "name": "Ca2+-channel  blockers felodipine and "}, "t": {"pos": [3, 4], "type": null, "name": "nicardipine  on CaMPDE."}}
{"relation": "INHIBITOR", "token": ["Recent studies have reported that ", "imatinib mesylate", ", a kinase inhibitor that targets the intracellular ", "tyrosine kinase", " BCR-ABL and the platelet derived growth factor (PDGF) receptor, is an effective inhibitor of the macrophage colony stimulating factor (M-CSF) receptor, c-FMS."], "h": {"pos": [1, 2], "type": null, "name": "imatinib mesylate , a kinase inhibitor that targets the intracellular "}, "t": {"pos": [3, 4], "type": null, "name": "tyrosine kinase  BCR-ABL and the platelet derived growth factor (PDGF) receptor, is an effective inhibitor of the macrophage colony stimulating factor (M-CSF) receptor, c-FMS."}}
{"relation": "INHIBITOR", "token": ["A phase III randomized placebo-controlled trial has examined the impact of everolimus in patients with clear cell renal cancers and progressive disease on or within 6 months of the VEGFR ", "tyrosine kinase", " inhibitors sunitinib and/or ", "sorafenib", "."], "h": {"pos": [1, 2], "type": null, "name": "tyrosine kinase  inhibitors sunitinib and/or "}, "t": {"pos": [3, 4], "type": null, "name": "sorafenib ."}}
{"relation": "INHIBITOR", "token": ["", "Sorafenib", " (BAY 43-9006, Nexavar), a dual-action inhibitor that targets ", "RAF", "/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature."], "h": {"pos": [1, 2], "type": null, "name": "Sorafenib  (BAY 43-9006, Nexavar), a dual-action inhibitor that targets "}, "t": {"pos": [3, 4], "type": null, "name": "RAF /MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature."}}
{"relation": "INHIBITOR", "token": ["Existing ", "ion channel", " blockers, such as ", "amiodarone", ", dronedarone, bepridil, aprindine, and cibenzoline, have been found to have an NCX inhibitory action."], "h": {"pos": [1, 2], "type": null, "name": "ion channel  blockers, such as "}, "t": {"pos": [3, 4], "type": null, "name": "amiodarone , dronedarone, bepridil, aprindine, and cibenzoline, have been found to have an NCX inhibitory action."}}
{"relation": "INHIBITOR", "token": ["The acetylcholinesterase (AChE) and ", "butyrylcholinesterase", " (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), ", "4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline", " (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."], "h": {"pos": [1, 2], "type": null, "name": "butyrylcholinesterase  (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), "}, "t": {"pos": [3, 4], "type": null, "name": "4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline  (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."}}
{"relation": "INHIBITOR", "token": ["In this study, we assessed the effects of ", "clopidogrel", " and clarithromycin, known CYP2B6 and ", "CYP3A", " inhibitors, respectively, on the enantioselective disposition of racemic sibutramine in conjunction with CYP2B6 polymorphisms in humans."], "h": {"pos": [1, 2], "type": null, "name": "clopidogrel  and clarithromycin, known CYP2B6 and "}, "t": {"pos": [3, 4], "type": null, "name": "CYP3A  inhibitors, respectively, on the enantioselective disposition of racemic sibutramine in conjunction with CYP2B6 polymorphisms in humans."}}
{"relation": "INHIBITOR", "token": ["ATB-429-induced antinociception was reversed by ", "glibenclamide", ", a ", "ATP-sensitive K(+) (K(ATP)) channel", " inhibitor."], "h": {"pos": [1, 2], "type": null, "name": "glibenclamide , a "}, "t": {"pos": [3, 4], "type": null, "name": "ATP-sensitive K(+) (K(ATP)) channel  inhibitor."}}
{"relation": "INHIBITOR", "token": ["Based on recent reports that the small molecules, isatin and ", "phthalimide", ", are suitable scaffolds for the design of high potency ", "monoamine oxidase", " (MAO) inhibitors, the present study examines the MAO inhibitory properties of a series of phthalide [2-benzofuran-1(3H)-one] analogues."], "h": {"pos": [1, 2], "type": null, "name": "phthalimide , are suitable scaffolds for the design of high potency "}, "t": {"pos": [3, 4], "type": null, "name": "monoamine oxidase  (MAO) inhibitors, the present study examines the MAO inhibitory properties of a series of phthalide [2-benzofuran-1(3H)-one] analogues."}}
{"relation": "INHIBITOR", "token": ["Mitochondrial ", "glutathione (GSH) reductase", " activity and the GSH/glutathione disulfide ratio were decreased by ", "TCDD", ", ultimately leading to mitochondrial dysfunction, characterized by decreased inner mitochondrial membrane potential and ATP production, and increased production of the reactive oxygen species (ROS), hydrogen peroxide."], "h": {"pos": [1, 2], "type": null, "name": "glutathione (GSH) reductase  activity and the GSH/glutathione disulfide ratio were decreased by "}, "t": {"pos": [3, 4], "type": null, "name": "TCDD , ultimately leading to mitochondrial dysfunction, characterized by decreased inner mitochondrial membrane potential and ATP production, and increased production of the reactive oxygen species (ROS), hydrogen peroxide."}}
{"relation": "INHIBITOR", "token": ["PURPOSE: To compare phenelzine (PLZ), an antidepressant drug with anxiolytic properties which inhibits monoamine oxidase (MAO) but also elevates rat brain levels of the amino acids ?-aminobutyric acid (GABA) and alanine (ALA), with vigabatrin (", "VIG", "), an anticonvulsant which elevates brain GABA by inhibition of ", "GABA transaminase", " (GABA-T), with regard to their actions on brain levels of GABA and ALA and on activities of MAO, GABA-T and ALA transaminase (ALA-T)."], "h": {"pos": [1, 2], "type": null, "name": "VIG ), an anticonvulsant which elevates brain GABA by inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "GABA transaminase  (GABA-T), with regard to their actions on brain levels of GABA and ALA and on activities of MAO, GABA-T and ALA transaminase (ALA-T)."}}
{"relation": "INHIBITOR", "token": ["", "MXF", " or VP-16 slightly affected cellular topo II activity in nuclear extracts derived from drug-treated cells while the combination enhanced inhibitory activity and the reduction in band depletion of ", "topo II", "."], "h": {"pos": [1, 2], "type": null, "name": "MXF  or VP-16 slightly affected cellular topo II activity in nuclear extracts derived from drug-treated cells while the combination enhanced inhibitory activity and the reduction in band depletion of "}, "t": {"pos": [3, 4], "type": null, "name": "topo II ."}}
{"relation": "INHIBITOR", "token": ["", "Troglitazone", ", a second ACS4 inhibitor, inhibited ", "ACS", " activity <10% in microsomes and mitochondria and 45% in MAM."], "h": {"pos": [1, 2], "type": null, "name": "Troglitazone , a second ACS4 inhibitor, inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "ACS  activity <10% in microsomes and mitochondria and 45% in MAM."}}
{"relation": "INHIBITOR", "token": ["", "Vandetanib", " (Caprelsa(\u00ae), AstraZeneca) is a once-daily oral tyrosine kinase inhibitor that selectively inhibits signalling mediated by ", "growth-factor receptor tyrosine kinase", " RET (constitutively activated in roughly 60\u00a0% of all MTCs), vascular endothelial growth-factor receptors 2 and 3, and epidermal growth-factor receptors."], "h": {"pos": [1, 2], "type": null, "name": "Vandetanib  (Caprelsa(\u00ae), AstraZeneca) is a once-daily oral tyrosine kinase inhibitor that selectively inhibits signalling mediated by "}, "t": {"pos": [3, 4], "type": null, "name": "growth-factor receptor tyrosine kinase  RET (constitutively activated in roughly 60\u00a0% of all MTCs), vascular endothelial growth-factor receptors 2 and 3, and epidermal growth-factor receptors."}}
{"relation": "INHIBITOR", "token": ["Chronic insulin (24 h) activates NHE3 through the classic phosphatidylinositol 3-kinase-serum- and glucocorticoid-dependent kinase 1 (", "PI3K", "-SGK1) pathway as insulin stimulates SGK1 phosphorylation and the insulin effect can be blocked by the PI3K inhibitor ", "wortmannin", " or a dominant-negative SGK1."], "h": {"pos": [1, 2], "type": null, "name": "PI3K -SGK1) pathway as insulin stimulates SGK1 phosphorylation and the insulin effect can be blocked by the PI3K inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "wortmannin  or a dominant-negative SGK1."}}
{"relation": "INHIBITOR", "token": ["", "Orlistat", ", a new ", "lipase", " inhibitor for the management of obesity."], "h": {"pos": [1, 2], "type": null, "name": "Orlistat , a new "}, "t": {"pos": [3, 4], "type": null, "name": "lipase  inhibitor for the management of obesity."}}
{"relation": "INHIBITOR", "token": ["We have examined the effect of ", "dihydropyridine", " ", "Ca2+-channel", " blockers felodipine and nicardipine on CaMPDE."], "h": {"pos": [1, 2], "type": null, "name": "dihydropyridine  "}, "t": {"pos": [3, 4], "type": null, "name": "Ca2+-channel  blockers felodipine and nicardipine on CaMPDE."}}
{"relation": "INHIBITOR", "token": ["Many clinical studies, both pre- and post-marketing, have demonstrated the clinical efficacy and safety of ", "sildenafil", " (Viagra, Pfizer) - the first approved selective ", "PDE", " inhibitor for the treatment of ED."], "h": {"pos": [1, 2], "type": null, "name": "sildenafil  (Viagra, Pfizer) - the first approved selective "}, "t": {"pos": [3, 4], "type": null, "name": "PDE  inhibitor for the treatment of ED."}}
{"relation": "INHIBITOR", "token": ["Preclinical pharmacokinetics and in vitro metabolism of dasatinib (", "BMS-354825", "): a potent oral multi-targeted ", "kinase", " inhibitor against SRC and BCR-ABL."], "h": {"pos": [1, 2], "type": null, "name": "BMS-354825 ): a potent oral multi-targeted "}, "t": {"pos": [3, 4], "type": null, "name": "kinase  inhibitor against SRC and BCR-ABL."}}
{"relation": "INHIBITOR", "token": ["The acetylcholinesterase (AChE) and butyrylcholinesterase (", "BuChE", ") inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ ", "4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine", " (16) are described."], "h": {"pos": [1, 2], "type": null, "name": "BuChE ) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ "}, "t": {"pos": [3, 4], "type": null, "name": "4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine  (16) are described."}}
{"relation": "INHIBITOR", "token": ["Cross-inhibition of ", "SR-BI", "- and ABCA1-mediated cholesterol transport by the small molecules BLT-4 and ", "glyburide", "."], "h": {"pos": [1, 2], "type": null, "name": "SR-BI - and ABCA1-mediated cholesterol transport by the small molecules BLT-4 and "}, "t": {"pos": [3, 4], "type": null, "name": "glyburide ."}}
{"relation": "INHIBITOR", "token": ["In this study, we have synthesized novel alpha-hydroxyphenylamide analogues of ", "diphenylhydantoin", " and examined their ability to inhibit ", "human Na(V)1.5", " sodium channels expressed in Chinese Hamster Ovary (CHO-K1) cells."], "h": {"pos": [1, 2], "type": null, "name": "diphenylhydantoin  and examined their ability to inhibit "}, "t": {"pos": [3, 4], "type": null, "name": "human Na(V)1.5  sodium channels expressed in Chinese Hamster Ovary (CHO-K1) cells."}}
{"relation": "INHIBITOR", "token": ["", "Sulindac sulfide", " inhibits ", "epidermal growth factor", "-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells."], "h": {"pos": [1, 2], "type": null, "name": "Sulindac sulfide  inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "epidermal growth factor -induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells."}}
{"relation": "INHIBITOR", "token": ["", "Sorafenib", " inhibited the kinase activity of both C-RAF and B-RAF (wild type and ", "V600E", " mutant)."], "h": {"pos": [1, 2], "type": null, "name": "Sorafenib  inhibited the kinase activity of both C-RAF and B-RAF (wild type and "}, "t": {"pos": [3, 4], "type": null, "name": "V600E  mutant)."}}
{"relation": "INHIBITOR", "token": ["Block of human NaV1.5 ", "sodium channels", " by novel alpha-hydroxyphenylamide analogues of ", "phenytoin", "."], "h": {"pos": [1, 2], "type": null, "name": "sodium channels  by novel alpha-hydroxyphenylamide analogues of "}, "t": {"pos": [3, 4], "type": null, "name": "phenytoin ."}}
{"relation": "INHIBITOR", "token": ["The selective PDE 4 inhibitors, and to a certain extent the ", "PDE3", " inhibitors amrinone and ", "milrinone", ", reduced the GM-CSF release in a concentration dependent manner."], "h": {"pos": [1, 2], "type": null, "name": "PDE3  inhibitors amrinone and "}, "t": {"pos": [3, 4], "type": null, "name": "milrinone , reduced the GM-CSF release in a concentration dependent manner."}}
{"relation": "INHIBITOR", "token": ["", "Licofelone", ", a dual anti-inflammatory drug that inhibits 5-lipoxygenase (LOX) and cyclooxygenase (", "COX", ") enzymes, may have a better cardiovascular profile that cycloxygenase-2 inhibitors due to cycloxygenase-1 blockade-mediated antithrombotic effect and a better gastrointestinal tolerability."], "h": {"pos": [1, 2], "type": null, "name": "Licofelone , a dual anti-inflammatory drug that inhibits 5-lipoxygenase (LOX) and cyclooxygenase ("}, "t": {"pos": [3, 4], "type": null, "name": "COX ) enzymes, may have a better cardiovascular profile that cycloxygenase-2 inhibitors due to cycloxygenase-1 blockade-mediated antithrombotic effect and a better gastrointestinal tolerability."}}
{"relation": "INHIBITOR", "token": ["The effects of meloxicam were compared with those of ", "diclofenac", ", a nonselective ", "COX", " inhibitor."], "h": {"pos": [1, 2], "type": null, "name": "diclofenac , a nonselective "}, "t": {"pos": [3, 4], "type": null, "name": "COX  inhibitor."}}
{"relation": "INHIBITOR", "token": ["Add-on therapy with the ", "DPP-4", " inhibitor ", "sitagliptin", " improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus."], "h": {"pos": [1, 2], "type": null, "name": "DPP-4  inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "sitagliptin  improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus."}}
{"relation": "INHIBITOR", "token": ["", "Carbonic anhydrase", " inhibitors: ", "aromatic and heterocyclic sulfonamides", " incorporating adamantyl moieties with strong anticonvulsant activity."], "h": {"pos": [1, 2], "type": null, "name": "Carbonic anhydrase  inhibitors: "}, "t": {"pos": [3, 4], "type": null, "name": "aromatic and heterocyclic sulfonamides  incorporating adamantyl moieties with strong anticonvulsant activity."}}
{"relation": "INHIBITOR", "token": ["Similarly, felodipine and the ", "p-chloro", " analogue blocked ", "myosin", " filament assembly induced by low concentrations of calmodulin, whereas the oxidized and t-butyl analogues did not."], "h": {"pos": [1, 2], "type": null, "name": "p-chloro  analogue blocked "}, "t": {"pos": [3, 4], "type": null, "name": "myosin  filament assembly induced by low concentrations of calmodulin, whereas the oxidized and t-butyl analogues did not."}}
{"relation": "INHIBITOR", "token": ["The acetylcholinesterase (AChE) and butyrylcholinesterase (", "BuChE", ") inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), ", "4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline", " (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."], "h": {"pos": [1, 2], "type": null, "name": "BuChE ) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), "}, "t": {"pos": [3, 4], "type": null, "name": "4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline  (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."}}
{"relation": "INHIBITOR", "token": ["Furthermore, ", "BRN-250", " inhibited the VEGF-induced phosphorylation and intracellular ", "tyrosine kinase", " activity of VEGF receptor 2 (VEGFR2) and the activation of its downstream AKT pathway."], "h": {"pos": [1, 2], "type": null, "name": "BRN-250  inhibited the VEGF-induced phosphorylation and intracellular "}, "t": {"pos": [3, 4], "type": null, "name": "tyrosine kinase  activity of VEGF receptor 2 (VEGFR2) and the activation of its downstream AKT pathway."}}
{"relation": "INHIBITOR", "token": ["Sorafenib (", "BAY 43-9006", ", Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and ", "tyrosine kinases", " VEGFR/PDGFR in tumor vasculature."], "h": {"pos": [1, 2], "type": null, "name": "BAY 43-9006 , Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and "}, "t": {"pos": [3, 4], "type": null, "name": "tyrosine kinases  VEGFR/PDGFR in tumor vasculature."}}
{"relation": "INHIBITOR", "token": ["This study explored whether ", "curcumin", " improves colonic inflammation in a rat colitis model through inhibition of the TLR4/", "NF-\u03baB", " signaling pathway and IL-27 expression."], "h": {"pos": [1, 2], "type": null, "name": "curcumin  improves colonic inflammation in a rat colitis model through inhibition of the TLR4/"}, "t": {"pos": [3, 4], "type": null, "name": "NF-\u03baB  signaling pathway and IL-27 expression."}}
{"relation": "INHIBITOR", "token": ["The Trx mimetics peptides (TXM) protected insulinoma INS 832/13 cells from oxidative stress induced by selectively inhibiting ", "TrxR", " with auranofin (", "AuF", ")."], "h": {"pos": [1, 2], "type": null, "name": "TrxR  with auranofin ("}, "t": {"pos": [3, 4], "type": null, "name": "AuF )."}}
{"relation": "INHIBITOR", "token": ["In ex vivo experiments with tumor cells from refractory chronic lymphoblastic leukemia, dose-dependent ", "CDK2", " inhibition associated with apoptotic changes was seen at concentrations greater than 100 nM of ", "flavopiridol", "."], "h": {"pos": [1, 2], "type": null, "name": "CDK2  inhibition associated with apoptotic changes was seen at concentrations greater than 100 nM of "}, "t": {"pos": [3, 4], "type": null, "name": "flavopiridol ."}}
{"relation": "INHIBITOR", "token": ["Sorafenib (", "BAY 43-9006", ", Nexavar), a dual-action inhibitor that targets ", "RAF", "/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature."], "h": {"pos": [1, 2], "type": null, "name": "BAY 43-9006 , Nexavar), a dual-action inhibitor that targets "}, "t": {"pos": [3, 4], "type": null, "name": "RAF /MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature."}}
{"relation": "INHIBITOR", "token": ["Importantly, pre-treatment with buthionine sulfoximine (", "BSO", "), an inhibitor of ", "\u03b3-GCS", ", prevented \u03b1-MeDA induced increase in GSH levels, but did not augment this metabolite cytotoxicity."], "h": {"pos": [1, 2], "type": null, "name": "BSO ), an inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "\u03b3-GCS , prevented \u03b1-MeDA induced increase in GSH levels, but did not augment this metabolite cytotoxicity."}}
{"relation": "INHIBITOR", "token": ["In vitro, ", "acetaminophen", " elicited a 4.4-fold selectivity toward COX-2 inhibition (IC(50)=113.7 micromol/L for COX-1; IC(50)=25.8 micromol/L for ", "COX-2", ")."], "h": {"pos": [1, 2], "type": null, "name": "acetaminophen  elicited a 4.4-fold selectivity toward COX-2 inhibition (IC(50)=113.7 micromol/L for COX-1; IC(50)=25.8 micromol/L for "}, "t": {"pos": [3, 4], "type": null, "name": "COX-2 )."}}
{"relation": "INHIBITOR", "token": ["Calmodulin was relatively ineffective in preventing inhibition of ", "cAMP phosphodiesterase", " by ", "felodipine", " and the p-chloro analogue."], "h": {"pos": [1, 2], "type": null, "name": "cAMP phosphodiesterase  by "}, "t": {"pos": [3, 4], "type": null, "name": "felodipine  and the p-chloro analogue."}}
{"relation": "INHIBITOR", "token": ["Here, we show that one ", "BLT", ", [1-(2-methoxy-phenyl)-3-naphthalen-2-yl-urea] (BLT-4), blocked ", "ABCA1", "-mediated cholesterol efflux to lipid-poor apoA-I at a potency similar to that for its inhibition of SR-BI (IC(50) approximately 55-60 microM)."], "h": {"pos": [1, 2], "type": null, "name": "BLT , [1-(2-methoxy-phenyl)-3-naphthalen-2-yl-urea] (BLT-4), blocked "}, "t": {"pos": [3, 4], "type": null, "name": "ABCA1 -mediated cholesterol efflux to lipid-poor apoA-I at a potency similar to that for its inhibition of SR-BI (IC(50) approximately 55-60 microM)."}}
{"relation": "INHIBITOR", "token": ["", "Indomethacin", " and SC-236, a selective ", "cyclooxygenase-2", " (COX-2) inhibitor, exerted a similar effect as sulindac."], "h": {"pos": [1, 2], "type": null, "name": "Indomethacin  and SC-236, a selective "}, "t": {"pos": [3, 4], "type": null, "name": "cyclooxygenase-2  (COX-2) inhibitor, exerted a similar effect as sulindac."}}
{"relation": "INHIBITOR", "token": ["Importantly, the carboxylic acid of ", "JY-3-094", " improves the physicochemical properties of the lead compound, which will facilitate the incorporation of additional hydrophobicity that might enhance ", "Myc", " inhibitory activity further still."], "h": {"pos": [1, 2], "type": null, "name": "JY-3-094  improves the physicochemical properties of the lead compound, which will facilitate the incorporation of additional hydrophobicity that might enhance "}, "t": {"pos": [3, 4], "type": null, "name": "Myc  inhibitory activity further still."}}
{"relation": "INHIBITOR", "token": ["The acetylcholinesterase (AChE) and ", "butyrylcholinesterase", " (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ ", "4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine", " (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."], "h": {"pos": [1, 2], "type": null, "name": "butyrylcholinesterase  (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ "}, "t": {"pos": [3, 4], "type": null, "name": "4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine  (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."}}
{"relation": "INHIBITOR", "token": ["Considerable attention has focused on the antitumor effect of ", "histone deacetylase", " inhibitor (", "Trichostatin A", ", TSA) as well as the coding gene expression-induced apoptosis of cancer cells."], "h": {"pos": [1, 2], "type": null, "name": "histone deacetylase  inhibitor ("}, "t": {"pos": [3, 4], "type": null, "name": "Trichostatin A , TSA) as well as the coding gene expression-induced apoptosis of cancer cells."}}
{"relation": "INHIBITOR", "token": ["Since gemfibrozil is known to activate peroxisome proliferator-activated receptor-alpha (PPAR-alpha), we investigated the role of PPAR-alpha in ", "gemfibrozil", "-mediated inhibition of ", "iNOS", "."], "h": {"pos": [1, 2], "type": null, "name": "gemfibrozil -mediated inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "iNOS ."}}
{"relation": "INHIBITOR", "token": ["Blockade of ", "JAK", " and ERK pathways with ", "AG490", " and U0126, respectively, abrogated the myocardial infarct size reduction by NDP-\u03b1-MSH."], "h": {"pos": [1, 2], "type": null, "name": "JAK  and ERK pathways with "}, "t": {"pos": [3, 4], "type": null, "name": "AG490  and U0126, respectively, abrogated the myocardial infarct size reduction by NDP-\u03b1-MSH."}}
{"relation": "INHIBITOR", "token": ["Coupling this computational technique with a high-quality low-throughput screen identified ", "5-(4-piperidyl)-3-isoxazolol", " (4-PIOL) as a potent ", "plasminogen", " binding inhibitor with the potential for the treatment of various bleeding disorders."], "h": {"pos": [1, 2], "type": null, "name": "5-(4-piperidyl)-3-isoxazolol  (4-PIOL) as a potent "}, "t": {"pos": [3, 4], "type": null, "name": "plasminogen  binding inhibitor with the potential for the treatment of various bleeding disorders."}}
{"relation": "INHIBITOR", "token": ["The acetylcholinesterase (AChE) and ", "butyrylcholinesterase", " (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), ", "4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines", " (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."], "h": {"pos": [1, 2], "type": null, "name": "butyrylcholinesterase  (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), "}, "t": {"pos": [3, 4], "type": null, "name": "4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines  (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."}}
{"relation": "INHIBITOR", "token": ["Block of ", "erg3", " by ", "sertindole", " also displayed a positive voltage-dependence."], "h": {"pos": [1, 2], "type": null, "name": "erg3  by "}, "t": {"pos": [3, 4], "type": null, "name": "sertindole  also displayed a positive voltage-dependence."}}
{"relation": "INHIBITOR", "token": ["A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, ", "caffeic acid", ", ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (", "CA", ", EC 4.2.1.1)."], "h": {"pos": [1, 2], "type": null, "name": "caffeic acid , ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase ("}, "t": {"pos": [3, 4], "type": null, "name": "CA , EC 4.2.1.1)."}}
{"relation": "INHIBITOR", "token": ["The antipsychotic drugs sertindole and ", "pimozide", " are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as HERG (", "human ether-a-go-go-related gene", "; erg1)."], "h": {"pos": [1, 2], "type": null, "name": "pimozide  are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as HERG ("}, "t": {"pos": [3, 4], "type": null, "name": "human ether-a-go-go-related gene ; erg1)."}}
{"relation": "INHIBITOR", "token": ["Felodipine and the ", "p-chloro", " analogue inhibited the actin-activated Mg2+-ATPase activity of smooth muscle ", "myosin", " (IC50 = 25.1 microM)."], "h": {"pos": [1, 2], "type": null, "name": "p-chloro  analogue inhibited the actin-activated Mg2+-ATPase activity of smooth muscle "}, "t": {"pos": [3, 4], "type": null, "name": "myosin  (IC50 = 25.1 microM)."}}
{"relation": "INHIBITOR", "token": ["Mutation of Ser-530 to Ala or Val-349 to Ala or Leu abolished the potent inhibition observed with wild-type ", "human COX-2", " and key ", "lumiracoxib", " analogs."], "h": {"pos": [1, 2], "type": null, "name": "human COX-2  and key "}, "t": {"pos": [3, 4], "type": null, "name": "lumiracoxib  analogs."}}
{"relation": "INHIBITOR", "token": ["Disposition of a specific ", "cyclooxygenase-2", " inhibitor, ", "valdecoxib", ", in human."], "h": {"pos": [1, 2], "type": null, "name": "cyclooxygenase-2  inhibitor, "}, "t": {"pos": [3, 4], "type": null, "name": "valdecoxib , in human."}}
{"relation": "INHIBITOR", "token": ["The purpose of the present study was to test our hypothesis that ", "amiloride", ", a specific ", "u-PA", " inhibitor, effectively decreases u-PA activity in cornea as well as in tear fluid and favourably affects corneal healing."], "h": {"pos": [1, 2], "type": null, "name": "amiloride , a specific "}, "t": {"pos": [3, 4], "type": null, "name": "u-PA  inhibitor, effectively decreases u-PA activity in cornea as well as in tear fluid and favourably affects corneal healing."}}
{"relation": "INHIBITOR", "token": ["The molecular mechanism studies suggested that ", "neoechinulin A", " may block the phosphorylation of mitogen-activated protein kinase (", "MAPK", ") molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-\u03baB (NF-\u03baB) p65 and p50 subunits."], "h": {"pos": [1, 2], "type": null, "name": "neoechinulin A  may block the phosphorylation of mitogen-activated protein kinase ("}, "t": {"pos": [3, 4], "type": null, "name": "MAPK ) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-\u03baB (NF-\u03baB) p65 and p50 subunits."}}
{"relation": "INHIBITOR", "token": ["", "Orlistat", " is a new inhibitor of ", "pancreatic lipase", " enzyme."], "h": {"pos": [1, 2], "type": null, "name": "Orlistat  is a new inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "pancreatic lipase  enzyme."}}
{"relation": "INHIBITOR", "token": ["In this study, we employed virtual screening and chemical synthesis to identify a series of ", "N-(thiophen-2-yl) benzamide", " derivatives as potent ", "BRAF", "(V600E) inhibitors."], "h": {"pos": [1, 2], "type": null, "name": "N-(thiophen-2-yl) benzamide  derivatives as potent "}, "t": {"pos": [3, 4], "type": null, "name": "BRAF (V600E) inhibitors."}}
{"relation": "INHIBITOR", "token": ["Moreover, the rank order for potency in inhibiting acetylcholinesterase (", "ambenonium", ">neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of ", "acetylcholinesterase", " also displaced [3H]-oxotremorine-M to the greatest extent."], "h": {"pos": [1, 2], "type": null, "name": "ambenonium >neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of "}, "t": {"pos": [3, 4], "type": null, "name": "acetylcholinesterase  also displaced [3H]-oxotremorine-M to the greatest extent."}}
{"relation": "INHIBITOR", "token": ["These observations suggest that uptake of ", "phenformin", " into liver mitochondria is at least partly mediated by OCTN1 and functionally relevant to its inhibition potential of ", "complex I", " respiration."], "h": {"pos": [1, 2], "type": null, "name": "phenformin  into liver mitochondria is at least partly mediated by OCTN1 and functionally relevant to its inhibition potential of "}, "t": {"pos": [3, 4], "type": null, "name": "complex I  respiration."}}
{"relation": "INHIBITOR", "token": ["", "Tolvaptan", " is a selective ", "arginine vasopressin (AVP) V(2) receptor", " blocker used to induce free water diuresis in the treatment of euvolemic or hypervolemic hyponatremia."], "h": {"pos": [1, 2], "type": null, "name": "Tolvaptan  is a selective "}, "t": {"pos": [3, 4], "type": null, "name": "arginine vasopressin (AVP) V(2) receptor  blocker used to induce free water diuresis in the treatment of euvolemic or hypervolemic hyponatremia."}}
{"relation": "INHIBITOR", "token": ["In addition, the new compound perviridicin B (2), three known ", "rocaglate", " derivatives (9, 11, 12), and a known sesquiterpene, 2-oxaisodauc-5-en-12-al (17), showed significant NF-\u03baB (", "p65", ") inhibitory activity in an ELISA assay."], "h": {"pos": [1, 2], "type": null, "name": "rocaglate  derivatives (9, 11, 12), and a known sesquiterpene, 2-oxaisodauc-5-en-12-al (17), showed significant NF-\u03baB ("}, "t": {"pos": [3, 4], "type": null, "name": "p65 ) inhibitory activity in an ELISA assay."}}
{"relation": "INHIBITOR", "token": ["", "Emodin-6-O-\u03b2-D-glucoside", " inhibits ", "HMGB1", "-induced inflammatory responses in vitro and in vivo."], "h": {"pos": [1, 2], "type": null, "name": "Emodin-6-O-\u03b2-D-glucoside  inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "HMGB1 -induced inflammatory responses in vitro and in vivo."}}
{"relation": "INHIBITOR", "token": ["Furthermore, these ", "phosphorylated flavonoids", " demonstrated good to high selectivity for ", "CEase", " over AChE, which only showed micromolar potency inhibition of AChE."], "h": {"pos": [1, 2], "type": null, "name": "phosphorylated flavonoids  demonstrated good to high selectivity for "}, "t": {"pos": [3, 4], "type": null, "name": "CEase  over AChE, which only showed micromolar potency inhibition of AChE."}}
{"relation": "INHIBITOR", "token": ["", "Aspirin", " (ASA) and other non-steroidal anti-inflammatory drugs, which are ", "cyclooxygenase", " (COX) inhibitors, precipitate asthmatic attacks in ASA-intolerant patients, while sodium salicylate, hardly active on COX by itself, is well tolerated by these patients."], "h": {"pos": [1, 2], "type": null, "name": "Aspirin  (ASA) and other non-steroidal anti-inflammatory drugs, which are "}, "t": {"pos": [3, 4], "type": null, "name": "cyclooxygenase  (COX) inhibitors, precipitate asthmatic attacks in ASA-intolerant patients, while sodium salicylate, hardly active on COX by itself, is well tolerated by these patients."}}
{"relation": "INHIBITOR", "token": ["", "Rasagiline", " does not modify CNS monoamine tissue levels or monoamine-induced behavioural syndromes at doses which selectively inhibit ", "MAO-B", " but not MAO-A."], "h": {"pos": [1, 2], "type": null, "name": "Rasagiline  does not modify CNS monoamine tissue levels or monoamine-induced behavioural syndromes at doses which selectively inhibit "}, "t": {"pos": [3, 4], "type": null, "name": "MAO-B  but not MAO-A."}}
{"relation": "INHIBITOR", "token": ["Previously, we have found that ", "BRN-103", ", a nicotinamide derivative, inhibits vascular endothelial growth factor (", "VEGF", ")-mediated angiogenesis signaling in human endothelial cells."], "h": {"pos": [1, 2], "type": null, "name": "BRN-103 , a nicotinamide derivative, inhibits vascular endothelial growth factor ("}, "t": {"pos": [3, 4], "type": null, "name": "VEGF )-mediated angiogenesis signaling in human endothelial cells."}}
{"relation": "INHIBITOR", "token": ["PURPOSE: Dasatinib (", "BMS-354825", "), a potent oral multi-targeted kinase inhibitor against SRC and BCR-", "ABL", ", has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance."], "h": {"pos": [1, 2], "type": null, "name": "BMS-354825 ), a potent oral multi-targeted kinase inhibitor against SRC and BCR-"}, "t": {"pos": [3, 4], "type": null, "name": "ABL , has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance."}}
{"relation": "INHIBITOR", "token": ["PURPOSE: ", "Dasatinib", " (BMS-354825), a potent oral multi-targeted ", "kinase", " inhibitor against SRC and BCR-ABL, has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance."], "h": {"pos": [1, 2], "type": null, "name": "Dasatinib  (BMS-354825), a potent oral multi-targeted "}, "t": {"pos": [3, 4], "type": null, "name": "kinase  inhibitor against SRC and BCR-ABL, has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance."}}
{"relation": "INHIBITOR", "token": ["However, combination of rasagiline (10 mg x kg(-1) i.p.) with L-DOPA or L-tryptophan (50 mg x kg(-1) i.p.), or rasagiline (10 mg x kg(-1) p.o.) with fluoxetine (10 mg x kg(-1) p.o.), did not induce the behavioural hyperactivity syndrome which is seen following inhibition of both MAO-A and ", "MAO-B", " by tranylcypromine together with the ", "monoamine", " precursors."], "h": {"pos": [1, 2], "type": null, "name": "MAO-B  by tranylcypromine together with the "}, "t": {"pos": [3, 4], "type": null, "name": "monoamine  precursors."}}
{"relation": "INHIBITOR", "token": ["Suppression of ", "T\u03b2R1", " by the pharmacological inhibitor (", "SB431542", ") markedly reduced VEGF release by HFL-1 in response to CSE and this effect was confirmed by T\u03b2R1 siRNA."], "h": {"pos": [1, 2], "type": null, "name": "T\u03b2R1  by the pharmacological inhibitor ("}, "t": {"pos": [3, 4], "type": null, "name": "SB431542 ) markedly reduced VEGF release by HFL-1 in response to CSE and this effect was confirmed by T\u03b2R1 siRNA."}}
{"relation": "INHIBITOR", "token": ["", "Auranofin", ", as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of ", "TLR4", "."], "h": {"pos": [1, 2], "type": null, "name": "Auranofin , as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of "}, "t": {"pos": [3, 4], "type": null, "name": "TLR4 ."}}
{"relation": "INHIBITOR", "token": ["These results suggest that ", "gemfibrozil", " inhibits the induction of iNOS probably by inhibiting the activation of NF-kappaB, AP-1, and ", "C/EBPbeta", " and that gemfibrozil, a prescribed drug for humans, may further find its therapeutic use in neuroinflammatory diseases."], "h": {"pos": [1, 2], "type": null, "name": "gemfibrozil  inhibits the induction of iNOS probably by inhibiting the activation of NF-kappaB, AP-1, and "}, "t": {"pos": [3, 4], "type": null, "name": "C/EBPbeta  and that gemfibrozil, a prescribed drug for humans, may further find its therapeutic use in neuroinflammatory diseases."}}
{"relation": "INHIBITOR", "token": ["Central and peripheral administration of ", "kisspeptin", " stimulates the hypothalamic-pituitary-gonadal (HPG) axis whilst pre-administration of a gonadotrophin releasing hormone (", "GnRH", ") antagonist abolishes this effect."], "h": {"pos": [1, 2], "type": null, "name": "kisspeptin  stimulates the hypothalamic-pituitary-gonadal (HPG) axis whilst pre-administration of a gonadotrophin releasing hormone ("}, "t": {"pos": [3, 4], "type": null, "name": "GnRH ) antagonist abolishes this effect."}}
{"relation": "INHIBITOR", "token": ["BACKGROUND: Since the introduction of the first ", "cholinesterase", " inhibitor (ChEI) in 1997, most clinicians and probably most patients would consider the cholinergic drugs, donepezil, galantamine and ", "rivastigmine", ", to be the first line pharmacotherapy for mild to moderate Alzheimer's disease.The drugs have slightly different pharmacological properties, but they all work by inhibiting the breakdown of acetylcholine, an important neurotransmitter associated with memory, by blocking the enzyme acetylcholinesterase."], "h": {"pos": [1, 2], "type": null, "name": "cholinesterase  inhibitor (ChEI) in 1997, most clinicians and probably most patients would consider the cholinergic drugs, donepezil, galantamine and "}, "t": {"pos": [3, 4], "type": null, "name": "rivastigmine , to be the first line pharmacotherapy for mild to moderate Alzheimer's disease.The drugs have slightly different pharmacological properties, but they all work by inhibiting the breakdown of acetylcholine, an important neurotransmitter associated with memory, by blocking the enzyme acetylcholinesterase."}}
{"relation": "INHIBITOR", "token": ["Depletion of putrescine, spermidine, and spermine by DL-alpha-difluoromethylornithine (", "DFMO", "), a specific inhibitor of ornithine decarboxylase (", "ODC", ") that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index."], "h": {"pos": [1, 2], "type": null, "name": "DFMO ), a specific inhibitor of ornithine decarboxylase ("}, "t": {"pos": [3, 4], "type": null, "name": "ODC ) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index."}}
{"relation": "INHIBITOR", "token": ["Polo-like kinase-2 (Plk-2) is a potential therapeutic target for Parkinson's disease and this Letter describes the SAR of a series of ", "dihydropteridinone", " based ", "Plk-2", " inhibitors."], "h": {"pos": [1, 2], "type": null, "name": "dihydropteridinone  based "}, "t": {"pos": [3, 4], "type": null, "name": "Plk-2  inhibitors."}}
{"relation": "INHIBITOR", "token": ["However, phosphorylation of the p65/", "RelA", " subunit was clearly inhibited by ", "PSE", " in stimulated cells."], "h": {"pos": [1, 2], "type": null, "name": "RelA  subunit was clearly inhibited by "}, "t": {"pos": [3, 4], "type": null, "name": "PSE  in stimulated cells."}}
{"relation": "INHIBITOR", "token": ["The structure-activity relationships revealed that the free ", "hydroxyl", " group at position 5 and phosphate group at position 7 of the phosphorylated flavonoids are favorable to the inhibition of ", "CEase", "."], "h": {"pos": [1, 2], "type": null, "name": "hydroxyl  group at position 5 and phosphate group at position 7 of the phosphorylated flavonoids are favorable to the inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "CEase ."}}
{"relation": "INHIBITOR", "token": ["One exception is tranexamic acid (", "TXA", "), which, as a lysine mimetic, inhibits binding of ", "plasminogen", " to fibrin."], "h": {"pos": [1, 2], "type": null, "name": "TXA ), which, as a lysine mimetic, inhibits binding of "}, "t": {"pos": [3, 4], "type": null, "name": "plasminogen  to fibrin."}}
{"relation": "INHIBITOR", "token": ["Taken together, ", "PTE", " is a potent inhibitor of osteosarcoma cell growth that targets the ", "JAK2", "/STAT3 signaling pathway."], "h": {"pos": [1, 2], "type": null, "name": "PTE  is a potent inhibitor of osteosarcoma cell growth that targets the "}, "t": {"pos": [3, 4], "type": null, "name": "JAK2 /STAT3 signaling pathway."}}
{"relation": "INHIBITOR", "token": ["The activities of ", "ABCA1", " and other ATP binding cassette superfamily members are inhibited by the drug ", "glyburide", ", and SR-BI-mediated lipid transport is blocked by small molecule inhibitors called BLTs."], "h": {"pos": [1, 2], "type": null, "name": "ABCA1  and other ATP binding cassette superfamily members are inhibited by the drug "}, "t": {"pos": [3, 4], "type": null, "name": "glyburide , and SR-BI-mediated lipid transport is blocked by small molecule inhibitors called BLTs."}}
{"relation": "INHIBITOR", "token": ["", "Pterostilbene", " exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/", "STAT3", " signaling pathway."], "h": {"pos": [1, 2], "type": null, "name": "Pterostilbene  exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/"}, "t": {"pos": [3, 4], "type": null, "name": "STAT3  signaling pathway."}}
{"relation": "INHIBITOR", "token": ["The mechanism of action of ", "Fc11a-2", " was related to the inhibition of the cleavage of pro-caspase-1, pro-IL-1\u03b2 and pro-IL-18 which in turn suppressed the activation of ", "NLRP3", " inflammasome."], "h": {"pos": [1, 2], "type": null, "name": "Fc11a-2  was related to the inhibition of the cleavage of pro-caspase-1, pro-IL-1\u03b2 and pro-IL-18 which in turn suppressed the activation of "}, "t": {"pos": [3, 4], "type": null, "name": "NLRP3  inflammasome."}}
{"relation": "INHIBITOR", "token": ["", "Parathion", " is a ", "cholinesterase", " inhibitor that induces the hydrolysis of body choline esters, including acetylcholine at cholinergic synapses."], "h": {"pos": [1, 2], "type": null, "name": "Parathion  is a "}, "t": {"pos": [3, 4], "type": null, "name": "cholinesterase  inhibitor that induces the hydrolysis of body choline esters, including acetylcholine at cholinergic synapses."}}
{"relation": "INHIBITOR", "token": ["A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, ", "gallic acid", ", syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, ", "EC 4.2.1.1", ")."], "h": {"pos": [1, 2], "type": null, "name": "gallic acid , syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, "}, "t": {"pos": [3, 4], "type": null, "name": "EC 4.2.1.1 )."}}
{"relation": "INHIBITOR", "token": ["Previous studies by this research team proved that vasodilating prostaglandins (", "PGs", ") E1, E2 and I2 inhibit ", "carbonic anhydrase", " (CA) in vitro and in vivo, which suggested involvement of CA in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of PGs."], "h": {"pos": [1, 2], "type": null, "name": "PGs ) E1, E2 and I2 inhibit "}, "t": {"pos": [3, 4], "type": null, "name": "carbonic anhydrase  (CA) in vitro and in vivo, which suggested involvement of CA in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of PGs."}}
{"relation": "INHIBITOR", "token": ["Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR/", "ErbB2", " kinase inhibitor ", "GW572016", "."], "h": {"pos": [1, 2], "type": null, "name": "ErbB2  kinase inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "GW572016 ."}}
{"relation": "INHIBITOR", "token": ["", "Epidermal growth factor receptor", " inhibitors currently under investigation include the small molecules gefitinib (Iressa, ZD1839) and erlotinib (Tarceva, OSI-774), as well as monoclonal antibodies such as ", "cetuximab", " (IMC-225, Erbitux)."], "h": {"pos": [1, 2], "type": null, "name": "Epidermal growth factor receptor  inhibitors currently under investigation include the small molecules gefitinib (Iressa, ZD1839) and erlotinib (Tarceva, OSI-774), as well as monoclonal antibodies such as "}, "t": {"pos": [3, 4], "type": null, "name": "cetuximab  (IMC-225, Erbitux)."}}
{"relation": "INHIBITOR", "token": ["The ", "acetylcholinesterase", " (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), ", "4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines", " (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."], "h": {"pos": [1, 2], "type": null, "name": "acetylcholinesterase  (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), "}, "t": {"pos": [3, 4], "type": null, "name": "4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines  (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."}}
{"relation": "INHIBITOR", "token": ["Ex vivo IC(50) values (COX-1: 105.2 micromol/L; ", "COX-2", ": 26.3 micromol/L) of ", "acetaminophen", " compared favorably with its in vitro IC(50) values."], "h": {"pos": [1, 2], "type": null, "name": "COX-2 : 26.3 micromol/L) of "}, "t": {"pos": [3, 4], "type": null, "name": "acetaminophen  compared favorably with its in vitro IC(50) values."}}
{"relation": "INHIBITOR", "token": ["To eliminate the interaction of ", "bupropion", " with ", "DAT", " or NET, nomifensine or desipramine, respectively, was included in the superfusion buffer."], "h": {"pos": [1, 2], "type": null, "name": "bupropion  with "}, "t": {"pos": [3, 4], "type": null, "name": "DAT  or NET, nomifensine or desipramine, respectively, was included in the superfusion buffer."}}
{"relation": "INHIBITOR", "token": ["In this study, focus was given to evaluate the ability of neoechinulin A, an ", "indole", " alkaloid isolated from marine-derived Microsporum sp., to attenuate microglial activation by oligomeric ", "amyloid-\u03b2 1-42", " (A\u03b242)."], "h": {"pos": [1, 2], "type": null, "name": "indole  alkaloid isolated from marine-derived Microsporum sp., to attenuate microglial activation by oligomeric "}, "t": {"pos": [3, 4], "type": null, "name": "amyloid-\u03b2 1-42  (A\u03b242)."}}
{"relation": "INHIBITOR", "token": ["", "2-Arylpropionic", " CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive ", "CXCL8", " inhibitors."], "h": {"pos": [1, 2], "type": null, "name": "2-Arylpropionic  CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive "}, "t": {"pos": [3, 4], "type": null, "name": "CXCL8  inhibitors."}}
{"relation": "INHIBITOR", "token": ["Taken together, these data demonstrate that ", "baicalin", " inhibits the metabolism of DXM in a concentration-dependent manner in rats, possibly through inhibiting hepatic CYP2D and ", "CYP3A", " activities."], "h": {"pos": [1, 2], "type": null, "name": "baicalin  inhibits the metabolism of DXM in a concentration-dependent manner in rats, possibly through inhibiting hepatic CYP2D and "}, "t": {"pos": [3, 4], "type": null, "name": "CYP3A  activities."}}
{"relation": "INHIBITOR", "token": ["Objective: This study explores the ability of ", "acyl glucuronides", " to act as substrates or inhibitors of human carboxylesterases 1 (hCES1) and 2 (", "hCES2", ")."], "h": {"pos": [1, 2], "type": null, "name": "acyl glucuronides  to act as substrates or inhibitors of human carboxylesterases 1 (hCES1) and 2 ("}, "t": {"pos": [3, 4], "type": null, "name": "hCES2 )."}}
{"relation": "INHIBITOR", "token": ["Because clinical studies investigating interactions between garlic and ", "human immunodeficiency virus protease", " inhibitors saquinavir and ", "ritonavir", " have already been performed, we used these in vivo data to evaluate the in vitro results and the reliability of the models employed as screening tools for forecasting the potential of first-pass intestinal metabolism changes."], "h": {"pos": [1, 2], "type": null, "name": "human immunodeficiency virus protease  inhibitors saquinavir and "}, "t": {"pos": [3, 4], "type": null, "name": "ritonavir  have already been performed, we used these in vivo data to evaluate the in vitro results and the reliability of the models employed as screening tools for forecasting the potential of first-pass intestinal metabolism changes."}}
{"relation": "INHIBITOR", "token": ["", "SL-11158", " inhibited ", "SSAT", " activity with a mixed type of inhibition in which the analogue had a 70-fold higher affinity for the enzyme than the natural substrate, spermine."], "h": {"pos": [1, 2], "type": null, "name": "SL-11158  inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "SSAT  activity with a mixed type of inhibition in which the analogue had a 70-fold higher affinity for the enzyme than the natural substrate, spermine."}}
{"relation": "INHIBITOR", "token": ["", "Doxycycline", " was shown to decrease cerebral ", "MMP-9", " activities and angiogenesis induced by vascular endothelial growth factor (VEGF)."], "h": {"pos": [1, 2], "type": null, "name": "Doxycycline  was shown to decrease cerebral "}, "t": {"pos": [3, 4], "type": null, "name": "MMP-9  activities and angiogenesis induced by vascular endothelial growth factor (VEGF)."}}
{"relation": "INHIBITOR", "token": ["INTRODUCTION: In this study, we examined the effects of the ", "alpha-glucosidase", " inhibitors acarbose and voglibose on postprandial plasma ", "glucose", " and serum triglyceride levels in patients with type 2 diabetes mellitus."], "h": {"pos": [1, 2], "type": null, "name": "alpha-glucosidase  inhibitors acarbose and voglibose on postprandial plasma "}, "t": {"pos": [3, 4], "type": null, "name": "glucose  and serum triglyceride levels in patients with type 2 diabetes mellitus."}}
{"relation": "INHIBITOR", "token": ["New classes of ", "pyrrole", "-derived nitrooxyalkyl inverse esters, carbonates, and ethers (7-10) as ", "COX-2", " selective inhibitors and NO donors were synthesized and are herein reported."], "h": {"pos": [1, 2], "type": null, "name": "pyrrole -derived nitrooxyalkyl inverse esters, carbonates, and ethers (7-10) as "}, "t": {"pos": [3, 4], "type": null, "name": "COX-2  selective inhibitors and NO donors were synthesized and are herein reported."}}
{"relation": "INHIBITOR", "token": ["Given that M-CSF signalling through ", "c-FMS", " plays an important role in osteoclast biology, we speculated that blocking such a pathway with ", "imatinib", " may modulate osteoclast activity."], "h": {"pos": [1, 2], "type": null, "name": "c-FMS  plays an important role in osteoclast biology, we speculated that blocking such a pathway with "}, "t": {"pos": [3, 4], "type": null, "name": "imatinib  may modulate osteoclast activity."}}
{"relation": "INHIBITOR", "token": ["", "Am80", " inhibited ", "VEGF", "-induced phosphorylation of VEGF receptor."], "h": {"pos": [1, 2], "type": null, "name": "Am80  inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "VEGF -induced phosphorylation of VEGF receptor."}}
{"relation": "INHIBITOR", "token": ["Coupling this computational technique with a high-quality low-throughput screen identified 5-(4-piperidyl)-3-isoxazolol (", "4-PIOL", ") as a potent ", "plasminogen", " binding inhibitor with the potential for the treatment of various bleeding disorders."], "h": {"pos": [1, 2], "type": null, "name": "4-PIOL ) as a potent "}, "t": {"pos": [3, 4], "type": null, "name": "plasminogen  binding inhibitor with the potential for the treatment of various bleeding disorders."}}
{"relation": "INHIBITOR", "token": ["Our results demonstrated that ", "auranofin", " suppressed TLR4-mediated activation of transcription factors, NF-kappaB and ", "IRF3", ", and expression of COX-2, a pro-inflammatory enzyme."], "h": {"pos": [1, 2], "type": null, "name": "auranofin  suppressed TLR4-mediated activation of transcription factors, NF-kappaB and "}, "t": {"pos": [3, 4], "type": null, "name": "IRF3 , and expression of COX-2, a pro-inflammatory enzyme."}}
{"relation": "INHIBITOR", "token": ["", "Epidermal growth factor receptor", " inhibitors currently under investigation include the small molecules gefitinib (", "Iressa", ", ZD1839) and erlotinib (Tarceva, OSI-774), as well as monoclonal antibodies such as cetuximab (IMC-225, Erbitux)."], "h": {"pos": [1, 2], "type": null, "name": "Epidermal growth factor receptor  inhibitors currently under investigation include the small molecules gefitinib ("}, "t": {"pos": [3, 4], "type": null, "name": "Iressa , ZD1839) and erlotinib (Tarceva, OSI-774), as well as monoclonal antibodies such as cetuximab (IMC-225, Erbitux)."}}
{"relation": "INHIBITOR", "token": ["Troglitazone inhibited LTB(4) production by the supernatant fraction of RBL-2H3 cell lysate with similar potency to zileuton, suggesting that ", "troglitazone", " inhibits LT production by direct inhibition of ", "5-LOX", " activity."], "h": {"pos": [1, 2], "type": null, "name": "troglitazone  inhibits LT production by direct inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "5-LOX  activity."}}
{"relation": "INHIBITOR", "token": ["The selective ", "PDE 4", " inhibitors, and to a certain extent the PDE3 inhibitors amrinone and ", "milrinone", ", reduced the GM-CSF release in a concentration dependent manner."], "h": {"pos": [1, 2], "type": null, "name": "PDE 4  inhibitors, and to a certain extent the PDE3 inhibitors amrinone and "}, "t": {"pos": [3, 4], "type": null, "name": "milrinone , reduced the GM-CSF release in a concentration dependent manner."}}
{"relation": "INHIBITOR", "token": ["Overall, although most anthocyanidins had no effects on AhR-CYP1A1 signaling, pelargonidin can bind to and activate the AhR and AhR-dependent gene expression, and pelargonidin and ", "delphinidin", " inhibit the ", "CYP1A1", " catalytic activity."], "h": {"pos": [1, 2], "type": null, "name": "delphinidin  inhibit the "}, "t": {"pos": [3, 4], "type": null, "name": "CYP1A1  catalytic activity."}}
{"relation": "INHIBITOR", "token": ["In this study, a novel series of ", "2-hydroxydiarylamide", " derivatives were synthesized and evaluated for inhibiting TMPRSS4 ", "serine protease", " activity and suppressing cancer cell invasion."], "h": {"pos": [1, 2], "type": null, "name": "2-hydroxydiarylamide  derivatives were synthesized and evaluated for inhibiting TMPRSS4 "}, "t": {"pos": [3, 4], "type": null, "name": "serine protease  activity and suppressing cancer cell invasion."}}
{"relation": "INHIBITOR", "token": ["", "Pseudoephedrine", " inhibits T-cell activation by targeting ", "NF-kappaB", ", NFAT and AP-1 signaling pathways."], "h": {"pos": [1, 2], "type": null, "name": "Pseudoephedrine  inhibits T-cell activation by targeting "}, "t": {"pos": [3, 4], "type": null, "name": "NF-kappaB , NFAT and AP-1 signaling pathways."}}
{"relation": "INHIBITOR", "token": ["Interestingly, a Val-349 to Ile mutant was inhibited with equal potency to ", "human COX-2", " with ", "2,6-dichloro", "-, 2,6-dimethyl-, or 2-chloro-6-methyl-substituted inhibitors and, in the case of lumiracoxib, actually showed an increase in potency."], "h": {"pos": [1, 2], "type": null, "name": "human COX-2  with "}, "t": {"pos": [3, 4], "type": null, "name": "2,6-dichloro -, 2,6-dimethyl-, or 2-chloro-6-methyl-substituted inhibitors and, in the case of lumiracoxib, actually showed an increase in potency."}}
{"relation": "INHIBITOR", "token": ["This work resulted in the discovery of the ", "5-morpholino-7H-thieno[3,2-b]pyran-7-one", " system as the foundation of a new compound class of potential PI3K inhibitors having improved potency toward ", "PI3K", "."], "h": {"pos": [1, 2], "type": null, "name": "5-morpholino-7H-thieno[3,2-b]pyran-7-one  system as the foundation of a new compound class of potential PI3K inhibitors having improved potency toward "}, "t": {"pos": [3, 4], "type": null, "name": "PI3K ."}}
{"relation": "INHIBITOR", "token": ["We conclude that ", "felbamate", " exhibits modest selectivity for ", "NMDA receptors", " composed of NR1a/NR2B subunits."], "h": {"pos": [1, 2], "type": null, "name": "felbamate  exhibits modest selectivity for "}, "t": {"pos": [3, 4], "type": null, "name": "NMDA receptors  composed of NR1a/NR2B subunits."}}
{"relation": "INHIBITOR", "token": ["The aim of this study was to evaluate the influence of hepatic impairment on the pharmacokinetics (PK) of the novel ", "cyclooxygenase-2", " (COX-2) selective inhibitor ", "lumiracoxib", " (Prexige), so that dose recommendations for clinical use can be provided."], "h": {"pos": [1, 2], "type": null, "name": "cyclooxygenase-2  (COX-2) selective inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "lumiracoxib  (Prexige), so that dose recommendations for clinical use can be provided."}}
{"relation": "INHIBITOR", "token": ["Pretreatment with lysosomal enzyme inhibitors [(2S, 3S)trans-epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester or chloroquine] or proteasome inhibitors (", "proteasome", " inhibitor I, ", "MG-132", ", or lactacystin) decreased the extent of U50,488H-induced down-regulation."], "h": {"pos": [1, 2], "type": null, "name": "proteasome  inhibitor I, "}, "t": {"pos": [3, 4], "type": null, "name": "MG-132 , or lactacystin) decreased the extent of U50,488H-induced down-regulation."}}
{"relation": "INHIBITOR", "token": ["These data suggest that the ", "lavandulyl", " side chain and the position of the hydroxy group are important for high ", "DGAT", " inhibitory activity."], "h": {"pos": [1, 2], "type": null, "name": "lavandulyl  side chain and the position of the hydroxy group are important for high "}, "t": {"pos": [3, 4], "type": null, "name": "DGAT  inhibitory activity."}}
{"relation": "INHIBITOR", "token": ["The ", "Na channel", " block caused by ", "lidocaine", " and RSD1235 can be through the open or inactivated states of the channel, but both equivalently inhibit a late component of Na current (I(Na)), recorded at 22 degrees C using whole-cell patch clamp of Nav 1.5 expressed in HEK cells."], "h": {"pos": [1, 2], "type": null, "name": "Na channel  block caused by "}, "t": {"pos": [3, 4], "type": null, "name": "lidocaine  and RSD1235 can be through the open or inactivated states of the channel, but both equivalently inhibit a late component of Na current (I(Na)), recorded at 22 degrees C using whole-cell patch clamp of Nav 1.5 expressed in HEK cells."}}
{"relation": "INHIBITOR", "token": ["To determine whether dysregulation of SIRT1 promotes NADPH oxidase-dependent production of reactive oxygen species (ROS) and impairs endothelial function we assessed the effects of three structurally different inhibitors of ", "SIRT1", " (nicotinamide, sirtinol, ", "EX527", ") in aorta segments isolated from young Wistar rats."], "h": {"pos": [1, 2], "type": null, "name": "SIRT1  (nicotinamide, sirtinol, "}, "t": {"pos": [3, 4], "type": null, "name": "EX527 ) in aorta segments isolated from young Wistar rats."}}
{"relation": "INHIBITOR", "token": ["", "Wogonoside", " also suppressed the activation of ", "mammalian target of rapamycin", " (mTOR) and p70-S6 kinase (p70S6K) by regulating the expression of the extracellular signal-regulated kinase (ERK1/2) and p38 involved mitogen-activated protein kinase (MAPK) signaling pathway."], "h": {"pos": [1, 2], "type": null, "name": "Wogonoside  also suppressed the activation of "}, "t": {"pos": [3, 4], "type": null, "name": "mammalian target of rapamycin  (mTOR) and p70-S6 kinase (p70S6K) by regulating the expression of the extracellular signal-regulated kinase (ERK1/2) and p38 involved mitogen-activated protein kinase (MAPK) signaling pathway."}}
{"relation": "INHIBITOR", "token": ["Inhibition of ", "gelatinase A", " (MMP-2) by batimastat and ", "captopril", " reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma."], "h": {"pos": [1, 2], "type": null, "name": "gelatinase A  (MMP-2) by batimastat and "}, "t": {"pos": [3, 4], "type": null, "name": "captopril  reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma."}}
{"relation": "INHIBITOR", "token": ["The results suggest that the suppression of ", "TLR4", " activity by ", "auranofin", " may be the molecular mechanism through which auranofin exerts anti-rheumatic activity."], "h": {"pos": [1, 2], "type": null, "name": "TLR4  activity by "}, "t": {"pos": [3, 4], "type": null, "name": "auranofin  may be the molecular mechanism through which auranofin exerts anti-rheumatic activity."}}
{"relation": "INHIBITOR", "token": ["First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, ", "TOP2", "-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, mitoxantrone, and ", "4'-(9-acridinylamino)methanesulfon-m-anisidide", ") was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected."], "h": {"pos": [1, 2], "type": null, "name": "TOP2 -mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, mitoxantrone, and "}, "t": {"pos": [3, 4], "type": null, "name": "4'-(9-acridinylamino)methanesulfon-m-anisidide ) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected."}}
{"relation": "INHIBITOR", "token": ["Kinetic mechanism of ", "quinone oxidoreductase 2", " and its inhibition by the antimalarial ", "quinolines", "."], "h": {"pos": [1, 2], "type": null, "name": "quinone oxidoreductase 2  and its inhibition by the antimalarial "}, "t": {"pos": [3, 4], "type": null, "name": "quinolines ."}}
{"relation": "INHIBITOR", "token": ["Using ", "paraoxon", " as a reference acetylcholinesterase (", "AChE", ") inhibitor, the objective of this study was to develop an adverse outcome pathway (AOP) that provided quantitative linkages across levels of biological organization during zebrafish embryogenesis."], "h": {"pos": [1, 2], "type": null, "name": "paraoxon  as a reference acetylcholinesterase ("}, "t": {"pos": [3, 4], "type": null, "name": "AChE ) inhibitor, the objective of this study was to develop an adverse outcome pathway (AOP) that provided quantitative linkages across levels of biological organization during zebrafish embryogenesis."}}
{"relation": "INHIBITOR", "token": ["Moreover, overexpressed CYP2J2 and ", "EETs", " inhibited ", "Ang II", "-induced macrophage migration in a VSMC-macrophage coculture system."], "h": {"pos": [1, 2], "type": null, "name": "EETs  inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "Ang II -induced macrophage migration in a VSMC-macrophage coculture system."}}
{"relation": "INHIBITOR", "token": ["Catecholamines (adrenaline, ", "noradrenaline", " and dopamine) are potent inhibitors of ", "phenylalanine 4-monooxygenase", " (phenylalanine hydroxylase, EC 1.14.16.1)."], "h": {"pos": [1, 2], "type": null, "name": "noradrenaline  and dopamine) are potent inhibitors of "}, "t": {"pos": [3, 4], "type": null, "name": "phenylalanine 4-monooxygenase  (phenylalanine hydroxylase, EC 1.14.16.1)."}}
{"relation": "INHIBITOR", "token": ["The results suggest that the 63-kDa (", "PDE 1B1", ") and 60-kDa (PDE 1A2) CaMPDE isozymes are inhibited by felodipine and ", "nicardipine", " by partial competitive inhibition and that these two Ca2+ antagonists appear to counteract each other."], "h": {"pos": [1, 2], "type": null, "name": "PDE 1B1 ) and 60-kDa (PDE 1A2) CaMPDE isozymes are inhibited by felodipine and "}, "t": {"pos": [3, 4], "type": null, "name": "nicardipine  by partial competitive inhibition and that these two Ca2+ antagonists appear to counteract each other."}}
{"relation": "INHIBITOR", "token": ["Four prenylflavonoids, kurarinone ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), ", "kushenol H", " ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase (", "DGAT", ")."], "h": {"pos": [1, 2], "type": null, "name": "kushenol H  ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase ("}, "t": {"pos": [3, 4], "type": null, "name": "DGAT )."}}
{"relation": "INHIBITOR", "token": ["No effects were observed when ", "fenclozic acid", " was assessed for P450-dependent and P450-independent cytotoxicity to THLE cell lines, time-dependent inhibition of five major human cytochrome P450 enzymes, inhibition of the biliary ", "efflux transporters", " BSEP and MRP2 or mitochondrial toxicity to THLE or HepG2 cells."], "h": {"pos": [1, 2], "type": null, "name": "fenclozic acid  was assessed for P450-dependent and P450-independent cytotoxicity to THLE cell lines, time-dependent inhibition of five major human cytochrome P450 enzymes, inhibition of the biliary "}, "t": {"pos": [3, 4], "type": null, "name": "efflux transporters  BSEP and MRP2 or mitochondrial toxicity to THLE or HepG2 cells."}}
{"relation": "INHIBITOR", "token": ["Neurochemical effects of the ", "monoamine oxidase", " inhibitor ", "phenelzine", " on brain GABA and alanine: A comparison with vigabatrin."], "h": {"pos": [1, 2], "type": null, "name": "monoamine oxidase  inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "phenelzine  on brain GABA and alanine: A comparison with vigabatrin."}}
{"relation": "INHIBITOR", "token": ["Inhibition of ", "mammalian isoforms I-XIV", " with a series of natural product polyphenols and ", "phenolic acids", "."], "h": {"pos": [1, 2], "type": null, "name": "mammalian isoforms I-XIV  with a series of natural product polyphenols and "}, "t": {"pos": [3, 4], "type": null, "name": "phenolic acids ."}}
{"relation": "INHIBITOR", "token": ["Sorafenib (", "BAY 43-9006", ", Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases ", "VEGFR", "/PDGFR in tumor vasculature."], "h": {"pos": [1, 2], "type": null, "name": "BAY 43-9006 , Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases "}, "t": {"pos": [3, 4], "type": null, "name": "VEGFR /PDGFR in tumor vasculature."}}
{"relation": "INHIBITOR", "token": ["Using whole-cell voltage clamp, we examined ", "mibefradil", " block of four Na+ channel isoforms expressed in human embryonic kidney cells: ", "Nav1.5", " (cardiac), Nav1.4 (skeletal muscle), Nav1.2 (brain), and Nav1.7 (peripheral nerve)."], "h": {"pos": [1, 2], "type": null, "name": "mibefradil  block of four Na+ channel isoforms expressed in human embryonic kidney cells: "}, "t": {"pos": [3, 4], "type": null, "name": "Nav1.5  (cardiac), Nav1.4 (skeletal muscle), Nav1.2 (brain), and Nav1.7 (peripheral nerve)."}}
{"relation": "INHIBITOR", "token": ["In comparison to diphenylhydantoin, the novel ", "chloro", "-substituted alpha-hydroxyphenylamide compounds produced as much as a 20-fold greater tonic and frequency-dependent blockade of ", "Na(V)1.5", " channels with an IC(50) value of 14.5 microM."], "h": {"pos": [1, 2], "type": null, "name": "chloro -substituted alpha-hydroxyphenylamide compounds produced as much as a 20-fold greater tonic and frequency-dependent blockade of "}, "t": {"pos": [3, 4], "type": null, "name": "Na(V)1.5  channels with an IC(50) value of 14.5 microM."}}
{"relation": "INHIBITOR", "token": ["Administration of a concentration (100 microM) of ", "dipyridamole", " that blocks ", "PDE8", " inhibited ecto-phosphodiesterase activity (by 44%)."], "h": {"pos": [1, 2], "type": null, "name": "dipyridamole  that blocks "}, "t": {"pos": [3, 4], "type": null, "name": "PDE8  inhibited ecto-phosphodiesterase activity (by 44%)."}}
{"relation": "INHIBITOR", "token": ["Pharmacological treatment has been studied and it could be demonstrated, that some mutant currents may be insufficiently suppressed by drugs targeted to block the specific current such as, e.g., sotalol or ", "ibutilide", " in patients with a mutation in the IKr-coding gene KCNH2 (", "HERG", ")."], "h": {"pos": [1, 2], "type": null, "name": "ibutilide  in patients with a mutation in the IKr-coding gene KCNH2 ("}, "t": {"pos": [3, 4], "type": null, "name": "HERG )."}}
{"relation": "INHIBITOR", "token": ["A significant decrease of aspartate aminotransferase, ", "alanine aminotransferase", ", lactate dehydrogenase (LDH) activities and glutathione (GSH) levels and an increase of malondialdehyde (MDA) quantity was observed after ", "CCl4", " and PC administration alone."], "h": {"pos": [1, 2], "type": null, "name": "alanine aminotransferase , lactate dehydrogenase (LDH) activities and glutathione (GSH) levels and an increase of malondialdehyde (MDA) quantity was observed after "}, "t": {"pos": [3, 4], "type": null, "name": "CCl4  and PC administration alone."}}
{"relation": "INHIBITOR", "token": ["Existing ion channel blockers, such as amiodarone, ", "dronedarone", ", bepridil, aprindine, and cibenzoline, have been found to have an ", "NCX", " inhibitory action."], "h": {"pos": [1, 2], "type": null, "name": "dronedarone , bepridil, aprindine, and cibenzoline, have been found to have an "}, "t": {"pos": [3, 4], "type": null, "name": "NCX  inhibitory action."}}
{"relation": "INHIBITOR", "token": ["INTRODUCTION: In this study, we examined the effects of the ", "alpha-glucosidase", " inhibitors acarbose and ", "voglibose", " on postprandial plasma glucose and serum triglyceride levels in patients with type 2 diabetes mellitus."], "h": {"pos": [1, 2], "type": null, "name": "alpha-glucosidase  inhibitors acarbose and "}, "t": {"pos": [3, 4], "type": null, "name": "voglibose  on postprandial plasma glucose and serum triglyceride levels in patients with type 2 diabetes mellitus."}}
{"relation": "INHIBITOR", "token": ["Recent studies have reported that ", "imatinib mesylate", ", a ", "kinase", " inhibitor that targets the intracellular tyrosine kinase BCR-ABL and the platelet derived growth factor (PDGF) receptor, is an effective inhibitor of the macrophage colony stimulating factor (M-CSF) receptor, c-FMS."], "h": {"pos": [1, 2], "type": null, "name": "imatinib mesylate , a "}, "t": {"pos": [3, 4], "type": null, "name": "kinase  inhibitor that targets the intracellular tyrosine kinase BCR-ABL and the platelet derived growth factor (PDGF) receptor, is an effective inhibitor of the macrophage colony stimulating factor (M-CSF) receptor, c-FMS."}}
{"relation": "INHIBITOR", "token": ["A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, ", "quercetin", ", and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (", "CA", ", EC 4.2.1.1)."], "h": {"pos": [1, 2], "type": null, "name": "quercetin , and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase ("}, "t": {"pos": [3, 4], "type": null, "name": "CA , EC 4.2.1.1)."}}
{"relation": "INHIBITOR", "token": ["A series of ", "benzenesulfonamides", " incorporating cyanoacrylamide moieties (tyrphostine analogs) were assayed as inhibitors of the ", "\u03b2-carbonic anhydrase", " (CA, EC 4.2.1.1) from Saccharomyces cerevisiae, ScCA."], "h": {"pos": [1, 2], "type": null, "name": "benzenesulfonamides  incorporating cyanoacrylamide moieties (tyrphostine analogs) were assayed as inhibitors of the "}, "t": {"pos": [3, 4], "type": null, "name": "\u03b2-carbonic anhydrase  (CA, EC 4.2.1.1) from Saccharomyces cerevisiae, ScCA."}}
{"relation": "INHIBITOR", "token": ["Three different 3D-QSAR models were built and validated by using a set of 66 ", "pyrazole", " (Model\u2005I) and furanopyrimidine (Model\u2005II) compounds with IC(50) values toward ", "Aurora kinase\u2005A", " ranging from 33\u2005nM to 10.5\u2005\u03bcM."], "h": {"pos": [1, 2], "type": null, "name": "pyrazole  (Model\u2005I) and furanopyrimidine (Model\u2005II) compounds with IC(50) values toward "}, "t": {"pos": [3, 4], "type": null, "name": "Aurora kinase\u2005A  ranging from 33\u2005nM to 10.5\u2005\u03bcM."}}
{"relation": "INHIBITOR", "token": ["", "Acetylcholinesterase", " (AChE) inhibited by the organophosphate soman (", "1,2,2-trimethyl-propylmethylphosphonofluoridate", ") rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex."], "h": {"pos": [1, 2], "type": null, "name": "Acetylcholinesterase  (AChE) inhibited by the organophosphate soman ("}, "t": {"pos": [3, 4], "type": null, "name": "1,2,2-trimethyl-propylmethylphosphonofluoridate ) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex."}}
{"relation": "INHIBITOR", "token": ["However, DeltahPPAR-alpha was unable to abrogate gemfibrozil-mediated inhibition of iNOS suggesting that ", "gemfibrozil", " inhibits ", "iNOS", " independent of PPAR-alpha."], "h": {"pos": [1, 2], "type": null, "name": "gemfibrozil  inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "iNOS  independent of PPAR-alpha."}}
{"relation": "INHIBITOR", "token": ["", "Methylphenidate", ", an inhibitor of dopamine and norepinephrine transporters (", "DAT", " and NET, respectively), is a standard treatment for ADHD."], "h": {"pos": [1, 2], "type": null, "name": "Methylphenidate , an inhibitor of dopamine and norepinephrine transporters ("}, "t": {"pos": [3, 4], "type": null, "name": "DAT  and NET, respectively), is a standard treatment for ADHD."}}
{"relation": "INHIBITOR", "token": ["Previously, we have found that ", "BRN-103", ", a nicotinamide derivative, inhibits ", "vascular endothelial growth factor", " (VEGF)-mediated angiogenesis signaling in human endothelial cells."], "h": {"pos": [1, 2], "type": null, "name": "BRN-103 , a nicotinamide derivative, inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "vascular endothelial growth factor  (VEGF)-mediated angiogenesis signaling in human endothelial cells."}}
{"relation": "INHIBITOR", "token": ["This study was conducted in order to understand the association between acute renal failure and the two ", "COX-2", " inhibitors ", "celecoxib", " and rofecoxib."], "h": {"pos": [1, 2], "type": null, "name": "COX-2  inhibitors "}, "t": {"pos": [3, 4], "type": null, "name": "celecoxib  and rofecoxib."}}
{"relation": "INHIBITOR", "token": ["", "Dasatinib", " (BMS-354825) inhibits KIT", "D816V", ", an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis."], "h": {"pos": [1, 2], "type": null, "name": "Dasatinib  (BMS-354825) inhibits KIT"}, "t": {"pos": [3, 4], "type": null, "name": "D816V , an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis."}}
{"relation": "INHIBITOR", "token": ["Here we found that the anticancer agent ", "cucurbitacin I", ", a Jak2 inhibitor, reduced the activation of ", "Rac1", " and motility in response to the ErbB3 ligand heregulin in breast cancer cells."], "h": {"pos": [1, 2], "type": null, "name": "cucurbitacin I , a Jak2 inhibitor, reduced the activation of "}, "t": {"pos": [3, 4], "type": null, "name": "Rac1  and motility in response to the ErbB3 ligand heregulin in breast cancer cells."}}
{"relation": "INHIBITOR", "token": ["On the basis of FIP1L1-PDGFRa fusion gene hypereosinophilic syndrome would be classified as a clonal disease and in the FIP1L1-PDGFRa positive cases the ", "tyrosine kinase", " inhibitor ", "imatinib mesylate", " (Glivec) would be effective."], "h": {"pos": [1, 2], "type": null, "name": "tyrosine kinase  inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "imatinib mesylate  (Glivec) would be effective."}}
{"relation": "INHIBITOR", "token": ["METHODS: ", "COX-1", " inhibition was determined by measuring thromboxane B2 (TXB2)-generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg meloxicam and 75 mg ", "diclofenac", " and at steady state (15 mg meloxicam daily and 150 mg diclofenac daily)."], "h": {"pos": [1, 2], "type": null, "name": "COX-1  inhibition was determined by measuring thromboxane B2 (TXB2)-generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg meloxicam and 75 mg "}, "t": {"pos": [3, 4], "type": null, "name": "diclofenac  and at steady state (15 mg meloxicam daily and 150 mg diclofenac daily)."}}
{"relation": "INHIBITOR", "token": ["Interestingly, disruption of the RhoA-ROCK pathway prevented the inhibitory effect of ", "cucurbitacin I", " on ", "Rac1", " activation by heregulin."], "h": {"pos": [1, 2], "type": null, "name": "cucurbitacin I  on "}, "t": {"pos": [3, 4], "type": null, "name": "Rac1  activation by heregulin."}}
{"relation": "INHIBITOR", "token": ["These results demonstrated that ", "thalidomide", " might inhibit growth of tumors through ", "COX-2", " degradation independent of antiangiogenesis."], "h": {"pos": [1, 2], "type": null, "name": "thalidomide  might inhibit growth of tumors through "}, "t": {"pos": [3, 4], "type": null, "name": "COX-2  degradation independent of antiangiogenesis."}}
{"relation": "INHIBITOR", "token": ["Agents that have only begun to undergo clinical evaluation include CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, and PKI166 and ", "GW572016", ", both examples of dual ", "kinase", " inhibitors (inhibiting epidermal growth factor receptor and Her2)."], "h": {"pos": [1, 2], "type": null, "name": "GW572016 , both examples of dual "}, "t": {"pos": [3, 4], "type": null, "name": "kinase  inhibitors (inhibiting epidermal growth factor receptor and Her2)."}}
{"relation": "INHIBITOR", "token": ["We have examined the effects of the synthetic matrix metalloproteinase inhibitor, batimastat (BB-94) and the ", "angiotensin-converting enzyme", " inhibitor, ", "captopril", ", on metalloproteinase activity of murine Lewis-lung-carcinoma cells (3LL) in vitro, and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice."], "h": {"pos": [1, 2], "type": null, "name": "angiotensin-converting enzyme  inhibitor, "}, "t": {"pos": [3, 4], "type": null, "name": "captopril , on metalloproteinase activity of murine Lewis-lung-carcinoma cells (3LL) in vitro, and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice."}}
{"relation": "INHIBITOR", "token": ["All these results demonstrate that ", "vitamin C", " prevents CS(E)-induced ", "NF-\u03baB", " activation and thus it could be used for the prevention of CS-induced inflammatory diseases."], "h": {"pos": [1, 2], "type": null, "name": "vitamin C  prevents CS(E)-induced "}, "t": {"pos": [3, 4], "type": null, "name": "NF-\u03baB  activation and thus it could be used for the prevention of CS-induced inflammatory diseases."}}
{"relation": "INHIBITOR", "token": ["The aim of this study was to evaluate the influence of hepatic impairment on the pharmacokinetics (PK) of the novel ", "cyclooxygenase-2", " (COX-2) selective inhibitor lumiracoxib (", "Prexige", "), so that dose recommendations for clinical use can be provided."], "h": {"pos": [1, 2], "type": null, "name": "cyclooxygenase-2  (COX-2) selective inhibitor lumiracoxib ("}, "t": {"pos": [3, 4], "type": null, "name": "Prexige ), so that dose recommendations for clinical use can be provided."}}
{"relation": "INHIBITOR", "token": ["The effects of ", "meloxicam", " were compared with those of diclofenac, a nonselective ", "COX", " inhibitor."], "h": {"pos": [1, 2], "type": null, "name": "meloxicam  were compared with those of diclofenac, a nonselective "}, "t": {"pos": [3, 4], "type": null, "name": "COX  inhibitor."}}
{"relation": "INHIBITOR", "token": ["Furthermore, ", "BRN-250", " inhibited the VEGF-induced phosphorylation and intracellular tyrosine kinase activity of VEGF receptor 2 (VEGFR2) and the activation of its downstream ", "AKT", " pathway."], "h": {"pos": [1, 2], "type": null, "name": "BRN-250  inhibited the VEGF-induced phosphorylation and intracellular tyrosine kinase activity of VEGF receptor 2 (VEGFR2) and the activation of its downstream "}, "t": {"pos": [3, 4], "type": null, "name": "AKT  pathway."}}
{"relation": "INHIBITOR", "token": ["TREK-1 currents are insensitive to pharmacological agents that block ", "TWIK-1", " activity such as ", "quinine", " and quinidine."], "h": {"pos": [1, 2], "type": null, "name": "TWIK-1  activity such as "}, "t": {"pos": [3, 4], "type": null, "name": "quinine  and quinidine."}}
{"relation": "INHIBITOR", "token": ["", "Sulindac", " metabolites simultaneously (a) increase cellular cyclic GMP and subsequently activate cyclic GMP-dependent protein kinase (PKG); (b) activate c-jun NH2-terminal kinase (", "JNK", "); (c) inhibit extracellular signal-regulated kinase 1/2 (ERK1/2); and (d) decrease beta-catenin protein expression at times and doses consistent with apoptosis."], "h": {"pos": [1, 2], "type": null, "name": "Sulindac  metabolites simultaneously (a) increase cellular cyclic GMP and subsequently activate cyclic GMP-dependent protein kinase (PKG); (b) activate c-jun NH2-terminal kinase ("}, "t": {"pos": [3, 4], "type": null, "name": "JNK ); (c) inhibit extracellular signal-regulated kinase 1/2 (ERK1/2); and (d) decrease beta-catenin protein expression at times and doses consistent with apoptosis."}}
{"relation": "INHIBITOR", "token": ["Block of ", "human NaV1.5", " sodium channels by novel ", "alpha-hydroxyphenylamide", " analogues of phenytoin."], "h": {"pos": [1, 2], "type": null, "name": "human NaV1.5  sodium channels by novel "}, "t": {"pos": [3, 4], "type": null, "name": "alpha-hydroxyphenylamide  analogues of phenytoin."}}
{"relation": "INHIBITOR", "token": ["Moreover, use of the pharmacological ", "AMP-activated protein kinase", " (AMPK) inhibitor ", "compound C", " revealed that AMPK is essential for suppressing SREBP-1c expression in phillyrin-treated cells."], "h": {"pos": [1, 2], "type": null, "name": "AMP-activated protein kinase  (AMPK) inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "compound C  revealed that AMPK is essential for suppressing SREBP-1c expression in phillyrin-treated cells."}}
{"relation": "INHIBITOR", "token": ["", "Felbamate", " produced a rapid, concentration-dependent block of currents evoked by 50 microM NMDA and 10 microM glycine in human embryonic kidney 293 cells expressing the rat NR1a subunit, and either the NR2A, NR2B or ", "NR2C", " subunits; the IC50 values for block were 2.6, 0.52 and 2.4 mM, respectively (holding potential, - 60 mV)."], "h": {"pos": [1, 2], "type": null, "name": "Felbamate  produced a rapid, concentration-dependent block of currents evoked by 50 microM NMDA and 10 microM glycine in human embryonic kidney 293 cells expressing the rat NR1a subunit, and either the NR2A, NR2B or "}, "t": {"pos": [3, 4], "type": null, "name": "NR2C  subunits; the IC50 values for block were 2.6, 0.52 and 2.4 mM, respectively (holding potential, - 60 mV)."}}
{"relation": "INHIBITOR", "token": ["Nevertheless, coperfusion with 0.1 and 0.3 mM ", "5-nitro-2-(3-phenylpropylamino) benzoic acid", ", which inhibits the ", "cystic fibrosis transmembrane conductor regulator", " (CFTR), dose dependently inhibited S3226-induced DBS."], "h": {"pos": [1, 2], "type": null, "name": "5-nitro-2-(3-phenylpropylamino) benzoic acid , which inhibits the "}, "t": {"pos": [3, 4], "type": null, "name": "cystic fibrosis transmembrane conductor regulator  (CFTR), dose dependently inhibited S3226-induced DBS."}}
{"relation": "INHIBITOR", "token": ["Existing ", "ion channel", " blockers, such as amiodarone, dronedarone, bepridil, aprindine, and ", "cibenzoline", ", have been found to have an NCX inhibitory action."], "h": {"pos": [1, 2], "type": null, "name": "ion channel  blockers, such as amiodarone, dronedarone, bepridil, aprindine, and "}, "t": {"pos": [3, 4], "type": null, "name": "cibenzoline , have been found to have an NCX inhibitory action."}}
{"relation": "INHIBITOR", "token": ["", "Wogonoside", " also suppressed the activation of mammalian target of rapamycin (mTOR) and p70-S6 kinase (", "p70S6K)", " by regulating the expression of the extracellular signal-regulated kinase (ERK1/2) and p38 involved mitogen-activated protein kinase (MAPK) signaling pathway."], "h": {"pos": [1, 2], "type": null, "name": "Wogonoside  also suppressed the activation of mammalian target of rapamycin (mTOR) and p70-S6 kinase ("}, "t": {"pos": [3, 4], "type": null, "name": "p70S6K)  by regulating the expression of the extracellular signal-regulated kinase (ERK1/2) and p38 involved mitogen-activated protein kinase (MAPK) signaling pathway."}}
{"relation": "INHIBITOR", "token": ["Sorafenib (BAY 43-9006, ", "Nexavar", "), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and ", "tyrosine kinases", " VEGFR/PDGFR in tumor vasculature."], "h": {"pos": [1, 2], "type": null, "name": "Nexavar ), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and "}, "t": {"pos": [3, 4], "type": null, "name": "tyrosine kinases  VEGFR/PDGFR in tumor vasculature."}}
{"relation": "INHIBITOR", "token": ["Using a unique biosensor-based assay, trifluoperazine (", "TFP", ") was identified as an inhibitor that disrupts the ", "S100A4", "/myosin-IIA interaction."], "h": {"pos": [1, 2], "type": null, "name": "TFP ) was identified as an inhibitor that disrupts the "}, "t": {"pos": [3, 4], "type": null, "name": "S100A4 /myosin-IIA interaction."}}
{"relation": "INHIBITOR", "token": ["Our data revealed that inhibition of ", "MAO-A", "-mediated metabolic elimination by ", "harmaline", " (2, 5, and 15 mg/kg) led to a sharp increase in systemic and cerebral exposure to 5-MeO-DMT (2 and 10 mg/kg) at all dose combinations."], "h": {"pos": [1, 2], "type": null, "name": "MAO-A -mediated metabolic elimination by "}, "t": {"pos": [3, 4], "type": null, "name": "harmaline  (2, 5, and 15 mg/kg) led to a sharp increase in systemic and cerebral exposure to 5-MeO-DMT (2 and 10 mg/kg) at all dose combinations."}}
{"relation": "INHIBITOR", "token": ["4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate and its ortho-halogenated (", "F", ", Cl, Br) derivatives are first-generation dual ", "aromatase", " and sulfatase inhibitors (DASIs)."], "h": {"pos": [1, 2], "type": null, "name": "F , Cl, Br) derivatives are first-generation dual "}, "t": {"pos": [3, 4], "type": null, "name": "aromatase  and sulfatase inhibitors (DASIs)."}}
{"relation": "INHIBITOR", "token": ["These findings demonstrate that cinnamon ", "polyphenols", " can exert the hypoglycemic and hypolipidemic effects through the mechanisms that may be associated with repairing pancreatic beta cells in diabetic mice and improving its anti-oxidative capacity, as well as attenuating cytotoxicity via inhibition of ", "iNOS", ", NF-\u03baB activation."], "h": {"pos": [1, 2], "type": null, "name": "polyphenols  can exert the hypoglycemic and hypolipidemic effects through the mechanisms that may be associated with repairing pancreatic beta cells in diabetic mice and improving its anti-oxidative capacity, as well as attenuating cytotoxicity via inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "iNOS , NF-\u03baB activation."}}
{"relation": "INHIBITOR", "token": ["Stereospecific inhibition of ", "monoamine uptake transporters", " by ", "meta-hydroxyephedrine", " isomers."], "h": {"pos": [1, 2], "type": null, "name": "monoamine uptake transporters  by "}, "t": {"pos": [3, 4], "type": null, "name": "meta-hydroxyephedrine  isomers."}}
{"relation": "INHIBITOR", "token": ["In contrast, ", "2, 4-dioxo-5-acetamido-6-phenylhexanoic acid", ", which is a competitive inhibitor with respect to ascorbate, exhibits a low degree of stereospecificity in binding to the ascorbate sites of both ", "PAM", " and dopamine-beta-hydroxylase."], "h": {"pos": [1, 2], "type": null, "name": "2, 4-dioxo-5-acetamido-6-phenylhexanoic acid , which is a competitive inhibitor with respect to ascorbate, exhibits a low degree of stereospecificity in binding to the ascorbate sites of both "}, "t": {"pos": [3, 4], "type": null, "name": "PAM  and dopamine-beta-hydroxylase."}}
{"relation": "INHIBITOR", "token": ["", "HSYA", " treatment also decreased NF-\u03baB p65 nuclear translocation and inhibited the phosphorylation of ", "p38", " mitogen-activated protein kinase (p38 MAPK)."], "h": {"pos": [1, 2], "type": null, "name": "HSYA  treatment also decreased NF-\u03baB p65 nuclear translocation and inhibited the phosphorylation of "}, "t": {"pos": [3, 4], "type": null, "name": "p38  mitogen-activated protein kinase (p38 MAPK)."}}
{"relation": "INHIBITOR", "token": ["BDZs and other positive GABA(A)R modulators, including barbiturates, ethanol, and ", "neurosteroids", ", can also inhibit ", "L-type voltage-gated calcium channels", " (L-VGCCs), which could contribute to reduced neuronal excitability."], "h": {"pos": [1, 2], "type": null, "name": "neurosteroids , can also inhibit "}, "t": {"pos": [3, 4], "type": null, "name": "L-type voltage-gated calcium channels  (L-VGCCs), which could contribute to reduced neuronal excitability."}}
{"relation": "INHIBITOR", "token": ["", "Mazindol", " analogues as potential inhibitors of the cocaine binding site at the ", "dopamine transporter", "."], "h": {"pos": [1, 2], "type": null, "name": "Mazindol  analogues as potential inhibitors of the cocaine binding site at the "}, "t": {"pos": [3, 4], "type": null, "name": "dopamine transporter ."}}
{"relation": "INHIBITOR", "token": ["", "N", "-alkylation of the pyridazinone ring markedly enhances potency against PDE4 but suppresses ", "PDE3", " inhibition."], "h": {"pos": [1, 2], "type": null, "name": "N -alkylation of the pyridazinone ring markedly enhances potency against PDE4 but suppresses "}, "t": {"pos": [3, 4], "type": null, "name": "PDE3  inhibition."}}
{"relation": "INHIBITOR", "token": ["", "DHODH", " inhibition occurs at lower concentrations of ", "A77 1726", " than that of tyrosine kinases and is currently considered the major mode of action."], "h": {"pos": [1, 2], "type": null, "name": "DHODH  inhibition occurs at lower concentrations of "}, "t": {"pos": [3, 4], "type": null, "name": "A77 1726  than that of tyrosine kinases and is currently considered the major mode of action."}}
{"relation": "INHIBITOR", "token": ["Furthermore, proteosomal inhibitor ", "MG132", " suppressed AMPK activation, ", "GSK3\u03b2", " phosphorylation, cleaved PARP and deceased AEG-1 induced by ursolic acid in HepG2 cells."], "h": {"pos": [1, 2], "type": null, "name": "MG132  suppressed AMPK activation, "}, "t": {"pos": [3, 4], "type": null, "name": "GSK3\u03b2  phosphorylation, cleaved PARP and deceased AEG-1 induced by ursolic acid in HepG2 cells."}}
{"relation": "INHIBITOR", "token": ["A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ", "ferulic acid", ", gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, ", "EC 4.2.1.1", ")."], "h": {"pos": [1, 2], "type": null, "name": "ferulic acid , gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, "}, "t": {"pos": [3, 4], "type": null, "name": "EC 4.2.1.1 )."}}
{"relation": "INHIBITOR", "token": ["Everolimus (RAD001, ", "Afinitor((R)) Novartis", ") is the first oral inhibitor of mTOR (", "mammalian target of rapamycin", ") to reach the oncology clinic."], "h": {"pos": [1, 2], "type": null, "name": "Afinitor((R)) Novartis ) is the first oral inhibitor of mTOR ("}, "t": {"pos": [3, 4], "type": null, "name": "mammalian target of rapamycin ) to reach the oncology clinic."}}
{"relation": "INHIBITOR", "token": ["A series of phenolic acids and phenol natural products, such as ", "p-hydroxybenzoic acid", ", p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the ", "metalloenzyme", " carbonic anhydrase (CA, EC 4.2.1.1)."], "h": {"pos": [1, 2], "type": null, "name": "p-hydroxybenzoic acid , p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the "}, "t": {"pos": [3, 4], "type": null, "name": "metalloenzyme  carbonic anhydrase (CA, EC 4.2.1.1)."}}
{"relation": "INHIBITOR", "token": ["", "Ca(v)1.3", " channels were less sensitive to pentobarbital inhibition than Ca(v)1.2 channels, similar to dihydropyridine (", "DHP", ") L-VGCC antagonists."], "h": {"pos": [1, 2], "type": null, "name": "Ca(v)1.3  channels were less sensitive to pentobarbital inhibition than Ca(v)1.2 channels, similar to dihydropyridine ("}, "t": {"pos": [3, 4], "type": null, "name": "DHP ) L-VGCC antagonists."}}
{"relation": "INHIBITOR", "token": ["Here we report the re-engineering of ", "navitoclax", " to create a highly potent, orally bioavailable and ", "BCL-2", "-selective inhibitor, ABT-199."], "h": {"pos": [1, 2], "type": null, "name": "navitoclax  to create a highly potent, orally bioavailable and "}, "t": {"pos": [3, 4], "type": null, "name": "BCL-2 -selective inhibitor, ABT-199."}}
{"relation": "INHIBITOR", "token": ["", "Licofelone", ", a dual anti-inflammatory drug that inhibits 5-lipoxygenase (LOX) and cyclooxygenase (COX) enzymes, may have a better cardiovascular profile that cycloxygenase-2 inhibitors due to ", "cycloxygenase-1", " blockade-mediated antithrombotic effect and a better gastrointestinal tolerability."], "h": {"pos": [1, 2], "type": null, "name": "Licofelone , a dual anti-inflammatory drug that inhibits 5-lipoxygenase (LOX) and cyclooxygenase (COX) enzymes, may have a better cardiovascular profile that cycloxygenase-2 inhibitors due to "}, "t": {"pos": [3, 4], "type": null, "name": "cycloxygenase-1  blockade-mediated antithrombotic effect and a better gastrointestinal tolerability."}}
{"relation": "INHIBITOR", "token": ["A pronounced NET knockout-induced shortening of the immobility time in the TST (by ca 50%) compared to WT mice was not reduced any further by ", "NET", "-inhibiting ADs such as reboxetine, desipramine, and ", "imipramine", "."], "h": {"pos": [1, 2], "type": null, "name": "NET -inhibiting ADs such as reboxetine, desipramine, and "}, "t": {"pos": [3, 4], "type": null, "name": "imipramine ."}}
{"relation": "INHIBITOR", "token": ["The reciprocal inhibition of SR-BI and ", "ABCA1", " by BLT-4 and ", "glyburide", " raises the possibility that these proteins may share similar or common steps in their mechanisms of lipid transport."], "h": {"pos": [1, 2], "type": null, "name": "ABCA1  by BLT-4 and "}, "t": {"pos": [3, 4], "type": null, "name": "glyburide  raises the possibility that these proteins may share similar or common steps in their mechanisms of lipid transport."}}
{"relation": "INHIBITOR", "token": ["Given that ", "FRD", ", present in all H. pylori strains, is immunogenic in H. pylori -infected patients and H. pylori growth in vitro can be inhibited by three anthelmintics (morantel, ", "oxantel", " and thiabendazole), this enzyme could potentially be used both as a novel drug target as well as in the development of vaccines for H. pylori prevention and eradication."], "h": {"pos": [1, 2], "type": null, "name": "FRD , present in all H. pylori strains, is immunogenic in H. pylori -infected patients and H. pylori growth in vitro can be inhibited by three anthelmintics (morantel, "}, "t": {"pos": [3, 4], "type": null, "name": "oxantel  and thiabendazole), this enzyme could potentially be used both as a novel drug target as well as in the development of vaccines for H. pylori prevention and eradication."}}
{"relation": "INHIBITOR", "token": ["Comparison of the ", "monoamine oxidase", " inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and ", "toloxatone", ", and assessment of their effect on psychometric performance in healthy subjects."], "h": {"pos": [1, 2], "type": null, "name": "monoamine oxidase  inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and "}, "t": {"pos": [3, 4], "type": null, "name": "toloxatone , and assessment of their effect on psychometric performance in healthy subjects."}}
{"relation": "INHIBITOR", "token": ["Again, inhibition of the actin-activated myosin Mg2+-ATPase and ", "myosin", " filament assembly by ", "felodipine", " and the p-chloro analogue could be reversed by raising the calmodulin concentration."], "h": {"pos": [1, 2], "type": null, "name": "myosin  filament assembly by "}, "t": {"pos": [3, 4], "type": null, "name": "felodipine  and the p-chloro analogue could be reversed by raising the calmodulin concentration."}}
{"relation": "INHIBITOR", "token": ["In this article, the action of ", "dasatinib", " (BMS-354825) is contrasted with that of imatinib, a ", "kinase", " inhibitor that is currently being used to treat chronic myelogenous leukemia and other disorders."], "h": {"pos": [1, 2], "type": null, "name": "dasatinib  (BMS-354825) is contrasted with that of imatinib, a "}, "t": {"pos": [3, 4], "type": null, "name": "kinase  inhibitor that is currently being used to treat chronic myelogenous leukemia and other disorders."}}
{"relation": "INHIBITOR", "token": ["Inhibition by phenformin of oxygen consumption via complex I respiration in isolated rat liver mitochondria was greater than that in heart mitochondria, whereas inhibitory effect of ", "phenformin", " on ", "complex I", " respiration was similar in inside-out structured submitochondrial particles prepared from rat livers and hearts."], "h": {"pos": [1, 2], "type": null, "name": "phenformin  on "}, "t": {"pos": [3, 4], "type": null, "name": "complex I  respiration was similar in inside-out structured submitochondrial particles prepared from rat livers and hearts."}}
{"relation": "INHIBITOR", "token": ["Interestingly, ", "gemfibrozil", " strongly inhibited the activation of NF-kappaB, ", "AP-1", ", and C/EBPbeta but not that of GAS in cytokine-stimulated astroglial cells."], "h": {"pos": [1, 2], "type": null, "name": "gemfibrozil  strongly inhibited the activation of NF-kappaB, "}, "t": {"pos": [3, 4], "type": null, "name": "AP-1 , and C/EBPbeta but not that of GAS in cytokine-stimulated astroglial cells."}}
{"relation": "INHIBITOR", "token": ["", "Glufosinate", " inhibits ", "glutamine synthetase", " and blocks biosynthesis of glutamine."], "h": {"pos": [1, 2], "type": null, "name": "Glufosinate  inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "glutamine synthetase  and blocks biosynthesis of glutamine."}}
{"relation": "INHIBITOR", "token": ["Existing ion channel blockers, such as amiodarone, dronedarone, bepridil, ", "aprindine", ", and cibenzoline, have been found to have an ", "NCX", " inhibitory action."], "h": {"pos": [1, 2], "type": null, "name": "aprindine , and cibenzoline, have been found to have an "}, "t": {"pos": [3, 4], "type": null, "name": "NCX  inhibitory action."}}
{"relation": "INHIBITOR", "token": ["Depletion of putrescine, spermidine, and spermine by ", "DL-alpha-difluoromethylornithine", " (DFMO), a specific inhibitor of ornithine decarboxylase (", "ODC", ") that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index."], "h": {"pos": [1, 2], "type": null, "name": "DL-alpha-difluoromethylornithine  (DFMO), a specific inhibitor of ornithine decarboxylase ("}, "t": {"pos": [3, 4], "type": null, "name": "ODC ) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index."}}
{"relation": "INHIBITOR", "token": ["Taken together, our study demonstrated that ", "SB365", " inhibits the AKT/", "mTOR", " pathway, leading to the suppression of tumor growth and angiogenesis together with induction of apoptosis."], "h": {"pos": [1, 2], "type": null, "name": "SB365  inhibits the AKT/"}, "t": {"pos": [3, 4], "type": null, "name": "mTOR  pathway, leading to the suppression of tumor growth and angiogenesis together with induction of apoptosis."}}
{"relation": "INHIBITOR", "token": ["Pharmacophore identification of ", "c-Myc", " inhibitor ", "10074-G5", "."], "h": {"pos": [1, 2], "type": null, "name": "c-Myc  inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "10074-G5 ."}}
{"relation": "INHIBITOR", "token": ["Both NS-398 and ", "Dup-697", " exhibited time-dependent inactivation of ", "hCOX-2", ", as did indomethacin on both enzymes."], "h": {"pos": [1, 2], "type": null, "name": "Dup-697  exhibited time-dependent inactivation of "}, "t": {"pos": [3, 4], "type": null, "name": "hCOX-2 , as did indomethacin on both enzymes."}}
{"relation": "INHIBITOR", "token": ["Nitrogen-containing bisphosphonates (N-", "BPs", ") induce apoptosis in tumor cells by inhibiting the prenylation of small ", "G-proteins", "."], "h": {"pos": [1, 2], "type": null, "name": "BPs ) induce apoptosis in tumor cells by inhibiting the prenylation of small "}, "t": {"pos": [3, 4], "type": null, "name": "G-proteins ."}}
{"relation": "INHIBITOR", "token": ["A series of ", "phosphorylated flavonoids", " were synthesized and investigated in\u00a0vitro as inhibitors of pancreatic cholesterol esterase (CEase) and acetylcholinesterase (", "AChE", ")."], "h": {"pos": [1, 2], "type": null, "name": "phosphorylated flavonoids  were synthesized and investigated in\u00a0vitro as inhibitors of pancreatic cholesterol esterase (CEase) and acetylcholinesterase ("}, "t": {"pos": [3, 4], "type": null, "name": "AChE )."}}
{"relation": "INHIBITOR", "token": ["Many clinical studies, both pre- and post-marketing, have demonstrated the clinical efficacy and safety of sildenafil (", "Viagra", ", Pfizer) - the first approved selective ", "PDE", " inhibitor for the treatment of ED."], "h": {"pos": [1, 2], "type": null, "name": "Viagra , Pfizer) - the first approved selective "}, "t": {"pos": [3, 4], "type": null, "name": "PDE  inhibitor for the treatment of ED."}}
{"relation": "INHIBITOR", "token": ["These results suggest that ", "gemfibrozil", " inhibits the induction of ", "iNOS", " probably by inhibiting the activation of NF-kappaB, AP-1, and C/EBPbeta and that gemfibrozil, a prescribed drug for humans, may further find its therapeutic use in neuroinflammatory diseases."], "h": {"pos": [1, 2], "type": null, "name": "gemfibrozil  inhibits the induction of "}, "t": {"pos": [3, 4], "type": null, "name": "iNOS  probably by inhibiting the activation of NF-kappaB, AP-1, and C/EBPbeta and that gemfibrozil, a prescribed drug for humans, may further find its therapeutic use in neuroinflammatory diseases."}}
{"relation": "INHIBITOR", "token": ["From these results, it is suggested that ", "troglitazone", " may enhance the vasodilatory effect of adenosine by inhibiting ", "ENT1", "."], "h": {"pos": [1, 2], "type": null, "name": "troglitazone  may enhance the vasodilatory effect of adenosine by inhibiting "}, "t": {"pos": [3, 4], "type": null, "name": "ENT1 ."}}
{"relation": "INHIBITOR", "token": ["", "Phenols", " like the ones investigated here possess a ", "CA", " inhibition mechanism distinct of that of the sulfonamides/sulfamates used clinically or the coumarins."], "h": {"pos": [1, 2], "type": null, "name": "Phenols  like the ones investigated here possess a "}, "t": {"pos": [3, 4], "type": null, "name": "CA  inhibition mechanism distinct of that of the sulfonamides/sulfamates used clinically or the coumarins."}}
{"relation": "INHIBITOR", "token": ["Catecholamines (adrenaline, noradrenaline and ", "dopamine", ") are potent inhibitors of phenylalanine 4-monooxygenase (phenylalanine hydroxylase, ", "EC 1.14.16.1", ")."], "h": {"pos": [1, 2], "type": null, "name": "dopamine ) are potent inhibitors of phenylalanine 4-monooxygenase (phenylalanine hydroxylase, "}, "t": {"pos": [3, 4], "type": null, "name": "EC 1.14.16.1 )."}}
{"relation": "INHIBITOR", "token": ["Given that ", "FRD", ", present in all H. pylori strains, is immunogenic in H. pylori -infected patients and H. pylori growth in vitro can be inhibited by three anthelmintics (", "morantel", ", oxantel and thiabendazole), this enzyme could potentially be used both as a novel drug target as well as in the development of vaccines for H. pylori prevention and eradication."], "h": {"pos": [1, 2], "type": null, "name": "FRD , present in all H. pylori strains, is immunogenic in H. pylori -infected patients and H. pylori growth in vitro can be inhibited by three anthelmintics ("}, "t": {"pos": [3, 4], "type": null, "name": "morantel , oxantel and thiabendazole), this enzyme could potentially be used both as a novel drug target as well as in the development of vaccines for H. pylori prevention and eradication."}}
{"relation": "INHIBITOR", "token": ["Synthesis, molecular modeling and evaluation of novel ", "N'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone", " derivatives as dual inhibitors for ", "cholinesterases", " and A\u03b2 aggregation."], "h": {"pos": [1, 2], "type": null, "name": "N'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone  derivatives as dual inhibitors for "}, "t": {"pos": [3, 4], "type": null, "name": "cholinesterases  and A\u03b2 aggregation."}}
{"relation": "INHIBITOR", "token": ["Regarding ", "urease", " inhibition, ", "n-butanol", " was the most potent fraction (IC50: 97 \u00b5g/mL)."], "h": {"pos": [1, 2], "type": null, "name": "urease  inhibition, "}, "t": {"pos": [3, 4], "type": null, "name": "n-butanol  was the most potent fraction (IC50: 97 \u00b5g/mL)."}}
{"relation": "INHIBITOR", "token": ["Therefore, the objective of the present study was to investigate the effects of ", "PLA2", " inhibitors p-bromophenacyl bromide (", "BPB", ") and arachidonyl trifluoromethyl ketone (AACOCF3) on interleukin-2 (IL-2) expression in murine primary splenocytes."], "h": {"pos": [1, 2], "type": null, "name": "PLA2  inhibitors p-bromophenacyl bromide ("}, "t": {"pos": [3, 4], "type": null, "name": "BPB ) and arachidonyl trifluoromethyl ketone (AACOCF3) on interleukin-2 (IL-2) expression in murine primary splenocytes."}}
{"relation": "INHIBITOR", "token": ["", "Nateglinide", " inhibits Kir6.2/", "SUR1", " and Kir6.2/SUR2B channels at 100 nM, and inhibits Kir6.2/SUR2A channels at high concentrations (1 microM)."], "h": {"pos": [1, 2], "type": null, "name": "Nateglinide  inhibits Kir6.2/"}, "t": {"pos": [3, 4], "type": null, "name": "SUR1  and Kir6.2/SUR2B channels at 100 nM, and inhibits Kir6.2/SUR2A channels at high concentrations (1 microM)."}}
{"relation": "INHIBITOR", "token": ["They included the COX-1 inhibitor indomethacin; the COX-2 inhibitor NS-398; the mixed ", "COX-1", "/COX-2 inhibitor ", "ibuprofen", "; the nitric oxide (NO) derivatives of indomethacin, ibuprofen and flurbiprofen; the 5-LOX inhibitor REV 5901; and the 5-LOX activating protein (FLAP) inhibitor MK-886."], "h": {"pos": [1, 2], "type": null, "name": "COX-1 /COX-2 inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "ibuprofen ; the nitric oxide (NO) derivatives of indomethacin, ibuprofen and flurbiprofen; the 5-LOX inhibitor REV 5901; and the 5-LOX activating protein (FLAP) inhibitor MK-886."}}
{"relation": "INHIBITOR", "token": ["", "Felbamate", " produced a rapid, concentration-dependent block of currents evoked by 50 microM NMDA and 10 microM glycine in human embryonic kidney 293 cells expressing the ", "rat NR1a", " subunit, and either the NR2A, NR2B or NR2C subunits; the IC50 values for block were 2.6, 0.52 and 2.4 mM, respectively (holding potential, - 60 mV)."], "h": {"pos": [1, 2], "type": null, "name": "Felbamate  produced a rapid, concentration-dependent block of currents evoked by 50 microM NMDA and 10 microM glycine in human embryonic kidney 293 cells expressing the "}, "t": {"pos": [3, 4], "type": null, "name": "rat NR1a  subunit, and either the NR2A, NR2B or NR2C subunits; the IC50 values for block were 2.6, 0.52 and 2.4 mM, respectively (holding potential, - 60 mV)."}}
{"relation": "INHIBITOR", "token": ["The results suggest that the 63-kDa (PDE 1B1) and 60-kDa (PDE 1A2) ", "CaMPDE", " isozymes are inhibited by felodipine and ", "nicardipine", " by partial competitive inhibition and that these two Ca2+ antagonists appear to counteract each other."], "h": {"pos": [1, 2], "type": null, "name": "CaMPDE  isozymes are inhibited by felodipine and "}, "t": {"pos": [3, 4], "type": null, "name": "nicardipine  by partial competitive inhibition and that these two Ca2+ antagonists appear to counteract each other."}}
{"relation": "INHIBITOR", "token": ["BDZs and other positive GABA(A)R modulators, including barbiturates, ", "ethanol", ", and neurosteroids, can also inhibit L-type voltage-gated calcium channels (", "L-VGCCs", "), which could contribute to reduced neuronal excitability."], "h": {"pos": [1, 2], "type": null, "name": "ethanol , and neurosteroids, can also inhibit L-type voltage-gated calcium channels ("}, "t": {"pos": [3, 4], "type": null, "name": "L-VGCCs ), which could contribute to reduced neuronal excitability."}}
{"relation": "INHIBITOR", "token": ["A series of ", "phosphorylated flavonoids", " were synthesized and investigated in\u00a0vitro as inhibitors of pancreatic cholesterol esterase (", "CEase", ") and acetylcholinesterase (AChE)."], "h": {"pos": [1, 2], "type": null, "name": "phosphorylated flavonoids  were synthesized and investigated in\u00a0vitro as inhibitors of pancreatic cholesterol esterase ("}, "t": {"pos": [3, 4], "type": null, "name": "CEase ) and acetylcholinesterase (AChE)."}}
{"relation": "INHIBITOR", "token": ["5-Fluorouracil (5-FU), 5-fluoro-2'-deoxyuridine (", "FdUrd", ") and 5-trifluorothymidine (F3(d)Thd) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of ", "thymidylate synthase", " (TS)."], "h": {"pos": [1, 2], "type": null, "name": "FdUrd ) and 5-trifluorothymidine (F3(d)Thd) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "thymidylate synthase  (TS)."}}
{"relation": "INHIBITOR", "token": ["Sorafenib (", "BAY 43-9006", ", Nexavar), a dual-action inhibitor that targets RAF/MEK/", "ERK", " pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature."], "h": {"pos": [1, 2], "type": null, "name": "BAY 43-9006 , Nexavar), a dual-action inhibitor that targets RAF/MEK/"}, "t": {"pos": [3, 4], "type": null, "name": "ERK  pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature."}}
{"relation": "INHIBITOR", "token": ["Pharmacological doses of the ", "mTOR", " inhibitor ", "rapamycin", " reduce albuminura in diabetes."], "h": {"pos": [1, 2], "type": null, "name": "mTOR  inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "rapamycin  reduce albuminura in diabetes."}}
{"relation": "INHIBITOR", "token": ["At the enzymatic activity level, ", "doxycycline", " started to suppress ", "MMP-9", " activity at 5 mg/kg/day (P<0.001), while minocycline had an effect at a lower dose, 1 mg/kg/day (P<0.02)."], "h": {"pos": [1, 2], "type": null, "name": "doxycycline  started to suppress "}, "t": {"pos": [3, 4], "type": null, "name": "MMP-9  activity at 5 mg/kg/day (P<0.001), while minocycline had an effect at a lower dose, 1 mg/kg/day (P<0.02)."}}
{"relation": "INHIBITOR", "token": ["The results suggest that the 63-kDa (PDE 1B1) and 60-kDa (PDE 1A2) ", "CaMPDE", " isozymes are inhibited by ", "felodipine", " and nicardipine by partial competitive inhibition and that these two Ca2+ antagonists appear to counteract each other."], "h": {"pos": [1, 2], "type": null, "name": "CaMPDE  isozymes are inhibited by "}, "t": {"pos": [3, 4], "type": null, "name": "felodipine  and nicardipine by partial competitive inhibition and that these two Ca2+ antagonists appear to counteract each other."}}
{"relation": "INHIBITOR", "token": ["Preclinical pharmacokinetics and in vitro metabolism of ", "dasatinib", " (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-", "ABL", "."], "h": {"pos": [1, 2], "type": null, "name": "dasatinib  (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-"}, "t": {"pos": [3, 4], "type": null, "name": "ABL ."}}
{"relation": "INHIBITOR", "token": ["", "Epidermal growth factor receptor", " inhibitors currently under investigation include the small molecules gefitinib (Iressa, ZD1839) and erlotinib (", "Tarceva", ", OSI-774), as well as monoclonal antibodies such as cetuximab (IMC-225, Erbitux)."], "h": {"pos": [1, 2], "type": null, "name": "Epidermal growth factor receptor  inhibitors currently under investigation include the small molecules gefitinib (Iressa, ZD1839) and erlotinib ("}, "t": {"pos": [3, 4], "type": null, "name": "Tarceva , OSI-774), as well as monoclonal antibodies such as cetuximab (IMC-225, Erbitux)."}}
{"relation": "INHIBITOR", "token": ["Second, ", "ICRF-187", ", a ", "Top2", " catalytic inhibitor known to deplete Top2\u03b2, specifically sensitized MEFs to CPT."], "h": {"pos": [1, 2], "type": null, "name": "ICRF-187 , a "}, "t": {"pos": [3, 4], "type": null, "name": "Top2  catalytic inhibitor known to deplete Top2\u03b2, specifically sensitized MEFs to CPT."}}
{"relation": "INHIBITOR", "token": ["The ", "acetylcholinesterase", " (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ ", "4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine", " (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."], "h": {"pos": [1, 2], "type": null, "name": "acetylcholinesterase  (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ "}, "t": {"pos": [3, 4], "type": null, "name": "4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine  (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."}}
{"relation": "INHIBITOR", "token": ["", "GW572016", ", a reversible small molecule inhibitor of EGFR and ", "ErbB2", " tyrosine kinases, inhibits baseline p95ErbB2 phosphorylation in BT474 cells and tumor xenografts."], "h": {"pos": [1, 2], "type": null, "name": "GW572016 , a reversible small molecule inhibitor of EGFR and "}, "t": {"pos": [3, 4], "type": null, "name": "ErbB2  tyrosine kinases, inhibits baseline p95ErbB2 phosphorylation in BT474 cells and tumor xenografts."}}
{"relation": "INHIBITOR", "token": ["Among the isolated compounds, trans-dihydromorin (8), oxyresveratrol (9), and ", "steppogenin", " (12) were found to exhibit significant ", "tyrosinase", " inhibition activities."], "h": {"pos": [1, 2], "type": null, "name": "steppogenin  (12) were found to exhibit significant "}, "t": {"pos": [3, 4], "type": null, "name": "tyrosinase  inhibition activities."}}
{"relation": "INHIBITOR", "token": ["Assays examining the ability of ", "TFP", " to block ", "S100A4", "-mediated disassembly of myosin-IIA filaments demonstrate that significant inhibition of S100A4 function occurs only at TFP concentrations that promote S100A4 oligomerization."], "h": {"pos": [1, 2], "type": null, "name": "TFP  to block "}, "t": {"pos": [3, 4], "type": null, "name": "S100A4 -mediated disassembly of myosin-IIA filaments demonstrate that significant inhibition of S100A4 function occurs only at TFP concentrations that promote S100A4 oligomerization."}}
{"relation": "INHIBITOR", "token": ["We previously employed a chemical genomic strategy to identify a novel small molecule, ", "MAC13243", ", as a likely inhibitor of the bacterial lipoprotein targeting chaperone, ", "LolA", "."], "h": {"pos": [1, 2], "type": null, "name": "MAC13243 , as a likely inhibitor of the bacterial lipoprotein targeting chaperone, "}, "t": {"pos": [3, 4], "type": null, "name": "LolA ."}}
{"relation": "INHIBITOR", "token": ["", "Wogonoside", " also suppressed the activation of mammalian target of rapamycin (", "mTOR", ") and p70-S6 kinase (p70S6K) by regulating the expression of the extracellular signal-regulated kinase (ERK1/2) and p38 involved mitogen-activated protein kinase (MAPK) signaling pathway."], "h": {"pos": [1, 2], "type": null, "name": "Wogonoside  also suppressed the activation of mammalian target of rapamycin ("}, "t": {"pos": [3, 4], "type": null, "name": "mTOR ) and p70-S6 kinase (p70S6K) by regulating the expression of the extracellular signal-regulated kinase (ERK1/2) and p38 involved mitogen-activated protein kinase (MAPK) signaling pathway."}}
{"relation": "INHIBITOR", "token": ["The inhibitory effects of iloprost on ", "tissue factor", " expression were also potentiated by isobutylmethylxanthine and mimicked by ", "forskolin", " and dibutyryl cyclic AMP but not dibutyryl cyclic GMP."], "h": {"pos": [1, 2], "type": null, "name": "tissue factor  expression were also potentiated by isobutylmethylxanthine and mimicked by "}, "t": {"pos": [3, 4], "type": null, "name": "forskolin  and dibutyryl cyclic AMP but not dibutyryl cyclic GMP."}}
{"relation": "INHIBITOR", "token": ["", "Mazindol", " analogues as potential inhibitors of the ", "cocaine binding site", " at the dopamine transporter."], "h": {"pos": [1, 2], "type": null, "name": "Mazindol  analogues as potential inhibitors of the "}, "t": {"pos": [3, 4], "type": null, "name": "cocaine binding site  at the dopamine transporter."}}
{"relation": "INHIBITOR", "token": ["", "Indomethacin", " treatment led to an increase in lipid peroxidation, glutathione peroxidase and glucose-6-phosphate dehydrogenase activities and to a decrease in ", "catalase", " activity and glutathione levels in gastric mucosa."], "h": {"pos": [1, 2], "type": null, "name": "Indomethacin  treatment led to an increase in lipid peroxidation, glutathione peroxidase and glucose-6-phosphate dehydrogenase activities and to a decrease in "}, "t": {"pos": [3, 4], "type": null, "name": "catalase  activity and glutathione levels in gastric mucosa."}}
{"relation": "INHIBITOR", "token": ["A novel class of ", "biaryl urea", " that inhibits C-RAF ", "kinase", " was discovered using a combination of medicinal and combinatorial chemistry approaches."], "h": {"pos": [1, 2], "type": null, "name": "biaryl urea  that inhibits C-RAF "}, "t": {"pos": [3, 4], "type": null, "name": "kinase  was discovered using a combination of medicinal and combinatorial chemistry approaches."}}
{"relation": "INHIBITOR", "token": ["The aim of this study was to evaluate the influence of hepatic impairment on the pharmacokinetics (PK) of the novel cyclooxygenase-2 (", "COX-2", ") selective inhibitor ", "lumiracoxib", " (Prexige), so that dose recommendations for clinical use can be provided."], "h": {"pos": [1, 2], "type": null, "name": "COX-2 ) selective inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "lumiracoxib  (Prexige), so that dose recommendations for clinical use can be provided."}}
{"relation": "INHIBITOR", "token": ["The antipsychotic drugs ", "sertindole", " and pimozide block erg3, a ", "human brain K(+) channel", "."], "h": {"pos": [1, 2], "type": null, "name": "sertindole  and pimozide block erg3, a "}, "t": {"pos": [3, 4], "type": null, "name": "human brain K(+) channel ."}}
{"relation": "INHIBITOR", "token": ["Likewise, IL-2 steady-state mRNA expression was inhibited by both ", "PLA2", " inhibitors in a concentration-dependent fashion with > 90% inhibition at 1 microM ", "BPB", " and 20 microM AACOCF3."], "h": {"pos": [1, 2], "type": null, "name": "PLA2  inhibitors in a concentration-dependent fashion with > 90% inhibition at 1 microM "}, "t": {"pos": [3, 4], "type": null, "name": "BPB  and 20 microM AACOCF3."}}
{"relation": "INHIBITOR", "token": ["Sodium salicylate and ", "aspirin", " also inhibited NF-kappa B-dependent transcription from the ", "Ig kappa", " enhancer and the human immunodeficiency virus (HIV) long terminal repeat (LTR) in transfected T cells."], "h": {"pos": [1, 2], "type": null, "name": "aspirin  also inhibited NF-kappa B-dependent transcription from the "}, "t": {"pos": [3, 4], "type": null, "name": "Ig kappa  enhancer and the human immunodeficiency virus (HIV) long terminal repeat (LTR) in transfected T cells."}}
{"relation": "INHIBITOR", "token": ["We describe the discovery of several ", "pyrrolopyrazines", " as potent and selective ", "Syk", " inhibitors and the efforts that eventually led to the desired improvements in physicochemical properties and human whole blood potencies."], "h": {"pos": [1, 2], "type": null, "name": "pyrrolopyrazines  as potent and selective "}, "t": {"pos": [3, 4], "type": null, "name": "Syk  inhibitors and the efforts that eventually led to the desired improvements in physicochemical properties and human whole blood potencies."}}
{"relation": "INHIBITOR", "token": ["No influence of moderate hepatic impairment on the pharmacokinetics of ", "lumiracoxib", ", an oral ", "COX-2", " selective inhibitor."], "h": {"pos": [1, 2], "type": null, "name": "lumiracoxib , an oral "}, "t": {"pos": [3, 4], "type": null, "name": "COX-2  selective inhibitor."}}
{"relation": "INHIBITOR", "token": ["Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>neostigmine=physostigmine =", "tacrine", ">pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of ", "acetylcholinesterase", " also displaced [3H]-oxotremorine-M to the greatest extent."], "h": {"pos": [1, 2], "type": null, "name": "tacrine >pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of "}, "t": {"pos": [3, 4], "type": null, "name": "acetylcholinesterase  also displaced [3H]-oxotremorine-M to the greatest extent."}}
{"relation": "INHIBITOR", "token": ["The antipsychotic drugs sertindole and ", "pimozide", " are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as HERG (human ether-a-go-go-related gene; ", "erg1", ")."], "h": {"pos": [1, 2], "type": null, "name": "pimozide  are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as HERG (human ether-a-go-go-related gene; "}, "t": {"pos": [3, 4], "type": null, "name": "erg1 )."}}
{"relation": "INHIBITOR", "token": ["The beta subunit has been cloned and shown to lower the K(m) of methionine adenosyltransferase II alpha2 (the ", "MAT2A", " product) for methionine and to render the enzyme more susceptible to ", "S-adenosylmethionine", " inhibition."], "h": {"pos": [1, 2], "type": null, "name": "MAT2A  product) for methionine and to render the enzyme more susceptible to "}, "t": {"pos": [3, 4], "type": null, "name": "S-adenosylmethionine  inhibition."}}
{"relation": "INHIBITOR", "token": ["OBJECTIVES: The alkaloid galantamine (", "GAL", "), which exhibits a combined ", "anticholinesterase", " and direct parasympathomimetic mechanism of action, is employed in conjunction with therapeutic interventions in the stimulation of central cholinergic transfer in cognitive diseases."], "h": {"pos": [1, 2], "type": null, "name": "GAL ), which exhibits a combined "}, "t": {"pos": [3, 4], "type": null, "name": "anticholinesterase  and direct parasympathomimetic mechanism of action, is employed in conjunction with therapeutic interventions in the stimulation of central cholinergic transfer in cognitive diseases."}}
{"relation": "INHIBITOR", "token": ["This suppression was well correlated with the inhibitory effect of ", "auranofin", " on the homodimerization of ", "TLR4", " induced by an agonist."], "h": {"pos": [1, 2], "type": null, "name": "auranofin  on the homodimerization of "}, "t": {"pos": [3, 4], "type": null, "name": "TLR4  induced by an agonist."}}
{"relation": "INHIBITOR", "token": ["Previous studies by this research team proved that vasodilating ", "prostaglandins", " (PGs) E1, E2 and I2 inhibit carbonic anhydrase (", "CA", ") in vitro and in vivo, which suggested involvement of CA in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of PGs."], "h": {"pos": [1, 2], "type": null, "name": "prostaglandins  (PGs) E1, E2 and I2 inhibit carbonic anhydrase ("}, "t": {"pos": [3, 4], "type": null, "name": "CA ) in vitro and in vivo, which suggested involvement of CA in gastric acid secretion inhibition and the increase of gastric mucosa blood flow produced by this group of PGs."}}
{"relation": "INHIBITOR", "token": ["", "Licofelone", " almost abolished ", "5-LOX", " activity by inhibiting leukotriene B4 generation in rabbit neutrophils and prevented platelet thromboxane B2 production from whole blood."], "h": {"pos": [1, 2], "type": null, "name": "Licofelone  almost abolished "}, "t": {"pos": [3, 4], "type": null, "name": "5-LOX  activity by inhibiting leukotriene B4 generation in rabbit neutrophils and prevented platelet thromboxane B2 production from whole blood."}}
{"relation": "INHIBITOR", "token": ["In this study, focus was given to evaluate the ability of neoechinulin A, an ", "indole", " alkaloid isolated from marine-derived Microsporum sp., to attenuate microglial activation by oligomeric amyloid-\u03b2 1-42 (", "A\u03b242", ")."], "h": {"pos": [1, 2], "type": null, "name": "indole  alkaloid isolated from marine-derived Microsporum sp., to attenuate microglial activation by oligomeric amyloid-\u03b2 1-42 ("}, "t": {"pos": [3, 4], "type": null, "name": "A\u03b242 )."}}
{"relation": "INHIBITOR", "token": ["Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the ", "thymidylate synthase", " inhibitor ", "Tomudex", "."], "h": {"pos": [1, 2], "type": null, "name": "thymidylate synthase  inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "Tomudex ."}}
{"relation": "INHIBITOR", "token": ["The present results indicated that ", "N", "-BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/MEK/", "ERK", " and Ras/mTOR pathways."], "h": {"pos": [1, 2], "type": null, "name": "N -BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/MEK/"}, "t": {"pos": [3, 4], "type": null, "name": "ERK  and Ras/mTOR pathways."}}
{"relation": "INHIBITOR", "token": ["Inhibition of gelatinase A (", "MMP-2", ") by ", "batimastat", " and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma."], "h": {"pos": [1, 2], "type": null, "name": "MMP-2 ) by "}, "t": {"pos": [3, 4], "type": null, "name": "batimastat  and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma."}}
{"relation": "INHIBITOR", "token": ["However, combination of rasagiline (10 mg x kg(-1) i.p.) with L-DOPA or L-tryptophan (50 mg x kg(-1) i.p.), or rasagiline (10 mg x kg(-1) p.o.) with fluoxetine (10 mg x kg(-1) p.o.), did not induce the behavioural hyperactivity syndrome which is seen following inhibition of both MAO-A and ", "MAO-B", " by ", "tranylcypromine", " together with the monoamine precursors."], "h": {"pos": [1, 2], "type": null, "name": "MAO-B  by "}, "t": {"pos": [3, 4], "type": null, "name": "tranylcypromine  together with the monoamine precursors."}}
{"relation": "INHIBITOR", "token": ["Inhibition of ", "gelatinase A", " (MMP-2) by ", "batimastat", " and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma."], "h": {"pos": [1, 2], "type": null, "name": "gelatinase A  (MMP-2) by "}, "t": {"pos": [3, 4], "type": null, "name": "batimastat  and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma."}}
{"relation": "INHIBITOR", "token": ["To investigate the possibility that felbamate's favorable toxicity profile could be related to NMDA receptor subtype selectivity, we examined the specificity of ", "felbamate", " block of recombinant ", "NMDA receptors", " composed of the NR1a subunit and various NR2 subunits."], "h": {"pos": [1, 2], "type": null, "name": "felbamate  block of recombinant "}, "t": {"pos": [3, 4], "type": null, "name": "NMDA receptors  composed of the NR1a subunit and various NR2 subunits."}}
{"relation": "INHIBITOR", "token": ["Again, inhibition of the actin-activated myosin ", "Mg2+-ATPase", " and myosin filament assembly by felodipine and the ", "p-chloro", " analogue could be reversed by raising the calmodulin concentration."], "h": {"pos": [1, 2], "type": null, "name": "Mg2+-ATPase  and myosin filament assembly by felodipine and the "}, "t": {"pos": [3, 4], "type": null, "name": "p-chloro  analogue could be reversed by raising the calmodulin concentration."}}
{"relation": "INHIBITOR", "token": ["", "Acetylcholinesterase", " (AChE) inhibited by the organophosphate ", "soman", " (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex."], "h": {"pos": [1, 2], "type": null, "name": "Acetylcholinesterase  (AChE) inhibited by the organophosphate "}, "t": {"pos": [3, 4], "type": null, "name": "soman  (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex."}}
{"relation": "INHIBITOR", "token": ["A ", "KCC", " inhibitor-[(dihydroindenyl)oxy] alkanoic acid (", "DIOA", ")-blocked RVD more in HCEC than RCEC."], "h": {"pos": [1, 2], "type": null, "name": "KCC  inhibitor-[(dihydroindenyl)oxy] alkanoic acid ("}, "t": {"pos": [3, 4], "type": null, "name": "DIOA )-blocked RVD more in HCEC than RCEC."}}
{"relation": "INHIBITOR", "token": ["Inhibition of ", "human iNOS promoter", "-driven luciferase activity by ", "gemfibrozil", " in cytokine-stimulated U373MG astroglial cells suggests that this compound inhibits the transcription of iNOS."], "h": {"pos": [1, 2], "type": null, "name": "human iNOS promoter -driven luciferase activity by "}, "t": {"pos": [3, 4], "type": null, "name": "gemfibrozil  in cytokine-stimulated U373MG astroglial cells suggests that this compound inhibits the transcription of iNOS."}}
{"relation": "INHIBITOR", "token": ["The antipsychotic drugs ", "sertindole", " and pimozide block ", "erg3", ", a human brain K(+) channel."], "h": {"pos": [1, 2], "type": null, "name": "sertindole  and pimozide block "}, "t": {"pos": [3, 4], "type": null, "name": "erg3 , a human brain K(+) channel."}}
{"relation": "INHIBITOR", "token": ["However, combination of rasagiline (10 mg x kg(-1) i.p.) with L-DOPA or L-tryptophan (50 mg x kg(-1) i.p.), or rasagiline (10 mg x kg(-1) p.o.) with fluoxetine (10 mg x kg(-1) p.o.), did not induce the behavioural hyperactivity syndrome which is seen following inhibition of both ", "MAO-A", " and MAO-B by ", "tranylcypromine", " together with the monoamine precursors."], "h": {"pos": [1, 2], "type": null, "name": "MAO-A  and MAO-B by "}, "t": {"pos": [3, 4], "type": null, "name": "tranylcypromine  together with the monoamine precursors."}}
{"relation": "INHIBITOR", "token": ["The capacity of ", "acetylcholinesterase", " inhibitors, with the exception of ", "tacrine", " and ambenonium, to displace bound [3H]-oxotremorine-M in preference to [3H]quinuclinidyl benzilate predicts that the former compounds could act as potential agonists at muscarinic receptors."], "h": {"pos": [1, 2], "type": null, "name": "acetylcholinesterase  inhibitors, with the exception of "}, "t": {"pos": [3, 4], "type": null, "name": "tacrine  and ambenonium, to displace bound [3H]-oxotremorine-M in preference to [3H]quinuclinidyl benzilate predicts that the former compounds could act as potential agonists at muscarinic receptors."}}
{"relation": "INHIBITOR", "token": ["Enalkiren (A-64662), a potent, ", "dipeptide", " renin inhibitor, mimics the transition state of the ", "human renin", " substrate, angiotensinogen."], "h": {"pos": [1, 2], "type": null, "name": "dipeptide  renin inhibitor, mimics the transition state of the "}, "t": {"pos": [3, 4], "type": null, "name": "human renin  substrate, angiotensinogen."}}
{"relation": "INHIBITOR", "token": ["The studies with dThyd rescue from ", "cyclin E", "-cdk2 protein overexpression and growth inhibition by ", "Tomudex", " indicate that increased cyclin E-cdk2 protein expression is associated with effective inhibition of thymidylate synthase and resultant dNTP pool imbalance."], "h": {"pos": [1, 2], "type": null, "name": "cyclin E -cdk2 protein overexpression and growth inhibition by "}, "t": {"pos": [3, 4], "type": null, "name": "Tomudex  indicate that increased cyclin E-cdk2 protein expression is associated with effective inhibition of thymidylate synthase and resultant dNTP pool imbalance."}}
{"relation": "INHIBITOR", "token": ["Synthesis and antitumor activity of 1,3,4-oxadiazole possessing ", "1,4-benzodioxan", " moiety as a novel class of potent ", "methionine aminopeptidase type II", " inhibitors."], "h": {"pos": [1, 2], "type": null, "name": "1,4-benzodioxan  moiety as a novel class of potent "}, "t": {"pos": [3, 4], "type": null, "name": "methionine aminopeptidase type II  inhibitors."}}
{"relation": "INHIBITOR", "token": ["A significant decrease of aspartate aminotransferase, alanine aminotransferase, ", "lactate dehydrogenase", " (LDH) activities and glutathione (GSH) levels and an increase of malondialdehyde (MDA) quantity was observed after ", "CCl4", " and PC administration alone."], "h": {"pos": [1, 2], "type": null, "name": "lactate dehydrogenase  (LDH) activities and glutathione (GSH) levels and an increase of malondialdehyde (MDA) quantity was observed after "}, "t": {"pos": [3, 4], "type": null, "name": "CCl4  and PC administration alone."}}
{"relation": "INHIBITOR", "token": ["An investigation is detailed of the structure activity relationships (SAR) of two sulfone side chains of compound (-)-1a (", "SCH 900229", "), a potent, PS1-selective ", "\u03b3-secretase", " inhibitor and clinical candidate for the treatment of Alzheimer's disease."], "h": {"pos": [1, 2], "type": null, "name": "SCH 900229 ), a potent, PS1-selective "}, "t": {"pos": [3, 4], "type": null, "name": "\u03b3-secretase  inhibitor and clinical candidate for the treatment of Alzheimer's disease."}}
{"relation": "INHIBITOR", "token": ["Furthermore, cAMP production and ", "protein kinase A", " (PKA) activity were suppressed by ", "artemisinic acid", "."], "h": {"pos": [1, 2], "type": null, "name": "protein kinase A  (PKA) activity were suppressed by "}, "t": {"pos": [3, 4], "type": null, "name": "artemisinic acid ."}}
{"relation": "INHIBITOR", "token": ["", "Carbonic anhydrase", " inhibitors: aromatic and heterocyclic sulfonamides incorporating ", "adamantyl", " moieties with strong anticonvulsant activity."], "h": {"pos": [1, 2], "type": null, "name": "Carbonic anhydrase  inhibitors: aromatic and heterocyclic sulfonamides incorporating "}, "t": {"pos": [3, 4], "type": null, "name": "adamantyl  moieties with strong anticonvulsant activity."}}
{"relation": "INHIBITOR", "token": ["The acetylcholinesterase (AChE) and ", "butyrylcholinesterase", " (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), ", "[1,8]naphthyridines", " (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."], "h": {"pos": [1, 2], "type": null, "name": "butyrylcholinesterase  (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), "}, "t": {"pos": [3, 4], "type": null, "name": "[1,8]naphthyridines  (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."}}
{"relation": "INHIBITOR", "token": ["In summary, ", "ketoconazole", " had no clinically significant effect on the pharmacokinetics or safety profile of ambrisentan; therefore, no changes in ambrisentan dose should be necessary when the drug is administered concomitantly with known ", "CYP3A4", " inhibitors."], "h": {"pos": [1, 2], "type": null, "name": "ketoconazole  had no clinically significant effect on the pharmacokinetics or safety profile of ambrisentan; therefore, no changes in ambrisentan dose should be necessary when the drug is administered concomitantly with known "}, "t": {"pos": [3, 4], "type": null, "name": "CYP3A4  inhibitors."}}
{"relation": "INHIBITOR", "token": ["", "Flavopiridol", ", a ", "cyclin-dependent kinase", " inhibitor, arrests cell division and causes apoptosis in non-small lung cancer cells [283660]."], "h": {"pos": [1, 2], "type": null, "name": "Flavopiridol , a "}, "t": {"pos": [3, 4], "type": null, "name": "cyclin-dependent kinase  inhibitor, arrests cell division and causes apoptosis in non-small lung cancer cells [283660]."}}
{"relation": "INHIBITOR", "token": ["The higher affinity of ", "felbamate", " block of ", "NMDA receptors", " containing the NR2B subunit could be accounted for by more rapid association and slower dissociation from these sites."], "h": {"pos": [1, 2], "type": null, "name": "felbamate  block of "}, "t": {"pos": [3, 4], "type": null, "name": "NMDA receptors  containing the NR2B subunit could be accounted for by more rapid association and slower dissociation from these sites."}}
{"relation": "INHIBITOR", "token": ["In this report, we evaluated the growth-inhibitory effects of ", "sulindac sulfide", ", a COX-1 and ", "COX-2", " inhibitor; exisulind (sulindac sulfone), a novel proapoptotic agent that does not inhibit COX enzymes; and nordihydroguaiaretic acid (NDGA), a lipoxygenase inhibitor on human lung cancer cell lines."], "h": {"pos": [1, 2], "type": null, "name": "sulindac sulfide , a COX-1 and "}, "t": {"pos": [3, 4], "type": null, "name": "COX-2  inhibitor; exisulind (sulindac sulfone), a novel proapoptotic agent that does not inhibit COX enzymes; and nordihydroguaiaretic acid (NDGA), a lipoxygenase inhibitor on human lung cancer cell lines."}}
{"relation": "INHIBITOR", "token": ["Four prenylflavonoids, ", "kurarinone", " ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase (", "DGAT", ")."], "h": {"pos": [1, 2], "type": null, "name": "kurarinone  ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase ("}, "t": {"pos": [3, 4], "type": null, "name": "DGAT )."}}
{"relation": "INHIBITOR", "token": ["Our recent study has demonstrated that coadministration of ", "monoamine oxidase A", " (MAO-A) inhibitor ", "harmaline", " (5 mg/kg) increases systemic exposure to 5-MeO-DMT (2 mg/kg) and active metabolite bufotenine."], "h": {"pos": [1, 2], "type": null, "name": "monoamine oxidase A  (MAO-A) inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "harmaline  (5 mg/kg) increases systemic exposure to 5-MeO-DMT (2 mg/kg) and active metabolite bufotenine."}}
{"relation": "INHIBITOR", "token": ["Diclofenac-\u03b2-d-glucuronide, clopidogrel-\u03b2-d-glucuronide, ibuprofen-\u03b2-d-glucuronide, ", "(R)-naproxen-\u03b2-d-glucuronide", ", and (S)-naproxen-\u03b2-d-glucuronide selectively inhibited ", "hCES1", ", with Ki values of 4.32 \u00b1 0.47, 24.8 \u00b1 4.2, 355 \u00b1 38, 468 \u00b1 21, 707 \u00b1 64 \u00b5M, respectively, but did not significantly inhibit hCES2."], "h": {"pos": [1, 2], "type": null, "name": "(R)-naproxen-\u03b2-d-glucuronide , and (S)-naproxen-\u03b2-d-glucuronide selectively inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "hCES1 , with Ki values of 4.32 \u00b1 0.47, 24.8 \u00b1 4.2, 355 \u00b1 38, 468 \u00b1 21, 707 \u00b1 64 \u00b5M, respectively, but did not significantly inhibit hCES2."}}
{"relation": "INHIBITOR", "token": ["Inhibition of p95ErbB2, p185ErbB2, and ", "EGFR", " phosphorylation by ", "GW572016", " resulted in the inhibition of downstream phospho-Erk1/2, phospho-AKT, and cyclin D steady-state protein levels."], "h": {"pos": [1, 2], "type": null, "name": "EGFR  phosphorylation by "}, "t": {"pos": [3, 4], "type": null, "name": "GW572016  resulted in the inhibition of downstream phospho-Erk1/2, phospho-AKT, and cyclin D steady-state protein levels."}}
{"relation": "INHIBITOR", "token": ["In unstimulated cells, ", "Nor-NOHA", " dose-dependently reduced the ", "arginase", " activity with maximal inhibition at 20 microM."], "h": {"pos": [1, 2], "type": null, "name": "Nor-NOHA  dose-dependently reduced the "}, "t": {"pos": [3, 4], "type": null, "name": "arginase  activity with maximal inhibition at 20 microM."}}
{"relation": "INHIBITOR", "token": ["The aim of this study was to determine the mechanism of ", "pranlukast", "-induced ", "interleukin-5", " (IL-5) inhibition in allergic inflammation."], "h": {"pos": [1, 2], "type": null, "name": "pranlukast -induced "}, "t": {"pos": [3, 4], "type": null, "name": "interleukin-5  (IL-5) inhibition in allergic inflammation."}}
{"relation": "INHIBITOR", "token": ["BACKGROUND: Since the introduction of the first ", "cholinesterase", " inhibitor (ChEI) in 1997, most clinicians and probably most patients would consider the cholinergic drugs, ", "donepezil", ", galantamine and rivastigmine, to be the first line pharmacotherapy for mild to moderate Alzheimer's disease.The drugs have slightly different pharmacological properties, but they all work by inhibiting the breakdown of acetylcholine, an important neurotransmitter associated with memory, by blocking the enzyme acetylcholinesterase."], "h": {"pos": [1, 2], "type": null, "name": "cholinesterase  inhibitor (ChEI) in 1997, most clinicians and probably most patients would consider the cholinergic drugs, "}, "t": {"pos": [3, 4], "type": null, "name": "donepezil , galantamine and rivastigmine, to be the first line pharmacotherapy for mild to moderate Alzheimer's disease.The drugs have slightly different pharmacological properties, but they all work by inhibiting the breakdown of acetylcholine, an important neurotransmitter associated with memory, by blocking the enzyme acetylcholinesterase."}}
{"relation": "INHIBITOR", "token": ["Increased phosphorylation of p95ErbB2 and ", "AKT", " in response to HRG was abrogated to varying degrees by ", "GW572016", "."], "h": {"pos": [1, 2], "type": null, "name": "AKT  in response to HRG was abrogated to varying degrees by "}, "t": {"pos": [3, 4], "type": null, "name": "GW572016 ."}}
{"relation": "INHIBITOR", "token": ["Concentration-dependent inhibitory effects of ", "baicalin", " on the metabolism of dextromethorphan, a dual probe of ", "CYP2D", " and CYP3A, in rats."], "h": {"pos": [1, 2], "type": null, "name": "baicalin  on the metabolism of dextromethorphan, a dual probe of "}, "t": {"pos": [3, 4], "type": null, "name": "CYP2D  and CYP3A, in rats."}}
{"relation": "INHIBITOR", "token": ["The activity of polymerases containing mutations known to confer resistance to foscarnet (V715M, T700A and ", "N495K", ") was inhibited by concentrations of ", "foscarnet", " eight to 14 times higher than those required to inhibit wild-type polymerases."], "h": {"pos": [1, 2], "type": null, "name": "N495K ) was inhibited by concentrations of "}, "t": {"pos": [3, 4], "type": null, "name": "foscarnet  eight to 14 times higher than those required to inhibit wild-type polymerases."}}
{"relation": "INHIBITOR", "token": ["", "3'-R/S-Hydroxyvoacamine", ", a potent ", "acetylcholinesterase", " inhibitor from Tabernaemontana divaricata."], "h": {"pos": [1, 2], "type": null, "name": "3'-R/S-Hydroxyvoacamine , a potent "}, "t": {"pos": [3, 4], "type": null, "name": "acetylcholinesterase  inhibitor from Tabernaemontana divaricata."}}
{"relation": "INHIBITOR", "token": ["CONCLUSION: Our results indicate that ", "pranlukast", " inhibits ", "IL-5", " synthesis via a mechanism distinct from CysLTR1 antagonism."], "h": {"pos": [1, 2], "type": null, "name": "pranlukast  inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "IL-5  synthesis via a mechanism distinct from CysLTR1 antagonism."}}
{"relation": "INHIBITOR", "token": ["One exception is tranexamic acid (TXA), which, as a ", "lysine", " mimetic, inhibits binding of ", "plasminogen", " to fibrin."], "h": {"pos": [1, 2], "type": null, "name": "lysine  mimetic, inhibits binding of "}, "t": {"pos": [3, 4], "type": null, "name": "plasminogen  to fibrin."}}
{"relation": "INHIBITOR", "token": ["Sorafenib (", "BAY 43-9006", ", Nexavar), a dual-action inhibitor that targets RAF/", "MEK", "/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature."], "h": {"pos": [1, 2], "type": null, "name": "BAY 43-9006 , Nexavar), a dual-action inhibitor that targets RAF/"}, "t": {"pos": [3, 4], "type": null, "name": "MEK /ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature."}}
{"relation": "INHIBITOR", "token": ["", "Neoechinulin A", " suppresses ", "amyloid-\u03b2", " oligomer-induced microglia activation and thereby protects PC-12 cells from inflammation-mediated toxicity."], "h": {"pos": [1, 2], "type": null, "name": "Neoechinulin A  suppresses "}, "t": {"pos": [3, 4], "type": null, "name": "amyloid-\u03b2  oligomer-induced microglia activation and thereby protects PC-12 cells from inflammation-mediated toxicity."}}
{"relation": "INHIBITOR", "token": ["In addition, the new compound ", "perviridicin B", " (2), three known rocaglate derivatives (9, 11, 12), and a known sesquiterpene, 2-oxaisodauc-5-en-12-al (17), showed significant ", "NF-\u03baB", " (p65) inhibitory activity in an ELISA assay."], "h": {"pos": [1, 2], "type": null, "name": "perviridicin B  (2), three known rocaglate derivatives (9, 11, 12), and a known sesquiterpene, 2-oxaisodauc-5-en-12-al (17), showed significant "}, "t": {"pos": [3, 4], "type": null, "name": "NF-\u03baB  (p65) inhibitory activity in an ELISA assay."}}
{"relation": "INHIBITOR", "token": ["The in vivo inhibitory effect of ", "harmaline", " on ", "CYP2D6", "-catalyzed bufotenine formation was confirmed by in vitro study using purified CYP2D6."], "h": {"pos": [1, 2], "type": null, "name": "harmaline  on "}, "t": {"pos": [3, 4], "type": null, "name": "CYP2D6 -catalyzed bufotenine formation was confirmed by in vitro study using purified CYP2D6."}}
{"relation": "INHIBITOR", "token": ["The demonstration that ", "sorafenib", " exhibits potent target inhibition and efficacy in ", "FLT3", "-driven models suggests that this compound may have a therapeutic benefit for patients with FLT3-driven leukemias."], "h": {"pos": [1, 2], "type": null, "name": "sorafenib  exhibits potent target inhibition and efficacy in "}, "t": {"pos": [3, 4], "type": null, "name": "FLT3 -driven models suggests that this compound may have a therapeutic benefit for patients with FLT3-driven leukemias."}}
{"relation": "INHIBITOR", "token": ["", "TAS-102", " currently undergoing clinical trials, has been demonstrated to have at least two mechanisms, inhibition of ", "TS", " and incorporation into DNA."], "h": {"pos": [1, 2], "type": null, "name": "TAS-102  currently undergoing clinical trials, has been demonstrated to have at least two mechanisms, inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "TS  and incorporation into DNA."}}
{"relation": "INHIBITOR", "token": ["When tested in the intact cells, only 4 of 16 ", "CGPs", " (at 10 \u03bcM) inhibited ", "MRP1", "-mediated calcein efflux by >50% (III-1, V-3, -4, -6) while a fifth (I-5) inhibited efflux by just 23%."], "h": {"pos": [1, 2], "type": null, "name": "CGPs  (at 10 \u03bcM) inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "MRP1 -mediated calcein efflux by >50% (III-1, V-3, -4, -6) while a fifth (I-5) inhibited efflux by just 23%."}}
{"relation": "INHIBITOR", "token": ["", "Statins", " are ", "3-hydroxy-3-methylglutaryl-CoA reductase", " inhibitors broadly used for the control of hypercholesterolemia."], "h": {"pos": [1, 2], "type": null, "name": "Statins  are "}, "t": {"pos": [3, 4], "type": null, "name": "3-hydroxy-3-methylglutaryl-CoA reductase  inhibitors broadly used for the control of hypercholesterolemia."}}
{"relation": "INHIBITOR", "token": ["Among the isolated compounds, trans-dihydromorin (8), ", "oxyresveratrol", " (9), and steppogenin (12) were found to exhibit significant ", "tyrosinase", " inhibition activities."], "h": {"pos": [1, 2], "type": null, "name": "oxyresveratrol  (9), and steppogenin (12) were found to exhibit significant "}, "t": {"pos": [3, 4], "type": null, "name": "tyrosinase  inhibition activities."}}
{"relation": "INHIBITOR", "token": ["Preferential block of late sodium current in the ", "LQT3 DeltaKPQ mutant", " by the class I(C) antiarrhythmic ", "flecainide", "."], "h": {"pos": [1, 2], "type": null, "name": "LQT3 DeltaKPQ mutant  by the class I(C) antiarrhythmic "}, "t": {"pos": [3, 4], "type": null, "name": "flecainide ."}}
{"relation": "INHIBITOR", "token": ["6-Ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide (", "TAK-441", ") is a potent, selective ", "hedgehog", " signaling pathway inhibitor that binds to Smo and is being developed for the treatment of cancer."], "h": {"pos": [1, 2], "type": null, "name": "TAK-441 ) is a potent, selective "}, "t": {"pos": [3, 4], "type": null, "name": "hedgehog  signaling pathway inhibitor that binds to Smo and is being developed for the treatment of cancer."}}
{"relation": "INHIBITOR", "token": ["Taken together, these data demonstrated that ", "PLA2", " inhibitors ", "BPB", " and AACOCF3 are robust inhibitors of IL-2 expression at both the mRNA and protein levels in murine splenocytes."], "h": {"pos": [1, 2], "type": null, "name": "PLA2  inhibitors "}, "t": {"pos": [3, 4], "type": null, "name": "BPB  and AACOCF3 are robust inhibitors of IL-2 expression at both the mRNA and protein levels in murine splenocytes."}}
{"relation": "INHIBITOR", "token": ["", "Beta-glucogallin", " (BGG), a recently described ", "AR", " inhibitor, was purified from extracts of the Indian gooseberry (Emblica officinalis)."], "h": {"pos": [1, 2], "type": null, "name": "Beta-glucogallin  (BGG), a recently described "}, "t": {"pos": [3, 4], "type": null, "name": "AR  inhibitor, was purified from extracts of the Indian gooseberry (Emblica officinalis)."}}
{"relation": "INHIBITOR", "token": ["RESULTS: Both PLZ and ", "VIG", " inhibited ", "GABA-T", " and elevated GABA levels."], "h": {"pos": [1, 2], "type": null, "name": "VIG  inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "GABA-T  and elevated GABA levels."}}
{"relation": "INHIBITOR", "token": ["Plerixafor (AMD3100, Genzyme Corporation) is a ", "bicyclam", " molecule that antagonizes the binding of the chemokine ", "stromal cell-derived factor-1", " (SDF-1) to its cognate receptor CXCR4."], "h": {"pos": [1, 2], "type": null, "name": "bicyclam  molecule that antagonizes the binding of the chemokine "}, "t": {"pos": [3, 4], "type": null, "name": "stromal cell-derived factor-1  (SDF-1) to its cognate receptor CXCR4."}}
{"relation": "INHIBITOR", "token": ["Agents that have only begun to undergo clinical evaluation include CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, and PKI166 and ", "GW572016", ", both examples of dual kinase inhibitors (inhibiting epidermal growth factor receptor and ", "Her2", ")."], "h": {"pos": [1, 2], "type": null, "name": "GW572016 , both examples of dual kinase inhibitors (inhibiting epidermal growth factor receptor and "}, "t": {"pos": [3, 4], "type": null, "name": "Her2 )."}}
{"relation": "INHIBITOR", "token": ["", "Reboxetine", ", a selective norepinephrine reuptake inhibitor, exhibits high affinity and selectivity for the ", "human norepinephrine transporter", "."], "h": {"pos": [1, 2], "type": null, "name": "Reboxetine , a selective norepinephrine reuptake inhibitor, exhibits high affinity and selectivity for the "}, "t": {"pos": [3, 4], "type": null, "name": "human norepinephrine transporter ."}}
{"relation": "INHIBITOR", "token": ["Diclofenac-\u03b2-d-glucuronide, clopidogrel-\u03b2-d-glucuronide, ", "ibuprofen-\u03b2-d-glucuronide", ", (R)-naproxen-\u03b2-d-glucuronide, and (S)-naproxen-\u03b2-d-glucuronide selectively inhibited ", "hCES1", ", with Ki values of 4.32 \u00b1 0.47, 24.8 \u00b1 4.2, 355 \u00b1 38, 468 \u00b1 21, 707 \u00b1 64 \u00b5M, respectively, but did not significantly inhibit hCES2."], "h": {"pos": [1, 2], "type": null, "name": "ibuprofen-\u03b2-d-glucuronide , (R)-naproxen-\u03b2-d-glucuronide, and (S)-naproxen-\u03b2-d-glucuronide selectively inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "hCES1 , with Ki values of 4.32 \u00b1 0.47, 24.8 \u00b1 4.2, 355 \u00b1 38, 468 \u00b1 21, 707 \u00b1 64 \u00b5M, respectively, but did not significantly inhibit hCES2."}}
{"relation": "INHIBITOR", "token": ["Experimental studies performed for characterizing the inhibitory mechanism indicate that ", "GSK-3\u03b2", " inhibition by ", "palinurin", " cannot be competed out by ATP nor peptide substrate."], "h": {"pos": [1, 2], "type": null, "name": "GSK-3\u03b2  inhibition by "}, "t": {"pos": [3, 4], "type": null, "name": "palinurin  cannot be competed out by ATP nor peptide substrate."}}
{"relation": "INHIBITOR", "token": ["Given these findings, a unified PK model including the inhibition of ", "MAO-A", "- and CYP2D6-catalyzed 5-MeO-DMT metabolism by ", "harmaline", " was developed to describe blood harmaline, 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models."], "h": {"pos": [1, 2], "type": null, "name": "MAO-A - and CYP2D6-catalyzed 5-MeO-DMT metabolism by "}, "t": {"pos": [3, 4], "type": null, "name": "harmaline  was developed to describe blood harmaline, 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models."}}
{"relation": "INHIBITOR", "token": ["Inhibition of ", "S-adenosylmethionine decarboxylase", " by a specific inhibitor [diethylglyoxal bis-(guanylhydrazone); ", "DEGBG", "] led to depletion of spermidine and spermine with a significant accumulation of putrescine and induction of ODC."], "h": {"pos": [1, 2], "type": null, "name": "S-adenosylmethionine decarboxylase  by a specific inhibitor [diethylglyoxal bis-(guanylhydrazone); "}, "t": {"pos": [3, 4], "type": null, "name": "DEGBG ] led to depletion of spermidine and spermine with a significant accumulation of putrescine and induction of ODC."}}
{"relation": "INHIBITOR", "token": ["NFAT cooperates with c-Jun, a compound of the AP-1 complex, to activate target genes, and we also found that ", "PSE", " inhibited both ", "JNK", " activation and AP-1 transcriptional activity."], "h": {"pos": [1, 2], "type": null, "name": "PSE  inhibited both "}, "t": {"pos": [3, 4], "type": null, "name": "JNK  activation and AP-1 transcriptional activity."}}
{"relation": "INHIBITOR", "token": ["Role of organic cation/carnitine transporter 1 in uptake of ", "phenformin", " and inhibitory effect on ", "complex I", " respiration in mitochondria."], "h": {"pos": [1, 2], "type": null, "name": "phenformin  and inhibitory effect on "}, "t": {"pos": [3, 4], "type": null, "name": "complex I  respiration in mitochondria."}}
{"relation": "INHIBITOR", "token": ["Plerixafor (", "AMD3100", ", Genzyme Corporation) is a bicyclam molecule that antagonizes the binding of the chemokine stromal cell-derived factor-1 (SDF-1) to its cognate receptor ", "CXCR4", "."], "h": {"pos": [1, 2], "type": null, "name": "AMD3100 , Genzyme Corporation) is a bicyclam molecule that antagonizes the binding of the chemokine stromal cell-derived factor-1 (SDF-1) to its cognate receptor "}, "t": {"pos": [3, 4], "type": null, "name": "CXCR4 ."}}
{"relation": "INHIBITOR", "token": ["(+/-)-Tamsulosin effectively antagonized the positive inotropic effect of phenylephrine even after inactivation of ", "alpha 1B-adrenoceptors", " by treatment with ", "chlorethylclonidine", ", which is an indication that the (+/-)-tamsulosin-sensitive subtype belongs to a class resistant to chlorethylclonidine."], "h": {"pos": [1, 2], "type": null, "name": "alpha 1B-adrenoceptors  by treatment with "}, "t": {"pos": [3, 4], "type": null, "name": "chlorethylclonidine , which is an indication that the (+/-)-tamsulosin-sensitive subtype belongs to a class resistant to chlorethylclonidine."}}
{"relation": "INHIBITOR", "token": ["", "5-(N,N-dimethyl)-amiloride", " (50 microM; DMA), a concentration that selectively inhibits the ", "NHE", " isoforms NHE1 and NHE2, but not NHE3, did not affect DBS."], "h": {"pos": [1, 2], "type": null, "name": "5-(N,N-dimethyl)-amiloride  (50 microM; DMA), a concentration that selectively inhibits the "}, "t": {"pos": [3, 4], "type": null, "name": "NHE  isoforms NHE1 and NHE2, but not NHE3, did not affect DBS."}}
{"relation": "INHIBITOR", "token": ["", "Torasemide", " inhibits ", "angiotensin II", "-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats."], "h": {"pos": [1, 2], "type": null, "name": "Torasemide  inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "angiotensin II -induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats."}}
{"relation": "INHIBITOR", "token": ["The structure-activity relationship of a series of ", "dihydroisoquinoline", " ", "BACE-1", " inhibitors is described."], "h": {"pos": [1, 2], "type": null, "name": "dihydroisoquinoline  "}, "t": {"pos": [3, 4], "type": null, "name": "BACE-1  inhibitors is described."}}
{"relation": "INHIBITOR", "token": ["", "Sorafenib", " (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/", "ERK", " pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature."], "h": {"pos": [1, 2], "type": null, "name": "Sorafenib  (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/"}, "t": {"pos": [3, 4], "type": null, "name": "ERK  pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature."}}
{"relation": "INHIBITOR", "token": ["We evaluated the effect of ", "anastrozole", ", a more selective ", "aromatase", " inhibitor, on the hormonal and semen profiles of infertile men with abnormal baseline testosterone-to-estradiol ratios."], "h": {"pos": [1, 2], "type": null, "name": "anastrozole , a more selective "}, "t": {"pos": [3, 4], "type": null, "name": "aromatase  inhibitor, on the hormonal and semen profiles of infertile men with abnormal baseline testosterone-to-estradiol ratios."}}
{"relation": "INHIBITOR", "token": ["These data support the conclusion that renal ecto-", "phosphodiesterase", " activity is not mediated by PDE1, PDE2, PDE3, PDE4, PDE5, PDE6, PDE7, PDE9, PDE10, or PDE11 and is inhibited by high concentrations of ", "dipyridamole", "."], "h": {"pos": [1, 2], "type": null, "name": "phosphodiesterase  activity is not mediated by PDE1, PDE2, PDE3, PDE4, PDE5, PDE6, PDE7, PDE9, PDE10, or PDE11 and is inhibited by high concentrations of "}, "t": {"pos": [3, 4], "type": null, "name": "dipyridamole ."}}
{"relation": "INHIBITOR", "token": ["The acetylcholinesterase (AChE) and butyrylcholinesterase (", "BuChE", ") inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), ", "4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines", " (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."], "h": {"pos": [1, 2], "type": null, "name": "BuChE ) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), "}, "t": {"pos": [3, 4], "type": null, "name": "4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines  (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."}}
{"relation": "INHIBITOR", "token": ["These results may have implications in the development of novel ", "DPP-IV", " inhibitors based on the use of ", "atorvastatin", " as a lead compound for the treatment of type 2 diabetes."], "h": {"pos": [1, 2], "type": null, "name": "DPP-IV  inhibitors based on the use of "}, "t": {"pos": [3, 4], "type": null, "name": "atorvastatin  as a lead compound for the treatment of type 2 diabetes."}}
{"relation": "INHIBITOR", "token": ["Reactivators showed different activity in the reactivation of ", "rat brain AChE", " after dichlorvos, ", "paraoxon", " and tabun inhibition."], "h": {"pos": [1, 2], "type": null, "name": "rat brain AChE  after dichlorvos, "}, "t": {"pos": [3, 4], "type": null, "name": "paraoxon  and tabun inhibition."}}
{"relation": "INHIBITOR", "token": ["Plerixafor (", "AMD3100", ", Genzyme Corporation) is a bicyclam molecule that antagonizes the binding of the ", "chemokine", " stromal cell-derived factor-1 (SDF-1) to its cognate receptor CXCR4."], "h": {"pos": [1, 2], "type": null, "name": "AMD3100 , Genzyme Corporation) is a bicyclam molecule that antagonizes the binding of the "}, "t": {"pos": [3, 4], "type": null, "name": "chemokine  stromal cell-derived factor-1 (SDF-1) to its cognate receptor CXCR4."}}
{"relation": "INHIBITOR", "token": ["Synthesis, molecular modeling and evaluation of novel ", "N'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone", " derivatives as dual inhibitors for cholinesterases and ", "A\u03b2", " aggregation."], "h": {"pos": [1, 2], "type": null, "name": "N'-2-(4-benzylpiperidin-/piperazin-1-yl)acylhydrazone  derivatives as dual inhibitors for cholinesterases and "}, "t": {"pos": [3, 4], "type": null, "name": "A\u03b2  aggregation."}}
{"relation": "INHIBITOR", "token": ["Structural optimization of ", "2,5-thiophene amides", " as highly potent and selective ", "17\u03b2-hydroxysteroid dehydrogenase type 2", " inhibitors for the treatment of osteoporosis."], "h": {"pos": [1, 2], "type": null, "name": "2,5-thiophene amides  as highly potent and selective "}, "t": {"pos": [3, 4], "type": null, "name": "17\u03b2-hydroxysteroid dehydrogenase type 2  inhibitors for the treatment of osteoporosis."}}
{"relation": "INHIBITOR", "token": ["Existing ion channel blockers, such as ", "amiodarone", ", dronedarone, bepridil, aprindine, and cibenzoline, have been found to have an ", "NCX", " inhibitory action."], "h": {"pos": [1, 2], "type": null, "name": "amiodarone , dronedarone, bepridil, aprindine, and cibenzoline, have been found to have an "}, "t": {"pos": [3, 4], "type": null, "name": "NCX  inhibitory action."}}
{"relation": "INHIBITOR", "token": ["Nevertheless, 3 mM ", "DMA", ", a higher concentration that inhibits NHE1, ", "NHE2", ", and NHE3, significantly increased DBS."], "h": {"pos": [1, 2], "type": null, "name": "DMA , a higher concentration that inhibits NHE1, "}, "t": {"pos": [3, 4], "type": null, "name": "NHE2 , and NHE3, significantly increased DBS."}}
{"relation": "INHIBITOR", "token": ["Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >", "desoxypeganine", ">parathion>gramine) indicated that the most effective inhibitors of ", "acetylcholinesterase", " also displaced [3H]-oxotremorine-M to the greatest extent."], "h": {"pos": [1, 2], "type": null, "name": "desoxypeganine >parathion>gramine) indicated that the most effective inhibitors of "}, "t": {"pos": [3, 4], "type": null, "name": "acetylcholinesterase  also displaced [3H]-oxotremorine-M to the greatest extent."}}
{"relation": "INHIBITOR", "token": ["", "Epidermal growth factor receptor", " inhibitors currently under investigation include the small molecules gefitinib (Iressa, ZD1839) and erlotinib (Tarceva, OSI-774), as well as monoclonal antibodies such as cetuximab (", "IMC-225", ", Erbitux)."], "h": {"pos": [1, 2], "type": null, "name": "Epidermal growth factor receptor  inhibitors currently under investigation include the small molecules gefitinib (Iressa, ZD1839) and erlotinib (Tarceva, OSI-774), as well as monoclonal antibodies such as cetuximab ("}, "t": {"pos": [3, 4], "type": null, "name": "IMC-225 , Erbitux)."}}
{"relation": "INHIBITOR", "token": ["Cyclopentenone prostaglandins were potent inhibitors of ", "iNOS", " induction and were more effective than their precursors, ", "prostaglandins E2 and D2", "."], "h": {"pos": [1, 2], "type": null, "name": "iNOS  induction and were more effective than their precursors, "}, "t": {"pos": [3, 4], "type": null, "name": "prostaglandins E2 and D2 ."}}
{"relation": "INHIBITOR", "token": ["Pharmacokinetic Interactions between ", "Monoamine Oxidase A", " Inhibitor ", "Harmaline", " and 5-Methoxy-N,N-Dimethyltryptamine, and the Impact of CYP2D6 Status."], "h": {"pos": [1, 2], "type": null, "name": "Monoamine Oxidase A  Inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "Harmaline  and 5-Methoxy-N,N-Dimethyltryptamine, and the Impact of CYP2D6 Status."}}
{"relation": "INHIBITOR", "token": ["The acetylcholinesterase (AChE) and butyrylcholinesterase (", "BuChE", ") inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), ", "[1,8]naphthyridines", " (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."], "h": {"pos": [1, 2], "type": null, "name": "BuChE ) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), "}, "t": {"pos": [3, 4], "type": null, "name": "[1,8]naphthyridines  (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."}}
{"relation": "INHIBITOR", "token": ["Using whole-cell voltage clamp, we examined ", "mibefradil", " block of four Na+ channel isoforms expressed in human embryonic kidney cells: Nav1.5 (cardiac), ", "Nav1.4", " (skeletal muscle), Nav1.2 (brain), and Nav1.7 (peripheral nerve)."], "h": {"pos": [1, 2], "type": null, "name": "mibefradil  block of four Na+ channel isoforms expressed in human embryonic kidney cells: Nav1.5 (cardiac), "}, "t": {"pos": [3, 4], "type": null, "name": "Nav1.4  (skeletal muscle), Nav1.2 (brain), and Nav1.7 (peripheral nerve)."}}
{"relation": "INHIBITOR", "token": ["A series of phenolic acids and ", "phenol", " natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme ", "carbonic anhydrase", " (CA, EC 4.2.1.1)."], "h": {"pos": [1, 2], "type": null, "name": "phenol  natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme "}, "t": {"pos": [3, 4], "type": null, "name": "carbonic anhydrase  (CA, EC 4.2.1.1)."}}
{"relation": "INHIBITOR", "token": ["", "Catecholamines", " (adrenaline, noradrenaline and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase (", "phenylalanine hydroxylase", ", EC 1.14.16.1)."], "h": {"pos": [1, 2], "type": null, "name": "Catecholamines  (adrenaline, noradrenaline and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase ("}, "t": {"pos": [3, 4], "type": null, "name": "phenylalanine hydroxylase , EC 1.14.16.1)."}}
{"relation": "INHIBITOR", "token": ["A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, ", "caffeic acid", ", ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the ", "metalloenzyme", " carbonic anhydrase (CA, EC 4.2.1.1)."], "h": {"pos": [1, 2], "type": null, "name": "caffeic acid , ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the "}, "t": {"pos": [3, 4], "type": null, "name": "metalloenzyme  carbonic anhydrase (CA, EC 4.2.1.1)."}}
{"relation": "INHIBITOR", "token": ["The ability of ", "sulindac", " to block ERK1/2 signaling by the ", "EGF receptor", " may account for at least part of its potent growth-inhibitory effects against cancer cells."], "h": {"pos": [1, 2], "type": null, "name": "sulindac  to block ERK1/2 signaling by the "}, "t": {"pos": [3, 4], "type": null, "name": "EGF receptor  may account for at least part of its potent growth-inhibitory effects against cancer cells."}}
{"relation": "INHIBITOR", "token": ["In the current study, we reveal the inhibitory effects of ", "baicalin", " on the metabolism of dextromethorphan (DXM), a dual probe substrate of CYP2D and ", "CYP3A", ", in rats."], "h": {"pos": [1, 2], "type": null, "name": "baicalin  on the metabolism of dextromethorphan (DXM), a dual probe substrate of CYP2D and "}, "t": {"pos": [3, 4], "type": null, "name": "CYP3A , in rats."}}
{"relation": "INHIBITOR", "token": ["Local ", "PGE2", " administration prevented the increase of airway IL-13 and ", "osteopontin", " and kept lung plasmacytoid dendritic cell counts close to baseline."], "h": {"pos": [1, 2], "type": null, "name": "PGE2  administration prevented the increase of airway IL-13 and "}, "t": {"pos": [3, 4], "type": null, "name": "osteopontin  and kept lung plasmacytoid dendritic cell counts close to baseline."}}
{"relation": "INHIBITOR", "token": ["Pretreatment with ", "dexamethasone", " significantly suppressed nasal allergy-like behaviors, up-regulation of histamine content, ", "HDC", " activity and HDC mRNA induced by TDI in TDI-sensitized rats."], "h": {"pos": [1, 2], "type": null, "name": "dexamethasone  significantly suppressed nasal allergy-like behaviors, up-regulation of histamine content, "}, "t": {"pos": [3, 4], "type": null, "name": "HDC  activity and HDC mRNA induced by TDI in TDI-sensitized rats."}}
{"relation": "INHIBITOR", "token": ["The refolding kinetics of guanidine-denatured disulfide-intact ", "bovine pancreatic ribonuclease A", " (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (", "2'CMP", ") inhibitor binding."], "h": {"pos": [1, 2], "type": null, "name": "bovine pancreatic ribonuclease A  (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate ("}, "t": {"pos": [3, 4], "type": null, "name": "2'CMP ) inhibitor binding."}}
{"relation": "INHIBITOR", "token": ["", "TZDs", " also inhibited ", "alkaline phosphatase", " activity (58-75%, p<0.046) and osteocalcin production (52-75%, p<0.031)."], "h": {"pos": [1, 2], "type": null, "name": "TZDs  also inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "alkaline phosphatase  activity (58-75%, p<0.046) and osteocalcin production (52-75%, p<0.031)."}}
{"relation": "INHIBITOR", "token": ["The acute toxicity of ", "organophosphorus", " (OP) compounds in mammals is due to their irreversible inhibition of ", "acetylcholinesterase", " (AChE) in the nervous system, which leads to increased synaptic acetylcholine levels."], "h": {"pos": [1, 2], "type": null, "name": "organophosphorus  (OP) compounds in mammals is due to their irreversible inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "acetylcholinesterase  (AChE) in the nervous system, which leads to increased synaptic acetylcholine levels."}}
{"relation": "INHIBITOR", "token": ["Clinical pharmacology of ", "enalkiren", ", a novel, dipeptide ", "renin", " inhibitor."], "h": {"pos": [1, 2], "type": null, "name": "enalkiren , a novel, dipeptide "}, "t": {"pos": [3, 4], "type": null, "name": "renin  inhibitor."}}
{"relation": "INHIBITOR", "token": ["The antipsychotic drugs ", "sertindole", " and pimozide are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as HERG (human ether-a-go-go-related gene; ", "erg1", ")."], "h": {"pos": [1, 2], "type": null, "name": "sertindole  and pimozide are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as HERG (human ether-a-go-go-related gene; "}, "t": {"pos": [3, 4], "type": null, "name": "erg1 )."}}
{"relation": "INHIBITOR", "token": ["", "Catecholamines", " (adrenaline, noradrenaline and dopamine) are potent inhibitors of ", "phenylalanine 4-monooxygenase", " (phenylalanine hydroxylase, EC 1.14.16.1)."], "h": {"pos": [1, 2], "type": null, "name": "Catecholamines  (adrenaline, noradrenaline and dopamine) are potent inhibitors of "}, "t": {"pos": [3, 4], "type": null, "name": "phenylalanine 4-monooxygenase  (phenylalanine hydroxylase, EC 1.14.16.1)."}}
{"relation": "INHIBITOR", "token": ["The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (RNase A) and its ", "proline-42-to-alanine", " mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate (", "2'CMP", ") inhibitor binding."], "h": {"pos": [1, 2], "type": null, "name": "proline-42-to-alanine  mutant (Pro42Ala) have been studied by monitoring tyrosine burial and 2'-cytidine monophosphate ("}, "t": {"pos": [3, 4], "type": null, "name": "2'CMP ) inhibitor binding."}}
{"relation": "INHIBITOR", "token": ["A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ", "ferulic acid", ", gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme ", "carbonic anhydrase", " (CA, EC 4.2.1.1)."], "h": {"pos": [1, 2], "type": null, "name": "ferulic acid , gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme "}, "t": {"pos": [3, 4], "type": null, "name": "carbonic anhydrase  (CA, EC 4.2.1.1)."}}
{"relation": "INHIBITOR", "token": ["First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, TOP2-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive ", "TOP2", " poisons (e.g. amonafide, batracylin, and ", "menadione", ") was only slightly (less than 3-fold) affected."], "h": {"pos": [1, 2], "type": null, "name": "TOP2  poisons (e.g. amonafide, batracylin, and "}, "t": {"pos": [3, 4], "type": null, "name": "menadione ) was only slightly (less than 3-fold) affected."}}
{"relation": "INHIBITOR", "token": ["Moreover, the rank order for potency in inhibiting ", "acetylcholinesterase", " (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=", "edrophonium", "=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent."], "h": {"pos": [1, 2], "type": null, "name": "acetylcholinesterase  (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine="}, "t": {"pos": [3, 4], "type": null, "name": "edrophonium =galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent."}}
{"relation": "INHIBITOR", "token": ["In addition, cells pre-treated with ", "DL-propargylglycine", " (PAG, 3 mM), a ", "CSE", " inhibitor, reduced the formation of H(2)S in caerulein treated cells, suggesting that CSE may be the main enzyme involved in H(2)S formation in mouse acinar cells."], "h": {"pos": [1, 2], "type": null, "name": "DL-propargylglycine  (PAG, 3 mM), a "}, "t": {"pos": [3, 4], "type": null, "name": "CSE  inhibitor, reduced the formation of H(2)S in caerulein treated cells, suggesting that CSE may be the main enzyme involved in H(2)S formation in mouse acinar cells."}}
{"relation": "INHIBITOR", "token": ["Interestingly, a ", "Val-349 to Ile", " mutant was inhibited with equal potency to human COX-2 with 2,6-dichloro-, 2,6-dimethyl-, or ", "2-chloro-6-methyl", "-substituted inhibitors and, in the case of lumiracoxib, actually showed an increase in potency."], "h": {"pos": [1, 2], "type": null, "name": "Val-349 to Ile  mutant was inhibited with equal potency to human COX-2 with 2,6-dichloro-, 2,6-dimethyl-, or "}, "t": {"pos": [3, 4], "type": null, "name": "2-chloro-6-methyl -substituted inhibitors and, in the case of lumiracoxib, actually showed an increase in potency."}}
{"relation": "INHIBITOR", "token": ["Moreover, the production of intracellular reactive oxygen species (ROS) elicited by AGE was also suppressed by ", "catalpol", " treatment, through dual action of reducing ROS itself and inhibiting ", "NADPH oxidase", " activity."], "h": {"pos": [1, 2], "type": null, "name": "catalpol  treatment, through dual action of reducing ROS itself and inhibiting "}, "t": {"pos": [3, 4], "type": null, "name": "NADPH oxidase  activity."}}
{"relation": "INHIBITOR", "token": ["Molecular determinants for the selective inhibition of ", "cyclooxygenase-2", " by ", "lumiracoxib", "."], "h": {"pos": [1, 2], "type": null, "name": "cyclooxygenase-2  by "}, "t": {"pos": [3, 4], "type": null, "name": "lumiracoxib ."}}
{"relation": "INHIBITOR", "token": ["", "Sorafenib", " (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/", "MEK", "/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature."], "h": {"pos": [1, 2], "type": null, "name": "Sorafenib  (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/"}, "t": {"pos": [3, 4], "type": null, "name": "MEK /ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature."}}
{"relation": "INHIBITOR", "token": ["We then showed that static exposure of embryos to ", "paraoxon", " (31.2-500 nM) from 5 to 96 hpf resulted in significant stage- and concentration-dependent ", "AChE", " inhibition, albeit these effects were fully reversible within 48 h following transfer to clean water."], "h": {"pos": [1, 2], "type": null, "name": "paraoxon  (31.2-500 nM) from 5 to 96 hpf resulted in significant stage- and concentration-dependent "}, "t": {"pos": [3, 4], "type": null, "name": "AChE  inhibition, albeit these effects were fully reversible within 48 h following transfer to clean water."}}
{"relation": "INHIBITOR", "token": ["We describe here the isolation and biochemical characterization of the marine natural ", "sesquiterpene", " palinurin as a ", "GSK-3\u03b2", " inhibitor."], "h": {"pos": [1, 2], "type": null, "name": "sesquiterpene  palinurin as a "}, "t": {"pos": [3, 4], "type": null, "name": "GSK-3\u03b2  inhibitor."}}
{"relation": "INHIBITOR", "token": ["Everolimus (RAD001, ", "Afinitor((R)) Novartis", ") is the first oral inhibitor of ", "mTOR", " (mammalian target of rapamycin) to reach the oncology clinic."], "h": {"pos": [1, 2], "type": null, "name": "Afinitor((R)) Novartis ) is the first oral inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "mTOR  (mammalian target of rapamycin) to reach the oncology clinic."}}
{"relation": "INHIBITOR", "token": ["Similarly, pretreatment with ", "sulindac sulfide", " blocks the ability of ", "EGF", " to induce ERK1/2 and Bad phosphorylation, but also down-regulates total Bad but not ERK1/2 protein levels."], "h": {"pos": [1, 2], "type": null, "name": "sulindac sulfide  blocks the ability of "}, "t": {"pos": [3, 4], "type": null, "name": "EGF  to induce ERK1/2 and Bad phosphorylation, but also down-regulates total Bad but not ERK1/2 protein levels."}}
{"relation": "INHIBITOR", "token": ["In conclusion, of the seven NSAIDs investigated, ", "niflumic acid", " was the most potent inhibitor of recombinant ", "UGT1A9", " via 4-MUG in a competitive manner."], "h": {"pos": [1, 2], "type": null, "name": "niflumic acid  was the most potent inhibitor of recombinant "}, "t": {"pos": [3, 4], "type": null, "name": "UGT1A9  via 4-MUG in a competitive manner."}}
{"relation": "INHIBITOR", "token": ["The inhibitory effects of iloprost on ", "tissue factor", " expression were also potentiated by ", "isobutylmethylxanthine", " and mimicked by forskolin and dibutyryl cyclic AMP but not dibutyryl cyclic GMP."], "h": {"pos": [1, 2], "type": null, "name": "tissue factor  expression were also potentiated by "}, "t": {"pos": [3, 4], "type": null, "name": "isobutylmethylxanthine  and mimicked by forskolin and dibutyryl cyclic AMP but not dibutyryl cyclic GMP."}}
{"relation": "INHIBITOR", "token": ["Four prenylflavonoids, kurarinone ( 1), a ", "chalcone", " of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase (", "DGAT", ")."], "h": {"pos": [1, 2], "type": null, "name": "chalcone  of 1, kuraridin ( 2), kurarinol ( 3), kushenol H ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on diacylglycerol acyltransferase ("}, "t": {"pos": [3, 4], "type": null, "name": "DGAT )."}}
{"relation": "INHIBITOR", "token": ["We have examined the effect of dihydropyridine ", "Ca2+-channel", " blockers ", "felodipine", " and nicardipine on CaMPDE."], "h": {"pos": [1, 2], "type": null, "name": "Ca2+-channel  blockers "}, "t": {"pos": [3, 4], "type": null, "name": "felodipine  and nicardipine on CaMPDE."}}
{"relation": "INHIBITOR", "token": ["ZD1839 (\"", "Iressa", "\"), a quinazoline tyrosine kinase inhibitor selective for the ", "EGFR", ", has shown good activity in preclinical studies and in the early phase of clinical trials."], "h": {"pos": [1, 2], "type": null, "name": "Iressa \"), a quinazoline tyrosine kinase inhibitor selective for the "}, "t": {"pos": [3, 4], "type": null, "name": "EGFR , has shown good activity in preclinical studies and in the early phase of clinical trials."}}
{"relation": "INHIBITOR", "token": ["All GABA(A)R modulators induced a negative shift in the steady-state inactivation curve of Ca(v)1.3 channels, but only BDZs and ", "pentobarbital", " induced a negative shift in ", "Ca(v)1.2", " channel inactivation."], "h": {"pos": [1, 2], "type": null, "name": "pentobarbital  induced a negative shift in "}, "t": {"pos": [3, 4], "type": null, "name": "Ca(v)1.2  channel inactivation."}}
{"relation": "INHIBITOR", "token": ["In this study, we demonstrate significant inhibitory activity of ", "dasatinib", " against both wild-type KIT and the ", "KIT", "D816V mutation in the nanomolar range in in vitro and cell-based kinase assays."], "h": {"pos": [1, 2], "type": null, "name": "dasatinib  against both wild-type KIT and the "}, "t": {"pos": [3, 4], "type": null, "name": "KIT D816V mutation in the nanomolar range in in vitro and cell-based kinase assays."}}
{"relation": "INHIBITOR", "token": ["Thus, ", "bupropion", " acts as an antagonist at alpha3beta2* and alpha3beta4* nAChRs in rat striatum and hippocampus, respectively, across the same concentration range that inhibits ", "DAT", " and NET function."], "h": {"pos": [1, 2], "type": null, "name": "bupropion  acts as an antagonist at alpha3beta2* and alpha3beta4* nAChRs in rat striatum and hippocampus, respectively, across the same concentration range that inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "DAT  and NET function."}}
{"relation": "INHIBITOR", "token": ["Spiro heterocycles as potential inhibitors of ", "SIRT1", ": Pd/C-mediated synthesis of novel ", "N-indolylmethyl spiroindoline-3,2'-quinazolines", "."], "h": {"pos": [1, 2], "type": null, "name": "SIRT1 : Pd/C-mediated synthesis of novel "}, "t": {"pos": [3, 4], "type": null, "name": "N-indolylmethyl spiroindoline-3,2'-quinazolines ."}}
{"relation": "INHIBITOR", "token": ["All GABA(A)R modulators induced a negative shift in the steady-state inactivation curve of Ca(v)1.3 channels, but only ", "BDZs", " and pentobarbital induced a negative shift in ", "Ca(v)1.2", " channel inactivation."], "h": {"pos": [1, 2], "type": null, "name": "BDZs  and pentobarbital induced a negative shift in "}, "t": {"pos": [3, 4], "type": null, "name": "Ca(v)1.2  channel inactivation."}}
{"relation": "INHIBITOR", "token": ["Interestingly, ", "gemfibrozil", " strongly inhibited the activation of ", "NF-kappaB", ", AP-1, and C/EBPbeta but not that of GAS in cytokine-stimulated astroglial cells."], "h": {"pos": [1, 2], "type": null, "name": "gemfibrozil  strongly inhibited the activation of "}, "t": {"pos": [3, 4], "type": null, "name": "NF-kappaB , AP-1, and C/EBPbeta but not that of GAS in cytokine-stimulated astroglial cells."}}
{"relation": "INHIBITOR", "token": ["", "S1P", " activated phosphatidylinositol 3-kinase (PI3K)/Akt signaling, leading to the inhibition of ", "glycogen synthase kinase-3\u03b2", " and the nuclear translocation of \u03b2-catenin, followed by the increase of the transcriptional activity by \u03b2-catenin/T-cell factor complex formation in both SaOS-2 cells and MC3T3-E1 cells."], "h": {"pos": [1, 2], "type": null, "name": "S1P  activated phosphatidylinositol 3-kinase (PI3K)/Akt signaling, leading to the inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "glycogen synthase kinase-3\u03b2  and the nuclear translocation of \u03b2-catenin, followed by the increase of the transcriptional activity by \u03b2-catenin/T-cell factor complex formation in both SaOS-2 cells and MC3T3-E1 cells."}}
{"relation": "INHIBITOR", "token": ["PTE, used in combination with a known JAK2/", "STAT3", " inhibitor, ", "AG490", ", further decreased the viability of osteosarcoma cells."], "h": {"pos": [1, 2], "type": null, "name": "STAT3  inhibitor, "}, "t": {"pos": [3, 4], "type": null, "name": "AG490 , further decreased the viability of osteosarcoma cells."}}
{"relation": "INHIBITOR", "token": ["In this study, uptake of phenformin and [(14)C]tetraethylammonium (TEA) and ", "complex I", " inhibition by ", "phenformin", " were examined in isolated liver and heart mitochondria."], "h": {"pos": [1, 2], "type": null, "name": "complex I  inhibition by "}, "t": {"pos": [3, 4], "type": null, "name": "phenformin  were examined in isolated liver and heart mitochondria."}}
{"relation": "INHIBITOR", "token": ["PURPOSE: ", "Dasatinib", " (BMS-354825), a potent oral multi-targeted kinase inhibitor against SRC and ", "BCR", "-ABL, has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance."], "h": {"pos": [1, 2], "type": null, "name": "Dasatinib  (BMS-354825), a potent oral multi-targeted kinase inhibitor against SRC and "}, "t": {"pos": [3, 4], "type": null, "name": "BCR -ABL, has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance."}}
{"relation": "INHIBITOR", "token": ["The modification of the inhibitor scaffold of 1 and 2 from a ", "dihydroquinolinone", " core to a tetrahydropyrazolopyridinone core led to discovery of a new series of potent ", "KAT II", " inhibitors with excellent physicochemical properties."], "h": {"pos": [1, 2], "type": null, "name": "dihydroquinolinone  core to a tetrahydropyrazolopyridinone core led to discovery of a new series of potent "}, "t": {"pos": [3, 4], "type": null, "name": "KAT II  inhibitors with excellent physicochemical properties."}}
{"relation": "INHIBITOR", "token": ["Comparison of ", "cyclooxygenase", " inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and ", "bromfenac sodium", "."], "h": {"pos": [1, 2], "type": null, "name": "cyclooxygenase  inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and "}, "t": {"pos": [3, 4], "type": null, "name": "bromfenac sodium ."}}
{"relation": "INHIBITOR", "token": ["Further characterization of ", "sorafenib", " revealed that this molecule was a multikinase inhibitor that targeted the vascular endothelial growth factor receptor family (VEGFR-2 and VEGFR-3) and platelet-derived growth factor receptor family (PDGFR-beta and ", "Kit", "), which play key roles in tumor progression and angiogenesis."], "h": {"pos": [1, 2], "type": null, "name": "sorafenib  revealed that this molecule was a multikinase inhibitor that targeted the vascular endothelial growth factor receptor family (VEGFR-2 and VEGFR-3) and platelet-derived growth factor receptor family (PDGFR-beta and "}, "t": {"pos": [3, 4], "type": null, "name": "Kit ), which play key roles in tumor progression and angiogenesis."}}
{"relation": "INHIBITOR", "token": ["Blockade of PDE1 (8-methoxymethyl-3-isobutyl-1-methylxanthine, 100 microM), PDE2 [erythro-9-(2-hydroxy-3-nonyl)adenine, 30 microM], PDE3 (milrinone, 10 microM; cGMP, 10 microM), PDE4 (Ro 20-1724 [4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one], 100 microM), PDE5 and ", "PDE6", " (", "zaprinast", ", 30 microM), and PDE7 [BRL-50481 (5-nitro-2,N,N-trimethylbenzenesulfonamide), 10 microM] did not alter renal ecto-phosphodiesterase activity."], "h": {"pos": [1, 2], "type": null, "name": "PDE6  ("}, "t": {"pos": [3, 4], "type": null, "name": "zaprinast , 30 microM), and PDE7 [BRL-50481 (5-nitro-2,N,N-trimethylbenzenesulfonamide), 10 microM] did not alter renal ecto-phosphodiesterase activity."}}
{"relation": "INHIBITOR", "token": ["Indomethacin and ", "SC-236", ", a selective cyclooxygenase-2 (", "COX-2", ") inhibitor, exerted a similar effect as sulindac."], "h": {"pos": [1, 2], "type": null, "name": "SC-236 , a selective cyclooxygenase-2 ("}, "t": {"pos": [3, 4], "type": null, "name": "COX-2 ) inhibitor, exerted a similar effect as sulindac."}}
{"relation": "INHIBITOR", "token": ["Structure-based design of ", "aliskiren", ", a novel orally effective ", "renin", " inhibitor."], "h": {"pos": [1, 2], "type": null, "name": "aliskiren , a novel orally effective "}, "t": {"pos": [3, 4], "type": null, "name": "renin  inhibitor."}}
{"relation": "INHIBITOR", "token": ["Our previous work, built on the early pioneering multikinase inhibitor ", "LY294002", ", resulted in the only PI3K vascular-targeted ", "PI3K", " inhibitor prodrug, SF1126, which has now completed Phase I clinical trials."], "h": {"pos": [1, 2], "type": null, "name": "LY294002 , resulted in the only PI3K vascular-targeted "}, "t": {"pos": [3, 4], "type": null, "name": "PI3K  inhibitor prodrug, SF1126, which has now completed Phase I clinical trials."}}
{"relation": "INHIBITOR", "token": ["In patients who do not reach the LDL-C target, combination therapy with additional ", "LDL", "-C lowering drugs (e.g. ", "ezetimibe", ", bile acid sequestrants or fibrates) should be considered."], "h": {"pos": [1, 2], "type": null, "name": "LDL -C lowering drugs (e.g. "}, "t": {"pos": [3, 4], "type": null, "name": "ezetimibe , bile acid sequestrants or fibrates) should be considered."}}
{"relation": "INHIBITOR", "token": ["", "Rapamycin", " inhibits ", "proteinase", " and selected peptidase activities of the catalytic core proteasome at low micromolar concentrations."], "h": {"pos": [1, 2], "type": null, "name": "Rapamycin  inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "proteinase  and selected peptidase activities of the catalytic core proteasome at low micromolar concentrations."}}
{"relation": "INHIBITOR", "token": ["Dasatinib (", "BMS-354825", ") is a novel orally bioavailable SRC/", "ABL", " inhibitor that has activity against multiple imatinib-resistant BCR-ABL isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia (CML)."], "h": {"pos": [1, 2], "type": null, "name": "BMS-354825 ) is a novel orally bioavailable SRC/"}, "t": {"pos": [3, 4], "type": null, "name": "ABL  inhibitor that has activity against multiple imatinib-resistant BCR-ABL isoforms in vitro that is presently showing considerable promise in early-phase clinical trials of chronic myeloid leukemia (CML)."}}
{"relation": "INHIBITOR", "token": ["Dexamethasone (", "DEX", ") inhibited the anti-", "CD3", "-induced production of IL-4, IL-5 and IFN-gamma in all 20 clones tested."], "h": {"pos": [1, 2], "type": null, "name": "DEX ) inhibited the anti-"}, "t": {"pos": [3, 4], "type": null, "name": "CD3 -induced production of IL-4, IL-5 and IFN-gamma in all 20 clones tested."}}
{"relation": "INHIBITOR", "token": ["Felodipine and the ", "p-chloro", " analogue inhibited the actin-activated ", "Mg2+-ATPase", " activity of smooth muscle myosin (IC50 = 25.1 microM)."], "h": {"pos": [1, 2], "type": null, "name": "p-chloro  analogue inhibited the actin-activated "}, "t": {"pos": [3, 4], "type": null, "name": "Mg2+-ATPase  activity of smooth muscle myosin (IC50 = 25.1 microM)."}}
{"relation": "INHIBITOR", "token": ["Effectiveness of ", "endopeptidase", " inhibition (", "candoxatril", ") in congestive heart failure."], "h": {"pos": [1, 2], "type": null, "name": "endopeptidase  inhibition ("}, "t": {"pos": [3, 4], "type": null, "name": "candoxatril ) in congestive heart failure."}}
{"relation": "INHIBITOR", "token": ["In patients who do not reach the LDL-C target, combination therapy with additional ", "LDL", "-C lowering drugs (e.g. ezetimibe, ", "bile acid", " sequestrants or fibrates) should be considered."], "h": {"pos": [1, 2], "type": null, "name": "LDL -C lowering drugs (e.g. ezetimibe, "}, "t": {"pos": [3, 4], "type": null, "name": "bile acid  sequestrants or fibrates) should be considered."}}
{"relation": "INHIBITOR", "token": ["N(5)-Substituted H(4)biopterin derivatives were not oxidized to products serving as substrates for dihydropteridine reductase and,depending on the substituent, were competitive inhibitors of phenylalanine hydroxylase: ", "N(5)-methyl", "- and N(5)-hydroxymethyl H(4)biopterin inhibited ", "phenylalanine hydroxylase", ", whereas N(5)-formyl- and N(5)-acetyl H(4)biopterin had no effect."], "h": {"pos": [1, 2], "type": null, "name": "N(5)-methyl - and N(5)-hydroxymethyl H(4)biopterin inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "phenylalanine hydroxylase , whereas N(5)-formyl- and N(5)-acetyl H(4)biopterin had no effect."}}
{"relation": "INHIBITOR", "token": ["Nevertheless, coperfusion with 0.1 and 0.3 mM ", "5-nitro-2-(3-phenylpropylamino) benzoic acid", ", which inhibits the cystic fibrosis transmembrane conductor regulator (", "CFTR", "), dose dependently inhibited S3226-induced DBS."], "h": {"pos": [1, 2], "type": null, "name": "5-nitro-2-(3-phenylpropylamino) benzoic acid , which inhibits the cystic fibrosis transmembrane conductor regulator ("}, "t": {"pos": [3, 4], "type": null, "name": "CFTR ), dose dependently inhibited S3226-induced DBS."}}
{"relation": "INHIBITOR", "token": ["", "Aliskiren", " represents the first in a novel class of ", "renin", " inhibitors with the potential for treatment of hypertension and related cardiovascular diseases."], "h": {"pos": [1, 2], "type": null, "name": "Aliskiren  represents the first in a novel class of "}, "t": {"pos": [3, 4], "type": null, "name": "renin  inhibitors with the potential for treatment of hypertension and related cardiovascular diseases."}}
{"relation": "INHIBITOR", "token": ["", "Nitrooxy", " derivatives showed NO-dependent vasorelaxing properties, while most of the compounds proved to be very potent and selective ", "COX-2", " inhibitors in in vitro experimental models."], "h": {"pos": [1, 2], "type": null, "name": "Nitrooxy  derivatives showed NO-dependent vasorelaxing properties, while most of the compounds proved to be very potent and selective "}, "t": {"pos": [3, 4], "type": null, "name": "COX-2  inhibitors in in vitro experimental models."}}
{"relation": "INHIBITOR", "token": ["", "Felodipine", " and the p-chloro analogue inhibited the actin-activated ", "Mg2+-ATPase", " activity of smooth muscle myosin (IC50 = 25.1 microM)."], "h": {"pos": [1, 2], "type": null, "name": "Felodipine  and the p-chloro analogue inhibited the actin-activated "}, "t": {"pos": [3, 4], "type": null, "name": "Mg2+-ATPase  activity of smooth muscle myosin (IC50 = 25.1 microM)."}}
{"relation": "INHIBITOR", "token": ["In catalytic properties, mouse CA V is closest to CA I; however, in inhibition by acetazolamide, ethoxzolamide, and ", "cyanate", ", CA V is very similar to ", "CA II", "."], "h": {"pos": [1, 2], "type": null, "name": "cyanate , CA V is very similar to "}, "t": {"pos": [3, 4], "type": null, "name": "CA II ."}}
{"relation": "INHIBITOR", "token": ["Also consistent with the involvement of Gq coupled EP1 receptors, the PGE1 stimulation is inhibited by the PKCI vector (encoding the PKC inhibitory domain), the ", "PKC", " inhibitor Go 6976, ", "thapsigargin", ", as well as the calmodulin antagonists W7 and W13."], "h": {"pos": [1, 2], "type": null, "name": "PKC  inhibitor Go 6976, "}, "t": {"pos": [3, 4], "type": null, "name": "thapsigargin , as well as the calmodulin antagonists W7 and W13."}}
{"relation": "INHIBITOR", "token": ["It was also antagonized by the non-specific cyclooxygenase (COX) inhibitor, indomethacin, and by the selective ", "COX-2", " inhibitor, ", "NS-398", ", but not by the specific COX-1 inhibitor, valeryl salicylate."], "h": {"pos": [1, 2], "type": null, "name": "COX-2  inhibitor, "}, "t": {"pos": [3, 4], "type": null, "name": "NS-398 , but not by the specific COX-1 inhibitor, valeryl salicylate."}}
{"relation": "INHIBITOR", "token": ["", "Mibefradil", " blocked currents of all ", "Na+ channel", " isoforms with similar affinity and a dependence on holding potential, and drug off-rate was slowed at depolarized potentials (k(off) was 0.024/s at -130 mV and 0.007/s at -100 mV for Nav1.5)."], "h": {"pos": [1, 2], "type": null, "name": "Mibefradil  blocked currents of all "}, "t": {"pos": [3, 4], "type": null, "name": "Na+ channel  isoforms with similar affinity and a dependence on holding potential, and drug off-rate was slowed at depolarized potentials (k(off) was 0.024/s at -130 mV and 0.007/s at -100 mV for Nav1.5)."}}
{"relation": "INHIBITOR", "token": ["In addition, the new compound perviridicin B (2), three known rocaglate derivatives (9, 11, 12), and a known ", "sesquiterpene", ", 2-oxaisodauc-5-en-12-al (17), showed significant ", "NF-\u03baB", " (p65) inhibitory activity in an ELISA assay."], "h": {"pos": [1, 2], "type": null, "name": "sesquiterpene , 2-oxaisodauc-5-en-12-al (17), showed significant "}, "t": {"pos": [3, 4], "type": null, "name": "NF-\u03baB  (p65) inhibitory activity in an ELISA assay."}}
{"relation": "INHIBITOR", "token": ["INTRODUCTION: In this study, we examined the effects of the ", "alpha-glucosidase", " inhibitors ", "acarbose", " and voglibose on postprandial plasma glucose and serum triglyceride levels in patients with type 2 diabetes mellitus."], "h": {"pos": [1, 2], "type": null, "name": "alpha-glucosidase  inhibitors "}, "t": {"pos": [3, 4], "type": null, "name": "acarbose  and voglibose on postprandial plasma glucose and serum triglyceride levels in patients with type 2 diabetes mellitus."}}
{"relation": "INHIBITOR", "token": ["To determine whether arginases modulate the endothelial NO synthesis, we investigated the effects of the competitive ", "arginase", " inhibitor N(omega)-hydroxy-nor-L-arginine (", "Nor-NOHA", ") on the activity of NOS, arginases, and L-arginine transporter and on NO release at surface of human umbilical vein endothelial cells (HUVECs)."], "h": {"pos": [1, 2], "type": null, "name": "arginase  inhibitor N(omega)-hydroxy-nor-L-arginine ("}, "t": {"pos": [3, 4], "type": null, "name": "Nor-NOHA ) on the activity of NOS, arginases, and L-arginine transporter and on NO release at surface of human umbilical vein endothelial cells (HUVECs)."}}
{"relation": "INHIBITOR", "token": ["The structure-based design, synthesis, and biological evaluation of a new ", "pyrazole", " series of irreversible ", "KAT II", " inhibitors are described herein."], "h": {"pos": [1, 2], "type": null, "name": "pyrazole  series of irreversible "}, "t": {"pos": [3, 4], "type": null, "name": "KAT II  inhibitors are described herein."}}
{"relation": "INHIBITOR", "token": ["Inhibition by ", "phenformin", " of oxygen consumption via ", "complex I", " respiration in isolated rat liver mitochondria was greater than that in heart mitochondria, whereas inhibitory effect of phenformin on complex I respiration was similar in inside-out structured submitochondrial particles prepared from rat livers and hearts."], "h": {"pos": [1, 2], "type": null, "name": "phenformin  of oxygen consumption via "}, "t": {"pos": [3, 4], "type": null, "name": "complex I  respiration in isolated rat liver mitochondria was greater than that in heart mitochondria, whereas inhibitory effect of phenformin on complex I respiration was similar in inside-out structured submitochondrial particles prepared from rat livers and hearts."}}
{"relation": "INHIBITOR", "token": ["A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, ", "gallic acid", ", syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (", "CA", ", EC 4.2.1.1)."], "h": {"pos": [1, 2], "type": null, "name": "gallic acid , syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase ("}, "t": {"pos": [3, 4], "type": null, "name": "CA , EC 4.2.1.1)."}}
{"relation": "INHIBITOR", "token": ["We show that sorafenib (", "BAY 43-9006", ", Nexavar) potently inhibits ", "FLT3", " enzymatic and signaling activities."], "h": {"pos": [1, 2], "type": null, "name": "BAY 43-9006 , Nexavar) potently inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "FLT3  enzymatic and signaling activities."}}
{"relation": "INHIBITOR", "token": ["In addition, the disease activity index, histopathologic scores and ", "myeloperoxidase", " activity were also significantly reduced by ", "Fc11a-2", " treatment."], "h": {"pos": [1, 2], "type": null, "name": "myeloperoxidase  activity were also significantly reduced by "}, "t": {"pos": [3, 4], "type": null, "name": "Fc11a-2  treatment."}}
{"relation": "INHIBITOR", "token": ["A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, ", "syringic acid", ", quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (", "CA", ", EC 4.2.1.1)."], "h": {"pos": [1, 2], "type": null, "name": "syringic acid , quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase ("}, "t": {"pos": [3, 4], "type": null, "name": "CA , EC 4.2.1.1)."}}
{"relation": "INHIBITOR", "token": ["The inhibition of ", "phosphoinositide 3-kinase", " using ", "Ly294002", " augmented a decrease in the p21 level induced by their combination, but it showed no significant effects on expression of Sp1 and cyclin D1."], "h": {"pos": [1, 2], "type": null, "name": "phosphoinositide 3-kinase  using "}, "t": {"pos": [3, 4], "type": null, "name": "Ly294002  augmented a decrease in the p21 level induced by their combination, but it showed no significant effects on expression of Sp1 and cyclin D1."}}
{"relation": "INHIBITOR", "token": ["This study explored whether ", "curcumin", " improves colonic inflammation in a rat colitis model through inhibition of the ", "TLR4", "/NF-\u03baB signaling pathway and IL-27 expression."], "h": {"pos": [1, 2], "type": null, "name": "curcumin  improves colonic inflammation in a rat colitis model through inhibition of the "}, "t": {"pos": [3, 4], "type": null, "name": "TLR4 /NF-\u03baB signaling pathway and IL-27 expression."}}
{"relation": "INHIBITOR", "token": ["This stimulation was attenuated by the ", "Pak", " inhibitor ", "2,2'-dihydroxy-1,1'-dinaphthyldisulfide", " (IPA3) or dominant-negative Pak1."], "h": {"pos": [1, 2], "type": null, "name": "Pak  inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "2,2'-dihydroxy-1,1'-dinaphthyldisulfide  (IPA3) or dominant-negative Pak1."}}
{"relation": "INHIBITOR", "token": ["", "Phosphate", ", a product of the reaction, was found to be a potent inhibitor of ", "MjAdSS", " showing biphasic inhibition of enzyme activity."], "h": {"pos": [1, 2], "type": null, "name": "Phosphate , a product of the reaction, was found to be a potent inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "MjAdSS  showing biphasic inhibition of enzyme activity."}}
{"relation": "INHIBITOR", "token": ["", "Acetazolamide", ", a specific inhibitor of ", "CA", ", reduces the activity of CA I and CA II from red cells."], "h": {"pos": [1, 2], "type": null, "name": "Acetazolamide , a specific inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "CA , reduces the activity of CA I and CA II from red cells."}}
{"relation": "INHIBITOR", "token": ["METHODS AND RESULTS: In 8 Langendorff-perfused rabbit hearts, ", "veratridine", " (0.1 microM), an inhibitor of ", "sodium channel", " inactivation, led to a marked increase in QT-interval and simultaneously recorded monophasic ventricular action potentials (MAPs) (p < 0.05) thereby mimicking LQT3."], "h": {"pos": [1, 2], "type": null, "name": "veratridine  (0.1 microM), an inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "sodium channel  inactivation, led to a marked increase in QT-interval and simultaneously recorded monophasic ventricular action potentials (MAPs) (p < 0.05) thereby mimicking LQT3."}}
{"relation": "INHIBITOR", "token": ["The activity of polymerases containing mutations known to confer resistance to foscarnet (", "V715M", ", T700A and N495K) was inhibited by concentrations of ", "foscarnet", " eight to 14 times higher than those required to inhibit wild-type polymerases."], "h": {"pos": [1, 2], "type": null, "name": "V715M , T700A and N495K) was inhibited by concentrations of "}, "t": {"pos": [3, 4], "type": null, "name": "foscarnet  eight to 14 times higher than those required to inhibit wild-type polymerases."}}
{"relation": "INHIBITOR", "token": ["", "Epidermal growth factor receptor", " inhibitors currently under investigation include the small molecules gefitinib (Iressa, ZD1839) and ", "erlotinib", " (Tarceva, OSI-774), as well as monoclonal antibodies such as cetuximab (IMC-225, Erbitux)."], "h": {"pos": [1, 2], "type": null, "name": "Epidermal growth factor receptor  inhibitors currently under investigation include the small molecules gefitinib (Iressa, ZD1839) and "}, "t": {"pos": [3, 4], "type": null, "name": "erlotinib  (Tarceva, OSI-774), as well as monoclonal antibodies such as cetuximab (IMC-225, Erbitux)."}}
{"relation": "INHIBITOR", "token": ["A series of benzenesulfonamides incorporating ", "cyanoacrylamide", " moieties (tyrphostine analogs) were assayed as inhibitors of the \u03b2-carbonic anhydrase (", "CA", ", EC 4.2.1.1) from Saccharomyces cerevisiae, ScCA."], "h": {"pos": [1, 2], "type": null, "name": "cyanoacrylamide  moieties (tyrphostine analogs) were assayed as inhibitors of the \u03b2-carbonic anhydrase ("}, "t": {"pos": [3, 4], "type": null, "name": "CA , EC 4.2.1.1) from Saccharomyces cerevisiae, ScCA."}}
{"relation": "INHIBITOR", "token": ["One exception is tranexamic acid (TXA), which, as a ", "lysine", " mimetic, inhibits binding of plasminogen to ", "fibrin", "."], "h": {"pos": [1, 2], "type": null, "name": "lysine  mimetic, inhibits binding of plasminogen to "}, "t": {"pos": [3, 4], "type": null, "name": "fibrin ."}}
{"relation": "INHIBITOR", "token": ["Blockade of PDE1 (8-methoxymethyl-3-isobutyl-1-methylxanthine, 100 microM), PDE2 [erythro-9-(2-hydroxy-3-nonyl)adenine, 30 microM], ", "PDE3", " (", "milrinone", ", 10 microM; cGMP, 10 microM), PDE4 (Ro 20-1724 [4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one], 100 microM), PDE5 and PDE6 (zaprinast, 30 microM), and PDE7 [BRL-50481 (5-nitro-2,N,N-trimethylbenzenesulfonamide), 10 microM] did not alter renal ecto-phosphodiesterase activity."], "h": {"pos": [1, 2], "type": null, "name": "PDE3  ("}, "t": {"pos": [3, 4], "type": null, "name": "milrinone , 10 microM; cGMP, 10 microM), PDE4 (Ro 20-1724 [4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one], 100 microM), PDE5 and PDE6 (zaprinast, 30 microM), and PDE7 [BRL-50481 (5-nitro-2,N,N-trimethylbenzenesulfonamide), 10 microM] did not alter renal ecto-phosphodiesterase activity."}}
{"relation": "INHIBITOR", "token": ["Interestingly, a Val-349 to Ile mutant was inhibited with equal potency to ", "human COX-2", " with 2,6-dichloro-, ", "2,6-dimethyl", "-, or 2-chloro-6-methyl-substituted inhibitors and, in the case of lumiracoxib, actually showed an increase in potency."], "h": {"pos": [1, 2], "type": null, "name": "human COX-2  with 2,6-dichloro-, "}, "t": {"pos": [3, 4], "type": null, "name": "2,6-dimethyl -, or 2-chloro-6-methyl-substituted inhibitors and, in the case of lumiracoxib, actually showed an increase in potency."}}
{"relation": "INHIBITOR", "token": ["A series of ", "phenolic acids", " and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the ", "metalloenzyme", " carbonic anhydrase (CA, EC 4.2.1.1)."], "h": {"pos": [1, 2], "type": null, "name": "phenolic acids  and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the "}, "t": {"pos": [3, 4], "type": null, "name": "metalloenzyme  carbonic anhydrase (CA, EC 4.2.1.1)."}}
{"relation": "INHIBITOR", "token": ["We have examined the effects of the synthetic ", "matrix metalloproteinase", " inhibitor, ", "batimastat", " (BB-94) and the angiotensin-converting enzyme inhibitor, captopril, on metalloproteinase activity of murine Lewis-lung-carcinoma cells (3LL) in vitro, and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice."], "h": {"pos": [1, 2], "type": null, "name": "matrix metalloproteinase  inhibitor, "}, "t": {"pos": [3, 4], "type": null, "name": "batimastat  (BB-94) and the angiotensin-converting enzyme inhibitor, captopril, on metalloproteinase activity of murine Lewis-lung-carcinoma cells (3LL) in vitro, and on local growth and lung metastasis of the same tumor implanted intramuscularly in syngeneic C57BL/6 mice."}}
{"relation": "INHIBITOR", "token": ["Furthermore, these ", "phosphorylated flavonoids", " demonstrated good to high selectivity for CEase over AChE, which only showed micromolar potency inhibition of ", "AChE", "."], "h": {"pos": [1, 2], "type": null, "name": "phosphorylated flavonoids  demonstrated good to high selectivity for CEase over AChE, which only showed micromolar potency inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "AChE ."}}
{"relation": "INHIBITOR", "token": ["The activity of polymerases containing mutations known to confer resistance to foscarnet (V715M, ", "T700A", " and N495K) was inhibited by concentrations of ", "foscarnet", " eight to 14 times higher than those required to inhibit wild-type polymerases."], "h": {"pos": [1, 2], "type": null, "name": "T700A  and N495K) was inhibited by concentrations of "}, "t": {"pos": [3, 4], "type": null, "name": "foscarnet  eight to 14 times higher than those required to inhibit wild-type polymerases."}}
{"relation": "INHIBITOR", "token": ["Depletion of putrescine, spermidine, and spermine by ", "DL-alpha-difluoromethylornithine", " (DFMO), a specific inhibitor of ", "ornithine decarboxylase", " (ODC) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index."], "h": {"pos": [1, 2], "type": null, "name": "DL-alpha-difluoromethylornithine  (DFMO), a specific inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "ornithine decarboxylase  (ODC) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index."}}
{"relation": "INHIBITOR", "token": ["Diclofenac-\u03b2-d-glucuronide, clopidogrel-\u03b2-d-glucuronide, ibuprofen-\u03b2-d-glucuronide, (R)-naproxen-\u03b2-d-glucuronide, and ", "(S)-naproxen-\u03b2-d-glucuronide", " selectively inhibited ", "hCES1", ", with Ki values of 4.32 \u00b1 0.47, 24.8 \u00b1 4.2, 355 \u00b1 38, 468 \u00b1 21, 707 \u00b1 64 \u00b5M, respectively, but did not significantly inhibit hCES2."], "h": {"pos": [1, 2], "type": null, "name": "(S)-naproxen-\u03b2-d-glucuronide  selectively inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "hCES1 , with Ki values of 4.32 \u00b1 0.47, 24.8 \u00b1 4.2, 355 \u00b1 38, 468 \u00b1 21, 707 \u00b1 64 \u00b5M, respectively, but did not significantly inhibit hCES2."}}
{"relation": "INHIBITOR", "token": ["In this study, focus was given to evaluate the ability of ", "neoechinulin A", ", an indole alkaloid isolated from marine-derived Microsporum sp., to attenuate microglial activation by oligomeric amyloid-\u03b2 1-42 (", "A\u03b242", ")."], "h": {"pos": [1, 2], "type": null, "name": "neoechinulin A , an indole alkaloid isolated from marine-derived Microsporum sp., to attenuate microglial activation by oligomeric amyloid-\u03b2 1-42 ("}, "t": {"pos": [3, 4], "type": null, "name": "A\u03b242 )."}}
{"relation": "INHIBITOR", "token": ["Pharmacological treatment has been studied and it could be demonstrated, that some mutant currents may be insufficiently suppressed by drugs targeted to block the specific current such as, e.g., ", "sotalol", " or ibutilide in patients with a mutation in the ", "IKr", "-coding gene KCNH2 (HERG)."], "h": {"pos": [1, 2], "type": null, "name": "sotalol  or ibutilide in patients with a mutation in the "}, "t": {"pos": [3, 4], "type": null, "name": "IKr -coding gene KCNH2 (HERG)."}}
{"relation": "INHIBITOR", "token": ["", "BDZs", " and other positive GABA(A)R modulators, including barbiturates, ethanol, and neurosteroids, can also inhibit L-type voltage-gated calcium channels (", "L-VGCCs", "), which could contribute to reduced neuronal excitability."], "h": {"pos": [1, 2], "type": null, "name": "BDZs  and other positive GABA(A)R modulators, including barbiturates, ethanol, and neurosteroids, can also inhibit L-type voltage-gated calcium channels ("}, "t": {"pos": [3, 4], "type": null, "name": "L-VGCCs ), which could contribute to reduced neuronal excitability."}}
{"relation": "INHIBITOR", "token": ["", "Rg1", " attenuated the ", "A\u03b225-35", "-associated mitochondrial apoptotic events, accompanied by inhibiting HIF-1\u03b1 expression followed by intracellular reactive nitrogen species generation, and protein nitrotyrosination."], "h": {"pos": [1, 2], "type": null, "name": "Rg1  attenuated the "}, "t": {"pos": [3, 4], "type": null, "name": "A\u03b225-35 -associated mitochondrial apoptotic events, accompanied by inhibiting HIF-1\u03b1 expression followed by intracellular reactive nitrogen species generation, and protein nitrotyrosination."}}
{"relation": "INHIBITOR", "token": ["Sodium salicylate and ", "aspirin", " also inhibited ", "NF-kappa B", "-dependent transcription from the Ig kappa enhancer and the human immunodeficiency virus (HIV) long terminal repeat (LTR) in transfected T cells."], "h": {"pos": [1, 2], "type": null, "name": "aspirin  also inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "NF-kappa B -dependent transcription from the Ig kappa enhancer and the human immunodeficiency virus (HIV) long terminal repeat (LTR) in transfected T cells."}}
{"relation": "INHIBITOR", "token": ["Insulin secretion stimulated by both 200 \u03bcM tolbutamide and 20 \u03bcM gliclazide, concentrations that had equivalent effects on membrane potential, was inhibited by thapsigargin (1 \u03bcM) or the ", "L-type Ca(2+) channel", " blocker ", "nicardipine", " (2 \u03bcM) and was potentiated by 8-pCPT-2'-O-Me-cAMP-AM at concentrations \u22652 \u03bcM in INS-1 cells."], "h": {"pos": [1, 2], "type": null, "name": "L-type Ca(2+) channel  blocker "}, "t": {"pos": [3, 4], "type": null, "name": "nicardipine  (2 \u03bcM) and was potentiated by 8-pCPT-2'-O-Me-cAMP-AM at concentrations \u22652 \u03bcM in INS-1 cells."}}
{"relation": "INHIBITOR", "token": ["First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, TOP2-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, etoposide, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive ", "TOP2", " poisons (e.g. amonafide, ", "batracylin", ", and menadione) was only slightly (less than 3-fold) affected."], "h": {"pos": [1, 2], "type": null, "name": "TOP2  poisons (e.g. amonafide, "}, "t": {"pos": [3, 4], "type": null, "name": "batracylin , and menadione) was only slightly (less than 3-fold) affected."}}
{"relation": "INHIBITOR", "token": ["The anti-inflammatory drugs ", "sodium salicylate", " and aspirin inhibited the activation of ", "NF-kappa B", ", which further explains the mechanism of action of these drugs."], "h": {"pos": [1, 2], "type": null, "name": "sodium salicylate  and aspirin inhibited the activation of "}, "t": {"pos": [3, 4], "type": null, "name": "NF-kappa B , which further explains the mechanism of action of these drugs."}}
{"relation": "INHIBITOR", "token": ["On the other hand, high doses of ", "okadaic acid", " (10 ng/mouse, i.c.v.) and cantharidin (1 microg/mouse, i.c.v.), which also block ", "PP1", ", and calyculin-A (0.1 fg/mouse-1 ng/mouse, i.c.v.), which inhibits equally both PP1 and PP2A, did not modify the morphine-induced antinociception."], "h": {"pos": [1, 2], "type": null, "name": "okadaic acid  (10 ng/mouse, i.c.v.) and cantharidin (1 microg/mouse, i.c.v.), which also block "}, "t": {"pos": [3, 4], "type": null, "name": "PP1 , and calyculin-A (0.1 fg/mouse-1 ng/mouse, i.c.v.), which inhibits equally both PP1 and PP2A, did not modify the morphine-induced antinociception."}}
{"relation": "INHIBITOR", "token": ["The contractions to 5-HT were inhibited by ", "ketanserin", " and alosetron indicating involvement of ", "5-HT(2A)", " and 5-HT(3) receptors, respectively."], "h": {"pos": [1, 2], "type": null, "name": "ketanserin  and alosetron indicating involvement of "}, "t": {"pos": [3, 4], "type": null, "name": "5-HT(2A)  and 5-HT(3) receptors, respectively."}}
{"relation": "INHIBITOR", "token": ["The tyrosine kinase inhibitor ZD1839 (\"", "Iressa", "\") inhibits HER2-driven signaling and suppresses the growth of ", "HER2", "-overexpressing tumor cells."], "h": {"pos": [1, 2], "type": null, "name": "Iressa \") inhibits HER2-driven signaling and suppresses the growth of "}, "t": {"pos": [3, 4], "type": null, "name": "HER2 -overexpressing tumor cells."}}
{"relation": "INHIBITOR", "token": ["", "Diclofenac-\u03b2-d-glucuronide", ", clopidogrel-\u03b2-d-glucuronide, ibuprofen-\u03b2-d-glucuronide, (R)-naproxen-\u03b2-d-glucuronide, and (S)-naproxen-\u03b2-d-glucuronide selectively inhibited ", "hCES1", ", with Ki values of 4.32 \u00b1 0.47, 24.8 \u00b1 4.2, 355 \u00b1 38, 468 \u00b1 21, 707 \u00b1 64 \u00b5M, respectively, but did not significantly inhibit hCES2."], "h": {"pos": [1, 2], "type": null, "name": "Diclofenac-\u03b2-d-glucuronide , clopidogrel-\u03b2-d-glucuronide, ibuprofen-\u03b2-d-glucuronide, (R)-naproxen-\u03b2-d-glucuronide, and (S)-naproxen-\u03b2-d-glucuronide selectively inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "hCES1 , with Ki values of 4.32 \u00b1 0.47, 24.8 \u00b1 4.2, 355 \u00b1 38, 468 \u00b1 21, 707 \u00b1 64 \u00b5M, respectively, but did not significantly inhibit hCES2."}}
{"relation": "INHIBITOR", "token": ["BDZs and other positive GABA(A)R modulators, including barbiturates, ", "ethanol", ", and neurosteroids, can also inhibit ", "L-type voltage-gated calcium channels", " (L-VGCCs), which could contribute to reduced neuronal excitability."], "h": {"pos": [1, 2], "type": null, "name": "ethanol , and neurosteroids, can also inhibit "}, "t": {"pos": [3, 4], "type": null, "name": "L-type voltage-gated calcium channels  (L-VGCCs), which could contribute to reduced neuronal excitability."}}
{"relation": "INHIBITOR", "token": ["", "Epidermal growth factor receptor", " inhibitors currently under investigation include the small molecules ", "gefitinib", " (Iressa, ZD1839) and erlotinib (Tarceva, OSI-774), as well as monoclonal antibodies such as cetuximab (IMC-225, Erbitux)."], "h": {"pos": [1, 2], "type": null, "name": "Epidermal growth factor receptor  inhibitors currently under investigation include the small molecules "}, "t": {"pos": [3, 4], "type": null, "name": "gefitinib  (Iressa, ZD1839) and erlotinib (Tarceva, OSI-774), as well as monoclonal antibodies such as cetuximab (IMC-225, Erbitux)."}}
{"relation": "INHIBITOR", "token": ["In addition, ", "BGG", "-mediated inhibition of ", "AR", " prevented LPS-induced activation of JNK and p38 and lowered ROS levels, which could inhibit LPS-induced apoptosis."], "h": {"pos": [1, 2], "type": null, "name": "BGG -mediated inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "AR  prevented LPS-induced activation of JNK and p38 and lowered ROS levels, which could inhibit LPS-induced apoptosis."}}
{"relation": "INHIBITOR", "token": ["Prostaglandin E1, E2, STA2 (a stable analogue of thromboxane A2), 17-phenyl-trinor-PGE2 (an EP1-selective agonist) and sulprostone (an EP3-selective agonist) inhibited the HVA Ca2+ current (HVA ICa) dose-dependently, and the rank order of potency to inhibit ", "HVA Ca2+ channels", " was sulprostone>PGE2, ", "PGE1", ">STA2>>17-phenyl-trinor-PGE2."], "h": {"pos": [1, 2], "type": null, "name": "HVA Ca2+ channels  was sulprostone>PGE2, "}, "t": {"pos": [3, 4], "type": null, "name": "PGE1 >STA2>>17-phenyl-trinor-PGE2."}}
{"relation": "INHIBITOR", "token": ["", "Cucurbitacin I", " inhibits ", "rac1", " activation in breast cancer cells by a reactive oxygen species-mediated mechanism and independently of janus tyrosine kinase 2 and p-rex1."], "h": {"pos": [1, 2], "type": null, "name": "Cucurbitacin I  inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "rac1  activation in breast cancer cells by a reactive oxygen species-mediated mechanism and independently of janus tyrosine kinase 2 and p-rex1."}}
{"relation": "INHIBITOR", "token": ["", "Aspirin", " (ASA) and other non-steroidal anti-inflammatory drugs, which are cyclooxygenase (", "COX", ") inhibitors, precipitate asthmatic attacks in ASA-intolerant patients, while sodium salicylate, hardly active on COX by itself, is well tolerated by these patients."], "h": {"pos": [1, 2], "type": null, "name": "Aspirin  (ASA) and other non-steroidal anti-inflammatory drugs, which are cyclooxygenase ("}, "t": {"pos": [3, 4], "type": null, "name": "COX ) inhibitors, precipitate asthmatic attacks in ASA-intolerant patients, while sodium salicylate, hardly active on COX by itself, is well tolerated by these patients."}}
{"relation": "INHIBITOR", "token": ["The effects of theophylline (unspecific PDE inhibitor), vinpocetine (PDE1 inhibitor), EHNA (PDE2 inhibitor) and the ", "PDE5", " inhibitors zaprinast and ", "E 4021", " were weak."], "h": {"pos": [1, 2], "type": null, "name": "PDE5  inhibitors zaprinast and "}, "t": {"pos": [3, 4], "type": null, "name": "E 4021  were weak."}}
{"relation": "INHIBITOR", "token": ["", "ABT-199", ", a potent and selective ", "BCL-2", " inhibitor, achieves antitumor activity while sparing platelets."], "h": {"pos": [1, 2], "type": null, "name": "ABT-199 , a potent and selective "}, "t": {"pos": [3, 4], "type": null, "name": "BCL-2  inhibitor, achieves antitumor activity while sparing platelets."}}
{"relation": "INHIBITOR", "token": ["Troglitazone inhibited the antigen-induced production of LTB(4), C(4) and E(4) and the potency of the inhibition was comparable to that of ", "zileuton", ", a specific inhibitor of ", "5-lipoxygenase", " (5-LOX) and a clinically used anti-asthmatic drug."], "h": {"pos": [1, 2], "type": null, "name": "zileuton , a specific inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "5-lipoxygenase  (5-LOX) and a clinically used anti-asthmatic drug."}}
{"relation": "INHIBITOR", "token": ["A series of phenolic acids and ", "phenol", " natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (", "CA", ", EC 4.2.1.1)."], "h": {"pos": [1, 2], "type": null, "name": "phenol  natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase ("}, "t": {"pos": [3, 4], "type": null, "name": "CA , EC 4.2.1.1)."}}
{"relation": "INHIBITOR", "token": ["A pronounced NET knockout-induced shortening of the immobility time in the TST (by ca 50%) compared to WT mice was not reduced any further by ", "NET", "-inhibiting ADs such as reboxetine, ", "desipramine", ", and imipramine."], "h": {"pos": [1, 2], "type": null, "name": "NET -inhibiting ADs such as reboxetine, "}, "t": {"pos": [3, 4], "type": null, "name": "desipramine , and imipramine."}}
{"relation": "INHIBITOR", "token": ["The molecular mechanism studies suggested that ", "neoechinulin A", " may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (", "ASK-1", ") and nuclear translocation of nuclear factor-\u03baB (NF-\u03baB) p65 and p50 subunits."], "h": {"pos": [1, 2], "type": null, "name": "neoechinulin A  may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 ("}, "t": {"pos": [3, 4], "type": null, "name": "ASK-1 ) and nuclear translocation of nuclear factor-\u03baB (NF-\u03baB) p65 and p50 subunits."}}
{"relation": "INHIBITOR", "token": ["To extend structure-activity analyses of binding sites within ", "monoamine transporters", " and to determine which stereoisomer displayed the best selectivity for PET imaging applications, we tested the ", "HED", " compounds for their abilities to inhibit [(3)H]neurotransmitter uptake into platelets, transfected cells, and chromaffin vesicles."], "h": {"pos": [1, 2], "type": null, "name": "monoamine transporters  and to determine which stereoisomer displayed the best selectivity for PET imaging applications, we tested the "}, "t": {"pos": [3, 4], "type": null, "name": "HED  compounds for their abilities to inhibit [(3)H]neurotransmitter uptake into platelets, transfected cells, and chromaffin vesicles."}}
{"relation": "INHIBITOR", "token": ["Consistent with these locations, ", "N-ethylmaleimide", ", an inhibitor of ", "ACS4", ", inhibited ACS activity 47% in MAM and 28% in endoplasmic reticulum."], "h": {"pos": [1, 2], "type": null, "name": "N-ethylmaleimide , an inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "ACS4 , inhibited ACS activity 47% in MAM and 28% in endoplasmic reticulum."}}
{"relation": "INHIBITOR", "token": ["To determine whether dysregulation of SIRT1 promotes NADPH oxidase-dependent production of reactive oxygen species (ROS) and impairs endothelial function we assessed the effects of three structurally different inhibitors of ", "SIRT1", " (", "nicotinamide", ", sirtinol, EX527) in aorta segments isolated from young Wistar rats."], "h": {"pos": [1, 2], "type": null, "name": "SIRT1  ("}, "t": {"pos": [3, 4], "type": null, "name": "nicotinamide , sirtinol, EX527) in aorta segments isolated from young Wistar rats."}}
{"relation": "INHIBITOR", "token": ["This action can be related to the ability of ", "torasemide", " to block the increase of [Ca(2+)](i) induced by ", "Ang II", " in VSMCs."], "h": {"pos": [1, 2], "type": null, "name": "torasemide  to block the increase of [Ca(2+)](i) induced by "}, "t": {"pos": [3, 4], "type": null, "name": "Ang II  in VSMCs."}}
{"relation": "INHIBITOR", "token": ["", "Benzenesulfonamides", " incorporating cyanoacrylamide moieties strongly inhibit ", "Saccharomyces cerevisiae \u03b2-carbonic anhydrase", "."], "h": {"pos": [1, 2], "type": null, "name": "Benzenesulfonamides  incorporating cyanoacrylamide moieties strongly inhibit "}, "t": {"pos": [3, 4], "type": null, "name": "Saccharomyces cerevisiae \u03b2-carbonic anhydrase ."}}
{"relation": "INHIBITOR", "token": ["15d-PGJ2 did not block nuclear translocation or DNA-binding activity of the transcription factor NFkappaB, but it did inhibit the activity of an NFkappaB reporter construct, suggesting that the mechanism of suppression of microglial ", "iNOS", " by ", "15d-PGJ2", " may involve interference with NFkappaB transcriptional activity in the nucleus."], "h": {"pos": [1, 2], "type": null, "name": "iNOS  by "}, "t": {"pos": [3, 4], "type": null, "name": "15d-PGJ2  may involve interference with NFkappaB transcriptional activity in the nucleus."}}
{"relation": "INHIBITOR", "token": ["Importantly, pre-treatment with ", "buthionine sulfoximine", " (BSO), an inhibitor of ", "\u03b3-GCS", ", prevented \u03b1-MeDA induced increase in GSH levels, but did not augment this metabolite cytotoxicity."], "h": {"pos": [1, 2], "type": null, "name": "buthionine sulfoximine  (BSO), an inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "\u03b3-GCS , prevented \u03b1-MeDA induced increase in GSH levels, but did not augment this metabolite cytotoxicity."}}
{"relation": "INHIBITOR", "token": ["", "Topotecan", " is a ", "topoisomerase I", " inhibitor which is currently evaluated as an adjuvant agent for malignant glioma."], "h": {"pos": [1, 2], "type": null, "name": "Topotecan  is a "}, "t": {"pos": [3, 4], "type": null, "name": "topoisomerase I  inhibitor which is currently evaluated as an adjuvant agent for malignant glioma."}}
{"relation": "INHIBITOR", "token": ["Pharmacological treatment has been studied and it could be demonstrated, that some mutant currents may be insufficiently suppressed by drugs targeted to block the specific current such as, e.g., ", "sotalol", " or ibutilide in patients with a mutation in the IKr-coding gene KCNH2 (", "HERG", ")."], "h": {"pos": [1, 2], "type": null, "name": "sotalol  or ibutilide in patients with a mutation in the IKr-coding gene KCNH2 ("}, "t": {"pos": [3, 4], "type": null, "name": "HERG )."}}
{"relation": "INHIBITOR", "token": ["In comparison to ", "diphenylhydantoin", ", the novel chloro-substituted alpha-hydroxyphenylamide compounds produced as much as a 20-fold greater tonic and frequency-dependent blockade of ", "Na(V)1.5", " channels with an IC(50) value of 14.5 microM."], "h": {"pos": [1, 2], "type": null, "name": "diphenylhydantoin , the novel chloro-substituted alpha-hydroxyphenylamide compounds produced as much as a 20-fold greater tonic and frequency-dependent blockade of "}, "t": {"pos": [3, 4], "type": null, "name": "Na(V)1.5  channels with an IC(50) value of 14.5 microM."}}
{"relation": "INHIBITOR", "token": ["", "Mibefradil", " blocked ", "Nav1.5", " in a use/frequency-dependent manner, indicating preferential binding to states visited during depolarization."], "h": {"pos": [1, 2], "type": null, "name": "Mibefradil  blocked "}, "t": {"pos": [3, 4], "type": null, "name": "Nav1.5  in a use/frequency-dependent manner, indicating preferential binding to states visited during depolarization."}}
{"relation": "INHIBITOR", "token": ["The refolding kinetics of guanidine-denatured disulfide-intact ", "bovine pancreatic ribonuclease A", " (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and ", "2'-cytidine monophosphate", " (2'CMP) inhibitor binding."], "h": {"pos": [1, 2], "type": null, "name": "bovine pancreatic ribonuclease A  (RNase A) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and "}, "t": {"pos": [3, 4], "type": null, "name": "2'-cytidine monophosphate  (2'CMP) inhibitor binding."}}
{"relation": "INHIBITOR", "token": ["The antipsychotic drugs ", "sertindole", " and pimozide are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as HERG (", "human ether-a-go-go-related gene", "; erg1)."], "h": {"pos": [1, 2], "type": null, "name": "sertindole  and pimozide are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as HERG ("}, "t": {"pos": [3, 4], "type": null, "name": "human ether-a-go-go-related gene ; erg1)."}}
{"relation": "INHIBITOR", "token": ["Moreover, the rank order for potency in inhibiting acetylcholinesterase (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=galanthamine >desoxypeganine>parathion>", "gramine", ") indicated that the most effective inhibitors of ", "acetylcholinesterase", " also displaced [3H]-oxotremorine-M to the greatest extent."], "h": {"pos": [1, 2], "type": null, "name": "gramine ) indicated that the most effective inhibitors of "}, "t": {"pos": [3, 4], "type": null, "name": "acetylcholinesterase  also displaced [3H]-oxotremorine-M to the greatest extent."}}
{"relation": "INHIBITOR", "token": ["Both ", "NS-398", " and Dup-697 exhibited time-dependent inactivation of ", "hCOX-2", ", as did indomethacin on both enzymes."], "h": {"pos": [1, 2], "type": null, "name": "NS-398  and Dup-697 exhibited time-dependent inactivation of "}, "t": {"pos": [3, 4], "type": null, "name": "hCOX-2 , as did indomethacin on both enzymes."}}
{"relation": "INHIBITOR", "token": ["", "Dexamethasone", " suppresses histamine synthesis by repressing both transcription and activity of ", "HDC", " in allergic rats."], "h": {"pos": [1, 2], "type": null, "name": "Dexamethasone  suppresses histamine synthesis by repressing both transcription and activity of "}, "t": {"pos": [3, 4], "type": null, "name": "HDC  in allergic rats."}}
{"relation": "INHIBITOR", "token": ["The aim of this study was to determine the mechanism of ", "pranlukast", "-induced interleukin-5 (", "IL-5", ") inhibition in allergic inflammation."], "h": {"pos": [1, 2], "type": null, "name": "pranlukast -induced interleukin-5 ("}, "t": {"pos": [3, 4], "type": null, "name": "IL-5 ) inhibition in allergic inflammation."}}
{"relation": "INHIBITOR", "token": ["", "GW572016", ", a reversible small molecule inhibitor of EGFR and ErbB2 ", "tyrosine kinases", ", inhibits baseline p95ErbB2 phosphorylation in BT474 cells and tumor xenografts."], "h": {"pos": [1, 2], "type": null, "name": "GW572016 , a reversible small molecule inhibitor of EGFR and ErbB2 "}, "t": {"pos": [3, 4], "type": null, "name": "tyrosine kinases , inhibits baseline p95ErbB2 phosphorylation in BT474 cells and tumor xenografts."}}
{"relation": "INHIBITOR", "token": ["", "5-Hydroxy-3,6,7,8,3'4'-hexamethoxyflavone", " inhibits nitric oxide production in lipopolysaccharide-stimulated BV2 microglia via ", "NF-\u03baB", " suppression and Nrf-2-dependent heme oxygenase-1 induction."], "h": {"pos": [1, 2], "type": null, "name": "5-Hydroxy-3,6,7,8,3'4'-hexamethoxyflavone  inhibits nitric oxide production in lipopolysaccharide-stimulated BV2 microglia via "}, "t": {"pos": [3, 4], "type": null, "name": "NF-\u03baB  suppression and Nrf-2-dependent heme oxygenase-1 induction."}}
{"relation": "INHIBITOR", "token": ["", "Jaspamide", " also inhibited other channels including ", "Cav1.2", ", Cav3.2, and HCN2; however, the Kv11.1 (hERG) channel was minimally affected."], "h": {"pos": [1, 2], "type": null, "name": "Jaspamide  also inhibited other channels including "}, "t": {"pos": [3, 4], "type": null, "name": "Cav1.2 , Cav3.2, and HCN2; however, the Kv11.1 (hERG) channel was minimally affected."}}
{"relation": "INHIBITOR", "token": ["PURPOSE: Dasatinib (", "BMS-354825", "), a potent oral multi-targeted kinase inhibitor against ", "SRC", " and BCR-ABL, has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance."], "h": {"pos": [1, 2], "type": null, "name": "BMS-354825 ), a potent oral multi-targeted kinase inhibitor against "}, "t": {"pos": [3, 4], "type": null, "name": "SRC  and BCR-ABL, has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance."}}
{"relation": "INHIBITOR", "token": ["Genistin decreased myosin light chain kinase (MLCK) protein contents and MLCK mRNA expression in IJS, and inhibited both phosphorylation and Mg(2+)-ATPase activity of purified myosin, implicating that the decrease of MLCK contents and inhibition of ", "MLCK", " activity are involved in the ", "genistin", "-induced inhibitory effects."], "h": {"pos": [1, 2], "type": null, "name": "MLCK  activity are involved in the "}, "t": {"pos": [3, 4], "type": null, "name": "genistin -induced inhibitory effects."}}
{"relation": "INHIBITOR", "token": ["The anti-inflammatory actions of ", "curcumin", " on colitis may involve inhibition of the TLR4/", "NF-\u03baB", " signaling pathway and of IL-27 expression."], "h": {"pos": [1, 2], "type": null, "name": "curcumin  on colitis may involve inhibition of the TLR4/"}, "t": {"pos": [3, 4], "type": null, "name": "NF-\u03baB  signaling pathway and of IL-27 expression."}}
{"relation": "INHIBITOR", "token": ["Sixteen of 34 ", "CGPs", " inhibited ", "MRP1", "-mediated E217\u03b2G uptake by >50% (IC50's 0.7-7.6 \u03bcM)."], "h": {"pos": [1, 2], "type": null, "name": "CGPs  inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "MRP1 -mediated E217\u03b2G uptake by >50% (IC50's 0.7-7.6 \u03bcM)."}}
{"relation": "INHIBITOR", "token": ["The refolding kinetics of guanidine-denatured disulfide-intact bovine pancreatic ribonuclease A (", "RNase A", ") and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and ", "2'-cytidine monophosphate", " (2'CMP) inhibitor binding."], "h": {"pos": [1, 2], "type": null, "name": "RNase A ) and its proline-42-to-alanine mutant (Pro42Ala) have been studied by monitoring tyrosine burial and "}, "t": {"pos": [3, 4], "type": null, "name": "2'-cytidine monophosphate  (2'CMP) inhibitor binding."}}
{"relation": "INHIBITOR", "token": ["Agents that have only begun to undergo clinical evaluation include CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, and ", "PKI166", " and GW572016, both examples of dual ", "kinase", " inhibitors (inhibiting epidermal growth factor receptor and Her2)."], "h": {"pos": [1, 2], "type": null, "name": "PKI166  and GW572016, both examples of dual "}, "t": {"pos": [3, 4], "type": null, "name": "kinase  inhibitors (inhibiting epidermal growth factor receptor and Her2)."}}
{"relation": "INHIBITOR", "token": ["", "(R)-Ketoprofen", " (1) was previously reported to be a potent and specific noncompetitive inhibitor of ", "CXCL8", "-induced human PMNs chemotaxis."], "h": {"pos": [1, 2], "type": null, "name": "(R)-Ketoprofen  (1) was previously reported to be a potent and specific noncompetitive inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "CXCL8 -induced human PMNs chemotaxis."}}
{"relation": "INHIBITOR", "token": ["A series of phenolic acids and phenol natural products, such as ", "p-hydroxybenzoic acid", ", p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, ", "EC 4.2.1.1", ")."], "h": {"pos": [1, 2], "type": null, "name": "p-hydroxybenzoic acid , p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, "}, "t": {"pos": [3, 4], "type": null, "name": "EC 4.2.1.1 )."}}
{"relation": "INHIBITOR", "token": ["", "Sorafenib", " inhibited the kinase activity of both C-RAF and ", "B-RAF", " (wild type and V600E mutant)."], "h": {"pos": [1, 2], "type": null, "name": "Sorafenib  inhibited the kinase activity of both C-RAF and "}, "t": {"pos": [3, 4], "type": null, "name": "B-RAF  (wild type and V600E mutant)."}}
{"relation": "INHIBITOR", "token": ["", "ZD1839", " (\"Iressa\"), a quinazoline tyrosine kinase inhibitor selective for the ", "EGFR", ", has shown good activity in preclinical studies and in the early phase of clinical trials."], "h": {"pos": [1, 2], "type": null, "name": "ZD1839  (\"Iressa\"), a quinazoline tyrosine kinase inhibitor selective for the "}, "t": {"pos": [3, 4], "type": null, "name": "EGFR , has shown good activity in preclinical studies and in the early phase of clinical trials."}}
{"relation": "INHIBITOR", "token": ["A series of ", "benzenesulfonamides", " incorporating cyanoacrylamide moieties (tyrphostine analogs) were assayed as inhibitors of the \u03b2-carbonic anhydrase (", "CA", ", EC 4.2.1.1) from Saccharomyces cerevisiae, ScCA."], "h": {"pos": [1, 2], "type": null, "name": "benzenesulfonamides  incorporating cyanoacrylamide moieties (tyrphostine analogs) were assayed as inhibitors of the \u03b2-carbonic anhydrase ("}, "t": {"pos": [3, 4], "type": null, "name": "CA , EC 4.2.1.1) from Saccharomyces cerevisiae, ScCA."}}
{"relation": "INHIBITOR", "token": ["With the use of ", "sildenafil", ", it has been clearly, clinically demonstrated that the selective inhibition of ", "PDE5", " is an appropriate, effective, safe method for the treatment of ED of all aetiologies and severities."], "h": {"pos": [1, 2], "type": null, "name": "sildenafil , it has been clearly, clinically demonstrated that the selective inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "PDE5  is an appropriate, effective, safe method for the treatment of ED of all aetiologies and severities."}}
{"relation": "INHIBITOR", "token": ["Here, we show that one BLT, [1-(2-methoxy-phenyl)-3-naphthalen-2-yl-urea] (", "BLT-4", "), blocked ", "ABCA1", "-mediated cholesterol efflux to lipid-poor apoA-I at a potency similar to that for its inhibition of SR-BI (IC(50) approximately 55-60 microM)."], "h": {"pos": [1, 2], "type": null, "name": "BLT-4 ), blocked "}, "t": {"pos": [3, 4], "type": null, "name": "ABCA1 -mediated cholesterol efflux to lipid-poor apoA-I at a potency similar to that for its inhibition of SR-BI (IC(50) approximately 55-60 microM)."}}
{"relation": "INHIBITOR", "token": ["Interestingly, ", "gemfibrozil", " strongly inhibited the activation of NF-kappaB, AP-1, and ", "C/EBPbeta", " but not that of GAS in cytokine-stimulated astroglial cells."], "h": {"pos": [1, 2], "type": null, "name": "gemfibrozil  strongly inhibited the activation of NF-kappaB, AP-1, and "}, "t": {"pos": [3, 4], "type": null, "name": "C/EBPbeta  but not that of GAS in cytokine-stimulated astroglial cells."}}
{"relation": "INHIBITOR", "token": ["Acetylcholinesterase (", "AChE", ") inhibited by the organophosphate soman (", "1,2,2-trimethyl-propylmethylphosphonofluoridate", ") rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex."], "h": {"pos": [1, 2], "type": null, "name": "AChE ) inhibited by the organophosphate soman ("}, "t": {"pos": [3, 4], "type": null, "name": "1,2,2-trimethyl-propylmethylphosphonofluoridate ) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex."}}
{"relation": "INHIBITOR", "token": ["Inhibition of ", "p95ErbB2", ", p185ErbB2, and EGFR phosphorylation by ", "GW572016", " resulted in the inhibition of downstream phospho-Erk1/2, phospho-AKT, and cyclin D steady-state protein levels."], "h": {"pos": [1, 2], "type": null, "name": "p95ErbB2 , p185ErbB2, and EGFR phosphorylation by "}, "t": {"pos": [3, 4], "type": null, "name": "GW572016  resulted in the inhibition of downstream phospho-Erk1/2, phospho-AKT, and cyclin D steady-state protein levels."}}
{"relation": "INHIBITOR", "token": ["Given these findings, a unified PK model including the inhibition of MAO-A- and ", "CYP2D6", "-catalyzed 5-MeO-DMT metabolism by harmaline was developed to describe blood ", "harmaline", ", 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models."], "h": {"pos": [1, 2], "type": null, "name": "CYP2D6 -catalyzed 5-MeO-DMT metabolism by harmaline was developed to describe blood "}, "t": {"pos": [3, 4], "type": null, "name": "harmaline , 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models."}}
{"relation": "INHIBITOR", "token": ["Several members of a new family of non-sugar-type ", "\u03b1-glycosidase", " inhibitors, bearing a ", "5-(p-toluenesulfonylamino)phthalimide", " moiety and various substituent at the N2 position, were synthesized and their activities were investigated."], "h": {"pos": [1, 2], "type": null, "name": "\u03b1-glycosidase  inhibitors, bearing a "}, "t": {"pos": [3, 4], "type": null, "name": "5-(p-toluenesulfonylamino)phthalimide  moiety and various substituent at the N2 position, were synthesized and their activities were investigated."}}
{"relation": "INHIBITOR", "token": ["Some of these derivatives showed good inhibitory potency against two human CA isozymes involved in important physiological processes, ", "CA I", ", and CA II, of the same order of magnitude as the clinically used drugs acetazolamide and ", "methazolamide", "."], "h": {"pos": [1, 2], "type": null, "name": "CA I , and CA II, of the same order of magnitude as the clinically used drugs acetazolamide and "}, "t": {"pos": [3, 4], "type": null, "name": "methazolamide ."}}
{"relation": "INHIBITOR", "token": ["A series of phenolic acids and ", "phenol", " natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, ", "EC 4.2.1.1", ")."], "h": {"pos": [1, 2], "type": null, "name": "phenol  natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (CA, "}, "t": {"pos": [3, 4], "type": null, "name": "EC 4.2.1.1 )."}}
{"relation": "INHIBITOR", "token": ["Inhibition of dipeptidyl peptidase-IV (", "DPP-IV", ") by ", "atorvastatin", "."], "h": {"pos": [1, 2], "type": null, "name": "DPP-IV ) by "}, "t": {"pos": [3, 4], "type": null, "name": "atorvastatin ."}}
{"relation": "INHIBITOR", "token": ["A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, ", "p-coumaric acid", ", caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (", "CA", ", EC 4.2.1.1)."], "h": {"pos": [1, 2], "type": null, "name": "p-coumaric acid , caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase ("}, "t": {"pos": [3, 4], "type": null, "name": "CA , EC 4.2.1.1)."}}
{"relation": "INHIBITOR", "token": ["A series of ", "carbamoylmethylene", " linked prodrugs of 1 (BMS-582949), a clinical ", "p38\u03b1", " inhibitor, were synthesized and evaluated."], "h": {"pos": [1, 2], "type": null, "name": "carbamoylmethylene  linked prodrugs of 1 (BMS-582949), a clinical "}, "t": {"pos": [3, 4], "type": null, "name": "p38\u03b1  inhibitor, were synthesized and evaluated."}}
{"relation": "INHIBITOR", "token": ["Indomethacin abolished the inhibitory effect of ", "acetazolamide", " on ", "CA I", " and CA II."], "h": {"pos": [1, 2], "type": null, "name": "acetazolamide  on "}, "t": {"pos": [3, 4], "type": null, "name": "CA I  and CA II."}}
{"relation": "INHIBITOR", "token": ["In cultured vascular smooth muscle cells (VSMCs), rAAV-mediated CYP2J2 overexpression and ", "EETs", " markedly suppressed ", "Ang II", "-induced inflammatory cytokine expression."], "h": {"pos": [1, 2], "type": null, "name": "EETs  markedly suppressed "}, "t": {"pos": [3, 4], "type": null, "name": "Ang II -induced inflammatory cytokine expression."}}
{"relation": "INHIBITOR", "token": ["In this study, using a model of gentamicin C (", "GMC", ")-induced reduction in ", "SGLT1", " activity, we examined whether ligands for megalin protect LLC-PK1 cells from the GMC-induced reduction in SGLT1 activity."], "h": {"pos": [1, 2], "type": null, "name": "GMC )-induced reduction in "}, "t": {"pos": [3, 4], "type": null, "name": "SGLT1  activity, we examined whether ligands for megalin protect LLC-PK1 cells from the GMC-induced reduction in SGLT1 activity."}}
{"relation": "INHIBITOR", "token": ["The acetylcholinesterase (AChE) and ", "butyrylcholinesterase", " (BuChE) inhibitory activities of a series of ", "pyrano[2,3-b]quinolines", " (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."], "h": {"pos": [1, 2], "type": null, "name": "butyrylcholinesterase  (BuChE) inhibitory activities of a series of "}, "t": {"pos": [3, 4], "type": null, "name": "pyrano[2,3-b]quinolines  (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."}}
{"relation": "INHIBITOR", "token": ["However, DeltahPPAR-alpha was unable to abrogate ", "gemfibrozil", "-mediated inhibition of ", "iNOS", " suggesting that gemfibrozil inhibits iNOS independent of PPAR-alpha."], "h": {"pos": [1, 2], "type": null, "name": "gemfibrozil -mediated inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "iNOS  suggesting that gemfibrozil inhibits iNOS independent of PPAR-alpha."}}
{"relation": "INHIBITOR", "token": ["Nevertheless, 3 mM ", "DMA", ", a higher concentration that inhibits NHE1, NHE2, and ", "NHE3", ", significantly increased DBS."], "h": {"pos": [1, 2], "type": null, "name": "DMA , a higher concentration that inhibits NHE1, NHE2, and "}, "t": {"pos": [3, 4], "type": null, "name": "NHE3 , significantly increased DBS."}}
{"relation": "INHIBITOR", "token": ["In conclusion, ", "F3(d)Thd", ", an antimetabolite that inhibits ", "TS", " activity, may be effective against 5-FU and/or FdUrd-resistance in colorectal cancer cells caused by amplification of TS and/or deletion of orotate phosphoribosyltransferase."], "h": {"pos": [1, 2], "type": null, "name": "F3(d)Thd , an antimetabolite that inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "TS  activity, may be effective against 5-FU and/or FdUrd-resistance in colorectal cancer cells caused by amplification of TS and/or deletion of orotate phosphoribosyltransferase."}}
{"relation": "INHIBITOR", "token": ["The higher affinity of ", "felbamate", " block of NMDA receptors containing the ", "NR2B", " subunit could be accounted for by more rapid association and slower dissociation from these sites."], "h": {"pos": [1, 2], "type": null, "name": "felbamate  block of NMDA receptors containing the "}, "t": {"pos": [3, 4], "type": null, "name": "NR2B  subunit could be accounted for by more rapid association and slower dissociation from these sites."}}
{"relation": "INHIBITOR", "token": ["5-(N,N-dimethyl)-amiloride (50 microM; ", "DMA", "), a concentration that selectively inhibits the NHE isoforms ", "NHE1", " and NHE2, but not NHE3, did not affect DBS."], "h": {"pos": [1, 2], "type": null, "name": "DMA ), a concentration that selectively inhibits the NHE isoforms "}, "t": {"pos": [3, 4], "type": null, "name": "NHE1  and NHE2, but not NHE3, did not affect DBS."}}
{"relation": "INHIBITOR", "token": ["A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ", "ellagic acid", ", were investigated for their inhibitory effects against the metalloenzyme ", "carbonic anhydrase", " (CA, EC 4.2.1.1)."], "h": {"pos": [1, 2], "type": null, "name": "ellagic acid , were investigated for their inhibitory effects against the metalloenzyme "}, "t": {"pos": [3, 4], "type": null, "name": "carbonic anhydrase  (CA, EC 4.2.1.1)."}}
{"relation": "INHIBITOR", "token": ["The results suggested that ", "fisetin", " treatment inhibits ", "mTORC1", " activity in an Akt-dependent manner."], "h": {"pos": [1, 2], "type": null, "name": "fisetin  treatment inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "mTORC1  activity in an Akt-dependent manner."}}
{"relation": "INHIBITOR", "token": ["Prostaglandin E1, E2, STA2 (a stable analogue of thromboxane A2), 17-phenyl-trinor-PGE2 (an EP1-selective agonist) and sulprostone (an EP3-selective agonist) inhibited the HVA Ca2+ current (HVA ICa) dose-dependently, and the rank order of potency to inhibit ", "HVA Ca2+ channels", " was ", "sulprostone", ">PGE2, PGE1>STA2>>17-phenyl-trinor-PGE2."], "h": {"pos": [1, 2], "type": null, "name": "HVA Ca2+ channels  was "}, "t": {"pos": [3, 4], "type": null, "name": "sulprostone >PGE2, PGE1>STA2>>17-phenyl-trinor-PGE2."}}
{"relation": "INHIBITOR", "token": ["The anticonvulsant ", "felbamate", " blocks ", "N-methyl-D-asparate (NMDA) receptors", " but fails to exhibit the neurobehavioral toxicity characteristic of other NMDA receptor antagonists."], "h": {"pos": [1, 2], "type": null, "name": "felbamate  blocks "}, "t": {"pos": [3, 4], "type": null, "name": "N-methyl-D-asparate (NMDA) receptors  but fails to exhibit the neurobehavioral toxicity characteristic of other NMDA receptor antagonists."}}
{"relation": "INHIBITOR", "token": ["Other ", "cholinesterase", " inhibitors, including ", "rivastigmine", ", with superior properties in terms of specificity of action and low risk of adverse effects, have now been introduced."], "h": {"pos": [1, 2], "type": null, "name": "cholinesterase  inhibitors, including "}, "t": {"pos": [3, 4], "type": null, "name": "rivastigmine , with superior properties in terms of specificity of action and low risk of adverse effects, have now been introduced."}}
{"relation": "INHIBITOR", "token": ["In vitro studies, however, revealed that ", "EO", " inhibits ", "fibrin", " clot formation because of the Ca2+-chelating ability of its constituent ethanolamine, although oleate or benzyl alcohol exhibited procoagulant activity in FPA formation in vitro."], "h": {"pos": [1, 2], "type": null, "name": "EO  inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "fibrin  clot formation because of the Ca2+-chelating ability of its constituent ethanolamine, although oleate or benzyl alcohol exhibited procoagulant activity in FPA formation in vitro."}}
{"relation": "INHIBITOR", "token": ["", "Amrinone", " and milrinone, selective ", "PDE3", " inhibitors, suppressed TNF secretion to a lesser extent."], "h": {"pos": [1, 2], "type": null, "name": "Amrinone  and milrinone, selective "}, "t": {"pos": [3, 4], "type": null, "name": "PDE3  inhibitors, suppressed TNF secretion to a lesser extent."}}
{"relation": "INHIBITOR", "token": ["", "Tomudex", " (ZD1694) is a specific antifolate-based ", "thymidylate synthase", " inhibitor active in a variety of solid tumor malignancies."], "h": {"pos": [1, 2], "type": null, "name": "Tomudex  (ZD1694) is a specific antifolate-based "}, "t": {"pos": [3, 4], "type": null, "name": "thymidylate synthase  inhibitor active in a variety of solid tumor malignancies."}}
{"relation": "INHIBITOR", "token": ["The clinical profile of the ", "angiotensin II receptor", " blocker ", "eprosartan", "."], "h": {"pos": [1, 2], "type": null, "name": "angiotensin II receptor  blocker "}, "t": {"pos": [3, 4], "type": null, "name": "eprosartan ."}}
{"relation": "INHIBITOR", "token": ["In study 1, cyclic ewes received vehicle, cortisol, ", "PF 915275", " (PF; a selective inhibitor of ", "HSD11B1", "), cortisol and PF, meloxicam (a selective inhibitor of PTGS2), cortisol and meloxicam, recombinant ovine IFNT, or IFNT and PF into the uterus from day 10 to day14 after estrus."], "h": {"pos": [1, 2], "type": null, "name": "PF 915275  (PF; a selective inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "HSD11B1 ), cortisol and PF, meloxicam (a selective inhibitor of PTGS2), cortisol and meloxicam, recombinant ovine IFNT, or IFNT and PF into the uterus from day 10 to day14 after estrus."}}
{"relation": "INHIBITOR", "token": ["METHODS: ", "COX-1", " inhibition was determined by measuring thromboxane B2 (TXB2)-generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg meloxicam and 75 mg diclofenac and at steady state (15 mg meloxicam daily and 150 mg ", "diclofenac", " daily)."], "h": {"pos": [1, 2], "type": null, "name": "COX-1  inhibition was determined by measuring thromboxane B2 (TXB2)-generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg meloxicam and 75 mg diclofenac and at steady state (15 mg meloxicam daily and 150 mg "}, "t": {"pos": [3, 4], "type": null, "name": "diclofenac  daily)."}}
{"relation": "INHIBITOR", "token": ["PURPOSE: ", "Dasatinib", " (BMS-354825), a potent oral multi-targeted kinase inhibitor against SRC and BCR-", "ABL", ", has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance."], "h": {"pos": [1, 2], "type": null, "name": "Dasatinib  (BMS-354825), a potent oral multi-targeted kinase inhibitor against SRC and BCR-"}, "t": {"pos": [3, 4], "type": null, "name": "ABL , has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance."}}
{"relation": "INHIBITOR", "token": ["Rasagiline is a ", "propargylamine", " and irreversible ", "monoamine oxidase (MAO) B", " inhibitor used for the treatment of Parkinson's disease (PD)."], "h": {"pos": [1, 2], "type": null, "name": "propargylamine  and irreversible "}, "t": {"pos": [3, 4], "type": null, "name": "monoamine oxidase (MAO) B  inhibitor used for the treatment of Parkinson's disease (PD)."}}
{"relation": "INHIBITOR", "token": ["A series of ", "phosphorylated flavonoids", " were synthesized and investigated in\u00a0vitro as inhibitors of pancreatic ", "cholesterol esterase", " (CEase) and acetylcholinesterase (AChE)."], "h": {"pos": [1, 2], "type": null, "name": "phosphorylated flavonoids  were synthesized and investigated in\u00a0vitro as inhibitors of pancreatic "}, "t": {"pos": [3, 4], "type": null, "name": "cholesterol esterase  (CEase) and acetylcholinesterase (AChE)."}}
{"relation": "INHIBITOR", "token": ["In this study, we have synthesized novel alpha-hydroxyphenylamide analogues of ", "diphenylhydantoin", " and examined their ability to inhibit human Na(V)1.5 ", "sodium channels", " expressed in Chinese Hamster Ovary (CHO-K1) cells."], "h": {"pos": [1, 2], "type": null, "name": "diphenylhydantoin  and examined their ability to inhibit human Na(V)1.5 "}, "t": {"pos": [3, 4], "type": null, "name": "sodium channels  expressed in Chinese Hamster Ovary (CHO-K1) cells."}}
{"relation": "INHIBITOR", "token": ["In addition, ", "5HHMF", " blocked LPS-induced phosphorylation of ", "I\u03baB", ", resulting in suppression of the nuclear translocation of nuclear factor-\u03baB (NF-\u03baB) subunits, namely p65 and p50, which are important molecules involved in the regulation of iNOS expression."], "h": {"pos": [1, 2], "type": null, "name": "5HHMF  blocked LPS-induced phosphorylation of "}, "t": {"pos": [3, 4], "type": null, "name": "I\u03baB , resulting in suppression of the nuclear translocation of nuclear factor-\u03baB (NF-\u03baB) subunits, namely p65 and p50, which are important molecules involved in the regulation of iNOS expression."}}
{"relation": "INHIBITOR", "token": ["BDZs and other positive GABA(A)R modulators, including barbiturates, ethanol, and ", "neurosteroids", ", can also inhibit L-type voltage-gated calcium channels (", "L-VGCCs", "), which could contribute to reduced neuronal excitability."], "h": {"pos": [1, 2], "type": null, "name": "neurosteroids , can also inhibit L-type voltage-gated calcium channels ("}, "t": {"pos": [3, 4], "type": null, "name": "L-VGCCs ), which could contribute to reduced neuronal excitability."}}
{"relation": "INHIBITOR", "token": ["The upregulation of calpain, tBid and ", "caspase-3", " activity were further inhibited by treatment with ", "EGTA", " in the presence of ALD."], "h": {"pos": [1, 2], "type": null, "name": "caspase-3  activity were further inhibited by treatment with "}, "t": {"pos": [3, 4], "type": null, "name": "EGTA  in the presence of ALD."}}
{"relation": "INHIBITOR", "token": ["The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of ", "navitoclax", ", a selective inhibitor of both BCL-2 and ", "BCL-2-like 1", " (BCL-X(L)), which has shown clinical efficacy in some BCL-2-dependent hematological cancers."], "h": {"pos": [1, 2], "type": null, "name": "navitoclax , a selective inhibitor of both BCL-2 and "}, "t": {"pos": [3, 4], "type": null, "name": "BCL-2-like 1  (BCL-X(L)), which has shown clinical efficacy in some BCL-2-dependent hematological cancers."}}
{"relation": "INHIBITOR", "token": ["Pyrrolidine dithiocarbamate (", "PDTC", "), a specific ", "NF-\u03baB", " inhibitor, along with 20S proteasome inhibitor (PSI) significantly inhibited LPS-induced iNOS expression, which indirectly suggested that 5HHMF downregulated iNOS expression by suppressing NF-\u03baB activity."], "h": {"pos": [1, 2], "type": null, "name": "PDTC ), a specific "}, "t": {"pos": [3, 4], "type": null, "name": "NF-\u03baB  inhibitor, along with 20S proteasome inhibitor (PSI) significantly inhibited LPS-induced iNOS expression, which indirectly suggested that 5HHMF downregulated iNOS expression by suppressing NF-\u03baB activity."}}
{"relation": "INHIBITOR", "token": ["The effects of two reversible, predominantly ", "monoamine oxidase-A", " (MAO-A) inhibitors, moclobemide (150 mg three times daily) and ", "toloxatone", " (400-200-400 mg day-1) on monoamine metabolites and psychometric performance were compared in a double-blind placebo controlled crossover study in 12 healthy subjects."], "h": {"pos": [1, 2], "type": null, "name": "monoamine oxidase-A  (MAO-A) inhibitors, moclobemide (150 mg three times daily) and "}, "t": {"pos": [3, 4], "type": null, "name": "toloxatone  (400-200-400 mg day-1) on monoamine metabolites and psychometric performance were compared in a double-blind placebo controlled crossover study in 12 healthy subjects."}}
{"relation": "INHIBITOR", "token": ["Although thioredoxin reductase (", "TRR", ") inhibitors (aurothioglucose and ", "Sb(III)", ") inhibited cytosolic DMAs(V) reduction, recombinant rat TRR plus NADPH, alone or when added to the cytosol, failed to support DMAs(V) reduction."], "h": {"pos": [1, 2], "type": null, "name": "TRR ) inhibitors (aurothioglucose and "}, "t": {"pos": [3, 4], "type": null, "name": "Sb(III) ) inhibited cytosolic DMAs(V) reduction, recombinant rat TRR plus NADPH, alone or when added to the cytosol, failed to support DMAs(V) reduction."}}
{"relation": "INHIBITOR", "token": ["The i.c.v. administration of very low doses of okadaic acid (0.001-1 pg/mouse) and ", "cantharidin", " (0.001-1 ng/mouse), which inhibit ", "PP2A", ", produced a dose-dependent antagonism of the antinociception induced by morphine (s.c.)."], "h": {"pos": [1, 2], "type": null, "name": "cantharidin  (0.001-1 ng/mouse), which inhibit "}, "t": {"pos": [3, 4], "type": null, "name": "PP2A , produced a dose-dependent antagonism of the antinociception induced by morphine (s.c.)."}}
{"relation": "INHIBITOR", "token": ["The cytosine analog 5-aza-2'-deoxycytidine (", "decitabine", ") hypomethylates DNA by inhibiting ", "DNA methyltransferase", "."], "h": {"pos": [1, 2], "type": null, "name": "decitabine ) hypomethylates DNA by inhibiting "}, "t": {"pos": [3, 4], "type": null, "name": "DNA methyltransferase ."}}
{"relation": "INHIBITOR", "token": ["Inhibition of ", "GluR5", " kainate receptors could represent a key mechanism underlying the anticonvulsant activity of ", "topiramate", "."], "h": {"pos": [1, 2], "type": null, "name": "GluR5  kainate receptors could represent a key mechanism underlying the anticonvulsant activity of "}, "t": {"pos": [3, 4], "type": null, "name": "topiramate ."}}
{"relation": "INHIBITOR", "token": ["Preclinical pharmacokinetics and in vitro metabolism of dasatinib (", "BMS-354825", "): a potent oral multi-targeted kinase inhibitor against SRC and ", "BCR", "-ABL."], "h": {"pos": [1, 2], "type": null, "name": "BMS-354825 ): a potent oral multi-targeted kinase inhibitor against SRC and "}, "t": {"pos": [3, 4], "type": null, "name": "BCR -ABL."}}
{"relation": "INHIBITOR", "token": ["", "Plerixafor", " (AMD3100, Genzyme Corporation) is a bicyclam molecule that antagonizes the binding of the ", "chemokine", " stromal cell-derived factor-1 (SDF-1) to its cognate receptor CXCR4."], "h": {"pos": [1, 2], "type": null, "name": "Plerixafor  (AMD3100, Genzyme Corporation) is a bicyclam molecule that antagonizes the binding of the "}, "t": {"pos": [3, 4], "type": null, "name": "chemokine  stromal cell-derived factor-1 (SDF-1) to its cognate receptor CXCR4."}}
{"relation": "INHIBITOR", "token": ["Agents that have only begun to undergo clinical evaluation include CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, and ", "PKI166", " and GW572016, both examples of dual kinase inhibitors (inhibiting ", "epidermal growth factor receptor", " and Her2)."], "h": {"pos": [1, 2], "type": null, "name": "PKI166  and GW572016, both examples of dual kinase inhibitors (inhibiting "}, "t": {"pos": [3, 4], "type": null, "name": "epidermal growth factor receptor  and Her2)."}}
{"relation": "INHIBITOR", "token": ["", "Everolimus", " (RAD001, Afinitor((R)) Novartis) is the first oral inhibitor of ", "mTOR", " (mammalian target of rapamycin) to reach the oncology clinic."], "h": {"pos": [1, 2], "type": null, "name": "Everolimus  (RAD001, Afinitor((R)) Novartis) is the first oral inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "mTOR  (mammalian target of rapamycin) to reach the oncology clinic."}}
{"relation": "INHIBITOR", "token": ["When selectively applied to channels after inducing slow inactivation with a 60-s pulse to -10 mV, ", "mibefradil", " (1 microM) produced 45% fractional block in ", "Nav1.5", " and greater block (88%) in an isoform (Nav1.4) that slow-inactivates more completely."], "h": {"pos": [1, 2], "type": null, "name": "mibefradil  (1 microM) produced 45% fractional block in "}, "t": {"pos": [3, 4], "type": null, "name": "Nav1.5  and greater block (88%) in an isoform (Nav1.4) that slow-inactivates more completely."}}
{"relation": "INHIBITOR", "token": ["Although the inhibition of ", "cyclooxygenases", " by ", "aspirin", ", which leads to its anti-inflammatory/analgesic properties, has been well studied, the mechanisms involved in its chemopreventive effects as well as some of its adverse effects are as yet ill-defined."], "h": {"pos": [1, 2], "type": null, "name": "cyclooxygenases  by "}, "t": {"pos": [3, 4], "type": null, "name": "aspirin , which leads to its anti-inflammatory/analgesic properties, has been well studied, the mechanisms involved in its chemopreventive effects as well as some of its adverse effects are as yet ill-defined."}}
{"relation": "INHIBITOR", "token": ["It is possible that ", "vitamin C", ", an antioxidant, may prevent cigarette smoke (CS)-induced ", "NF-\u03baB", " activation that involves degradation of I-\u03baB\u03b5 and nuclear translocation of c-Rel/p50 in alveolar epithelial cells."], "h": {"pos": [1, 2], "type": null, "name": "vitamin C , an antioxidant, may prevent cigarette smoke (CS)-induced "}, "t": {"pos": [3, 4], "type": null, "name": "NF-\u03baB  activation that involves degradation of I-\u03baB\u03b5 and nuclear translocation of c-Rel/p50 in alveolar epithelial cells."}}
{"relation": "INHIBITOR", "token": ["Block of ", "human NaV1.5", " sodium channels by novel alpha-hydroxyphenylamide analogues of ", "phenytoin", "."], "h": {"pos": [1, 2], "type": null, "name": "human NaV1.5  sodium channels by novel alpha-hydroxyphenylamide analogues of "}, "t": {"pos": [3, 4], "type": null, "name": "phenytoin ."}}
{"relation": "INHIBITOR", "token": ["Overall, although most anthocyanidins had no effects on AhR-CYP1A1 signaling, pelargonidin can bind to and activate the AhR and AhR-dependent gene expression, and ", "pelargonidin", " and delphinidin inhibit the ", "CYP1A1", " catalytic activity."], "h": {"pos": [1, 2], "type": null, "name": "pelargonidin  and delphinidin inhibit the "}, "t": {"pos": [3, 4], "type": null, "name": "CYP1A1  catalytic activity."}}
{"relation": "INHIBITOR", "token": ["New classes of pyrrole-derived ", "nitrooxyalkyl", " inverse esters, carbonates, and ethers (7-10) as ", "COX-2", " selective inhibitors and NO donors were synthesized and are herein reported."], "h": {"pos": [1, 2], "type": null, "name": "nitrooxyalkyl  inverse esters, carbonates, and ethers (7-10) as "}, "t": {"pos": [3, 4], "type": null, "name": "COX-2  selective inhibitors and NO donors were synthesized and are herein reported."}}
{"relation": "INHIBITOR", "token": ["A new inhibitor of ", "VEGF receptor tyrosine kinases", ", ", "vegfrecine", " (1), was isolated from the culture broth of Streptomyces sp."], "h": {"pos": [1, 2], "type": null, "name": "VEGF receptor tyrosine kinases , "}, "t": {"pos": [3, 4], "type": null, "name": "vegfrecine  (1), was isolated from the culture broth of Streptomyces sp."}}
{"relation": "INHIBITOR", "token": ["", "Sorafenib", " inhibited the ", "kinase", " activity of both C-RAF and B-RAF (wild type and V600E mutant)."], "h": {"pos": [1, 2], "type": null, "name": "Sorafenib  inhibited the "}, "t": {"pos": [3, 4], "type": null, "name": "kinase  activity of both C-RAF and B-RAF (wild type and V600E mutant)."}}
{"relation": "INHIBITOR", "token": ["AIM: To assess the efficacy and safety of a 24-week treatment with ", "sitagliptin", ", a highly selective once-daily oral dipeptidyl peptidase-4 (", "DPP-4", ") inhibitor, in patients with type 2 diabetes who had inadequate glycaemic control [glycosylated haemoglobin (HbA(1c)) >or=7.5% and <or=10.5%] while on glimepiride alone or in combination with metformin."], "h": {"pos": [1, 2], "type": null, "name": "sitagliptin , a highly selective once-daily oral dipeptidyl peptidase-4 ("}, "t": {"pos": [3, 4], "type": null, "name": "DPP-4 ) inhibitor, in patients with type 2 diabetes who had inadequate glycaemic control [glycosylated haemoglobin (HbA(1c)) >or=7.5% and <or=10.5%] while on glimepiride alone or in combination with metformin."}}
{"relation": "INHIBITOR", "token": ["", "Nateglinide", " inhibits ", "Kir6.2", "/SUR1 and Kir6.2/SUR2B channels at 100 nM, and inhibits Kir6.2/SUR2A channels at high concentrations (1 microM)."], "h": {"pos": [1, 2], "type": null, "name": "Nateglinide  inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "Kir6.2 /SUR1 and Kir6.2/SUR2B channels at 100 nM, and inhibits Kir6.2/SUR2A channels at high concentrations (1 microM)."}}
{"relation": "INHIBITOR", "token": ["Our results first demonstrate that ", "auranofin", " suppresses the multiple steps in TLR4 signaling, especially the homodimerization of ", "TLR4", "."], "h": {"pos": [1, 2], "type": null, "name": "auranofin  suppresses the multiple steps in TLR4 signaling, especially the homodimerization of "}, "t": {"pos": [3, 4], "type": null, "name": "TLR4 ."}}
{"relation": "INHIBITOR", "token": ["We show that both ", "darapladib", " and a novel class of structurally distinct carbamate inhibitors inactivate ", "Lp-PLA(2)", " in mouse tissues and human cell lines with high selectivity."], "h": {"pos": [1, 2], "type": null, "name": "darapladib  and a novel class of structurally distinct carbamate inhibitors inactivate "}, "t": {"pos": [3, 4], "type": null, "name": "Lp-PLA(2)  in mouse tissues and human cell lines with high selectivity."}}
{"relation": "INHIBITOR", "token": ["In activated microglia, ", "15d-PGJ2", " suppressed ", "iNOS promoter", " activity, iNOS mRNA, and protein levels."], "h": {"pos": [1, 2], "type": null, "name": "15d-PGJ2  suppressed "}, "t": {"pos": [3, 4], "type": null, "name": "iNOS promoter  activity, iNOS mRNA, and protein levels."}}
{"relation": "INHIBITOR", "token": ["In this article, the action of dasatinib (", "BMS-354825", ") is contrasted with that of imatinib, a ", "kinase", " inhibitor that is currently being used to treat chronic myelogenous leukemia and other disorders."], "h": {"pos": [1, 2], "type": null, "name": "BMS-354825 ) is contrasted with that of imatinib, a "}, "t": {"pos": [3, 4], "type": null, "name": "kinase  inhibitor that is currently being used to treat chronic myelogenous leukemia and other disorders."}}
{"relation": "INHIBITOR", "token": ["In this report, we evaluated the growth-inhibitory effects of sulindac sulfide, a COX-1 and COX-2 inhibitor; exisulind (sulindac sulfone), a novel proapoptotic agent that does not inhibit COX enzymes; and nordihydroguaiaretic acid (", "NDGA", "), a ", "lipoxygenase", " inhibitor on human lung cancer cell lines."], "h": {"pos": [1, 2], "type": null, "name": "NDGA ), a "}, "t": {"pos": [3, 4], "type": null, "name": "lipoxygenase  inhibitor on human lung cancer cell lines."}}
{"relation": "INHIBITOR", "token": ["However, a lower concentration of ", "dipyridamole", " (3 microM) that blocks PDE9, ", "PDE10", ", and PDE11, but not PDE8, did not inhibit ecto-phosphodiesterase activity."], "h": {"pos": [1, 2], "type": null, "name": "dipyridamole  (3 microM) that blocks PDE9, "}, "t": {"pos": [3, 4], "type": null, "name": "PDE10 , and PDE11, but not PDE8, did not inhibit ecto-phosphodiesterase activity."}}
{"relation": "INHIBITOR", "token": ["A significant decrease of ", "aspartate aminotransferase", ", alanine aminotransferase, lactate dehydrogenase (LDH) activities and glutathione (GSH) levels and an increase of malondialdehyde (MDA) quantity was observed after ", "CCl4", " and PC administration alone."], "h": {"pos": [1, 2], "type": null, "name": "aspartate aminotransferase , alanine aminotransferase, lactate dehydrogenase (LDH) activities and glutathione (GSH) levels and an increase of malondialdehyde (MDA) quantity was observed after "}, "t": {"pos": [3, 4], "type": null, "name": "CCl4  and PC administration alone."}}
{"relation": "INHIBITOR", "token": ["The studies with dThyd rescue from cyclin E-cdk2 protein overexpression and growth inhibition by ", "Tomudex", " indicate that increased cyclin E-cdk2 protein expression is associated with effective inhibition of ", "thymidylate synthase", " and resultant dNTP pool imbalance."], "h": {"pos": [1, 2], "type": null, "name": "Tomudex  indicate that increased cyclin E-cdk2 protein expression is associated with effective inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "thymidylate synthase  and resultant dNTP pool imbalance."}}
{"relation": "INHIBITOR", "token": ["They included the COX-1 inhibitor indomethacin; the COX-2 inhibitor NS-398; the mixed COX-1/COX-2 inhibitor ibuprofen; the nitric oxide (NO) derivatives of indomethacin, ibuprofen and flurbiprofen; the 5-LOX inhibitor REV 5901; and the ", "5-LOX activating protein", " (FLAP) inhibitor ", "MK-886", "."], "h": {"pos": [1, 2], "type": null, "name": "5-LOX activating protein  (FLAP) inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "MK-886 ."}}
{"relation": "INHIBITOR", "token": ["", "Felbamate", " block of recombinant ", "N-methyl-D-aspartate receptors", ": selectivity for the NR2B subunit."], "h": {"pos": [1, 2], "type": null, "name": "Felbamate  block of recombinant "}, "t": {"pos": [3, 4], "type": null, "name": "N-methyl-D-aspartate receptors : selectivity for the NR2B subunit."}}
{"relation": "INHIBITOR", "token": ["Indomethacin and ", "SC-236", ", a selective ", "cyclooxygenase-2", " (COX-2) inhibitor, exerted a similar effect as sulindac."], "h": {"pos": [1, 2], "type": null, "name": "SC-236 , a selective "}, "t": {"pos": [3, 4], "type": null, "name": "cyclooxygenase-2  (COX-2) inhibitor, exerted a similar effect as sulindac."}}
{"relation": "INHIBITOR", "token": ["This stimulation was attenuated by the ", "Pak", " inhibitor 2,2'-dihydroxy-1,1'-dinaphthyldisulfide (", "IPA3", ") or dominant-negative Pak1."], "h": {"pos": [1, 2], "type": null, "name": "Pak  inhibitor 2,2'-dihydroxy-1,1'-dinaphthyldisulfide ("}, "t": {"pos": [3, 4], "type": null, "name": "IPA3 ) or dominant-negative Pak1."}}
{"relation": "INHIBITOR", "token": ["We topically applied the ", "nitric oxide synthase", " (NOS) inhibitor, ", "NG-nitro-L-arginine", ", on sciatic nerve and observed reduced inhibition of NBF in EDN, which was correctable with a cilazapril diet."], "h": {"pos": [1, 2], "type": null, "name": "nitric oxide synthase  (NOS) inhibitor, "}, "t": {"pos": [3, 4], "type": null, "name": "NG-nitro-L-arginine , on sciatic nerve and observed reduced inhibition of NBF in EDN, which was correctable with a cilazapril diet."}}
{"relation": "INHIBITOR", "token": ["Pharmacological treatment has been studied and it could be demonstrated, that some mutant currents may be insufficiently suppressed by drugs targeted to block the specific current such as, e.g., sotalol or ", "ibutilide", " in patients with a mutation in the IKr-coding gene ", "KCNH2", " (HERG)."], "h": {"pos": [1, 2], "type": null, "name": "ibutilide  in patients with a mutation in the IKr-coding gene "}, "t": {"pos": [3, 4], "type": null, "name": "KCNH2  (HERG)."}}
{"relation": "INHIBITOR", "token": ["Here, we show that one BLT, [", "1-(2-methoxy-phenyl)-3-naphthalen-2-yl-urea", "] (BLT-4), blocked ABCA1-mediated cholesterol efflux to lipid-poor apoA-I at a potency similar to that for its inhibition of ", "SR-BI", " (IC(50) approximately 55-60 microM)."], "h": {"pos": [1, 2], "type": null, "name": "1-(2-methoxy-phenyl)-3-naphthalen-2-yl-urea ] (BLT-4), blocked ABCA1-mediated cholesterol efflux to lipid-poor apoA-I at a potency similar to that for its inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "SR-BI  (IC(50) approximately 55-60 microM)."}}
{"relation": "INHIBITOR", "token": ["Patch-clamp analysis using inside-out recording configuration showed that ", "mitiglinide", " inhibits the ", "Kir6.2", "/SUR1 channel currents in a dose-dependent manner (IC50 value, 100 nM) but does not significantly inhibit either Kir6.2/SUR2A or Kir6.2/SUR2B channel currents even at high doses (more than 10 microM)."], "h": {"pos": [1, 2], "type": null, "name": "mitiglinide  inhibits the "}, "t": {"pos": [3, 4], "type": null, "name": "Kir6.2 /SUR1 channel currents in a dose-dependent manner (IC50 value, 100 nM) but does not significantly inhibit either Kir6.2/SUR2A or Kir6.2/SUR2B channel currents even at high doses (more than 10 microM)."}}
{"relation": "INHIBITOR", "token": ["", "Amiloride", " is a specific inhibitor of ", "uPA", " but does not inhibit tPA."], "h": {"pos": [1, 2], "type": null, "name": "Amiloride  is a specific inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "uPA  but does not inhibit tPA."}}
{"relation": "INHIBITOR", "token": ["", "Valdecoxib", " is a potent and specific inhibitor of ", "cyclooxygenase-2", ", which is used for the treatment of rheumatoid arthritis, osteoarthritis, and the dysmenorrhea pain."], "h": {"pos": [1, 2], "type": null, "name": "Valdecoxib  is a potent and specific inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "cyclooxygenase-2 , which is used for the treatment of rheumatoid arthritis, osteoarthritis, and the dysmenorrhea pain."}}
{"relation": "INHIBITOR", "token": ["8-pCPT-2'-O-Me-cAMP-AM potentiation of insulin secretion stimulated by tolbutamide was markedly inhibited by 2-APB (25 \u03bcM) and enhanced by the ", "PKC", " inhibitor ", "bisindolylmaleimide I", " (1 \u03bcM)."], "h": {"pos": [1, 2], "type": null, "name": "PKC  inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "bisindolylmaleimide I  (1 \u03bcM)."}}
{"relation": "INHIBITOR", "token": ["Assays examining the ability of ", "TFP", " to block S100A4-mediated disassembly of ", "myosin-IIA", " filaments demonstrate that significant inhibition of S100A4 function occurs only at TFP concentrations that promote S100A4 oligomerization."], "h": {"pos": [1, 2], "type": null, "name": "TFP  to block S100A4-mediated disassembly of "}, "t": {"pos": [3, 4], "type": null, "name": "myosin-IIA  filaments demonstrate that significant inhibition of S100A4 function occurs only at TFP concentrations that promote S100A4 oligomerization."}}
{"relation": "INHIBITOR", "token": ["Compared with the untreated colitis group, the ", "curcumin", "-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, ", "myeloperoxidase", " activity, and expressions of NF-\u03baB mRNA, IL-27 mRNA, TLR4 protein, NF-\u03baB p65 protein, and IL-27 p28 protein (p < 0.05)."], "h": {"pos": [1, 2], "type": null, "name": "curcumin -treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, "}, "t": {"pos": [3, 4], "type": null, "name": "myeloperoxidase  activity, and expressions of NF-\u03baB mRNA, IL-27 mRNA, TLR4 protein, NF-\u03baB p65 protein, and IL-27 p28 protein (p < 0.05)."}}
{"relation": "INHIBITOR", "token": ["We evaluated the effects of angiotensin II and an ", "angiotensin-converting enzyme", " inhibitor (", "cilazapril", ") on nerve blood flow (NBF) and electrophysiology in control and diabetic rats."], "h": {"pos": [1, 2], "type": null, "name": "angiotensin-converting enzyme  inhibitor ("}, "t": {"pos": [3, 4], "type": null, "name": "cilazapril ) on nerve blood flow (NBF) and electrophysiology in control and diabetic rats."}}
{"relation": "INHIBITOR", "token": ["Moreover, they established that the inhibitory effect of ", "cucurbitacin I", " on ", "Rac1", " activity involves the alteration of the balance between Rho and Rac."], "h": {"pos": [1, 2], "type": null, "name": "cucurbitacin I  on "}, "t": {"pos": [3, 4], "type": null, "name": "Rac1  activity involves the alteration of the balance between Rho and Rac."}}
{"relation": "INHIBITOR", "token": ["The effects of theophylline (unspecific PDE inhibitor), vinpocetine (PDE1 inhibitor), EHNA (PDE2 inhibitor) and the ", "PDE5", " inhibitors ", "zaprinast", " and E 4021 were weak."], "h": {"pos": [1, 2], "type": null, "name": "PDE5  inhibitors "}, "t": {"pos": [3, 4], "type": null, "name": "zaprinast  and E 4021 were weak."}}
{"relation": "INHIBITOR", "token": ["A ", "KCC", " inhibitor-", "[(dihydroindenyl)oxy] alkanoic acid", " (DIOA)-blocked RVD more in HCEC than RCEC."], "h": {"pos": [1, 2], "type": null, "name": "KCC  inhibitor-"}, "t": {"pos": [3, 4], "type": null, "name": "[(dihydroindenyl)oxy] alkanoic acid  (DIOA)-blocked RVD more in HCEC than RCEC."}}
{"relation": "INHIBITOR", "token": ["The structure-activity relationships revealed that the free hydroxyl group at position 5 and ", "phosphate", " group at position 7 of the phosphorylated flavonoids are favorable to the inhibition of ", "CEase", "."], "h": {"pos": [1, 2], "type": null, "name": "phosphate  group at position 7 of the phosphorylated flavonoids are favorable to the inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "CEase ."}}
{"relation": "INHIBITOR", "token": ["A series of phenolic acids and phenol natural products, such as p-hydroxybenzoic acid, p-coumaric acid, caffeic acid, ferulic acid, ", "gallic acid", ", syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the ", "metalloenzyme", " carbonic anhydrase (CA, EC 4.2.1.1)."], "h": {"pos": [1, 2], "type": null, "name": "gallic acid , syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the "}, "t": {"pos": [3, 4], "type": null, "name": "metalloenzyme  carbonic anhydrase (CA, EC 4.2.1.1)."}}
{"relation": "INHIBITOR", "token": ["METHODS: ", "COX-1", " inhibition was determined by measuring thromboxane B2 (TXB2)-generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg meloxicam and 75 mg diclofenac and at steady state (15 mg ", "meloxicam", " daily and 150 mg diclofenac daily)."], "h": {"pos": [1, 2], "type": null, "name": "COX-1  inhibition was determined by measuring thromboxane B2 (TXB2)-generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg meloxicam and 75 mg diclofenac and at steady state (15 mg "}, "t": {"pos": [3, 4], "type": null, "name": "meloxicam  daily and 150 mg diclofenac daily)."}}
{"relation": "INHIBITOR", "token": ["New classes of pyrrole-derived nitrooxyalkyl inverse esters, ", "carbonates", ", and ethers (7-10) as ", "COX-2", " selective inhibitors and NO donors were synthesized and are herein reported."], "h": {"pos": [1, 2], "type": null, "name": "carbonates , and ethers (7-10) as "}, "t": {"pos": [3, 4], "type": null, "name": "COX-2  selective inhibitors and NO donors were synthesized and are herein reported."}}
{"relation": "INHIBITOR", "token": ["Furthermore, a decreased CD11c(+) macrophage infiltration in colons and inactivation of ", "caspase-1", " in peritoneal macrophages were detected in ", "Fc11a", "-2-treated mice."], "h": {"pos": [1, 2], "type": null, "name": "caspase-1  in peritoneal macrophages were detected in "}, "t": {"pos": [3, 4], "type": null, "name": "Fc11a -2-treated mice."}}
{"relation": "INHIBITOR", "token": ["Methods: Stabilized anaplastic thyroid cancer cell lines (BHT-101 and CAL-62) and primary cultures from patients who underwent thyroidectomy for anaplastic thyroid cancer were treated with the ", "histone deacetylase", " inhibitor ", "LBH589", "."], "h": {"pos": [1, 2], "type": null, "name": "histone deacetylase  inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "LBH589 ."}}
{"relation": "INHIBITOR", "token": ["The pharmacology of NCX inhibitors has been studied extensively since the development of KB-R7943, a prototype ", "benzyloxyphenyl", " ", "NCX", " inhibitor, in 1996."], "h": {"pos": [1, 2], "type": null, "name": "benzyloxyphenyl  "}, "t": {"pos": [3, 4], "type": null, "name": "NCX  inhibitor, in 1996."}}
{"relation": "INHIBITOR", "token": ["The results suggest that the 63-kDa (", "PDE 1B1", ") and 60-kDa (PDE 1A2) CaMPDE isozymes are inhibited by ", "felodipine", " and nicardipine by partial competitive inhibition and that these two Ca2+ antagonists appear to counteract each other."], "h": {"pos": [1, 2], "type": null, "name": "PDE 1B1 ) and 60-kDa (PDE 1A2) CaMPDE isozymes are inhibited by "}, "t": {"pos": [3, 4], "type": null, "name": "felodipine  and nicardipine by partial competitive inhibition and that these two Ca2+ antagonists appear to counteract each other."}}
{"relation": "INHIBITOR", "token": ["The anti-hyperthermic effect of Lu AF21934 (5 mg/kg) in the SIH test was inhibited by the benzodiazepine receptor antagonist flumazenil (10 mg/kg) and was not serotonin-dependent, as it persisted in serotonin-deficient mice and upon blockade of either 5-HT(1A) receptors by WAY100635, or ", "5-HT(2A/2C)", " receptors by ", "ritanserin", "."], "h": {"pos": [1, 2], "type": null, "name": "5-HT(2A/2C)  receptors by "}, "t": {"pos": [3, 4], "type": null, "name": "ritanserin ."}}
{"relation": "INHIBITOR", "token": ["OBJECTIVE: To evaluate the extent of human cyclooxygenase-1 (COX-1) inhibition by ", "meloxicam", ", which has been reported to preferentially inhibit cyclooxygenase-2 (", "COX-2", ")."], "h": {"pos": [1, 2], "type": null, "name": "meloxicam , which has been reported to preferentially inhibit cyclooxygenase-2 ("}, "t": {"pos": [3, 4], "type": null, "name": "COX-2 )."}}
{"relation": "INHIBITOR", "token": ["Indomethacin inhibited both hCOX-1 and hCOX-2, whereas NS-398 and ", "Dup-697", " selectively inhibited ", "hCOX-2", "."], "h": {"pos": [1, 2], "type": null, "name": "Dup-697  selectively inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "hCOX-2 ."}}
{"relation": "INHIBITOR", "token": ["We show that both darapladib and a novel class of structurally distinct ", "carbamate", " inhibitors inactivate ", "Lp-PLA(2)", " in mouse tissues and human cell lines with high selectivity."], "h": {"pos": [1, 2], "type": null, "name": "carbamate  inhibitors inactivate "}, "t": {"pos": [3, 4], "type": null, "name": "Lp-PLA(2)  in mouse tissues and human cell lines with high selectivity."}}
{"relation": "INHIBITOR", "token": ["In the interaction of ", "GAL", " and CAR, ", "AChE", " inhibition was stronger but without any statistical significance."], "h": {"pos": [1, 2], "type": null, "name": "GAL  and CAR, "}, "t": {"pos": [3, 4], "type": null, "name": "AChE  inhibition was stronger but without any statistical significance."}}
{"relation": "INHIBITOR", "token": ["Benzenesulfonamides incorporating ", "cyanoacrylamide", " moieties strongly inhibit ", "Saccharomyces cerevisiae \u03b2-carbonic anhydrase", "."], "h": {"pos": [1, 2], "type": null, "name": "cyanoacrylamide  moieties strongly inhibit "}, "t": {"pos": [3, 4], "type": null, "name": "Saccharomyces cerevisiae \u03b2-carbonic anhydrase ."}}
{"relation": "INHIBITOR", "token": ["5-Fluorouracil (5-FU), 5-fluoro-2'-deoxyuridine (", "FdUrd", ") and 5-trifluorothymidine (F3(d)Thd) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of thymidylate synthase (", "TS", ")."], "h": {"pos": [1, 2], "type": null, "name": "FdUrd ) and 5-trifluorothymidine (F3(d)Thd) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of thymidylate synthase ("}, "t": {"pos": [3, 4], "type": null, "name": "TS )."}}
{"relation": "INHIBITOR", "token": ["The purpose of the present study was to test our hypothesis that ", "amiloride", ", a specific u-PA inhibitor, effectively decreases ", "u-PA", " activity in cornea as well as in tear fluid and favourably affects corneal healing."], "h": {"pos": [1, 2], "type": null, "name": "amiloride , a specific u-PA inhibitor, effectively decreases "}, "t": {"pos": [3, 4], "type": null, "name": "u-PA  activity in cornea as well as in tear fluid and favourably affects corneal healing."}}
{"relation": "INHIBITOR", "token": ["We report here that ", "lovastatin", ", a drug clinically used for lowering cholesterol levels, inhibits the interaction of ", "human LFA-1", " with its counter-receptor intercellular adhesion molecule-1."], "h": {"pos": [1, 2], "type": null, "name": "lovastatin , a drug clinically used for lowering cholesterol levels, inhibits the interaction of "}, "t": {"pos": [3, 4], "type": null, "name": "human LFA-1  with its counter-receptor intercellular adhesion molecule-1."}}
{"relation": "INHIBITOR", "token": ["A decrease in ", "ADA", " activity was observed when the slices were exposed to ", "organoselenium", " at the concentrations of 1, 10 and 30 \u00b5M."], "h": {"pos": [1, 2], "type": null, "name": "ADA  activity was observed when the slices were exposed to "}, "t": {"pos": [3, 4], "type": null, "name": "organoselenium  at the concentrations of 1, 10 and 30 \u00b5M."}}
{"relation": "INHIBITOR", "token": ["In this study, focus was given to evaluate the ability of ", "neoechinulin A", ", an indole alkaloid isolated from marine-derived Microsporum sp., to attenuate microglial activation by oligomeric ", "amyloid-\u03b2 1-42", " (A\u03b242)."], "h": {"pos": [1, 2], "type": null, "name": "neoechinulin A , an indole alkaloid isolated from marine-derived Microsporum sp., to attenuate microglial activation by oligomeric "}, "t": {"pos": [3, 4], "type": null, "name": "amyloid-\u03b2 1-42  (A\u03b242)."}}
{"relation": "INHIBITOR", "token": ["This paper describes the identification and synthesis of substituted ", "benzofurans", " as ", "LTH(4)H", " inhibitors."], "h": {"pos": [1, 2], "type": null, "name": "benzofurans  as "}, "t": {"pos": [3, 4], "type": null, "name": "LTH(4)H  inhibitors."}}
{"relation": "INHIBITOR", "token": ["First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, TOP2-mediated DNA cleavage induced by ATP-sensitive ", "TOP2", " poisons (e.g. doxorubicin, etoposide, mitoxantrone, and ", "4'-(9-acridinylamino)methanesulfon-m-anisidide", ") was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected."], "h": {"pos": [1, 2], "type": null, "name": "TOP2  poisons (e.g. doxorubicin, etoposide, mitoxantrone, and "}, "t": {"pos": [3, 4], "type": null, "name": "4'-(9-acridinylamino)methanesulfon-m-anisidide ) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected."}}
{"relation": "INHIBITOR", "token": ["In contrast, zinc protoporphyrin (", "ZnPP", "), a specific ", "HO-1", " inhibitor, showed a partial suppressive effect of 5HHMF on LPS-induced NO production."], "h": {"pos": [1, 2], "type": null, "name": "ZnPP ), a specific "}, "t": {"pos": [3, 4], "type": null, "name": "HO-1  inhibitor, showed a partial suppressive effect of 5HHMF on LPS-induced NO production."}}
{"relation": "INHIBITOR", "token": ["Moreover, the rank order for potency in inhibiting ", "acetylcholinesterase", " (ambenonium>neostigmine=physostigmine =tacrine>", "pyridostigmine", "=edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent."], "h": {"pos": [1, 2], "type": null, "name": "acetylcholinesterase  (ambenonium>neostigmine=physostigmine =tacrine>"}, "t": {"pos": [3, 4], "type": null, "name": "pyridostigmine =edrophonium=galanthamine >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent."}}
{"relation": "INHIBITOR", "token": ["", "Enalkiren", " has been shown to produce dose-related suppression of plasma ", "renin", " activity (PRA) and angiotensin II when administered intravenously."], "h": {"pos": [1, 2], "type": null, "name": "Enalkiren  has been shown to produce dose-related suppression of plasma "}, "t": {"pos": [3, 4], "type": null, "name": "renin  activity (PRA) and angiotensin II when administered intravenously."}}
{"relation": "INHIBITOR", "token": ["However, combination of rasagiline (10 mg x kg(-1) i.p.) with L-DOPA or L-tryptophan (50 mg x kg(-1) i.p.), or rasagiline (10 mg x kg(-1) p.o.) with fluoxetine (10 mg x kg(-1) p.o.), did not induce the behavioural hyperactivity syndrome which is seen following inhibition of both ", "MAO-A", " and MAO-B by tranylcypromine together with the ", "monoamine", " precursors."], "h": {"pos": [1, 2], "type": null, "name": "MAO-A  and MAO-B by tranylcypromine together with the "}, "t": {"pos": [3, 4], "type": null, "name": "monoamine  precursors."}}
{"relation": "INHIBITOR", "token": ["", "Imatinib", " was also found to inhibit ", "M-CSF", "-induced osteoclast survival as well as M-CSF-induced osteoclast bone resorbing activity, but was without effect on interleukin 1alpha (IL-1alpha) and receptor activator of nuclear factor kappa B ligand (RANKL)-induced inhibition of osteoclasts apoptosis, further supporting the hypothesis that imatinib may affect mature osteoclasts through the inhibition of c-FMS."], "h": {"pos": [1, 2], "type": null, "name": "Imatinib  was also found to inhibit "}, "t": {"pos": [3, 4], "type": null, "name": "M-CSF -induced osteoclast survival as well as M-CSF-induced osteoclast bone resorbing activity, but was without effect on interleukin 1alpha (IL-1alpha) and receptor activator of nuclear factor kappa B ligand (RANKL)-induced inhibition of osteoclasts apoptosis, further supporting the hypothesis that imatinib may affect mature osteoclasts through the inhibition of c-FMS."}}
{"relation": "INHIBITOR", "token": ["", "Indomethacin", " inhibited both ", "hCOX-1", " and hCOX-2, whereas NS-398 and Dup-697 selectively inhibited hCOX-2."], "h": {"pos": [1, 2], "type": null, "name": "Indomethacin  inhibited both "}, "t": {"pos": [3, 4], "type": null, "name": "hCOX-1  and hCOX-2, whereas NS-398 and Dup-697 selectively inhibited hCOX-2."}}
{"relation": "INHIBITOR", "token": ["Additionally, ", "dasatinib", " leads to growth inhibition of a KIT", "D816V", "-harboring human masto-cytosis cell line."], "h": {"pos": [1, 2], "type": null, "name": "dasatinib  leads to growth inhibition of a KIT"}, "t": {"pos": [3, 4], "type": null, "name": "D816V -harboring human masto-cytosis cell line."}}
{"relation": "INHIBITOR", "token": ["The tyrosine kinase inhibitor ZD1839 (\"", "Iressa", "\") inhibits ", "HER2", "-driven signaling and suppresses the growth of HER2-overexpressing tumor cells."], "h": {"pos": [1, 2], "type": null, "name": "Iressa \") inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "HER2 -driven signaling and suppresses the growth of HER2-overexpressing tumor cells."}}
{"relation": "INHIBITOR", "token": ["In conclusion, the results suggest that the enhancement in the reduction of ", "topo II", " activity by the combined MXF/", "VP-16", " treatments was probably due to the increase in the level of the DNA-enzyme cleavable complexes formed by both drugs."], "h": {"pos": [1, 2], "type": null, "name": "topo II  activity by the combined MXF/"}, "t": {"pos": [3, 4], "type": null, "name": "VP-16  treatments was probably due to the increase in the level of the DNA-enzyme cleavable complexes formed by both drugs."}}
{"relation": "INHIBITOR", "token": ["The selective ", "PDE 4", " inhibitors, and to a certain extent the PDE3 inhibitors ", "amrinone", " and milrinone, reduced the GM-CSF release in a concentration dependent manner."], "h": {"pos": [1, 2], "type": null, "name": "PDE 4  inhibitors, and to a certain extent the PDE3 inhibitors "}, "t": {"pos": [3, 4], "type": null, "name": "amrinone  and milrinone, reduced the GM-CSF release in a concentration dependent manner."}}
{"relation": "INHIBITOR", "token": ["Anti-inflammatory effect of ", "prunetin", " via the suppression of ", "NF-\u03baB", " pathway."], "h": {"pos": [1, 2], "type": null, "name": "prunetin  via the suppression of "}, "t": {"pos": [3, 4], "type": null, "name": "NF-\u03baB  pathway."}}
{"relation": "INHIBITOR", "token": ["In most instances, C6-substituted ", "phthalides", " exhibit ", "MAO-B", " specific inhibition."], "h": {"pos": [1, 2], "type": null, "name": "phthalides  exhibit "}, "t": {"pos": [3, 4], "type": null, "name": "MAO-B  specific inhibition."}}
{"relation": "INHIBITOR", "token": ["Activating glucocorticoid receptor-ERK signaling pathway contributes to ", "ginsenoside Rg1", " protection against ", "\u03b2-amyloid peptide", "-induced human endothelial cells apoptosis."], "h": {"pos": [1, 2], "type": null, "name": "ginsenoside Rg1  protection against "}, "t": {"pos": [3, 4], "type": null, "name": "\u03b2-amyloid peptide -induced human endothelial cells apoptosis."}}
{"relation": "INHIBITOR", "token": ["Inhibition of GluR5 ", "kainate receptors", " could represent a key mechanism underlying the anticonvulsant activity of ", "topiramate", "."], "h": {"pos": [1, 2], "type": null, "name": "kainate receptors  could represent a key mechanism underlying the anticonvulsant activity of "}, "t": {"pos": [3, 4], "type": null, "name": "topiramate ."}}
{"relation": "INHIBITOR", "token": ["Particularly, the effects of ", "doxycycline", " used as a non selective ", "MMP", " inhibitor in experimental and clinical studies will be discussed."], "h": {"pos": [1, 2], "type": null, "name": "doxycycline  used as a non selective "}, "t": {"pos": [3, 4], "type": null, "name": "MMP  inhibitor in experimental and clinical studies will be discussed."}}
{"relation": "INHIBITOR", "token": ["", "Nateglinide", " inhibits Kir6.2/SUR1 and ", "Kir6.2", "/SUR2B channels at 100 nM, and inhibits Kir6.2/SUR2A channels at high concentrations (1 microM)."], "h": {"pos": [1, 2], "type": null, "name": "Nateglinide  inhibits Kir6.2/SUR1 and "}, "t": {"pos": [3, 4], "type": null, "name": "Kir6.2 /SUR2B channels at 100 nM, and inhibits Kir6.2/SUR2A channels at high concentrations (1 microM)."}}
{"relation": "INHIBITOR", "token": ["First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, ", "TOP2", "-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, ", "etoposide", ", mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected."], "h": {"pos": [1, 2], "type": null, "name": "TOP2 -mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. doxorubicin, "}, "t": {"pos": [3, 4], "type": null, "name": "etoposide , mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected."}}
{"relation": "INHIBITOR", "token": ["The results of clinical trials with ", "enalkiren", " are encouraging, and suggest that ", "renin", " inhibitors may be safe, useful therapeutic agents in the management of hypertension."], "h": {"pos": [1, 2], "type": null, "name": "enalkiren  are encouraging, and suggest that "}, "t": {"pos": [3, 4], "type": null, "name": "renin  inhibitors may be safe, useful therapeutic agents in the management of hypertension."}}
{"relation": "INHIBITOR", "token": ["Molecular modeling of the kinase domain of mutant c-Kit (V654A) and AXL showed no binding to IM but efficient binding to ", "MP470", ", a novel ", "c-Kit", "/AXL kinase inhibitor."], "h": {"pos": [1, 2], "type": null, "name": "MP470 , a novel "}, "t": {"pos": [3, 4], "type": null, "name": "c-Kit /AXL kinase inhibitor."}}
{"relation": "INHIBITOR", "token": ["BACKGROUND: Since the introduction of the first cholinesterase inhibitor (ChEI) in 1997, most clinicians and probably most patients would consider the cholinergic drugs, ", "donepezil", ", galantamine and rivastigmine, to be the first line pharmacotherapy for mild to moderate Alzheimer's disease.The drugs have slightly different pharmacological properties, but they all work by inhibiting the breakdown of acetylcholine, an important neurotransmitter associated with memory, by blocking the enzyme ", "acetylcholinesterase", "."], "h": {"pos": [1, 2], "type": null, "name": "donepezil , galantamine and rivastigmine, to be the first line pharmacotherapy for mild to moderate Alzheimer's disease.The drugs have slightly different pharmacological properties, but they all work by inhibiting the breakdown of acetylcholine, an important neurotransmitter associated with memory, by blocking the enzyme "}, "t": {"pos": [3, 4], "type": null, "name": "acetylcholinesterase ."}}
{"relation": "INHIBITOR", "token": ["Pharmacological treatment has been studied and it could be demonstrated, that some mutant currents may be insufficiently suppressed by drugs targeted to block the specific current such as, e.g., sotalol or ", "ibutilide", " in patients with a mutation in the ", "IKr", "-coding gene KCNH2 (HERG)."], "h": {"pos": [1, 2], "type": null, "name": "ibutilide  in patients with a mutation in the "}, "t": {"pos": [3, 4], "type": null, "name": "IKr -coding gene KCNH2 (HERG)."}}
{"relation": "INHIBITOR", "token": ["", "Fisetin", " treatment of preadipocytes reduced the phosphorylation of ", "S6K1", " and mTORC1 in a time- and concentration-dependent manner."], "h": {"pos": [1, 2], "type": null, "name": "Fisetin  treatment of preadipocytes reduced the phosphorylation of "}, "t": {"pos": [3, 4], "type": null, "name": "S6K1  and mTORC1 in a time- and concentration-dependent manner."}}
{"relation": "INHIBITOR", "token": ["Acetylcholinesterase (", "AChE", ") inhibited by the ", "organophosphate", " soman (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex."], "h": {"pos": [1, 2], "type": null, "name": "AChE ) inhibited by the "}, "t": {"pos": [3, 4], "type": null, "name": "organophosphate  soman (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by oximes due to dealkylation of the soman-enzyme complex."}}
{"relation": "INHIBITOR", "token": ["Before the next drug intake, ", "MAO-A", " inhibition, as judged by the decrease of plasma DHPG concentration, was significantly different from placebo with moclobemide but not with ", "toloxatone", "."], "h": {"pos": [1, 2], "type": null, "name": "MAO-A  inhibition, as judged by the decrease of plasma DHPG concentration, was significantly different from placebo with moclobemide but not with "}, "t": {"pos": [3, 4], "type": null, "name": "toloxatone ."}}
{"relation": "INHIBITOR", "token": ["", "Vitamin C", " forestalls cigarette smoke induced ", "NF-\u03baB", " activation in alveolar epithelial cells."], "h": {"pos": [1, 2], "type": null, "name": "Vitamin C  forestalls cigarette smoke induced "}, "t": {"pos": [3, 4], "type": null, "name": "NF-\u03baB  activation in alveolar epithelial cells."}}
{"relation": "INHIBITOR", "token": ["", "15d-PGJ2", " did not block nuclear translocation or DNA-binding activity of the transcription factor NFkappaB, but it did inhibit the activity of an ", "NFkappaB", " reporter construct, suggesting that the mechanism of suppression of microglial iNOS by 15d-PGJ2 may involve interference with NFkappaB transcriptional activity in the nucleus."], "h": {"pos": [1, 2], "type": null, "name": "15d-PGJ2  did not block nuclear translocation or DNA-binding activity of the transcription factor NFkappaB, but it did inhibit the activity of an "}, "t": {"pos": [3, 4], "type": null, "name": "NFkappaB  reporter construct, suggesting that the mechanism of suppression of microglial iNOS by 15d-PGJ2 may involve interference with NFkappaB transcriptional activity in the nucleus."}}
{"relation": "INHIBITOR", "token": ["Here, we show that one BLT, [1-(2-methoxy-phenyl)-3-naphthalen-2-yl-urea] (", "BLT-4", "), blocked ABCA1-mediated cholesterol efflux to lipid-poor apoA-I at a potency similar to that for its inhibition of ", "SR-BI", " (IC(50) approximately 55-60 microM)."], "h": {"pos": [1, 2], "type": null, "name": "BLT-4 ), blocked ABCA1-mediated cholesterol efflux to lipid-poor apoA-I at a potency similar to that for its inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "SR-BI  (IC(50) approximately 55-60 microM)."}}
{"relation": "INHIBITOR", "token": ["Enzyme kinetic analyses using human liver microsomes revealed inhibition of ", "CYP1A1", " activity by delphinidin (IC50 78 \u03bcM) and ", "pelargonidin", " (IC50 33 \u03bcM)."], "h": {"pos": [1, 2], "type": null, "name": "CYP1A1  activity by delphinidin (IC50 78 \u03bcM) and "}, "t": {"pos": [3, 4], "type": null, "name": "pelargonidin  (IC50 33 \u03bcM)."}}
{"relation": "INHIBITOR", "token": ["", "Sodium salicylate", " and aspirin also inhibited ", "NF-kappa B", "-dependent transcription from the Ig kappa enhancer and the human immunodeficiency virus (HIV) long terminal repeat (LTR) in transfected T cells."], "h": {"pos": [1, 2], "type": null, "name": "Sodium salicylate  and aspirin also inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "NF-kappa B -dependent transcription from the Ig kappa enhancer and the human immunodeficiency virus (HIV) long terminal repeat (LTR) in transfected T cells."}}
{"relation": "INHIBITOR", "token": ["They display sensitivity to ", "TK", " inhibitors, including ", "gefitinib", " and erlotinib."], "h": {"pos": [1, 2], "type": null, "name": "TK  inhibitors, including "}, "t": {"pos": [3, 4], "type": null, "name": "gefitinib  and erlotinib."}}
{"relation": "INHIBITOR", "token": ["The most potent in\u2005vitro DASI discovered is an ", "imidazole", " derivative with IC50 values against ", "aromatase", " and steroid sulfatase in a JEG-3 cell preparation of 0.2 and 2.5\u2005nM, respectively."], "h": {"pos": [1, 2], "type": null, "name": "imidazole  derivative with IC50 values against "}, "t": {"pos": [3, 4], "type": null, "name": "aromatase  and steroid sulfatase in a JEG-3 cell preparation of 0.2 and 2.5\u2005nM, respectively."}}
{"relation": "INHIBITOR", "token": ["Repression of HDC gene expression and ", "HDC", " activity by ", "dexamethasone", " may underlie its therapeutic effect in the treatment of allergy."], "h": {"pos": [1, 2], "type": null, "name": "HDC  activity by "}, "t": {"pos": [3, 4], "type": null, "name": "dexamethasone  may underlie its therapeutic effect in the treatment of allergy."}}
{"relation": "INHIBITOR", "token": ["PURPOSE: Dasatinib (", "BMS-354825", "), a potent oral multi-targeted ", "kinase", " inhibitor against SRC and BCR-ABL, has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance."], "h": {"pos": [1, 2], "type": null, "name": "BMS-354825 ), a potent oral multi-targeted "}, "t": {"pos": [3, 4], "type": null, "name": "kinase  inhibitor against SRC and BCR-ABL, has recently been approved for the treatment of chronic myelogenous leukaemia (CML) in imatinib-acquired resistance and intolerance."}}
{"relation": "INHIBITOR", "token": ["Furthermore, N-", "BPs", " decreased the levels of phosphorylated extracellular signal-regulated kinase (ERK) and mTOR via suppression of ", "Ras", " prenylation and enhanced Bim expression."], "h": {"pos": [1, 2], "type": null, "name": "BPs  decreased the levels of phosphorylated extracellular signal-regulated kinase (ERK) and mTOR via suppression of "}, "t": {"pos": [3, 4], "type": null, "name": "Ras  prenylation and enhanced Bim expression."}}
{"relation": "INHIBITOR", "token": ["Cells were also evaluated in the presence of ", "wortmannin", ", an inhibitor of ", "phosphatidylinositol 3-kinases", " and thus AKt (0-100 nM)."], "h": {"pos": [1, 2], "type": null, "name": "wortmannin , an inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "phosphatidylinositol 3-kinases  and thus AKt (0-100 nM)."}}
{"relation": "INHIBITOR", "token": ["Beta-glucogallin (", "BGG", "), a recently described ", "AR", " inhibitor, was purified from extracts of the Indian gooseberry (Emblica officinalis)."], "h": {"pos": [1, 2], "type": null, "name": "BGG ), a recently described "}, "t": {"pos": [3, 4], "type": null, "name": "AR  inhibitor, was purified from extracts of the Indian gooseberry (Emblica officinalis)."}}
{"relation": "INHIBITOR", "token": ["In this study, we found that ", "BGG", " showed low cytotoxicity in Raw264.7 murine macrophages and effectively inhibited ", "AR", " activity as measured by a decrease in sorbitol accumulation."], "h": {"pos": [1, 2], "type": null, "name": "BGG  showed low cytotoxicity in Raw264.7 murine macrophages and effectively inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "AR  activity as measured by a decrease in sorbitol accumulation."}}
{"relation": "INHIBITOR", "token": ["Using whole-cell voltage clamp, we examined ", "mibefradil", " block of four Na+ channel isoforms expressed in human embryonic kidney cells: Nav1.5 (cardiac), Nav1.4 (skeletal muscle), ", "Nav1.2", " (brain), and Nav1.7 (peripheral nerve)."], "h": {"pos": [1, 2], "type": null, "name": "mibefradil  block of four Na+ channel isoforms expressed in human embryonic kidney cells: Nav1.5 (cardiac), Nav1.4 (skeletal muscle), "}, "t": {"pos": [3, 4], "type": null, "name": "Nav1.2  (brain), and Nav1.7 (peripheral nerve)."}}
{"relation": "INHIBITOR", "token": ["Two mechanisms of action have been identified for ", "A77 1726", ": inhibition of dihydroorotate dehydrogenase (DHODH) and inhibition of ", "tyrosine kinases", "."], "h": {"pos": [1, 2], "type": null, "name": "A77 1726 : inhibition of dihydroorotate dehydrogenase (DHODH) and inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "tyrosine kinases ."}}
{"relation": "INHIBITOR", "token": ["These data demonstrated that 1) gemcitabine and ", "pemetrexed", " synergistically interact against NSCLC cells through the suppression of ", "Akt", " phosphorylation and induction of apoptosis; 2) the gene expression profile of critical genes may predict for drug chemosensitivity; and 3) pemetrexed enhances dCK and hENT1 expression, thus suggesting the role of gene-expression modulation for rational development of chemotherapy combinations."], "h": {"pos": [1, 2], "type": null, "name": "pemetrexed  synergistically interact against NSCLC cells through the suppression of "}, "t": {"pos": [3, 4], "type": null, "name": "Akt  phosphorylation and induction of apoptosis; 2) the gene expression profile of critical genes may predict for drug chemosensitivity; and 3) pemetrexed enhances dCK and hENT1 expression, thus suggesting the role of gene-expression modulation for rational development of chemotherapy combinations."}}
{"relation": "INHIBITOR", "token": ["The cytosine analog ", "5-aza-2'-deoxycytidine", " (decitabine) hypomethylates DNA by inhibiting ", "DNA methyltransferase", "."], "h": {"pos": [1, 2], "type": null, "name": "5-aza-2'-deoxycytidine  (decitabine) hypomethylates DNA by inhibiting "}, "t": {"pos": [3, 4], "type": null, "name": "DNA methyltransferase ."}}
{"relation": "INHIBITOR", "token": ["Ca(v)1.3 channels were less sensitive to ", "pentobarbital", " inhibition than ", "Ca(v)1.2", " channels, similar to dihydropyridine (DHP) L-VGCC antagonists."], "h": {"pos": [1, 2], "type": null, "name": "pentobarbital  inhibition than "}, "t": {"pos": [3, 4], "type": null, "name": "Ca(v)1.2  channels, similar to dihydropyridine (DHP) L-VGCC antagonists."}}
{"relation": "INHIBITOR", "token": ["Block of human NaV1.5 ", "sodium channels", " by novel ", "alpha-hydroxyphenylamide", " analogues of phenytoin."], "h": {"pos": [1, 2], "type": null, "name": "sodium channels  by novel "}, "t": {"pos": [3, 4], "type": null, "name": "alpha-hydroxyphenylamide  analogues of phenytoin."}}
{"relation": "INHIBITOR", "token": ["PURPOSE: To compare ", "phenelzine", " (PLZ), an antidepressant drug with anxiolytic properties which inhibits monoamine oxidase (", "MAO", ") but also elevates rat brain levels of the amino acids ?-aminobutyric acid (GABA) and alanine (ALA), with vigabatrin (VIG), an anticonvulsant which elevates brain GABA by inhibition of GABA transaminase (GABA-T), with regard to their actions on brain levels of GABA and ALA and on activities of MAO, GABA-T and ALA transaminase (ALA-T)."], "h": {"pos": [1, 2], "type": null, "name": "phenelzine  (PLZ), an antidepressant drug with anxiolytic properties which inhibits monoamine oxidase ("}, "t": {"pos": [3, 4], "type": null, "name": "MAO ) but also elevates rat brain levels of the amino acids ?-aminobutyric acid (GABA) and alanine (ALA), with vigabatrin (VIG), an anticonvulsant which elevates brain GABA by inhibition of GABA transaminase (GABA-T), with regard to their actions on brain levels of GABA and ALA and on activities of MAO, GABA-T and ALA transaminase (ALA-T)."}}
{"relation": "INHIBITOR", "token": ["A series of ", "phosphorylated flavonoids", " were synthesized and investigated in\u00a0vitro as inhibitors of pancreatic cholesterol esterase (CEase) and ", "acetylcholinesterase", " (AChE)."], "h": {"pos": [1, 2], "type": null, "name": "phosphorylated flavonoids  were synthesized and investigated in\u00a0vitro as inhibitors of pancreatic cholesterol esterase (CEase) and "}, "t": {"pos": [3, 4], "type": null, "name": "acetylcholinesterase  (AChE)."}}
{"relation": "INHIBITOR", "token": ["The major ingredient of ginger, ", "[6]-gingerol", ", could inhibit ", "angiotensin II type 1 receptor", " activation, which partially clarified the mechanism of ginger regulating blood pressure and strengthening heart in the cardiovascular system."], "h": {"pos": [1, 2], "type": null, "name": "[6]-gingerol , could inhibit "}, "t": {"pos": [3, 4], "type": null, "name": "angiotensin II type 1 receptor  activation, which partially clarified the mechanism of ginger regulating blood pressure and strengthening heart in the cardiovascular system."}}
{"relation": "INHIBITOR", "token": ["", "Mitiglinide", " (KAD-1229), a new anti-diabetic drug, is thought to stimulate insulin secretion by closing the ", "ATP-sensitive K+ (K(ATP)) channels", " in pancreatic beta-cells."], "h": {"pos": [1, 2], "type": null, "name": "Mitiglinide  (KAD-1229), a new anti-diabetic drug, is thought to stimulate insulin secretion by closing the "}, "t": {"pos": [3, 4], "type": null, "name": "ATP-sensitive K+ (K(ATP)) channels  in pancreatic beta-cells."}}
{"relation": "INHIBITOR", "token": ["", "5-FU", " interferes with DNA synthesis by blocking ", "thymidylate synthase", " (TS) but is inactivated by dihydropyrimidine dehydrogenase (DPD)."], "h": {"pos": [1, 2], "type": null, "name": "5-FU  interferes with DNA synthesis by blocking "}, "t": {"pos": [3, 4], "type": null, "name": "thymidylate synthase  (TS) but is inactivated by dihydropyrimidine dehydrogenase (DPD)."}}
{"relation": "INHIBITOR", "token": ["Prostaglandin E1, E2, STA2 (a stable analogue of thromboxane A2), 17-phenyl-trinor-PGE2 (an EP1-selective agonist) and sulprostone (an EP3-selective agonist) inhibited the HVA Ca2+ current (HVA ICa) dose-dependently, and the rank order of potency to inhibit ", "HVA Ca2+ channels", " was sulprostone>PGE2, PGE1>STA2>>", "17-phenyl-trinor-PGE2", "."], "h": {"pos": [1, 2], "type": null, "name": "HVA Ca2+ channels  was sulprostone>PGE2, PGE1>STA2>>"}, "t": {"pos": [3, 4], "type": null, "name": "17-phenyl-trinor-PGE2 ."}}
{"relation": "INHIBITOR", "token": ["This study was conducted in order to understand the association between acute renal failure and the two ", "COX-2", " inhibitors celecoxib and ", "rofecoxib", "."], "h": {"pos": [1, 2], "type": null, "name": "COX-2  inhibitors celecoxib and "}, "t": {"pos": [3, 4], "type": null, "name": "rofecoxib ."}}
{"relation": "INHIBITOR", "token": ["The present results indicated that N-", "BPs", " induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/", "MEK", "/ERK and Ras/mTOR pathways."], "h": {"pos": [1, 2], "type": null, "name": "BPs  induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/"}, "t": {"pos": [3, 4], "type": null, "name": "MEK /ERK and Ras/mTOR pathways."}}
{"relation": "INHIBITOR", "token": ["Blockade of PDE1 (8-methoxymethyl-3-isobutyl-1-methylxanthine, 100 microM), PDE2 [erythro-9-(2-hydroxy-3-nonyl)adenine, 30 microM], PDE3 (milrinone, 10 microM; cGMP, 10 microM), ", "PDE4", " (Ro 20-1724 ", " 4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one", "], 100 microM), PDE5 and PDE6 (zaprinast, 30 microM), and PDE7 [BRL-50481 (5-nitro-2,N,N-trimethylbenzenesulfonamide), 10 microM] did not alter renal ecto-phosphodiesterase activity."], "h": {"pos": [1, 2], "type": null, "name": "PDE4  (Ro 20-1724 "}, "t": {"pos": [3, 4], "type": null, "name": " 4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one ], 100 microM), PDE5 and PDE6 (zaprinast, 30 microM), and PDE7 [BRL-50481 (5-nitro-2,N,N-trimethylbenzenesulfonamide), 10 microM] did not alter renal ecto-phosphodiesterase activity."}}
{"relation": "INHIBITOR", "token": ["Here we found that the anticancer agent ", "cucurbitacin I", ", a ", "Jak2", " inhibitor, reduced the activation of Rac1 and motility in response to the ErbB3 ligand heregulin in breast cancer cells."], "h": {"pos": [1, 2], "type": null, "name": "cucurbitacin I , a "}, "t": {"pos": [3, 4], "type": null, "name": "Jak2  inhibitor, reduced the activation of Rac1 and motility in response to the ErbB3 ligand heregulin in breast cancer cells."}}
{"relation": "INHIBITOR", "token": ["Both the ", "5 alpha-reductase", " inhibitor ", "finasteride", " and alpha 1-adrenoceptor antagonists (e.g. alfuzosin, doxazosin, prazosin, tamsulosin and terazosin) have been recommended as appropriate treatment options for patients with lower urinary tract symptoms (LUTS) associated with benign prostatic obstruction (BPO), and their efficacy has been proven in several placebo-controlled trials."], "h": {"pos": [1, 2], "type": null, "name": "5 alpha-reductase  inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "finasteride  and alpha 1-adrenoceptor antagonists (e.g. alfuzosin, doxazosin, prazosin, tamsulosin and terazosin) have been recommended as appropriate treatment options for patients with lower urinary tract symptoms (LUTS) associated with benign prostatic obstruction (BPO), and their efficacy has been proven in several placebo-controlled trials."}}
{"relation": "INHIBITOR", "token": ["PF-04859989 as a template for structure-based drug design: identification of new ", "pyrazole", " series of irreversible ", "KAT II", " inhibitors with improved lipophilic efficiency."], "h": {"pos": [1, 2], "type": null, "name": "pyrazole  series of irreversible "}, "t": {"pos": [3, 4], "type": null, "name": "KAT II  inhibitors with improved lipophilic efficiency."}}
{"relation": "INHIBITOR", "token": ["", "Acetaminophen", " plasma concentrations remained above the in vitro IC(50) for ", "COX-2", " for at least 5 h postadministration."], "h": {"pos": [1, 2], "type": null, "name": "Acetaminophen  plasma concentrations remained above the in vitro IC(50) for "}, "t": {"pos": [3, 4], "type": null, "name": "COX-2  for at least 5 h postadministration."}}
{"relation": "INHIBITOR", "token": ["Concentration-dependent inhibitory effects of ", "baicalin", " on the metabolism of dextromethorphan, a dual probe of CYP2D and ", "CYP3A", ", in rats."], "h": {"pos": [1, 2], "type": null, "name": "baicalin  on the metabolism of dextromethorphan, a dual probe of CYP2D and "}, "t": {"pos": [3, 4], "type": null, "name": "CYP3A , in rats."}}
{"relation": "INHIBITOR", "token": ["", "Pyrrolidine dithiocarbamate", " (PDTC), a specific ", "NF-\u03baB", " inhibitor, along with 20S proteasome inhibitor (PSI) significantly inhibited LPS-induced iNOS expression, which indirectly suggested that 5HHMF downregulated iNOS expression by suppressing NF-\u03baB activity."], "h": {"pos": [1, 2], "type": null, "name": "Pyrrolidine dithiocarbamate  (PDTC), a specific "}, "t": {"pos": [3, 4], "type": null, "name": "NF-\u03baB  inhibitor, along with 20S proteasome inhibitor (PSI) significantly inhibited LPS-induced iNOS expression, which indirectly suggested that 5HHMF downregulated iNOS expression by suppressing NF-\u03baB activity."}}
{"relation": "INHIBITOR", "token": ["The effects of PLZ on both amino acids and their transaminases were blocked by pre-treatment with the ", "MAO", " inhibitor ", "tranylcypromine", "."], "h": {"pos": [1, 2], "type": null, "name": "MAO  inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "tranylcypromine ."}}
{"relation": "INHIBITOR", "token": ["Treatment of A549 and H1299 cells with ", "dioscin", " caused a dose-dependent increase in ERK1/2 and JNK1/2 activity, accompanied with a decreased PI3K expression and decreased phosphorylation of Akt and ", "mTOR", "."], "h": {"pos": [1, 2], "type": null, "name": "dioscin  caused a dose-dependent increase in ERK1/2 and JNK1/2 activity, accompanied with a decreased PI3K expression and decreased phosphorylation of Akt and "}, "t": {"pos": [3, 4], "type": null, "name": "mTOR ."}}
{"relation": "INHIBITOR", "token": ["Nanobody-albumin nanoparticles (NANAPs) for the delivery of a ", "multikinase", " inhibitor ", "17864", " to EGFR overexpressing tumor cells."], "h": {"pos": [1, 2], "type": null, "name": "multikinase  inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "17864  to EGFR overexpressing tumor cells."}}
{"relation": "INHIBITOR", "token": ["The growth of the ", "FLT3", "-independent RS4-11 cell line was only weakly inhibited by ", "sorafenib", "."], "h": {"pos": [1, 2], "type": null, "name": "FLT3 -independent RS4-11 cell line was only weakly inhibited by "}, "t": {"pos": [3, 4], "type": null, "name": "sorafenib ."}}
{"relation": "INHIBITOR", "token": ["", "[-]-Huperzine A", " ([-]-Hup A), is a naturally occurring potent reversible ", "AChE", " inhibitor that penetrates the blood-brain barrier."], "h": {"pos": [1, 2], "type": null, "name": "[-]-Huperzine A  ([-]-Hup A), is a naturally occurring potent reversible "}, "t": {"pos": [3, 4], "type": null, "name": "AChE  inhibitor that penetrates the blood-brain barrier."}}
{"relation": "INHIBITOR", "token": ["The activity of ", "polymerases", " containing mutations known to confer resistance to foscarnet (V715M, T700A and N495K) was inhibited by concentrations of ", "foscarnet", " eight to 14 times higher than those required to inhibit wild-type polymerases."], "h": {"pos": [1, 2], "type": null, "name": "polymerases  containing mutations known to confer resistance to foscarnet (V715M, T700A and N495K) was inhibited by concentrations of "}, "t": {"pos": [3, 4], "type": null, "name": "foscarnet  eight to 14 times higher than those required to inhibit wild-type polymerases."}}
{"relation": "INHIBITOR", "token": ["No effects were observed when ", "fenclozic acid", " was assessed for P450-dependent and P450-independent cytotoxicity to THLE cell lines, time-dependent inhibition of five major human cytochrome P450 enzymes, inhibition of the biliary efflux transporters ", "BSEP", " and MRP2 or mitochondrial toxicity to THLE or HepG2 cells."], "h": {"pos": [1, 2], "type": null, "name": "fenclozic acid  was assessed for P450-dependent and P450-independent cytotoxicity to THLE cell lines, time-dependent inhibition of five major human cytochrome P450 enzymes, inhibition of the biliary efflux transporters "}, "t": {"pos": [3, 4], "type": null, "name": "BSEP  and MRP2 or mitochondrial toxicity to THLE or HepG2 cells."}}
{"relation": "INHIBITOR", "token": ["ThioTEPA (CYP2B6 inhibitor, 25 \u03bcM) and the monoclonal antibody against CYP2B6 but not ", "troleandomycin", " (", "CYP3A4", " inhibitor, 25 \u03bcM) or the monoclonal antibody against CYP3A4 inhibited ketamine N-demethylation at clinically relevant concentrations."], "h": {"pos": [1, 2], "type": null, "name": "troleandomycin  ("}, "t": {"pos": [3, 4], "type": null, "name": "CYP3A4  inhibitor, 25 \u03bcM) or the monoclonal antibody against CYP3A4 inhibited ketamine N-demethylation at clinically relevant concentrations."}}
{"relation": "INHIBITOR", "token": ["Taken together, these data demonstrate that ", "baicalin", " inhibits the metabolism of DXM in a concentration-dependent manner in rats, possibly through inhibiting hepatic ", "CYP2D", " and CYP3A activities."], "h": {"pos": [1, 2], "type": null, "name": "baicalin  inhibits the metabolism of DXM in a concentration-dependent manner in rats, possibly through inhibiting hepatic "}, "t": {"pos": [3, 4], "type": null, "name": "CYP2D  and CYP3A activities."}}
{"relation": "INHIBITOR", "token": ["Catecholamines (adrenaline, noradrenaline and ", "dopamine", ") are potent inhibitors of ", "phenylalanine 4-monooxygenase", " (phenylalanine hydroxylase, EC 1.14.16.1)."], "h": {"pos": [1, 2], "type": null, "name": "dopamine ) are potent inhibitors of "}, "t": {"pos": [3, 4], "type": null, "name": "phenylalanine 4-monooxygenase  (phenylalanine hydroxylase, EC 1.14.16.1)."}}
{"relation": "INHIBITOR", "token": ["Comparison of the monoamine oxidase inhibiting properties of two reversible and selective ", "monoamine oxidase-A", " inhibitors ", "moclobemide", " and toloxatone, and assessment of their effect on psychometric performance in healthy subjects."], "h": {"pos": [1, 2], "type": null, "name": "monoamine oxidase-A  inhibitors "}, "t": {"pos": [3, 4], "type": null, "name": "moclobemide  and toloxatone, and assessment of their effect on psychometric performance in healthy subjects."}}
{"relation": "INHIBITOR", "token": ["Similarly, felodipine and the ", "p-chloro", " analogue inhibited ", "myosin light chain kinase", " activity whether the isolated 20 kD light chain (IC50 = 12.6 microM) or intact myosin (IC50 = 11.0 microM) was used as substrate."], "h": {"pos": [1, 2], "type": null, "name": "p-chloro  analogue inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "myosin light chain kinase  activity whether the isolated 20 kD light chain (IC50 = 12.6 microM) or intact myosin (IC50 = 11.0 microM) was used as substrate."}}
{"relation": "INHIBITOR", "token": ["The stimulatory effect of [Ca(2+)](i) induced by a submaximal concentration of ", "Ang II", " (10(-7) mol/L) was blocked by ", "torasemide", " (IC(50)=0.5+/-0.3 nmol/L)."], "h": {"pos": [1, 2], "type": null, "name": "Ang II  (10(-7) mol/L) was blocked by "}, "t": {"pos": [3, 4], "type": null, "name": "torasemide  (IC(50)=0.5+/-0.3 nmol/L)."}}
{"relation": "INHIBITOR", "token": ["Effects of ", "felodipine", " (a dihydropyridine ", "calcium channel", " blocker) and analogues on calmodulin-dependent enzymes."], "h": {"pos": [1, 2], "type": null, "name": "felodipine  (a dihydropyridine "}, "t": {"pos": [3, 4], "type": null, "name": "calcium channel  blocker) and analogues on calmodulin-dependent enzymes."}}
{"relation": "INHIBITOR", "token": ["", "Dasatinib", " (BMS-354825) inhibits ", "KIT", "D816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis."], "h": {"pos": [1, 2], "type": null, "name": "Dasatinib  (BMS-354825) inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "KIT D816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis."}}
{"relation": "INHIBITOR", "token": ["The tyrosine kinase inhibitor ", "ZD1839", " (\"Iressa\") inhibits ", "HER2", "-driven signaling and suppresses the growth of HER2-overexpressing tumor cells."], "h": {"pos": [1, 2], "type": null, "name": "ZD1839  (\"Iressa\") inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "HER2 -driven signaling and suppresses the growth of HER2-overexpressing tumor cells."}}
{"relation": "INHIBITOR", "token": ["The acetylcholinesterase (", "AChE", ") and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), ", "4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline", " (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."], "h": {"pos": [1, 2], "type": null, "name": "AChE ) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), "}, "t": {"pos": [3, 4], "type": null, "name": "4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline  (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."}}
{"relation": "INHIBITOR", "token": ["", "Wogonoside", " also suppressed the activation of mammalian target of rapamycin (mTOR) and ", "p70-S6 kinase", " (p70S6K) by regulating the expression of the extracellular signal-regulated kinase (ERK1/2) and p38 involved mitogen-activated protein kinase (MAPK) signaling pathway."], "h": {"pos": [1, 2], "type": null, "name": "Wogonoside  also suppressed the activation of mammalian target of rapamycin (mTOR) and "}, "t": {"pos": [3, 4], "type": null, "name": "p70-S6 kinase  (p70S6K) by regulating the expression of the extracellular signal-regulated kinase (ERK1/2) and p38 involved mitogen-activated protein kinase (MAPK) signaling pathway."}}
{"relation": "INHIBITOR", "token": ["", "Mibefradil", " blocked currents of all Na+ channel isoforms with similar affinity and a dependence on holding potential, and drug off-rate was slowed at depolarized potentials (k(off) was 0.024/s at -130 mV and 0.007/s at -100 mV for ", "Nav1.5", ")."], "h": {"pos": [1, 2], "type": null, "name": "Mibefradil  blocked currents of all Na+ channel isoforms with similar affinity and a dependence on holding potential, and drug off-rate was slowed at depolarized potentials (k(off) was 0.024/s at -130 mV and 0.007/s at -100 mV for "}, "t": {"pos": [3, 4], "type": null, "name": "Nav1.5 )."}}
{"relation": "INHIBITOR", "token": ["The present results indicated that ", "N", "-BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/", "MEK", "/ERK and Ras/mTOR pathways."], "h": {"pos": [1, 2], "type": null, "name": "N -BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing Bim expression through inhibition of the Ras/"}, "t": {"pos": [3, 4], "type": null, "name": "MEK /ERK and Ras/mTOR pathways."}}
{"relation": "INHIBITOR", "token": ["However, ", "topiramate", " at low concentrations causes slow inhibition of GluR5 kainate receptor-mediated synaptic currents in the basolateral amygdala, indicating that it may protect against seizures, at least in part, through suppression of ", "GluR5", " kainate receptor responses."], "h": {"pos": [1, 2], "type": null, "name": "topiramate  at low concentrations causes slow inhibition of GluR5 kainate receptor-mediated synaptic currents in the basolateral amygdala, indicating that it may protect against seizures, at least in part, through suppression of "}, "t": {"pos": [3, 4], "type": null, "name": "GluR5  kainate receptor responses."}}
{"relation": "INHIBITOR", "token": ["", "SNP", " inhibits the accumulation of HIF-1alpha, the regulatory subunit of ", "HIF-1", ", and the transcriptional activation of HIF-1alpha via a mechanism that is not dependent on either NO or soluble guanylate cyclase."], "h": {"pos": [1, 2], "type": null, "name": "SNP  inhibits the accumulation of HIF-1alpha, the regulatory subunit of "}, "t": {"pos": [3, 4], "type": null, "name": "HIF-1 , and the transcriptional activation of HIF-1alpha via a mechanism that is not dependent on either NO or soluble guanylate cyclase."}}
{"relation": "INHIBITOR", "token": ["Reactivators showed different activity in the reactivation of ", "rat brain AChE", " after dichlorvos, paraoxon and ", "tabun", " inhibition."], "h": {"pos": [1, 2], "type": null, "name": "rat brain AChE  after dichlorvos, paraoxon and "}, "t": {"pos": [3, 4], "type": null, "name": "tabun  inhibition."}}
{"relation": "INHIBITOR", "token": ["", "Troglitazone", ", a second ", "ACS4", " inhibitor, inhibited ACS activity <10% in microsomes and mitochondria and 45% in MAM."], "h": {"pos": [1, 2], "type": null, "name": "Troglitazone , a second "}, "t": {"pos": [3, 4], "type": null, "name": "ACS4  inhibitor, inhibited ACS activity <10% in microsomes and mitochondria and 45% in MAM."}}
{"relation": "INHIBITOR", "token": ["Cross-inhibition of SR-BI- and ", "ABCA1", "-mediated cholesterol transport by the small molecules BLT-4 and ", "glyburide", "."], "h": {"pos": [1, 2], "type": null, "name": "ABCA1 -mediated cholesterol transport by the small molecules BLT-4 and "}, "t": {"pos": [3, 4], "type": null, "name": "glyburide ."}}
{"relation": "INHIBITOR", "token": ["A series of phenolic acids and phenol natural products, such as ", "p-hydroxybenzoic acid", ", p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase (", "CA", ", EC 4.2.1.1)."], "h": {"pos": [1, 2], "type": null, "name": "p-hydroxybenzoic acid , p-coumaric acid, caffeic acid, ferulic acid, gallic acid, syringic acid, quercetin, and ellagic acid, were investigated for their inhibitory effects against the metalloenzyme carbonic anhydrase ("}, "t": {"pos": [3, 4], "type": null, "name": "CA , EC 4.2.1.1)."}}
{"relation": "INHIBITOR", "token": ["Molecular modeling of the kinase domain of mutant c-Kit (V654A) and AXL showed no binding to IM but efficient binding to ", "MP470", ", a novel c-Kit/", "AXL", " kinase inhibitor."], "h": {"pos": [1, 2], "type": null, "name": "MP470 , a novel c-Kit/"}, "t": {"pos": [3, 4], "type": null, "name": "AXL  kinase inhibitor."}}
{"relation": "INHIBITOR", "token": ["Ca(v)1.3 channels were less sensitive to pentobarbital inhibition than ", "Ca(v)1.2", " channels, similar to dihydropyridine (", "DHP", ") L-VGCC antagonists."], "h": {"pos": [1, 2], "type": null, "name": "Ca(v)1.2  channels, similar to dihydropyridine ("}, "t": {"pos": [3, 4], "type": null, "name": "DHP ) L-VGCC antagonists."}}
{"relation": "INHIBITOR", "token": ["", "Vandetanib", " (Caprelsa(\u00ae), AstraZeneca) is a once-daily oral tyrosine kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor tyrosine kinase ", "RET", " (constitutively activated in roughly 60\u00a0% of all MTCs), vascular endothelial growth-factor receptors 2 and 3, and epidermal growth-factor receptors."], "h": {"pos": [1, 2], "type": null, "name": "Vandetanib  (Caprelsa(\u00ae), AstraZeneca) is a once-daily oral tyrosine kinase inhibitor that selectively inhibits signalling mediated by growth-factor receptor tyrosine kinase "}, "t": {"pos": [3, 4], "type": null, "name": "RET  (constitutively activated in roughly 60\u00a0% of all MTCs), vascular endothelial growth-factor receptors 2 and 3, and epidermal growth-factor receptors."}}
{"relation": "INHIBITOR", "token": ["", "Licofelone", ", a balanced inhibitor of ", "cyclooxygenase", " and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis."], "h": {"pos": [1, 2], "type": null, "name": "Licofelone , a balanced inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "cyclooxygenase  and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis."}}
{"relation": "INHIBITOR", "token": ["Sorafenib (BAY 43-9006, ", "Nexavar", "), a dual-action inhibitor that targets RAF/MEK/", "ERK", " pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature."], "h": {"pos": [1, 2], "type": null, "name": "Nexavar ), a dual-action inhibitor that targets RAF/MEK/"}, "t": {"pos": [3, 4], "type": null, "name": "ERK  pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature."}}
{"relation": "INHIBITOR", "token": ["", "Nitrogen", "-containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of ", "Ras", " signaling pathways and Bim-mediated activation of the intrinsic apoptotic pathway."], "h": {"pos": [1, 2], "type": null, "name": "Nitrogen -containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "Ras  signaling pathways and Bim-mediated activation of the intrinsic apoptotic pathway."}}
{"relation": "INHIBITOR", "token": ["Some of these derivatives showed good inhibitory potency against two human CA isozymes involved in important physiological processes, CA I, and ", "CA II", ", of the same order of magnitude as the clinically used drugs acetazolamide and ", "methazolamide", "."], "h": {"pos": [1, 2], "type": null, "name": "CA II , of the same order of magnitude as the clinically used drugs acetazolamide and "}, "t": {"pos": [3, 4], "type": null, "name": "methazolamide ."}}
{"relation": "INHIBITOR", "token": ["Molecular modeling of the kinase domain of mutant c-Kit (V654A) and AXL showed no binding to IM but efficient binding to ", "MP470", ", a novel c-Kit/AXL ", "kinase", " inhibitor."], "h": {"pos": [1, 2], "type": null, "name": "MP470 , a novel c-Kit/AXL "}, "t": {"pos": [3, 4], "type": null, "name": "kinase  inhibitor."}}
{"relation": "INHIBITOR", "token": ["METHODS: ", "COX-1", " inhibition was determined by measuring thromboxane B2 (TXB2)-generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg ", "meloxicam", " and 75 mg diclofenac and at steady state (15 mg meloxicam daily and 150 mg diclofenac daily)."], "h": {"pos": [1, 2], "type": null, "name": "COX-1  inhibition was determined by measuring thromboxane B2 (TXB2)-generation from clotting whole blood ex vivo after single oral doses of 7.5 and 15 mg "}, "t": {"pos": [3, 4], "type": null, "name": "meloxicam  and 75 mg diclofenac and at steady state (15 mg meloxicam daily and 150 mg diclofenac daily)."}}
{"relation": "INHIBITOR", "token": ["We conclude that ", "erg3", " can be blocked by certain antipsychotic drugs like ", "sertindole", " and pimozide."], "h": {"pos": [1, 2], "type": null, "name": "erg3  can be blocked by certain antipsychotic drugs like "}, "t": {"pos": [3, 4], "type": null, "name": "sertindole  and pimozide."}}
{"relation": "INHIBITOR", "token": ["", "Sildenafil", " is inhibitory of PDE5 at a rate tenfold higher than for the next PDE (", "PDE6", "), which produces visual changes through the retinal rods."], "h": {"pos": [1, 2], "type": null, "name": "Sildenafil  is inhibitory of PDE5 at a rate tenfold higher than for the next PDE ("}, "t": {"pos": [3, 4], "type": null, "name": "PDE6 ), which produces visual changes through the retinal rods."}}
{"relation": "INHIBITOR", "token": ["Reciprocally, ", "glyburide", " blocked ", "SR-BI", "-mediated selective lipid uptake and efflux at a potency similar to that for its inhibition of ABCA1 (IC(50) approximately 275-300 microM)."], "h": {"pos": [1, 2], "type": null, "name": "glyburide  blocked "}, "t": {"pos": [3, 4], "type": null, "name": "SR-BI -mediated selective lipid uptake and efflux at a potency similar to that for its inhibition of ABCA1 (IC(50) approximately 275-300 microM)."}}
{"relation": "INHIBITOR", "token": ["The potent and selective third-generation ", "aromatase", " inhibitors anastrozole, ", "letrozole", " and exemestane were introduced to the market as endocrine therapy in postmenopausal patients failing anti-estrogen therapy alone, or multiple hormonal therapies."], "h": {"pos": [1, 2], "type": null, "name": "aromatase  inhibitors anastrozole, "}, "t": {"pos": [3, 4], "type": null, "name": "letrozole  and exemestane were introduced to the market as endocrine therapy in postmenopausal patients failing anti-estrogen therapy alone, or multiple hormonal therapies."}}
{"relation": "INHIBITOR", "token": ["Moreover, kinetic analysis revealed that inhibition by ", "reserpine", ", a typical ", "VMAT2", " inhibitor, was uncompetitive, decreasing maximum velocity and affinity for dopamine."], "h": {"pos": [1, 2], "type": null, "name": "reserpine , a typical "}, "t": {"pos": [3, 4], "type": null, "name": "VMAT2  inhibitor, was uncompetitive, decreasing maximum velocity and affinity for dopamine."}}
{"relation": "INHIBITOR", "token": ["", "Curcumin", " improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/", "NF-\u03baB", " signaling pathway."], "h": {"pos": [1, 2], "type": null, "name": "Curcumin  improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/"}, "t": {"pos": [3, 4], "type": null, "name": "NF-\u03baB  signaling pathway."}}
{"relation": "INHIBITOR", "token": ["The selective PDE 4 inhibitors, and to a certain extent the ", "PDE3", " inhibitors ", "amrinone", " and milrinone, reduced the GM-CSF release in a concentration dependent manner."], "h": {"pos": [1, 2], "type": null, "name": "PDE3  inhibitors "}, "t": {"pos": [3, 4], "type": null, "name": "amrinone  and milrinone, reduced the GM-CSF release in a concentration dependent manner."}}
{"relation": "INHIBITOR", "token": ["Given these findings, a unified PK model including the inhibition of MAO-A- and ", "CYP2D6", "-catalyzed 5-MeO-DMT metabolism by ", "harmaline", " was developed to describe blood harmaline, 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models."], "h": {"pos": [1, 2], "type": null, "name": "CYP2D6 -catalyzed 5-MeO-DMT metabolism by "}, "t": {"pos": [3, 4], "type": null, "name": "harmaline  was developed to describe blood harmaline, 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models."}}
{"relation": "INHIBITOR", "token": ["", "CP-690550", ", a ", "JAK3", " inhibitor is currently in phase II clinical trials.FK778, is a synthetic malononitrilamide that targets the critical enzyme of the de novo pyrimidine synthesis, dihydroorotic acid dehydrogenase, and receptor-associated tyrosine kinases has completed phase II trials."], "h": {"pos": [1, 2], "type": null, "name": "CP-690550 , a "}, "t": {"pos": [3, 4], "type": null, "name": "JAK3  inhibitor is currently in phase II clinical trials.FK778, is a synthetic malononitrilamide that targets the critical enzyme of the de novo pyrimidine synthesis, dihydroorotic acid dehydrogenase, and receptor-associated tyrosine kinases has completed phase II trials."}}
{"relation": "INHIBITOR", "token": ["Again, inhibition of the actin-activated myosin Mg2+-ATPase and ", "myosin", " filament assembly by felodipine and the ", "p-chloro", " analogue could be reversed by raising the calmodulin concentration."], "h": {"pos": [1, 2], "type": null, "name": "myosin  filament assembly by felodipine and the "}, "t": {"pos": [3, 4], "type": null, "name": "p-chloro  analogue could be reversed by raising the calmodulin concentration."}}
{"relation": "INHIBITOR", "token": ["The ", "acetylcholinesterase", " (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ ", "4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine", " (16) are described."], "h": {"pos": [1, 2], "type": null, "name": "acetylcholinesterase  (AChE) and butyrylcholinesterase (BuChE) inhibitory activities of a series of pyrano[2,3-b]quinolines (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ "}, "t": {"pos": [3, 4], "type": null, "name": "4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine  (16) are described."}}
{"relation": "INHIBITOR", "token": ["The synthetic stereoisomer, ", "[+]-Hup A", ", is less toxic due to poor ", "AChE", " inhibition and is suitable for both pre-/post-exposure treatments of nerve agent toxicity."], "h": {"pos": [1, 2], "type": null, "name": "[+]-Hup A , is less toxic due to poor "}, "t": {"pos": [3, 4], "type": null, "name": "AChE  inhibition and is suitable for both pre-/post-exposure treatments of nerve agent toxicity."}}
{"relation": "INHIBITOR", "token": ["Kinetic parameters for ", "PAM", " inactivation by ", "4-oxo-5-acetamido-6-phenyl-hex-2-enoic acid and 4-oxo-5-acetamido-6-(2-thienyl)-hex-2-enoic acid", " were obtained by using both the conventional dilution assay method and the more complex progress curve method."], "h": {"pos": [1, 2], "type": null, "name": "PAM  inactivation by "}, "t": {"pos": [3, 4], "type": null, "name": "4-oxo-5-acetamido-6-phenyl-hex-2-enoic acid and 4-oxo-5-acetamido-6-(2-thienyl)-hex-2-enoic acid  were obtained by using both the conventional dilution assay method and the more complex progress curve method."}}
{"relation": "INHIBITOR", "token": ["The most potent in\u2005vitro DASI discovered is an ", "imidazole", " derivative with IC50 values against aromatase and ", "steroid sulfatase", " in a JEG-3 cell preparation of 0.2 and 2.5\u2005nM, respectively."], "h": {"pos": [1, 2], "type": null, "name": "imidazole  derivative with IC50 values against aromatase and "}, "t": {"pos": [3, 4], "type": null, "name": "steroid sulfatase  in a JEG-3 cell preparation of 0.2 and 2.5\u2005nM, respectively."}}
{"relation": "INHIBITOR", "token": ["In vitro, ", "acetaminophen", " elicited a 4.4-fold selectivity toward ", "COX-2", " inhibition (IC(50)=113.7 micromol/L for COX-1; IC(50)=25.8 micromol/L for COX-2)."], "h": {"pos": [1, 2], "type": null, "name": "acetaminophen  elicited a 4.4-fold selectivity toward "}, "t": {"pos": [3, 4], "type": null, "name": "COX-2  inhibition (IC(50)=113.7 micromol/L for COX-1; IC(50)=25.8 micromol/L for COX-2)."}}
{"relation": "INHIBITOR", "token": ["Despite the structural similarity between benzothiazepines and BDZs, mutation of an amino acid important for diltiazem potency (", "I1150A", ") did not affect ", "diazepam", " potency."], "h": {"pos": [1, 2], "type": null, "name": "I1150A ) did not affect "}, "t": {"pos": [3, 4], "type": null, "name": "diazepam  potency."}}
{"relation": "INHIBITOR", "token": ["Interestingly, a ", "Val-349 to Ile", " mutant was inhibited with equal potency to human COX-2 with 2,6-dichloro-, 2,6-dimethyl-, or 2-chloro-6-methyl-substituted inhibitors and, in the case of ", "lumiracoxib", ", actually showed an increase in potency."], "h": {"pos": [1, 2], "type": null, "name": "Val-349 to Ile  mutant was inhibited with equal potency to human COX-2 with 2,6-dichloro-, 2,6-dimethyl-, or 2-chloro-6-methyl-substituted inhibitors and, in the case of "}, "t": {"pos": [3, 4], "type": null, "name": "lumiracoxib , actually showed an increase in potency."}}
{"relation": "INHIBITOR", "token": ["When further examined for its anticancer mechanism, ", "SB365", " effectively suppressed the AKT/", "mTOR", " pathway both in vitro and in vivo."], "h": {"pos": [1, 2], "type": null, "name": "SB365  effectively suppressed the AKT/"}, "t": {"pos": [3, 4], "type": null, "name": "mTOR  pathway both in vitro and in vivo."}}
{"relation": "INHIBITOR", "token": ["Given these findings, a unified PK model including the inhibition of MAO-A- and CYP2D6-catalyzed 5-MeO-DMT metabolism by harmaline was developed to describe blood ", "harmaline", ", 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-", "CYP2D6", " mouse models."], "h": {"pos": [1, 2], "type": null, "name": "harmaline , 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-"}, "t": {"pos": [3, 4], "type": null, "name": "CYP2D6  mouse models."}}
{"relation": "INHIBITOR", "token": ["Troglitazone inhibited the antigen-induced production of LTB(4), C(4) and E(4) and the potency of the inhibition was comparable to that of ", "zileuton", ", a specific inhibitor of 5-lipoxygenase (", "5-LOX", ") and a clinically used anti-asthmatic drug."], "h": {"pos": [1, 2], "type": null, "name": "zileuton , a specific inhibitor of 5-lipoxygenase ("}, "t": {"pos": [3, 4], "type": null, "name": "5-LOX ) and a clinically used anti-asthmatic drug."}}
{"relation": "INHIBITOR", "token": ["First, in the presence of 1 mm ATP or the nonhydrolyzable analog adenosine 5'-(beta,gamma-imino)triphosphate, ", "TOP2", "-mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. ", "doxorubicin", ", etoposide, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected."], "h": {"pos": [1, 2], "type": null, "name": "TOP2 -mediated DNA cleavage induced by ATP-sensitive TOP2 poisons (e.g. "}, "t": {"pos": [3, 4], "type": null, "name": "doxorubicin , etoposide, mitoxantrone, and 4'-(9-acridinylamino)methanesulfon-m-anisidide) was 30-100-fold stimulated, whereas DNA cleavage induced by ATP-insensitive TOP2 poisons (e.g. amonafide, batracylin, and menadione) was only slightly (less than 3-fold) affected."}}
{"relation": "INHIBITOR", "token": ["A series of carbamoylmethylene linked prodrugs of 1 (", "BMS-582949", "), a clinical ", "p38\u03b1", " inhibitor, were synthesized and evaluated."], "h": {"pos": [1, 2], "type": null, "name": "BMS-582949 ), a clinical "}, "t": {"pos": [3, 4], "type": null, "name": "p38\u03b1  inhibitor, were synthesized and evaluated."}}
{"relation": "INHIBITOR", "token": ["Inhibition of ", "S-adenosylmethionine decarboxylase", " by a specific inhibitor ", " diethylglyoxal bis-(guanylhydrazone)", "; DEGBG] led to depletion of spermidine and spermine with a significant accumulation of putrescine and induction of ODC."], "h": {"pos": [1, 2], "type": null, "name": "S-adenosylmethionine decarboxylase  by a specific inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": " diethylglyoxal bis-(guanylhydrazone) ; DEGBG] led to depletion of spermidine and spermine with a significant accumulation of putrescine and induction of ODC."}}
{"relation": "INHIBITOR", "token": ["Four prenylflavonoids, kurarinone ( 1), a chalcone of 1, kuraridin ( 2), kurarinol ( 3), ", "kushenol H", " ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on ", "diacylglycerol acyltransferase", " (DGAT)."], "h": {"pos": [1, 2], "type": null, "name": "kushenol H  ( 4) and kushenol K ( 5) isolated from the roots of Sophora flavescens were investigated for their inhibitory effects on "}, "t": {"pos": [3, 4], "type": null, "name": "diacylglycerol acyltransferase  (DGAT)."}}
{"relation": "INHIBITOR", "token": ["", "Methylphenidate", ", an inhibitor of dopamine and norepinephrine transporters (DAT and ", "NET", ", respectively), is a standard treatment for ADHD."], "h": {"pos": [1, 2], "type": null, "name": "Methylphenidate , an inhibitor of dopamine and norepinephrine transporters (DAT and "}, "t": {"pos": [3, 4], "type": null, "name": "NET , respectively), is a standard treatment for ADHD."}}
{"relation": "INHIBITOR", "token": ["The effect of the four mono- and bisquaternary ammonium compounds tetramethylammonium (TMA), hexamethonium, decamethonium and suxamethonium on the reactivatability of ", "soman", "-inhibited, solubilized ", "AChE", " from human erythrocytes was investigated in vitro."], "h": {"pos": [1, 2], "type": null, "name": "soman -inhibited, solubilized "}, "t": {"pos": [3, 4], "type": null, "name": "AChE  from human erythrocytes was investigated in vitro."}}
{"relation": "INHIBITOR", "token": ["", "Imatinib", " was also found to inhibit M-CSF-induced osteoclast survival as well as ", "M-CSF", "-induced osteoclast bone resorbing activity, but was without effect on interleukin 1alpha (IL-1alpha) and receptor activator of nuclear factor kappa B ligand (RANKL)-induced inhibition of osteoclasts apoptosis, further supporting the hypothesis that imatinib may affect mature osteoclasts through the inhibition of c-FMS."], "h": {"pos": [1, 2], "type": null, "name": "Imatinib  was also found to inhibit M-CSF-induced osteoclast survival as well as "}, "t": {"pos": [3, 4], "type": null, "name": "M-CSF -induced osteoclast bone resorbing activity, but was without effect on interleukin 1alpha (IL-1alpha) and receptor activator of nuclear factor kappa B ligand (RANKL)-induced inhibition of osteoclasts apoptosis, further supporting the hypothesis that imatinib may affect mature osteoclasts through the inhibition of c-FMS."}}
{"relation": "INHIBITOR", "token": ["Inhibition of angiogenesis and invasion by ", "DMBT", " is mediated by downregulation of VEGF and MMP-9 through ", "Akt", " pathway in MDA-MB-231 breast cancer cells."], "h": {"pos": [1, 2], "type": null, "name": "DMBT  is mediated by downregulation of VEGF and MMP-9 through "}, "t": {"pos": [3, 4], "type": null, "name": "Akt  pathway in MDA-MB-231 breast cancer cells."}}
{"relation": "INHIBITOR", "token": ["Pretreatment of rats with the ", "MAO", " inhibitor ", "tranylcypromine", " prevented the increase in brain GABA and ALA levels with PLZ, but did not block the effect of VIG on GABA."], "h": {"pos": [1, 2], "type": null, "name": "MAO  inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "tranylcypromine  prevented the increase in brain GABA and ALA levels with PLZ, but did not block the effect of VIG on GABA."}}
{"relation": "INHIBITOR", "token": ["Our previous work, built on the early pioneering multikinase inhibitor ", "LY294002", ", resulted in the only ", "PI3K", " vascular-targeted PI3K inhibitor prodrug, SF1126, which has now completed Phase I clinical trials."], "h": {"pos": [1, 2], "type": null, "name": "LY294002 , resulted in the only "}, "t": {"pos": [3, 4], "type": null, "name": "PI3K  vascular-targeted PI3K inhibitor prodrug, SF1126, which has now completed Phase I clinical trials."}}
{"relation": "INHIBITOR", "token": ["Potentiation was prevented by catalase, the catalase/superoxide dismutase mimetic manganese porphyrin and the ", "NADPH oxidase", " inhibitor ", "apocynin", "."], "h": {"pos": [1, 2], "type": null, "name": "NADPH oxidase  inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "apocynin ."}}
{"relation": "INHIBITOR", "token": ["The channel activators avermectin and ", "moxidectin", " usually retain their inhibitory potency in the ", "Rdl", " subunit mutants."], "h": {"pos": [1, 2], "type": null, "name": "moxidectin  usually retain their inhibitory potency in the "}, "t": {"pos": [3, 4], "type": null, "name": "Rdl  subunit mutants."}}
{"relation": "INHIBITOR", "token": ["", "Acetaminophen", " (paracetamol) is a selective ", "cyclooxygenase-2", " inhibitor in man."], "h": {"pos": [1, 2], "type": null, "name": "Acetaminophen  (paracetamol) is a selective "}, "t": {"pos": [3, 4], "type": null, "name": "cyclooxygenase-2  inhibitor in man."}}
{"relation": "INHIBITOR", "token": ["The fact that ", "acetaminophen", " acts functionally as a selective ", "COX-2", " inhibitor led us to investigate the hypothesis of whether it works via preferential COX-2 blockade."], "h": {"pos": [1, 2], "type": null, "name": "acetaminophen  acts functionally as a selective "}, "t": {"pos": [3, 4], "type": null, "name": "COX-2  inhibitor led us to investigate the hypothesis of whether it works via preferential COX-2 blockade."}}
{"relation": "INHIBITOR", "token": ["A series of benzenesulfonamides incorporating ", "cyanoacrylamide", " moieties (tyrphostine analogs) were assayed as inhibitors of the \u03b2-carbonic anhydrase (CA, ", "EC 4.2.1.1", ") from Saccharomyces cerevisiae, ScCA."], "h": {"pos": [1, 2], "type": null, "name": "cyanoacrylamide  moieties (tyrphostine analogs) were assayed as inhibitors of the \u03b2-carbonic anhydrase (CA, "}, "t": {"pos": [3, 4], "type": null, "name": "EC 4.2.1.1 ) from Saccharomyces cerevisiae, ScCA."}}
{"relation": "INHIBITOR", "token": ["The antipsychotic drugs sertindole and ", "pimozide", " are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as ", "HERG", " (human ether-a-go-go-related gene; erg1)."], "h": {"pos": [1, 2], "type": null, "name": "pimozide  are known to prolong the QT interval on the electrocardiogram via a high affinity block of the cardiac K(+) channel known as "}, "t": {"pos": [3, 4], "type": null, "name": "HERG  (human ether-a-go-go-related gene; erg1)."}}
{"relation": "INHIBITOR", "token": ["5-Fluorouracil (5-FU), 5-fluoro-2'-deoxyuridine (FdUrd) and 5-trifluorothymidine (", "F3(d)Thd", ") are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of ", "thymidylate synthase", " (TS)."], "h": {"pos": [1, 2], "type": null, "name": "F3(d)Thd ) are antimetabolites which are metabolized to their corresponding active forms which inhibit DNA synthesis via inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "thymidylate synthase  (TS)."}}
{"relation": "INHIBITOR", "token": ["Our results demonstrated that ", "auranofin", " suppressed TLR4-mediated activation of transcription factors, ", "NF-kappaB", " and IRF3, and expression of COX-2, a pro-inflammatory enzyme."], "h": {"pos": [1, 2], "type": null, "name": "auranofin  suppressed TLR4-mediated activation of transcription factors, "}, "t": {"pos": [3, 4], "type": null, "name": "NF-kappaB  and IRF3, and expression of COX-2, a pro-inflammatory enzyme."}}
{"relation": "INHIBITOR", "token": ["Our results suggest that ", "mibefradil", " blocks ", "Na+ channels", " in a state-dependent manner that does not depend on fast inactivation but probably involves interaction with one or more slow-inactivated state(s)."], "h": {"pos": [1, 2], "type": null, "name": "mibefradil  blocks "}, "t": {"pos": [3, 4], "type": null, "name": "Na+ channels  in a state-dependent manner that does not depend on fast inactivation but probably involves interaction with one or more slow-inactivated state(s)."}}
{"relation": "INHIBITOR", "token": ["", "Bupropion", ", an efficacious antidepressant and smoking cessation agent, inhibits dopamine and norepinephrine transporters (", "DAT", " and NET, respectively)."], "h": {"pos": [1, 2], "type": null, "name": "Bupropion , an efficacious antidepressant and smoking cessation agent, inhibits dopamine and norepinephrine transporters ("}, "t": {"pos": [3, 4], "type": null, "name": "DAT  and NET, respectively)."}}
{"relation": "INHIBITOR", "token": ["", "4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate", " and its ortho-halogenated (F, Cl, Br) derivatives are first-generation dual ", "aromatase", " and sulfatase inhibitors (DASIs)."], "h": {"pos": [1, 2], "type": null, "name": "4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate  and its ortho-halogenated (F, Cl, Br) derivatives are first-generation dual "}, "t": {"pos": [3, 4], "type": null, "name": "aromatase  and sulfatase inhibitors (DASIs)."}}
{"relation": "INHIBITOR", "token": ["To investigate the mechanism and consequences of inhibition of QR2 by the ", "quinolines", " further, we have used steady-state and transient-state kinetics to define the mechanism of ", "QR2", "."], "h": {"pos": [1, 2], "type": null, "name": "quinolines  further, we have used steady-state and transient-state kinetics to define the mechanism of "}, "t": {"pos": [3, 4], "type": null, "name": "QR2 ."}}
{"relation": "INHIBITOR", "token": ["Consistent with these locations, ", "N-ethylmaleimide", ", an inhibitor of ACS4, inhibited ", "ACS", " activity 47% in MAM and 28% in endoplasmic reticulum."], "h": {"pos": [1, 2], "type": null, "name": "N-ethylmaleimide , an inhibitor of ACS4, inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "ACS  activity 47% in MAM and 28% in endoplasmic reticulum."}}
{"relation": "INHIBITOR", "token": ["In conclusion, early application of ", "amiloride", " inhibited ", "u-PA", " activity in UVB-irradiated corneas as well as in tear fluid and diminished the development of corneal pathology."], "h": {"pos": [1, 2], "type": null, "name": "amiloride  inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "u-PA  activity in UVB-irradiated corneas as well as in tear fluid and diminished the development of corneal pathology."}}
{"relation": "INHIBITOR", "token": ["Objective: This study explores the ability of ", "acyl glucuronides", " to act as substrates or inhibitors of human carboxylesterases 1 (", "hCES1", ") and 2 (hCES2)."], "h": {"pos": [1, 2], "type": null, "name": "acyl glucuronides  to act as substrates or inhibitors of human carboxylesterases 1 ("}, "t": {"pos": [3, 4], "type": null, "name": "hCES1 ) and 2 (hCES2)."}}
{"relation": "INHIBITOR", "token": ["This led to the discovery of aliskiren, a highly potent and selective inhibitor of human renin in vitro, and in vivo; once-daily oral doses of ", "aliskiren", " inhibit ", "renin", " and lower blood pressure in sodium-depleted marmosets and hypertensive human patients."], "h": {"pos": [1, 2], "type": null, "name": "aliskiren  inhibit "}, "t": {"pos": [3, 4], "type": null, "name": "renin  and lower blood pressure in sodium-depleted marmosets and hypertensive human patients."}}
{"relation": "INHIBITOR", "token": ["Effects of inhibition of urokinase-type plasminogen activator (", "u-PA", ") by ", "amiloride", " in the cornea and tear fluid of eyes irradiated with UVB."], "h": {"pos": [1, 2], "type": null, "name": "u-PA ) by "}, "t": {"pos": [3, 4], "type": null, "name": "amiloride  in the cornea and tear fluid of eyes irradiated with UVB."}}
{"relation": "INHIBITOR", "token": ["Multiple exposure to ", "theophylline", ", a phosphodiesterase (", "PDE", ") inhibitor, induces acinar hypertrophy in the salivary gland."], "h": {"pos": [1, 2], "type": null, "name": "theophylline , a phosphodiesterase ("}, "t": {"pos": [3, 4], "type": null, "name": "PDE ) inhibitor, induces acinar hypertrophy in the salivary gland."}}
{"relation": "INHIBITOR", "token": ["Agents that have only begun to undergo clinical evaluation include ", "CI-1033", ", an irreversible pan-erbB ", "tyrosine kinase", " inhibitor, and PKI166 and GW572016, both examples of dual kinase inhibitors (inhibiting epidermal growth factor receptor and Her2)."], "h": {"pos": [1, 2], "type": null, "name": "CI-1033 , an irreversible pan-erbB "}, "t": {"pos": [3, 4], "type": null, "name": "tyrosine kinase  inhibitor, and PKI166 and GW572016, both examples of dual kinase inhibitors (inhibiting epidermal growth factor receptor and Her2)."}}
{"relation": "INHIBITOR", "token": ["The acetylcholinesterase (", "AChE", ") and butyrylcholinesterase (BuChE) inhibitory activities of a series of ", "pyrano[2,3-b]quinolines", " (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."], "h": {"pos": [1, 2], "type": null, "name": "AChE ) and butyrylcholinesterase (BuChE) inhibitory activities of a series of "}, "t": {"pos": [3, 4], "type": null, "name": "pyrano[2,3-b]quinolines  (2, 3), [1,8]naphthyridines (5, 6), 4-amino-2,3-diaryl-5,6,7,8-tetrahydrofuro[2,3-b]quinolines (11-13)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]furo[2,3-b]pyridine (14), 4-amino-5,6,7,8-tetrahydro-2,3-diphenylthieno[2,3-b]quinoline (15)/ 4-amino-6,7,8,9-tetrahydro-2,3-diphenyl-5H-cyclohepta[e]thieno[2,3-b]pyridine (16) are described."}}
{"relation": "INHIBITOR", "token": ["N-alkylation of the ", "pyridazinone", " ring markedly enhances potency against PDE4 but suppresses ", "PDE3", " inhibition."], "h": {"pos": [1, 2], "type": null, "name": "pyridazinone  ring markedly enhances potency against PDE4 but suppresses "}, "t": {"pos": [3, 4], "type": null, "name": "PDE3  inhibition."}}
{"relation": "INHIBITOR", "token": ["Moreover, the rank order for potency in inhibiting ", "acetylcholinesterase", " (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium=", "galanthamine", " >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent."], "h": {"pos": [1, 2], "type": null, "name": "acetylcholinesterase  (ambenonium>neostigmine=physostigmine =tacrine>pyridostigmine=edrophonium="}, "t": {"pos": [3, 4], "type": null, "name": "galanthamine  >desoxypeganine>parathion>gramine) indicated that the most effective inhibitors of acetylcholinesterase also displaced [3H]-oxotremorine-M to the greatest extent."}}
{"relation": "INHIBITOR", "token": ["In comparison to diphenylhydantoin, the novel chloro-substituted ", "alpha-hydroxyphenylamide", " compounds produced as much as a 20-fold greater tonic and frequency-dependent blockade of ", "Na(V)1.5", " channels with an IC(50) value of 14.5 microM."], "h": {"pos": [1, 2], "type": null, "name": "alpha-hydroxyphenylamide  compounds produced as much as a 20-fold greater tonic and frequency-dependent blockade of "}, "t": {"pos": [3, 4], "type": null, "name": "Na(V)1.5  channels with an IC(50) value of 14.5 microM."}}
{"relation": "INHIBITOR", "token": ["Kinetic studies with ", "lumiracoxib", " demonstrated that it was a time-dependent and slowly reversible inhibitor of ", "human COX-2", " that exhibited at least two binding steps during inhibition."], "h": {"pos": [1, 2], "type": null, "name": "lumiracoxib  demonstrated that it was a time-dependent and slowly reversible inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "human COX-2  that exhibited at least two binding steps during inhibition."}}
{"relation": "INHIBITOR", "token": ["", "Benzofuran", " 28 showed dose responsive target engagement and provides a useful tool to explore a ", "LTA(4)H", " inhibitor for the treatment of inflammatory diseases, such as asthma and inflammatory bowel disease (IBD)."], "h": {"pos": [1, 2], "type": null, "name": "Benzofuran  28 showed dose responsive target engagement and provides a useful tool to explore a "}, "t": {"pos": [3, 4], "type": null, "name": "LTA(4)H  inhibitor for the treatment of inflammatory diseases, such as asthma and inflammatory bowel disease (IBD)."}}
{"relation": "INHIBITOR", "token": ["Clinical pharmacology of enalkiren, a novel, ", "dipeptide", " ", "renin", " inhibitor."], "h": {"pos": [1, 2], "type": null, "name": "dipeptide  "}, "t": {"pos": [3, 4], "type": null, "name": "renin  inhibitor."}}
{"relation": "INHIBITOR", "token": ["Moreover, ", "S1611", " and S3226, both specific inhibitors of ", "NHE3", " only, or perfusion with Na+-free solutions, dose dependently increased DBS, as measured by pH-stat and CO2-sensitive electrode, without affecting intracellular pH."], "h": {"pos": [1, 2], "type": null, "name": "S1611  and S3226, both specific inhibitors of "}, "t": {"pos": [3, 4], "type": null, "name": "NHE3  only, or perfusion with Na+-free solutions, dose dependently increased DBS, as measured by pH-stat and CO2-sensitive electrode, without affecting intracellular pH."}}
{"relation": "INHIBITOR", "token": ["Catecholamines (adrenaline, ", "noradrenaline", " and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase (", "phenylalanine hydroxylase", ", EC 1.14.16.1)."], "h": {"pos": [1, 2], "type": null, "name": "noradrenaline  and dopamine) are potent inhibitors of phenylalanine 4-monooxygenase ("}, "t": {"pos": [3, 4], "type": null, "name": "phenylalanine hydroxylase , EC 1.14.16.1)."}}
{"relation": "ANTAGONIST", "token": ["The potent ", "histamine H(1)-receptor", " antagonist cetirizine (Zyrtec) is a racemic mixture of ", "levocetirizine", " (now available under the trademark Xyzal and dextrocetirizine."], "h": {"pos": [1, 2], "type": null, "name": "histamine H(1)-receptor  antagonist cetirizine (Zyrtec) is a racemic mixture of "}, "t": {"pos": [3, 4], "type": null, "name": "levocetirizine  (now available under the trademark Xyzal and dextrocetirizine."}}
{"relation": "ANTAGONIST", "token": ["Doses of dimethocaine (1.7 mg/kg) and cocaine (0.3 mg/kg) which produced full (> 80%) substitution for cocaine were administered in combination with the ", "dopamine D1 receptor", " antagonist SCH 39166 (", "(-)-trans-6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-N-methyl-5H -benzo [d]naphtho-(2,1-b)azepine", ") and the dopamine D2 receptor antagonist raclopride (both at 0.003-0.03 mg/kg)."], "h": {"pos": [1, 2], "type": null, "name": "dopamine D1 receptor  antagonist SCH 39166 ("}, "t": {"pos": [3, 4], "type": null, "name": "(-)-trans-6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-N-methyl-5H -benzo [d]naphtho-(2,1-b)azepine ) and the dopamine D2 receptor antagonist raclopride (both at 0.003-0.03 mg/kg)."}}
{"relation": "ANTAGONIST", "token": ["Synthesis and in Vitro Characterisation of Ifenprodil-Based ", "Fluorescein", " Conjugates as GluN1/GluN2B ", "N-Methyl-D-aspartate Receptor", " Antagonists."], "h": {"pos": [1, 2], "type": null, "name": "Fluorescein  Conjugates as GluN1/GluN2B "}, "t": {"pos": [3, 4], "type": null, "name": "N-Methyl-D-aspartate Receptor  Antagonists."}}
{"relation": "ANTAGONIST", "token": ["EP(1) and EP(3) receptor antagonists ONO-8713 and ONO-AE3-240, but not the ", "EP(4)", " antagonists ONO-AE3-208 and ", "AH 23848", ", inhibited tumor cell proliferation, indicating the significance of EP(1) and EP(3) but not EP(4) for MB growth."], "h": {"pos": [1, 2], "type": null, "name": "EP(4)  antagonists ONO-AE3-208 and "}, "t": {"pos": [3, 4], "type": null, "name": "AH 23848 , inhibited tumor cell proliferation, indicating the significance of EP(1) and EP(3) but not EP(4) for MB growth."}}
{"relation": "ANTAGONIST", "token": ["The most potent compound, ", "D,L-4-(3,4-dichlorobenzoylamino)-5-(dipentylamino)-5-oxo-pen tanoic acid", " (lorglumide, CR 1409), has a great affinity for the pancreatic CCK receptors and is a competitive, specific and potent ", "CCK", " antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the CCK-induced amylase secretion of isolated pancreatic acini."], "h": {"pos": [1, 2], "type": null, "name": "D,L-4-(3,4-dichlorobenzoylamino)-5-(dipentylamino)-5-oxo-pen tanoic acid  (lorglumide, CR 1409), has a great affinity for the pancreatic CCK receptors and is a competitive, specific and potent "}, "t": {"pos": [3, 4], "type": null, "name": "CCK  antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the CCK-induced amylase secretion of isolated pancreatic acini."}}
{"relation": "ANTAGONIST", "token": ["", "Betaxolol", ", a ", "beta(1)-adrenoceptor", " antagonist used for the treatment of glaucoma, is known to be neuroprotective in paradigms of ischaemia/excitotoxicity."], "h": {"pos": [1, 2], "type": null, "name": "Betaxolol , a "}, "t": {"pos": [3, 4], "type": null, "name": "beta(1)-adrenoceptor  antagonist used for the treatment of glaucoma, is known to be neuroprotective in paradigms of ischaemia/excitotoxicity."}}
{"relation": "ANTAGONIST", "token": ["In membranes from HEK293 cells transfected with ", "alpha2-receptors", ", etomidate inhibited binding of the alpha2-antagonist, ", "[3H]RX821002", ", with higher potency from alpha2B- and alpha2C-receptors than from alpha2A-receptors (Ki alpha2A 208 microm, alpha2B 26 microm, alpha2C 56 microm)."], "h": {"pos": [1, 2], "type": null, "name": "alpha2-receptors , etomidate inhibited binding of the alpha2-antagonist, "}, "t": {"pos": [3, 4], "type": null, "name": "[3H]RX821002 , with higher potency from alpha2B- and alpha2C-receptors than from alpha2A-receptors (Ki alpha2A 208 microm, alpha2B 26 microm, alpha2C 56 microm)."}}
{"relation": "ANTAGONIST", "token": ["Pretreatment with tropisetron (1 microM), a 5-HT3 antagonist, ketanserin (10 microM), a 5-HT2 antagonist, ", "thioperamide", " (10 microM), a ", "histamine H3", " antagonist, or phentolamine (10 microM), an alpha-adrenergic antagonist, however, had no effect."], "h": {"pos": [1, 2], "type": null, "name": "thioperamide  (10 microM), a "}, "t": {"pos": [3, 4], "type": null, "name": "histamine H3  antagonist, or phentolamine (10 microM), an alpha-adrenergic antagonist, however, had no effect."}}
{"relation": "ANTAGONIST", "token": ["We conclude that ", "alprenolol", " and BAAM are competitive slowly reversible ", "beta 1-adrenoceptor", " antagonists on rat left atria."], "h": {"pos": [1, 2], "type": null, "name": "alprenolol  and BAAM are competitive slowly reversible "}, "t": {"pos": [3, 4], "type": null, "name": "beta 1-adrenoceptor  antagonists on rat left atria."}}
{"relation": "ANTAGONIST", "token": ["In the rabbit pulmonary artery, ", "rilmenidine", " and oxymetazoline are potent full agonists, whereas in the human atrial appendages they are antagonists at the ", "alpha(2)-autoreceptors", ", sharing this property with rauwolscine, phentolamine, and idazoxan."], "h": {"pos": [1, 2], "type": null, "name": "rilmenidine  and oxymetazoline are potent full agonists, whereas in the human atrial appendages they are antagonists at the "}, "t": {"pos": [3, 4], "type": null, "name": "alpha(2)-autoreceptors , sharing this property with rauwolscine, phentolamine, and idazoxan."}}
{"relation": "ANTAGONIST", "token": ["", "Ambrisentan", " is an ", "endothelin type A (ET(A))-selective receptor", " antagonist that is metabolized primarily by glucuronidation but also undergoes oxidative metabolism by CYP3A4."], "h": {"pos": [1, 2], "type": null, "name": "Ambrisentan  is an "}, "t": {"pos": [3, 4], "type": null, "name": "endothelin type A (ET(A))-selective receptor  antagonist that is metabolized primarily by glucuronidation but also undergoes oxidative metabolism by CYP3A4."}}
{"relation": "ANTAGONIST", "token": ["These results confirm the selective mGlu2 agonist and ", "mGlu3", " antagonist actions of ", "LY541850", "."], "h": {"pos": [1, 2], "type": null, "name": "mGlu3  antagonist actions of "}, "t": {"pos": [3, 4], "type": null, "name": "LY541850 ."}}
{"relation": "ANTAGONIST", "token": ["(+)-Tamsulosin, (-)-tamsulosin, ", "SL 89,0591", ", Rec 15/2739, SNAP 1069 and RS 17053 appeared to act as competitive antagonists of noradrenaline-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned ", "human alpha 1D adrenoceptors", "."], "h": {"pos": [1, 2], "type": null, "name": "SL 89,0591 , Rec 15/2739, SNAP 1069 and RS 17053 appeared to act as competitive antagonists of noradrenaline-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned "}, "t": {"pos": [3, 4], "type": null, "name": "human alpha 1D adrenoceptors ."}}
{"relation": "ANTAGONIST", "token": ["Doses of dimethocaine (1.7 mg/kg) and cocaine (0.3 mg/kg) which produced full (> 80%) substitution for cocaine were administered in combination with the dopamine D1 receptor antagonist SCH 39166 ((-)-trans-6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-N-methyl-5H -benzo [d]naphtho-(2,1-b)azepine) and the ", "dopamine D2 receptor", " antagonist ", "raclopride", " (both at 0.003-0.03 mg/kg)."], "h": {"pos": [1, 2], "type": null, "name": "dopamine D2 receptor  antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "raclopride  (both at 0.003-0.03 mg/kg)."}}
{"relation": "ANTAGONIST", "token": ["The potent ", "histamine H(1)-receptor", " antagonist cetirizine (Zyrtec) is a racemic mixture of levocetirizine (now available under the trademark ", "Xyzal", " and dextrocetirizine."], "h": {"pos": [1, 2], "type": null, "name": "histamine H(1)-receptor  antagonist cetirizine (Zyrtec) is a racemic mixture of levocetirizine (now available under the trademark "}, "t": {"pos": [3, 4], "type": null, "name": "Xyzal  and dextrocetirizine."}}
{"relation": "ANTAGONIST", "token": ["", "Astemizole", ", a potent ", "histamine H1-receptor", " antagonist: effect in allergic rhinoconjunctivitis, on antigen and histamine induced skin weal responses and relationship to serum levels."], "h": {"pos": [1, 2], "type": null, "name": "Astemizole , a potent "}, "t": {"pos": [3, 4], "type": null, "name": "histamine H1-receptor  antagonist: effect in allergic rhinoconjunctivitis, on antigen and histamine induced skin weal responses and relationship to serum levels."}}
{"relation": "ANTAGONIST", "token": ["The ARB ", "eprosartan", " is a nonbiphenyl nontetrazole ", "angiotensin II type 1 receptor", " (AT1) antagonist, which acts to decrease total peripheral resistance."], "h": {"pos": [1, 2], "type": null, "name": "eprosartan  is a nonbiphenyl nontetrazole "}, "t": {"pos": [3, 4], "type": null, "name": "angiotensin II type 1 receptor  (AT1) antagonist, which acts to decrease total peripheral resistance."}}
{"relation": "ANTAGONIST", "token": ["Ca(v)1.3 channels were less sensitive to pentobarbital inhibition than Ca(v)1.2 channels, similar to dihydropyridine (", "DHP", ") ", "L-VGCC", " antagonists."], "h": {"pos": [1, 2], "type": null, "name": "DHP ) "}, "t": {"pos": [3, 4], "type": null, "name": "L-VGCC  antagonists."}}
{"relation": "ANTAGONIST", "token": ["A series of 2-carbonyl analogues of the muscarinic antagonist ", "diphenidol", " bearing 1-substituents of different lipophilic, electronic, and steric properties was synthesized and their affinity for the ", "M2 and M3 muscarinic receptor", " subtypes was evaluated by functional tests."], "h": {"pos": [1, 2], "type": null, "name": "diphenidol  bearing 1-substituents of different lipophilic, electronic, and steric properties was synthesized and their affinity for the "}, "t": {"pos": [3, 4], "type": null, "name": "M2 and M3 muscarinic receptor  subtypes was evaluated by functional tests."}}
{"relation": "ANTAGONIST", "token": ["", "(+/-)-Tamsulosin", " effectively antagonized the positive inotropic effect of phenylephrine even after inactivation of ", "alpha 1B-adrenoceptors", " by treatment with chlorethylclonidine, which is an indication that the (+/-)-tamsulosin-sensitive subtype belongs to a class resistant to chlorethylclonidine."], "h": {"pos": [1, 2], "type": null, "name": "(+/-)-Tamsulosin  effectively antagonized the positive inotropic effect of phenylephrine even after inactivation of "}, "t": {"pos": [3, 4], "type": null, "name": "alpha 1B-adrenoceptors  by treatment with chlorethylclonidine, which is an indication that the (+/-)-tamsulosin-sensitive subtype belongs to a class resistant to chlorethylclonidine."}}
{"relation": "ANTAGONIST", "token": ["Local LC citalopram effect was abolished by LC presence of the ", "5-HT3", " receptor antagonist ", "MDL72222", " (1\u00a0\u03bcM) but not the 5-HT1/2 receptor antagonist methiothepin (1\u00a0\u03bcM)."], "h": {"pos": [1, 2], "type": null, "name": "5-HT3  receptor antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "MDL72222  (1\u00a0\u03bcM) but not the 5-HT1/2 receptor antagonist methiothepin (1\u00a0\u03bcM)."}}
{"relation": "ANTAGONIST", "token": ["This effect has been attributed to the antagonist effects of ", "pindolol", " at the ", "5-HT(1A)", " receptor."], "h": {"pos": [1, 2], "type": null, "name": "pindolol  at the "}, "t": {"pos": [3, 4], "type": null, "name": "5-HT(1A)  receptor."}}
{"relation": "ANTAGONIST", "token": ["These protective effects were abolished by ", "glucocorticoid receptor", " (GR) antagonist ", "RU486", " or p-ERK inhibitor U0126 rather than estrogen receptor \u03b1 antagonist ICI 82,780."], "h": {"pos": [1, 2], "type": null, "name": "glucocorticoid receptor  (GR) antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "RU486  or p-ERK inhibitor U0126 rather than estrogen receptor \u03b1 antagonist ICI 82,780."}}
{"relation": "ANTAGONIST", "token": ["The potency of the antipsychotic drug, ", "risperidone", ", to antagonize alpha 1A-adrenoceptor-mediated contraction in rat vas deferens and vasoconstriction in rat perfused kidney, and alpha 1B-adrenoceptor-mediated contractions in spleen from guinea-pig and mouse was evaluated and compared to that of ", "alpha 1-adrenoceptor", " subtype-discriminating antagonists."], "h": {"pos": [1, 2], "type": null, "name": "risperidone , to antagonize alpha 1A-adrenoceptor-mediated contraction in rat vas deferens and vasoconstriction in rat perfused kidney, and alpha 1B-adrenoceptor-mediated contractions in spleen from guinea-pig and mouse was evaluated and compared to that of "}, "t": {"pos": [3, 4], "type": null, "name": "alpha 1-adrenoceptor  subtype-discriminating antagonists."}}
{"relation": "ANTAGONIST", "token": ["In order to examine the site of action of an ", "NR2B", " subtype-selective NMDA antagonist ", "CP-101,606", ", we investigated its analgesic effect in a rat model of neuropathic pain at various routes of administration."], "h": {"pos": [1, 2], "type": null, "name": "NR2B  subtype-selective NMDA antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "CP-101,606 , we investigated its analgesic effect in a rat model of neuropathic pain at various routes of administration."}}
{"relation": "ANTAGONIST", "token": ["In the local presence into the LC of the ", "\u03b12-adrenoceptor", " antagonist ", "RS79948", " (1\u00a0\u03bcM), systemic citalopram increased NA in the LC (Emax\u2009=\u2009157\u2009\u00b1\u200925\u00a0%) and PFC (Emax\u2009=\u2009175\u2009\u00b1\u200924\u00a0%)."], "h": {"pos": [1, 2], "type": null, "name": "\u03b12-adrenoceptor  antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "RS79948  (1\u00a0\u03bcM), systemic citalopram increased NA in the LC (Emax\u2009=\u2009157\u2009\u00b1\u200925\u00a0%) and PFC (Emax\u2009=\u2009175\u2009\u00b1\u200924\u00a0%)."}}
{"relation": "ANTAGONIST", "token": ["Clinical effects of ", "pranlukast", ", an oral ", "leukotriene receptor", " antagonist, in mild-to-moderate asthma: a 4 week randomized multicentre controlled trial."], "h": {"pos": [1, 2], "type": null, "name": "pranlukast , an oral "}, "t": {"pos": [3, 4], "type": null, "name": "leukotriene receptor  antagonist, in mild-to-moderate asthma: a 4 week randomized multicentre controlled trial."}}
{"relation": "ANTAGONIST", "token": ["The ", "alpha(1)-adrenoceptor", " antagonist, ", "tamsulosin", ", is selective for alpha(1A)- and alpha(1D)- over alpha(1B)-adrenoceptors."], "h": {"pos": [1, 2], "type": null, "name": "alpha(1)-adrenoceptor  antagonist, "}, "t": {"pos": [3, 4], "type": null, "name": "tamsulosin , is selective for alpha(1A)- and alpha(1D)- over alpha(1B)-adrenoceptors."}}
{"relation": "ANTAGONIST", "token": ["Pharmacological properties of ", "lorglumide", " as a member of a new class of ", "cholecystokinin", " antagonists."], "h": {"pos": [1, 2], "type": null, "name": "lorglumide  as a member of a new class of "}, "t": {"pos": [3, 4], "type": null, "name": "cholecystokinin  antagonists."}}
{"relation": "ANTAGONIST", "token": ["Synthesis and in Vitro Characterisation of ", "Ifenprodil", "-Based Fluorescein Conjugates as ", "GluN1", "/GluN2B N-Methyl-D-aspartate Receptor Antagonists."], "h": {"pos": [1, 2], "type": null, "name": "Ifenprodil -Based Fluorescein Conjugates as "}, "t": {"pos": [3, 4], "type": null, "name": "GluN1 /GluN2B N-Methyl-D-aspartate Receptor Antagonists."}}
{"relation": "ANTAGONIST", "token": ["In contrast, the D-1997-induced responses were potently and concentration-dependently antagonized by the mixed ", "5-HT1-like", " and 5-HT2 receptor antagonist ", "methiothepin", " (0.01-1 microM)."], "h": {"pos": [1, 2], "type": null, "name": "5-HT1-like  and 5-HT2 receptor antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "methiothepin  (0.01-1 microM)."}}
{"relation": "ANTAGONIST", "token": ["", "Mibefradil", " is a ", "T-type Ca2+ channel", " antagonist with reported cross-reactivity with other classes of ion channels, including K+, Cl-, and Na+ channels."], "h": {"pos": [1, 2], "type": null, "name": "Mibefradil  is a "}, "t": {"pos": [3, 4], "type": null, "name": "T-type Ca2+ channel  antagonist with reported cross-reactivity with other classes of ion channels, including K+, Cl-, and Na+ channels."}}
{"relation": "ANTAGONIST", "token": ["The effects of D-1997 in the basilar artery were not modified by incubation with either the ", "5-HT2 receptor", " antagonist ", "ketanserin", " (0.01-1 microM), the 5-HT3 and 5-HT4 receptor antagonist ICS205930 (tropisetron; 0.1-10 microM), the 5-HT1A receptor antagonist spiroxatrine (0.01-1 microM), the beta-adrenoceptor blocker with high affinity for 5-HT1A and 5-HT1B binding sites (+/-)-pindolol (0.01-1 microM), or the alpha 1-adrenoceptor antagonist prazosin (0.01-1 microM)."], "h": {"pos": [1, 2], "type": null, "name": "5-HT2 receptor  antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "ketanserin  (0.01-1 microM), the 5-HT3 and 5-HT4 receptor antagonist ICS205930 (tropisetron; 0.1-10 microM), the 5-HT1A receptor antagonist spiroxatrine (0.01-1 microM), the beta-adrenoceptor blocker with high affinity for 5-HT1A and 5-HT1B binding sites (+/-)-pindolol (0.01-1 microM), or the alpha 1-adrenoceptor antagonist prazosin (0.01-1 microM)."}}
{"relation": "ANTAGONIST", "token": ["The potent ", "histamine H(1)-receptor", " antagonist ", "cetirizine", " (Zyrtec) is a racemic mixture of levocetirizine (now available under the trademark Xyzal and dextrocetirizine."], "h": {"pos": [1, 2], "type": null, "name": "histamine H(1)-receptor  antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "cetirizine  (Zyrtec) is a racemic mixture of levocetirizine (now available under the trademark Xyzal and dextrocetirizine."}}
{"relation": "ANTAGONIST", "token": ["The chemistry, pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosages of the nonsedating ", "histamine H1-receptor", " antagonists ", "terfenadine", ", astemizole, loratadine, and acrivastine are reviewed."], "h": {"pos": [1, 2], "type": null, "name": "histamine H1-receptor  antagonists "}, "t": {"pos": [3, 4], "type": null, "name": "terfenadine , astemizole, loratadine, and acrivastine are reviewed."}}
{"relation": "ANTAGONIST", "token": ["The most potent compound, D,L-4-(3,4-dichlorobenzoylamino)-5-(dipentylamino)-5-oxo-pen tanoic acid (lorglumide, ", "CR 1409", "), has a great affinity for the pancreatic CCK receptors and is a competitive, specific and potent ", "CCK", " antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the CCK-induced amylase secretion of isolated pancreatic acini."], "h": {"pos": [1, 2], "type": null, "name": "CR 1409 ), has a great affinity for the pancreatic CCK receptors and is a competitive, specific and potent "}, "t": {"pos": [3, 4], "type": null, "name": "CCK  antagonist on the smooth muscles of the gall bladder and ileum of the guinea pig and on the CCK-induced amylase secretion of isolated pancreatic acini."}}
{"relation": "ANTAGONIST", "token": ["Like other ", "NMDA receptor", " antagonists, ", "memantine", " at high concentrations can inhibit mechanisms of synaptic plasticity that are believed to underlie learning and memory."], "h": {"pos": [1, 2], "type": null, "name": "NMDA receptor  antagonists, "}, "t": {"pos": [3, 4], "type": null, "name": "memantine  at high concentrations can inhibit mechanisms of synaptic plasticity that are believed to underlie learning and memory."}}
{"relation": "ANTAGONIST", "token": ["Since the original discovery of ", "azoles", " analogs as ", "PXR", " antagonists, we have preliminarily defined an important PXR antagonist pharmacophore and developed less-toxic PXR antagonists."], "h": {"pos": [1, 2], "type": null, "name": "azoles  analogs as "}, "t": {"pos": [3, 4], "type": null, "name": "PXR  antagonists, we have preliminarily defined an important PXR antagonist pharmacophore and developed less-toxic PXR antagonists."}}
{"relation": "ANTAGONIST", "token": ["Pretreatment with ", "tropisetron", " (1 microM), a ", "5-HT3", " antagonist, ketanserin (10 microM), a 5-HT2 antagonist, thioperamide (10 microM), a histamine H3 antagonist, or phentolamine (10 microM), an alpha-adrenergic antagonist, however, had no effect."], "h": {"pos": [1, 2], "type": null, "name": "tropisetron  (1 microM), a "}, "t": {"pos": [3, 4], "type": null, "name": "5-HT3  antagonist, ketanserin (10 microM), a 5-HT2 antagonist, thioperamide (10 microM), a histamine H3 antagonist, or phentolamine (10 microM), an alpha-adrenergic antagonist, however, had no effect."}}
{"relation": "ANTAGONIST", "token": ["The non-selective ", "adenosine receptor", " antagonist (", "caffeine", "), and the selective adenosine A1 receptor antagonist (DPCPX), injected 15 min before the application of pentetrazole and flumazenil, were able to intensify BDZ withdrawal signs in mice."], "h": {"pos": [1, 2], "type": null, "name": "adenosine receptor  antagonist ("}, "t": {"pos": [3, 4], "type": null, "name": "caffeine ), and the selective adenosine A1 receptor antagonist (DPCPX), injected 15 min before the application of pentetrazole and flumazenil, were able to intensify BDZ withdrawal signs in mice."}}
{"relation": "ANTAGONIST", "token": ["In the present study, we compared the pharmacology of (+/-)pindolol, ", "WAY-100635", " (a ", "5-HT(1A)", " antagonist), GR127935 (a 5-HT(1B/1D) antagonist), and isamoltane (a 5-HT(1B) antagonist), when given acutely in combination with fluoxetine, using in vivo microdialysis in the frontal cortex of the freely moving rat."], "h": {"pos": [1, 2], "type": null, "name": "WAY-100635  (a "}, "t": {"pos": [3, 4], "type": null, "name": "5-HT(1A)  antagonist), GR127935 (a 5-HT(1B/1D) antagonist), and isamoltane (a 5-HT(1B) antagonist), when given acutely in combination with fluoxetine, using in vivo microdialysis in the frontal cortex of the freely moving rat."}}
{"relation": "ANTAGONIST", "token": ["", "(+/-)-Tamsulosin", ", over the range of concentrations at which it antagonized the positive inotropic effect mediated by ", "alpha 1-adrenoceptors", ", did not affect the accumulation of [3H]inositol phosphates that was induced by 10 microM phenylephrine."], "h": {"pos": [1, 2], "type": null, "name": "(+/-)-Tamsulosin , over the range of concentrations at which it antagonized the positive inotropic effect mediated by "}, "t": {"pos": [3, 4], "type": null, "name": "alpha 1-adrenoceptors , did not affect the accumulation of [3H]inositol phosphates that was induced by 10 microM phenylephrine."}}
{"relation": "ANTAGONIST", "token": ["Both the 5 alpha-reductase inhibitor finasteride and ", "alpha 1-adrenoceptor", " antagonists (e.g. alfuzosin, doxazosin, prazosin, tamsulosin and ", "terazosin", ") have been recommended as appropriate treatment options for patients with lower urinary tract symptoms (LUTS) associated with benign prostatic obstruction (BPO), and their efficacy has been proven in several placebo-controlled trials."], "h": {"pos": [1, 2], "type": null, "name": "alpha 1-adrenoceptor  antagonists (e.g. alfuzosin, doxazosin, prazosin, tamsulosin and "}, "t": {"pos": [3, 4], "type": null, "name": "terazosin ) have been recommended as appropriate treatment options for patients with lower urinary tract symptoms (LUTS) associated with benign prostatic obstruction (BPO), and their efficacy has been proven in several placebo-controlled trials."}}
{"relation": "ANTAGONIST", "token": ["Pretreatment of the tissues with combined ", "5-HT1", "/5-HT2 antagonists, methysergide (1 microM) or ", "methiothepin", " (0.1 microM), significantly attenuated the inhibitory effect of epinastine on the noncholinergic contraction."], "h": {"pos": [1, 2], "type": null, "name": "5-HT1 /5-HT2 antagonists, methysergide (1 microM) or "}, "t": {"pos": [3, 4], "type": null, "name": "methiothepin  (0.1 microM), significantly attenuated the inhibitory effect of epinastine on the noncholinergic contraction."}}
{"relation": "ANTAGONIST", "token": ["", "LY541850", " was claimed from human mGlu receptors expressed in non-neuronal cells to be a selective orthosteric mGlu2 agonist and ", "mGlu3", " antagonist."], "h": {"pos": [1, 2], "type": null, "name": "LY541850  was claimed from human mGlu receptors expressed in non-neuronal cells to be a selective orthosteric mGlu2 agonist and "}, "t": {"pos": [3, 4], "type": null, "name": "mGlu3  antagonist."}}
{"relation": "ANTAGONIST", "token": ["Brain but not spinal NR2B receptor is responsible for the anti-allodynic effect of an ", "NR2B", " subunit-selective antagonist ", "CP-101,606", " in a rat chronic constriction injury model."], "h": {"pos": [1, 2], "type": null, "name": "NR2B  subunit-selective antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "CP-101,606  in a rat chronic constriction injury model."}}
{"relation": "ANTAGONIST", "token": ["", "Betaxolol", ", a ", "beta(1)-adrenoceptor", " antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists."], "h": {"pos": [1, 2], "type": null, "name": "Betaxolol , a "}, "t": {"pos": [3, 4], "type": null, "name": "beta(1)-adrenoceptor  antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists."}}
{"relation": "ANTAGONIST", "token": ["In contrast, the D-1997-induced responses were potently and concentration-dependently antagonized by the mixed 5-HT1-like and ", "5-HT2 receptor", " antagonist ", "methiothepin", " (0.01-1 microM)."], "h": {"pos": [1, 2], "type": null, "name": "5-HT2 receptor  antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "methiothepin  (0.01-1 microM)."}}
{"relation": "ANTAGONIST", "token": ["In vivo ", "lorglumide", " antagonizes the contraction of the gall bladder of the guinea pig and of the dog provoked by i.v. ", "CCK-8", " or ceruletide (caerulein)."], "h": {"pos": [1, 2], "type": null, "name": "lorglumide  antagonizes the contraction of the gall bladder of the guinea pig and of the dog provoked by i.v. "}, "t": {"pos": [3, 4], "type": null, "name": "CCK-8  or ceruletide (caerulein)."}}
{"relation": "ANTAGONIST", "token": ["", "Nizatidine", " (LY139037), a selective ", "histamine H2-receptor", " antagonist, is a potent inhibitor of gastric acid secretion."], "h": {"pos": [1, 2], "type": null, "name": "Nizatidine  (LY139037), a selective "}, "t": {"pos": [3, 4], "type": null, "name": "histamine H2-receptor  antagonist, is a potent inhibitor of gastric acid secretion."}}
{"relation": "ANTAGONIST", "token": ["Pretreatment with ", "pranlukast", " (1.5 ng/mouse, intracerebroventricularly), a ", "CysLT(1)R", " antagonist, blocked LTD4-induced amyloidogenesis, memory deficits."], "h": {"pos": [1, 2], "type": null, "name": "pranlukast  (1.5 ng/mouse, intracerebroventricularly), a "}, "t": {"pos": [3, 4], "type": null, "name": "CysLT(1)R  antagonist, blocked LTD4-induced amyloidogenesis, memory deficits."}}
{"relation": "ANTAGONIST", "token": ["", "Kynurenic acid", " (KA) is an endogenous ", "glutamate receptor", " antagonist at the level of the different ionotropic glutamate receptors."], "h": {"pos": [1, 2], "type": null, "name": "Kynurenic acid  (KA) is an endogenous "}, "t": {"pos": [3, 4], "type": null, "name": "glutamate receptor  antagonist at the level of the different ionotropic glutamate receptors."}}
{"relation": "ANTAGONIST", "token": ["In many countries, a ", "mu-opioid receptor", " antagonist ", "naltrexone", " has been used in the treatment of alcohol dependence."], "h": {"pos": [1, 2], "type": null, "name": "mu-opioid receptor  antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "naltrexone  has been used in the treatment of alcohol dependence."}}
{"relation": "ANTAGONIST", "token": ["In the rabbit pulmonary artery, rilmenidine and oxymetazoline are potent full agonists, whereas in the human atrial appendages they are antagonists at the ", "alpha(2)-autoreceptors", ", sharing this property with ", "rauwolscine", ", phentolamine, and idazoxan."], "h": {"pos": [1, 2], "type": null, "name": "alpha(2)-autoreceptors , sharing this property with "}, "t": {"pos": [3, 4], "type": null, "name": "rauwolscine , phentolamine, and idazoxan."}}
{"relation": "ANTAGONIST", "token": ["In order to examine the site of action of an NR2B subtype-selective ", "NMDA", " antagonist ", "CP-101,606", ", we investigated its analgesic effect in a rat model of neuropathic pain at various routes of administration."], "h": {"pos": [1, 2], "type": null, "name": "NMDA  antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "CP-101,606 , we investigated its analgesic effect in a rat model of neuropathic pain at various routes of administration."}}
{"relation": "ANTAGONIST", "token": ["The potentiation of the contractile effect induced by 5-HT is only somewhat modified by deendothelialization, but abolished by the ", "thromboxane A2 receptor", " antagonists ", "GR32191", " and ridogrel."], "h": {"pos": [1, 2], "type": null, "name": "thromboxane A2 receptor  antagonists "}, "t": {"pos": [3, 4], "type": null, "name": "GR32191  and ridogrel."}}
{"relation": "ANTAGONIST", "token": ["Compared pharmacological characteristics in humans of racemic cetirizine and ", "levocetirizine", ", two ", "histamine H1-receptor", " antagonists."], "h": {"pos": [1, 2], "type": null, "name": "levocetirizine , two "}, "t": {"pos": [3, 4], "type": null, "name": "histamine H1-receptor  antagonists."}}
{"relation": "ANTAGONIST", "token": ["Synthesis and antagonistic activity at ", "muscarinic receptor", " subtypes of some 2-carbonyl derivatives of ", "diphenidol", "."], "h": {"pos": [1, 2], "type": null, "name": "muscarinic receptor  subtypes of some 2-carbonyl derivatives of "}, "t": {"pos": [3, 4], "type": null, "name": "diphenidol ."}}
{"relation": "ANTAGONIST", "token": ["Both the 5 alpha-reductase inhibitor finasteride and ", "alpha 1-adrenoceptor", " antagonists (e.g. alfuzosin, doxazosin, ", "prazosin", ", tamsulosin and terazosin) have been recommended as appropriate treatment options for patients with lower urinary tract symptoms (LUTS) associated with benign prostatic obstruction (BPO), and their efficacy has been proven in several placebo-controlled trials."], "h": {"pos": [1, 2], "type": null, "name": "alpha 1-adrenoceptor  antagonists (e.g. alfuzosin, doxazosin, "}, "t": {"pos": [3, 4], "type": null, "name": "prazosin , tamsulosin and terazosin) have been recommended as appropriate treatment options for patients with lower urinary tract symptoms (LUTS) associated with benign prostatic obstruction (BPO), and their efficacy has been proven in several placebo-controlled trials."}}
{"relation": "ANTAGONIST", "token": ["This selectivity could, in part, account for the more favorable clinical profile of ", "felbamate", " in comparison with ", "NMDA receptor", " antagonists that do not show subunit selectivity."], "h": {"pos": [1, 2], "type": null, "name": "felbamate  in comparison with "}, "t": {"pos": [3, 4], "type": null, "name": "NMDA receptor  antagonists that do not show subunit selectivity."}}
{"relation": "ANTAGONIST", "token": ["Alprenolol and ", "BAAM", " also caused surmountable antagonism of isoprenaline responses, and this ", "beta 1-adrenoceptor", " antagonism was slowly reversible."], "h": {"pos": [1, 2], "type": null, "name": "BAAM  also caused surmountable antagonism of isoprenaline responses, and this "}, "t": {"pos": [3, 4], "type": null, "name": "beta 1-adrenoceptor  antagonism was slowly reversible."}}
{"relation": "ANTAGONIST", "token": ["In the present study, we compared the pharmacology of ", "(+/-)pindolol", ", WAY-100635 (a ", "5-HT(1A)", " antagonist), GR127935 (a 5-HT(1B/1D) antagonist), and isamoltane (a 5-HT(1B) antagonist), when given acutely in combination with fluoxetine, using in vivo microdialysis in the frontal cortex of the freely moving rat."], "h": {"pos": [1, 2], "type": null, "name": "(+/-)pindolol , WAY-100635 (a "}, "t": {"pos": [3, 4], "type": null, "name": "5-HT(1A)  antagonist), GR127935 (a 5-HT(1B/1D) antagonist), and isamoltane (a 5-HT(1B) antagonist), when given acutely in combination with fluoxetine, using in vivo microdialysis in the frontal cortex of the freely moving rat."}}
{"relation": "ANTAGONIST", "token": ["The chemistry, pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosages of the nonsedating ", "histamine H1-receptor", " antagonists terfenadine, astemizole, ", "loratadine", ", and acrivastine are reviewed."], "h": {"pos": [1, 2], "type": null, "name": "histamine H1-receptor  antagonists terfenadine, astemizole, "}, "t": {"pos": [3, 4], "type": null, "name": "loratadine , and acrivastine are reviewed."}}
{"relation": "ANTAGONIST", "token": ["", "ORF 17583", ", a ", "histamine H2-receptor", " antagonist, inhibited gastric acid secretion in pylorus-ligated rats (ED50 = 4.9 mg/kg intraduodenal; 3.4 mg/kg p.o.; and 0.21 mg/kg i.p.) and in total gastric fistula or Heidenhain pouch dogs stimulated by betazole (ED50 = 0.12 mg/kg p.o. and 0.08 mg/kg i.v.), histamine, tetragastrin, bethanechol, 2-deoxy-D-glucose or a meal (ED50 values ranged from 0.11-0.26 mg/kg p.o.)."], "h": {"pos": [1, 2], "type": null, "name": "ORF 17583 , a "}, "t": {"pos": [3, 4], "type": null, "name": "histamine H2-receptor  antagonist, inhibited gastric acid secretion in pylorus-ligated rats (ED50 = 4.9 mg/kg intraduodenal; 3.4 mg/kg p.o.; and 0.21 mg/kg i.p.) and in total gastric fistula or Heidenhain pouch dogs stimulated by betazole (ED50 = 0.12 mg/kg p.o. and 0.08 mg/kg i.v.), histamine, tetragastrin, bethanechol, 2-deoxy-D-glucose or a meal (ED50 values ranged from 0.11-0.26 mg/kg p.o.)."}}
{"relation": "ANTAGONIST", "token": ["The selective ", "beta1AR", " antagonists ", "atenolol", " and metoprolol blocked isoproterenol-induced enhancement, with apparent K(b) values of 85 +/- 36 and 3.9 +/- 1.7 nM, respectively."], "h": {"pos": [1, 2], "type": null, "name": "beta1AR  antagonists "}, "t": {"pos": [3, 4], "type": null, "name": "atenolol  and metoprolol blocked isoproterenol-induced enhancement, with apparent K(b) values of 85 +/- 36 and 3.9 +/- 1.7 nM, respectively."}}
{"relation": "ANTAGONIST", "token": ["In contrast, the selective ", "beta2AR", " antagonists ICI-118,551 and ", "butoxamine", " inhibited isoproterenol-mediated enhancement with apparent low affinities (K(b) of 222 +/- 61 and 9268 +/- 512 nM, respectively)."], "h": {"pos": [1, 2], "type": null, "name": "beta2AR  antagonists ICI-118,551 and "}, "t": {"pos": [3, 4], "type": null, "name": "butoxamine  inhibited isoproterenol-mediated enhancement with apparent low affinities (K(b) of 222 +/- 61 and 9268 +/- 512 nM, respectively)."}}
{"relation": "ANTAGONIST", "token": ["Conversely, opioid antagonists such as ", "naloxone", " and naltrexone (which bind to non-selectively ", "opioid receptors", ") have been shown to decrease alcohol consumption under various experimental conditions."], "h": {"pos": [1, 2], "type": null, "name": "naloxone  and naltrexone (which bind to non-selectively "}, "t": {"pos": [3, 4], "type": null, "name": "opioid receptors ) have been shown to decrease alcohol consumption under various experimental conditions."}}
{"relation": "ANTAGONIST", "token": ["RGM-1 cells were treated with CDCA or GW4064, an FXR agonist, in the presence or absence of ", "guggulsterone", ", an ", "FXR", " antagonist."], "h": {"pos": [1, 2], "type": null, "name": "guggulsterone , an "}, "t": {"pos": [3, 4], "type": null, "name": "FXR  antagonist."}}
{"relation": "ANTAGONIST", "token": ["The putative alpha 1L-adrenoceptor antagonist JTH-601, but not the ", "alpha 1B-adrenoceptor", " antagonist ", "chloroethylclonidine", " (10 microM) antagonized noradrenaline-induced contractions of SMA."], "h": {"pos": [1, 2], "type": null, "name": "alpha 1B-adrenoceptor  antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "chloroethylclonidine  (10 microM) antagonized noradrenaline-induced contractions of SMA."}}
{"relation": "ANTAGONIST", "token": ["EP(1) and ", "EP(3) receptor", " antagonists ONO-8713 and ", "ONO-AE3-240", ", but not the EP(4) antagonists ONO-AE3-208 and AH 23848, inhibited tumor cell proliferation, indicating the significance of EP(1) and EP(3) but not EP(4) for MB growth."], "h": {"pos": [1, 2], "type": null, "name": "EP(3) receptor  antagonists ONO-8713 and "}, "t": {"pos": [3, 4], "type": null, "name": "ONO-AE3-240 , but not the EP(4) antagonists ONO-AE3-208 and AH 23848, inhibited tumor cell proliferation, indicating the significance of EP(1) and EP(3) but not EP(4) for MB growth."}}
{"relation": "ANTAGONIST", "token": ["", "[6]-Gingerol", " derived from Zingiber officinale Roscoe (ginger) was identified as a novel ", "angiotensin II type 1 receptor", " antagonist, with an IC50 value of 8.173 \u00b5M."], "h": {"pos": [1, 2], "type": null, "name": "[6]-Gingerol  derived from Zingiber officinale Roscoe (ginger) was identified as a novel "}, "t": {"pos": [3, 4], "type": null, "name": "angiotensin II type 1 receptor  antagonist, with an IC50 value of 8.173 \u00b5M."}}
{"relation": "ANTAGONIST", "token": ["In the rabbit pulmonary artery, rilmenidine and oxymetazoline are potent full agonists, whereas in the human atrial appendages they are antagonists at the ", "alpha(2)-autoreceptors", ", sharing this property with rauwolscine, ", "phentolamine", ", and idazoxan."], "h": {"pos": [1, 2], "type": null, "name": "alpha(2)-autoreceptors , sharing this property with rauwolscine, "}, "t": {"pos": [3, 4], "type": null, "name": "phentolamine , and idazoxan."}}
{"relation": "ANTAGONIST", "token": ["The potency of the selective alpha 1D-adrenoceptor antagonist BMY 7378 against noradrenaline (pA2 = 6.16 +/- 0.13) and of the selective ", "alpha 1A-adrenoceptor", " antagonist ", "RS-17053", " against noradrenaline (pKB = 8.35 +/- 0.10) and against the selective alpha 1A-adrenoceptor agonist A-61603 (pKB = 8.40 +/- 0.09) were too low to account for alpha 1D- and alpha 1A-adrenoceptor involvement."], "h": {"pos": [1, 2], "type": null, "name": "alpha 1A-adrenoceptor  antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "RS-17053  against noradrenaline (pKB = 8.35 +/- 0.10) and against the selective alpha 1A-adrenoceptor agonist A-61603 (pKB = 8.40 +/- 0.09) were too low to account for alpha 1D- and alpha 1A-adrenoceptor involvement."}}
{"relation": "ANTAGONIST", "token": ["Prazosin (nonselective alpha(1)-adrenoceptor antagonist), silodosin (selective alpha(1A)-adrenoceptor antagonist) and BMY-7378 (", "8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride", ") (selective ", "alpha(1D)-adrenoceptor", " antagonist) competitively antagonized the phenylephrine-induced contraction (pA(2) values, 8.60+/-0.07, 9.44+/-0.06 and 5.75+/-0.07, respectively)."], "h": {"pos": [1, 2], "type": null, "name": "8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride ) (selective "}, "t": {"pos": [3, 4], "type": null, "name": "alpha(1D)-adrenoceptor  antagonist) competitively antagonized the phenylephrine-induced contraction (pA(2) values, 8.60+/-0.07, 9.44+/-0.06 and 5.75+/-0.07, respectively)."}}
{"relation": "ANTAGONIST", "token": ["", "(+/-)-tamsulosin", ", an ", "alpha 1A-adrenoceptor", " antagonist, inhibits the positive inotropic effect but not the accumulation of inositol phosphates in rabbit heart."], "h": {"pos": [1, 2], "type": null, "name": "(+/-)-tamsulosin , an "}, "t": {"pos": [3, 4], "type": null, "name": "alpha 1A-adrenoceptor  antagonist, inhibits the positive inotropic effect but not the accumulation of inositol phosphates in rabbit heart."}}
{"relation": "ANTAGONIST", "token": ["Synthesis and in Vitro Characterisation of Ifenprodil-Based ", "Fluorescein", " Conjugates as GluN1/", "GluN2B", " N-Methyl-D-aspartate Receptor Antagonists."], "h": {"pos": [1, 2], "type": null, "name": "Fluorescein  Conjugates as GluN1/"}, "t": {"pos": [3, 4], "type": null, "name": "GluN2B  N-Methyl-D-aspartate Receptor Antagonists."}}
{"relation": "ANTAGONIST", "token": ["", "Ifenprodil", ", known as the ", "GluNR2B", " antagonist of reference, was chosen as the template for the elaboration of probes."], "h": {"pos": [1, 2], "type": null, "name": "Ifenprodil , known as the "}, "t": {"pos": [3, 4], "type": null, "name": "GluNR2B  antagonist of reference, was chosen as the template for the elaboration of probes."}}
{"relation": "ANTAGONIST", "token": ["Inhibition of binding of the ", "alpha2-receptor", " antagonist ", "[3H]RX821002", " to recombinant alpha2-receptors by etomidate was tested in human embryonic kidney (HEK293) cells in vitro."], "h": {"pos": [1, 2], "type": null, "name": "alpha2-receptor  antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "[3H]RX821002  to recombinant alpha2-receptors by etomidate was tested in human embryonic kidney (HEK293) cells in vitro."}}
{"relation": "ANTAGONIST", "token": ["These protective effects were abolished by glucocorticoid receptor (GR) antagonist RU486 or p-ERK inhibitor U0126 rather than ", "estrogen receptor \u03b1", " antagonist ", "ICI 82,780", "."], "h": {"pos": [1, 2], "type": null, "name": "estrogen receptor \u03b1  antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "ICI 82,780 ."}}
{"relation": "ANTAGONIST", "token": ["In contrast, intrathecal injection of a non-selective ", "NMDA", " antagonist, ", "memantine", ", significantly inhibited CCI-induced mechanical allodynia at a dose of 300 nmol, indicating the difference in the site of action between the non-selective NMDA antagonist and the NR2B-specific NMDA antagonist."], "h": {"pos": [1, 2], "type": null, "name": "NMDA  antagonist, "}, "t": {"pos": [3, 4], "type": null, "name": "memantine , significantly inhibited CCI-induced mechanical allodynia at a dose of 300 nmol, indicating the difference in the site of action between the non-selective NMDA antagonist and the NR2B-specific NMDA antagonist."}}
{"relation": "ANTAGONIST", "token": ["Eight normal males received single oral doses of BRL35135 8 mg (BRL) or the selective beta 2-adrenoceptor agonist salbutamol 8 mg (SAL), after pretreatment with either placebo (PL), ", "bisoprolol", " 5 mg (B5) as a selective ", "beta 1-adrenoceptor", " antagonist, or nadolol 20 mg (N20) to block beta 1- and beta 2- but not beta 3-receptors."], "h": {"pos": [1, 2], "type": null, "name": "bisoprolol  5 mg (B5) as a selective "}, "t": {"pos": [3, 4], "type": null, "name": "beta 1-adrenoceptor  antagonist, or nadolol 20 mg (N20) to block beta 1- and beta 2- but not beta 3-receptors."}}
{"relation": "ANTAGONIST", "token": ["A novel class of ", "quinoxalines", " has been discovered as antagonists of the IgG:", "FcRn", " protein-protein interaction through optimization of a hit derived from a virtual ligand-based screen."], "h": {"pos": [1, 2], "type": null, "name": "quinoxalines  has been discovered as antagonists of the IgG:"}, "t": {"pos": [3, 4], "type": null, "name": "FcRn  protein-protein interaction through optimization of a hit derived from a virtual ligand-based screen."}}
{"relation": "ANTAGONIST", "token": ["The selective GluR5 kainate receptor agonist ATPA induces spontaneous epileptiform bursting that is sensitive to the ", "GluR5", " kainate receptor antagonist ", "LY293558", "."], "h": {"pos": [1, 2], "type": null, "name": "GluR5  kainate receptor antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "LY293558 ."}}
{"relation": "ANTAGONIST", "token": ["The antagonistic property of ", "rilmenidine", " at ", "human alpha(2A)-adrenoceptors", " indicates that in contrast to the suggestion based on rabbit data, the hypotensive property of the drug in humans is not due to activation of alpha(2A)-adrenoceptors but other, presumably I(1)-imidazoline receptors, are probably involved."], "h": {"pos": [1, 2], "type": null, "name": "rilmenidine  at "}, "t": {"pos": [3, 4], "type": null, "name": "human alpha(2A)-adrenoceptors  indicates that in contrast to the suggestion based on rabbit data, the hypotensive property of the drug in humans is not due to activation of alpha(2A)-adrenoceptors but other, presumably I(1)-imidazoline receptors, are probably involved."}}
{"relation": "ANTAGONIST", "token": ["Selective antagonism of GluR5 ", "kainate-receptor", "-mediated synaptic currents by ", "topiramate", " in rat basolateral amygdala neurons."], "h": {"pos": [1, 2], "type": null, "name": "kainate-receptor -mediated synaptic currents by "}, "t": {"pos": [3, 4], "type": null, "name": "topiramate  in rat basolateral amygdala neurons."}}
{"relation": "ANTAGONIST", "token": ["(+)-Tamsulosin, ", "(-)-tamsulosin", ", SL 89,0591, Rec 15/2739, SNAP 1069 and RS 17053 appeared to act as competitive antagonists of noradrenaline-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned ", "human alpha 1D adrenoceptors", "."], "h": {"pos": [1, 2], "type": null, "name": "(-)-tamsulosin , SL 89,0591, Rec 15/2739, SNAP 1069 and RS 17053 appeared to act as competitive antagonists of noradrenaline-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned "}, "t": {"pos": [3, 4], "type": null, "name": "human alpha 1D adrenoceptors ."}}
{"relation": "ANTAGONIST", "token": ["EP(1) and EP(3) receptor antagonists ONO-8713 and ONO-AE3-240, but not the ", "EP(4)", " antagonists ", "ONO-AE3-208", " and AH 23848, inhibited tumor cell proliferation, indicating the significance of EP(1) and EP(3) but not EP(4) for MB growth."], "h": {"pos": [1, 2], "type": null, "name": "EP(4)  antagonists "}, "t": {"pos": [3, 4], "type": null, "name": "ONO-AE3-208  and AH 23848, inhibited tumor cell proliferation, indicating the significance of EP(1) and EP(3) but not EP(4) for MB growth."}}
{"relation": "ANTAGONIST", "token": ["The 5-HT(1/2/5/7)-receptor antagonist methysergide and the 5-HT(2A/2B/2C)-receptor antagonist LY 53857 enhanced clomipramine-induced hyperglycemia, while the ", "5-HT(1A/1B)-receptor", " antagonist ", "(-)-propranolol", " and the 5-HT(3/4)-receptor antagonist tropisetron did not affect it."], "h": {"pos": [1, 2], "type": null, "name": "5-HT(1A/1B)-receptor  antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "(-)-propranolol  and the 5-HT(3/4)-receptor antagonist tropisetron did not affect it."}}
{"relation": "ANTAGONIST", "token": ["Kynurenic acid (", "KA", ") is an endogenous ", "glutamate receptor", " antagonist at the level of the different ionotropic glutamate receptors."], "h": {"pos": [1, 2], "type": null, "name": "KA ) is an endogenous "}, "t": {"pos": [3, 4], "type": null, "name": "glutamate receptor  antagonist at the level of the different ionotropic glutamate receptors."}}
{"relation": "ANTAGONIST", "token": ["", "Pranlukast", ", a leukotriene receptor antagonist, inhibits interleukin-5 production via a mechanism distinct from ", "leukotriene receptor", " antagonism."], "h": {"pos": [1, 2], "type": null, "name": "Pranlukast , a leukotriene receptor antagonist, inhibits interleukin-5 production via a mechanism distinct from "}, "t": {"pos": [3, 4], "type": null, "name": "leukotriene receptor  antagonism."}}
{"relation": "ANTAGONIST", "token": ["Prazosin (nonselective alpha(1)-adrenoceptor antagonist), silodosin (selective alpha(1A)-adrenoceptor antagonist) and ", "BMY-7378", " (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride) (selective ", "alpha(1D)-adrenoceptor", " antagonist) competitively antagonized the phenylephrine-induced contraction (pA(2) values, 8.60+/-0.07, 9.44+/-0.06 and 5.75+/-0.07, respectively)."], "h": {"pos": [1, 2], "type": null, "name": "BMY-7378  (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride) (selective "}, "t": {"pos": [3, 4], "type": null, "name": "alpha(1D)-adrenoceptor  antagonist) competitively antagonized the phenylephrine-induced contraction (pA(2) values, 8.60+/-0.07, 9.44+/-0.06 and 5.75+/-0.07, respectively)."}}
{"relation": "ANTAGONIST", "token": ["Doses of dimethocaine (1.7 mg/kg) and cocaine (0.3 mg/kg) which produced full (> 80%) substitution for cocaine were administered in combination with the ", "dopamine D1 receptor", " antagonist ", "SCH 39166", " ((-)-trans-6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-N-methyl-5H -benzo [d]naphtho-(2,1-b)azepine) and the dopamine D2 receptor antagonist raclopride (both at 0.003-0.03 mg/kg)."], "h": {"pos": [1, 2], "type": null, "name": "dopamine D1 receptor  antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "SCH 39166  ((-)-trans-6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-N-methyl-5H -benzo [d]naphtho-(2,1-b)azepine) and the dopamine D2 receptor antagonist raclopride (both at 0.003-0.03 mg/kg)."}}
{"relation": "ANTAGONIST", "token": ["The ", "5-HT(2B/2C)-receptor", " antagonist ", "SB 206553", " facilitated hyperglycemia induced by clomipramine, although the 5-HT(2A)-receptor antagonist ketanserin was without effect."], "h": {"pos": [1, 2], "type": null, "name": "5-HT(2B/2C)-receptor  antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "SB 206553  facilitated hyperglycemia induced by clomipramine, although the 5-HT(2A)-receptor antagonist ketanserin was without effect."}}
{"relation": "ANTAGONIST", "token": ["The potent ", "histamine H(1)-receptor", " antagonist cetirizine (Zyrtec) is a racemic mixture of levocetirizine (now available under the trademark Xyzal and ", "dextrocetirizine", "."], "h": {"pos": [1, 2], "type": null, "name": "histamine H(1)-receptor  antagonist cetirizine (Zyrtec) is a racemic mixture of levocetirizine (now available under the trademark Xyzal and "}, "t": {"pos": [3, 4], "type": null, "name": "dextrocetirizine ."}}
{"relation": "ANTAGONIST", "token": ["Pretreatment of the tissues with combined ", "5-HT1", "/5-HT2 antagonists, ", "methysergide", " (1 microM) or methiothepin (0.1 microM), significantly attenuated the inhibitory effect of epinastine on the noncholinergic contraction."], "h": {"pos": [1, 2], "type": null, "name": "5-HT1 /5-HT2 antagonists, "}, "t": {"pos": [3, 4], "type": null, "name": "methysergide  (1 microM) or methiothepin (0.1 microM), significantly attenuated the inhibitory effect of epinastine on the noncholinergic contraction."}}
{"relation": "ANTAGONIST", "token": ["(+)-Tamsulosin, (-)-tamsulosin, SL 89,0591, Rec 15/2739, SNAP 1069 and ", "RS 17053", " appeared to act as competitive antagonists of noradrenaline-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned ", "human alpha 1D adrenoceptors", "."], "h": {"pos": [1, 2], "type": null, "name": "RS 17053  appeared to act as competitive antagonists of noradrenaline-mediated contractions of rat aorta yielding pA2 affinity estimates which were similar to binding affinities at cloned "}, "t": {"pos": [3, 4], "type": null, "name": "human alpha 1D adrenoceptors ."}}
{"relation": "ANTAGONIST", "token": ["Compared pharmacological characteristics in humans of racemic ", "cetirizine", " and levocetirizine, two ", "histamine H1-receptor", " antagonists."], "h": {"pos": [1, 2], "type": null, "name": "cetirizine  and levocetirizine, two "}, "t": {"pos": [3, 4], "type": null, "name": "histamine H1-receptor  antagonists."}}
{"relation": "ANTAGONIST", "token": ["Comparison of all the ", "beta-adrenoceptor", " antagonists tested revealed a potency order of propranolol>betaxolol approximately levobetaxolol>levobunolol approximately carteolol>/=timolol>", "atenolol", "."], "h": {"pos": [1, 2], "type": null, "name": "beta-adrenoceptor  antagonists tested revealed a potency order of propranolol>betaxolol approximately levobetaxolol>levobunolol approximately carteolol>/=timolol>"}, "t": {"pos": [3, 4], "type": null, "name": "atenolol ."}}
{"relation": "ANTAGONIST", "token": ["The involvement of EP1 and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and ", "AH 6809", " (", "EP1", " and EP2 specific)."], "h": {"pos": [1, 2], "type": null, "name": "AH 6809  ("}, "t": {"pos": [3, 4], "type": null, "name": "EP1  and EP2 specific)."}}
{"relation": "ANTAGONIST", "token": ["In membranes from HEK293 cells transfected with alpha2-receptors, etomidate inhibited binding of the alpha2-antagonist, ", "[3H]RX821002", ", with higher potency from alpha2B- and alpha2C-receptors than from ", "alpha2A-receptors", " (Ki alpha2A 208 microm, alpha2B 26 microm, alpha2C 56 microm)."], "h": {"pos": [1, 2], "type": null, "name": "[3H]RX821002 , with higher potency from alpha2B- and alpha2C-receptors than from "}, "t": {"pos": [3, 4], "type": null, "name": "alpha2A-receptors  (Ki alpha2A 208 microm, alpha2B 26 microm, alpha2C 56 microm)."}}
{"relation": "ANTAGONIST", "token": ["Inhibition of binding of the alpha2-receptor antagonist ", "[3H]RX821002", " to recombinant ", "alpha2-receptors", " by etomidate was tested in human embryonic kidney (HEK293) cells in vitro."], "h": {"pos": [1, 2], "type": null, "name": "[3H]RX821002  to recombinant "}, "t": {"pos": [3, 4], "type": null, "name": "alpha2-receptors  by etomidate was tested in human embryonic kidney (HEK293) cells in vitro."}}
{"relation": "ANTAGONIST", "token": ["The anticonvulsant ", "felbamate", " blocks N-methyl-D-asparate (NMDA) receptors but fails to exhibit the neurobehavioral toxicity characteristic of other ", "NMDA receptor", " antagonists."], "h": {"pos": [1, 2], "type": null, "name": "felbamate  blocks N-methyl-D-asparate (NMDA) receptors but fails to exhibit the neurobehavioral toxicity characteristic of other "}, "t": {"pos": [3, 4], "type": null, "name": "NMDA receptor  antagonists."}}
{"relation": "ANTAGONIST", "token": ["The potency of the antipsychotic drug, ", "risperidone", ", to antagonize ", "alpha 1A-adrenoceptor", "-mediated contraction in rat vas deferens and vasoconstriction in rat perfused kidney, and alpha 1B-adrenoceptor-mediated contractions in spleen from guinea-pig and mouse was evaluated and compared to that of alpha 1-adrenoceptor subtype-discriminating antagonists."], "h": {"pos": [1, 2], "type": null, "name": "risperidone , to antagonize "}, "t": {"pos": [3, 4], "type": null, "name": "alpha 1A-adrenoceptor -mediated contraction in rat vas deferens and vasoconstriction in rat perfused kidney, and alpha 1B-adrenoceptor-mediated contractions in spleen from guinea-pig and mouse was evaluated and compared to that of alpha 1-adrenoceptor subtype-discriminating antagonists."}}
{"relation": "ANTAGONIST", "token": ["", "Chlorpheniramine", " (10 microM), another ", "histamine H1 receptor", " antagonist without significant 5-HT receptor binding affinity, did not produce any inhibition of the eNANC contraction."], "h": {"pos": [1, 2], "type": null, "name": "Chlorpheniramine  (10 microM), another "}, "t": {"pos": [3, 4], "type": null, "name": "histamine H1 receptor  antagonist without significant 5-HT receptor binding affinity, did not produce any inhibition of the eNANC contraction."}}
{"relation": "ANTAGONIST", "token": ["Selective antagonism of ", "GluR5", " kainate-receptor-mediated synaptic currents by ", "topiramate", " in rat basolateral amygdala neurons."], "h": {"pos": [1, 2], "type": null, "name": "GluR5  kainate-receptor-mediated synaptic currents by "}, "t": {"pos": [3, 4], "type": null, "name": "topiramate  in rat basolateral amygdala neurons."}}
{"relation": "ANTAGONIST", "token": ["Derivatives of ", "5-(dipentylamino)-5-oxo-pentanoic acid", " are a new class of non-peptide ", "cholecystokinin", " (CCK) antagonists."], "h": {"pos": [1, 2], "type": null, "name": "5-(dipentylamino)-5-oxo-pentanoic acid  are a new class of non-peptide "}, "t": {"pos": [3, 4], "type": null, "name": "cholecystokinin  (CCK) antagonists."}}
{"relation": "ANTAGONIST", "token": ["The animals were divided into thirteen groups (n=4 each) receiving an i.v. bolus injection of, either physiological saline (0.3 ml/kg; control), or the antagonists SB224289 (300 microg/kg; 5-HT1B), ", "BRL15572", " (300 microg/kg; ", "5-HT1D", "), rauwolscine (300 microg/kg; alpha2), SB224289 + BRL15572 (300 microg/kg each), SB224289 + rauwolscine (300 microg/kg each), BRL15572 + rauwolscine (300 microg/kg each), rauwolscine (300 microg/kg) + prazosin (100 microg/kg; alpha1), SB224289 (300 microg/kg) + prazosin (100 microg/kg), SB224289 (300 microg/kg) + rauwolscine (300 microg/kg) + prazosin (100 microg/kg), SB224289 (300 microg/kg) + prazosin (100 microg/kg) + BRL44408 (1,000 microg/kg; alpha2A), SB224289 (300 microg/kg) + prazosin (100 microg/kg)+ imiloxan (1,000 microg/kg; alpha2B), or SB224289 (300 microg/kg) + prazosin (100 microg/kg) + MK912 (300 microg/kg; alpha2C)."], "h": {"pos": [1, 2], "type": null, "name": "BRL15572  (300 microg/kg; "}, "t": {"pos": [3, 4], "type": null, "name": "5-HT1D ), rauwolscine (300 microg/kg; alpha2), SB224289 + BRL15572 (300 microg/kg each), SB224289 + rauwolscine (300 microg/kg each), BRL15572 + rauwolscine (300 microg/kg each), rauwolscine (300 microg/kg) + prazosin (100 microg/kg; alpha1), SB224289 (300 microg/kg) + prazosin (100 microg/kg), SB224289 (300 microg/kg) + rauwolscine (300 microg/kg) + prazosin (100 microg/kg), SB224289 (300 microg/kg) + prazosin (100 microg/kg) + BRL44408 (1,000 microg/kg; alpha2A), SB224289 (300 microg/kg) + prazosin (100 microg/kg)+ imiloxan (1,000 microg/kg; alpha2B), or SB224289 (300 microg/kg) + prazosin (100 microg/kg) + MK912 (300 microg/kg; alpha2C)."}}
{"relation": "ANTAGONIST", "token": ["Differentiating the roles of mGlu2 and mGlu3 receptors using ", "LY541850", ", an mGlu2 agonist/", "mGlu3", " antagonist."], "h": {"pos": [1, 2], "type": null, "name": "LY541850 , an mGlu2 agonist/"}, "t": {"pos": [3, 4], "type": null, "name": "mGlu3  antagonist."}}
{"relation": "ANTAGONIST", "token": ["The chemistry, pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosages of the nonsedating ", "histamine H1-receptor", " antagonists terfenadine, astemizole, loratadine, and ", "acrivastine", " are reviewed."], "h": {"pos": [1, 2], "type": null, "name": "histamine H1-receptor  antagonists terfenadine, astemizole, loratadine, and "}, "t": {"pos": [3, 4], "type": null, "name": "acrivastine  are reviewed."}}
{"relation": "ANTAGONIST", "token": ["It is concluded that labetalol and ", "dilevalol", " are ", "beta 1-adrenoceptor", " selective antagonists."], "h": {"pos": [1, 2], "type": null, "name": "dilevalol  are "}, "t": {"pos": [3, 4], "type": null, "name": "beta 1-adrenoceptor  selective antagonists."}}
{"relation": "ANTAGONIST", "token": ["In further studies, the diuretic effects of the CB1 agonist AM4054 were similar in male and female rats, displayed a relatively rapid onset to action, and were dose-dependently antagonized by 30 minutes pretreatment with rimonabant, but not by the vanilloid receptor type I antagonist capsazepine, nor were the effects of WIN 55,212 antagonized by the ", "CB2", " antagonist AM630 ", " (6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl) methanone)", "]."], "h": {"pos": [1, 2], "type": null, "name": "CB2  antagonist AM630 "}, "t": {"pos": [3, 4], "type": null, "name": " (6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl) methanone) ]."}}
{"relation": "ANTAGONIST", "token": ["The 5-HT(1/2/5/7)-receptor antagonist methysergide and the ", "5-HT(2A/2B/2C)-receptor", " antagonist ", "LY 53857", " enhanced clomipramine-induced hyperglycemia, while the 5-HT(1A/1B)-receptor antagonist (-)-propranolol and the 5-HT(3/4)-receptor antagonist tropisetron did not affect it."], "h": {"pos": [1, 2], "type": null, "name": "5-HT(2A/2B/2C)-receptor  antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "LY 53857  enhanced clomipramine-induced hyperglycemia, while the 5-HT(1A/1B)-receptor antagonist (-)-propranolol and the 5-HT(3/4)-receptor antagonist tropisetron did not affect it."}}
{"relation": "ANTAGONIST", "token": ["The concomitant application of subconvulsive dose of pentetrazole (55.0 mg/kg) with low dose of ", "flumazenil", " (5.0 mg/kg) - a ", "BDZ receptor", " antagonist, immediately induced BDZ withdrawal signs in these animals."], "h": {"pos": [1, 2], "type": null, "name": "flumazenil  (5.0 mg/kg) - a "}, "t": {"pos": [3, 4], "type": null, "name": "BDZ receptor  antagonist, immediately induced BDZ withdrawal signs in these animals."}}
{"relation": "ANTAGONIST", "token": ["The 5-HT(2B/2C)-receptor antagonist SB 206553 facilitated hyperglycemia induced by clomipramine, although the ", "5-HT(2A)", "-receptor antagonist ", "ketanserin", " was without effect."], "h": {"pos": [1, 2], "type": null, "name": "5-HT(2A) -receptor antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "ketanserin  was without effect."}}
{"relation": "ANTAGONIST", "token": ["The putative ", "alpha 1L-adrenoceptor", " antagonist ", "JTH-601", ", but not the alpha 1B-adrenoceptor antagonist chloroethylclonidine (10 microM) antagonized noradrenaline-induced contractions of SMA."], "h": {"pos": [1, 2], "type": null, "name": "alpha 1L-adrenoceptor  antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "JTH-601 , but not the alpha 1B-adrenoceptor antagonist chloroethylclonidine (10 microM) antagonized noradrenaline-induced contractions of SMA."}}
{"relation": "ANTAGONIST", "token": ["In further studies, the diuretic effects of the CB1 agonist AM4054 were similar in male and female rats, displayed a relatively rapid onset to action, and were dose-dependently antagonized by 30 minutes pretreatment with rimonabant, but not by the vanilloid receptor type I antagonist capsazepine, nor were the effects of WIN 55,212 antagonized by the ", "CB2", " antagonist ", "AM630", " [(6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl) methanone)]."], "h": {"pos": [1, 2], "type": null, "name": "CB2  antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "AM630  [(6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl) methanone)]."}}
{"relation": "ANTAGONIST", "token": ["Brain but not spinal ", "NR2B", " receptor is responsible for the anti-allodynic effect of an NR2B subunit-selective antagonist ", "CP-101,606", " in a rat chronic constriction injury model."], "h": {"pos": [1, 2], "type": null, "name": "NR2B  receptor is responsible for the anti-allodynic effect of an NR2B subunit-selective antagonist "}, "t": {"pos": [3, 4], "type": null, "name": "CP-101,606  in a rat chronic constriction injury model."}}
{"relation": "ANTAGONIST", "token": ["", "Alprenolol", " and bromoacetylalprenololmenthane are competitive slowly reversible antagonists at the ", "beta 1-adrenoceptors", " of rat left atria."], "h": {"pos": [1, 2], "type": null, "name": "Alprenolol  and bromoacetylalprenololmenthane are competitive slowly reversible antagonists at the "}, "t": {"pos": [3, 4], "type": null, "name": "beta 1-adrenoceptors  of rat left atria."}}
{"relation": "AGONIST", "token": ["As far as we are aware, the compound's ", "1,3,5-triazine", " scaffold represents a new core structure for ", "CB2", " agonists."], "h": {"pos": [1, 2], "type": null, "name": "1,3,5-triazine  scaffold represents a new core structure for "}, "t": {"pos": [3, 4], "type": null, "name": "CB2  agonists."}}
{"relation": "AGONIST", "token": ["Antiarrhythmic effects of ", "(-)-epicatechin-3-gallate", ", a novel ", "sodium channel", " agonist in cultured neonatal rat ventricular myocytes."], "h": {"pos": [1, 2], "type": null, "name": "(-)-epicatechin-3-gallate , a novel "}, "t": {"pos": [3, 4], "type": null, "name": "sodium channel  agonist in cultured neonatal rat ventricular myocytes."}}
{"relation": "AGONIST", "token": ["", "Terbutaline", " (Bricanyl) and its prodrug Bambuterol (Bambec) are highly potent ", "beta(2)-adrenoceptor", " agonists often used in asthma patients."], "h": {"pos": [1, 2], "type": null, "name": "Terbutaline  (Bricanyl) and its prodrug Bambuterol (Bambec) are highly potent "}, "t": {"pos": [3, 4], "type": null, "name": "beta(2)-adrenoceptor  agonists often used in asthma patients."}}
{"relation": "AGONIST", "token": ["Dexamethasone (", "DEX", "), betamethasone (BM), and their esterified-derivatives had full transrepression agonistic activity in a reporter assay using CV-1 cells transfected with either ", "human or rat GR", "."], "h": {"pos": [1, 2], "type": null, "name": "DEX ), betamethasone (BM), and their esterified-derivatives had full transrepression agonistic activity in a reporter assay using CV-1 cells transfected with either "}, "t": {"pos": [3, 4], "type": null, "name": "human or rat GR ."}}
{"relation": "AGONIST", "token": ["Pre-clinical pharmacology of ", "zolmitriptan", " (Zomig; formerly 311C90), a centrally and peripherally acting ", "5HT1B/1D", " agonist for migraine."], "h": {"pos": [1, 2], "type": null, "name": "zolmitriptan  (Zomig; formerly 311C90), a centrally and peripherally acting "}, "t": {"pos": [3, 4], "type": null, "name": "5HT1B/1D  agonist for migraine."}}
{"relation": "AGONIST", "token": ["Direct-acting ", "CB1", " agonists, including \u0394(9)-tetrahydrocannabinol, WIN 55,212 [R-(1)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate], AM2389 [9\u03b2-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol], and ", "AM4054", " [9\u03b2-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol], produced dose-dependent increases in diuresis and decreases in colonic temperature, with slightly lower ED(50) values for diuresis than for hypothermia."], "h": {"pos": [1, 2], "type": null, "name": "CB1  agonists, including \u0394(9)-tetrahydrocannabinol, WIN 55,212 [R-(1)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate], AM2389 [9\u03b2-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol], and "}, "t": {"pos": [3, 4], "type": null, "name": "AM4054  [9\u03b2-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol], produced dose-dependent increases in diuresis and decreases in colonic temperature, with slightly lower ED(50) values for diuresis than for hypothermia."}}
{"relation": "AGONIST", "token": ["While there is considerable indirect evidence to implicate ", "histamine", " in the pathogenesis of asthma, a critical evaluation of H1-receptor antagonism in this condition has, until recently, proved difficult, as many of the early ", "H1-receptor", " antagonists possessed additional actions, such as anti-cholinergic, local anaesthetic, alpha-adrenoceptor antagonistic and anti-serotonin activity."], "h": {"pos": [1, 2], "type": null, "name": "histamine  in the pathogenesis of asthma, a critical evaluation of H1-receptor antagonism in this condition has, until recently, proved difficult, as many of the early "}, "t": {"pos": [3, 4], "type": null, "name": "H1-receptor  antagonists possessed additional actions, such as anti-cholinergic, local anaesthetic, alpha-adrenoceptor antagonistic and anti-serotonin activity."}}
{"relation": "AGONIST", "token": ["The use of ", "A3 receptor", " agonist ", "IB-MECA", " attenuates EAP."], "h": {"pos": [1, 2], "type": null, "name": "A3 receptor  agonist "}, "t": {"pos": [3, 4], "type": null, "name": "IB-MECA  attenuates EAP."}}
{"relation": "AGONIST", "token": ["The experiments were performed on 80 male Wistar rats, 58 of which survived, subdivided into 3 groups: C-control rats, I-EAP group, and II-EAP group treated with the ", "adenosine A3 receptor", " agonist IB-MECA ", "(1-deoxy-1-6[[(3-iodophenyl) methyl]amino]-9H-purin-9-yl)-N-methyl-B-D-ribofuronamide", " at a dose of 0.75\u00a0mg/kg b.w."], "h": {"pos": [1, 2], "type": null, "name": "adenosine A3 receptor  agonist IB-MECA "}, "t": {"pos": [3, 4], "type": null, "name": "(1-deoxy-1-6[[(3-iodophenyl) methyl]amino]-9H-purin-9-yl)-N-methyl-B-D-ribofuronamide  at a dose of 0.75\u00a0mg/kg b.w."}}
{"relation": "AGONIST", "token": ["Endothelium-dependent relaxations, nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF)-type, were studied in rabbit iliac artery and aortic rings using the ", "G protein-coupled receptor", " agonist ", "acetylcholine", " (ACh) and by cyclopiazonic acid (CPA), which promotes store-operated Ca(2+) entry by inhibiting the endothelial SERCA pump."], "h": {"pos": [1, 2], "type": null, "name": "G protein-coupled receptor  agonist "}, "t": {"pos": [3, 4], "type": null, "name": "acetylcholine  (ACh) and by cyclopiazonic acid (CPA), which promotes store-operated Ca(2+) entry by inhibiting the endothelial SERCA pump."}}
{"relation": "AGONIST", "token": ["Together, this pharmacological profile of subtype-selective betaAR antagonists indicates that in this model, ", "beta1AR", " activation is responsible for the enhanced hippocampal CA3 network activity initiated by ", "isoproterenol", "."], "h": {"pos": [1, 2], "type": null, "name": "beta1AR  activation is responsible for the enhanced hippocampal CA3 network activity initiated by "}, "t": {"pos": [3, 4], "type": null, "name": "isoproterenol ."}}
{"relation": "AGONIST", "token": ["", "Agmatine", ", locally synthesized, is an endogenous agonist at ", "imidazoline receptors", ", a noncatecholamine ligand at alpha 2-adrenergic receptors and may act as a neurotransmitter."], "h": {"pos": [1, 2], "type": null, "name": "Agmatine , locally synthesized, is an endogenous agonist at "}, "t": {"pos": [3, 4], "type": null, "name": "imidazoline receptors , a noncatecholamine ligand at alpha 2-adrenergic receptors and may act as a neurotransmitter."}}
{"relation": "AGONIST", "token": ["Effect of (S)-N-[2-(1,6,7,8-tetrahydro-2H-indeno-[5,4-b]furan-8-yl)ethyl]propionamide (", "ramelteon", ", TAK-375), a selective ", "MT1/MT2 receptor", " agonist, on motor coordination was studied using rota-rod performance in mice."], "h": {"pos": [1, 2], "type": null, "name": "ramelteon , TAK-375), a selective "}, "t": {"pos": [3, 4], "type": null, "name": "MT1/MT2 receptor  agonist, on motor coordination was studied using rota-rod performance in mice."}}
{"relation": "AGONIST", "token": ["OBJECTIVES: The aim of this study was to determine whether cocaine's sympathomimetic actions can be reversed by a potent centrally acting ", "alpha2 adrenergic receptor", " (AR) agonist (", "dexmedetomidine", ")."], "h": {"pos": [1, 2], "type": null, "name": "alpha2 adrenergic receptor  (AR) agonist ("}, "t": {"pos": [3, 4], "type": null, "name": "dexmedetomidine )."}}
{"relation": "AGONIST", "token": ["The ", "A2A adenosine receptor", " agonist CGS21680 (", "C23H29N7O6.HCl.xH2O", ") (0.001-0.1 \u03bcM) did not alter NE oxidation currents."], "h": {"pos": [1, 2], "type": null, "name": "A2A adenosine receptor  agonist CGS21680 ("}, "t": {"pos": [3, 4], "type": null, "name": "C23H29N7O6.HCl.xH2O ) (0.001-0.1 \u03bcM) did not alter NE oxidation currents."}}
{"relation": "AGONIST", "token": ["Differentiating the roles of mGlu2 and mGlu3 receptors using ", "LY541850", ", an ", "mGlu2", " agonist/mGlu3 antagonist."], "h": {"pos": [1, 2], "type": null, "name": "LY541850 , an "}, "t": {"pos": [3, 4], "type": null, "name": "mGlu2  agonist/mGlu3 antagonist."}}
{"relation": "AGONIST", "token": ["The aim of the present study was to evaluate the cardiac effects of the ", "beta 3-adrenoceptor", " agonist ", "BRL35135", ", and determine whether beta 3-receptors are involved in mediating chronotropic or inotropic responses in man."], "h": {"pos": [1, 2], "type": null, "name": "beta 3-adrenoceptor  agonist "}, "t": {"pos": [3, 4], "type": null, "name": "BRL35135 , and determine whether beta 3-receptors are involved in mediating chronotropic or inotropic responses in man."}}
{"relation": "AGONIST", "token": ["", "H1-receptor", " antagonists have been utilized, following their initial chemical synthesis in 1933, both in the treatment of conditions in which ", "histamine", " is considered to be of pathogenic importance and conversely to help elucidate the role of histamine in disease, through an evaluation of their influence on disease expression."], "h": {"pos": [1, 2], "type": null, "name": "H1-receptor  antagonists have been utilized, following their initial chemical synthesis in 1933, both in the treatment of conditions in which "}, "t": {"pos": [3, 4], "type": null, "name": "histamine  is considered to be of pathogenic importance and conversely to help elucidate the role of histamine in disease, through an evaluation of their influence on disease expression."}}
{"relation": "AGONIST", "token": ["", "Ramelteon", " (Rozerem; Takeda Pharmaceutical Company Limited, Osaka, Japan) is an orally active, highly selective melatonin ", "MT(1)", "/MT(2) receptor agonist."], "h": {"pos": [1, 2], "type": null, "name": "Ramelteon  (Rozerem; Takeda Pharmaceutical Company Limited, Osaka, Japan) is an orally active, highly selective melatonin "}, "t": {"pos": [3, 4], "type": null, "name": "MT(1) /MT(2) receptor agonist."}}
{"relation": "AGONIST", "token": ["Effect of (S)-N-[2-(1,6,7,8-tetrahydro-2H-indeno-[5,4-b]furan-8-yl)ethyl]propionamide (ramelteon, ", "TAK-375", "), a selective ", "MT1/MT2 receptor", " agonist, on motor coordination was studied using rota-rod performance in mice."], "h": {"pos": [1, 2], "type": null, "name": "TAK-375 ), a selective "}, "t": {"pos": [3, 4], "type": null, "name": "MT1/MT2 receptor  agonist, on motor coordination was studied using rota-rod performance in mice."}}
{"relation": "AGONIST", "token": ["Pharmacology of ", "ramelteon", ", a selective ", "MT1", "/MT2 receptor agonist: a novel therapeutic drug for sleep disorders."], "h": {"pos": [1, 2], "type": null, "name": "ramelteon , a selective "}, "t": {"pos": [3, 4], "type": null, "name": "MT1 /MT2 receptor agonist: a novel therapeutic drug for sleep disorders."}}
{"relation": "AGONIST", "token": ["Two beta(2)-agonists, formoterol and ", "salmeterol", ", are approved for treating asthma and have an extended duration of action and increased safety, associated with greater ", "beta(2)-adrenoceptor", " selectivity."], "h": {"pos": [1, 2], "type": null, "name": "salmeterol , are approved for treating asthma and have an extended duration of action and increased safety, associated with greater "}, "t": {"pos": [3, 4], "type": null, "name": "beta(2)-adrenoceptor  selectivity."}}
{"relation": "AGONIST", "token": ["The selective ", "betaAR", " agonist ", "isoproterenol", " caused an enhancement of hippocampal CA3 network activity, as measured by an increase in frequency of spontaneous burst discharges recorded in the CA3 region."], "h": {"pos": [1, 2], "type": null, "name": "betaAR  agonist "}, "t": {"pos": [3, 4], "type": null, "name": "isoproterenol  caused an enhancement of hippocampal CA3 network activity, as measured by an increase in frequency of spontaneous burst discharges recorded in the CA3 region."}}
{"relation": "AGONIST", "token": ["Sepracor in the US is developing arformoterol [R,R-formoterol], a single isomer form of the ", "beta(2)-adrenoceptor", " agonist ", "formoterol", " [eformoterol]."], "h": {"pos": [1, 2], "type": null, "name": "beta(2)-adrenoceptor  agonist "}, "t": {"pos": [3, 4], "type": null, "name": "formoterol  [eformoterol]."}}
{"relation": "AGONIST", "token": ["", "Zolmitriptan", " (Zomig; formerly 311C90) is a novel ", "5-hydroxytryptamine (5HT)1B/1D", " receptor agonist with proven efficacy in the acute treatment of migraine with or without preceding aura."], "h": {"pos": [1, 2], "type": null, "name": "Zolmitriptan  (Zomig; formerly 311C90) is a novel "}, "t": {"pos": [3, 4], "type": null, "name": "5-hydroxytryptamine (5HT)1B/1D  receptor agonist with proven efficacy in the acute treatment of migraine with or without preceding aura."}}
{"relation": "AGONIST", "token": ["OBJECTIVE: Preclinical evaluation of ", "DRF 2655", ", a peroxisome proliferator-activated receptor alpha (", "PPARalpha", ") and PPARgamma agonist, as a body-weight lowering, hypolipidemic and euglycemic agent."], "h": {"pos": [1, 2], "type": null, "name": "DRF 2655 , a peroxisome proliferator-activated receptor alpha ("}, "t": {"pos": [3, 4], "type": null, "name": "PPARalpha ) and PPARgamma agonist, as a body-weight lowering, hypolipidemic and euglycemic agent."}}
{"relation": "AGONIST", "token": ["Thus, ", "amitriptyline", " acts as a TrkA and ", "TrkB", " agonist and possesses marked neurotrophic activity."], "h": {"pos": [1, 2], "type": null, "name": "amitriptyline  acts as a TrkA and "}, "t": {"pos": [3, 4], "type": null, "name": "TrkB  agonist and possesses marked neurotrophic activity."}}
{"relation": "AGONIST", "token": ["These results confirm the selective ", "mGlu2", " agonist and mGlu3 antagonist actions of ", "LY541850", "."], "h": {"pos": [1, 2], "type": null, "name": "mGlu2  agonist and mGlu3 antagonist actions of "}, "t": {"pos": [3, 4], "type": null, "name": "LY541850 ."}}
{"relation": "AGONIST", "token": ["", "Dexamethasone", " (DEX), betamethasone (BM), and their esterified-derivatives had full transrepression agonistic activity in a reporter assay using CV-1 cells transfected with either ", "human or rat GR", "."], "h": {"pos": [1, 2], "type": null, "name": "Dexamethasone  (DEX), betamethasone (BM), and their esterified-derivatives had full transrepression agonistic activity in a reporter assay using CV-1 cells transfected with either "}, "t": {"pos": [3, 4], "type": null, "name": "human or rat GR ."}}
{"relation": "AGONIST", "token": ["The involvement of ", "EP1", " and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and ", "AH 6809", " (EP1 and EP2 specific)."], "h": {"pos": [1, 2], "type": null, "name": "EP1  and EP2 receptors is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and "}, "t": {"pos": [3, 4], "type": null, "name": "AH 6809  (EP1 and EP2 specific)."}}
{"relation": "AGONIST", "token": ["METHODS: Part A compared the effects of placebo to four doses of a ", "5-HT(4)", " receptor antagonist (SB-207266) on the ", "cisapride", " mediated increase in plasma aldosterone (a 5-HT(4) mediated response) and orocaecal transit in 18 subjects."], "h": {"pos": [1, 2], "type": null, "name": "5-HT(4)  receptor antagonist (SB-207266) on the "}, "t": {"pos": [3, 4], "type": null, "name": "cisapride  mediated increase in plasma aldosterone (a 5-HT(4) mediated response) and orocaecal transit in 18 subjects."}}
{"relation": "AGONIST", "token": ["The involvement of EP1 and ", "EP2 receptors", " is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and ", "AH 6809", " (EP1 and EP2 specific)."], "h": {"pos": [1, 2], "type": null, "name": "EP2 receptors  is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and "}, "t": {"pos": [3, 4], "type": null, "name": "AH 6809  (EP1 and EP2 specific)."}}
{"relation": "AGONIST", "token": ["OBJECTIVES: The aim of this study was to determine whether cocaine's sympathomimetic actions can be reversed by a potent centrally acting alpha2 adrenergic receptor (", "AR", ") agonist (", "dexmedetomidine", ")."], "h": {"pos": [1, 2], "type": null, "name": "AR ) agonist ("}, "t": {"pos": [3, 4], "type": null, "name": "dexmedetomidine )."}}
{"relation": "AGONIST", "token": ["Terbutaline (", "Bricanyl", ") and its prodrug Bambuterol (Bambec) are highly potent ", "beta(2)-adrenoceptor", " agonists often used in asthma patients."], "h": {"pos": [1, 2], "type": null, "name": "Bricanyl ) and its prodrug Bambuterol (Bambec) are highly potent "}, "t": {"pos": [3, 4], "type": null, "name": "beta(2)-adrenoceptor  agonists often used in asthma patients."}}
{"relation": "AGONIST", "token": ["In contrast, the ", "D-1997", "-induced responses were potently and concentration-dependently antagonized by the mixed ", "5-HT1-like", " and 5-HT2 receptor antagonist methiothepin (0.01-1 microM)."], "h": {"pos": [1, 2], "type": null, "name": "D-1997 -induced responses were potently and concentration-dependently antagonized by the mixed "}, "t": {"pos": [3, 4], "type": null, "name": "5-HT1-like  and 5-HT2 receptor antagonist methiothepin (0.01-1 microM)."}}
{"relation": "AGONIST", "token": ["After extensive washout (3 h, 37 degrees C), isometric contractions were measured to the full ", "muscarinic receptor", " agonist ", "methacholine", ", the partial muscarinic receptor agonist 4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium (McN-A-343) and histamine."], "h": {"pos": [1, 2], "type": null, "name": "muscarinic receptor  agonist "}, "t": {"pos": [3, 4], "type": null, "name": "methacholine , the partial muscarinic receptor agonist 4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium (McN-A-343) and histamine."}}
{"relation": "AGONIST", "token": ["Effect of ", "(S)-N-[2-(1,6,7,8-tetrahydro-2H-indeno-[5,4-b]furan-8-yl)ethyl]propionamide", " (ramelteon, TAK-375), a selective ", "MT1/MT2 receptor", " agonist, on motor coordination was studied using rota-rod performance in mice."], "h": {"pos": [1, 2], "type": null, "name": "(S)-N-[2-(1,6,7,8-tetrahydro-2H-indeno-[5,4-b]furan-8-yl)ethyl]propionamide  (ramelteon, TAK-375), a selective "}, "t": {"pos": [3, 4], "type": null, "name": "MT1/MT2 receptor  agonist, on motor coordination was studied using rota-rod performance in mice."}}
{"relation": "AGONIST", "token": ["After extensive washout (3 h, 37 degrees C), isometric contractions were measured to the full muscarinic receptor agonist methacholine, the partial ", "muscarinic receptor", " agonist 4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium (McN-A-343) and ", "histamine", "."], "h": {"pos": [1, 2], "type": null, "name": "muscarinic receptor  agonist 4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium (McN-A-343) and "}, "t": {"pos": [3, 4], "type": null, "name": "histamine ."}}
{"relation": "AGONIST", "token": ["", "H1-receptor", " antagonists have been utilized, following their initial chemical synthesis in 1933, both in the treatment of conditions in which histamine is considered to be of pathogenic importance and conversely to help elucidate the role of ", "histamine", " in disease, through an evaluation of their influence on disease expression."], "h": {"pos": [1, 2], "type": null, "name": "H1-receptor  antagonists have been utilized, following their initial chemical synthesis in 1933, both in the treatment of conditions in which histamine is considered to be of pathogenic importance and conversely to help elucidate the role of "}, "t": {"pos": [3, 4], "type": null, "name": "histamine  in disease, through an evaluation of their influence on disease expression."}}
{"relation": "AGONIST", "token": ["Methanandamide (10.0 mg/kg) had lesser effect than other CB agonists, and the ", "CB2", " agonist ", "AM1241", " [1-(methylpiperidin-2-ylmethyl)-3-(2-iodo-5-nitrobenzoyl)indole], the anandamide transport inhibitor AM404, and the CB antagonist rimonabant did not have diuretic effects."], "h": {"pos": [1, 2], "type": null, "name": "CB2  agonist "}, "t": {"pos": [3, 4], "type": null, "name": "AM1241  [1-(methylpiperidin-2-ylmethyl)-3-(2-iodo-5-nitrobenzoyl)indole], the anandamide transport inhibitor AM404, and the CB antagonist rimonabant did not have diuretic effects."}}
{"relation": "AGONIST", "token": ["Pre-clinical pharmacology of zolmitriptan (Zomig; formerly ", "311C90", "), a centrally and peripherally acting ", "5HT1B/1D", " agonist for migraine."], "h": {"pos": [1, 2], "type": null, "name": "311C90 ), a centrally and peripherally acting "}, "t": {"pos": [3, 4], "type": null, "name": "5HT1B/1D  agonist for migraine."}}
{"relation": "AGONIST", "token": ["Direct-acting ", "CB1", " agonists, including \u0394(9)-tetrahydrocannabinol, WIN 55,212 ", " R-(1)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate", "], AM2389 [9\u03b2-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol], and AM4054 [9\u03b2-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol], produced dose-dependent increases in diuresis and decreases in colonic temperature, with slightly lower ED(50) values for diuresis than for hypothermia."], "h": {"pos": [1, 2], "type": null, "name": "CB1  agonists, including \u0394(9)-tetrahydrocannabinol, WIN 55,212 "}, "t": {"pos": [3, 4], "type": null, "name": " R-(1)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate ], AM2389 [9\u03b2-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol], and AM4054 [9\u03b2-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol], produced dose-dependent increases in diuresis and decreases in colonic temperature, with slightly lower ED(50) values for diuresis than for hypothermia."}}
{"relation": "AGONIST", "token": ["Thus, ", "amitriptyline", " acts as a ", "TrkA", " and TrkB agonist and possesses marked neurotrophic activity."], "h": {"pos": [1, 2], "type": null, "name": "amitriptyline  acts as a "}, "t": {"pos": [3, 4], "type": null, "name": "TrkA  and TrkB agonist and possesses marked neurotrophic activity."}}
{"relation": "AGONIST", "token": ["The identification of the succinate receptor ", "SUCNR1", " in platelets is of particular interest, because physiologically relevant concentrations of ", "succinate", " were shown to potentiate the effect of low doses of a variety of platelet agonists."], "h": {"pos": [1, 2], "type": null, "name": "SUCNR1  in platelets is of particular interest, because physiologically relevant concentrations of "}, "t": {"pos": [3, 4], "type": null, "name": "succinate  were shown to potentiate the effect of low doses of a variety of platelet agonists."}}
{"relation": "AGONIST", "token": ["METHODS: Sedative and cardiovascular responses to etomidate and the alpha2-agonist, ", "dexmedetomidine", ", were determined in mice deficient in ", "alpha2-receptor", " subtypes."], "h": {"pos": [1, 2], "type": null, "name": "dexmedetomidine , were determined in mice deficient in "}, "t": {"pos": [3, 4], "type": null, "name": "alpha2-receptor  subtypes."}}
{"relation": "AGONIST", "token": ["Unlike the sedative hypnotics that target GABA(A) receptor complexes, ", "ramelteon", " is a chronohypnotic that acts on the melatonin MT(1) and ", "MT(2)", " receptors, which are primarily located in the suprachiasmatic nucleus, the body's \"master clock.\" As such, ramelteon possesses the first new therapeutic mechanism of action for a prescription insomnia medication in over three decades."], "h": {"pos": [1, 2], "type": null, "name": "ramelteon  is a chronohypnotic that acts on the melatonin MT(1) and "}, "t": {"pos": [3, 4], "type": null, "name": "MT(2)  receptors, which are primarily located in the suprachiasmatic nucleus, the body's \"master clock.\" As such, ramelteon possesses the first new therapeutic mechanism of action for a prescription insomnia medication in over three decades."}}
{"relation": "AGONIST", "token": ["Zolmitriptan (Zomig; formerly ", "311C90", ") is a novel ", "5-hydroxytryptamine (5HT)1B/1D", " receptor agonist with proven efficacy in the acute treatment of migraine with or without preceding aura."], "h": {"pos": [1, 2], "type": null, "name": "311C90 ) is a novel "}, "t": {"pos": [3, 4], "type": null, "name": "5-hydroxytryptamine (5HT)1B/1D  receptor agonist with proven efficacy in the acute treatment of migraine with or without preceding aura."}}
{"relation": "AGONIST", "token": ["", "2-(2-Aminoethyl)-quinoline", " (D-1997): a novel agonist at ", "5-hydroxytryptamine1-like receptors", " in the canine basilar artery."], "h": {"pos": [1, 2], "type": null, "name": "2-(2-Aminoethyl)-quinoline  (D-1997): a novel agonist at "}, "t": {"pos": [3, 4], "type": null, "name": "5-hydroxytryptamine1-like receptors  in the canine basilar artery."}}
{"relation": "AGONIST", "token": ["Direct-acting ", "CB1", " agonists, including ", "\u0394(9)-tetrahydrocannabinol", ", WIN 55,212 [R-(1)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate], AM2389 [9\u03b2-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol], and AM4054 [9\u03b2-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol], produced dose-dependent increases in diuresis and decreases in colonic temperature, with slightly lower ED(50) values for diuresis than for hypothermia."], "h": {"pos": [1, 2], "type": null, "name": "CB1  agonists, including "}, "t": {"pos": [3, 4], "type": null, "name": "\u0394(9)-tetrahydrocannabinol , WIN 55,212 [R-(1)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate], AM2389 [9\u03b2-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol], and AM4054 [9\u03b2-(hydroxymethyl)-3-(1-adamantyl)-hexahydrocannabinol], produced dose-dependent increases in diuresis and decreases in colonic temperature, with slightly lower ED(50) values for diuresis than for hypothermia."}}
{"relation": "AGONIST", "token": ["Methanandamide (10.0 mg/kg) had lesser effect than other CB agonists, and the ", "CB2", " agonist AM1241 ", " 1-(methylpiperidin-2-ylmethyl)-3-(2-iodo-5-nitrobenzoyl)indole", "], the anandamide transport inhibitor AM404, and the CB antagonist rimonabant did not have diuretic effects."], "h": {"pos": [1, 2], "type": null, "name": "CB2  agonist AM1241 "}, "t": {"pos": [3, 4], "type": null, "name": " 1-(methylpiperidin-2-ylmethyl)-3-(2-iodo-5-nitrobenzoyl)indole ], the anandamide transport inhibitor AM404, and the CB antagonist rimonabant did not have diuretic effects."}}
{"relation": "AGONIST", "token": ["Eight normal males received single oral doses of BRL35135 8 mg (BRL) or the selective ", "beta 2-adrenoceptor", " agonist ", "salbutamol", " 8 mg (SAL), after pretreatment with either placebo (PL), bisoprolol 5 mg (B5) as a selective beta 1-adrenoceptor antagonist, or nadolol 20 mg (N20) to block beta 1- and beta 2- but not beta 3-receptors."], "h": {"pos": [1, 2], "type": null, "name": "beta 2-adrenoceptor  agonist "}, "t": {"pos": [3, 4], "type": null, "name": "salbutamol  8 mg (SAL), after pretreatment with either placebo (PL), bisoprolol 5 mg (B5) as a selective beta 1-adrenoceptor antagonist, or nadolol 20 mg (N20) to block beta 1- and beta 2- but not beta 3-receptors."}}
{"relation": "AGONIST", "token": ["The involvement of EP1 and EP2 receptors is indicated by studies with the ", "EP1", " selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists ", "SC-51089", " (EP1 specific) and AH 6809 (EP1 and EP2 specific)."], "h": {"pos": [1, 2], "type": null, "name": "EP1  selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists "}, "t": {"pos": [3, 4], "type": null, "name": "SC-51089  (EP1 specific) and AH 6809 (EP1 and EP2 specific)."}}
{"relation": "AGONIST", "token": ["Brexpiprazole reversed the inhibitory effect of the DA agonist ", "apomorphine", " on VTA DA neurons (ED50 = 61 mug/kg), whereas it was ineffective when administered alone, indicating partial agonistic action on ", "D2 receptors", "."], "h": {"pos": [1, 2], "type": null, "name": "apomorphine  on VTA DA neurons (ED50 = 61 mug/kg), whereas it was ineffective when administered alone, indicating partial agonistic action on "}, "t": {"pos": [3, 4], "type": null, "name": "D2 receptors ."}}
{"relation": "AGONIST", "token": ["Pre-clinical pharmacology of zolmitriptan (", "Zomig", "; formerly 311C90), a centrally and peripherally acting ", "5HT1B/1D", " agonist for migraine."], "h": {"pos": [1, 2], "type": null, "name": "Zomig ; formerly 311C90), a centrally and peripherally acting "}, "t": {"pos": [3, 4], "type": null, "name": "5HT1B/1D  agonist for migraine."}}
{"relation": "AGONIST", "token": ["Although generally highly specific for angiotensin II type 1 receptors, some ARBs, particularly ", "telmisartan", ", are partial agonists at ", "peroxisome proliferator-activated receptor-\u03b3", "."], "h": {"pos": [1, 2], "type": null, "name": "telmisartan , are partial agonists at "}, "t": {"pos": [3, 4], "type": null, "name": "peroxisome proliferator-activated receptor-\u03b3 ."}}
{"relation": "AGONIST", "token": ["Noradrenaline and ", "phenylephrine", " (", "alpha(1)-adrenoceptor", " agonist) each produced a concentration-dependent tonic contraction, their pD(2) values being 6.87+/-0.08 and 6.10+/-0.05, respectively."], "h": {"pos": [1, 2], "type": null, "name": "phenylephrine  ("}, "t": {"pos": [3, 4], "type": null, "name": "alpha(1)-adrenoceptor  agonist) each produced a concentration-dependent tonic contraction, their pD(2) values being 6.87+/-0.08 and 6.10+/-0.05, respectively."}}
{"relation": "AGONIST", "token": ["These results indicate that the positive inotropic effect, mediated via (+/-)-tamsulosin- and ", "oxymetazoline", "-sensitive subtype of ", "alpha 1-adrenoceptors", ", is exerted by a subcellular mechanism that is independent of the accumulation of inositol phosphates."], "h": {"pos": [1, 2], "type": null, "name": "oxymetazoline -sensitive subtype of "}, "t": {"pos": [3, 4], "type": null, "name": "alpha 1-adrenoceptors , is exerted by a subcellular mechanism that is independent of the accumulation of inositol phosphates."}}
{"relation": "AGONIST", "token": ["Dexamethasone (DEX), ", "betamethasone", " (BM), and their esterified-derivatives had full transrepression agonistic activity in a reporter assay using CV-1 cells transfected with either ", "human or rat GR", "."], "h": {"pos": [1, 2], "type": null, "name": "betamethasone  (BM), and their esterified-derivatives had full transrepression agonistic activity in a reporter assay using CV-1 cells transfected with either "}, "t": {"pos": [3, 4], "type": null, "name": "human or rat GR ."}}
{"relation": "AGONIST", "token": ["One of the ", "CB2", " agonists, ", "N-cyclopentyl-4-ethoxy-6-(4-methylpiperidin-1-yl)-1,3,5-triazin-2-amine", " (19, -logEC(50)=7.5, E(max)=255%) was selected for further development."], "h": {"pos": [1, 2], "type": null, "name": "CB2  agonists, "}, "t": {"pos": [3, 4], "type": null, "name": "N-cyclopentyl-4-ethoxy-6-(4-methylpiperidin-1-yl)-1,3,5-triazin-2-amine  (19, -logEC(50)=7.5, E(max)=255%) was selected for further development."}}
{"relation": "AGONIST", "token": ["At 10(-6)M in transcription assays, none of these compounds showed progestin agonist activity, whereas ", "mifepristone", " and its monodemethylated metabolite manifested slight ", "glucocorticoid", " agonist activity."], "h": {"pos": [1, 2], "type": null, "name": "mifepristone  and its monodemethylated metabolite manifested slight "}, "t": {"pos": [3, 4], "type": null, "name": "glucocorticoid  agonist activity."}}
{"relation": "AGONIST", "token": ["The sympathetic nerves of both the human atrial appendages and rabbit pulmonary artery are endowed with ", "alpha(2A)-autoreceptors", ", at which, however, both rilmenidine and ", "oxymetazoline", " exhibit different properties (antagonism and agonism, respectively)."], "h": {"pos": [1, 2], "type": null, "name": "alpha(2A)-autoreceptors , at which, however, both rilmenidine and "}, "t": {"pos": [3, 4], "type": null, "name": "oxymetazoline  exhibit different properties (antagonism and agonism, respectively)."}}
{"relation": "AGONIST", "token": ["The recent development of ", "H1-receptor", " antagonists devoid of clinical sedative effects has enabled the administration of doses of H1-antihistamines which achieve a greater degree of H1-receptor blockade within the airways, thus permitting a better appraisal of the role of ", "histamine", " in this condition."], "h": {"pos": [1, 2], "type": null, "name": "H1-receptor  antagonists devoid of clinical sedative effects has enabled the administration of doses of H1-antihistamines which achieve a greater degree of H1-receptor blockade within the airways, thus permitting a better appraisal of the role of "}, "t": {"pos": [3, 4], "type": null, "name": "histamine  in this condition."}}
{"relation": "AGONIST", "token": ["Effect of ramelteon (", "TAK-375", "), a selective ", "MT1/MT2 receptor", " agonist, on motor performance in mice."], "h": {"pos": [1, 2], "type": null, "name": "TAK-375 ), a selective "}, "t": {"pos": [3, 4], "type": null, "name": "MT1/MT2 receptor  agonist, on motor performance in mice."}}
{"relation": "AGONIST", "token": ["The involvement of EP1 and ", "EP2 receptors", " is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist ", "butaprost", " (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific)."], "h": {"pos": [1, 2], "type": null, "name": "EP2 receptors  is indicated by studies with the EP1 selective agonist 17-phenyl trinor PGE2, and the EP2 selective agonist "}, "t": {"pos": [3, 4], "type": null, "name": "butaprost  (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific)."}}
{"relation": "AGONIST", "token": ["Endothelium-dependent relaxations, nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF)-type, were studied in rabbit iliac artery and aortic rings using the ", "G protein-coupled receptor", " agonist acetylcholine (", "ACh", ") and by cyclopiazonic acid (CPA), which promotes store-operated Ca(2+) entry by inhibiting the endothelial SERCA pump."], "h": {"pos": [1, 2], "type": null, "name": "G protein-coupled receptor  agonist acetylcholine ("}, "t": {"pos": [3, 4], "type": null, "name": "ACh ) and by cyclopiazonic acid (CPA), which promotes store-operated Ca(2+) entry by inhibiting the endothelial SERCA pump."}}
{"relation": "AGONIST", "token": ["In contrast, the ", "D-1997", "-induced responses were potently and concentration-dependently antagonized by the mixed 5-HT1-like and ", "5-HT2 receptor", " antagonist methiothepin (0.01-1 microM)."], "h": {"pos": [1, 2], "type": null, "name": "D-1997 -induced responses were potently and concentration-dependently antagonized by the mixed 5-HT1-like and "}, "t": {"pos": [3, 4], "type": null, "name": "5-HT2 receptor  antagonist methiothepin (0.01-1 microM)."}}
{"relation": "AGONIST", "token": ["", "2-Amino-3-[3-hydroxy-5-(2-thiazolyl)-4-isoxazolyl]propionic acid", " (1) is a potent ", "AMPA receptor", " agonist with moderate affinity for native kainic acid (KA) receptors, whereas (S)-E-4-(2,2-dimethylpropylidene)glutamic acid (3) show high affinity for the GluR5 subtype of KA receptors and much lower affinity for the GluR2 subtype of AMPA receptors."], "h": {"pos": [1, 2], "type": null, "name": "2-Amino-3-[3-hydroxy-5-(2-thiazolyl)-4-isoxazolyl]propionic acid  (1) is a potent "}, "t": {"pos": [3, 4], "type": null, "name": "AMPA receptor  agonist with moderate affinity for native kainic acid (KA) receptors, whereas (S)-E-4-(2,2-dimethylpropylidene)glutamic acid (3) show high affinity for the GluR5 subtype of KA receptors and much lower affinity for the GluR2 subtype of AMPA receptors."}}
{"relation": "AGONIST", "token": ["Terbutaline (Bricanyl) and its prodrug Bambuterol (", "Bambec", ") are highly potent ", "beta(2)-adrenoceptor", " agonists often used in asthma patients."], "h": {"pos": [1, 2], "type": null, "name": "Bambec ) are highly potent "}, "t": {"pos": [3, 4], "type": null, "name": "beta(2)-adrenoceptor  agonists often used in asthma patients."}}
{"relation": "AGONIST", "token": ["In the locus coeruleus, brexpiprazole reversed the inhibitory effect of the preferential ", "5-HT2A", " receptor agonist DOI (", "2,5-dimethoxy-4-iodoamphetamine", ") on norepinephrine neuronal firing (ED50 = 110 mug/kg), demonstrating 5-HT2A antagonistic action."], "h": {"pos": [1, 2], "type": null, "name": "5-HT2A  receptor agonist DOI ("}, "t": {"pos": [3, 4], "type": null, "name": "2,5-dimethoxy-4-iodoamphetamine ) on norepinephrine neuronal firing (ED50 = 110 mug/kg), demonstrating 5-HT2A antagonistic action."}}
{"relation": "AGONIST", "token": ["The involvement of ", "EP1", " and EP2 receptors is indicated by studies with the EP1 selective agonist ", "17-phenyl trinor PGE2", ", and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific)."], "h": {"pos": [1, 2], "type": null, "name": "EP1  and EP2 receptors is indicated by studies with the EP1 selective agonist "}, "t": {"pos": [3, 4], "type": null, "name": "17-phenyl trinor PGE2 , and the EP2 selective agonist butaprost (which stimulate), as well as by studies with the antagonists SC-51089 (EP1 specific) and AH 6809 (EP1 and EP2 specific)."}}
{"relation": "AGONIST", "token": ["After extensive washout (3 h, 37 degrees C), isometric contractions were measured to the full muscarinic receptor agonist methacholine, the partial ", "muscarinic receptor", " agonist ", "4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium", " (McN-A-343) and histamine."], "h": {"pos": [1, 2], "type": null, "name": "muscarinic receptor  agonist "}, "t": {"pos": [3, 4], "type": null, "name": "4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium  (McN-A-343) and histamine."}}
{"relation": "AGONIST", "token": ["", "Adenosine", " and N(6)-cyclopentyl-adenosine (CPA, ", "A1R", " agonist) constricted MVs but not MAs."], "h": {"pos": [1, 2], "type": null, "name": "Adenosine  and N(6)-cyclopentyl-adenosine (CPA, "}, "t": {"pos": [3, 4], "type": null, "name": "A1R  agonist) constricted MVs but not MAs."}}
{"relation": "AGONIST", "token": ["", "Amitriptyline", " is a TrkA and ", "TrkB", " receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity."], "h": {"pos": [1, 2], "type": null, "name": "Amitriptyline  is a TrkA and "}, "t": {"pos": [3, 4], "type": null, "name": "TrkB  receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity."}}
{"relation": "AGONIST", "token": ["RESULTS: In drug discrimination studies, ", "lisuride", " fully mimicked the ", "5-HT(1A)", " agonist LY 293284, only partially substituted for LSD and DOI, and failed to substitute for (+)-amphetamine."], "h": {"pos": [1, 2], "type": null, "name": "lisuride  fully mimicked the "}, "t": {"pos": [3, 4], "type": null, "name": "5-HT(1A)  agonist LY 293284, only partially substituted for LSD and DOI, and failed to substitute for (+)-amphetamine."}}
{"relation": "AGONIST", "token": ["Prostaglandin E1, E2, STA2 (a stable analogue of thromboxane A2), ", "17-phenyl-trinor-PGE2", " (an ", "EP1", "-selective agonist) and sulprostone (an EP3-selective agonist) inhibited the HVA Ca2+ current (HVA ICa) dose-dependently, and the rank order of potency to inhibit HVA Ca2+ channels was sulprostone>PGE2, PGE1>STA2>>17-phenyl-trinor-PGE2."], "h": {"pos": [1, 2], "type": null, "name": "17-phenyl-trinor-PGE2  (an "}, "t": {"pos": [3, 4], "type": null, "name": "EP1 -selective agonist) and sulprostone (an EP3-selective agonist) inhibited the HVA Ca2+ current (HVA ICa) dose-dependently, and the rank order of potency to inhibit HVA Ca2+ channels was sulprostone>PGE2, PGE1>STA2>>17-phenyl-trinor-PGE2."}}
{"relation": "AGONIST", "token": ["The ", "beta(2)-adrenoceptor", " (beta(2)-AR) agonists ", "clenbuterol", " and fenoterol have similar beneficial effects in animal models of heart failure."], "h": {"pos": [1, 2], "type": null, "name": "beta(2)-adrenoceptor  (beta(2)-AR) agonists "}, "t": {"pos": [3, 4], "type": null, "name": "clenbuterol  and fenoterol have similar beneficial effects in animal models of heart failure."}}
{"relation": "AGONIST", "token": ["", "Amitriptyline", " is a ", "TrkA", " and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity."], "h": {"pos": [1, 2], "type": null, "name": "Amitriptyline  is a "}, "t": {"pos": [3, 4], "type": null, "name": "TrkA  and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity."}}
{"relation": "AGONIST", "token": ["In further studies, the diuretic effects of the ", "CB1", " agonist ", "AM4054", " were similar in male and female rats, displayed a relatively rapid onset to action, and were dose-dependently antagonized by 30 minutes pretreatment with rimonabant, but not by the vanilloid receptor type I antagonist capsazepine, nor were the effects of WIN 55,212 antagonized by the CB2 antagonist AM630 [(6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl) methanone)]."], "h": {"pos": [1, 2], "type": null, "name": "CB1  agonist "}, "t": {"pos": [3, 4], "type": null, "name": "AM4054  were similar in male and female rats, displayed a relatively rapid onset to action, and were dose-dependently antagonized by 30 minutes pretreatment with rimonabant, but not by the vanilloid receptor type I antagonist capsazepine, nor were the effects of WIN 55,212 antagonized by the CB2 antagonist AM630 [(6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl) methanone)]."}}
{"relation": "DOWNREGULATOR", "token": ["Inhibition of angiogenesis and invasion by ", "DMBT", " is mediated by downregulation of VEGF and ", "MMP-9", " through Akt pathway in MDA-MB-231 breast cancer cells."], "h": {"pos": [1, 2], "type": null, "name": "DMBT  is mediated by downregulation of VEGF and "}, "t": {"pos": [3, 4], "type": null, "name": "MMP-9  through Akt pathway in MDA-MB-231 breast cancer cells."}}
{"relation": "DOWNREGULATOR", "token": ["In combination with ", "clofarabine", ", the ability of resveratrol to reduce the contents of ", "Sp1", " and its target gene products was also evident in a time- and dose-dependent experiment."], "h": {"pos": [1, 2], "type": null, "name": "clofarabine , the ability of resveratrol to reduce the contents of "}, "t": {"pos": [3, 4], "type": null, "name": "Sp1  and its target gene products was also evident in a time- and dose-dependent experiment."}}
{"relation": "DOWNREGULATOR", "token": ["The pretreatment with 20\u00a0mg\u2009L(-1) ", "La(III)", " could alleviate the effects of UV-B radiation on the activities of nitrate reductase, glutamine synthetase, ", "glutamate synthase", ", and glutamate dehydrogenase, promoting amino acid conversion and protein synthesis in soybean seedlings."], "h": {"pos": [1, 2], "type": null, "name": "La(III)  could alleviate the effects of UV-B radiation on the activities of nitrate reductase, glutamine synthetase, "}, "t": {"pos": [3, 4], "type": null, "name": "glutamate synthase , and glutamate dehydrogenase, promoting amino acid conversion and protein synthesis in soybean seedlings."}}
{"relation": "DOWNREGULATOR", "token": ["At a low pH (pH 7.4), but not pH 7.9, ", "ifenprodil", " reduces the mean open time of GluN1/", "GluN2B", " receptors, which may be responsible for its usefulness as a context-dependent inhibitor in conditions like ischemia and stroke, when the pH of the extracellular milieu becomes acidic."], "h": {"pos": [1, 2], "type": null, "name": "ifenprodil  reduces the mean open time of GluN1/"}, "t": {"pos": [3, 4], "type": null, "name": "GluN2B  receptors, which may be responsible for its usefulness as a context-dependent inhibitor in conditions like ischemia and stroke, when the pH of the extracellular milieu becomes acidic."}}
{"relation": "DOWNREGULATOR", "token": ["Ten IU/mL urokinase was also incubated with pooled plasma of stroke patients, that was previously oxidized with the singlet oxygen (1O2) donor chloramine T (", "CT", "), to destroy ", "plasmatic PAI-1", " and alpha2-antiplasmin."], "h": {"pos": [1, 2], "type": null, "name": "CT ), to destroy "}, "t": {"pos": [3, 4], "type": null, "name": "plasmatic PAI-1  and alpha2-antiplasmin."}}
{"relation": "DOWNREGULATOR", "token": ["A dose of 25 microg kg(-1) day(-1) of formoterol elicited greater EDL and soleus hypertrophy than ", "salmeterol", ", but resulted in similar ", "beta-adrenoceptor", " downregulation."], "h": {"pos": [1, 2], "type": null, "name": "salmeterol , but resulted in similar "}, "t": {"pos": [3, 4], "type": null, "name": "beta-adrenoceptor  downregulation."}}
{"relation": "DOWNREGULATOR", "token": ["", "Pinosylvin", " inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (", "CDK2", "), CDK4, c-Myc, and retinoblastoma protein (pRb), and the upregulation of p21(WAF1/CIP1) and p53."], "h": {"pos": [1, 2], "type": null, "name": "Pinosylvin  inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 ("}, "t": {"pos": [3, 4], "type": null, "name": "CDK2 ), CDK4, c-Myc, and retinoblastoma protein (pRb), and the upregulation of p21(WAF1/CIP1) and p53."}}
{"relation": "DOWNREGULATOR", "token": ["Expression of the dominant negative mutants rab5A-N133I or ", "rab7", "-N125I blunted ", "U50,488H", "-induced down-regulation."], "h": {"pos": [1, 2], "type": null, "name": "rab7 -N125I blunted "}, "t": {"pos": [3, 4], "type": null, "name": "U50,488H -induced down-regulation."}}
{"relation": "DOWNREGULATOR", "token": ["The pretreatment with 20\u00a0mg\u2009L(-1) ", "La(III)", " could alleviate the effects of UV-B radiation on the activities of nitrate reductase, ", "glutamine synthetase", ", glutamate synthase, and glutamate dehydrogenase, promoting amino acid conversion and protein synthesis in soybean seedlings."], "h": {"pos": [1, 2], "type": null, "name": "La(III)  could alleviate the effects of UV-B radiation on the activities of nitrate reductase, "}, "t": {"pos": [3, 4], "type": null, "name": "glutamine synthetase , glutamate synthase, and glutamate dehydrogenase, promoting amino acid conversion and protein synthesis in soybean seedlings."}}
{"relation": "DOWNREGULATOR", "token": ["Moreover, ", "BH(4)", " treatment of the fructose-fed rats markedly reduced the lipid peroxide content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors, ", "nuclear factor-kappaB", " and activating protein-1, which were increased in fructose-fed rats."], "h": {"pos": [1, 2], "type": null, "name": "BH(4)  treatment of the fructose-fed rats markedly reduced the lipid peroxide content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors, "}, "t": {"pos": [3, 4], "type": null, "name": "nuclear factor-kappaB  and activating protein-1, which were increased in fructose-fed rats."}}
{"relation": "DOWNREGULATOR", "token": ["The results showed that IR tyrosine phosphorylation (pIR) was reduced by 42\u00a0% in ", "MSG", "-obese mice (MSG, 6.7\u00a0\u00b1\u00a00.2\u00a0arbitrary units (a.u.); control, 11.5\u00a0\u00b1\u00a00.4\u00a0a.u.); on the other hand, exercise training increased ", "pIR", " by 76\u00a0% in MSG mice without affecting control mice (MSG, 11.8\u00a0\u00b1\u00a00.3; control, 12.8\u00a0\u00b1\u00a00.2\u00a0a.u.)."], "h": {"pos": [1, 2], "type": null, "name": "MSG -obese mice (MSG, 6.7\u00a0\u00b1\u00a00.2\u00a0arbitrary units (a.u.); control, 11.5\u00a0\u00b1\u00a00.4\u00a0a.u.); on the other hand, exercise training increased "}, "t": {"pos": [3, 4], "type": null, "name": "pIR  by 76\u00a0% in MSG mice without affecting control mice (MSG, 11.8\u00a0\u00b1\u00a00.3; control, 12.8\u00a0\u00b1\u00a00.2\u00a0a.u.)."}}
{"relation": "DOWNREGULATOR", "token": ["Apple ", "polyphenols", " suppress antigen presentation of ", "ovalbumin", " by THP-1-derived dendritic cells."], "h": {"pos": [1, 2], "type": null, "name": "polyphenols  suppress antigen presentation of "}, "t": {"pos": [3, 4], "type": null, "name": "ovalbumin  by THP-1-derived dendritic cells."}}
{"relation": "DOWNREGULATOR", "token": ["CRH caused a rise in plasma ACTH after both loperamide (from 30 +/- 16.6 to a peak of 108 +/- 31 pmol/l) and placebo (from 98.5 +/- 47 to 211 +/- 61.7 pmol/l): the interaction between treatments and time was significant, and the first phase of ", "CRH", "-induced ACTH secretion was significantly lower after ", "loperamide", "."], "h": {"pos": [1, 2], "type": null, "name": "CRH -induced ACTH secretion was significantly lower after "}, "t": {"pos": [3, 4], "type": null, "name": "loperamide ."}}
{"relation": "DOWNREGULATOR", "token": ["In addition, ", "ethanol", " induced degradation of DNA methyltransferases (DNMT-1, DNMT-3a, and DNMT-3b), as well as the methyl CpG-binding proteins (MeCP-2, ", "MBD-2", " and MBD-3), in MEF cells by the proteasomal pathway."], "h": {"pos": [1, 2], "type": null, "name": "ethanol  induced degradation of DNA methyltransferases (DNMT-1, DNMT-3a, and DNMT-3b), as well as the methyl CpG-binding proteins (MeCP-2, "}, "t": {"pos": [3, 4], "type": null, "name": "MBD-2  and MBD-3), in MEF cells by the proteasomal pathway."}}
{"relation": "DOWNREGULATOR", "token": ["Inhibition of angiogenesis and invasion by ", "DMBT", " is mediated by downregulation of ", "VEGF", " and MMP-9 through Akt pathway in MDA-MB-231 breast cancer cells."], "h": {"pos": [1, 2], "type": null, "name": "DMBT  is mediated by downregulation of "}, "t": {"pos": [3, 4], "type": null, "name": "VEGF  and MMP-9 through Akt pathway in MDA-MB-231 breast cancer cells."}}
{"relation": "DOWNREGULATOR", "token": ["Correlation between activation of PPAR\u03b3 and ", "resistin", " downregulation in a mouse adipocyte cell line by a series of ", "thiazolidinediones", "."], "h": {"pos": [1, 2], "type": null, "name": "resistin  downregulation in a mouse adipocyte cell line by a series of "}, "t": {"pos": [3, 4], "type": null, "name": "thiazolidinediones ."}}
{"relation": "DOWNREGULATOR", "token": ["On the other hand, in patients with a mean serum ", "carvedilol", " level (Cmin) of less than 2.5 nmol/l up to 2 weeks after the start ofcarvedilol therapy, the degree of reduction in the ", "BNP", " value after the 3rd month was significantly larger, relative to the patient group with Cmin over 2.5 nmol/l."], "h": {"pos": [1, 2], "type": null, "name": "carvedilol  level (Cmin) of less than 2.5 nmol/l up to 2 weeks after the start ofcarvedilol therapy, the degree of reduction in the "}, "t": {"pos": [3, 4], "type": null, "name": "BNP  value after the 3rd month was significantly larger, relative to the patient group with Cmin over 2.5 nmol/l."}}
{"relation": "DOWNREGULATOR", "token": ["To further our understanding of how ", "fisetin", " negatively regulates ", "mTORC1", " signaling, we analyzed the phosphorylation of S6K1, mTOR and Akt in fisetin-treated TSC2-knockdown cells."], "h": {"pos": [1, 2], "type": null, "name": "fisetin  negatively regulates "}, "t": {"pos": [3, 4], "type": null, "name": "mTORC1  signaling, we analyzed the phosphorylation of S6K1, mTOR and Akt in fisetin-treated TSC2-knockdown cells."}}
{"relation": "DOWNREGULATOR", "token": ["Moreover, ", "BH(4)", " treatment of the fructose-fed rats markedly reduced the lipid peroxide content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors, nuclear factor-kappaB and ", "activating protein-1", ", which were increased in fructose-fed rats."], "h": {"pos": [1, 2], "type": null, "name": "BH(4)  treatment of the fructose-fed rats markedly reduced the lipid peroxide content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors, nuclear factor-kappaB and "}, "t": {"pos": [3, 4], "type": null, "name": "activating protein-1 , which were increased in fructose-fed rats."}}
{"relation": "DOWNREGULATOR", "token": ["", "Pinosylvin", " inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, c-Myc, and ", "retinoblastoma protein", " (pRb), and the upregulation of p21(WAF1/CIP1) and p53."], "h": {"pos": [1, 2], "type": null, "name": "Pinosylvin  inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, c-Myc, and "}, "t": {"pos": [3, 4], "type": null, "name": "retinoblastoma protein  (pRb), and the upregulation of p21(WAF1/CIP1) and p53."}}
{"relation": "DOWNREGULATOR", "token": ["Although both intracellular and membrane Cx43 pools were markedly reduced in cells released from contact inhibition by ", "TCDD", ", siRNA-mediated ", "Cx43", " knock-down was not sufficient to stimulate proliferation in contact-inhibited cells."], "h": {"pos": [1, 2], "type": null, "name": "TCDD , siRNA-mediated "}, "t": {"pos": [3, 4], "type": null, "name": "Cx43  knock-down was not sufficient to stimulate proliferation in contact-inhibited cells."}}
{"relation": "DOWNREGULATOR", "token": ["We previously reported that ", "aminoglycoside", " antibiotics reduce ", "SGLT1", "-dependent glucose transport in pig proximal tubular epithelial LLC-PK1 cells in parallel with the order of their nephrotoxicity."], "h": {"pos": [1, 2], "type": null, "name": "aminoglycoside  antibiotics reduce "}, "t": {"pos": [3, 4], "type": null, "name": "SGLT1 -dependent glucose transport in pig proximal tubular epithelial LLC-PK1 cells in parallel with the order of their nephrotoxicity."}}
{"relation": "DOWNREGULATOR", "token": ["A dose of 25 microg kg(-1) day(-1) of ", "formoterol", " elicited greater EDL and soleus hypertrophy than salmeterol, but resulted in similar ", "beta-adrenoceptor", " downregulation."], "h": {"pos": [1, 2], "type": null, "name": "formoterol  elicited greater EDL and soleus hypertrophy than salmeterol, but resulted in similar "}, "t": {"pos": [3, 4], "type": null, "name": "beta-adrenoceptor  downregulation."}}
{"relation": "DOWNREGULATOR", "token": ["Discovery and optimization of ", "anthranilic acid sulfonamides", " as inhibitors of methionine aminopeptidase-2: a structural basis for the reduction of ", "albumin", " binding."], "h": {"pos": [1, 2], "type": null, "name": "anthranilic acid sulfonamides  as inhibitors of methionine aminopeptidase-2: a structural basis for the reduction of "}, "t": {"pos": [3, 4], "type": null, "name": "albumin  binding."}}
{"relation": "DOWNREGULATOR", "token": ["At a low pH (pH 7.4), but not pH 7.9, ", "ifenprodil", " reduces the mean open time of ", "GluN1", "/GluN2B receptors, which may be responsible for its usefulness as a context-dependent inhibitor in conditions like ischemia and stroke, when the pH of the extracellular milieu becomes acidic."], "h": {"pos": [1, 2], "type": null, "name": "ifenprodil  reduces the mean open time of "}, "t": {"pos": [3, 4], "type": null, "name": "GluN1 /GluN2B receptors, which may be responsible for its usefulness as a context-dependent inhibitor in conditions like ischemia and stroke, when the pH of the extracellular milieu becomes acidic."}}
{"relation": "DOWNREGULATOR", "token": ["The results showed that IR tyrosine phosphorylation (", "pIR", ") was reduced by 42\u00a0% in ", "MSG", "-obese mice (MSG, 6.7\u00a0\u00b1\u00a00.2\u00a0arbitrary units (a.u.); control, 11.5\u00a0\u00b1\u00a00.4\u00a0a.u.); on the other hand, exercise training increased pIR by 76\u00a0% in MSG mice without affecting control mice (MSG, 11.8\u00a0\u00b1\u00a00.3; control, 12.8\u00a0\u00b1\u00a00.2\u00a0a.u.)."], "h": {"pos": [1, 2], "type": null, "name": "pIR ) was reduced by 42\u00a0% in "}, "t": {"pos": [3, 4], "type": null, "name": "MSG -obese mice (MSG, 6.7\u00a0\u00b1\u00a00.2\u00a0arbitrary units (a.u.); control, 11.5\u00a0\u00b1\u00a00.4\u00a0a.u.); on the other hand, exercise training increased pIR by 76\u00a0% in MSG mice without affecting control mice (MSG, 11.8\u00a0\u00b1\u00a00.3; control, 12.8\u00a0\u00b1\u00a00.2\u00a0a.u.)."}}
{"relation": "DOWNREGULATOR", "token": ["Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of ", "inducible nitric-oxide synthase", " by ", "15-deoxy-Delta12,14-prostaglandin J2", "."], "h": {"pos": [1, 2], "type": null, "name": "inducible nitric-oxide synthase  by "}, "t": {"pos": [3, 4], "type": null, "name": "15-deoxy-Delta12,14-prostaglandin J2 ."}}
{"relation": "DOWNREGULATOR", "token": ["Expression of the dominant negative mutants rab5A-N133I or rab7-", "N125I", " blunted ", "U50,488H", "-induced down-regulation."], "h": {"pos": [1, 2], "type": null, "name": "N125I  blunted "}, "t": {"pos": [3, 4], "type": null, "name": "U50,488H -induced down-regulation."}}
{"relation": "DOWNREGULATOR", "token": ["In addition, ", "ethanol", " induced degradation of DNA methyltransferases (", "DNMT-", "1, DNMT-3a, and DNMT-3b), as well as the methyl CpG-binding proteins (MeCP-2, MBD-2 and MBD-3), in MEF cells by the proteasomal pathway."], "h": {"pos": [1, 2], "type": null, "name": "ethanol  induced degradation of DNA methyltransferases ("}, "t": {"pos": [3, 4], "type": null, "name": "DNMT- 1, DNMT-3a, and DNMT-3b), as well as the methyl CpG-binding proteins (MeCP-2, MBD-2 and MBD-3), in MEF cells by the proteasomal pathway."}}
{"relation": "DOWNREGULATOR", "token": ["The results showed that (1) 15mg/kg body weight PhIP induced obvious histopathological changes in gastric mucosa; (2) ", "PhIP", " (10 and/or 15mg/kg) significantly decreased ", "superoxide dismutase", " (SOD) and glutathioneperoxidase (GPx) activities, while increased catalase (CAT) activity compared with the control."], "h": {"pos": [1, 2], "type": null, "name": "PhIP  (10 and/or 15mg/kg) significantly decreased "}, "t": {"pos": [3, 4], "type": null, "name": "superoxide dismutase  (SOD) and glutathioneperoxidase (GPx) activities, while increased catalase (CAT) activity compared with the control."}}
{"relation": "DOWNREGULATOR", "token": ["Thus prolonged activation of NMDA receptors in hippocampal neurons reduced ", "GABAR \u03b4 subunit", " expression through ", "Ca2+", " entry and at least in part by ERK1/2 activation."], "h": {"pos": [1, 2], "type": null, "name": "GABAR \u03b4 subunit  expression through "}, "t": {"pos": [3, 4], "type": null, "name": "Ca2+  entry and at least in part by ERK1/2 activation."}}
{"relation": "DOWNREGULATOR", "token": ["", "U50, 488H", " caused a significant down-regulation of the ", "hkor", ", although etorphine did not."], "h": {"pos": [1, 2], "type": null, "name": "U50, 488H  caused a significant down-regulation of the "}, "t": {"pos": [3, 4], "type": null, "name": "hkor , although etorphine did not."}}
{"relation": "DOWNREGULATOR", "token": ["Thus, the ", "TCDD", "-induced reduction in canonical Wnt signaling is associated with a decrease in activators (", "Rspo2", " and Rspo3) rather than an increase in inhibitors (Dkk1 and Dkk2) of the pathway."], "h": {"pos": [1, 2], "type": null, "name": "TCDD -induced reduction in canonical Wnt signaling is associated with a decrease in activators ("}, "t": {"pos": [3, 4], "type": null, "name": "Rspo2  and Rspo3) rather than an increase in inhibitors (Dkk1 and Dkk2) of the pathway."}}
{"relation": "DOWNREGULATOR", "token": ["It is not yet clear whether ", "tamoxifen", " can reduce breast cancer incidence in women with BRCA1 and BRCA2 mutations, although preliminary evidence favors benefit for at least those with a ", "BRCA2", " mutation."], "h": {"pos": [1, 2], "type": null, "name": "tamoxifen  can reduce breast cancer incidence in women with BRCA1 and BRCA2 mutations, although preliminary evidence favors benefit for at least those with a "}, "t": {"pos": [3, 4], "type": null, "name": "BRCA2  mutation."}}
{"relation": "DOWNREGULATOR", "token": ["Taken together, our findings indicate that 5HHMF suppresses ", "NO", " production through modulation of iNOS, consequently suppressing NF-\u03baB activity and induction of Nrf2-dependent ", "HO-1", " activity."], "h": {"pos": [1, 2], "type": null, "name": "NO  production through modulation of iNOS, consequently suppressing NF-\u03baB activity and induction of Nrf2-dependent "}, "t": {"pos": [3, 4], "type": null, "name": "HO-1  activity."}}
{"relation": "DOWNREGULATOR", "token": ["Thus, the ", "TCDD", "-induced reduction in canonical Wnt signaling is associated with a decrease in activators (Rspo2 and ", "Rspo3", ") rather than an increase in inhibitors (Dkk1 and Dkk2) of the pathway."], "h": {"pos": [1, 2], "type": null, "name": "TCDD -induced reduction in canonical Wnt signaling is associated with a decrease in activators (Rspo2 and "}, "t": {"pos": [3, 4], "type": null, "name": "Rspo3 ) rather than an increase in inhibitors (Dkk1 and Dkk2) of the pathway."}}
{"relation": "DOWNREGULATOR", "token": ["", "Crocin", " (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of caspase 3 and release of ", "cytochrome c", " to the cytosol induced by DZN."], "h": {"pos": [1, 2], "type": null, "name": "Crocin  (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of caspase 3 and release of "}, "t": {"pos": [3, 4], "type": null, "name": "cytochrome c  to the cytosol induced by DZN."}}
{"relation": "DOWNREGULATOR", "token": ["We observed a significant reduction in CSE induced luciferase expression, NF-\u03baB DNA binding, ", "I-\u03baB\u03b5", " degradation and c-Rel nuclear translocation in cells pretreated with ", "vitamin C", "."], "h": {"pos": [1, 2], "type": null, "name": "I-\u03baB\u03b5  degradation and c-Rel nuclear translocation in cells pretreated with "}, "t": {"pos": [3, 4], "type": null, "name": "vitamin C ."}}
{"relation": "DOWNREGULATOR", "token": ["The results showed that (1) 15mg/kg body weight PhIP induced obvious histopathological changes in gastric mucosa; (2) ", "PhIP", " (10 and/or 15mg/kg) significantly decreased superoxide dismutase (SOD) and ", "glutathioneperoxidase", " (GPx) activities, while increased catalase (CAT) activity compared with the control."], "h": {"pos": [1, 2], "type": null, "name": "PhIP  (10 and/or 15mg/kg) significantly decreased superoxide dismutase (SOD) and "}, "t": {"pos": [3, 4], "type": null, "name": "glutathioneperoxidase  (GPx) activities, while increased catalase (CAT) activity compared with the control."}}
{"relation": "DOWNREGULATOR", "token": ["Ten IU/mL urokinase was also incubated with pooled plasma of stroke patients, that was previously oxidized with the singlet oxygen (1O2) donor ", "chloramine T", " (CT), to destroy ", "plasmatic PAI-1", " and alpha2-antiplasmin."], "h": {"pos": [1, 2], "type": null, "name": "chloramine T  (CT), to destroy "}, "t": {"pos": [3, 4], "type": null, "name": "plasmatic PAI-1  and alpha2-antiplasmin."}}
{"relation": "DOWNREGULATOR", "token": ["", "Pinosylvin", " inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, c-Myc, and retinoblastoma protein (", "pRb", "), and the upregulation of p21(WAF1/CIP1) and p53."], "h": {"pos": [1, 2], "type": null, "name": "Pinosylvin  inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, c-Myc, and retinoblastoma protein ("}, "t": {"pos": [3, 4], "type": null, "name": "pRb ), and the upregulation of p21(WAF1/CIP1) and p53."}}
{"relation": "DOWNREGULATOR", "token": ["Inhibition of SIRT1 significantly increased vascular superoxide production, enhanced ", "NADPH oxidase", " activity, and mRNA expression of its subunits p22(phox) and NOX4, which were prevented by ", "resveratrol", "."], "h": {"pos": [1, 2], "type": null, "name": "NADPH oxidase  activity, and mRNA expression of its subunits p22(phox) and NOX4, which were prevented by "}, "t": {"pos": [3, 4], "type": null, "name": "resveratrol ."}}
{"relation": "DOWNREGULATOR", "token": ["High ", "glucose", " (HG) induces apoptosis of podocytes, inhibits AMPK activation, inactivates ", "tuberin", " and activates mTOR."], "h": {"pos": [1, 2], "type": null, "name": "glucose  (HG) induces apoptosis of podocytes, inhibits AMPK activation, inactivates "}, "t": {"pos": [3, 4], "type": null, "name": "tuberin  and activates mTOR."}}
{"relation": "DOWNREGULATOR", "token": ["This observation suggests that ", "MDMA", "-induced reductions in ", "SERT", " density do not represent neuroadaptive responses to decreased levels of brain serotonin, but may occur in response to some other stimulus or to the neurotoxic effects of MDMA."], "h": {"pos": [1, 2], "type": null, "name": "MDMA -induced reductions in "}, "t": {"pos": [3, 4], "type": null, "name": "SERT  density do not represent neuroadaptive responses to decreased levels of brain serotonin, but may occur in response to some other stimulus or to the neurotoxic effects of MDMA."}}
{"relation": "DOWNREGULATOR", "token": ["Taken together, our findings indicate that 5HHMF suppresses ", "NO", " production through modulation of iNOS, consequently suppressing NF-\u03baB activity and induction of ", "Nrf2", "-dependent HO-1 activity."], "h": {"pos": [1, 2], "type": null, "name": "NO  production through modulation of iNOS, consequently suppressing NF-\u03baB activity and induction of "}, "t": {"pos": [3, 4], "type": null, "name": "Nrf2 -dependent HO-1 activity."}}
{"relation": "DOWNREGULATOR", "token": ["Fisetin treatment inhibited adipocyte differentiation, consistent with the negative effect of ", "fisetin", " on ", "mTOR", "."], "h": {"pos": [1, 2], "type": null, "name": "fisetin  on "}, "t": {"pos": [3, 4], "type": null, "name": "mTOR ."}}
{"relation": "DOWNREGULATOR", "token": ["", "PKC", " isoforms did show different sensitivity and selectivity for down-regulation by I3A and phorbol 12-myristate 13-acetate (", "PMA", ") in WEHI-231, HOP-92, and Colo-205 cells."], "h": {"pos": [1, 2], "type": null, "name": "PKC  isoforms did show different sensitivity and selectivity for down-regulation by I3A and phorbol 12-myristate 13-acetate ("}, "t": {"pos": [3, 4], "type": null, "name": "PMA ) in WEHI-231, HOP-92, and Colo-205 cells."}}
{"relation": "DOWNREGULATOR", "token": ["It is not yet clear whether ", "tamoxifen", " can reduce breast cancer incidence in women with BRCA1 and ", "BRCA2", " mutations, although preliminary evidence favors benefit for at least those with a BRCA2 mutation."], "h": {"pos": [1, 2], "type": null, "name": "tamoxifen  can reduce breast cancer incidence in women with BRCA1 and "}, "t": {"pos": [3, 4], "type": null, "name": "BRCA2  mutations, although preliminary evidence favors benefit for at least those with a BRCA2 mutation."}}
{"relation": "DOWNREGULATOR", "token": ["RESULTS: Ketorolac was six times more active against ", "COX-1", " (IC(50) = 0.02 microM) than COX-2 (IC(50) = 0.12 microM) while ", "bromfenac", " was approximately 32 times more active against COX-2 (IC(50) = 0.0066 microM) than COX-1 (IC(50) = 0.210 microM)."], "h": {"pos": [1, 2], "type": null, "name": "COX-1  (IC(50) = 0.02 microM) than COX-2 (IC(50) = 0.12 microM) while "}, "t": {"pos": [3, 4], "type": null, "name": "bromfenac  was approximately 32 times more active against COX-2 (IC(50) = 0.0066 microM) than COX-1 (IC(50) = 0.210 microM)."}}
{"relation": "DOWNREGULATOR", "token": ["Association of PGE2 or ", "acetazolamide", " to NSAIDs reduced NSAID-induced activation of CA I and ", "CA II", "."], "h": {"pos": [1, 2], "type": null, "name": "acetazolamide  to NSAIDs reduced NSAID-induced activation of CA I and "}, "t": {"pos": [3, 4], "type": null, "name": "CA II ."}}
{"relation": "DOWNREGULATOR", "token": ["Moreover, recent in vitro studies suggest that ", "memantine", " abrogates beta-amyloid (", "Abeta", ") toxicity and possibly inhibits Abeta production."], "h": {"pos": [1, 2], "type": null, "name": "memantine  abrogates beta-amyloid ("}, "t": {"pos": [3, 4], "type": null, "name": "Abeta ) toxicity and possibly inhibits Abeta production."}}
{"relation": "DOWNREGULATOR", "token": ["Ten IU/mL urokinase was also incubated with pooled plasma of stroke patients, that was previously oxidized with the singlet oxygen (", "1O2", ") donor chloramine T (CT), to destroy ", "plasmatic PAI-1", " and alpha2-antiplasmin."], "h": {"pos": [1, 2], "type": null, "name": "1O2 ) donor chloramine T (CT), to destroy "}, "t": {"pos": [3, 4], "type": null, "name": "plasmatic PAI-1  and alpha2-antiplasmin."}}
{"relation": "DOWNREGULATOR", "token": ["Low levels of ", "serotonin", " may reduce the density of the serotonin transporter (", "SERT", ") by either increasing trafficking or reducing synthesis; a \"neuroadaptive response\"."], "h": {"pos": [1, 2], "type": null, "name": "serotonin  may reduce the density of the serotonin transporter ("}, "t": {"pos": [3, 4], "type": null, "name": "SERT ) by either increasing trafficking or reducing synthesis; a \"neuroadaptive response\"."}}
{"relation": "DOWNREGULATOR", "token": ["", "PKC", " isoforms did show different sensitivity and selectivity for down-regulation by ", "I3A", " and phorbol 12-myristate 13-acetate (PMA) in WEHI-231, HOP-92, and Colo-205 cells."], "h": {"pos": [1, 2], "type": null, "name": "PKC  isoforms did show different sensitivity and selectivity for down-regulation by "}, "t": {"pos": [3, 4], "type": null, "name": "I3A  and phorbol 12-myristate 13-acetate (PMA) in WEHI-231, HOP-92, and Colo-205 cells."}}
{"relation": "DOWNREGULATOR", "token": ["RESULTS: Ketorolac was six times more active against COX-1 (IC(50) = 0.02 microM) than ", "COX-2", " (IC(50) = 0.12 microM) while ", "bromfenac", " was approximately 32 times more active against COX-2 (IC(50) = 0.0066 microM) than COX-1 (IC(50) = 0.210 microM)."], "h": {"pos": [1, 2], "type": null, "name": "COX-2  (IC(50) = 0.12 microM) while "}, "t": {"pos": [3, 4], "type": null, "name": "bromfenac  was approximately 32 times more active against COX-2 (IC(50) = 0.0066 microM) than COX-1 (IC(50) = 0.210 microM)."}}
{"relation": "DOWNREGULATOR", "token": ["The pretreatment with 20\u00a0mg\u2009L(-1) ", "La(III)", " could alleviate the effects of UV-B radiation on the activities of ", "nitrate reductase", ", glutamine synthetase, glutamate synthase, and glutamate dehydrogenase, promoting amino acid conversion and protein synthesis in soybean seedlings."], "h": {"pos": [1, 2], "type": null, "name": "La(III)  could alleviate the effects of UV-B radiation on the activities of "}, "t": {"pos": [3, 4], "type": null, "name": "nitrate reductase , glutamine synthetase, glutamate synthase, and glutamate dehydrogenase, promoting amino acid conversion and protein synthesis in soybean seedlings."}}
{"relation": "DOWNREGULATOR", "token": ["", "Pinosylvin", " inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, ", "cyclin E", ", cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, c-Myc, and retinoblastoma protein (pRb), and the upregulation of p21(WAF1/CIP1) and p53."], "h": {"pos": [1, 2], "type": null, "name": "Pinosylvin  inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, "}, "t": {"pos": [3, 4], "type": null, "name": "cyclin E , cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, c-Myc, and retinoblastoma protein (pRb), and the upregulation of p21(WAF1/CIP1) and p53."}}
{"relation": "DOWNREGULATOR", "token": ["These results suggest that prostacyclin may play a role in downregulating ", "tissue factor", " expression in monocytes, at least in part via elevation of intracellular levels of ", "cyclic AMP", "."], "h": {"pos": [1, 2], "type": null, "name": "tissue factor  expression in monocytes, at least in part via elevation of intracellular levels of "}, "t": {"pos": [3, 4], "type": null, "name": "cyclic AMP ."}}
{"relation": "DOWNREGULATOR", "token": ["Suppression of Src/", "ERK", " and GSK-3/\u03b2-catenin signaling by ", "pinosylvin", " inhibits the growth of human colorectal cancer cells."], "h": {"pos": [1, 2], "type": null, "name": "ERK  and GSK-3/\u03b2-catenin signaling by "}, "t": {"pos": [3, 4], "type": null, "name": "pinosylvin  inhibits the growth of human colorectal cancer cells."}}
{"relation": "DOWNREGULATOR", "token": ["", "Pinosylvin", " inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, ", "c-Myc", ", and retinoblastoma protein (pRb), and the upregulation of p21(WAF1/CIP1) and p53."], "h": {"pos": [1, 2], "type": null, "name": "Pinosylvin  inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, "}, "t": {"pos": [3, 4], "type": null, "name": "c-Myc , and retinoblastoma protein (pRb), and the upregulation of p21(WAF1/CIP1) and p53."}}
{"relation": "DOWNREGULATOR", "token": ["In combination with clofarabine, the ability of ", "resveratrol", " to reduce the contents of ", "Sp1", " and its target gene products was also evident in a time- and dose-dependent experiment."], "h": {"pos": [1, 2], "type": null, "name": "resveratrol  to reduce the contents of "}, "t": {"pos": [3, 4], "type": null, "name": "Sp1  and its target gene products was also evident in a time- and dose-dependent experiment."}}
{"relation": "DOWNREGULATOR", "token": ["Moreover, recent in vitro studies suggest that ", "memantine", " abrogates ", "beta-amyloid", " (Abeta) toxicity and possibly inhibits Abeta production."], "h": {"pos": [1, 2], "type": null, "name": "memantine  abrogates "}, "t": {"pos": [3, 4], "type": null, "name": "beta-amyloid  (Abeta) toxicity and possibly inhibits Abeta production."}}
{"relation": "DOWNREGULATOR", "token": ["", "Pinosylvin", " inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), ", "CDK4", ", c-Myc, and retinoblastoma protein (pRb), and the upregulation of p21(WAF1/CIP1) and p53."], "h": {"pos": [1, 2], "type": null, "name": "Pinosylvin  inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), "}, "t": {"pos": [3, 4], "type": null, "name": "CDK4 , c-Myc, and retinoblastoma protein (pRb), and the upregulation of p21(WAF1/CIP1) and p53."}}
{"relation": "DOWNREGULATOR", "token": ["Ten IU/mL urokinase was also incubated with pooled plasma of stroke patients, that was previously oxidized with the singlet oxygen (1O2) donor chloramine T (", "CT", "), to destroy plasmatic PAI-1 and alpha2-anti", "plasmin", "."], "h": {"pos": [1, 2], "type": null, "name": "CT ), to destroy plasmatic PAI-1 and alpha2-anti"}, "t": {"pos": [3, 4], "type": null, "name": "plasmin ."}}
{"relation": "DOWNREGULATOR", "token": ["Treatment of C57 BL/6 mice with ", "bleomycin", " increased fibroblast viability and collagen production and significantly downregulated ", "Nrf2", "."], "h": {"pos": [1, 2], "type": null, "name": "bleomycin  increased fibroblast viability and collagen production and significantly downregulated "}, "t": {"pos": [3, 4], "type": null, "name": "Nrf2 ."}}
{"relation": "DOWNREGULATOR", "token": ["To determine whether ", "3,4-methylenedioxymethamphetamine", " (MDMA)-induced reductions in ", "SERT", " density could be related to such a mechanism, p-chlorophenylalanine or MDMA was administered to rats, and brain serotonin and SERT density were measured."], "h": {"pos": [1, 2], "type": null, "name": "3,4-methylenedioxymethamphetamine  (MDMA)-induced reductions in "}, "t": {"pos": [3, 4], "type": null, "name": "SERT  density could be related to such a mechanism, p-chlorophenylalanine or MDMA was administered to rats, and brain serotonin and SERT density were measured."}}
{"relation": "PRODUCT-OF", "token": ["", "Uridine 5'-diphosphate- glucuronosyltransferases", " are colocalized with carboxylesterases and have the potential to further metabolize carboxylic acids to acyl glucuronides, but it is currently unknown if ", "acyl glucuronides", ", being esters, also interact with carboxylesterases."], "h": {"pos": [1, 2], "type": null, "name": "Uridine 5'-diphosphate- glucuronosyltransferases  are colocalized with carboxylesterases and have the potential to further metabolize carboxylic acids to acyl glucuronides, but it is currently unknown if "}, "t": {"pos": [3, 4], "type": null, "name": "acyl glucuronides , being esters, also interact with carboxylesterases."}}
{"relation": "PRODUCT-OF", "token": ["Reduced synthesis of nitric oxide (", "NO", ") contributes to the endothelial dysfunction and may be related to limited availability of L-arginine, the common substrate of constitutive nitric-oxide synthase (NOS) and cytosolic ", "arginase I", " and mitochondrial arginase II."], "h": {"pos": [1, 2], "type": null, "name": "NO ) contributes to the endothelial dysfunction and may be related to limited availability of L-arginine, the common substrate of constitutive nitric-oxide synthase (NOS) and cytosolic "}, "t": {"pos": [3, 4], "type": null, "name": "arginase I  and mitochondrial arginase II."}}
{"relation": "PRODUCT-OF", "token": ["6-DHSG was metabolised by GSH to form a GSH conjugate (", "GS-6-DHSG", ") in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of ", "glutathione-S-transferase", " (GST)."], "h": {"pos": [1, 2], "type": null, "name": "GS-6-DHSG ) in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of "}, "t": {"pos": [3, 4], "type": null, "name": "glutathione-S-transferase  (GST)."}}
{"relation": "PRODUCT-OF", "token": ["In addition, cells pre-treated with DL-propargylglycine (PAG, 3 mM), a CSE inhibitor, reduced the formation of H(2)S in caerulein treated cells, suggesting that ", "CSE", " may be the main enzyme involved in ", "H(2)S", " formation in mouse acinar cells."], "h": {"pos": [1, 2], "type": null, "name": "CSE  may be the main enzyme involved in "}, "t": {"pos": [3, 4], "type": null, "name": "H(2)S  formation in mouse acinar cells."}}
{"relation": "PRODUCT-OF", "token": ["During early pregnancy in sheep, the elongating conceptus secretes interferon-\u03c4 (IFNT) and the conceptus as well as endometrial epithelia produce ", "prostaglandins", " (PG) via PG synthase 2 (", "PTGS2", ") and cortisol via hydroxysteroid (11-\u03b2) dehydrogenase 1 (HSD11B1)."], "h": {"pos": [1, 2], "type": null, "name": "prostaglandins  (PG) via PG synthase 2 ("}, "t": {"pos": [3, 4], "type": null, "name": "PTGS2 ) and cortisol via hydroxysteroid (11-\u03b2) dehydrogenase 1 (HSD11B1)."}}
{"relation": "PRODUCT-OF", "token": ["", "Hydrogen sulphide", " (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (", "CBS", ")."], "h": {"pos": [1, 2], "type": null, "name": "Hydrogen sulphide  (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase ("}, "t": {"pos": [3, 4], "type": null, "name": "CBS )."}}
{"relation": "PRODUCT-OF", "token": ["The ultimate carcinogenic Phase I BP metabolite anti-BP-7,8-dihydrodiol-9,10-epoxide (BPDE) can be detoxified by ", "glutathione", " conjugate formation catalyzed by ", "glutathione S-transferases", "."], "h": {"pos": [1, 2], "type": null, "name": "glutathione  conjugate formation catalyzed by "}, "t": {"pos": [3, 4], "type": null, "name": "glutathione S-transferases ."}}
{"relation": "PRODUCT-OF", "token": ["As predicted, TES enhanced the production of both peroxynitrite precursors (i.e., superoxide and nitic oxide), and ", "xanthine oxidase", " was identified as the likely source of ", "TES", "-stimulated superoxide production."], "h": {"pos": [1, 2], "type": null, "name": "xanthine oxidase  was identified as the likely source of "}, "t": {"pos": [3, 4], "type": null, "name": "TES -stimulated superoxide production."}}
{"relation": "PRODUCT-OF", "token": ["PIP5K1B encodes phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I (", "pip5k1\u03b2", "), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate ", " PI(4,5)P2", "]."], "h": {"pos": [1, 2], "type": null, "name": "pip5k1\u03b2 ), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate "}, "t": {"pos": [3, 4], "type": null, "name": " PI(4,5)P2 ]."}}
{"relation": "PRODUCT-OF", "token": ["Ferredoxin 1 (", "FDX1", "; adrenodoxin) is an iron-sulfur protein that is involved in various metabolic processes, including ", "steroid", " hormone synthesis in mammalian tissues."], "h": {"pos": [1, 2], "type": null, "name": "FDX1 ; adrenodoxin) is an iron-sulfur protein that is involved in various metabolic processes, including "}, "t": {"pos": [3, 4], "type": null, "name": "steroid  hormone synthesis in mammalian tissues."}}
{"relation": "PRODUCT-OF", "token": ["However, whether increasing ", "EETs", " production by ", "CYP2J2", " overexpression in vivo could prevent abdominal aortic aneurysm (AAA) remains unknown."], "h": {"pos": [1, 2], "type": null, "name": "EETs  production by "}, "t": {"pos": [3, 4], "type": null, "name": "CYP2J2  overexpression in vivo could prevent abdominal aortic aneurysm (AAA) remains unknown."}}
{"relation": "PRODUCT-OF", "token": ["BACKGROUND AND AIMS: Glutamic acid decarboxylase (GAD, ", "EC 4.1.1.15", ") catalyses the conversion of glutamate to gamma-aminobutyric acid (", "GABA", ")."], "h": {"pos": [1, 2], "type": null, "name": "EC 4.1.1.15 ) catalyses the conversion of glutamate to gamma-aminobutyric acid ("}, "t": {"pos": [3, 4], "type": null, "name": "GABA )."}}
{"relation": "PRODUCT-OF", "token": ["", "Adenylosuccinate synthetase", " (AdSS) catalyzes the Mg2+ dependent condensation of a molecule of IMP with aspartate to form ", "adenylosuccinate", ", in a reaction driven by the hydrolysis of GTP to GDP."], "h": {"pos": [1, 2], "type": null, "name": "Adenylosuccinate synthetase  (AdSS) catalyzes the Mg2+ dependent condensation of a molecule of IMP with aspartate to form "}, "t": {"pos": [3, 4], "type": null, "name": "adenylosuccinate , in a reaction driven by the hydrolysis of GTP to GDP."}}
{"relation": "PRODUCT-OF", "token": ["In contrast, there was little change in mRNA levels for GTP cyclohydrolase I (", "GTPCH", "), the rate limiting enzyme in synthesis of the tetrahydrobiopterin (", "BH4", "), the obligate cofactor for TPH."], "h": {"pos": [1, 2], "type": null, "name": "GTPCH ), the rate limiting enzyme in synthesis of the tetrahydrobiopterin ("}, "t": {"pos": [3, 4], "type": null, "name": "BH4 ), the obligate cofactor for TPH."}}
{"relation": "PRODUCT-OF", "token": ["", "ATP-binding cassette transporter A1", " is involved in hepatic ", "alpha-tocopherol", " secretion."], "h": {"pos": [1, 2], "type": null, "name": "ATP-binding cassette transporter A1  is involved in hepatic "}, "t": {"pos": [3, 4], "type": null, "name": "alpha-tocopherol  secretion."}}
{"relation": "PRODUCT-OF", "token": ["PURPOSE: The fluoropyrimidine carbamate (capecitabine) is converted to 5-fluorouracil (", "5-FU", ") by thymidine phosphorylase (", "TP", ") inside target tissues."], "h": {"pos": [1, 2], "type": null, "name": "5-FU ) by thymidine phosphorylase ("}, "t": {"pos": [3, 4], "type": null, "name": "TP ) inside target tissues."}}
{"relation": "PRODUCT-OF", "token": ["However the regulatory mechanism of ", "histamine", " synthesis by ", "HDC", " remains to be elucidated."], "h": {"pos": [1, 2], "type": null, "name": "histamine  synthesis by "}, "t": {"pos": [3, 4], "type": null, "name": "HDC  remains to be elucidated."}}
{"relation": "PRODUCT-OF", "token": ["We concluded that FDH has no direct role in the regulation of the above two pathways of Ser synthesis; the breakdown of formate to ", "CO(2)", " by the ", "FDH", " reaction is the primary and preferred fate of the organic acid in Arabidopsis."], "h": {"pos": [1, 2], "type": null, "name": "CO(2)  by the "}, "t": {"pos": [3, 4], "type": null, "name": "FDH  reaction is the primary and preferred fate of the organic acid in Arabidopsis."}}
{"relation": "PRODUCT-OF", "token": ["The COX pathway generates inflammatory prostaglandins, while the ", "5-LOX", " pathway generates inflammatory ", "leukotrienes", "."], "h": {"pos": [1, 2], "type": null, "name": "5-LOX  pathway generates inflammatory "}, "t": {"pos": [3, 4], "type": null, "name": "leukotrienes ."}}
{"relation": "PRODUCT-OF", "token": ["Gemfibrozil, a lipid-lowering drug, inhibited cytokine-induced production of NO and the expression of ", "inducible nitric-oxide synthase", "", "nitric-oxide", " synthase (iNOS) in human U373MG astroglial cells and primary astrocytes."], "h": {"pos": [1, 2], "type": null, "name": "inducible nitric-oxide synthase "}, "t": {"pos": [3, 4], "type": null, "name": "nitric-oxide  synthase (iNOS) in human U373MG astroglial cells and primary astrocytes."}}
{"relation": "PRODUCT-OF", "token": ["The enzyme ", "cyclo-oxygenase", " catalyses the oxygenation of arachidonic acid, leading to the formation of ", "prostaglandins", "."], "h": {"pos": [1, 2], "type": null, "name": "cyclo-oxygenase  catalyses the oxygenation of arachidonic acid, leading to the formation of "}, "t": {"pos": [3, 4], "type": null, "name": "prostaglandins ."}}
{"relation": "PRODUCT-OF", "token": ["BACKGROUND AND AIMS: Glutamic acid decarboxylase (", "GAD", ", EC 4.1.1.15) catalyses the conversion of glutamate to gamma-aminobutyric acid (", "GABA", ")."], "h": {"pos": [1, 2], "type": null, "name": "GAD , EC 4.1.1.15) catalyses the conversion of glutamate to gamma-aminobutyric acid ("}, "t": {"pos": [3, 4], "type": null, "name": "GABA )."}}
{"relation": "PRODUCT-OF", "token": ["PURPOSE: The fluoropyrimidine carbamate (capecitabine) is converted to ", "5-fluorouracil", " (5-FU) by thymidine phosphorylase (", "TP", ") inside target tissues."], "h": {"pos": [1, 2], "type": null, "name": "5-fluorouracil  (5-FU) by thymidine phosphorylase ("}, "t": {"pos": [3, 4], "type": null, "name": "TP ) inside target tissues."}}
{"relation": "PRODUCT-OF", "token": ["", "Adenine phosphoribosyltransferase", " plays a role in purine salvage by catalyzing the direct conversion of adenine to ", "adenosine monophosphate", "."], "h": {"pos": [1, 2], "type": null, "name": "Adenine phosphoribosyltransferase  plays a role in purine salvage by catalyzing the direct conversion of adenine to "}, "t": {"pos": [3, 4], "type": null, "name": "adenosine monophosphate ."}}
{"relation": "PRODUCT-OF", "token": ["Favorable enzyme profiles (high ", "TP", " and low DPD) generate high intratumor levels of ", "5-FU", " that are effective against many tumors, especially those with low TS."], "h": {"pos": [1, 2], "type": null, "name": "TP  and low DPD) generate high intratumor levels of "}, "t": {"pos": [3, 4], "type": null, "name": "5-FU  that are effective against many tumors, especially those with low TS."}}
{"relation": "PRODUCT-OF", "token": ["Immunohistochemical characterization of ", "pyrimidine", " synthetic enzymes, thymidine kinase-1 and ", "thymidylate synthase", ", in various types of cancer."], "h": {"pos": [1, 2], "type": null, "name": "pyrimidine  synthetic enzymes, thymidine kinase-1 and "}, "t": {"pos": [3, 4], "type": null, "name": "thymidylate synthase , in various types of cancer."}}
{"relation": "PRODUCT-OF", "token": ["These results suggest that ACS1 and ", "ACS4", " may be linked to ", "triacylglycerol", " synthesis."], "h": {"pos": [1, 2], "type": null, "name": "ACS4  may be linked to "}, "t": {"pos": [3, 4], "type": null, "name": "triacylglycerol  synthesis."}}
{"relation": "PRODUCT-OF", "token": ["Cytochrome P450 epoxygenase 2J2 (", "CYP2J2", ") metabolizes arachidonic acids to form epoxyeicosatrienoic acids (", "EETs", "), which possess various beneficial effects on the cardiovascular system."], "h": {"pos": [1, 2], "type": null, "name": "CYP2J2 ) metabolizes arachidonic acids to form epoxyeicosatrienoic acids ("}, "t": {"pos": [3, 4], "type": null, "name": "EETs ), which possess various beneficial effects on the cardiovascular system."}}
{"relation": "PRODUCT-OF", "token": ["", "PGE(2)", " is synthesized from arachidonic acid by cyclooxygenases (COX) and prostaglandin E synthases (", "PGES", ") and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4)."], "h": {"pos": [1, 2], "type": null, "name": "PGE(2)  is synthesized from arachidonic acid by cyclooxygenases (COX) and prostaglandin E synthases ("}, "t": {"pos": [3, 4], "type": null, "name": "PGES ) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4)."}}
{"relation": "PRODUCT-OF", "token": ["We have previously reported that TZDs reduce ", "estrogen", " synthesis by inhibiting ", "aromatase", " activity in human granulosa cells (HGC)."], "h": {"pos": [1, 2], "type": null, "name": "estrogen  synthesis by inhibiting "}, "t": {"pos": [3, 4], "type": null, "name": "aromatase  activity in human granulosa cells (HGC)."}}
{"relation": "PRODUCT-OF", "token": ["BACKGROUND AND AIMS: ", "Glutamic acid decarboxylase", " (GAD, EC 4.1.1.15) catalyses the conversion of glutamate to ", "gamma-aminobutyric acid", " (GABA)."], "h": {"pos": [1, 2], "type": null, "name": "Glutamic acid decarboxylase  (GAD, EC 4.1.1.15) catalyses the conversion of glutamate to "}, "t": {"pos": [3, 4], "type": null, "name": "gamma-aminobutyric acid  (GABA)."}}
{"relation": "PRODUCT-OF", "token": ["As predicted, TES enhanced the production of both peroxynitrite precursors (i.e., superoxide and nitic oxide), and ", "xanthine oxidase", " was identified as the likely source of TES-stimulated ", "superoxide", " production."], "h": {"pos": [1, 2], "type": null, "name": "xanthine oxidase  was identified as the likely source of TES-stimulated "}, "t": {"pos": [3, 4], "type": null, "name": "superoxide  production."}}
{"relation": "PRODUCT-OF", "token": ["", "Hydrogen sulphide", " (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (", "CSE", ") and cystathionine-beta-synthase (CBS)."], "h": {"pos": [1, 2], "type": null, "name": "Hydrogen sulphide  (H(2)S) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase ("}, "t": {"pos": [3, 4], "type": null, "name": "CSE ) and cystathionine-beta-synthase (CBS)."}}
{"relation": "PRODUCT-OF", "token": ["", "L-serine dehydratase", " (SDH), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and L-threonine to yield pyruvate or ", "2-oxobutyrate", "."], "h": {"pos": [1, 2], "type": null, "name": "L-serine dehydratase  (SDH), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and L-threonine to yield pyruvate or "}, "t": {"pos": [3, 4], "type": null, "name": "2-oxobutyrate ."}}
{"relation": "PRODUCT-OF", "token": ["These results suggest that the altered gamma-glutamyl kinase results in stabilization of the complex or has an indirect effect on ", "gamma-glutamyl phosphate reductase", " activity, which leads to an increase in ", "L-proline", " production in Saccharomyces cerevisiae."], "h": {"pos": [1, 2], "type": null, "name": "gamma-glutamyl phosphate reductase  activity, which leads to an increase in "}, "t": {"pos": [3, 4], "type": null, "name": "L-proline  production in Saccharomyces cerevisiae."}}
{"relation": "PRODUCT-OF", "token": ["Gemfibrozil, a lipid-lowering drug, inhibited cytokine-induced production of NO and the expression of inducible ", "nitric-oxide", " synthase (", "iNOS", ") in human U373MG astroglial cells and primary astrocytes."], "h": {"pos": [1, 2], "type": null, "name": "nitric-oxide  synthase ("}, "t": {"pos": [3, 4], "type": null, "name": "iNOS ) in human U373MG astroglial cells and primary astrocytes."}}
{"relation": "PRODUCT-OF", "token": ["Gemfibrozil, a lipid-lowering drug, inhibited cytokine-induced production of ", "NO", " and the expression of ", "inducible nitric-oxide synthase", " (iNOS) in human U373MG astroglial cells and primary astrocytes."], "h": {"pos": [1, 2], "type": null, "name": "NO  and the expression of "}, "t": {"pos": [3, 4], "type": null, "name": "inducible nitric-oxide synthase  (iNOS) in human U373MG astroglial cells and primary astrocytes."}}
{"relation": "PRODUCT-OF", "token": ["Interestingly, the allele of PRO1 was shown to enhance the activities of ", "gamma-glutamyl kinase", " and gamma-glutamyl phosphate reductase, both of which catalyze the first two steps of ", "L-proline", " synthesis from L-glutamate and which together may form a complex in vivo."], "h": {"pos": [1, 2], "type": null, "name": "gamma-glutamyl kinase  and gamma-glutamyl phosphate reductase, both of which catalyze the first two steps of "}, "t": {"pos": [3, 4], "type": null, "name": "L-proline  synthesis from L-glutamate and which together may form a complex in vivo."}}
{"relation": "PRODUCT-OF", "token": ["One of the enzymes responsible for the production of ", "KA", ", ", "kynurenine aminotransferase I", " (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15)."], "h": {"pos": [1, 2], "type": null, "name": "KA , "}, "t": {"pos": [3, 4], "type": null, "name": "kynurenine aminotransferase I  (KATI), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15)."}}
{"relation": "PRODUCT-OF", "token": ["", "PIP5K1B", " encodes phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I (pip5k1\u03b2), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate ", " PI(4,5)P2", "]."], "h": {"pos": [1, 2], "type": null, "name": "PIP5K1B  encodes phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I (pip5k1\u03b2), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate "}, "t": {"pos": [3, 4], "type": null, "name": " PI(4,5)P2 ]."}}
{"relation": "PRODUCT-OF", "token": ["Interestingly, the allele of PRO1 was shown to enhance the activities of gamma-glutamyl kinase and ", "gamma-glutamyl phosphate reductase", ", both of which catalyze the first two steps of ", "L-proline", " synthesis from L-glutamate and which together may form a complex in vivo."], "h": {"pos": [1, 2], "type": null, "name": "gamma-glutamyl phosphate reductase , both of which catalyze the first two steps of "}, "t": {"pos": [3, 4], "type": null, "name": "L-proline  synthesis from L-glutamate and which together may form a complex in vivo."}}
{"relation": "PRODUCT-OF", "token": ["", "ACTH", "-stimulated peak cortisol, ", "delta cortisol", ", and delta DHEA-S levels are decreased during hyperthyroidism, probably due to increased turnover."], "h": {"pos": [1, 2], "type": null, "name": "ACTH -stimulated peak cortisol, "}, "t": {"pos": [3, 4], "type": null, "name": "delta cortisol , and delta DHEA-S levels are decreased during hyperthyroidism, probably due to increased turnover."}}
{"relation": "PRODUCT-OF", "token": ["Inhibition of ", "S-adenosylmethionine decarboxylase", " by a specific inhibitor [diethylglyoxal bis-(guanylhydrazone); DEGBG] led to depletion of ", "spermidine", " and spermine with a significant accumulation of putrescine and induction of ODC."], "h": {"pos": [1, 2], "type": null, "name": "S-adenosylmethionine decarboxylase  by a specific inhibitor [diethylglyoxal bis-(guanylhydrazone); DEGBG] led to depletion of "}, "t": {"pos": [3, 4], "type": null, "name": "spermidine  and spermine with a significant accumulation of putrescine and induction of ODC."}}
{"relation": "PRODUCT-OF", "token": ["Leukotriene A(4) hydrolase (", "LTA(4)H", ") is a cystolic enzyme that stereospecifically catalyzes the transformation of LTA(4) to ", "LTB(4)", "."], "h": {"pos": [1, 2], "type": null, "name": "LTA(4)H ) is a cystolic enzyme that stereospecifically catalyzes the transformation of LTA(4) to "}, "t": {"pos": [3, 4], "type": null, "name": "LTB(4) ."}}
{"relation": "PRODUCT-OF", "token": ["During early pregnancy in sheep, the elongating conceptus secretes interferon-\u03c4 (IFNT) and the conceptus as well as endometrial epithelia produce ", "prostaglandins", " (PG) via ", "PG synthase 2", " (PTGS2) and cortisol via hydroxysteroid (11-\u03b2) dehydrogenase 1 (HSD11B1)."], "h": {"pos": [1, 2], "type": null, "name": "prostaglandins  (PG) via "}, "t": {"pos": [3, 4], "type": null, "name": "PG synthase 2  (PTGS2) and cortisol via hydroxysteroid (11-\u03b2) dehydrogenase 1 (HSD11B1)."}}
{"relation": "PRODUCT-OF", "token": ["", "PGE(2)", " is synthesized from arachidonic acid by cyclooxygenases (", "COX", ") and prostaglandin E synthases (PGES) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4)."], "h": {"pos": [1, 2], "type": null, "name": "PGE(2)  is synthesized from arachidonic acid by cyclooxygenases ("}, "t": {"pos": [3, 4], "type": null, "name": "COX ) and prostaglandin E synthases (PGES) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4)."}}
{"relation": "PRODUCT-OF", "token": ["Inhibition of ", "S-adenosylmethionine decarboxylase", " by a specific inhibitor [diethylglyoxal bis-(guanylhydrazone); DEGBG] led to depletion of spermidine and ", "spermine", " with a significant accumulation of putrescine and induction of ODC."], "h": {"pos": [1, 2], "type": null, "name": "S-adenosylmethionine decarboxylase  by a specific inhibitor [diethylglyoxal bis-(guanylhydrazone); DEGBG] led to depletion of spermidine and "}, "t": {"pos": [3, 4], "type": null, "name": "spermine  with a significant accumulation of putrescine and induction of ODC."}}
{"relation": "PRODUCT-OF", "token": ["We have shown that ", "COX-2", " mediates acid-induced ", "PGE2", " production."], "h": {"pos": [1, 2], "type": null, "name": "COX-2  mediates acid-induced "}, "t": {"pos": [3, 4], "type": null, "name": "PGE2  production."}}
{"relation": "PRODUCT-OF", "token": ["Uridine 5'-diphosphate- glucuronosyltransferases are colocalized with ", "carboxylesterases", " and have the potential to further metabolize carboxylic acids to ", "acyl glucuronides", ", but it is currently unknown if acyl glucuronides, being esters, also interact with carboxylesterases."], "h": {"pos": [1, 2], "type": null, "name": "carboxylesterases  and have the potential to further metabolize carboxylic acids to "}, "t": {"pos": [3, 4], "type": null, "name": "acyl glucuronides , but it is currently unknown if acyl glucuronides, being esters, also interact with carboxylesterases."}}
{"relation": "PRODUCT-OF", "token": ["CONCLUSIONS: Total vitamin B6 is abnormally high in autism, consistent with previous reports of an impaired ", "pyridoxal kinase", " for the conversion of pyridoxine and pyridoxal to ", "PLP", "."], "h": {"pos": [1, 2], "type": null, "name": "pyridoxal kinase  for the conversion of pyridoxine and pyridoxal to "}, "t": {"pos": [3, 4], "type": null, "name": "PLP ."}}
{"relation": "PRODUCT-OF", "token": ["", "ACTH", "-stimulated peak ", "cortisol", ", delta cortisol, and delta DHEA-S levels are decreased during hyperthyroidism, probably due to increased turnover."], "h": {"pos": [1, 2], "type": null, "name": "ACTH -stimulated peak "}, "t": {"pos": [3, 4], "type": null, "name": "cortisol , delta cortisol, and delta DHEA-S levels are decreased during hyperthyroidism, probably due to increased turnover."}}
{"relation": "PRODUCT-OF", "token": ["These results suggest that the pro-inflammatory effect of ", "H(2)S", " may be mediated by ", "SP", "-NK-1R related pathway in mouse pancreatic acinar cells."], "h": {"pos": [1, 2], "type": null, "name": "H(2)S  may be mediated by "}, "t": {"pos": [3, 4], "type": null, "name": "SP -NK-1R related pathway in mouse pancreatic acinar cells."}}
{"relation": "PRODUCT-OF", "token": ["", "CPT I", " (carnitine palmitoyltransferase I) catalyses the conversion of palmitoyl-CoA into ", "palmitoylcarnitine", " in the presence of L-carnitine, facilitating the entry of fatty acids into mitochondria."], "h": {"pos": [1, 2], "type": null, "name": "CPT I  (carnitine palmitoyltransferase I) catalyses the conversion of palmitoyl-CoA into "}, "t": {"pos": [3, 4], "type": null, "name": "palmitoylcarnitine  in the presence of L-carnitine, facilitating the entry of fatty acids into mitochondria."}}
{"relation": "PRODUCT-OF", "token": ["PIP5K1B encodes ", "phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I", " (pip5k1\u03b2), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate ", " PI(4,5)P2", "]."], "h": {"pos": [1, 2], "type": null, "name": "phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I  (pip5k1\u03b2), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate "}, "t": {"pos": [3, 4], "type": null, "name": " PI(4,5)P2 ]."}}
{"relation": "PRODUCT-OF", "token": ["", "Thymidine kinase-1", " (TK-1) and thymidylate synthase (TS) are key enzymes for salvage and de novo ", "pyrimidine", " synthesis, respectively."], "h": {"pos": [1, 2], "type": null, "name": "Thymidine kinase-1  (TK-1) and thymidylate synthase (TS) are key enzymes for salvage and de novo "}, "t": {"pos": [3, 4], "type": null, "name": "pyrimidine  synthesis, respectively."}}
{"relation": "PRODUCT-OF", "token": ["Carnitine acetyltransferases (", "CrAT", ") catalyze the reversible conversion of acetyl-CoA and carnitine to ", "acetylcarnitine", " and free CoA."], "h": {"pos": [1, 2], "type": null, "name": "CrAT ) catalyze the reversible conversion of acetyl-CoA and carnitine to "}, "t": {"pos": [3, 4], "type": null, "name": "acetylcarnitine  and free CoA."}}
{"relation": "PRODUCT-OF", "token": ["Coagulation-induced ", "thromboxane B(2)", " and lipopolysaccharide-induced prostaglandin E(2) were measured ex vivo and in vitro in human whole blood as indices of ", "COX-1", " and COX-2 activity."], "h": {"pos": [1, 2], "type": null, "name": "thromboxane B(2)  and lipopolysaccharide-induced prostaglandin E(2) were measured ex vivo and in vitro in human whole blood as indices of "}, "t": {"pos": [3, 4], "type": null, "name": "COX-1  and COX-2 activity."}}
{"relation": "PRODUCT-OF", "token": ["Reduced synthesis of nitric oxide (", "NO", ") contributes to the endothelial dysfunction and may be related to limited availability of L-arginine, the common substrate of constitutive nitric-oxide synthase (", "NOS", ") and cytosolic arginase I and mitochondrial arginase II."], "h": {"pos": [1, 2], "type": null, "name": "NO ) contributes to the endothelial dysfunction and may be related to limited availability of L-arginine, the common substrate of constitutive nitric-oxide synthase ("}, "t": {"pos": [3, 4], "type": null, "name": "NOS ) and cytosolic arginase I and mitochondrial arginase II."}}
{"relation": "PRODUCT-OF", "token": ["BACKGROUND AND AIMS: Glutamic acid decarboxylase (", "GAD", ", EC 4.1.1.15) catalyses the conversion of glutamate to ", "gamma-aminobutyric acid", " (GABA)."], "h": {"pos": [1, 2], "type": null, "name": "GAD , EC 4.1.1.15) catalyses the conversion of glutamate to "}, "t": {"pos": [3, 4], "type": null, "name": "gamma-aminobutyric acid  (GABA)."}}
{"relation": "PRODUCT-OF", "token": ["Follicle-stimulating hormone (", "FSH", "), a dimeric glycoprotein synthesized in the anterior pituitary gland, is important for the production of sex ", "steroids", " and gametes."], "h": {"pos": [1, 2], "type": null, "name": "FSH ), a dimeric glycoprotein synthesized in the anterior pituitary gland, is important for the production of sex "}, "t": {"pos": [3, 4], "type": null, "name": "steroids  and gametes."}}
{"relation": "PRODUCT-OF", "token": ["In contrast, there was little change in mRNA levels for GTP cyclohydrolase I (", "GTPCH", "), the rate limiting enzyme in synthesis of the ", "tetrahydrobiopterin", " (BH4), the obligate cofactor for TPH."], "h": {"pos": [1, 2], "type": null, "name": "GTPCH ), the rate limiting enzyme in synthesis of the "}, "t": {"pos": [3, 4], "type": null, "name": "tetrahydrobiopterin  (BH4), the obligate cofactor for TPH."}}
{"relation": "PRODUCT-OF", "token": ["BACKGROUND AND AIMS: ", "Glutamic acid decarboxylase", " (GAD, EC 4.1.1.15) catalyses the conversion of glutamate to gamma-aminobutyric acid (", "GABA", ")."], "h": {"pos": [1, 2], "type": null, "name": "Glutamic acid decarboxylase  (GAD, EC 4.1.1.15) catalyses the conversion of glutamate to gamma-aminobutyric acid ("}, "t": {"pos": [3, 4], "type": null, "name": "GABA )."}}
{"relation": "PRODUCT-OF", "token": ["", "Cytochrome P450 epoxygenase 2J2", " (CYP2J2) metabolizes arachidonic acids to form ", "epoxyeicosatrienoic acids", " (EETs), which possess various beneficial effects on the cardiovascular system."], "h": {"pos": [1, 2], "type": null, "name": "Cytochrome P450 epoxygenase 2J2  (CYP2J2) metabolizes arachidonic acids to form "}, "t": {"pos": [3, 4], "type": null, "name": "epoxyeicosatrienoic acids  (EETs), which possess various beneficial effects on the cardiovascular system."}}
{"relation": "PRODUCT-OF", "token": ["Gemfibrozil, a lipid-lowering drug, inhibits the induction of ", "nitric-oxide synthase", "", "nitric-oxide", " synthase in human astrocytes."], "h": {"pos": [1, 2], "type": null, "name": "nitric-oxide synthase "}, "t": {"pos": [3, 4], "type": null, "name": "nitric-oxide  synthase in human astrocytes."}}
{"relation": "PRODUCT-OF", "token": ["Inhibition of ", "SIRT1", " significantly increased vascular ", "superoxide", " production, enhanced NADPH oxidase activity, and mRNA expression of its subunits p22(phox) and NOX4, which were prevented by resveratrol."], "h": {"pos": [1, 2], "type": null, "name": "SIRT1  significantly increased vascular "}, "t": {"pos": [3, 4], "type": null, "name": "superoxide  production, enhanced NADPH oxidase activity, and mRNA expression of its subunits p22(phox) and NOX4, which were prevented by resveratrol."}}
{"relation": "PRODUCT-OF", "token": ["Hydrogen sulphide (", "H(2)S", ") is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (", "CBS", ")."], "h": {"pos": [1, 2], "type": null, "name": "H(2)S ) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase ("}, "t": {"pos": [3, 4], "type": null, "name": "CBS )."}}
{"relation": "PRODUCT-OF", "token": ["The ratio between the GDC/", "SHMT", " and C1-THF synthase/SHMT pathways of ", "Ser", " synthesis from [alpha-(13)C]Gly and [(13)C]formate, respectively, in Arabidopsis shoots was 21 : 1; in roots, 9 : 1."], "h": {"pos": [1, 2], "type": null, "name": "SHMT  and C1-THF synthase/SHMT pathways of "}, "t": {"pos": [3, 4], "type": null, "name": "Ser  synthesis from [alpha-(13)C]Gly and [(13)C]formate, respectively, in Arabidopsis shoots was 21 : 1; in roots, 9 : 1."}}
{"relation": "PRODUCT-OF", "token": ["", "LDH", " is responsible for pyruvate conversion to ", "lactate", " through glycolysis."], "h": {"pos": [1, 2], "type": null, "name": "LDH  is responsible for pyruvate conversion to "}, "t": {"pos": [3, 4], "type": null, "name": "lactate  through glycolysis."}}
{"relation": "PRODUCT-OF", "token": ["Adenylosuccinate synthetase (", "AdSS", ") catalyzes the Mg2+ dependent condensation of a molecule of IMP with aspartate to form ", "adenylosuccinate", ", in a reaction driven by the hydrolysis of GTP to GDP."], "h": {"pos": [1, 2], "type": null, "name": "AdSS ) catalyzes the Mg2+ dependent condensation of a molecule of IMP with aspartate to form "}, "t": {"pos": [3, 4], "type": null, "name": "adenylosuccinate , in a reaction driven by the hydrolysis of GTP to GDP."}}
{"relation": "PRODUCT-OF", "token": ["", "Phosphatidylserine", " (PtdSer) is made in mammalian cells by two PtdSer synthases, PSS1 and ", "PSS2", "."], "h": {"pos": [1, 2], "type": null, "name": "Phosphatidylserine  (PtdSer) is made in mammalian cells by two PtdSer synthases, PSS1 and "}, "t": {"pos": [3, 4], "type": null, "name": "PSS2 ."}}
{"relation": "PRODUCT-OF", "token": ["Platelet-induced ", "COX-2", "-dependent ", "PGE2", " synthesis in HT29 cells was involved in downregulation of p21(WAF1/CIP1) and upregulation of cyclinB1, since these effects were prevented by rofecoxib(a selective COX-2 inhibitor) and rescued by exogenous PGE2."], "h": {"pos": [1, 2], "type": null, "name": "COX-2 -dependent "}, "t": {"pos": [3, 4], "type": null, "name": "PGE2  synthesis in HT29 cells was involved in downregulation of p21(WAF1/CIP1) and upregulation of cyclinB1, since these effects were prevented by rofecoxib(a selective COX-2 inhibitor) and rescued by exogenous PGE2."}}
{"relation": "PRODUCT-OF", "token": ["", "Uridine 5'-diphosphate- glucuronosyltransferases", " are colocalized with carboxylesterases and have the potential to further metabolize carboxylic acids to ", "acyl glucuronides", ", but it is currently unknown if acyl glucuronides, being esters, also interact with carboxylesterases."], "h": {"pos": [1, 2], "type": null, "name": "Uridine 5'-diphosphate- glucuronosyltransferases  are colocalized with carboxylesterases and have the potential to further metabolize carboxylic acids to "}, "t": {"pos": [3, 4], "type": null, "name": "acyl glucuronides , but it is currently unknown if acyl glucuronides, being esters, also interact with carboxylesterases."}}
{"relation": "PRODUCT-OF", "token": ["These findings, derived from a variety of analytical and functional approaches, provide evidence for a novel nongenomic signaling mechanism for androgen action in the microvasculature: TES-stimulated vasodilation mediated primarily by ", "peroxynitrite", " formed from ", "xanthine oxidase", "-generated superoxide and NO."], "h": {"pos": [1, 2], "type": null, "name": "peroxynitrite  formed from "}, "t": {"pos": [3, 4], "type": null, "name": "xanthine oxidase -generated superoxide and NO."}}
{"relation": "PRODUCT-OF", "token": ["First, addition of apolipoprotein A-I (", "apoA-I", "), a direct acceptor of the ATP-binding cassette transporter A1 (ABCA1)-secreted lipids, increased ", "alpha-tocopherol", " secretion in a dose-dependent manner."], "h": {"pos": [1, 2], "type": null, "name": "apoA-I ), a direct acceptor of the ATP-binding cassette transporter A1 (ABCA1)-secreted lipids, increased "}, "t": {"pos": [3, 4], "type": null, "name": "alpha-tocopherol  secretion in a dose-dependent manner."}}
{"relation": "PRODUCT-OF", "token": ["These results suggest that the altered ", "gamma-glutamyl kinase", " results in stabilization of the complex or has an indirect effect on gamma-glutamyl phosphate reductase activity, which leads to an increase in ", "L-proline", " production in Saccharomyces cerevisiae."], "h": {"pos": [1, 2], "type": null, "name": "gamma-glutamyl kinase  results in stabilization of the complex or has an indirect effect on gamma-glutamyl phosphate reductase activity, which leads to an increase in "}, "t": {"pos": [3, 4], "type": null, "name": "L-proline  production in Saccharomyces cerevisiae."}}
{"relation": "PRODUCT-OF", "token": ["We also shortly discuss the ongoing debate on whether ", "NO", " is the actual reaction product of ", "NOS", " catalysis, as well as the phenomenon of NO-mediated autoinhibition."], "h": {"pos": [1, 2], "type": null, "name": "NO  is the actual reaction product of "}, "t": {"pos": [3, 4], "type": null, "name": "NOS  catalysis, as well as the phenomenon of NO-mediated autoinhibition."}}
{"relation": "PRODUCT-OF", "token": ["Gemfibrozil, a lipid-lowering drug, inhibited cytokine-induced production of ", "NO", " and the expression of inducible nitric-oxide synthase (", "iNOS", ") in human U373MG astroglial cells and primary astrocytes."], "h": {"pos": [1, 2], "type": null, "name": "NO  and the expression of inducible nitric-oxide synthase ("}, "t": {"pos": [3, 4], "type": null, "name": "iNOS ) in human U373MG astroglial cells and primary astrocytes."}}
{"relation": "PRODUCT-OF", "token": ["", "Carboxylesterases", " hydrolyze esters, amides, and thioesters to produce ", "carboxylic acids", " and resulting alcohols, amines, and thiols, respectively."], "h": {"pos": [1, 2], "type": null, "name": "Carboxylesterases  hydrolyze esters, amides, and thioesters to produce "}, "t": {"pos": [3, 4], "type": null, "name": "carboxylic acids  and resulting alcohols, amines, and thiols, respectively."}}
{"relation": "PRODUCT-OF", "token": ["First, addition of apolipoprotein A-I (apoA-I), a direct acceptor of the ", "ATP-binding cassette transporter A1", " (ABCA1)-secreted lipids, increased ", "alpha-tocopherol", " secretion in a dose-dependent manner."], "h": {"pos": [1, 2], "type": null, "name": "ATP-binding cassette transporter A1  (ABCA1)-secreted lipids, increased "}, "t": {"pos": [3, 4], "type": null, "name": "alpha-tocopherol  secretion in a dose-dependent manner."}}
{"relation": "PRODUCT-OF", "token": ["Unlike mouse RetSat (mRetSat), ", "zRetSat A", " had an altered bond specificity saturating either the 13-14 or 7-8 double bonds of all-trans-retinol to produce either all-trans-13,14-dihydroretinol or ", "all-trans-7,8-dihydroretinol", ", respectively."], "h": {"pos": [1, 2], "type": null, "name": "zRetSat A  had an altered bond specificity saturating either the 13-14 or 7-8 double bonds of all-trans-retinol to produce either all-trans-13,14-dihydroretinol or "}, "t": {"pos": [3, 4], "type": null, "name": "all-trans-7,8-dihydroretinol , respectively."}}
{"relation": "PRODUCT-OF", "token": ["L-serine dehydratase (", "SDH", "), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and L-threonine to yield ", "pyruvate", " or 2-oxobutyrate."], "h": {"pos": [1, 2], "type": null, "name": "SDH ), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and L-threonine to yield "}, "t": {"pos": [3, 4], "type": null, "name": "pyruvate  or 2-oxobutyrate."}}
{"relation": "PRODUCT-OF", "token": ["", "Leukotriene A(4) hydrolase", " (LTA(4)H) is a cystolic enzyme that stereospecifically catalyzes the transformation of LTA(4) to ", "LTB(4)", "."], "h": {"pos": [1, 2], "type": null, "name": "Leukotriene A(4) hydrolase  (LTA(4)H) is a cystolic enzyme that stereospecifically catalyzes the transformation of LTA(4) to "}, "t": {"pos": [3, 4], "type": null, "name": "LTB(4) ."}}
{"relation": "PRODUCT-OF", "token": ["", "Aldo-keto reductases", " (AKRs) metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons (PAHs), generating metabolites (o-quinones) and reactive ", "oxygen", " species (ROS), which are capable of initiating and promoting carcinogenesis."], "h": {"pos": [1, 2], "type": null, "name": "Aldo-keto reductases  (AKRs) metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons (PAHs), generating metabolites (o-quinones) and reactive "}, "t": {"pos": [3, 4], "type": null, "name": "oxygen  species (ROS), which are capable of initiating and promoting carcinogenesis."}}
{"relation": "PRODUCT-OF", "token": ["6-DHSG was metabolised by GSH to form a GSH conjugate (", "GS-6-DHSG", ") in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of glutathione-S-transferase (", "GST", ")."], "h": {"pos": [1, 2], "type": null, "name": "GS-6-DHSG ) in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of glutathione-S-transferase ("}, "t": {"pos": [3, 4], "type": null, "name": "GST )."}}
{"relation": "PRODUCT-OF", "token": ["L-serine dehydratase (", "SDH", "), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and L-threonine to yield pyruvate or ", "2-oxobutyrate", "."], "h": {"pos": [1, 2], "type": null, "name": "SDH ), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and L-threonine to yield pyruvate or "}, "t": {"pos": [3, 4], "type": null, "name": "2-oxobutyrate ."}}
{"relation": "PRODUCT-OF", "token": ["The latter reaction, catalyzed by aspartoacylase (", "ASPA", "), produces acetyl groups plus ", "aspartate", " and has been proposed to occur in both soluble and membranous subfractions of white matter."], "h": {"pos": [1, 2], "type": null, "name": "ASPA ), produces acetyl groups plus "}, "t": {"pos": [3, 4], "type": null, "name": "aspartate  and has been proposed to occur in both soluble and membranous subfractions of white matter."}}
{"relation": "PRODUCT-OF", "token": ["Depletion of ", "putrescine", ", spermidine, and spermine by DL-alpha-difluoromethylornithine (DFMO), a specific inhibitor of ornithine decarboxylase (", "ODC", ") that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index."], "h": {"pos": [1, 2], "type": null, "name": "putrescine , spermidine, and spermine by DL-alpha-difluoromethylornithine (DFMO), a specific inhibitor of ornithine decarboxylase ("}, "t": {"pos": [3, 4], "type": null, "name": "ODC ) that is the first rate-limiting enzyme for polyamine biosynthesis, decreased the apoptotic index."}}
{"relation": "PRODUCT-OF", "token": ["We conclude that ", "mPGES1", " mediates acid-induced increase in ", "PGE2", " production and cell proliferation."], "h": {"pos": [1, 2], "type": null, "name": "mPGES1  mediates acid-induced increase in "}, "t": {"pos": [3, 4], "type": null, "name": "PGE2  production and cell proliferation."}}
{"relation": "PRODUCT-OF", "token": ["Favorable enzyme profiles (high TP and low ", "DPD", ") generate high intratumor levels of ", "5-FU", " that are effective against many tumors, especially those with low TS."], "h": {"pos": [1, 2], "type": null, "name": "DPD ) generate high intratumor levels of "}, "t": {"pos": [3, 4], "type": null, "name": "5-FU  that are effective against many tumors, especially those with low TS."}}
{"relation": "PRODUCT-OF", "token": ["Cycloxygenase-2 (", "COX-2", ")-derived prostaglandin E2 (", "PGE2", ") has been shown to be important in esophageal tumorigenesis."], "h": {"pos": [1, 2], "type": null, "name": "COX-2 )-derived prostaglandin E2 ("}, "t": {"pos": [3, 4], "type": null, "name": "PGE2 ) has been shown to be important in esophageal tumorigenesis."}}
{"relation": "PRODUCT-OF", "token": ["These results strongly suggest that ", "ABCA1", " is substantially involved in hepatic ", "alpha-tocopherol", " secretion."], "h": {"pos": [1, 2], "type": null, "name": "ABCA1  is substantially involved in hepatic "}, "t": {"pos": [3, 4], "type": null, "name": "alpha-tocopherol  secretion."}}
{"relation": "PRODUCT-OF", "token": ["Hydrogen sulphide (", "H(2)S", ") is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and ", "cystathionine-beta-synthase", " (CBS)."], "h": {"pos": [1, 2], "type": null, "name": "H(2)S ) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (CSE) and "}, "t": {"pos": [3, 4], "type": null, "name": "cystathionine-beta-synthase  (CBS)."}}
{"relation": "PRODUCT-OF", "token": ["Unlike mouse RetSat (mRetSat), ", "zRetSat A", " had an altered bond specificity saturating either the 13-14 or 7-8 double bonds of all-trans-retinol to produce either ", "all-trans-13,14-dihydroretinol", " or all-trans-7,8-dihydroretinol, respectively."], "h": {"pos": [1, 2], "type": null, "name": "zRetSat A  had an altered bond specificity saturating either the 13-14 or 7-8 double bonds of all-trans-retinol to produce either "}, "t": {"pos": [3, 4], "type": null, "name": "all-trans-13,14-dihydroretinol  or all-trans-7,8-dihydroretinol, respectively."}}
{"relation": "PRODUCT-OF", "token": ["One of the enzymes responsible for the production of ", "KA", ", kynurenine aminotransferase I (", "KATI", "), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15)."], "h": {"pos": [1, 2], "type": null, "name": "KA , kynurenine aminotransferase I ("}, "t": {"pos": [3, 4], "type": null, "name": "KATI ), also catalyses the reversible transamination of glutamine to oxoglutaramic acid (GTK, EC 2.6.1.15)."}}
{"relation": "PRODUCT-OF", "token": ["Hydrogen sulphide (", "H(2)S", ") is synthesized from L-cysteine via the action of ", "cystathionine-gamma-lyase", " (CSE) and cystathionine-beta-synthase (CBS)."], "h": {"pos": [1, 2], "type": null, "name": "H(2)S ) is synthesized from L-cysteine via the action of "}, "t": {"pos": [3, 4], "type": null, "name": "cystathionine-gamma-lyase  (CSE) and cystathionine-beta-synthase (CBS)."}}
{"relation": "PRODUCT-OF", "token": ["", "Mouse brain serine racemase", " catalyzes specific elimination of L-serine to ", "pyruvate", "."], "h": {"pos": [1, 2], "type": null, "name": "Mouse brain serine racemase  catalyzes specific elimination of L-serine to "}, "t": {"pos": [3, 4], "type": null, "name": "pyruvate ."}}
{"relation": "PRODUCT-OF", "token": ["", "Mitochondrial arginase II", " modulates ", "nitric-oxide", " synthesis through nonfreely exchangeable L-arginine pools in human endothelial cells."], "h": {"pos": [1, 2], "type": null, "name": "Mitochondrial arginase II  modulates "}, "t": {"pos": [3, 4], "type": null, "name": "nitric-oxide  synthesis through nonfreely exchangeable L-arginine pools in human endothelial cells."}}
{"relation": "PRODUCT-OF", "token": ["Our results indicate that Salix extract 1520L inhibits ", "COX-2", "-mediated ", "PGE2", " release through compounds other than salicin or salicylate."], "h": {"pos": [1, 2], "type": null, "name": "COX-2 -mediated "}, "t": {"pos": [3, 4], "type": null, "name": "PGE2  release through compounds other than salicin or salicylate."}}
{"relation": "PRODUCT-OF", "token": ["Aldo-keto reductases (", "AKRs", ") metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons (PAHs), generating metabolites (o-quinones) and reactive ", "oxygen", " species (ROS), which are capable of initiating and promoting carcinogenesis."], "h": {"pos": [1, 2], "type": null, "name": "AKRs ) metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons (PAHs), generating metabolites (o-quinones) and reactive "}, "t": {"pos": [3, 4], "type": null, "name": "oxygen  species (ROS), which are capable of initiating and promoting carcinogenesis."}}
{"relation": "PRODUCT-OF", "token": ["", "ACTH", "-stimulated peak cortisol, delta cortisol, and ", "delta DHEA", "-S levels are decreased during hyperthyroidism, probably due to increased turnover."], "h": {"pos": [1, 2], "type": null, "name": "ACTH -stimulated peak cortisol, delta cortisol, and "}, "t": {"pos": [3, 4], "type": null, "name": "delta DHEA -S levels are decreased during hyperthyroidism, probably due to increased turnover."}}
{"relation": "PRODUCT-OF", "token": ["Methionine synthase reductase (", "MTRR", ") is an enzyme involved in the conversion of Hcy to ", "methionine", "."], "h": {"pos": [1, 2], "type": null, "name": "MTRR ) is an enzyme involved in the conversion of Hcy to "}, "t": {"pos": [3, 4], "type": null, "name": "methionine ."}}
{"relation": "PRODUCT-OF", "token": ["These results suggest that ", "ACS1", " and ACS4 may be linked to ", "triacylglycerol", " synthesis."], "h": {"pos": [1, 2], "type": null, "name": "ACS1  and ACS4 may be linked to "}, "t": {"pos": [3, 4], "type": null, "name": "triacylglycerol  synthesis."}}
{"relation": "PRODUCT-OF", "token": ["N-Acetylglucosamine-1-phosphodiester alpha-N-Acetylglucosaminidase (", "EC 3.1.4.45", "; phosphodiester alpha-GlcNAcase) catalyzes the second step in the synthesis of the ", "mannose 6-phosphate", " determinant required for efficient intracellular targeting of newly synthesized lysosomal hydrolases to the lysosome."], "h": {"pos": [1, 2], "type": null, "name": "EC 3.1.4.45 ; phosphodiester alpha-GlcNAcase) catalyzes the second step in the synthesis of the "}, "t": {"pos": [3, 4], "type": null, "name": "mannose 6-phosphate  determinant required for efficient intracellular targeting of newly synthesized lysosomal hydrolases to the lysosome."}}
{"relation": "PRODUCT-OF", "token": ["PIP5K1B encodes phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I (", "pip5k1\u03b2", "), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate ", "phosphatidylinositol-4,5-bisphosphate", " [PI(4,5)P2]."], "h": {"pos": [1, 2], "type": null, "name": "pip5k1\u03b2 ), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate [PI(4)P] to generate "}, "t": {"pos": [3, 4], "type": null, "name": "phosphatidylinositol-4,5-bisphosphate  [PI(4,5)P2]."}}
{"relation": "PRODUCT-OF", "token": ["Hydrogen sulphide (", "H(2)S", ") is synthesized from L-cysteine via the action of cystathionine-gamma-lyase (", "CSE", ") and cystathionine-beta-synthase (CBS)."], "h": {"pos": [1, 2], "type": null, "name": "H(2)S ) is synthesized from L-cysteine via the action of cystathionine-gamma-lyase ("}, "t": {"pos": [3, 4], "type": null, "name": "CSE ) and cystathionine-beta-synthase (CBS)."}}
{"relation": "PRODUCT-OF", "token": ["", "L-proline", " accumulation and freeze tolerance of Saccharomyces cerevisiae are caused by a mutation in the PRO1 gene encoding ", "gamma-glutamyl kinase", "."], "h": {"pos": [1, 2], "type": null, "name": "L-proline  accumulation and freeze tolerance of Saccharomyces cerevisiae are caused by a mutation in the PRO1 gene encoding "}, "t": {"pos": [3, 4], "type": null, "name": "gamma-glutamyl kinase ."}}
{"relation": "PRODUCT-OF", "token": ["In contrast, there was little change in mRNA levels for ", "GTP cyclohydrolase I", " (GTPCH), the rate limiting enzyme in synthesis of the ", "tetrahydrobiopterin", " (BH4), the obligate cofactor for TPH."], "h": {"pos": [1, 2], "type": null, "name": "GTP cyclohydrolase I  (GTPCH), the rate limiting enzyme in synthesis of the "}, "t": {"pos": [3, 4], "type": null, "name": "tetrahydrobiopterin  (BH4), the obligate cofactor for TPH."}}
{"relation": "PRODUCT-OF", "token": ["BACKGROUND & AIMS: Of the 2 genes (MAT1A, MAT2A) encoding ", "methionine adenosyltransferase", ", the enzyme that synthesizes ", "S-adenosylmethionine", ", MAT1A, is expressed in liver, whereas MAT2A is expressed in extrahepatic tissues."], "h": {"pos": [1, 2], "type": null, "name": "methionine adenosyltransferase , the enzyme that synthesizes "}, "t": {"pos": [3, 4], "type": null, "name": "S-adenosylmethionine , MAT1A, is expressed in liver, whereas MAT2A is expressed in extrahepatic tissues."}}
{"relation": "PRODUCT-OF", "token": ["Ferredoxin 1 (FDX1; ", "adrenodoxin", ") is an iron-sulfur protein that is involved in various metabolic processes, including ", "steroid hormone", " synthesis in mammalian tissues."], "h": {"pos": [1, 2], "type": null, "name": "adrenodoxin ) is an iron-sulfur protein that is involved in various metabolic processes, including "}, "t": {"pos": [3, 4], "type": null, "name": "steroid hormone  synthesis in mammalian tissues."}}
{"relation": "PRODUCT-OF", "token": ["Reduced synthesis of ", "nitric oxide", " (NO) contributes to the endothelial dysfunction and may be related to limited availability of L-arginine, the common substrate of constitutive nitric-oxide synthase (", "NOS", ") and cytosolic arginase I and mitochondrial arginase II."], "h": {"pos": [1, 2], "type": null, "name": "nitric oxide  (NO) contributes to the endothelial dysfunction and may be related to limited availability of L-arginine, the common substrate of constitutive nitric-oxide synthase ("}, "t": {"pos": [3, 4], "type": null, "name": "NOS ) and cytosolic arginase I and mitochondrial arginase II."}}
{"relation": "PRODUCT-OF", "token": ["The ", "COX", " pathway generates inflammatory ", "prostaglandins", ", while the 5-LOX pathway generates inflammatory leukotrienes."], "h": {"pos": [1, 2], "type": null, "name": "COX  pathway generates inflammatory "}, "t": {"pos": [3, 4], "type": null, "name": "prostaglandins , while the 5-LOX pathway generates inflammatory leukotrienes."}}
{"relation": "PRODUCT-OF", "token": ["BACKGROUND & AIMS: Of the 2 genes (", "MAT1A", ", MAT2A) encoding methionine adenosyltransferase, the enzyme that synthesizes ", "S-adenosylmethionine", ", MAT1A, is expressed in liver, whereas MAT2A is expressed in extrahepatic tissues."], "h": {"pos": [1, 2], "type": null, "name": "MAT1A , MAT2A) encoding methionine adenosyltransferase, the enzyme that synthesizes "}, "t": {"pos": [3, 4], "type": null, "name": "S-adenosylmethionine , MAT1A, is expressed in liver, whereas MAT2A is expressed in extrahepatic tissues."}}
{"relation": "PRODUCT-OF", "token": ["METHODS: ", "Cyclooxygenase", " activity and selectivity was determined in vitro by measuring ", "prostaglandin E(2)", " (PGE(2)) production following incubation of varying concentrations of NSAID with human recombinant COX-1 or COX-2 and arachidonic acid."], "h": {"pos": [1, 2], "type": null, "name": "Cyclooxygenase  activity and selectivity was determined in vitro by measuring "}, "t": {"pos": [3, 4], "type": null, "name": "prostaglandin E(2)  (PGE(2)) production following incubation of varying concentrations of NSAID with human recombinant COX-1 or COX-2 and arachidonic acid."}}
{"relation": "PRODUCT-OF", "token": ["First, addition of apolipoprotein A-I (apoA-I), a direct acceptor of the ATP-binding cassette transporter A1 (", "ABCA1", ")-secreted lipids, increased ", "alpha-tocopherol", " secretion in a dose-dependent manner."], "h": {"pos": [1, 2], "type": null, "name": "ABCA1 )-secreted lipids, increased "}, "t": {"pos": [3, 4], "type": null, "name": "alpha-tocopherol  secretion in a dose-dependent manner."}}
{"relation": "PRODUCT-OF", "token": ["Third, ", "ABCA1", "-RNAi suppressed hepatic ", "alpha-tocopherol", " secretion."], "h": {"pos": [1, 2], "type": null, "name": "ABCA1 -RNAi suppressed hepatic "}, "t": {"pos": [3, 4], "type": null, "name": "alpha-tocopherol  secretion."}}
{"relation": "PRODUCT-OF", "token": ["Humans with ", "FSH beta", " gene mutations tend to have a more severe phenotype than those with FSHR gene mutations, although infertility and varying degrees of impaired sex ", "steroid", " production occur in both types of mutations."], "h": {"pos": [1, 2], "type": null, "name": "FSH beta  gene mutations tend to have a more severe phenotype than those with FSHR gene mutations, although infertility and varying degrees of impaired sex "}, "t": {"pos": [3, 4], "type": null, "name": "steroid  production occur in both types of mutations."}}
{"relation": "PRODUCT-OF", "token": ["In kidneys, stimulation of adenylyl cyclase causes egress of cAMP, conversion of cAMP to ", "AMP", " by ecto-", "phosphodiesterase", ", and metabolism of AMP to adenosine by ecto-5'-nucleotidase."], "h": {"pos": [1, 2], "type": null, "name": "AMP  by ecto-"}, "t": {"pos": [3, 4], "type": null, "name": "phosphodiesterase , and metabolism of AMP to adenosine by ecto-5'-nucleotidase."}}
{"relation": "SUBSTRATE", "token": ["One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, ", "EC 2.1.1.10", ") and serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) with ", "glycine", " (Gly) as one-carbon (1-C) source."], "h": {"pos": [1, 2], "type": null, "name": "EC 2.1.1.10 ) and serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) with "}, "t": {"pos": [3, 4], "type": null, "name": "glycine  (Gly) as one-carbon (1-C) source."}}
{"relation": "SUBSTRATE", "token": ["Uridine 5'-diphosphate- glucuronosyltransferases are colocalized with ", "carboxylesterases", " and have the potential to further metabolize ", "carboxylic acids", " to acyl glucuronides, but it is currently unknown if acyl glucuronides, being esters, also interact with carboxylesterases."], "h": {"pos": [1, 2], "type": null, "name": "carboxylesterases  and have the potential to further metabolize "}, "t": {"pos": [3, 4], "type": null, "name": "carboxylic acids  to acyl glucuronides, but it is currently unknown if acyl glucuronides, being esters, also interact with carboxylesterases."}}
{"relation": "SUBSTRATE", "token": ["The ", "M564G", " mutated CrAT showed higher activity toward longer chain ", "acyl-CoAs", ": activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, acetyl-CoA."], "h": {"pos": [1, 2], "type": null, "name": "M564G  mutated CrAT showed higher activity toward longer chain "}, "t": {"pos": [3, 4], "type": null, "name": "acyl-CoAs : activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, acetyl-CoA."}}
{"relation": "SUBSTRATE", "token": ["In the presence of the system L inhibitor BCH, Na(+)-dependent ", "l-alanine", " uptake in WKY and SHR PTE cells was inhibited by alanine, serine, and cysteine, which is consistent with amino acid transport through ", "ASCT2", "."], "h": {"pos": [1, 2], "type": null, "name": "l-alanine  uptake in WKY and SHR PTE cells was inhibited by alanine, serine, and cysteine, which is consistent with amino acid transport through "}, "t": {"pos": [3, 4], "type": null, "name": "ASCT2 ."}}
{"relation": "SUBSTRATE", "token": ["PURPOSE: The ", "fluoropyrimidine carbamate", " (capecitabine) is converted to 5-fluorouracil (5-FU) by ", "thymidine phosphorylase", " (TP) inside target tissues."], "h": {"pos": [1, 2], "type": null, "name": "fluoropyrimidine carbamate  (capecitabine) is converted to 5-fluorouracil (5-FU) by "}, "t": {"pos": [3, 4], "type": null, "name": "thymidine phosphorylase  (TP) inside target tissues."}}
{"relation": "SUBSTRATE", "token": ["Abstract 1.\u2002We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (CYP3A) in rats using dexamethasone 21-phosphate (DEX-P) and midazolam (", "MDZ", ") as an inducer and a substrate to ", "CYP3A", ", respectively."], "h": {"pos": [1, 2], "type": null, "name": "MDZ ) as an inducer and a substrate to "}, "t": {"pos": [3, 4], "type": null, "name": "CYP3A , respectively."}}
{"relation": "SUBSTRATE", "token": ["Among the [Fe-S] cluster biosynthetic proteins are included a pyridoxal phosphate-dependent enzyme (", "NifS", ") that is involved in the activation of sulphur from ", "l-cysteine", ", and a molecular scaffold protein (NifU) upon which [Fe-S] cluster precursors are formed."], "h": {"pos": [1, 2], "type": null, "name": "NifS ) that is involved in the activation of sulphur from "}, "t": {"pos": [3, 4], "type": null, "name": "l-cysteine , and a molecular scaffold protein (NifU) upon which [Fe-S] cluster precursors are formed."}}
{"relation": "SUBSTRATE", "token": ["Choline dehydrogenase (", "CHDH", ") and betaine-homocysteine methyltransferase (BHMT) are 2 enzymes involved in ", "choline", " oxidation."], "h": {"pos": [1, 2], "type": null, "name": "CHDH ) and betaine-homocysteine methyltransferase (BHMT) are 2 enzymes involved in "}, "t": {"pos": [3, 4], "type": null, "name": "choline  oxidation."}}
{"relation": "SUBSTRATE", "token": ["Possession of ", "CYP2C9", "*2 or CYP2C9*3 variant alleles, which result in decreased enzyme activity, is associated with a significant decrease in the mean ", "warfarin", " dose."], "h": {"pos": [1, 2], "type": null, "name": "CYP2C9 *2 or CYP2C9*3 variant alleles, which result in decreased enzyme activity, is associated with a significant decrease in the mean "}, "t": {"pos": [3, 4], "type": null, "name": "warfarin  dose."}}
{"relation": "SUBSTRATE", "token": ["The protein exhibited modest H(2)O(2)-dependent ", "peroxidase", " activities with guaiacol, ", "potassium iodide", ", and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS)."], "h": {"pos": [1, 2], "type": null, "name": "peroxidase  activities with guaiacol, "}, "t": {"pos": [3, 4], "type": null, "name": "potassium iodide , and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS)."}}
{"relation": "SUBSTRATE", "token": ["", "Ketamine", " is primarily metabolized to norketamine by hepatic ", "cytochrome P450 (CYP) 2B6", " and CYP3A4-mediated N-demethylation."], "h": {"pos": [1, 2], "type": null, "name": "Ketamine  is primarily metabolized to norketamine by hepatic "}, "t": {"pos": [3, 4], "type": null, "name": "cytochrome P450 (CYP) 2B6  and CYP3A4-mediated N-demethylation."}}
{"relation": "SUBSTRATE", "token": ["In the reverse case, mutation of the orthologous glycine (Gly553) to methionine in ", "carnitine octanoyltransferase", " (COT) decreased activity toward its natural substrates, medium- and long-chain acyl-CoAs, and increased activity toward short-chain ", "acyl-CoAs", "."], "h": {"pos": [1, 2], "type": null, "name": "carnitine octanoyltransferase  (COT) decreased activity toward its natural substrates, medium- and long-chain acyl-CoAs, and increased activity toward short-chain "}, "t": {"pos": [3, 4], "type": null, "name": "acyl-CoAs ."}}
{"relation": "SUBSTRATE", "token": ["Mazindol analogues as potential inhibitors of the cocaine binding site at the ", "dopamine transporter", "", "dopamine", " transporter."], "h": {"pos": [1, 2], "type": null, "name": "dopamine transporter "}, "t": {"pos": [3, 4], "type": null, "name": "dopamine  transporter."}}
{"relation": "SUBSTRATE", "token": ["The ", "CYP2B6*6", " Allele Significantly Alters the N-demethylation of ", "Ketamine", " Enantiomers In Vitro."], "h": {"pos": [1, 2], "type": null, "name": "CYP2B6*6  Allele Significantly Alters the N-demethylation of "}, "t": {"pos": [3, 4], "type": null, "name": "Ketamine  Enantiomers In Vitro."}}
{"relation": "SUBSTRATE", "token": ["Reduced synthesis of nitric oxide (NO) contributes to the endothelial dysfunction and may be related to limited availability of ", "L-arginine", ", the common substrate of constitutive nitric-oxide synthase (NOS) and cytosolic arginase I and ", "mitochondrial arginase II", "."], "h": {"pos": [1, 2], "type": null, "name": "L-arginine , the common substrate of constitutive nitric-oxide synthase (NOS) and cytosolic arginase I and "}, "t": {"pos": [3, 4], "type": null, "name": "mitochondrial arginase II ."}}
{"relation": "SUBSTRATE", "token": ["Compound 6 stimulated OATP1B3-mediated ", "estradiol 17\u03b2-glucuronide", " uptake by increasing the apparent affinity of ", "OATP1B3", " for its substrate."], "h": {"pos": [1, 2], "type": null, "name": "estradiol 17\u03b2-glucuronide  uptake by increasing the apparent affinity of "}, "t": {"pos": [3, 4], "type": null, "name": "OATP1B3  for its substrate."}}
{"relation": "SUBSTRATE", "token": ["Beta-1,4-galactosyltransferase I (beta4Gal-T1) normally transfers Gal from ", "UDP-Gal", " to GlcNAc in the presence of Mn(2+) ion (", "Gal-T", " activity) and also transfers Glc from UDP-Glc to GlcNAc (Glc-T activity), albeit at only 0.3% efficiency."], "h": {"pos": [1, 2], "type": null, "name": "UDP-Gal  to GlcNAc in the presence of Mn(2+) ion ("}, "t": {"pos": [3, 4], "type": null, "name": "Gal-T  activity) and also transfers Glc from UDP-Glc to GlcNAc (Glc-T activity), albeit at only 0.3% efficiency."}}
{"relation": "SUBSTRATE", "token": ["Firstly, transgenic plants overexpressing formate dehydrogenase (FDH, EC 1.2.1.2) were used to continue our previous studies on the function of ", "FDH", " in ", "formate", " metabolism."], "h": {"pos": [1, 2], "type": null, "name": "FDH  in "}, "t": {"pos": [3, 4], "type": null, "name": "formate  metabolism."}}
{"relation": "SUBSTRATE", "token": ["Phenytoin (diphenylhydantoin, DPH) is an established ", "sodium channel", "", "sodium", " channel blocker and is a useful anticonvulsant and class 1b antiarrhythmic, and has been effectively used in the treatment of neuropathic pain."], "h": {"pos": [1, 2], "type": null, "name": "sodium channel "}, "t": {"pos": [3, 4], "type": null, "name": "sodium  channel blocker and is a useful anticonvulsant and class 1b antiarrhythmic, and has been effectively used in the treatment of neuropathic pain."}}
{"relation": "SUBSTRATE", "token": ["The ", "CYP2B6*6", " allele is associated with reduced enzyme expression and activity that may lead to interindividual variability in ", "ketamine", " metabolism."], "h": {"pos": [1, 2], "type": null, "name": "CYP2B6*6  allele is associated with reduced enzyme expression and activity that may lead to interindividual variability in "}, "t": {"pos": [3, 4], "type": null, "name": "ketamine  metabolism."}}
{"relation": "SUBSTRATE", "token": ["In vitro accumulation studies conducted in Madin-Darby canine kidney II cells indicate that ", "dabrafenib", " is an avid substrate for both ", "P-gp", " and BCRP."], "h": {"pos": [1, 2], "type": null, "name": "dabrafenib  is an avid substrate for both "}, "t": {"pos": [3, 4], "type": null, "name": "P-gp  and BCRP."}}
{"relation": "SUBSTRATE", "token": ["Absorption and secretion of ", "fluoride", " increase at acid pH levels, possibly because of its non-ionized state at these pHs and/or because of participation of a F(-)/H(+) cotransporter or a ", "F(-)/OH(-) antiporter", "."], "h": {"pos": [1, 2], "type": null, "name": "fluoride  increase at acid pH levels, possibly because of its non-ionized state at these pHs and/or because of participation of a F(-)/H(+) cotransporter or a "}, "t": {"pos": [3, 4], "type": null, "name": "F(-)/OH(-) antiporter ."}}
{"relation": "SUBSTRATE", "token": ["Then the cells were treated with various concentrations of apoE3, lactoferrin and bovine serum albumin with or without 100 microg/ml of GMC, and the ", "SGLT1", "-dependent ", "methyl alpha-D-glucopyranoside", " (AMG) uptake and levels of SGLT1 expression were determined."], "h": {"pos": [1, 2], "type": null, "name": "SGLT1 -dependent "}, "t": {"pos": [3, 4], "type": null, "name": "methyl alpha-D-glucopyranoside  (AMG) uptake and levels of SGLT1 expression were determined."}}
{"relation": "SUBSTRATE", "token": ["Monocarboxylate transporters (", "MCTs", ") are proton-linked membrane carriers involved in the transport of monocarboxylates such as lactate, ", "pyruvate", ", as well as ketone bodies."], "h": {"pos": [1, 2], "type": null, "name": "MCTs ) are proton-linked membrane carriers involved in the transport of monocarboxylates such as lactate, "}, "t": {"pos": [3, 4], "type": null, "name": "pyruvate , as well as ketone bodies."}}
{"relation": "SUBSTRATE", "token": ["The acute toxicity of organophosphorus (OP) compounds in mammals is due to their irreversible inhibition of acetylcholinesterase (", "AChE", ") in the nervous system, which leads to increased synaptic ", "acetylcholine", " levels."], "h": {"pos": [1, 2], "type": null, "name": "AChE ) in the nervous system, which leads to increased synaptic "}, "t": {"pos": [3, 4], "type": null, "name": "acetylcholine  levels."}}
{"relation": "SUBSTRATE", "token": ["They all expressed ASS, but not ornithine transcarbamylase (OTC), the enzyme that converts ornithine, the product of degradation of arginine with rhArg, to citrulline, which is converted back to ", "arginine", " via ", "ASS", "."], "h": {"pos": [1, 2], "type": null, "name": "arginine  via "}, "t": {"pos": [3, 4], "type": null, "name": "ASS ."}}
{"relation": "SUBSTRATE", "token": ["Polyclonal antisera to either b5R or ", "cyt b5", " significantly inhibited ", "N-hydroxy-4-aminobiphenyl", " (NHOH-4-ABP) reduction by 95 and 89%, respectively, and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both NHOH-4-ABP and N-hydroxy-PhIP (NHOH-PhIP)."], "h": {"pos": [1, 2], "type": null, "name": "cyt b5  significantly inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "N-hydroxy-4-aminobiphenyl  (NHOH-4-ABP) reduction by 95 and 89%, respectively, and immunoreactive cyt b5 protein content in individual HLM was significantly correlated with individual reduction of both NHOH-4-ABP and N-hydroxy-PhIP (NHOH-PhIP)."}}
{"relation": "SUBSTRATE", "token": ["Choline dehydrogenase (CHDH) and betaine-homocysteine methyltransferase (", "BHMT", ") are 2 enzymes involved in ", "choline", " oxidation."], "h": {"pos": [1, 2], "type": null, "name": "BHMT ) are 2 enzymes involved in "}, "t": {"pos": [3, 4], "type": null, "name": "choline  oxidation."}}
{"relation": "SUBSTRATE", "token": ["These results suggest that CYP2B6 genotype is the most important patient variable for predicting the level of ", "CYP2B6", " activity in women, when measured by the metabolism of ", "bupropion", "."], "h": {"pos": [1, 2], "type": null, "name": "CYP2B6  activity in women, when measured by the metabolism of "}, "t": {"pos": [3, 4], "type": null, "name": "bupropion ."}}
{"relation": "SUBSTRATE", "token": ["In the reverse case, mutation of the orthologous glycine (Gly553) to methionine in carnitine octanoyltransferase (", "COT", ") decreased activity toward its natural substrates, medium- and long-chain acyl-CoAs, and increased activity toward short-chain ", "acyl-CoAs", "."], "h": {"pos": [1, 2], "type": null, "name": "COT ) decreased activity toward its natural substrates, medium- and long-chain acyl-CoAs, and increased activity toward short-chain "}, "t": {"pos": [3, 4], "type": null, "name": "acyl-CoAs ."}}
{"relation": "SUBSTRATE", "token": ["Although a proton-stimulated uptake of ", "cefadroxil", " was demonstrated in ", "PEPT2", "(+/+) mice (pH 6.5 versus pH 7.4; p < 0.01), no pH dependence was observed in PEPT2(-/-) mice."], "h": {"pos": [1, 2], "type": null, "name": "cefadroxil  was demonstrated in "}, "t": {"pos": [3, 4], "type": null, "name": "PEPT2 (+/+) mice (pH 6.5 versus pH 7.4; p < 0.01), no pH dependence was observed in PEPT2(-/-) mice."}}
{"relation": "SUBSTRATE", "token": ["In conclusion, immortalized SHR and WKY PTE cells take up ", "l-alanine", " mainly through a high-affinity Na(+)-dependent amino acid transporter, with functional features of ", "ASCT2", " transport."], "h": {"pos": [1, 2], "type": null, "name": "l-alanine  mainly through a high-affinity Na(+)-dependent amino acid transporter, with functional features of "}, "t": {"pos": [3, 4], "type": null, "name": "ASCT2  transport."}}
{"relation": "SUBSTRATE", "token": ["Growth inhibition of these tumor cell lines was associated with the dephosphorylation of EGFR, HER2, and HER3, accompanied by the loss of association of HER3 with ", "phosphatidylinositol 3-kinase", "", "phosphatidylinositol", " 3-kinase, and down-regulation of Akt activity."], "h": {"pos": [1, 2], "type": null, "name": "phosphatidylinositol 3-kinase "}, "t": {"pos": [3, 4], "type": null, "name": "phosphatidylinositol  3-kinase, and down-regulation of Akt activity."}}
{"relation": "SUBSTRATE", "token": ["Even though the activities of ", "MAT", " and GNMT were elevated, the concentration of liver ", "S-adenosylmethionine", " was decreased (24%, p<0.001) and S-adenosylhomocysteine increased (113%, p<0.001) in the dwarf mice."], "h": {"pos": [1, 2], "type": null, "name": "MAT  and GNMT were elevated, the concentration of liver "}, "t": {"pos": [3, 4], "type": null, "name": "S-adenosylmethionine  was decreased (24%, p<0.001) and S-adenosylhomocysteine increased (113%, p<0.001) in the dwarf mice."}}
{"relation": "SUBSTRATE", "token": ["4-Hydroxynonenal (4-HNE) is a mutagenic ", "alpha,beta-unsaturated aldehyde", " produced during oxidative injury that is conjugated by several glutathione S-transferase (", "GST", ") isoforms."], "h": {"pos": [1, 2], "type": null, "name": "alpha,beta-unsaturated aldehyde  produced during oxidative injury that is conjugated by several glutathione S-transferase ("}, "t": {"pos": [3, 4], "type": null, "name": "GST ) isoforms."}}
{"relation": "SUBSTRATE", "token": ["The ", "bupropion", " metabolic ratio appears to detect known differences in ", "CYP2B6", " activity associated with genetic polymorphism, across different ethnic groups."], "h": {"pos": [1, 2], "type": null, "name": "bupropion  metabolic ratio appears to detect known differences in "}, "t": {"pos": [3, 4], "type": null, "name": "CYP2B6  activity associated with genetic polymorphism, across different ethnic groups."}}
{"relation": "SUBSTRATE", "token": ["Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of L-alanine for aminopeptidase N, 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and 4-methoxy-2-naphthylamide of ", "L-arginine", " for ", "aminopeptidase B", "."], "h": {"pos": [1, 2], "type": null, "name": "L-arginine  for "}, "t": {"pos": [3, 4], "type": null, "name": "aminopeptidase B ."}}
{"relation": "SUBSTRATE", "token": ["Objective: This study explores the ability of ", "acyl glucuronides", " to act as substrates or inhibitors of ", "human carboxylesterases 1", " (hCES1) and 2 (hCES2)."], "h": {"pos": [1, 2], "type": null, "name": "acyl glucuronides  to act as substrates or inhibitors of "}, "t": {"pos": [3, 4], "type": null, "name": "human carboxylesterases 1  (hCES1) and 2 (hCES2)."}}
{"relation": "SUBSTRATE", "token": ["Specifically, ", "hGSTA4", " cells had significantly higher GSH concentrations when exposed to 5-15 microM ", "4-HNE", ", but not at 20 microM 4-HNE, suggesting extensive GSH utilization at high concentrations of 4-HNE."], "h": {"pos": [1, 2], "type": null, "name": "hGSTA4  cells had significantly higher GSH concentrations when exposed to 5-15 microM "}, "t": {"pos": [3, 4], "type": null, "name": "4-HNE , but not at 20 microM 4-HNE, suggesting extensive GSH utilization at high concentrations of 4-HNE."}}
{"relation": "SUBSTRATE", "token": ["Moreover, kinetic analysis revealed that inhibition by reserpine, a typical ", "VMAT2", " inhibitor, was uncompetitive, decreasing maximum velocity and affinity for ", "dopamine", "."], "h": {"pos": [1, 2], "type": null, "name": "VMAT2  inhibitor, was uncompetitive, decreasing maximum velocity and affinity for "}, "t": {"pos": [3, 4], "type": null, "name": "dopamine ."}}
{"relation": "SUBSTRATE", "token": ["The frdA gene coding for subunit A of FRD, and two control genes, ", "copA", " and copP associated with the export of ", "copper", " out of H. pylori, were inactivated by insertion of the chloramphenicol acetyltransferase cassette into these individual genes."], "h": {"pos": [1, 2], "type": null, "name": "copA  and copP associated with the export of "}, "t": {"pos": [3, 4], "type": null, "name": "copper  out of H. pylori, were inactivated by insertion of the chloramphenicol acetyltransferase cassette into these individual genes."}}
{"relation": "SUBSTRATE", "token": ["In addition, ", "tolvaptan", " is metabolized by the ", "CYP3A4", " system; thus physicians should be aware of the potential for increased interactions with other medications."], "h": {"pos": [1, 2], "type": null, "name": "tolvaptan  is metabolized by the "}, "t": {"pos": [3, 4], "type": null, "name": "CYP3A4  system; thus physicians should be aware of the potential for increased interactions with other medications."}}
{"relation": "SUBSTRATE", "token": ["", "Mammalian ALDH1B1", ", another mitochondrial enzyme sharing 72% identity with ALDH2, is also capable of metabolizing ", "acetaldehyde", " but has a tissue distribution and pattern of activity distinct from that of ALDH2."], "h": {"pos": [1, 2], "type": null, "name": "Mammalian ALDH1B1 , another mitochondrial enzyme sharing 72% identity with ALDH2, is also capable of metabolizing "}, "t": {"pos": [3, 4], "type": null, "name": "acetaldehyde  but has a tissue distribution and pattern of activity distinct from that of ALDH2."}}
{"relation": "SUBSTRATE", "token": ["PGE(2) is synthesized from ", "arachidonic acid", " by cyclooxygenases (COX) and prostaglandin E synthases (", "PGES", ") and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4)."], "h": {"pos": [1, 2], "type": null, "name": "arachidonic acid  by cyclooxygenases (COX) and prostaglandin E synthases ("}, "t": {"pos": [3, 4], "type": null, "name": "PGES ) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4)."}}
{"relation": "SUBSTRATE", "token": ["", "Cholesterol esterase", " (CE) induced surface erosion of ", "poly(ethylene carbonate)", " (PEC) and drug release from PEC under mild physiological environment was investigated."], "h": {"pos": [1, 2], "type": null, "name": "Cholesterol esterase  (CE) induced surface erosion of "}, "t": {"pos": [3, 4], "type": null, "name": "poly(ethylene carbonate)  (PEC) and drug release from PEC under mild physiological environment was investigated."}}
{"relation": "SUBSTRATE", "token": ["Cytochrome P450 epoxygenase 2J2 (", "CYP2J2", ") metabolizes ", "arachidonic acids", " to form epoxyeicosatrienoic acids (EETs), which possess various beneficial effects on the cardiovascular system."], "h": {"pos": [1, 2], "type": null, "name": "CYP2J2 ) metabolizes "}, "t": {"pos": [3, 4], "type": null, "name": "arachidonic acids  to form epoxyeicosatrienoic acids (EETs), which possess various beneficial effects on the cardiovascular system."}}
{"relation": "SUBSTRATE", "token": ["To identify important covariates associated with interindividual variation in CYP2B6 activity in vivo, we evaluated these effects in healthy volunteers using bupropion (", "Wellbutrin SR", " GlaxoSmithKline, Research Triangle Park, NC) as a ", "CYP2B6", " probe substrate."], "h": {"pos": [1, 2], "type": null, "name": "Wellbutrin SR  GlaxoSmithKline, Research Triangle Park, NC) as a "}, "t": {"pos": [3, 4], "type": null, "name": "CYP2B6  probe substrate."}}
{"relation": "SUBSTRATE", "token": ["", "zRetSat A", " also saturated the 13-14 or 7-8 double bonds of all-trans-3,4-didehydroretinol (", "vitamin A2", "), a second endogenous form of vitamin A in zebrafish."], "h": {"pos": [1, 2], "type": null, "name": "zRetSat A  also saturated the 13-14 or 7-8 double bonds of all-trans-3,4-didehydroretinol ("}, "t": {"pos": [3, 4], "type": null, "name": "vitamin A2 ), a second endogenous form of vitamin A in zebrafish."}}
{"relation": "SUBSTRATE", "token": ["The alpha class ", "human GSTA4-4", " enzyme (hGSTA4-4) has a particularly high catalytic efficiency toward ", "4-HNE", " conjugation."], "h": {"pos": [1, 2], "type": null, "name": "human GSTA4-4  enzyme (hGSTA4-4) has a particularly high catalytic efficiency toward "}, "t": {"pos": [3, 4], "type": null, "name": "4-HNE  conjugation."}}
{"relation": "SUBSTRATE", "token": ["2.\u2002 We have developed a convenient quantitative multi-well plate assay to measure the glucuronidation rate of ", "7-hydroxy-4-trifluoromethylcoumarin", " (HFC) for several ", "UGTs", "."], "h": {"pos": [1, 2], "type": null, "name": "7-hydroxy-4-trifluoromethylcoumarin  (HFC) for several "}, "t": {"pos": [3, 4], "type": null, "name": "UGTs ."}}
{"relation": "SUBSTRATE", "token": ["bis(Ethyl) oligoamine analogues of polyamines, such as SL-11144 and SL-11158, as well as arylamine analogues [BW-1, a bis(phenylbenzyl) 3-7-3 analogue] blocked uptake and interconversion of spermine at micromolar levels and, in the case of ", "BW-1", ", acted as substrate for ", "PAO", "."], "h": {"pos": [1, 2], "type": null, "name": "BW-1 , acted as substrate for "}, "t": {"pos": [3, 4], "type": null, "name": "PAO ."}}
{"relation": "SUBSTRATE", "token": ["Uptake of the radiolabeled model substrates estradiol 17\u03b2-glucuronide, estrone 3-sulfate, and ", "dehydroepiandrosterone sulfate", " (DHEAS) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary (CHO) cells stably expressing either ", "OATP1B1", " or OATP1B3."], "h": {"pos": [1, 2], "type": null, "name": "dehydroepiandrosterone sulfate  (DHEAS) was determined in the absence and presence of compounds 1-6 using Chinese hamster ovary (CHO) cells stably expressing either "}, "t": {"pos": [3, 4], "type": null, "name": "OATP1B1  or OATP1B3."}}
{"relation": "SUBSTRATE", "token": ["Aldose reductase (", "AR", ") catalyzes the reduction of toxic lipid ", "aldehydes", " to their alcohol products and mediates inflammatory signals triggered by lipopolysaccharide (LPS)."], "h": {"pos": [1, 2], "type": null, "name": "AR ) catalyzes the reduction of toxic lipid "}, "t": {"pos": [3, 4], "type": null, "name": "aldehydes  to their alcohol products and mediates inflammatory signals triggered by lipopolysaccharide (LPS)."}}
{"relation": "SUBSTRATE", "token": ["For determination of [", "PA", "+Pli]-activity, ", "arginine", " was added after this incubation."], "h": {"pos": [1, 2], "type": null, "name": "PA +Pli]-activity, "}, "t": {"pos": [3, 4], "type": null, "name": "arginine  was added after this incubation."}}
{"relation": "SUBSTRATE", "token": ["The ratio between the GDC/SHMT and ", "C1-THF synthase", "/SHMT pathways of Ser synthesis from [alpha-(13)C]Gly and ", "[(13)C]formate", ", respectively, in Arabidopsis shoots was 21 : 1; in roots, 9 : 1."], "h": {"pos": [1, 2], "type": null, "name": "C1-THF synthase /SHMT pathways of Ser synthesis from [alpha-(13)C]Gly and "}, "t": {"pos": [3, 4], "type": null, "name": "[(13)C]formate , respectively, in Arabidopsis shoots was 21 : 1; in roots, 9 : 1."}}
{"relation": "SUBSTRATE", "token": ["PGE(2) is synthesized from ", "arachidonic acid", " by ", "cyclooxygenases", " (COX) and prostaglandin E synthases (PGES) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4)."], "h": {"pos": [1, 2], "type": null, "name": "arachidonic acid  by "}, "t": {"pos": [3, 4], "type": null, "name": "cyclooxygenases  (COX) and prostaglandin E synthases (PGES) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4)."}}
{"relation": "SUBSTRATE", "token": ["Differences in magnitude of Na(+)-dependent ", "l-alanine", " uptake through ", "ASCT2", " between WKY and SHR PTE cells correlated positively with differences in ASCT2 protein expression, this being more abundant in WKY PTE cells."], "h": {"pos": [1, 2], "type": null, "name": "l-alanine  uptake through "}, "t": {"pos": [3, 4], "type": null, "name": "ASCT2  between WKY and SHR PTE cells correlated positively with differences in ASCT2 protein expression, this being more abundant in WKY PTE cells."}}
{"relation": "SUBSTRATE", "token": ["", "Doxorubicin", " is mainly excreted into the bile via ", "P-glycoprotein", " (P-gp) and multidrug resistance-associated protein 2 (Mrp2) in hepatobiliary route and metabolized via cytochrome P450 (CYP) 3A subfamily."], "h": {"pos": [1, 2], "type": null, "name": "Doxorubicin  is mainly excreted into the bile via "}, "t": {"pos": [3, 4], "type": null, "name": "P-glycoprotein  (P-gp) and multidrug resistance-associated protein 2 (Mrp2) in hepatobiliary route and metabolized via cytochrome P450 (CYP) 3A subfamily."}}
{"relation": "SUBSTRATE", "token": ["CPT I (", "carnitine palmitoyltransferase I", ") catalyses the conversion of ", "palmitoyl-CoA", " into palmitoylcarnitine in the presence of L-carnitine, facilitating the entry of fatty acids into mitochondria."], "h": {"pos": [1, 2], "type": null, "name": "carnitine palmitoyltransferase I ) catalyses the conversion of "}, "t": {"pos": [3, 4], "type": null, "name": "palmitoyl-CoA  into palmitoylcarnitine in the presence of L-carnitine, facilitating the entry of fatty acids into mitochondria."}}
{"relation": "SUBSTRATE", "token": ["", "UGT1A6", " exhibited a significantly higher Vmax and Km values toward both HFC and UDP-", "glucuronic acid", " than the other UGTs."], "h": {"pos": [1, 2], "type": null, "name": "UGT1A6  exhibited a significantly higher Vmax and Km values toward both HFC and UDP-"}, "t": {"pos": [3, 4], "type": null, "name": "glucuronic acid  than the other UGTs."}}
{"relation": "SUBSTRATE", "token": ["OBJECTIVE: The aim was to test whether the common deletion [T/-] in the promoter of ", "FADS2", " affects the PUFA biosynthetic pathway and consequently modifies the effect of ", "alpha-linolenic acid", " (ALA) on myocardial infarction (MI)."], "h": {"pos": [1, 2], "type": null, "name": "FADS2  affects the PUFA biosynthetic pathway and consequently modifies the effect of "}, "t": {"pos": [3, 4], "type": null, "name": "alpha-linolenic acid  (ALA) on myocardial infarction (MI)."}}
{"relation": "SUBSTRATE", "token": ["Both ", "risperidone", " and 9-hydroxyrisperidone are substrates of P-glycoprotein (", "P-gp", "), a transport protein involved in drug absorption, distribution, and elimination."], "h": {"pos": [1, 2], "type": null, "name": "risperidone  and 9-hydroxyrisperidone are substrates of P-glycoprotein ("}, "t": {"pos": [3, 4], "type": null, "name": "P-gp ), a transport protein involved in drug absorption, distribution, and elimination."}}
{"relation": "SUBSTRATE", "token": ["Interestingly, the allele of PRO1 was shown to enhance the activities of ", "gamma-glutamyl kinase", " and gamma-glutamyl phosphate reductase, both of which catalyze the first two steps of L-proline synthesis from ", "L-glutamate", " and which together may form a complex in vivo."], "h": {"pos": [1, 2], "type": null, "name": "gamma-glutamyl kinase  and gamma-glutamyl phosphate reductase, both of which catalyze the first two steps of L-proline synthesis from "}, "t": {"pos": [3, 4], "type": null, "name": "L-glutamate  and which together may form a complex in vivo."}}
{"relation": "SUBSTRATE", "token": ["These five CGPs also inhibited ", "[(3)H]E217\u03b2G", " uptake by ", "MRP4", "."], "h": {"pos": [1, 2], "type": null, "name": "[(3)H]E217\u03b2G  uptake by "}, "t": {"pos": [3, 4], "type": null, "name": "MRP4 ."}}
{"relation": "SUBSTRATE", "token": ["TAS-102 is a novel drug containing ", "trifluorothymidine", ", which is phosphorylated by ", "TK-1", " to its active monophosphated form, that in turn can inhibit TS."], "h": {"pos": [1, 2], "type": null, "name": "trifluorothymidine , which is phosphorylated by "}, "t": {"pos": [3, 4], "type": null, "name": "TK-1  to its active monophosphated form, that in turn can inhibit TS."}}
{"relation": "SUBSTRATE", "token": ["", "Voltage-gated sodium (Na) channels", "", "Na", ") channels are a critical component of electrically excitable cells."], "h": {"pos": [1, 2], "type": null, "name": "Voltage-gated sodium (Na) channels "}, "t": {"pos": [3, 4], "type": null, "name": "Na ) channels are a critical component of electrically excitable cells."}}
{"relation": "SUBSTRATE", "token": ["The protein exhibited modest H(2)O(2)-dependent ", "peroxidase", " activities with ", "guaiacol", ", potassium iodide, and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS)."], "h": {"pos": [1, 2], "type": null, "name": "peroxidase  activities with "}, "t": {"pos": [3, 4], "type": null, "name": "guaiacol , potassium iodide, and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS)."}}
{"relation": "SUBSTRATE", "token": ["", "Risperidone", " is metabolized to its active metabolite, 9-hydroxyrisperidone, mainly by the ", "cytochrome P450", " enzymes CYP2D6 and 3A4."], "h": {"pos": [1, 2], "type": null, "name": "Risperidone  is metabolized to its active metabolite, 9-hydroxyrisperidone, mainly by the "}, "t": {"pos": [3, 4], "type": null, "name": "cytochrome P450  enzymes CYP2D6 and 3A4."}}
{"relation": "SUBSTRATE", "token": ["", "Voltage-gated sodium (Na) channels", "", "sodium", " (Na) channels are a critical component of electrically excitable cells."], "h": {"pos": [1, 2], "type": null, "name": "Voltage-gated sodium (Na) channels "}, "t": {"pos": [3, 4], "type": null, "name": "sodium  (Na) channels are a critical component of electrically excitable cells."}}
{"relation": "SUBSTRATE", "token": ["The purified ", "phosphodiester alpha-GlcNAcase", " has a specific activity of 498 micromol of [3H]GlcNAc-alpha-phosphomannose-alpha-methyl cleaved per h per mg of protein using 0.5 mM ", "[3H]GlcNAc-alpha-phosphomannose-alpha-methyl", " as substrate."], "h": {"pos": [1, 2], "type": null, "name": "phosphodiester alpha-GlcNAcase  has a specific activity of 498 micromol of [3H]GlcNAc-alpha-phosphomannose-alpha-methyl cleaved per h per mg of protein using 0.5 mM "}, "t": {"pos": [3, 4], "type": null, "name": "[3H]GlcNAc-alpha-phosphomannose-alpha-methyl  as substrate."}}
{"relation": "SUBSTRATE", "token": ["Here, we demonstrate that peptidyl-prolyl cis/trans-isomerase A1 (", "Pin1", "), an enzyme that catalyzes the conversion of the peptide bond of pSer/", "pThr", "-Pro moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification."], "h": {"pos": [1, 2], "type": null, "name": "Pin1 ), an enzyme that catalyzes the conversion of the peptide bond of pSer/"}, "t": {"pos": [3, 4], "type": null, "name": "pThr -Pro moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification."}}
{"relation": "SUBSTRATE", "token": ["In the reverse case, mutation of the orthologous glycine (Gly553) to methionine in carnitine octanoyltransferase (", "COT", ") decreased activity toward its natural substrates, medium- and long-chain ", "acyl-CoAs", ", and increased activity toward short-chain acyl-CoAs."], "h": {"pos": [1, 2], "type": null, "name": "COT ) decreased activity toward its natural substrates, medium- and long-chain "}, "t": {"pos": [3, 4], "type": null, "name": "acyl-CoAs , and increased activity toward short-chain acyl-CoAs."}}
{"relation": "SUBSTRATE", "token": ["", "Levodopa", " is absorbed in the small bowel and is rapidly catabolized by aromatic-L-amino-acid decarboxylase (AADC) and ", "catechol-O-methyltransferase", " (COMT)."], "h": {"pos": [1, 2], "type": null, "name": "Levodopa  is absorbed in the small bowel and is rapidly catabolized by aromatic-L-amino-acid decarboxylase (AADC) and "}, "t": {"pos": [3, 4], "type": null, "name": "catechol-O-methyltransferase  (COMT)."}}
{"relation": "SUBSTRATE", "token": ["In the present study, we have evaluated possible participation of monocarboxylate transporters (", "MCTs", ") responsible for the bidirectional membrane transport of ", "pyruvate", " in the cytoprotective property in osteoblasts."], "h": {"pos": [1, 2], "type": null, "name": "MCTs ) responsible for the bidirectional membrane transport of "}, "t": {"pos": [3, 4], "type": null, "name": "pyruvate  in the cytoprotective property in osteoblasts."}}
{"relation": "SUBSTRATE", "token": ["One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, EC 2.1.1.10) and serine hydroxymethyltransferase (", "SHMT", ", EC 2.1.2.1) with ", "glycine", " (Gly) as one-carbon (1-C) source."], "h": {"pos": [1, 2], "type": null, "name": "SHMT , EC 2.1.2.1) with "}, "t": {"pos": [3, 4], "type": null, "name": "glycine  (Gly) as one-carbon (1-C) source."}}
{"relation": "SUBSTRATE", "token": ["Absorption and secretion of ", "fluoride", " increase at acid pH levels, possibly because of its non-ionized state at these pHs and/or because of participation of a ", "F(-)/H(+) cotransporter", " or a F(-)/OH(-) antiporter."], "h": {"pos": [1, 2], "type": null, "name": "fluoride  increase at acid pH levels, possibly because of its non-ionized state at these pHs and/or because of participation of a "}, "t": {"pos": [3, 4], "type": null, "name": "F(-)/H(+) cotransporter  or a F(-)/OH(-) antiporter."}}
{"relation": "SUBSTRATE", "token": ["", "SR-BI", " is a receptor that binds HDL with high affinity and mediates both the selective lipid uptake of cholesteryl esters from lipid-rich HDL to cells and the efflux of unesterified ", "cholesterol", " from cells to HDL."], "h": {"pos": [1, 2], "type": null, "name": "SR-BI  is a receptor that binds HDL with high affinity and mediates both the selective lipid uptake of cholesteryl esters from lipid-rich HDL to cells and the efflux of unesterified "}, "t": {"pos": [3, 4], "type": null, "name": "cholesterol  from cells to HDL."}}
{"relation": "SUBSTRATE", "token": ["In addition to affecting ", "DAT", " function, MDMA rapidly decreased vesicular ", "DA", " transport as assessed in striatal vesicles prepared from treated rats."], "h": {"pos": [1, 2], "type": null, "name": "DAT  function, MDMA rapidly decreased vesicular "}, "t": {"pos": [3, 4], "type": null, "name": "DA  transport as assessed in striatal vesicles prepared from treated rats."}}
{"relation": "SUBSTRATE", "token": ["Aldo-keto reductases (", "AKRs", ") metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons (", "PAHs", "), generating metabolites (o-quinones) and reactive oxygen species (ROS), which are capable of initiating and promoting carcinogenesis."], "h": {"pos": [1, 2], "type": null, "name": "AKRs ) metabolize a wide range of substrates, including polycyclic aromatic hydrocarbons ("}, "t": {"pos": [3, 4], "type": null, "name": "PAHs ), generating metabolites (o-quinones) and reactive oxygen species (ROS), which are capable of initiating and promoting carcinogenesis."}}
{"relation": "SUBSTRATE", "token": ["4-Hydroxynonenal (", "4-HNE", ") is a mutagenic alpha,beta-unsaturated aldehyde produced during oxidative injury that is conjugated by several glutathione S-transferase (", "GST", ") isoforms."], "h": {"pos": [1, 2], "type": null, "name": "4-HNE ) is a mutagenic alpha,beta-unsaturated aldehyde produced during oxidative injury that is conjugated by several glutathione S-transferase ("}, "t": {"pos": [3, 4], "type": null, "name": "GST ) isoforms."}}
{"relation": "SUBSTRATE", "token": ["This study examined the inward transport of ", "l-[(14)C]alanine", ", an ", "ASCT2", " preferential substrate, in monolayers of immortalized renal proximal tubular epithelial (PTE) cells from Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) rats."], "h": {"pos": [1, 2], "type": null, "name": "l-[(14)C]alanine , an "}, "t": {"pos": [3, 4], "type": null, "name": "ASCT2  preferential substrate, in monolayers of immortalized renal proximal tubular epithelial (PTE) cells from Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) rats."}}
{"relation": "SUBSTRATE", "token": ["", "Mouse brain serine racemase", " catalyzes specific elimination of ", "L-serine", " to pyruvate."], "h": {"pos": [1, 2], "type": null, "name": "Mouse brain serine racemase  catalyzes specific elimination of "}, "t": {"pos": [3, 4], "type": null, "name": "L-serine  to pyruvate."}}
{"relation": "SUBSTRATE", "token": ["The M564G mutated ", "CrAT", " showed higher activity toward longer chain acyl-CoAs: activity toward ", "myristoyl-CoA", " was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, acetyl-CoA."], "h": {"pos": [1, 2], "type": null, "name": "CrAT  showed higher activity toward longer chain acyl-CoAs: activity toward "}, "t": {"pos": [3, 4], "type": null, "name": "myristoyl-CoA  was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, acetyl-CoA."}}
{"relation": "SUBSTRATE", "token": ["Indoleamine 2,3-dioxygenase (", "IDO", "), a ", "tryptophan", " catabolizing enzyme, has been implicated in the pathogenesis of various neurological disorders."], "h": {"pos": [1, 2], "type": null, "name": "IDO ), a "}, "t": {"pos": [3, 4], "type": null, "name": "tryptophan  catabolizing enzyme, has been implicated in the pathogenesis of various neurological disorders."}}
{"relation": "SUBSTRATE", "token": ["", "Spermidine/spermine N1-acetyltransferase", " (SSAT) is a key enzyme in the control of polyamine levels in human cells, as acetylation of ", "spermidine", " and spermine triggers export or degradation."], "h": {"pos": [1, 2], "type": null, "name": "Spermidine/spermine N1-acetyltransferase  (SSAT) is a key enzyme in the control of polyamine levels in human cells, as acetylation of "}, "t": {"pos": [3, 4], "type": null, "name": "spermidine  and spermine triggers export or degradation."}}
{"relation": "SUBSTRATE", "token": ["Transport by OATP1B1 and ", "OATP1B3", " enhances the cytotoxicity of epigallocatechin 3-O-gallate and several ", "quercetin", " derivatives."], "h": {"pos": [1, 2], "type": null, "name": "OATP1B3  enhances the cytotoxicity of epigallocatechin 3-O-gallate and several "}, "t": {"pos": [3, 4], "type": null, "name": "quercetin  derivatives."}}
{"relation": "SUBSTRATE", "token": ["UGT1A6 exhibited a significantly higher Vmax and Km values toward both ", "HFC", " and UDP-glucuronic acid than the other ", "UGTs", "."], "h": {"pos": [1, 2], "type": null, "name": "HFC  and UDP-glucuronic acid than the other "}, "t": {"pos": [3, 4], "type": null, "name": "UGTs ."}}
{"relation": "SUBSTRATE", "token": ["On the basis of our findings with structurally similar arylhydroxylamine metabolites of therapeutic drugs, we hypothesized that the reductive detoxification of ", "arylhydroxylamine", " carcinogens was catalyzed by NADH cytochrome b5 reductase (", "b5R", ") and cytochrome b5 (cyt b5)."], "h": {"pos": [1, 2], "type": null, "name": "arylhydroxylamine  carcinogens was catalyzed by NADH cytochrome b5 reductase ("}, "t": {"pos": [3, 4], "type": null, "name": "b5R ) and cytochrome b5 (cyt b5)."}}
{"relation": "SUBSTRATE", "token": ["They all expressed ASS, but not ornithine transcarbamylase (OTC), the enzyme that converts ornithine, the product of degradation of ", "arginine", " with ", "rhArg", ", to citrulline, which is converted back to arginine via ASS."], "h": {"pos": [1, 2], "type": null, "name": "arginine  with "}, "t": {"pos": [3, 4], "type": null, "name": "rhArg , to citrulline, which is converted back to arginine via ASS."}}
{"relation": "SUBSTRATE", "token": ["4.\u2002 At a substrate concentration of 20\u2009\u00b5M, the most active ", "HFC", " glucuronidation catalysts were UGT1A10 followed by UGT1A6 >UGT1A7 >", "UGT2A1", ", whereas at 300\u2009\u00b5M UGT1A6 was about 10 times better catalyst than the other recombinant UGTs."], "h": {"pos": [1, 2], "type": null, "name": "HFC  glucuronidation catalysts were UGT1A10 followed by UGT1A6 >UGT1A7 >"}, "t": {"pos": [3, 4], "type": null, "name": "UGT2A1 , whereas at 300\u2009\u00b5M UGT1A6 was about 10 times better catalyst than the other recombinant UGTs."}}
{"relation": "SUBSTRATE", "token": ["The beta subunit has been cloned and shown to lower the K(m) of methionine adenosyltransferase II alpha2 (the ", "MAT2A", " product) for ", "methionine", " and to render the enzyme more susceptible to S-adenosylmethionine inhibition."], "h": {"pos": [1, 2], "type": null, "name": "MAT2A  product) for "}, "t": {"pos": [3, 4], "type": null, "name": "methionine  and to render the enzyme more susceptible to S-adenosylmethionine inhibition."}}
{"relation": "SUBSTRATE", "token": ["PIP5K1B encodes ", "phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I", " (pip5k1\u03b2), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates ", "phosphatidylinositol 4-phosphate", " [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2]."], "h": {"pos": [1, 2], "type": null, "name": "phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I  (pip5k1\u03b2), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates "}, "t": {"pos": [3, 4], "type": null, "name": "phosphatidylinositol 4-phosphate  [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2]."}}
{"relation": "SUBSTRATE", "token": ["In the current study, we reveal the inhibitory effects of baicalin on the metabolism of dextromethorphan (", "DXM", "), a dual probe substrate of ", "CYP2D", " and CYP3A, in rats."], "h": {"pos": [1, 2], "type": null, "name": "DXM ), a dual probe substrate of "}, "t": {"pos": [3, 4], "type": null, "name": "CYP2D  and CYP3A, in rats."}}
{"relation": "SUBSTRATE", "token": ["Catalytic-site affinities for cGMP, vardenafil, sildenafil, ", "tadalafil", ", or 3-isobutyl-1-methylxanthine (IBMX) were respectively weakened 14-, 123-, 30-, 51-, and 43-fold for Y612A; 63-, 511-, 43-, 95- and 61-fold for ", "Q817A", "; and 59-, 448-, 71-, 137-, and 93-fold for F820A."], "h": {"pos": [1, 2], "type": null, "name": "tadalafil , or 3-isobutyl-1-methylxanthine (IBMX) were respectively weakened 14-, 123-, 30-, 51-, and 43-fold for Y612A; 63-, 511-, 43-, 95- and 61-fold for "}, "t": {"pos": [3, 4], "type": null, "name": "Q817A ; and 59-, 448-, 71-, 137-, and 93-fold for F820A."}}
{"relation": "SUBSTRATE", "token": ["", "Phenytoin", " is principally metabolized by ", "CYP2C9", ", and both are probable substrates of the drug transporter P-glycoprotein."], "h": {"pos": [1, 2], "type": null, "name": "Phenytoin  is principally metabolized by "}, "t": {"pos": [3, 4], "type": null, "name": "CYP2C9 , and both are probable substrates of the drug transporter P-glycoprotein."}}
{"relation": "SUBSTRATE", "token": ["4-Hydroxynonenal (4-HNE) is a mutagenic ", "alpha,beta-unsaturated aldehyde", " produced during oxidative injury that is conjugated by several ", "glutathione S-transferase", " (GST) isoforms."], "h": {"pos": [1, 2], "type": null, "name": "alpha,beta-unsaturated aldehyde  produced during oxidative injury that is conjugated by several "}, "t": {"pos": [3, 4], "type": null, "name": "glutathione S-transferase  (GST) isoforms."}}
{"relation": "SUBSTRATE", "token": ["We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (", "4-ABP", "; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only ", "human b5R", " and cyt b5."], "h": {"pos": [1, 2], "type": null, "name": "4-ABP ; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only "}, "t": {"pos": [3, 4], "type": null, "name": "human b5R  and cyt b5."}}
{"relation": "SUBSTRATE", "token": ["", "Cholesterol", " uptake from ", "lipoproteins", ", intracellular vesicle transport and lipid transfer are also modified by oxysterols."], "h": {"pos": [1, 2], "type": null, "name": "Cholesterol  uptake from "}, "t": {"pos": [3, 4], "type": null, "name": "lipoproteins , intracellular vesicle transport and lipid transfer are also modified by oxysterols."}}
{"relation": "SUBSTRATE", "token": ["The choroid plexus uptake of ", "[(3)H]cefadroxil", " was studied in peptide transporter 2 (", "PEPT2", ") wild-type and null mice as a function of temperature, transport inhibitors, pH, and saturability."], "h": {"pos": [1, 2], "type": null, "name": "[(3)H]cefadroxil  was studied in peptide transporter 2 ("}, "t": {"pos": [3, 4], "type": null, "name": "PEPT2 ) wild-type and null mice as a function of temperature, transport inhibitors, pH, and saturability."}}
{"relation": "SUBSTRATE", "token": ["Given these findings, a unified PK model including the inhibition of MAO-A- and ", "CYP2D6", "-catalyzed 5-MeO-DMT metabolism by harmaline was developed to describe blood harmaline, ", "5-MeO-DMT", ", and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models."], "h": {"pos": [1, 2], "type": null, "name": "CYP2D6 -catalyzed 5-MeO-DMT metabolism by harmaline was developed to describe blood harmaline, "}, "t": {"pos": [3, 4], "type": null, "name": "5-MeO-DMT , and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models."}}
{"relation": "SUBSTRATE", "token": ["Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: ", "4-methoxy-2-naphthylamide", " of L-alanine for ", "aminopeptidase N", ", 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B."], "h": {"pos": [1, 2], "type": null, "name": "4-methoxy-2-naphthylamide  of L-alanine for "}, "t": {"pos": [3, 4], "type": null, "name": "aminopeptidase N , 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B."}}
{"relation": "SUBSTRATE", "token": ["The slower CL was due to the reduction of hepatic biliary excretion (67.0% decrease) and hepatic ", "CYP3A", " subfamily-mediated metabolism (21.9% decrease) of ", "doxorubicin", "."], "h": {"pos": [1, 2], "type": null, "name": "CYP3A  subfamily-mediated metabolism (21.9% decrease) of "}, "t": {"pos": [3, 4], "type": null, "name": "doxorubicin ."}}
{"relation": "SUBSTRATE", "token": ["L-serine dehydratase (", "SDH", "), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and ", "L-threonine", " to yield pyruvate or 2-oxobutyrate."], "h": {"pos": [1, 2], "type": null, "name": "SDH ), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and "}, "t": {"pos": [3, 4], "type": null, "name": "L-threonine  to yield pyruvate or 2-oxobutyrate."}}
{"relation": "SUBSTRATE", "token": ["PIP5K1B encodes phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I (", "pip5k1\u03b2", "), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates ", "phosphatidylinositol 4-phosphate", " [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2]."], "h": {"pos": [1, 2], "type": null, "name": "pip5k1\u03b2 ), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates "}, "t": {"pos": [3, 4], "type": null, "name": "phosphatidylinositol 4-phosphate  [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2]."}}
{"relation": "SUBSTRATE", "token": ["The purified human enzyme also does not oxidize eight representative antitumor polyamine analogues; however, specific oligamine analogues were found to be potent inhibitors of the oxidation of ", "spermine", " by ", "PAOh1", "/SMO."], "h": {"pos": [1, 2], "type": null, "name": "spermine  by "}, "t": {"pos": [3, 4], "type": null, "name": "PAOh1 /SMO."}}
{"relation": "SUBSTRATE", "token": ["Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both ", "cAMP", " and cGMP (", "PDE10A", ")."], "h": {"pos": [1, 2], "type": null, "name": "cAMP  and cGMP ("}, "t": {"pos": [3, 4], "type": null, "name": "PDE10A )."}}
{"relation": "SUBSTRATE", "token": ["For determination of ", "plasmin", " activity, 10 microL thereof was incubated with 150 microL 1.5 M ", "arginine", ", pH 8.7, and 100 microL 20 mM CT preoxidized (15 minutes 37 degrees C) pooled normal citrate buffered EDTA-plasma for 30 minutes (37 degrees C)."], "h": {"pos": [1, 2], "type": null, "name": "plasmin  activity, 10 microL thereof was incubated with 150 microL 1.5 M "}, "t": {"pos": [3, 4], "type": null, "name": "arginine , pH 8.7, and 100 microL 20 mM CT preoxidized (15 minutes 37 degrees C) pooled normal citrate buffered EDTA-plasma for 30 minutes (37 degrees C)."}}
{"relation": "SUBSTRATE", "token": ["", "QR2", " catalyzes the two-electron reduction of menadione via the oxidation of N-alkylated or ", "N-ribosylated nicotinamides", "."], "h": {"pos": [1, 2], "type": null, "name": "QR2  catalyzes the two-electron reduction of menadione via the oxidation of N-alkylated or "}, "t": {"pos": [3, 4], "type": null, "name": "N-ribosylated nicotinamides ."}}
{"relation": "SUBSTRATE", "token": ["Several active analogues were also evaluated for their ability to block uptake of DA, ", "5-HT", ", and NE and inhibit binding of [(125)I] RTI-55 at HEK-hDAT, HEK-", "hSERT", ", and HEK-hNET cells."], "h": {"pos": [1, 2], "type": null, "name": "5-HT , and NE and inhibit binding of [(125)I] RTI-55 at HEK-hDAT, HEK-"}, "t": {"pos": [3, 4], "type": null, "name": "hSERT , and HEK-hNET cells."}}
{"relation": "SUBSTRATE", "token": ["The present study examined the effect of antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), on ", "VMAT2", " activity by measuring adenosine triphosphate-dependent ", "[(3)H]dopamine", " uptake into synaptic vesicles prepared from rat striatum."], "h": {"pos": [1, 2], "type": null, "name": "VMAT2  activity by measuring adenosine triphosphate-dependent "}, "t": {"pos": [3, 4], "type": null, "name": "[(3)H]dopamine  uptake into synaptic vesicles prepared from rat striatum."}}
{"relation": "SUBSTRATE", "token": ["Cross-inhibition of SR-BI- and ", "ABCA1", "-mediated ", "cholesterol", " transport by the small molecules BLT-4 and glyburide."], "h": {"pos": [1, 2], "type": null, "name": "ABCA1 -mediated "}, "t": {"pos": [3, 4], "type": null, "name": "cholesterol  transport by the small molecules BLT-4 and glyburide."}}
{"relation": "SUBSTRATE", "token": ["We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (", "PhIP", "; found in grilled meats) was indeed catalyzed by a purified system containing only ", "human b5R", " and cyt b5."], "h": {"pos": [1, 2], "type": null, "name": "PhIP ; found in grilled meats) was indeed catalyzed by a purified system containing only "}, "t": {"pos": [3, 4], "type": null, "name": "human b5R  and cyt b5."}}
{"relation": "SUBSTRATE", "token": ["In relation to zinc bioavailability, \u03b1-CPPs, \u03b2-CPPs, ", "\u03b1(s1)-CN", "(64-74)4P and \u03b2-CN(1-25)4P increased ", "zinc", " uptake."], "h": {"pos": [1, 2], "type": null, "name": "\u03b1(s1)-CN (64-74)4P and \u03b2-CN(1-25)4P increased "}, "t": {"pos": [3, 4], "type": null, "name": "zinc  uptake."}}
{"relation": "SUBSTRATE", "token": ["We examined the N-demethylation of individual ", "ketamine", " enantiomers using human liver microsomes (HLMs) genotyped for the ", "CYP2B6*6", " allele, insect cell expressed recombinant CYP2B6 and CYP3A4 enzymes and COS-1 cell expressed recombinant CYP2B6.1 and CYP2B6.6 protein variant."], "h": {"pos": [1, 2], "type": null, "name": "ketamine  enantiomers using human liver microsomes (HLMs) genotyped for the "}, "t": {"pos": [3, 4], "type": null, "name": "CYP2B6*6  allele, insect cell expressed recombinant CYP2B6 and CYP3A4 enzymes and COS-1 cell expressed recombinant CYP2B6.1 and CYP2B6.6 protein variant."}}
{"relation": "SUBSTRATE", "token": ["CONCLUSIONS: Total vitamin B6 is abnormally high in autism, consistent with previous reports of an impaired ", "pyridoxal kinase", " for the conversion of ", "pyridoxine", " and pyridoxal to PLP."], "h": {"pos": [1, 2], "type": null, "name": "pyridoxal kinase  for the conversion of "}, "t": {"pos": [3, 4], "type": null, "name": "pyridoxine  and pyridoxal to PLP."}}
{"relation": "SUBSTRATE", "token": ["Pharmacogenetic analysis of two genes, the ", "warfarin", " metabolic enzyme ", "CYP2C9", " and warfarin target enzyme, vitamin K epoxide reductase complex 1 VKORC1, confirmed their influence on warfarin maintenance dose."], "h": {"pos": [1, 2], "type": null, "name": "warfarin  metabolic enzyme "}, "t": {"pos": [3, 4], "type": null, "name": "CYP2C9  and warfarin target enzyme, vitamin K epoxide reductase complex 1 VKORC1, confirmed their influence on warfarin maintenance dose."}}
{"relation": "SUBSTRATE", "token": ["Astrocytes may play a role in these manifestations because astrocytes are essential in the regulation of released ", "glutamate", " and its conversion to glutamine through the enzyme ", "glutamine synthetase", " (GS)."], "h": {"pos": [1, 2], "type": null, "name": "glutamate  and its conversion to glutamine through the enzyme "}, "t": {"pos": [3, 4], "type": null, "name": "glutamine synthetase  (GS)."}}
{"relation": "SUBSTRATE", "token": ["Firstly, transgenic plants overexpressing formate dehydrogenase (", "FDH", ", EC 1.2.1.2) were used to continue our previous studies on the function of FDH in ", "formate", " metabolism."], "h": {"pos": [1, 2], "type": null, "name": "FDH , EC 1.2.1.2) were used to continue our previous studies on the function of FDH in "}, "t": {"pos": [3, 4], "type": null, "name": "formate  metabolism."}}
{"relation": "SUBSTRATE", "token": ["EGCG, 1, and 3 were the most potent cytotoxic compounds, with ", "EGCG", " and 3 selectively killing ", "OATP1B3", "-expressing cells."], "h": {"pos": [1, 2], "type": null, "name": "EGCG  and 3 selectively killing "}, "t": {"pos": [3, 4], "type": null, "name": "OATP1B3 -expressing cells."}}
{"relation": "SUBSTRATE", "token": ["Firstly, the V(max) of ", "GAD", " was increased when ApoCaM was present whereas the affinity for the substrate, ", "glutamate", ", was not affected."], "h": {"pos": [1, 2], "type": null, "name": "GAD  was increased when ApoCaM was present whereas the affinity for the substrate, "}, "t": {"pos": [3, 4], "type": null, "name": "glutamate , was not affected."}}
{"relation": "SUBSTRATE", "token": ["Stable ", "ABCC1", ", ABCC2 and ABCC3 knockdown cell lines were generated, thus making it possible to demonstrate that ABCC1 mediates the basolateral and ABCC2 the apical excretion of ", "BPDE glutathione", " conjugates."], "h": {"pos": [1, 2], "type": null, "name": "ABCC1 , ABCC2 and ABCC3 knockdown cell lines were generated, thus making it possible to demonstrate that ABCC1 mediates the basolateral and ABCC2 the apical excretion of "}, "t": {"pos": [3, 4], "type": null, "name": "BPDE glutathione  conjugates."}}
{"relation": "SUBSTRATE", "token": ["Taken together, these data demonstrate that baicalin inhibits the metabolism of ", "DXM", " in a concentration-dependent manner in rats, possibly through inhibiting hepatic ", "CYP2D", " and CYP3A activities."], "h": {"pos": [1, 2], "type": null, "name": "DXM  in a concentration-dependent manner in rats, possibly through inhibiting hepatic "}, "t": {"pos": [3, 4], "type": null, "name": "CYP2D  and CYP3A activities."}}
{"relation": "SUBSTRATE", "token": ["", "SR-BI", " is a receptor that binds HDL with high affinity and mediates both the selective lipid uptake of ", "cholesteryl esters", " from lipid-rich HDL to cells and the efflux of unesterified cholesterol from cells to HDL."], "h": {"pos": [1, 2], "type": null, "name": "SR-BI  is a receptor that binds HDL with high affinity and mediates both the selective lipid uptake of "}, "t": {"pos": [3, 4], "type": null, "name": "cholesteryl esters  from lipid-rich HDL to cells and the efflux of unesterified cholesterol from cells to HDL."}}
{"relation": "SUBSTRATE", "token": ["4-Hydroxynonenal (", "4-HNE", ") is a mutagenic alpha,beta-unsaturated aldehyde produced during oxidative injury that is conjugated by several ", "glutathione S-transferase", " (GST) isoforms."], "h": {"pos": [1, 2], "type": null, "name": "4-HNE ) is a mutagenic alpha,beta-unsaturated aldehyde produced during oxidative injury that is conjugated by several "}, "t": {"pos": [3, 4], "type": null, "name": "glutathione S-transferase  (GST) isoforms."}}
{"relation": "SUBSTRATE", "token": ["Density functional theory calculations using the hybrid functional B3LYP have been performed to study the ", "methyl", " transfer step in glycine N-methyltransferase (", "GNMT", ")."], "h": {"pos": [1, 2], "type": null, "name": "methyl  transfer step in glycine N-methyltransferase ("}, "t": {"pos": [3, 4], "type": null, "name": "GNMT )."}}
{"relation": "SUBSTRATE", "token": ["In kidneys, stimulation of adenylyl cyclase causes egress of cAMP, conversion of cAMP to AMP by ecto-phosphodiesterase, and metabolism of ", "AMP", " to adenosine by ", "ecto-5'-nucleotidase", "."], "h": {"pos": [1, 2], "type": null, "name": "AMP  to adenosine by "}, "t": {"pos": [3, 4], "type": null, "name": "ecto-5'-nucleotidase ."}}
{"relation": "SUBSTRATE", "token": ["L-serine dehydratase (", "SDH", "), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of ", "L-serine", " and L-threonine to yield pyruvate or 2-oxobutyrate."], "h": {"pos": [1, 2], "type": null, "name": "SDH ), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of "}, "t": {"pos": [3, 4], "type": null, "name": "L-serine  and L-threonine to yield pyruvate or 2-oxobutyrate."}}
{"relation": "SUBSTRATE", "token": ["Using a transient heterologous cell expression system, we find that the transport activities of the ", "short OATP2B1", " variant towards substrates ", "estrone sulfate", " and rosuvastatin are similar to the well-characterized full length variant."], "h": {"pos": [1, 2], "type": null, "name": "short OATP2B1  variant towards substrates "}, "t": {"pos": [3, 4], "type": null, "name": "estrone sulfate  and rosuvastatin are similar to the well-characterized full length variant."}}
{"relation": "SUBSTRATE", "token": ["These and other data have generated a working hypothesis that activation of the terminal ", "serotonin autoreceptor", " enhances the kinetics of ", "5-HT", " uptake through an effect on the serotonin transporter."], "h": {"pos": [1, 2], "type": null, "name": "serotonin autoreceptor  enhances the kinetics of "}, "t": {"pos": [3, 4], "type": null, "name": "5-HT  uptake through an effect on the serotonin transporter."}}
{"relation": "SUBSTRATE", "token": ["", "PIP5K1B", " encodes phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I (pip5k1\u03b2), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate ", " PI(4)P", "] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2]."], "h": {"pos": [1, 2], "type": null, "name": "PIP5K1B  encodes phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I (pip5k1\u03b2), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate "}, "t": {"pos": [3, 4], "type": null, "name": " PI(4)P ] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2]."}}
{"relation": "SUBSTRATE", "token": ["Cytotoxicity assays demonstrated that epigallocatechin 3-O-gallate (", "EGCG", ") and most of compounds 1-6 killed preferentially ", "OATP", "-expressing CHO cells."], "h": {"pos": [1, 2], "type": null, "name": "EGCG ) and most of compounds 1-6 killed preferentially "}, "t": {"pos": [3, 4], "type": null, "name": "OATP -expressing CHO cells."}}
{"relation": "SUBSTRATE", "token": ["In the present study, we have evaluated possible participation of ", "monocarboxylate transporters", " (MCTs) responsible for the bidirectional membrane transport of ", "pyruvate", " in the cytoprotective property in osteoblasts."], "h": {"pos": [1, 2], "type": null, "name": "monocarboxylate transporters  (MCTs) responsible for the bidirectional membrane transport of "}, "t": {"pos": [3, 4], "type": null, "name": "pyruvate  in the cytoprotective property in osteoblasts."}}
{"relation": "SUBSTRATE", "token": ["In kidneys, stimulation of adenylyl cyclase causes egress of cAMP, conversion of ", "cAMP", " to AMP by ecto-", "phosphodiesterase", ", and metabolism of AMP to adenosine by ecto-5'-nucleotidase."], "h": {"pos": [1, 2], "type": null, "name": "cAMP  to AMP by ecto-"}, "t": {"pos": [3, 4], "type": null, "name": "phosphodiesterase , and metabolism of AMP to adenosine by ecto-5'-nucleotidase."}}
{"relation": "SUBSTRATE", "token": ["Choline dehydrogenase (CHDH) and ", "betaine-homocysteine methyltransferase", " (BHMT) are 2 enzymes involved in ", "choline", " oxidation."], "h": {"pos": [1, 2], "type": null, "name": "betaine-homocysteine methyltransferase  (BHMT) are 2 enzymes involved in "}, "t": {"pos": [3, 4], "type": null, "name": "choline  oxidation."}}
{"relation": "SUBSTRATE", "token": ["Specifically, ", "hGSTA4", " cells had significantly higher GSH concentrations when exposed to 5-15 microM 4-HNE, but not at 20 microM ", "4-HNE", ", suggesting extensive GSH utilization at high concentrations of 4-HNE."], "h": {"pos": [1, 2], "type": null, "name": "hGSTA4  cells had significantly higher GSH concentrations when exposed to 5-15 microM 4-HNE, but not at 20 microM "}, "t": {"pos": [3, 4], "type": null, "name": "4-HNE , suggesting extensive GSH utilization at high concentrations of 4-HNE."}}
{"relation": "SUBSTRATE", "token": ["", "N(5)-Substituted H(4)biopterin", " derivatives were not oxidized to products serving as substrates for ", "dihydropteridine reductase", " and,depending on the substituent, were competitive inhibitors of phenylalanine hydroxylase: N(5)-methyl- and N(5)-hydroxymethyl H(4)biopterin inhibited phenylalanine hydroxylase, whereas N(5)-formyl- and N(5)-acetyl H(4)biopterin had no effect."], "h": {"pos": [1, 2], "type": null, "name": "N(5)-Substituted H(4)biopterin  derivatives were not oxidized to products serving as substrates for "}, "t": {"pos": [3, 4], "type": null, "name": "dihydropteridine reductase  and,depending on the substituent, were competitive inhibitors of phenylalanine hydroxylase: N(5)-methyl- and N(5)-hydroxymethyl H(4)biopterin inhibited phenylalanine hydroxylase, whereas N(5)-formyl- and N(5)-acetyl H(4)biopterin had no effect."}}
{"relation": "SUBSTRATE", "token": ["PIP5K1B encodes phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I (", "pip5k1\u03b2", "), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate ", " PI(4)P", "] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2]."], "h": {"pos": [1, 2], "type": null, "name": "pip5k1\u03b2 ), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate "}, "t": {"pos": [3, 4], "type": null, "name": " PI(4)P ] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2]."}}
{"relation": "SUBSTRATE", "token": ["The frdA gene coding for subunit A of FRD, and two control genes, copA and ", "copP", " associated with the export of ", "copper", " out of H. pylori, were inactivated by insertion of the chloramphenicol acetyltransferase cassette into these individual genes."], "h": {"pos": [1, 2], "type": null, "name": "copP  associated with the export of "}, "t": {"pos": [3, 4], "type": null, "name": "copper  out of H. pylori, were inactivated by insertion of the chloramphenicol acetyltransferase cassette into these individual genes."}}
{"relation": "SUBSTRATE", "token": ["The protein exhibited modest H(2)O(2)-dependent ", "peroxidase", " activities with guaiacol, potassium iodide, and ", "2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid", " (ABTS)."], "h": {"pos": [1, 2], "type": null, "name": "peroxidase  activities with guaiacol, potassium iodide, and "}, "t": {"pos": [3, 4], "type": null, "name": "2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid  (ABTS)."}}
{"relation": "SUBSTRATE", "token": ["These results indicate a major role of ", "CYP2B6", " in ", "ketamine", " N-demethylation in vitro and a significant impact of the CYP2B6*6 allele on enzyme-ketamine binding and catalytic activity."], "h": {"pos": [1, 2], "type": null, "name": "CYP2B6  in "}, "t": {"pos": [3, 4], "type": null, "name": "ketamine  N-demethylation in vitro and a significant impact of the CYP2B6*6 allele on enzyme-ketamine binding and catalytic activity."}}
{"relation": "SUBSTRATE", "token": ["2.\u2002 We have developed a convenient quantitative multi-well plate assay to measure the glucuronidation rate of 7-hydroxy-4-trifluoromethylcoumarin (", "HFC", ") for several ", "UGTs", "."], "h": {"pos": [1, 2], "type": null, "name": "HFC ) for several "}, "t": {"pos": [3, 4], "type": null, "name": "UGTs ."}}
{"relation": "SUBSTRATE", "token": ["The ", "Na(+)/Ca(2+) exchanger", " (NCX) is a bidirectional transporter that normally extrudes ", "Ca(2+)", " from the cell (forward mode), but also brings Ca(2+) into the cell (reverse mode) under special conditions such as intracellular Na(+) (Na(+)(i)) accumulation or membrane depolarization."], "h": {"pos": [1, 2], "type": null, "name": "Na(+)/Ca(2+) exchanger  (NCX) is a bidirectional transporter that normally extrudes "}, "t": {"pos": [3, 4], "type": null, "name": "Ca(2+)  from the cell (forward mode), but also brings Ca(2+) into the cell (reverse mode) under special conditions such as intracellular Na(+) (Na(+)(i)) accumulation or membrane depolarization."}}
{"relation": "SUBSTRATE", "token": ["Stable ABCC1, ABCC2 and ABCC3 knockdown cell lines were generated, thus making it possible to demonstrate that ", "ABCC1", " mediates the basolateral and ABCC2 the apical excretion of ", "BPDE glutathione", " conjugates."], "h": {"pos": [1, 2], "type": null, "name": "ABCC1  mediates the basolateral and ABCC2 the apical excretion of "}, "t": {"pos": [3, 4], "type": null, "name": "BPDE glutathione  conjugates."}}
{"relation": "SUBSTRATE", "token": ["Cross-inhibition of ", "SR-BI", "- and ABCA1-mediated ", "cholesterol", " transport by the small molecules BLT-4 and glyburide."], "h": {"pos": [1, 2], "type": null, "name": "SR-BI - and ABCA1-mediated "}, "t": {"pos": [3, 4], "type": null, "name": "cholesterol  transport by the small molecules BLT-4 and glyburide."}}
{"relation": "SUBSTRATE", "token": ["Carnitine acetyltransferases (", "CrAT", ") catalyze the reversible conversion of ", "acetyl-CoA", " and carnitine to acetylcarnitine and free CoA."], "h": {"pos": [1, 2], "type": null, "name": "CrAT ) catalyze the reversible conversion of "}, "t": {"pos": [3, 4], "type": null, "name": "acetyl-CoA  and carnitine to acetylcarnitine and free CoA."}}
{"relation": "SUBSTRATE", "token": ["Here, we demonstrate that ", "peptidyl-prolyl cis/trans-isomerase A1", " (Pin1), an enzyme that catalyzes the conversion of the peptide bond of pSer/pThr-", "Pro", " moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification."], "h": {"pos": [1, 2], "type": null, "name": "peptidyl-prolyl cis/trans-isomerase A1  (Pin1), an enzyme that catalyzes the conversion of the peptide bond of pSer/pThr-"}, "t": {"pos": [3, 4], "type": null, "name": "Pro  moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification."}}
{"relation": "SUBSTRATE", "token": ["Transport by ", "OATP1B1", " and OATP1B3 enhances the cytotoxicity of ", "epigallocatechin 3-O-gallate", " and several quercetin derivatives."], "h": {"pos": [1, 2], "type": null, "name": "OATP1B1  and OATP1B3 enhances the cytotoxicity of "}, "t": {"pos": [3, 4], "type": null, "name": "epigallocatechin 3-O-gallate  and several quercetin derivatives."}}
{"relation": "SUBSTRATE", "token": ["METHODS: (+/-)-Modafinil and its R-(-)- and S-(+)-enantiomers were synthesized and tested for inhibition of ", "[(3)H] dopamine", " (DA) uptake and [(3)H]WIN 35428 binding in human dopamine transporter (", "DAT", ") wild-type and mutants with altered conformational equilibria."], "h": {"pos": [1, 2], "type": null, "name": "[(3)H] dopamine  (DA) uptake and [(3)H]WIN 35428 binding in human dopamine transporter ("}, "t": {"pos": [3, 4], "type": null, "name": "DAT ) wild-type and mutants with altered conformational equilibria."}}
{"relation": "SUBSTRATE", "token": ["Block of ", "human NaV1.5", " ", "sodium", " channels by novel alpha-hydroxyphenylamide analogues of phenytoin."], "h": {"pos": [1, 2], "type": null, "name": "human NaV1.5  "}, "t": {"pos": [3, 4], "type": null, "name": "sodium  channels by novel alpha-hydroxyphenylamide analogues of phenytoin."}}
{"relation": "SUBSTRATE", "token": ["", "Ketamine", " is primarily metabolized to norketamine by hepatic cytochrome P450 (CYP) 2B6 and ", "CYP3A4", "-mediated N-demethylation."], "h": {"pos": [1, 2], "type": null, "name": "Ketamine  is primarily metabolized to norketamine by hepatic cytochrome P450 (CYP) 2B6 and "}, "t": {"pos": [3, 4], "type": null, "name": "CYP3A4 -mediated N-demethylation."}}
{"relation": "SUBSTRATE", "token": ["One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (", "GDC", ", EC 2.1.1.10) and serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) with ", "glycine", " (Gly) as one-carbon (1-C) source."], "h": {"pos": [1, 2], "type": null, "name": "GDC , EC 2.1.1.10) and serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) with "}, "t": {"pos": [3, 4], "type": null, "name": "glycine  (Gly) as one-carbon (1-C) source."}}
{"relation": "SUBSTRATE", "token": ["", "6-DHSG", " was metabolised by GSH to form a GSH conjugate (GS-6-DHSG) in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of glutathione-S-transferase (", "GST", ")."], "h": {"pos": [1, 2], "type": null, "name": "6-DHSG  was metabolised by GSH to form a GSH conjugate (GS-6-DHSG) in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of glutathione-S-transferase ("}, "t": {"pos": [3, 4], "type": null, "name": "GST )."}}
{"relation": "SUBSTRATE", "token": ["In relation to zinc bioavailability, \u03b1-CPPs, \u03b2-CPPs, \u03b1(s1)-CN(64-74)4P and ", "\u03b2-CN", "(1-25)4P increased ", "zinc", " uptake."], "h": {"pos": [1, 2], "type": null, "name": "\u03b2-CN (1-25)4P increased "}, "t": {"pos": [3, 4], "type": null, "name": "zinc  uptake."}}
{"relation": "SUBSTRATE", "token": ["Racemization of ", "serine", " is catalyzed by ", "serine racemase", ", a pyridoxal 5'-phosphate-dependent enzyme expressed mainly in brain and liver."], "h": {"pos": [1, 2], "type": null, "name": "serine  is catalyzed by "}, "t": {"pos": [3, 4], "type": null, "name": "serine racemase , a pyridoxal 5'-phosphate-dependent enzyme expressed mainly in brain and liver."}}
{"relation": "SUBSTRATE", "token": ["", "UGT1A6", " exhibited a significantly higher Vmax and Km values toward both HFC and ", "UDP", "-glucuronic acid than the other UGTs."], "h": {"pos": [1, 2], "type": null, "name": "UGT1A6  exhibited a significantly higher Vmax and Km values toward both HFC and "}, "t": {"pos": [3, 4], "type": null, "name": "UDP -glucuronic acid than the other UGTs."}}
{"relation": "SUBSTRATE", "token": ["4.\u2002 At a substrate concentration of 20\u2009\u00b5M, the most active ", "HFC", " glucuronidation catalysts were UGT1A10 followed by UGT1A6 >UGT1A7 >UGT2A1, whereas at 300\u2009\u00b5M UGT1A6 was about 10 times better catalyst than the other recombinant ", "UGTs", "."], "h": {"pos": [1, 2], "type": null, "name": "HFC  glucuronidation catalysts were UGT1A10 followed by UGT1A6 >UGT1A7 >UGT2A1, whereas at 300\u2009\u00b5M UGT1A6 was about 10 times better catalyst than the other recombinant "}, "t": {"pos": [3, 4], "type": null, "name": "UGTs ."}}
{"relation": "SUBSTRATE", "token": ["Reductive detoxification of ", "arylhydroxylamine", " carcinogens by human NADH cytochrome b5 reductase and ", "cytochrome b5", "."], "h": {"pos": [1, 2], "type": null, "name": "arylhydroxylamine  carcinogens by human NADH cytochrome b5 reductase and "}, "t": {"pos": [3, 4], "type": null, "name": "cytochrome b5 ."}}
{"relation": "SUBSTRATE", "token": ["Abstract 1.\u2002We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (CYP3A) in rats using dexamethasone 21-phosphate (DEX-P) and ", "midazolam", " (MDZ) as an inducer and a substrate to ", "CYP3A", ", respectively."], "h": {"pos": [1, 2], "type": null, "name": "midazolam  (MDZ) as an inducer and a substrate to "}, "t": {"pos": [3, 4], "type": null, "name": "CYP3A , respectively."}}
{"relation": "SUBSTRATE", "token": ["One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (", "GDC", ", EC 2.1.1.10) and serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) with glycine (", "Gly", ") as one-carbon (1-C) source."], "h": {"pos": [1, 2], "type": null, "name": "GDC , EC 2.1.1.10) and serine hydroxymethyltransferase (SHMT, EC 2.1.2.1) with glycine ("}, "t": {"pos": [3, 4], "type": null, "name": "Gly ) as one-carbon (1-C) source."}}
{"relation": "SUBSTRATE", "token": ["", "TAS-102", " is a novel drug containing trifluorothymidine, which is phosphorylated by ", "TK-1", " to its active monophosphated form, that in turn can inhibit TS."], "h": {"pos": [1, 2], "type": null, "name": "TAS-102  is a novel drug containing trifluorothymidine, which is phosphorylated by "}, "t": {"pos": [3, 4], "type": null, "name": "TK-1  to its active monophosphated form, that in turn can inhibit TS."}}
{"relation": "SUBSTRATE", "token": ["The protein exhibited modest H(2)O(2)-dependent ", "peroxidase", " activities with guaiacol, potassium iodide, and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (", "ABTS", ")."], "h": {"pos": [1, 2], "type": null, "name": "peroxidase  activities with guaiacol, potassium iodide, and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid ("}, "t": {"pos": [3, 4], "type": null, "name": "ABTS )."}}
{"relation": "SUBSTRATE", "token": ["", "L-serine dehydratase", " (SDH), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and ", "L-threonine", " to yield pyruvate or 2-oxobutyrate."], "h": {"pos": [1, 2], "type": null, "name": "L-serine dehydratase  (SDH), a member of the beta-family of pyridoxal phosphate-dependent (PLP) enzymes, catalyzes the deamination of L-serine and "}, "t": {"pos": [3, 4], "type": null, "name": "L-threonine  to yield pyruvate or 2-oxobutyrate."}}
{"relation": "SUBSTRATE", "token": ["These observations suggest that uptake of ", "phenformin", " into liver mitochondria is at least partly mediated by ", "OCTN1", " and functionally relevant to its inhibition potential of complex I respiration."], "h": {"pos": [1, 2], "type": null, "name": "phenformin  into liver mitochondria is at least partly mediated by "}, "t": {"pos": [3, 4], "type": null, "name": "OCTN1  and functionally relevant to its inhibition potential of complex I respiration."}}
{"relation": "SUBSTRATE", "token": ["Objective: This study explores the ability of ", "acyl glucuronides", " to act as substrates or inhibitors of human carboxylesterases 1 (hCES1) and 2 (", "hCES2", ")."], "h": {"pos": [1, 2], "type": null, "name": "acyl glucuronides  to act as substrates or inhibitors of human carboxylesterases 1 (hCES1) and 2 ("}, "t": {"pos": [3, 4], "type": null, "name": "hCES2 )."}}
{"relation": "SUBSTRATE", "token": ["Both risperidone and ", "9-hydroxyrisperidone", " are substrates of P-glycoprotein (", "P-gp", "), a transport protein involved in drug absorption, distribution, and elimination."], "h": {"pos": [1, 2], "type": null, "name": "9-hydroxyrisperidone  are substrates of P-glycoprotein ("}, "t": {"pos": [3, 4], "type": null, "name": "P-gp ), a transport protein involved in drug absorption, distribution, and elimination."}}
{"relation": "SUBSTRATE", "token": ["PIP5K1B encodes ", "phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I", " (pip5k1\u03b2), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate ", " PI(4)P", "] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2]."], "h": {"pos": [1, 2], "type": null, "name": "phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I  (pip5k1\u03b2), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates phosphatidylinositol 4-phosphate "}, "t": {"pos": [3, 4], "type": null, "name": " PI(4)P ] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2]."}}
{"relation": "SUBSTRATE", "token": ["Taken together, these data demonstrate that baicalin inhibits the metabolism of ", "DXM", " in a concentration-dependent manner in rats, possibly through inhibiting hepatic CYP2D and ", "CYP3A", " activities."], "h": {"pos": [1, 2], "type": null, "name": "DXM  in a concentration-dependent manner in rats, possibly through inhibiting hepatic CYP2D and "}, "t": {"pos": [3, 4], "type": null, "name": "CYP3A  activities."}}
{"relation": "SUBSTRATE", "token": ["At normal pH (7.4) and temperature (37 degrees C), the uptake of 1 microM ", "cefadroxil", " was reduced by 83% in PEPT2(-/-) mice as compared with ", "PEPT2", "(+/+) mice (p < 0.001)."], "h": {"pos": [1, 2], "type": null, "name": "cefadroxil  was reduced by 83% in PEPT2(-/-) mice as compared with "}, "t": {"pos": [3, 4], "type": null, "name": "PEPT2 (+/+) mice (p < 0.001)."}}
{"relation": "SUBSTRATE", "token": ["One major route involves the tetrahydrofolate (THF)-dependent activities of the glycine decarboxylase complex (GDC, EC 2.1.1.10) and ", "serine hydroxymethyltransferase", " (SHMT, EC 2.1.2.1) with glycine (", "Gly", ") as one-carbon (1-C) source."], "h": {"pos": [1, 2], "type": null, "name": "serine hydroxymethyltransferase  (SHMT, EC 2.1.2.1) with glycine ("}, "t": {"pos": [3, 4], "type": null, "name": "Gly ) as one-carbon (1-C) source."}}
{"relation": "SUBSTRATE", "token": ["", "Monocarboxylate transporters", " (MCTs) are proton-linked membrane carriers involved in the transport of monocarboxylates such as lactate, ", "pyruvate", ", as well as ketone bodies."], "h": {"pos": [1, 2], "type": null, "name": "Monocarboxylate transporters  (MCTs) are proton-linked membrane carriers involved in the transport of monocarboxylates such as lactate, "}, "t": {"pos": [3, 4], "type": null, "name": "pyruvate , as well as ketone bodies."}}
{"relation": "SUBSTRATE", "token": ["BACKGROUND: Histamine synthesized by histidine decarboxylase (", "HDC", ") from ", "L-histidine", " is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity."], "h": {"pos": [1, 2], "type": null, "name": "HDC ) from "}, "t": {"pos": [3, 4], "type": null, "name": "L-histidine  is a major chemical mediator in the development of nasal allergy which is characterized by nasal hypersensitivity."}}
{"relation": "SUBSTRATE", "token": ["", "Indoleamine 2,3-dioxygenase", " (IDO), a ", "tryptophan", " catabolizing enzyme, has been implicated in the pathogenesis of various neurological disorders."], "h": {"pos": [1, 2], "type": null, "name": "Indoleamine 2,3-dioxygenase  (IDO), a "}, "t": {"pos": [3, 4], "type": null, "name": "tryptophan  catabolizing enzyme, has been implicated in the pathogenesis of various neurological disorders."}}
{"relation": "SUBSTRATE", "token": ["Abstract 1.\u2002We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal ", "cytochrome P450 3A", " (CYP3A) in rats using dexamethasone 21-phosphate (DEX-P) and ", "midazolam", " (MDZ) as an inducer and a substrate to CYP3A, respectively."], "h": {"pos": [1, 2], "type": null, "name": "cytochrome P450 3A  (CYP3A) in rats using dexamethasone 21-phosphate (DEX-P) and "}, "t": {"pos": [3, 4], "type": null, "name": "midazolam  (MDZ) as an inducer and a substrate to CYP3A, respectively."}}
{"relation": "SUBSTRATE", "token": ["", "6-DHSG", " was metabolised by GSH to form a GSH conjugate (GS-6-DHSG) in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of ", "glutathione-S-transferase", " (GST)."], "h": {"pos": [1, 2], "type": null, "name": "6-DHSG  was metabolised by GSH to form a GSH conjugate (GS-6-DHSG) in RAW 264.7 cells, via a potential mechanism involving the catalytic activity of "}, "t": {"pos": [3, 4], "type": null, "name": "glutathione-S-transferase  (GST)."}}
{"relation": "SUBSTRATE", "token": ["Five classes of chalcogenopyrylium dyes (CGPs) were examined for their ability to modulate transport of [(3)H]estradiol glucuronide (", "E217\u03b2G", ") (a prototypical ", "MRP", " substrate) into MRP-enriched inside-out membrane vesicles."], "h": {"pos": [1, 2], "type": null, "name": "E217\u03b2G ) (a prototypical "}, "t": {"pos": [3, 4], "type": null, "name": "MRP  substrate) into MRP-enriched inside-out membrane vesicles."}}
{"relation": "SUBSTRATE", "token": ["4.\u2002 At a substrate concentration of 20\u2009\u00b5M, the most active ", "HFC", " glucuronidation catalysts were UGT1A10 followed by UGT1A6 >", "UGT1A7", " >UGT2A1, whereas at 300\u2009\u00b5M UGT1A6 was about 10 times better catalyst than the other recombinant UGTs."], "h": {"pos": [1, 2], "type": null, "name": "HFC  glucuronidation catalysts were UGT1A10 followed by UGT1A6 >"}, "t": {"pos": [3, 4], "type": null, "name": "UGT1A7  >UGT2A1, whereas at 300\u2009\u00b5M UGT1A6 was about 10 times better catalyst than the other recombinant UGTs."}}
{"relation": "SUBSTRATE", "token": ["The ", "M564G", " mutated CrAT showed higher activity toward longer chain acyl-CoAs: activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, ", "acetyl-CoA", "."], "h": {"pos": [1, 2], "type": null, "name": "M564G  mutated CrAT showed higher activity toward longer chain acyl-CoAs: activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, "}, "t": {"pos": [3, 4], "type": null, "name": "acetyl-CoA ."}}
{"relation": "SUBSTRATE", "token": ["Here, we demonstrate that ", "peptidyl-prolyl cis/trans-isomerase A1", " (Pin1), an enzyme that catalyzes the conversion of the peptide bond of pSer/", "pThr", "-Pro moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification."], "h": {"pos": [1, 2], "type": null, "name": "peptidyl-prolyl cis/trans-isomerase A1  (Pin1), an enzyme that catalyzes the conversion of the peptide bond of pSer/"}, "t": {"pos": [3, 4], "type": null, "name": "pThr -Pro moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification."}}
{"relation": "SUBSTRATE", "token": ["This surprising correlation between the lack of OTC expression and sensitivity of ASS-positive HCC cells shows that OTC-deficient HCCs are sensitive to ", "rhArg", "-mediated ", "arginine", " depletion."], "h": {"pos": [1, 2], "type": null, "name": "rhArg -mediated "}, "t": {"pos": [3, 4], "type": null, "name": "arginine  depletion."}}
{"relation": "SUBSTRATE", "token": ["The ", "calcium", " homeostasis proteins sarcoendoplasmic reticulum ATPase 2a (SERCA2a), sodium calcium exchanger-1, phospholamban (", "PLB", "), phospho-PLB, and calsequestrin 2 are important for contraction and relaxation."], "h": {"pos": [1, 2], "type": null, "name": "calcium  homeostasis proteins sarcoendoplasmic reticulum ATPase 2a (SERCA2a), sodium calcium exchanger-1, phospholamban ("}, "t": {"pos": [3, 4], "type": null, "name": "PLB ), phospho-PLB, and calsequestrin 2 are important for contraction and relaxation."}}
{"relation": "SUBSTRATE", "token": ["The M564G mutated CrAT showed higher activity toward longer chain ", "acyl-CoAs", ": activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type ", "CrAT", ", and lower activity toward its natural substrate, acetyl-CoA."], "h": {"pos": [1, 2], "type": null, "name": "acyl-CoAs : activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type "}, "t": {"pos": [3, 4], "type": null, "name": "CrAT , and lower activity toward its natural substrate, acetyl-CoA."}}
{"relation": "SUBSTRATE", "token": ["", "PIP5K1B", " encodes phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I (pip5k1\u03b2), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates ", "phosphatidylinositol 4-phosphate", " [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2]."], "h": {"pos": [1, 2], "type": null, "name": "PIP5K1B  encodes phosphatidylinositol 4-phosphate 5-kinase \u03b2 type I (pip5k1\u03b2), an enzyme functionally linked to actin cytoskeleton dynamics that phosphorylates "}, "t": {"pos": [3, 4], "type": null, "name": "phosphatidylinositol 4-phosphate  [PI(4)P] to generate phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2]."}}
{"relation": "SUBSTRATE", "token": ["The ", "mitochondrial respiratory chain complex IV", " (cytochrome c oxidase) is a multi-subunit enzyme that transfers electrons from cytochrome c to molecular ", "oxygen", ", yielding water."], "h": {"pos": [1, 2], "type": null, "name": "mitochondrial respiratory chain complex IV  (cytochrome c oxidase) is a multi-subunit enzyme that transfers electrons from cytochrome c to molecular "}, "t": {"pos": [3, 4], "type": null, "name": "oxygen , yielding water."}}
{"relation": "SUBSTRATE", "token": ["In the presence of the system L inhibitor BCH, Na(+)-dependent l-alanine uptake in WKY and SHR PTE cells was inhibited by alanine, serine, and cysteine, which is consistent with ", "amino acid", " transport through ", "ASCT2", "."], "h": {"pos": [1, 2], "type": null, "name": "amino acid  transport through "}, "t": {"pos": [3, 4], "type": null, "name": "ASCT2 ."}}
{"relation": "SUBSTRATE", "token": ["Megalin, a family of endocytic receptors related to the ", "low-density lipoprotein (LDL) receptor", ", is a major pathway for proximal tubular ", "aminoglycoside", " accumulation."], "h": {"pos": [1, 2], "type": null, "name": "low-density lipoprotein (LDL) receptor , is a major pathway for proximal tubular "}, "t": {"pos": [3, 4], "type": null, "name": "aminoglycoside  accumulation."}}
{"relation": "SUBSTRATE", "token": ["HepG2 cells transfected with an hGSTA4 vector construct exhibited high steady-state hGSTA4 mRNA, high ", "GST-4", "", "4-HNE", " catalytic activities, but lower basal glutathione (GSH) concentrations relative to insert-free vector (control) cells."], "h": {"pos": [1, 2], "type": null, "name": "GST-4 "}, "t": {"pos": [3, 4], "type": null, "name": "4-HNE  catalytic activities, but lower basal glutathione (GSH) concentrations relative to insert-free vector (control) cells."}}
{"relation": "SUBSTRATE", "token": ["METHODS: (+/-)-Modafinil and its R-(-)- and S-(+)-enantiomers were synthesized and tested for inhibition of ", "[(3)H] dopamine", " (DA) uptake and [(3)H]WIN 35428 binding in ", "human dopamine transporter", " (DAT) wild-type and mutants with altered conformational equilibria."], "h": {"pos": [1, 2], "type": null, "name": "[(3)H] dopamine  (DA) uptake and [(3)H]WIN 35428 binding in "}, "t": {"pos": [3, 4], "type": null, "name": "human dopamine transporter  (DAT) wild-type and mutants with altered conformational equilibria."}}
{"relation": "SUBSTRATE", "token": ["It has been claimed that hCTR1, the ", "human high affinity copper transporter", ", is the major entry pathway for ", "cDDP", " and related drugs via a mechanism that mimics copper."], "h": {"pos": [1, 2], "type": null, "name": "human high affinity copper transporter , is the major entry pathway for "}, "t": {"pos": [3, 4], "type": null, "name": "cDDP  and related drugs via a mechanism that mimics copper."}}
{"relation": "SUBSTRATE", "token": ["For determination of [PA+", "Pli", "]-activity, ", "arginine", " was added after this incubation."], "h": {"pos": [1, 2], "type": null, "name": "Pli ]-activity, "}, "t": {"pos": [3, 4], "type": null, "name": "arginine  was added after this incubation."}}
{"relation": "SUBSTRATE", "token": ["Block of human NaV1.5 ", "sodium channels", "", "sodium", " channels by novel alpha-hydroxyphenylamide analogues of phenytoin."], "h": {"pos": [1, 2], "type": null, "name": "sodium channels "}, "t": {"pos": [3, 4], "type": null, "name": "sodium  channels by novel alpha-hydroxyphenylamide analogues of phenytoin."}}
{"relation": "SUBSTRATE", "token": ["Introduction: ", "5-Lipoxygenase", " (5-LO) is a crucial enzyme of the ", "arachidonic acid", " (AA) cascade and catalyzes the formation of bioactive leukotrienes (LTs) with the help of FLAP, the 5-LO-activating protein."], "h": {"pos": [1, 2], "type": null, "name": "5-Lipoxygenase  (5-LO) is a crucial enzyme of the "}, "t": {"pos": [3, 4], "type": null, "name": "arachidonic acid  (AA) cascade and catalyzes the formation of bioactive leukotrienes (LTs) with the help of FLAP, the 5-LO-activating protein."}}
{"relation": "SUBSTRATE", "token": ["The M564G mutated ", "CrAT", " showed higher activity toward longer chain acyl-CoAs: activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, ", "acetyl-CoA", "."], "h": {"pos": [1, 2], "type": null, "name": "CrAT  showed higher activity toward longer chain acyl-CoAs: activity toward myristoyl-CoA was 1250-fold higher than that of the wild-type CrAT, and lower activity toward its natural substrate, "}, "t": {"pos": [3, 4], "type": null, "name": "acetyl-CoA ."}}
{"relation": "SUBSTRATE", "token": ["", "zRetSat A", " also saturated the 13-14 or 7-8 double bonds of ", "all-trans-3,4-didehydroretinol", " (vitamin A2), a second endogenous form of vitamin A in zebrafish."], "h": {"pos": [1, 2], "type": null, "name": "zRetSat A  also saturated the 13-14 or 7-8 double bonds of "}, "t": {"pos": [3, 4], "type": null, "name": "all-trans-3,4-didehydroretinol  (vitamin A2), a second endogenous form of vitamin A in zebrafish."}}
{"relation": "SUBSTRATE", "token": ["Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of L-alanine for aminopeptidase N, 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and ", "4-methoxy-2-naphthylamide", " of L-arginine for ", "aminopeptidase B", "."], "h": {"pos": [1, 2], "type": null, "name": "4-methoxy-2-naphthylamide  of L-arginine for "}, "t": {"pos": [3, 4], "type": null, "name": "aminopeptidase B ."}}
{"relation": "SUBSTRATE", "token": ["A high throughput assay for the glucuronidation of ", "7-hydroxy-4-trifluoromethylcoumarin", " by recombinant ", "human UDP-glucuronosyltransferases", " and liver microsomes."], "h": {"pos": [1, 2], "type": null, "name": "7-hydroxy-4-trifluoromethylcoumarin  by recombinant "}, "t": {"pos": [3, 4], "type": null, "name": "human UDP-glucuronosyltransferases  and liver microsomes."}}
{"relation": "SUBSTRATE", "token": ["Both ", "risperidone", " and 9-hydroxyrisperidone are substrates of ", "P-glycoprotein", " (P-gp), a transport protein involved in drug absorption, distribution, and elimination."], "h": {"pos": [1, 2], "type": null, "name": "risperidone  and 9-hydroxyrisperidone are substrates of "}, "t": {"pos": [3, 4], "type": null, "name": "P-glycoprotein  (P-gp), a transport protein involved in drug absorption, distribution, and elimination."}}
{"relation": "SUBSTRATE", "token": ["We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (4-ABP; found in cigarette smoke) and the ", "heterocyclic amine", " 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and ", "cyt b5", "."], "h": {"pos": [1, 2], "type": null, "name": "heterocyclic amine  2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and "}, "t": {"pos": [3, 4], "type": null, "name": "cyt b5 ."}}
{"relation": "SUBSTRATE", "token": ["PURPOSE: The fluoropyrimidine carbamate (", "capecitabine", ") is converted to 5-fluorouracil (5-FU) by thymidine phosphorylase (", "TP", ") inside target tissues."], "h": {"pos": [1, 2], "type": null, "name": "capecitabine ) is converted to 5-fluorouracil (5-FU) by thymidine phosphorylase ("}, "t": {"pos": [3, 4], "type": null, "name": "TP ) inside target tissues."}}
{"relation": "SUBSTRATE", "token": ["Using a transient heterologous cell expression system, we find that the transport activities of the ", "short OATP2B1", " variant towards substrates estrone sulfate and ", "rosuvastatin", " are similar to the well-characterized full length variant."], "h": {"pos": [1, 2], "type": null, "name": "short OATP2B1  variant towards substrates estrone sulfate and "}, "t": {"pos": [3, 4], "type": null, "name": "rosuvastatin  are similar to the well-characterized full length variant."}}
{"relation": "SUBSTRATE", "token": ["Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of L-alanine for aminopeptidase N, 4-methoxy-2-naphthylamide of ", "L-leucine", " for ", "leucine aminopeptidase", ", 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B."], "h": {"pos": [1, 2], "type": null, "name": "L-leucine  for "}, "t": {"pos": [3, 4], "type": null, "name": "leucine aminopeptidase , 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B."}}
{"relation": "SUBSTRATE", "token": ["RESULTS: (+/-)-, R-, and S-modafinil bind to the ", "DAT", " and inhibit ", "DA", " uptake less potently than cocaine, with R-modafinil having approximately threefold higher affinity than its S-enantiomer."], "h": {"pos": [1, 2], "type": null, "name": "DAT  and inhibit "}, "t": {"pos": [3, 4], "type": null, "name": "DA  uptake less potently than cocaine, with R-modafinil having approximately threefold higher affinity than its S-enantiomer."}}
{"relation": "SUBSTRATE", "token": ["Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of L-alanine for aminopeptidase N, 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, ", "4-methoxy-2-naphthylamide", " of L-glutamic acid for ", "aminopeptidase A", " and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B."], "h": {"pos": [1, 2], "type": null, "name": "4-methoxy-2-naphthylamide  of L-glutamic acid for "}, "t": {"pos": [3, 4], "type": null, "name": "aminopeptidase A  and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B."}}
{"relation": "SUBSTRATE", "token": ["Here, we demonstrate that peptidyl-prolyl cis/trans-isomerase A1 (", "Pin1", "), an enzyme that catalyzes the conversion of the peptide bond of ", "pSer", "/pThr-Pro moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification."], "h": {"pos": [1, 2], "type": null, "name": "Pin1 ), an enzyme that catalyzes the conversion of the peptide bond of "}, "t": {"pos": [3, 4], "type": null, "name": "pSer /pThr-Pro moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification."}}
{"relation": "SUBSTRATE", "token": ["In functional transport assays, we found that one of the identified molecules, ATM7, increased the reuptake of ", "serotonin", ", possibly by facilitating the interaction of serotonin with transport-ready conformations of ", "SERT", " when concentrations of serotonin were low and rate limiting."], "h": {"pos": [1, 2], "type": null, "name": "serotonin , possibly by facilitating the interaction of serotonin with transport-ready conformations of "}, "t": {"pos": [3, 4], "type": null, "name": "SERT  when concentrations of serotonin were low and rate limiting."}}
{"relation": "SUBSTRATE", "token": ["We found that reduction of the carcinogenic hydroxylamines of the aromatic amine 4-aminobiphenyl (", "4-ABP", "; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and ", "cyt b5", "."], "h": {"pos": [1, 2], "type": null, "name": "4-ABP ; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only human b5R and "}, "t": {"pos": [3, 4], "type": null, "name": "cyt b5 ."}}
{"relation": "SUBSTRATE", "token": ["", "Monocarboxylate transporters", " (MCTs) are proton-linked membrane carriers involved in the transport of ", "monocarboxylates", " such as lactate, pyruvate, as well as ketone bodies."], "h": {"pos": [1, 2], "type": null, "name": "Monocarboxylate transporters  (MCTs) are proton-linked membrane carriers involved in the transport of "}, "t": {"pos": [3, 4], "type": null, "name": "monocarboxylates  such as lactate, pyruvate, as well as ketone bodies."}}
{"relation": "SUBSTRATE", "token": ["BACKGROUND: Since the introduction of the first cholinesterase inhibitor (ChEI) in 1997, most clinicians and probably most patients would consider the cholinergic drugs, donepezil, galantamine and rivastigmine, to be the first line pharmacotherapy for mild to moderate Alzheimer's disease.The drugs have slightly different pharmacological properties, but they all work by inhibiting the breakdown of ", "acetylcholine", ", an important neurotransmitter associated with memory, by blocking the enzyme ", "acetylcholinesterase", "."], "h": {"pos": [1, 2], "type": null, "name": "acetylcholine , an important neurotransmitter associated with memory, by blocking the enzyme "}, "t": {"pos": [3, 4], "type": null, "name": "acetylcholinesterase ."}}
{"relation": "SUBSTRATE", "token": ["PGE(2) is synthesized from ", "arachidonic acid", " by cyclooxygenases (COX) and ", "prostaglandin E synthases", " (PGES) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4)."], "h": {"pos": [1, 2], "type": null, "name": "arachidonic acid  by cyclooxygenases (COX) and "}, "t": {"pos": [3, 4], "type": null, "name": "prostaglandin E synthases  (PGES) and mediates its biological activity through binding to the four prostanoid receptors EP(1) through EP(4)."}}
{"relation": "SUBSTRATE", "token": ["Possession of CYP2C9*2 or ", "CYP2C9", "*3 variant alleles, which result in decreased enzyme activity, is associated with a significant decrease in the mean ", "warfarin", " dose."], "h": {"pos": [1, 2], "type": null, "name": "CYP2C9 *3 variant alleles, which result in decreased enzyme activity, is associated with a significant decrease in the mean "}, "t": {"pos": [3, 4], "type": null, "name": "warfarin  dose."}}
{"relation": "SUBSTRATE", "token": ["The concomitantly administered effects of ", "rifampicin", " on other drugs can result in their altered metabolism or transportation that are metabolised by ", "cytochromes P450", " or transported by p-glycoprotein in the gastrointestinal tract and liver."], "h": {"pos": [1, 2], "type": null, "name": "rifampicin  on other drugs can result in their altered metabolism or transportation that are metabolised by "}, "t": {"pos": [3, 4], "type": null, "name": "cytochromes P450  or transported by p-glycoprotein in the gastrointestinal tract and liver."}}
{"relation": "SUBSTRATE", "token": ["The ", "Na(+)/Ca(2+) exchanger", " (NCX) is a bidirectional transporter that normally extrudes Ca(2+) from the cell (forward mode), but also brings ", "Ca(2+)", " into the cell (reverse mode) under special conditions such as intracellular Na(+) (Na(+)(i)) accumulation or membrane depolarization."], "h": {"pos": [1, 2], "type": null, "name": "Na(+)/Ca(2+) exchanger  (NCX) is a bidirectional transporter that normally extrudes Ca(2+) from the cell (forward mode), but also brings "}, "t": {"pos": [3, 4], "type": null, "name": "Ca(2+)  into the cell (reverse mode) under special conditions such as intracellular Na(+) (Na(+)(i)) accumulation or membrane depolarization."}}
{"relation": "SUBSTRATE", "token": ["", "CPT I", " (carnitine palmitoyltransferase I) catalyses the conversion of ", "palmitoyl-CoA", " into palmitoylcarnitine in the presence of L-carnitine, facilitating the entry of fatty acids into mitochondria."], "h": {"pos": [1, 2], "type": null, "name": "CPT I  (carnitine palmitoyltransferase I) catalyses the conversion of "}, "t": {"pos": [3, 4], "type": null, "name": "palmitoyl-CoA  into palmitoylcarnitine in the presence of L-carnitine, facilitating the entry of fatty acids into mitochondria."}}
{"relation": "SUBSTRATE", "token": ["In relation to zinc bioavailability, ", "\u03b1-CPPs", ", \u03b2-CPPs, \u03b1(s1)-CN(64-74)4P and \u03b2-CN(1-25)4P increased ", "zinc", " uptake."], "h": {"pos": [1, 2], "type": null, "name": "\u03b1-CPPs , \u03b2-CPPs, \u03b1(s1)-CN(64-74)4P and \u03b2-CN(1-25)4P increased "}, "t": {"pos": [3, 4], "type": null, "name": "zinc  uptake."}}
{"relation": "SUBSTRATE", "token": ["3.\u2002 We have used this method to screen 11 recombinant ", "human UGTs", " for ", "HFC", " glucuronidation activity and studied the reaction kinetics with the most active enzymes."], "h": {"pos": [1, 2], "type": null, "name": "human UGTs  for "}, "t": {"pos": [3, 4], "type": null, "name": "HFC  glucuronidation activity and studied the reaction kinetics with the most active enzymes."}}
{"relation": "SUBSTRATE", "token": ["The mouse ", "CYP2J", " subfamily includes members that have wide tissue distribution and are active in the metabolism of ", "arachidonic acid", " (AA), linoleic acid (LA), and other lipids and xenobiotics."], "h": {"pos": [1, 2], "type": null, "name": "CYP2J  subfamily includes members that have wide tissue distribution and are active in the metabolism of "}, "t": {"pos": [3, 4], "type": null, "name": "arachidonic acid  (AA), linoleic acid (LA), and other lipids and xenobiotics."}}
{"relation": "SUBSTRATE", "token": ["Specifically, ", "all-trans-13,14-dihydroretinol", " is transiently oxidized to all-trans-13,14-dihydroretinoic acid before being oxidized further by ", "Cyp26", " enzymes."], "h": {"pos": [1, 2], "type": null, "name": "all-trans-13,14-dihydroretinol  is transiently oxidized to all-trans-13,14-dihydroretinoic acid before being oxidized further by "}, "t": {"pos": [3, 4], "type": null, "name": "Cyp26  enzymes."}}
{"relation": "SUBSTRATE", "token": ["The alpha class human GSTA4-4 enzyme (", "hGSTA4-4", ") has a particularly high catalytic efficiency toward ", "4-HNE", " conjugation."], "h": {"pos": [1, 2], "type": null, "name": "hGSTA4-4 ) has a particularly high catalytic efficiency toward "}, "t": {"pos": [3, 4], "type": null, "name": "4-HNE  conjugation."}}
{"relation": "SUBSTRATE", "token": ["In summary, our data indicates that over-expression of hGSTA4 at levels conferring high ", "GST", "-", "4-HNE", " conjugating activity confers a partial growth advantage to HepG2 cells and protects against 4-HNE oxidative injury."], "h": {"pos": [1, 2], "type": null, "name": "GST -"}, "t": {"pos": [3, 4], "type": null, "name": "4-HNE  conjugating activity confers a partial growth advantage to HepG2 cells and protects against 4-HNE oxidative injury."}}
{"relation": "SUBSTRATE", "token": ["We found that reduction of the carcinogenic hydroxylamines of the aromatic amine ", "4-aminobiphenyl", " (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only ", "human b5R", " and cyt b5."], "h": {"pos": [1, 2], "type": null, "name": "4-aminobiphenyl  (4-ABP; found in cigarette smoke) and the heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP; found in grilled meats) was indeed catalyzed by a purified system containing only "}, "t": {"pos": [3, 4], "type": null, "name": "human b5R  and cyt b5."}}
{"relation": "SUBSTRATE", "token": ["The starting point for the calculations is the recent X-ray crystal structure of ", "GNMT", " complexed with ", "SAM", " and acetate."], "h": {"pos": [1, 2], "type": null, "name": "GNMT  complexed with "}, "t": {"pos": [3, 4], "type": null, "name": "SAM  and acetate."}}
{"relation": "SUBSTRATE", "token": ["Purified PAOh1/", "SMO", " oxidizes both ", "spermine", " (K(m)=1.6 microM) and N(1)-acetylspermine (K(m)=51 microM), but does not oxidize spermidine."], "h": {"pos": [1, 2], "type": null, "name": "SMO  oxidizes both "}, "t": {"pos": [3, 4], "type": null, "name": "spermine  (K(m)=1.6 microM) and N(1)-acetylspermine (K(m)=51 microM), but does not oxidize spermidine."}}
{"relation": "SUBSTRATE", "token": ["", "Omega class GSTs", " have dehydroascorbate reductase and thioltransferase activities and also catalyze the reduction of ", "monomethylarsonate", ", an intermediate in the pathway of arsenic biotransformation."], "h": {"pos": [1, 2], "type": null, "name": "Omega class GSTs  have dehydroascorbate reductase and thioltransferase activities and also catalyze the reduction of "}, "t": {"pos": [3, 4], "type": null, "name": "monomethylarsonate , an intermediate in the pathway of arsenic biotransformation."}}
{"relation": "SUBSTRATE", "token": ["These results suggest that PDE4B mediates the antipsychotic effects of rolipram in CAR and that the ", "PDE4B", "-regulated ", "cyclic adenosine monophosphate", " signaling pathway may play a role in the pathophysiology and pharmacotherapy of psychosis."], "h": {"pos": [1, 2], "type": null, "name": "PDE4B -regulated "}, "t": {"pos": [3, 4], "type": null, "name": "cyclic adenosine monophosphate  signaling pathway may play a role in the pathophysiology and pharmacotherapy of psychosis."}}
{"relation": "SUBSTRATE", "token": ["The scientific basis of this treatment of ED includes relaxation of the corpus cavernosum smooth muscle tissue by inhibition of ", "PDE5", " that breaks down ", "cGMP", ", the key pathway for the production of erectile function in humans."], "h": {"pos": [1, 2], "type": null, "name": "PDE5  that breaks down "}, "t": {"pos": [3, 4], "type": null, "name": "cGMP , the key pathway for the production of erectile function in humans."}}
{"relation": "SUBSTRATE", "token": ["Glycylsarcosine coadministration could inhibit the uptake of ", "cefadroxil", " in ", "PEPT2", "(+/+) mice (p < 0.01) but not PEPT2(-/-) mice."], "h": {"pos": [1, 2], "type": null, "name": "cefadroxil  in "}, "t": {"pos": [3, 4], "type": null, "name": "PEPT2 (+/+) mice (p < 0.01) but not PEPT2(-/-) mice."}}
{"relation": "SUBSTRATE", "token": ["Adenylosuccinate synthetase (", "AdSS", ") catalyzes the ", "Mg2+", " dependent condensation of a molecule of IMP with aspartate to form adenylosuccinate, in a reaction driven by the hydrolysis of GTP to GDP."], "h": {"pos": [1, 2], "type": null, "name": "AdSS ) catalyzes the "}, "t": {"pos": [3, 4], "type": null, "name": "Mg2+  dependent condensation of a molecule of IMP with aspartate to form adenylosuccinate, in a reaction driven by the hydrolysis of GTP to GDP."}}
{"relation": "SUBSTRATE", "token": ["", "Cat-1", ", the transporter for the essential amino acids, arginine and ", "lysine", ", is one of the up-regulated genes."], "h": {"pos": [1, 2], "type": null, "name": "Cat-1 , the transporter for the essential amino acids, arginine and "}, "t": {"pos": [3, 4], "type": null, "name": "lysine , is one of the up-regulated genes."}}
{"relation": "SUBSTRATE", "token": ["Cytotoxicity assays demonstrated that ", "epigallocatechin 3-O-gallate", " (EGCG) and most of compounds 1-6 killed preferentially ", "OATP", "-expressing CHO cells."], "h": {"pos": [1, 2], "type": null, "name": "epigallocatechin 3-O-gallate  (EGCG) and most of compounds 1-6 killed preferentially "}, "t": {"pos": [3, 4], "type": null, "name": "OATP -expressing CHO cells."}}
{"relation": "SUBSTRATE", "token": ["The ", "calcium", " homeostasis proteins ", "sarcoendoplasmic reticulum ATPase 2a", " (SERCA2a), sodium calcium exchanger-1, phospholamban (PLB), phospho-PLB, and calsequestrin 2 are important for contraction and relaxation."], "h": {"pos": [1, 2], "type": null, "name": "calcium  homeostasis proteins "}, "t": {"pos": [3, 4], "type": null, "name": "sarcoendoplasmic reticulum ATPase 2a  (SERCA2a), sodium calcium exchanger-1, phospholamban (PLB), phospho-PLB, and calsequestrin 2 are important for contraction and relaxation."}}
{"relation": "SUBSTRATE", "token": ["Recombinant ", "PDE10A", " transfected and expressed in COS-7 cells hydrolyzed cAMP and cGMP with Km values of 0.26 and 7.2 microM, respectively, and Vmax with ", "cGMP", " was almost twice that with cAMP."], "h": {"pos": [1, 2], "type": null, "name": "PDE10A  transfected and expressed in COS-7 cells hydrolyzed cAMP and cGMP with Km values of 0.26 and 7.2 microM, respectively, and Vmax with "}, "t": {"pos": [3, 4], "type": null, "name": "cGMP  was almost twice that with cAMP."}}
{"relation": "SUBSTRATE", "token": ["Here, we demonstrate that peptidyl-prolyl cis/trans-isomerase A1 (", "Pin1", "), an enzyme that catalyzes the conversion of the peptide bond of pSer/pThr-", "Pro", " moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification."], "h": {"pos": [1, 2], "type": null, "name": "Pin1 ), an enzyme that catalyzes the conversion of the peptide bond of pSer/pThr-"}, "t": {"pos": [3, 4], "type": null, "name": "Pro  moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification."}}
{"relation": "SUBSTRATE", "token": ["Methods: The stability of six ", "acyl glucuronides", " in the presence of ", "hCES1", ", hCES2, and buffer alone (100 mM potassium phosphate, pH 7.4, 37\u00b0C) were investigated."], "h": {"pos": [1, 2], "type": null, "name": "acyl glucuronides  in the presence of "}, "t": {"pos": [3, 4], "type": null, "name": "hCES1 , hCES2, and buffer alone (100 mM potassium phosphate, pH 7.4, 37\u00b0C) were investigated."}}
{"relation": "SUBSTRATE", "token": ["Given these findings, a unified PK model including the inhibition of MAO-A- and ", "CYP2D6", "-catalyzed ", "5-MeO-DMT", " metabolism by harmaline was developed to describe blood harmaline, 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models."], "h": {"pos": [1, 2], "type": null, "name": "CYP2D6 -catalyzed "}, "t": {"pos": [3, 4], "type": null, "name": "5-MeO-DMT  metabolism by harmaline was developed to describe blood harmaline, 5-MeO-DMT, and bufotenine PK profiles in both wild-type and Tg-CYP2D6 mouse models."}}
{"relation": "SUBSTRATE", "token": ["Concentration-dependent inhibitory effects of baicalin on the metabolism of ", "dextromethorphan", ", a dual probe of CYP2D and ", "CYP3A", ", in rats."], "h": {"pos": [1, 2], "type": null, "name": "dextromethorphan , a dual probe of CYP2D and "}, "t": {"pos": [3, 4], "type": null, "name": "CYP3A , in rats."}}
{"relation": "SUBSTRATE", "token": ["", "Doxorubicin", " is mainly excreted into the bile via P-glycoprotein (P-gp) and multidrug resistance-associated protein 2 (Mrp2) in hepatobiliary route and metabolized via ", "cytochrome P450 (CYP) 3A", " subfamily."], "h": {"pos": [1, 2], "type": null, "name": "Doxorubicin  is mainly excreted into the bile via P-glycoprotein (P-gp) and multidrug resistance-associated protein 2 (Mrp2) in hepatobiliary route and metabolized via "}, "t": {"pos": [3, 4], "type": null, "name": "cytochrome P450 (CYP) 3A  subfamily."}}
{"relation": "SUBSTRATE", "token": ["", "Cat-1", ", the transporter for the essential ", "amino acids", ", arginine and lysine, is one of the up-regulated genes."], "h": {"pos": [1, 2], "type": null, "name": "Cat-1 , the transporter for the essential "}, "t": {"pos": [3, 4], "type": null, "name": "amino acids , arginine and lysine, is one of the up-regulated genes."}}
{"relation": "SUBSTRATE", "token": ["The enzyme dimethylarginine dimethylaminohydrolase (", "DDAH", ") specifically hydrolyzes these asymmetrically methylated ", "arginine", " residues to citrulline and methylamines."], "h": {"pos": [1, 2], "type": null, "name": "DDAH ) specifically hydrolyzes these asymmetrically methylated "}, "t": {"pos": [3, 4], "type": null, "name": "arginine  residues to citrulline and methylamines."}}
{"relation": "SUBSTRATE", "token": ["Purified ", "PAOh1", "/SMO oxidizes both spermine (K(m)=1.6 microM) and ", "N(1)-acetylspermine", " (K(m)=51 microM), but does not oxidize spermidine."], "h": {"pos": [1, 2], "type": null, "name": "PAOh1 /SMO oxidizes both spermine (K(m)=1.6 microM) and "}, "t": {"pos": [3, 4], "type": null, "name": "N(1)-acetylspermine  (K(m)=51 microM), but does not oxidize spermidine."}}
{"relation": "SUBSTRATE", "token": ["Purified ", "PAOh1", "/SMO oxidizes both ", "spermine", " (K(m)=1.6 microM) and N(1)-acetylspermine (K(m)=51 microM), but does not oxidize spermidine."], "h": {"pos": [1, 2], "type": null, "name": "PAOh1 /SMO oxidizes both "}, "t": {"pos": [3, 4], "type": null, "name": "spermine  (K(m)=1.6 microM) and N(1)-acetylspermine (K(m)=51 microM), but does not oxidize spermidine."}}
{"relation": "SUBSTRATE", "token": ["On the basis of our findings with structurally similar arylhydroxylamine metabolites of therapeutic drugs, we hypothesized that the reductive detoxification of ", "arylhydroxylamine", " carcinogens was catalyzed by ", "NADH cytochrome b5 reductase", " (b5R) and cytochrome b5 (cyt b5)."], "h": {"pos": [1, 2], "type": null, "name": "arylhydroxylamine  carcinogens was catalyzed by "}, "t": {"pos": [3, 4], "type": null, "name": "NADH cytochrome b5 reductase  (b5R) and cytochrome b5 (cyt b5)."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The studies with dThyd rescue from ", "cyclin E", "-cdk2 protein overexpression and growth inhibition by ", "Tomudex", " indicate that increased cyclin E-cdk2 protein expression is associated with effective inhibition of thymidylate synthase and resultant dNTP pool imbalance."], "h": {"pos": [1, 2], "type": null, "name": "cyclin E -cdk2 protein overexpression and growth inhibition by "}, "t": {"pos": [3, 4], "type": null, "name": "Tomudex  indicate that increased cyclin E-cdk2 protein expression is associated with effective inhibition of thymidylate synthase and resultant dNTP pool imbalance."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Additionally, ", "MPTP", " significantly down-regulated Bcl-2 expression in the mitochondria of dopaminergic cells in the SN, followed by an increase in ", "Bax", " expression, cytochrome C translocation to the cytosol, andcleaved-caspase-3 expression, whereas these were inhibited by CRE or EB treatment."], "h": {"pos": [1, 2], "type": null, "name": "MPTP  significantly down-regulated Bcl-2 expression in the mitochondria of dopaminergic cells in the SN, followed by an increase in "}, "t": {"pos": [3, 4], "type": null, "name": "Bax  expression, cytochrome C translocation to the cytosol, andcleaved-caspase-3 expression, whereas these were inhibited by CRE or EB treatment."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Brain tissue analyses revealed that neonatal quinpirole treatment produced a significant decrease in hippocampal ", "NGF", ", BDNF and ChAT that was eliminated by ", "olanzapine", " treatment."], "h": {"pos": [1, 2], "type": null, "name": "NGF , BDNF and ChAT that was eliminated by "}, "t": {"pos": [3, 4], "type": null, "name": "olanzapine  treatment."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["These results showed that WNT6 and ", "Cav1", " are upregulated by chemotherapeutics and enhance the resistance of GC cells to ", "anthracycline", " drugs."], "h": {"pos": [1, 2], "type": null, "name": "Cav1  are upregulated by chemotherapeutics and enhance the resistance of GC cells to "}, "t": {"pos": [3, 4], "type": null, "name": "anthracycline  drugs."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The results showed that administration of ", "AlCl3", " resulted in a significant elevation in the levels of AchE activity, CRP, ", "NF-\u03baB", ", and MCP-1 accompanied with a significant depletion in the Ach level."], "h": {"pos": [1, 2], "type": null, "name": "AlCl3  resulted in a significant elevation in the levels of AchE activity, CRP, "}, "t": {"pos": [3, 4], "type": null, "name": "NF-\u03baB , and MCP-1 accompanied with a significant depletion in the Ach level."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Liver ", "BHMT", " activity was 1.3-fold higher in rats fed the Met deficient diet containing ", "choline", ", which was reflected in corresponding increases in mRNA content and immunodetectable protein."], "h": {"pos": [1, 2], "type": null, "name": "BHMT  activity was 1.3-fold higher in rats fed the Met deficient diet containing "}, "t": {"pos": [3, 4], "type": null, "name": "choline , which was reflected in corresponding increases in mRNA content and immunodetectable protein."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "S1P", " activated ", "phosphatidylinositol 3-kinase", " (PI3K)/Akt signaling, leading to the inhibition of glycogen synthase kinase-3\u03b2 and the nuclear translocation of \u03b2-catenin, followed by the increase of the transcriptional activity by \u03b2-catenin/T-cell factor complex formation in both SaOS-2 cells and MC3T3-E1 cells."], "h": {"pos": [1, 2], "type": null, "name": "S1P  activated "}, "t": {"pos": [3, 4], "type": null, "name": "phosphatidylinositol 3-kinase  (PI3K)/Akt signaling, leading to the inhibition of glycogen synthase kinase-3\u03b2 and the nuclear translocation of \u03b2-catenin, followed by the increase of the transcriptional activity by \u03b2-catenin/T-cell factor complex formation in both SaOS-2 cells and MC3T3-E1 cells."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["RESULTS: Fractionated bulb extracts and the two isolated ", "steroidal glycoalkaloids", " (1) and (2) induced NO production and ", "TGF-\u03b2 receptor I", " mRNA expression in fibroblast cell culture."], "h": {"pos": [1, 2], "type": null, "name": "steroidal glycoalkaloids  (1) and (2) induced NO production and "}, "t": {"pos": [3, 4], "type": null, "name": "TGF-\u03b2 receptor I  mRNA expression in fibroblast cell culture."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Platelet-induced COX-2-dependent PGE2 synthesis in HT29 cells was involved in downregulation of p21(WAF1/", "CIP1", ") and upregulation of cyclinB1, since these effects were prevented by ", "rofecoxib", "(a selective COX-2 inhibitor) and rescued by exogenous PGE2."], "h": {"pos": [1, 2], "type": null, "name": "CIP1 ) and upregulation of cyclinB1, since these effects were prevented by "}, "t": {"pos": [3, 4], "type": null, "name": "rofecoxib (a selective COX-2 inhibitor) and rescued by exogenous PGE2."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["However, after 12h ", "CdCl2", " treatment, cell viability diminished in 50%, accompanied by a drastic decrease of metallothionein-II production, and an increase in p53 activation and the pro-apoptotic protein ", "Bax", "."], "h": {"pos": [1, 2], "type": null, "name": "CdCl2  treatment, cell viability diminished in 50%, accompanied by a drastic decrease of metallothionein-II production, and an increase in p53 activation and the pro-apoptotic protein "}, "t": {"pos": [3, 4], "type": null, "name": "Bax ."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Weekly subcutaneous ", "decitabine", " produces cumulative increases in ", "HbF", " and total hemoglobin through a noncytotoxic mechanism of action."], "h": {"pos": [1, 2], "type": null, "name": "decitabine  produces cumulative increases in "}, "t": {"pos": [3, 4], "type": null, "name": "HbF  and total hemoglobin through a noncytotoxic mechanism of action."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["These data demonstrated that 1) gemcitabine and pemetrexed synergistically interact against NSCLC cells through the suppression of Akt phosphorylation and induction of apoptosis; 2) the gene expression profile of critical genes may predict for drug chemosensitivity; and 3) ", "pemetrexed", " enhances ", "dCK", " and hENT1 expression, thus suggesting the role of gene-expression modulation for rational development of chemotherapy combinations."], "h": {"pos": [1, 2], "type": null, "name": "pemetrexed  enhances "}, "t": {"pos": [3, 4], "type": null, "name": "dCK  and hENT1 expression, thus suggesting the role of gene-expression modulation for rational development of chemotherapy combinations."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Consumption of ", "alcohol", " for 8weeks induced severe liver damage with increases in prognostic indicators such as ", "aspartate transaminase", ", alanine transaminase in serum whereas co-administration of CNF suppressed their increases."], "h": {"pos": [1, 2], "type": null, "name": "alcohol  for 8weeks induced severe liver damage with increases in prognostic indicators such as "}, "t": {"pos": [3, 4], "type": null, "name": "aspartate transaminase , alanine transaminase in serum whereas co-administration of CNF suppressed their increases."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Fisetin", " treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), NF-kB p65 unit (in pancreas) and IL-1\u03b2 (plasma), serum nitric oxide (NO) with an elevation in plasma ", "insulin", "."], "h": {"pos": [1, 2], "type": null, "name": "Fisetin  treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), NF-kB p65 unit (in pancreas) and IL-1\u03b2 (plasma), serum nitric oxide (NO) with an elevation in plasma "}, "t": {"pos": [3, 4], "type": null, "name": "insulin ."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Sitagliptin. ", "Sitagliptin", ", an oral dipeptidyl peptidase-4 (DPP-4) inhibitor, improves glycaemic control by inhibiting DPP-4 inactivation of the incretin hormones ", "glucagon-like peptide-1", " and glucose-dependent insulinotropic polypeptide."], "h": {"pos": [1, 2], "type": null, "name": "Sitagliptin , an oral dipeptidyl peptidase-4 (DPP-4) inhibitor, improves glycaemic control by inhibiting DPP-4 inactivation of the incretin hormones "}, "t": {"pos": [3, 4], "type": null, "name": "glucagon-like peptide-1  and glucose-dependent insulinotropic polypeptide."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "PTE", " also down-regulated the expression of STAT3 target genes, including the anti-apoptotic proteins Bcl-xL and Mcl-1, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, ", "Bak", ", cytosolic Cytochrome c, and cleaved Caspase3) and cyclin-dependent kinase inhibitors such as p21 and p27."], "h": {"pos": [1, 2], "type": null, "name": "PTE  also down-regulated the expression of STAT3 target genes, including the anti-apoptotic proteins Bcl-xL and Mcl-1, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, "}, "t": {"pos": [3, 4], "type": null, "name": "Bak , cytosolic Cytochrome c, and cleaved Caspase3) and cyclin-dependent kinase inhibitors such as p21 and p27."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "GW9662", ", a PPARgamma antagonist, prevented (P < 0.01) the lutein-induced ", "iNOS", " mRNA downregulation in HD11 cells."], "h": {"pos": [1, 2], "type": null, "name": "GW9662 , a PPARgamma antagonist, prevented (P < 0.01) the lutein-induced "}, "t": {"pos": [3, 4], "type": null, "name": "iNOS  mRNA downregulation in HD11 cells."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Furthermore, compared with control groups, the plaque endothelium level of ", "p75(NTR)", " was 3-fold increased and the liver level of p75(NTR) was 17.4-fold increased by ", "SFO", "-HD."], "h": {"pos": [1, 2], "type": null, "name": "p75(NTR)  was 3-fold increased and the liver level of p75(NTR) was 17.4-fold increased by "}, "t": {"pos": [3, 4], "type": null, "name": "SFO -HD."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Luciferase reporter assays showed that transcription of ", "FDX1", " was synergistically activated by the NR5A family and ", "8Br-cAMP", " treatment through two SF-1 binding sites and a CRE-like sequence in a human ovarian granulosa cell line, KGN."], "h": {"pos": [1, 2], "type": null, "name": "FDX1  was synergistically activated by the NR5A family and "}, "t": {"pos": [3, 4], "type": null, "name": "8Br-cAMP  treatment through two SF-1 binding sites and a CRE-like sequence in a human ovarian granulosa cell line, KGN."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The obtained results showed that ", "pioglitazone", " improved the renal function, structural changes, renal malondialdehyde (MDA), tumor necrosis factor alpha (TNF-\u03b1), ", "nuclear factor kappa B", " (NF-\u03baB) genes expression in cisplatin injected rats."], "h": {"pos": [1, 2], "type": null, "name": "pioglitazone  improved the renal function, structural changes, renal malondialdehyde (MDA), tumor necrosis factor alpha (TNF-\u03b1), "}, "t": {"pos": [3, 4], "type": null, "name": "nuclear factor kappa B  (NF-\u03baB) genes expression in cisplatin injected rats."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Methylation-specific PCR and bisulfite sequencing identified methylation of this CpG (", "(m)CpG", ") island of the glut3 gene, frequency of methylation increasing 2.5-fold with a 1.6-fold increase in ", "DNA methyl transferase 3a", " concentrations noted with advancing postnatal age (PN14 vs PN3)."], "h": {"pos": [1, 2], "type": null, "name": "(m)CpG ) island of the glut3 gene, frequency of methylation increasing 2.5-fold with a 1.6-fold increase in "}, "t": {"pos": [3, 4], "type": null, "name": "DNA methyl transferase 3a  concentrations noted with advancing postnatal age (PN14 vs PN3)."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Furthermore, ", "N", "-BPs decreased the levels of phosphorylated extracellular signal-regulated kinase (ERK) and mTOR via suppression of Ras prenylation and enhanced ", "Bim", " expression."], "h": {"pos": [1, 2], "type": null, "name": "N -BPs decreased the levels of phosphorylated extracellular signal-regulated kinase (ERK) and mTOR via suppression of Ras prenylation and enhanced "}, "t": {"pos": [3, 4], "type": null, "name": "Bim  expression."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["In addition, ADP was shown to strongly antagonize ", "TOP2", "-mediated DNA cleavage induced by ", "ATP", "-sensitive but not ATP-insensitive TOP2 poisons."], "h": {"pos": [1, 2], "type": null, "name": "TOP2 -mediated DNA cleavage induced by "}, "t": {"pos": [3, 4], "type": null, "name": "ATP -sensitive but not ATP-insensitive TOP2 poisons."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers (sulforaphane, tert-butylhydroquinone, cinnamic aldehyde, and ", "hydrogen peroxide", ") showed that the ", "aldo-keto reductase (AKR) 1C1", " is highly inducible by all treatments."], "h": {"pos": [1, 2], "type": null, "name": "hydrogen peroxide ) showed that the "}, "t": {"pos": [3, 4], "type": null, "name": "aldo-keto reductase (AKR) 1C1  is highly inducible by all treatments."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Furthermore, ", "substance P", " (SP) concentration in the acini and expression of SP gene (preprotachykinin-A, PPT-A) and neurokinin-1 receptor (NK-1R), the primary receptor for SP, are increased in secretagogue ", "caerulein", "-treated acinar cells."], "h": {"pos": [1, 2], "type": null, "name": "substance P  (SP) concentration in the acini and expression of SP gene (preprotachykinin-A, PPT-A) and neurokinin-1 receptor (NK-1R), the primary receptor for SP, are increased in secretagogue "}, "t": {"pos": [3, 4], "type": null, "name": "caerulein -treated acinar cells."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Furthermore, proteosomal inhibitor ", "MG132", " suppressed AMPK activation, GSK3\u03b2 phosphorylation, cleaved PARP and deceased ", "AEG-1", " induced by ursolic acid in HepG2 cells."], "h": {"pos": [1, 2], "type": null, "name": "MG132  suppressed AMPK activation, GSK3\u03b2 phosphorylation, cleaved PARP and deceased "}, "t": {"pos": [3, 4], "type": null, "name": "AEG-1  induced by ursolic acid in HepG2 cells."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Pretreatment with dexamethasone significantly suppressed nasal allergy-like behaviors, up-regulation of histamine content, HDC activity and ", "HDC", " mRNA induced by ", "TDI", " in TDI-sensitized rats."], "h": {"pos": [1, 2], "type": null, "name": "HDC  mRNA induced by "}, "t": {"pos": [3, 4], "type": null, "name": "TDI  in TDI-sensitized rats."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Tissue-type plasminogen activator (tPA), a ", "serine", " protease well known for generating ", "plasmin", ", has been demonstrated to induce matrix metalloproteinase-9 (MMP-9) gene expression and protein secretion in renal interstitial fibroblasts."], "h": {"pos": [1, 2], "type": null, "name": "serine  protease well known for generating "}, "t": {"pos": [3, 4], "type": null, "name": "plasmin , has been demonstrated to induce matrix metalloproteinase-9 (MMP-9) gene expression and protein secretion in renal interstitial fibroblasts."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Meanwhile, autophagy was detected as early as 12\u00a0h after an exposure to low-dose ", "dioscin", ", as indicated by an up-regulated expression of LC3-II and ", "beclin-1", " proteins."], "h": {"pos": [1, 2], "type": null, "name": "dioscin , as indicated by an up-regulated expression of LC3-II and "}, "t": {"pos": [3, 4], "type": null, "name": "beclin-1  proteins."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Activation of an apoptotic signal transduction pathway involved in the upregulation of ", "calpain", " and apoptosis-inducing factor in ", "aldosterone", "-induced primary cultured cardiomyocytes."], "h": {"pos": [1, 2], "type": null, "name": "calpain  and apoptosis-inducing factor in "}, "t": {"pos": [3, 4], "type": null, "name": "aldosterone -induced primary cultured cardiomyocytes."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "LTD4", " also induced expression of cysteinyl leukotriene receptor 1 (CysLT(1)R) and ", "NF-\u03baB", " p65 in the hippocampus and cortex."], "h": {"pos": [1, 2], "type": null, "name": "LTD4  also induced expression of cysteinyl leukotriene receptor 1 (CysLT(1)R) and "}, "t": {"pos": [3, 4], "type": null, "name": "NF-\u03baB  p65 in the hippocampus and cortex."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Interestingly, the ", "CP[c]Ph", " dependent up-regulation of ", "CYP1A", " mRNA is positively correlated with the incidences of clastogenic changes in rainbow trout erythrocytes."], "h": {"pos": [1, 2], "type": null, "name": "CP[c]Ph  dependent up-regulation of "}, "t": {"pos": [3, 4], "type": null, "name": "CYP1A  mRNA is positively correlated with the incidences of clastogenic changes in rainbow trout erythrocytes."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["This initial action was accompanied by up-regulation of ", "cyclooxygenase-2", " (COX-2), an important inflammation marker within 1h after ", "TCDD", " treatment."], "h": {"pos": [1, 2], "type": null, "name": "cyclooxygenase-2  (COX-2), an important inflammation marker within 1h after "}, "t": {"pos": [3, 4], "type": null, "name": "TCDD  treatment."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["To determine whether H(2)S itself provoked inflammation in acinar cells, the cells were treated with H(2)S donor drug, sodium hydrosulphide (", "NaHS", "), (10, 50 and 100 muM), that resulted in a significant increase in ", "SP", " concentration and expression of PPT-A and NK1-R in acinar cells."], "h": {"pos": [1, 2], "type": null, "name": "NaHS ), (10, 50 and 100 muM), that resulted in a significant increase in "}, "t": {"pos": [3, 4], "type": null, "name": "SP  concentration and expression of PPT-A and NK1-R in acinar cells."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Cobalt chloride", ", a typical HIF activator, induced the gene expression of CAR-target genes, including ", "cyp2b9", " and cyp2b10, an accumulation of nuclear CAR and an increase in the PB-responsive enhancer module-mediated transactivation in the mouse liver."], "h": {"pos": [1, 2], "type": null, "name": "Cobalt chloride , a typical HIF activator, induced the gene expression of CAR-target genes, including "}, "t": {"pos": [3, 4], "type": null, "name": "cyp2b9  and cyp2b10, an accumulation of nuclear CAR and an increase in the PB-responsive enhancer module-mediated transactivation in the mouse liver."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["It was found that expression of ", "Sim2", " protein in cortical neurons was increased in ", "streptozotocin", "-induced diabetes mellitus rat model."], "h": {"pos": [1, 2], "type": null, "name": "Sim2  protein in cortical neurons was increased in "}, "t": {"pos": [3, 4], "type": null, "name": "streptozotocin -induced diabetes mellitus rat model."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Exposure to ", "PAHs", ", their metabolites, and ROS further increase ", "AKRs", " isoform expression that may amplify oxidative damage."], "h": {"pos": [1, 2], "type": null, "name": "PAHs , their metabolites, and ROS further increase "}, "t": {"pos": [3, 4], "type": null, "name": "AKRs  isoform expression that may amplify oxidative damage."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "RORalpha", " ectopic expression activated the cAspAT gene transcription in absence of rosiglitazone, and its protein amount in nuclear extracts is 1.8-fold increased by ", "rosiglitazone", " treatment of adipocytes."], "h": {"pos": [1, 2], "type": null, "name": "RORalpha  ectopic expression activated the cAspAT gene transcription in absence of rosiglitazone, and its protein amount in nuclear extracts is 1.8-fold increased by "}, "t": {"pos": [3, 4], "type": null, "name": "rosiglitazone  treatment of adipocytes."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Treatment of HDP cells with a c-Jun NH2-terminal kinase (JNK) inhibitor also reduced ", "butein", "-induced ", "HO-1", " expression, and butein treatment led to increased JNK phosphorylation."], "h": {"pos": [1, 2], "type": null, "name": "butein -induced "}, "t": {"pos": [3, 4], "type": null, "name": "HO-1  expression, and butein treatment led to increased JNK phosphorylation."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["In conclusion, ", "IL-8", " production and neutrophil infiltration are increased in high-", "glucose", " environment due to elevated ROS level and contributed to impaired wound healing in diabetic skin."], "h": {"pos": [1, 2], "type": null, "name": "IL-8  production and neutrophil infiltration are increased in high-"}, "t": {"pos": [3, 4], "type": null, "name": "glucose  environment due to elevated ROS level and contributed to impaired wound healing in diabetic skin."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["These findings suggest that ", "S1P", " activates the PI3K/Akt signaling pathway leading to the promotion of nuclear translocation of \u03b2-catenin in osteoblast-like cells, resulting in the upregulation of osteoptotegerin and osteoblast differentiation markers including ", "alkaline phosphatase", ", probably relating to the inhibition of osteoclast formation and the mineralization, respectively."], "h": {"pos": [1, 2], "type": null, "name": "S1P  activates the PI3K/Akt signaling pathway leading to the promotion of nuclear translocation of \u03b2-catenin in osteoblast-like cells, resulting in the upregulation of osteoptotegerin and osteoblast differentiation markers including "}, "t": {"pos": [3, 4], "type": null, "name": "alkaline phosphatase , probably relating to the inhibition of osteoclast formation and the mineralization, respectively."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["These findings suggest that ", "S1P", " activates the PI3K/Akt signaling pathway leading to the promotion of nuclear translocation of ", "\u03b2-catenin", " in osteoblast-like cells, resulting in the upregulation of osteoptotegerin and osteoblast differentiation markers including alkaline phosphatase, probably relating to the inhibition of osteoclast formation and the mineralization, respectively."], "h": {"pos": [1, 2], "type": null, "name": "S1P  activates the PI3K/Akt signaling pathway leading to the promotion of nuclear translocation of "}, "t": {"pos": [3, 4], "type": null, "name": "\u03b2-catenin  in osteoblast-like cells, resulting in the upregulation of osteoptotegerin and osteoblast differentiation markers including alkaline phosphatase, probably relating to the inhibition of osteoclast formation and the mineralization, respectively."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Here, we have now found that activation of ", "p38", " MAPK by ", "anisomycin", " potentiated induction of CYP2B6 mRNA by CAR ligand in HepG2 cells to levels observed in ligand-treated human primary hepatocytes."], "h": {"pos": [1, 2], "type": null, "name": "p38  MAPK by "}, "t": {"pos": [3, 4], "type": null, "name": "anisomycin  potentiated induction of CYP2B6 mRNA by CAR ligand in HepG2 cells to levels observed in ligand-treated human primary hepatocytes."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Here, we have determined the molecular mechanism of this male-specific activation of the ", "Kcnk1", " gene and characterized KCNK1 as a ", "phenobarbital", "-inducible antihyperplasia factor."], "h": {"pos": [1, 2], "type": null, "name": "Kcnk1  gene and characterized KCNK1 as a "}, "t": {"pos": [3, 4], "type": null, "name": "phenobarbital -inducible antihyperplasia factor."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["In addition, the number and area of glutathione S-transferase placental form (GST-P) positive foci and ", "proliferating cell nuclear antigen", " (PCNA) positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mg/kg ", "MEG", " compared with the control animals."], "h": {"pos": [1, 2], "type": null, "name": "proliferating cell nuclear antigen  (PCNA) positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mg/kg "}, "t": {"pos": [3, 4], "type": null, "name": "MEG  compared with the control animals."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Phenobarbital", " (PB), a typical CAR activator, increased the gene expression of HIF-target genes in the livers of mice, including erythropoietin, heme oxygenase-1 and ", "vascular endothelial growth factor-a", "."], "h": {"pos": [1, 2], "type": null, "name": "Phenobarbital  (PB), a typical CAR activator, increased the gene expression of HIF-target genes in the livers of mice, including erythropoietin, heme oxygenase-1 and "}, "t": {"pos": [3, 4], "type": null, "name": "vascular endothelial growth factor-a ."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "\u03b2-ionone", " was also shown to induce the expression of cleaved-", "caspase-3", " and inhibit bcl-2 expression in SGC-7901 cells in a dose-dependent manner."], "h": {"pos": [1, 2], "type": null, "name": "\u03b2-ionone  was also shown to induce the expression of cleaved-"}, "t": {"pos": [3, 4], "type": null, "name": "caspase-3  and inhibit bcl-2 expression in SGC-7901 cells in a dose-dependent manner."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Aldosterone", "-induced ENaC and basal ", "Na(+)/K(+)-ATPase", " trafficking via protein kinase D1-phosphatidylinositol 4-kinaseIII\u03b2 trans Golgi signalling in M1 cortical collecting duct cells."], "h": {"pos": [1, 2], "type": null, "name": "Aldosterone -induced ENaC and basal "}, "t": {"pos": [3, 4], "type": null, "name": "Na(+)/K(+)-ATPase  trafficking via protein kinase D1-phosphatidylinositol 4-kinaseIII\u03b2 trans Golgi signalling in M1 cortical collecting duct cells."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Furthermore, treatment with spironoclactone not only attenuated the pro-apoptotic effect of ALD but reversed the ", "ALD", "-induced increase of ", "calpain", " and AIF levels."], "h": {"pos": [1, 2], "type": null, "name": "ALD -induced increase of "}, "t": {"pos": [3, 4], "type": null, "name": "calpain  and AIF levels."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Consumption of ", "alcohol", " for 8weeks induced severe liver damage with increases in prognostic indicators such as aspartate transaminase, ", "alanine transaminase", " in serum whereas co-administration of CNF suppressed their increases."], "h": {"pos": [1, 2], "type": null, "name": "alcohol  for 8weeks induced severe liver damage with increases in prognostic indicators such as aspartate transaminase, "}, "t": {"pos": [3, 4], "type": null, "name": "alanine transaminase  in serum whereas co-administration of CNF suppressed their increases."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["We examined if subcutaneous ", "decitabine", " could increase ", "HbF", " levels and improve SSD pathophysiology without cytotoxicity."], "h": {"pos": [1, 2], "type": null, "name": "decitabine  could increase "}, "t": {"pos": [3, 4], "type": null, "name": "HbF  levels and improve SSD pathophysiology without cytotoxicity."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Thus, we found that ", "5HHMF", " enhances ", "heme oxygenase-1", " (HO-1) expression via nuclear factor-erythroid 2-related factor 2 (Nrf2) activation."], "h": {"pos": [1, 2], "type": null, "name": "5HHMF  enhances "}, "t": {"pos": [3, 4], "type": null, "name": "heme oxygenase-1  (HO-1) expression via nuclear factor-erythroid 2-related factor 2 (Nrf2) activation."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Furthermore, ", "butein", " treatment caused nuclear accumulation of ", "nuclear factor-E2-related factor 2", " (Nrf2) and increased the promoter activity of antioxidant response elements (AREs)."], "h": {"pos": [1, 2], "type": null, "name": "butein  treatment caused nuclear accumulation of "}, "t": {"pos": [3, 4], "type": null, "name": "nuclear factor-E2-related factor 2  (Nrf2) and increased the promoter activity of antioxidant response elements (AREs)."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["On study day 1, ", "candoxatril", " acutely increased plasma ", "ANP", " levels, suppressed aldosterone and decreased right atrial and pulmonary capillary wedge pressures."], "h": {"pos": [1, 2], "type": null, "name": "candoxatril  acutely increased plasma "}, "t": {"pos": [3, 4], "type": null, "name": "ANP  levels, suppressed aldosterone and decreased right atrial and pulmonary capillary wedge pressures."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The hemoglobin A1c (", "HbA1c", ") of all patients improved significantly from 8.1\u00b11.2% to 7.6\u00b11.1% after 12 weeks of add-on therapy with ", "sitagliptin", " (p<0.01), and the insulin dosage was reduced from 27.3\u00b115.8 U/day to 24.5\u00b116.5 U/day (p<0.001)."], "h": {"pos": [1, 2], "type": null, "name": "HbA1c ) of all patients improved significantly from 8.1\u00b11.2% to 7.6\u00b11.1% after 12 weeks of add-on therapy with "}, "t": {"pos": [3, 4], "type": null, "name": "sitagliptin  (p<0.01), and the insulin dosage was reduced from 27.3\u00b115.8 U/day to 24.5\u00b116.5 U/day (p<0.001)."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["In addition, ", "Silibinin", " caused an increase in p53 and ", "p21", " protein level as well as mRNA levels."], "h": {"pos": [1, 2], "type": null, "name": "Silibinin  caused an increase in p53 and "}, "t": {"pos": [3, 4], "type": null, "name": "p21  protein level as well as mRNA levels."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["8-pCPT-2'-O-Me-cAMP-AM potentiation of ", "insulin", " secretion stimulated by tolbutamide was markedly inhibited by 2-APB (25 \u03bcM) and enhanced by the PKC inhibitor ", "bisindolylmaleimide I", " (1 \u03bcM)."], "h": {"pos": [1, 2], "type": null, "name": "insulin  secretion stimulated by tolbutamide was markedly inhibited by 2-APB (25 \u03bcM) and enhanced by the PKC inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "bisindolylmaleimide I  (1 \u03bcM)."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The results demonstrated that intracerebral infusions of ", "LTD4", " (1 ng/mouse) produced memory impairment as determined by Morris water maze test and Y-maze test in mice, and caused the accumulation of A\u03b21-40 and A\u03b21-42 in the hippocampus and cortex through increased activity of \u03b2- and \u03b3-secretases accompanied with increased expression of ", "amyloid precursor protein", " (APP)."], "h": {"pos": [1, 2], "type": null, "name": "LTD4  (1 ng/mouse) produced memory impairment as determined by Morris water maze test and Y-maze test in mice, and caused the accumulation of A\u03b21-40 and A\u03b21-42 in the hippocampus and cortex through increased activity of \u03b2- and \u03b3-secretases accompanied with increased expression of "}, "t": {"pos": [3, 4], "type": null, "name": "amyloid precursor protein  (APP)."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The present results indicated that N-", "BPs", " induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing ", "Bim", " expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways."], "h": {"pos": [1, 2], "type": null, "name": "BPs  induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing "}, "t": {"pos": [3, 4], "type": null, "name": "Bim  expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "CYP1A1", " and CYP1A2 mRNAs were also increased by ", "pelargonidin", " in three primary human hepatocytes cultures (approximately 5% of TCDD potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme."], "h": {"pos": [1, 2], "type": null, "name": "CYP1A1  and CYP1A2 mRNAs were also increased by "}, "t": {"pos": [3, 4], "type": null, "name": "pelargonidin  in three primary human hepatocytes cultures (approximately 5% of TCDD potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Compared with DM8W group, ", "SOD", " and ALDH2 in ", "EtOH", "+DM8W group was increased, MDA was decreased."], "h": {"pos": [1, 2], "type": null, "name": "SOD  and ALDH2 in "}, "t": {"pos": [3, 4], "type": null, "name": "EtOH +DM8W group was increased, MDA was decreased."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Furthermore, ", "butein", " treatment caused nuclear accumulation of nuclear factor-E2-related factor 2 (Nrf2) and increased the promoter activity of ", "antioxidant response elements", " (AREs)."], "h": {"pos": [1, 2], "type": null, "name": "butein  treatment caused nuclear accumulation of nuclear factor-E2-related factor 2 (Nrf2) and increased the promoter activity of "}, "t": {"pos": [3, 4], "type": null, "name": "antioxidant response elements  (AREs)."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["In the liver of rats given ", "flutamide", " as initiating agent at the dose of 500 mg/kg/week for 6 successive weeks, ", "gamma-glutamyltraspeptidase", "-positive foci were detected only in 3 of 10 rats."], "h": {"pos": [1, 2], "type": null, "name": "flutamide  as initiating agent at the dose of 500 mg/kg/week for 6 successive weeks, "}, "t": {"pos": [3, 4], "type": null, "name": "gamma-glutamyltraspeptidase -positive foci were detected only in 3 of 10 rats."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Furthermore, ", "butein", " treatment caused nuclear accumulation of nuclear factor-E2-related factor 2 (Nrf2) and increased the promoter activity of antioxidant response elements (", "AREs", ")."], "h": {"pos": [1, 2], "type": null, "name": "butein  treatment caused nuclear accumulation of nuclear factor-E2-related factor 2 (Nrf2) and increased the promoter activity of antioxidant response elements ("}, "t": {"pos": [3, 4], "type": null, "name": "AREs )."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["RORalpha ectopic expression activated the ", "cAspAT", " gene transcription in absence of rosiglitazone, and its protein amount in nuclear extracts is 1.8-fold increased by ", "rosiglitazone", " treatment of adipocytes."], "h": {"pos": [1, 2], "type": null, "name": "cAspAT  gene transcription in absence of rosiglitazone, and its protein amount in nuclear extracts is 1.8-fold increased by "}, "t": {"pos": [3, 4], "type": null, "name": "rosiglitazone  treatment of adipocytes."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Furthermore, ", "butein", " treatment caused nuclear accumulation of nuclear factor-E2-related factor 2 (", "Nrf2", ") and increased the promoter activity of antioxidant response elements (AREs)."], "h": {"pos": [1, 2], "type": null, "name": "butein  treatment caused nuclear accumulation of nuclear factor-E2-related factor 2 ("}, "t": {"pos": [3, 4], "type": null, "name": "Nrf2 ) and increased the promoter activity of antioxidant response elements (AREs)."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The results demonstrated that intracerebral infusions of ", "LTD4", " (1 ng/mouse) produced memory impairment as determined by Morris water maze test and Y-maze test in mice, and caused the accumulation of A\u03b21-40 and ", "A\u03b21-42", " in the hippocampus and cortex through increased activity of \u03b2- and \u03b3-secretases accompanied with increased expression of amyloid precursor protein (APP)."], "h": {"pos": [1, 2], "type": null, "name": "LTD4  (1 ng/mouse) produced memory impairment as determined by Morris water maze test and Y-maze test in mice, and caused the accumulation of A\u03b21-40 and "}, "t": {"pos": [3, 4], "type": null, "name": "A\u03b21-42  in the hippocampus and cortex through increased activity of \u03b2- and \u03b3-secretases accompanied with increased expression of amyloid precursor protein (APP)."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Whereas, the levels of both the basal and ", "sulforaphane", "-inducible expression of ", "AKR1C1", " were significantly reduced in NRF2-silenced stable U937 cells compared to the control cells."], "h": {"pos": [1, 2], "type": null, "name": "sulforaphane -inducible expression of "}, "t": {"pos": [3, 4], "type": null, "name": "AKR1C1  were significantly reduced in NRF2-silenced stable U937 cells compared to the control cells."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Here, we have now found that activation of p38 MAPK by ", "anisomycin", " potentiated induction of ", "CYP2B6", " mRNA by CAR ligand in HepG2 cells to levels observed in ligand-treated human primary hepatocytes."], "h": {"pos": [1, 2], "type": null, "name": "anisomycin  potentiated induction of "}, "t": {"pos": [3, 4], "type": null, "name": "CYP2B6  mRNA by CAR ligand in HepG2 cells to levels observed in ligand-treated human primary hepatocytes."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Platelet-induced COX-2-dependent PGE2 synthesis in HT29 cells was involved in downregulation of p21(", "WAF1", "/CIP1) and upregulation of cyclinB1, since these effects were prevented by ", "rofecoxib", "(a selective COX-2 inhibitor) and rescued by exogenous PGE2."], "h": {"pos": [1, 2], "type": null, "name": "WAF1 /CIP1) and upregulation of cyclinB1, since these effects were prevented by "}, "t": {"pos": [3, 4], "type": null, "name": "rofecoxib (a selective COX-2 inhibitor) and rescued by exogenous PGE2."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Furthermore, tPA induced rapid ", "tyrosine", " phosphorylation on the beta subunit of LRP-1, which was followed by the activation of ", "Mek1", " and its downstream Erk-1 and -2."], "h": {"pos": [1, 2], "type": null, "name": "tyrosine  phosphorylation on the beta subunit of LRP-1, which was followed by the activation of "}, "t": {"pos": [3, 4], "type": null, "name": "Mek1  and its downstream Erk-1 and -2."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["In addition to CYP2B6, ", "anisomycin", " co-treatment potentiated an increase in ", "CYP2A7", " and CYP2C9 mRNAs but not CYP3A4 or UDP-glucuronosyltransferase 1A1 mRNAs."], "h": {"pos": [1, 2], "type": null, "name": "anisomycin  co-treatment potentiated an increase in "}, "t": {"pos": [3, 4], "type": null, "name": "CYP2A7  and CYP2C9 mRNAs but not CYP3A4 or UDP-glucuronosyltransferase 1A1 mRNAs."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The treatment with ", "arsenic", " exhibited a significant increase in some serum hepatic and renal biochemical parameters (alanine aminotransferase, aspartate aminotransferase, ", "alkaline phosphatase", ", total protein, albumin, bilirubin, cholesterol, urea and creatinine)."], "h": {"pos": [1, 2], "type": null, "name": "arsenic  exhibited a significant increase in some serum hepatic and renal biochemical parameters (alanine aminotransferase, aspartate aminotransferase, "}, "t": {"pos": [3, 4], "type": null, "name": "alkaline phosphatase , total protein, albumin, bilirubin, cholesterol, urea and creatinine)."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["In this study, aldosterone (", "ALD", ")-induced apoptosis of cardiomyocyte was evaluated based on the previous studies, and the roles of ", "calpain", " signaling were clarified."], "h": {"pos": [1, 2], "type": null, "name": "ALD )-induced apoptosis of cardiomyocyte was evaluated based on the previous studies, and the roles of "}, "t": {"pos": [3, 4], "type": null, "name": "calpain  signaling were clarified."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to NRF2 inducers (sulforaphane, ", "tert-butylhydroquinone", ", cinnamic aldehyde, and hydrogen peroxide) showed that the ", "aldo-keto reductase (AKR) 1C1", " is highly inducible by all treatments."], "h": {"pos": [1, 2], "type": null, "name": "tert-butylhydroquinone , cinnamic aldehyde, and hydrogen peroxide) showed that the "}, "t": {"pos": [3, 4], "type": null, "name": "aldo-keto reductase (AKR) 1C1  is highly inducible by all treatments."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Aldosterone", "-induced ", "ENaC", " and basal Na(+)/K(+)-ATPase trafficking via protein kinase D1-phosphatidylinositol 4-kinaseIII\u03b2 trans Golgi signalling in M1 cortical collecting duct cells."], "h": {"pos": [1, 2], "type": null, "name": "Aldosterone -induced "}, "t": {"pos": [3, 4], "type": null, "name": "ENaC  and basal Na(+)/K(+)-ATPase trafficking via protein kinase D1-phosphatidylinositol 4-kinaseIII\u03b2 trans Golgi signalling in M1 cortical collecting duct cells."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Quantitative real-time polymerase chain reaction analysis showed that following the exposure of cells to ", "SiO(2)", " NPs, the messenger RNA level of apoptotic genes (caspase-3 and ", "caspase-9", ") were upregulated in a dose-dependent manner."], "h": {"pos": [1, 2], "type": null, "name": "SiO(2)  NPs, the messenger RNA level of apoptotic genes (caspase-3 and "}, "t": {"pos": [3, 4], "type": null, "name": "caspase-9 ) were upregulated in a dose-dependent manner."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Synergistic cytotoxicity was demonstrated, and ", "pemetrexed", " significantly decreased the amount of phosphorylated Akt, enhanced apoptosis, and increased the expression of dCK in A549 and Calu-6 cells, as well as the expression of the ", "human nucleoside equilibrative transporter 1", " (hENT1) in all cell lines."], "h": {"pos": [1, 2], "type": null, "name": "pemetrexed  significantly decreased the amount of phosphorylated Akt, enhanced apoptosis, and increased the expression of dCK in A549 and Calu-6 cells, as well as the expression of the "}, "t": {"pos": [3, 4], "type": null, "name": "human nucleoside equilibrative transporter 1  (hENT1) in all cell lines."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Saturated ", "palmitic and stearic acids", " increased ceramides, up-regulated PTP1B, and had ", "AKt", " and PTP1B phosphorylation at Ser 50 impaired."], "h": {"pos": [1, 2], "type": null, "name": "palmitic and stearic acids  increased ceramides, up-regulated PTP1B, and had "}, "t": {"pos": [3, 4], "type": null, "name": "AKt  and PTP1B phosphorylation at Ser 50 impaired."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["To determine whether H(2)S itself provoked inflammation in acinar cells, the cells were treated with H(2)S donor drug, ", "sodium hydrosulphide", " (NaHS), (10, 50 and 100 muM), that resulted in a significant increase in ", "SP", " concentration and expression of PPT-A and NK1-R in acinar cells."], "h": {"pos": [1, 2], "type": null, "name": "sodium hydrosulphide  (NaHS), (10, 50 and 100 muM), that resulted in a significant increase in "}, "t": {"pos": [3, 4], "type": null, "name": "SP  concentration and expression of PPT-A and NK1-R in acinar cells."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Ozone", " plus PM(2.5) exposure, however, induced CRP, IL-6, CK, ", "LDH", " and MDA increase, SOD and HRV decrease significantly in a dose-response way."], "h": {"pos": [1, 2], "type": null, "name": "Ozone  plus PM(2.5) exposure, however, induced CRP, IL-6, CK, "}, "t": {"pos": [3, 4], "type": null, "name": "LDH  and MDA increase, SOD and HRV decrease significantly in a dose-response way."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Quantitative real-time polymerase chain reaction analysis showed that following the exposure of cells to ", "SiO(2)", " NPs, the messenger RNA level of apoptotic genes (", "caspase-3", " and caspase-9) were upregulated in a dose-dependent manner."], "h": {"pos": [1, 2], "type": null, "name": "SiO(2)  NPs, the messenger RNA level of apoptotic genes ("}, "t": {"pos": [3, 4], "type": null, "name": "caspase-3  and caspase-9) were upregulated in a dose-dependent manner."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Although Bak and Bcl-2-associated X protein (Bax), another member of the Bcl-2 family, are generally thought to be functionally redundant, only Bak is necessary and sufficient for ", "VK2", "-induced cytochrome c (", "cyt c", ") release and cell death."], "h": {"pos": [1, 2], "type": null, "name": "VK2 -induced cytochrome c ("}, "t": {"pos": [3, 4], "type": null, "name": "cyt c ) release and cell death."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The ", "BH(4)", " treatment also partially improved the ", "insulin", " sensitivity and blood pressure, as well as the serum triglyceride concentration, in the fructose-fed rats."], "h": {"pos": [1, 2], "type": null, "name": "BH(4)  treatment also partially improved the "}, "t": {"pos": [3, 4], "type": null, "name": "insulin  sensitivity and blood pressure, as well as the serum triglyceride concentration, in the fructose-fed rats."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Moreover, ", "curcumin", " alleviated ", "Sim2", " expression, and reversely raised Drebrin expression in neurons treated with hyperglycaemia."], "h": {"pos": [1, 2], "type": null, "name": "curcumin  alleviated "}, "t": {"pos": [3, 4], "type": null, "name": "Sim2  expression, and reversely raised Drebrin expression in neurons treated with hyperglycaemia."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["On the other hand, treatment with ", "gentianine", " significantly increased adipogenesis, which was associated with a significant increase in the mRNA expression of PPAR-\u03b3, GLUT-4 and ", "adiponectin", "."], "h": {"pos": [1, 2], "type": null, "name": "gentianine  significantly increased adipogenesis, which was associated with a significant increase in the mRNA expression of PPAR-\u03b3, GLUT-4 and "}, "t": {"pos": [3, 4], "type": null, "name": "adiponectin ."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The reduction of ", "P2X3", " expression levels was reversed by the proteasomal inhibitor ", "MG-132", "."], "h": {"pos": [1, 2], "type": null, "name": "P2X3  expression levels was reversed by the proteasomal inhibitor "}, "t": {"pos": [3, 4], "type": null, "name": "MG-132 ."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Ginsenosides Rb2, Rd and Rg1 significantly decreased ", "norepinephrine", " and/or epinephrine-induced increase of ", "IL-6", " level in macrophage cell line (RAW 264.7)."], "h": {"pos": [1, 2], "type": null, "name": "norepinephrine  and/or epinephrine-induced increase of "}, "t": {"pos": [3, 4], "type": null, "name": "IL-6  level in macrophage cell line (RAW 264.7)."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["In Alexander cells, only when they were transfected with FXR+RXR, ", "GW4064", " caused up-regulation of SHP and ", "OST\u03b2", ", and a down-regulation of CYP27A1."], "h": {"pos": [1, 2], "type": null, "name": "GW4064  caused up-regulation of SHP and "}, "t": {"pos": [3, 4], "type": null, "name": "OST\u03b2 , and a down-regulation of CYP27A1."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Additionally, ", "MPTP", " significantly down-regulated Bcl-2 expression in the mitochondria of dopaminergic cells in the SN, followed by an increase in Bax expression, cytochrome C translocation to the cytosol, andcleaved-", "caspase-3", " expression, whereas these were inhibited by CRE or EB treatment."], "h": {"pos": [1, 2], "type": null, "name": "MPTP  significantly down-regulated Bcl-2 expression in the mitochondria of dopaminergic cells in the SN, followed by an increase in Bax expression, cytochrome C translocation to the cytosol, andcleaved-"}, "t": {"pos": [3, 4], "type": null, "name": "caspase-3  expression, whereas these were inhibited by CRE or EB treatment."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The activation may be accelerated by an acute inflammatory process provoked by ", "oleate", ", which is supported by such clinical manifestations as mild fever, retrosternal pain leukocytosis and an increase in plasma ", "fibrinogen", " level which was observed in all during the period."], "h": {"pos": [1, 2], "type": null, "name": "oleate , which is supported by such clinical manifestations as mild fever, retrosternal pain leukocytosis and an increase in plasma "}, "t": {"pos": [3, 4], "type": null, "name": "fibrinogen  level which was observed in all during the period."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Conversely, AMPK inhibitor compound C or GSK3\u03b2 inhibitor SB216763 blocked the cleavages of PARP and ", "caspase 3", " induced by ", "ursolic acid", " in HepG2 cells."], "h": {"pos": [1, 2], "type": null, "name": "caspase 3  induced by "}, "t": {"pos": [3, 4], "type": null, "name": "ursolic acid  in HepG2 cells."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Leukotriene D4", " induces cognitive impairment through enhancement of CysLT\u2081 R-mediated ", "amyloid-\u03b2", " generation in mice."], "h": {"pos": [1, 2], "type": null, "name": "Leukotriene D4  induces cognitive impairment through enhancement of CysLT\u2081 R-mediated "}, "t": {"pos": [3, 4], "type": null, "name": "amyloid-\u03b2  generation in mice."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["In addition, the number and area of ", "glutathione S-transferase placental form", " (GST-P) positive foci and proliferating cell nuclear antigen (PCNA) positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mg/kg ", "MEG", " compared with the control animals."], "h": {"pos": [1, 2], "type": null, "name": "glutathione S-transferase placental form  (GST-P) positive foci and proliferating cell nuclear antigen (PCNA) positive cell ratios in the hepatocytes were significantly increased in the male and female rats that were administered 100mg/kg "}, "t": {"pos": [3, 4], "type": null, "name": "MEG  compared with the control animals."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Furthermore, substance P (SP) concentration in the acini and expression of ", "SP", " gene (preprotachykinin-A, PPT-A) and neurokinin-1 receptor (NK-1R), the primary receptor for SP, are increased in secretagogue ", "caerulein", "-treated acinar cells."], "h": {"pos": [1, 2], "type": null, "name": "SP  gene (preprotachykinin-A, PPT-A) and neurokinin-1 receptor (NK-1R), the primary receptor for SP, are increased in secretagogue "}, "t": {"pos": [3, 4], "type": null, "name": "caerulein -treated acinar cells."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Co-treatment of astrocytes with antofine and the intracellular Ca(2+) chelator ", "BAPTA-AM", " prevented downregulation of ", "Cx43", " and inhibition of GJIC."], "h": {"pos": [1, 2], "type": null, "name": "BAPTA-AM  prevented downregulation of "}, "t": {"pos": [3, 4], "type": null, "name": "Cx43  and inhibition of GJIC."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["These data demonstrated that 1) gemcitabine and pemetrexed synergistically interact against NSCLC cells through the suppression of Akt phosphorylation and induction of apoptosis; 2) the gene expression profile of critical genes may predict for drug chemosensitivity; and 3) ", "pemetrexed", " enhances dCK and ", "hENT1", " expression, thus suggesting the role of gene-expression modulation for rational development of chemotherapy combinations."], "h": {"pos": [1, 2], "type": null, "name": "pemetrexed  enhances dCK and "}, "t": {"pos": [3, 4], "type": null, "name": "hENT1  expression, thus suggesting the role of gene-expression modulation for rational development of chemotherapy combinations."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The treatment with ", "arsenic", " exhibited a significant increase in some serum hepatic and renal biochemical parameters (alanine aminotransferase, ", "aspartate aminotransferase", ", alkaline phosphatase, total protein, albumin, bilirubin, cholesterol, urea and creatinine)."], "h": {"pos": [1, 2], "type": null, "name": "arsenic  exhibited a significant increase in some serum hepatic and renal biochemical parameters (alanine aminotransferase, "}, "t": {"pos": [3, 4], "type": null, "name": "aspartate aminotransferase , alkaline phosphatase, total protein, albumin, bilirubin, cholesterol, urea and creatinine)."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["siRNA knockdown of p38 MAPK abrogated the ability of ", "anisomycin", " to synergistically induce ", "CYP2B6", " mRNA."], "h": {"pos": [1, 2], "type": null, "name": "anisomycin  to synergistically induce "}, "t": {"pos": [3, 4], "type": null, "name": "CYP2B6  mRNA."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["(3)H-CGP 12177A saturation binding, in the presence of ", "propranolol", ", increased approximately 5-fold following overexpression of ", "beta(1)-adrenoceptors", "."], "h": {"pos": [1, 2], "type": null, "name": "propranolol , increased approximately 5-fold following overexpression of "}, "t": {"pos": [3, 4], "type": null, "name": "beta(1)-adrenoceptors ."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Crocin", " (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of ", "caspase 3", " and release of cytochrome c to the cytosol induced by DZN."], "h": {"pos": [1, 2], "type": null, "name": "Crocin  (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of "}, "t": {"pos": [3, 4], "type": null, "name": "caspase 3  and release of cytochrome c to the cytosol induced by DZN."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "(3)H-CGP 12177A", " saturation binding, in the presence of propranolol, increased approximately 5-fold following overexpression of ", "beta(1)-adrenoceptors", "."], "h": {"pos": [1, 2], "type": null, "name": "(3)H-CGP 12177A  saturation binding, in the presence of propranolol, increased approximately 5-fold following overexpression of "}, "t": {"pos": [3, 4], "type": null, "name": "beta(1)-adrenoceptors ."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Upon co-exposure to V(5+) and TCDD, ", "V(5+)", " significantly potentiated the TCDD-mediated induction of the Cyp1a1, ", "Cyp1a2", ", and Cyp1b1 mRNA, protein, and catalytic activity levels at 24\u00a0h."], "h": {"pos": [1, 2], "type": null, "name": "V(5+)  significantly potentiated the TCDD-mediated induction of the Cyp1a1, "}, "t": {"pos": [3, 4], "type": null, "name": "Cyp1a2 , and Cyp1b1 mRNA, protein, and catalytic activity levels at 24\u00a0h."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Caerulein", " increased the levels of H(2)S and ", "CSE", " mRNA expression while CBS mRNA expression was decreased."], "h": {"pos": [1, 2], "type": null, "name": "Caerulein  increased the levels of H(2)S and "}, "t": {"pos": [3, 4], "type": null, "name": "CSE  mRNA expression while CBS mRNA expression was decreased."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Ozone", " plus PM(2.5) exposure, however, induced CRP, IL-6, ", "CK", ", LDH and MDA increase, SOD and HRV decrease significantly in a dose-response way."], "h": {"pos": [1, 2], "type": null, "name": "Ozone  plus PM(2.5) exposure, however, induced CRP, IL-6, "}, "t": {"pos": [3, 4], "type": null, "name": "CK , LDH and MDA increase, SOD and HRV decrease significantly in a dose-response way."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Brain tissue analyses revealed that neonatal quinpirole treatment produced a significant decrease in hippocampal NGF, ", "BDNF", " and ChAT that was eliminated by ", "olanzapine", " treatment."], "h": {"pos": [1, 2], "type": null, "name": "BDNF  and ChAT that was eliminated by "}, "t": {"pos": [3, 4], "type": null, "name": "olanzapine  treatment."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["For ", "AII", " and ET1, MAP was also increased for the ", "fenofibrate", " group but not in a dose-dependent fashion."], "h": {"pos": [1, 2], "type": null, "name": "AII  and ET1, MAP was also increased for the "}, "t": {"pos": [3, 4], "type": null, "name": "fenofibrate  group but not in a dose-dependent fashion."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "I3A", " induced a higher level of secretion of the inflammatory ", "cytokine", " interleukin 6 compared with PMA in the WEHI-231 cells and displayed a marked biphasic dose-response curve for the induction."], "h": {"pos": [1, 2], "type": null, "name": "I3A  induced a higher level of secretion of the inflammatory "}, "t": {"pos": [3, 4], "type": null, "name": "cytokine  interleukin 6 compared with PMA in the WEHI-231 cells and displayed a marked biphasic dose-response curve for the induction."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The data show that CP[c]Ph is less potent at inducing ", "CYP1A", " gene expression in rainbow trout than ", "benzo[a]pyrene", " (B[a]P), a well-known Ah-receptor agonist."], "h": {"pos": [1, 2], "type": null, "name": "CYP1A  gene expression in rainbow trout than "}, "t": {"pos": [3, 4], "type": null, "name": "benzo[a]pyrene  (B[a]P), a well-known Ah-receptor agonist."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Re-feeding normal chow or a high ", "sucrose", " diet for 24 h after a 48-h fast increased both ", "ACS1", " and ACS4 protein expression 1.5-2.0-fold, consistent with inhibition studies."], "h": {"pos": [1, 2], "type": null, "name": "sucrose  diet for 24 h after a 48-h fast increased both "}, "t": {"pos": [3, 4], "type": null, "name": "ACS1  and ACS4 protein expression 1.5-2.0-fold, consistent with inhibition studies."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Among these differentially expressed lncRNAs, the greatest change was noted for ", "uc002mbe.2", ", which had more than 300 folds induction upon ", "TSA", " treatment."], "h": {"pos": [1, 2], "type": null, "name": "uc002mbe.2 , which had more than 300 folds induction upon "}, "t": {"pos": [3, 4], "type": null, "name": "TSA  treatment."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Compared with DM8W group, SOD and ", "ALDH2", " in ", "EtOH", "+DM8W group was increased, MDA was decreased."], "h": {"pos": [1, 2], "type": null, "name": "ALDH2  in "}, "t": {"pos": [3, 4], "type": null, "name": "EtOH +DM8W group was increased, MDA was decreased."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "OMT", " showed partial protection in the cortical neurons via down-regulation of NR2B containing NMDA receptors and up-regulation of ", "Bcl-2", " family."], "h": {"pos": [1, 2], "type": null, "name": "OMT  showed partial protection in the cortical neurons via down-regulation of NR2B containing NMDA receptors and up-regulation of "}, "t": {"pos": [3, 4], "type": null, "name": "Bcl-2  family."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Orlistat", " treatment also results in modest improvements in total cholesterol, ", "low-density lipoprotein", ", blood pressure, and fasting glucose and insulin concentrations."], "h": {"pos": [1, 2], "type": null, "name": "Orlistat  treatment also results in modest improvements in total cholesterol, "}, "t": {"pos": [3, 4], "type": null, "name": "low-density lipoprotein , blood pressure, and fasting glucose and insulin concentrations."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["CONCLUSIONS A diet that partially replaces ", "carbohydrate", " with unsaturated fat may improve ", "insulin", " sensitivity in a population at risk for cardiovascular disease."], "h": {"pos": [1, 2], "type": null, "name": "carbohydrate  with unsaturated fat may improve "}, "t": {"pos": [3, 4], "type": null, "name": "insulin  sensitivity in a population at risk for cardiovascular disease."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Dietary EPA/", "DHA", " treatment restored endogenous biosynthesis of n-3 derived lipid mediators in obesity while attenuating adipose tissue inflammation and improving ", "insulin", " sensitivity."], "h": {"pos": [1, 2], "type": null, "name": "DHA  treatment restored endogenous biosynthesis of n-3 derived lipid mediators in obesity while attenuating adipose tissue inflammation and improving "}, "t": {"pos": [3, 4], "type": null, "name": "insulin  sensitivity."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["First, we showed that intracerebroventricular administration of ", "glucose", " in rats increases ", "DBI", " expression in hypothalamic glial-like tanycytes."], "h": {"pos": [1, 2], "type": null, "name": "glucose  in rats increases "}, "t": {"pos": [3, 4], "type": null, "name": "DBI  expression in hypothalamic glial-like tanycytes."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The results demonstrated that intracerebral infusions of ", "LTD4", " (1 ng/mouse) produced memory impairment as determined by Morris water maze test and Y-maze test in mice, and caused the accumulation of A\u03b21-40 and A\u03b21-42 in the hippocampus and cortex through increased activity of \u03b2- and \u03b3-secretases accompanied with increased expression of amyloid precursor protein (", "APP", ")."], "h": {"pos": [1, 2], "type": null, "name": "LTD4  (1 ng/mouse) produced memory impairment as determined by Morris water maze test and Y-maze test in mice, and caused the accumulation of A\u03b21-40 and A\u03b21-42 in the hippocampus and cortex through increased activity of \u03b2- and \u03b3-secretases accompanied with increased expression of amyloid precursor protein ("}, "t": {"pos": [3, 4], "type": null, "name": "APP )."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Further, ", "5HHMF", " increased specific DNA-binding activity of Nrf2, and transient knockdown with Nrf2 siRNA subsequently reversed 5HHMF-induced NO inhibition, which was followed by suppression of ", "HO-1", " activity."], "h": {"pos": [1, 2], "type": null, "name": "5HHMF  increased specific DNA-binding activity of Nrf2, and transient knockdown with Nrf2 siRNA subsequently reversed 5HHMF-induced NO inhibition, which was followed by suppression of "}, "t": {"pos": [3, 4], "type": null, "name": "HO-1  activity."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["In hippocampal dentate gyrus, ", "MPH", "-receiving rats showed a 51% decrease in NET-ir density and a 61% expanded distribution of the new-cell marker PSA-NCAM (polysialylated form of ", "neural cell adhesion molecule", ")."], "h": {"pos": [1, 2], "type": null, "name": "MPH -receiving rats showed a 51% decrease in NET-ir density and a 61% expanded distribution of the new-cell marker PSA-NCAM (polysialylated form of "}, "t": {"pos": [3, 4], "type": null, "name": "neural cell adhesion molecule )."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Furthermore, treatment with spironoclactone not only attenuated the pro-apoptotic effect of ALD but reversed the ", "ALD", "-induced increase of calpain and ", "AIF", " levels."], "h": {"pos": [1, 2], "type": null, "name": "ALD -induced increase of calpain and "}, "t": {"pos": [3, 4], "type": null, "name": "AIF  levels."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["We investigated the involvement of the farnesoid X receptor (FXR), a nuclear receptor for bile acids, in the ", "chenodeoxycholic acid", " (CDCA)-induced expression of ", "Cdx2", " and MUC2 in normal rat gastric epithelial cells (RGM-1 cells)."], "h": {"pos": [1, 2], "type": null, "name": "chenodeoxycholic acid  (CDCA)-induced expression of "}, "t": {"pos": [3, 4], "type": null, "name": "Cdx2  and MUC2 in normal rat gastric epithelial cells (RGM-1 cells)."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The results demonstrated that intracerebral infusions of ", "LTD4", " (1 ng/mouse) produced memory impairment as determined by Morris water maze test and Y-maze test in mice, and caused the accumulation of ", "A\u03b21-40", " and A\u03b21-42 in the hippocampus and cortex through increased activity of \u03b2- and \u03b3-secretases accompanied with increased expression of amyloid precursor protein (APP)."], "h": {"pos": [1, 2], "type": null, "name": "LTD4  (1 ng/mouse) produced memory impairment as determined by Morris water maze test and Y-maze test in mice, and caused the accumulation of "}, "t": {"pos": [3, 4], "type": null, "name": "A\u03b21-40  and A\u03b21-42 in the hippocampus and cortex through increased activity of \u03b2- and \u03b3-secretases accompanied with increased expression of amyloid precursor protein (APP)."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Apoptosis studies (DAPI staining and ", "caspase 3", " activity) showed a marked increase in the presence of ", "MXF", " and VP-16 compared to VP-16 alone."], "h": {"pos": [1, 2], "type": null, "name": "caspase 3  activity) showed a marked increase in the presence of "}, "t": {"pos": [3, 4], "type": null, "name": "MXF  and VP-16 compared to VP-16 alone."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Transduction with constitutively active forms of GSK-3\u03b2 could protect against the downregulation of p65 and upregulation of cleaved-", "PARP", " that are induced by ", "cinobufagin", " treatment."], "h": {"pos": [1, 2], "type": null, "name": "PARP  that are induced by "}, "t": {"pos": [3, 4], "type": null, "name": "cinobufagin  treatment."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The above results indicate that polyamine depletion delays the onset of apoptosis in IEC-6 cells and confers protection against DNA damaging agents, suggesting that ", "polyamines", " might be involved in the ", "caspase", " activating signal cascade."], "h": {"pos": [1, 2], "type": null, "name": "polyamines  might be involved in the "}, "t": {"pos": [3, 4], "type": null, "name": "caspase  activating signal cascade."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Apoptosis studies (DAPI staining and ", "caspase 3", " activity) showed a marked increase in the presence of MXF and VP-16 compared to ", "VP-16", " alone."], "h": {"pos": [1, 2], "type": null, "name": "caspase 3  activity) showed a marked increase in the presence of MXF and VP-16 compared to "}, "t": {"pos": [3, 4], "type": null, "name": "VP-16  alone."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The treatment with ", "arsenic", " exhibited a significant increase in some serum hepatic and renal biochemical parameters (alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, total protein, ", "albumin", ", bilirubin, cholesterol, urea and creatinine)."], "h": {"pos": [1, 2], "type": null, "name": "arsenic  exhibited a significant increase in some serum hepatic and renal biochemical parameters (alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, total protein, "}, "t": {"pos": [3, 4], "type": null, "name": "albumin , bilirubin, cholesterol, urea and creatinine)."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["These results showed that ", "WNT6", " and Cav1 are upregulated by chemotherapeutics and enhance the resistance of GC cells to ", "anthracycline", " drugs."], "h": {"pos": [1, 2], "type": null, "name": "WNT6  and Cav1 are upregulated by chemotherapeutics and enhance the resistance of GC cells to "}, "t": {"pos": [3, 4], "type": null, "name": "anthracycline  drugs."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The studies with dThyd rescue from cyclin E-cdk2 protein overexpression and growth inhibition by ", "Tomudex", " indicate that increased cyclin E-", "cdk2", " protein expression is associated with effective inhibition of thymidylate synthase and resultant dNTP pool imbalance."], "h": {"pos": [1, 2], "type": null, "name": "Tomudex  indicate that increased cyclin E-"}, "t": {"pos": [3, 4], "type": null, "name": "cdk2  protein expression is associated with effective inhibition of thymidylate synthase and resultant dNTP pool imbalance."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "PTE", " also down-regulated the expression of STAT3 target genes, including the anti-apoptotic proteins Bcl-xL and Mcl-1, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, Bak, cytosolic Cytochrome c, and cleaved Caspase3) and cyclin-dependent kinase inhibitors such as p21 and ", "p27", "."], "h": {"pos": [1, 2], "type": null, "name": "PTE  also down-regulated the expression of STAT3 target genes, including the anti-apoptotic proteins Bcl-xL and Mcl-1, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, Bak, cytosolic Cytochrome c, and cleaved Caspase3) and cyclin-dependent kinase inhibitors such as p21 and "}, "t": {"pos": [3, 4], "type": null, "name": "p27 ."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Here, we have now found that activation of p38 ", "MAPK", " by ", "anisomycin", " potentiated induction of CYP2B6 mRNA by CAR ligand in HepG2 cells to levels observed in ligand-treated human primary hepatocytes."], "h": {"pos": [1, 2], "type": null, "name": "MAPK  by "}, "t": {"pos": [3, 4], "type": null, "name": "anisomycin  potentiated induction of CYP2B6 mRNA by CAR ligand in HepG2 cells to levels observed in ligand-treated human primary hepatocytes."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["In Alexander cells, only when they were transfected with FXR+RXR, ", "GW4064", " caused up-regulation of ", "SHP", " and OST\u03b2, and a down-regulation of CYP27A1."], "h": {"pos": [1, 2], "type": null, "name": "GW4064  caused up-regulation of "}, "t": {"pos": [3, 4], "type": null, "name": "SHP  and OST\u03b2, and a down-regulation of CYP27A1."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["In this study, ", "aldosterone", " (ALD)-induced apoptosis of cardiomyocyte was evaluated based on the previous studies, and the roles of ", "calpain", " signaling were clarified."], "h": {"pos": [1, 2], "type": null, "name": "aldosterone  (ALD)-induced apoptosis of cardiomyocyte was evaluated based on the previous studies, and the roles of "}, "t": {"pos": [3, 4], "type": null, "name": "calpain  signaling were clarified."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Furthermore, tPA induced rapid ", "tyrosine", " phosphorylation on the beta subunit of LRP-1, which was followed by the activation of Mek1 and its downstream ", "Erk-1 and -2", "."], "h": {"pos": [1, 2], "type": null, "name": "tyrosine  phosphorylation on the beta subunit of LRP-1, which was followed by the activation of Mek1 and its downstream "}, "t": {"pos": [3, 4], "type": null, "name": "Erk-1 and -2 ."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["There was also an increase in c-kit, Trio, Rho-A, Rac-3, EGFR, Notch-4, Dvl-2, Ezrin, ", "beta catenin", " and mutant p53 protein expression in the ", "parathion", "-treated cells."], "h": {"pos": [1, 2], "type": null, "name": "beta catenin  and mutant p53 protein expression in the "}, "t": {"pos": [3, 4], "type": null, "name": "parathion -treated cells."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The results showed that administration of ", "AlCl3", " resulted in a significant elevation in the levels of AchE activity, CRP, NF-\u03baB, and ", "MCP-1", " accompanied with a significant depletion in the Ach level."], "h": {"pos": [1, 2], "type": null, "name": "AlCl3  resulted in a significant elevation in the levels of AchE activity, CRP, NF-\u03baB, and "}, "t": {"pos": [3, 4], "type": null, "name": "MCP-1  accompanied with a significant depletion in the Ach level."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Improvements from baseline in mean glycosylated haemoglobin (", "HbA(1c)", ") were significantly greater with ", "sitagliptin", " monotherapy than with placebo in patients with type 2 diabetes."], "h": {"pos": [1, 2], "type": null, "name": "HbA(1c) ) were significantly greater with "}, "t": {"pos": [3, 4], "type": null, "name": "sitagliptin  monotherapy than with placebo in patients with type 2 diabetes."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["On the other hand, treatment with ", "gentianine", " significantly increased adipogenesis, which was associated with a significant increase in the mRNA expression of ", "PPAR-\u03b3", ", GLUT-4 and adiponectin."], "h": {"pos": [1, 2], "type": null, "name": "gentianine  significantly increased adipogenesis, which was associated with a significant increase in the mRNA expression of "}, "t": {"pos": [3, 4], "type": null, "name": "PPAR-\u03b3 , GLUT-4 and adiponectin."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Human and rat renin", " and angiotensinogen genes were downregulated in dTGR and were increased by losartan and ", "cilazapril", " treatments, whereas no changes in the expression of rat ACE and AT1A receptor genes were observed."], "h": {"pos": [1, 2], "type": null, "name": "Human and rat renin  and angiotensinogen genes were downregulated in dTGR and were increased by losartan and "}, "t": {"pos": [3, 4], "type": null, "name": "cilazapril  treatments, whereas no changes in the expression of rat ACE and AT1A receptor genes were observed."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["For AII and ", "ET1", ", MAP was also increased for the ", "fenofibrate", " group but not in a dose-dependent fashion."], "h": {"pos": [1, 2], "type": null, "name": "ET1 , MAP was also increased for the "}, "t": {"pos": [3, 4], "type": null, "name": "fenofibrate  group but not in a dose-dependent fashion."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "LTD4", " also induced expression of ", "cysteinyl leukotriene receptor 1", " (CysLT(1)R) and NF-\u03baB p65 in the hippocampus and cortex."], "h": {"pos": [1, 2], "type": null, "name": "LTD4  also induced expression of "}, "t": {"pos": [3, 4], "type": null, "name": "cysteinyl leukotriene receptor 1  (CysLT(1)R) and NF-\u03baB p65 in the hippocampus and cortex."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "8-pCPT-2'-O-Me-cAMP-AM", " potentiation of ", "insulin", " secretion stimulated by tolbutamide was markedly inhibited by 2-APB (25 \u03bcM) and enhanced by the PKC inhibitor bisindolylmaleimide I (1 \u03bcM)."], "h": {"pos": [1, 2], "type": null, "name": "8-pCPT-2'-O-Me-cAMP-AM  potentiation of "}, "t": {"pos": [3, 4], "type": null, "name": "insulin  secretion stimulated by tolbutamide was markedly inhibited by 2-APB (25 \u03bcM) and enhanced by the PKC inhibitor bisindolylmaleimide I (1 \u03bcM)."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Platelet-induced COX-2-dependent PGE2 synthesis in HT29 cells was involved in downregulation of ", "p21", "(WAF1/CIP1) and upregulation of cyclinB1, since these effects were prevented by ", "rofecoxib", "(a selective COX-2 inhibitor) and rescued by exogenous PGE2."], "h": {"pos": [1, 2], "type": null, "name": "p21 (WAF1/CIP1) and upregulation of cyclinB1, since these effects were prevented by "}, "t": {"pos": [3, 4], "type": null, "name": "rofecoxib (a selective COX-2 inhibitor) and rescued by exogenous PGE2."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Upon co-exposure to ", "V(5+)", " and TCDD, V(5+) significantly potentiated the TCDD-mediated induction of the ", "Cyp1a1", ", Cyp1a2, and Cyp1b1 mRNA, protein, and catalytic activity levels at 24\u00a0h."], "h": {"pos": [1, 2], "type": null, "name": "V(5+)  and TCDD, V(5+) significantly potentiated the TCDD-mediated induction of the "}, "t": {"pos": [3, 4], "type": null, "name": "Cyp1a1 , Cyp1a2, and Cyp1b1 mRNA, protein, and catalytic activity levels at 24\u00a0h."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "TCDD", " also caused a fast (within 30min as judged by the increase in its mRNA level) activation of cytosolic phospholipase A2 (", "cPLA2", ")."], "h": {"pos": [1, 2], "type": null, "name": "TCDD  also caused a fast (within 30min as judged by the increase in its mRNA level) activation of cytosolic phospholipase A2 ("}, "t": {"pos": [3, 4], "type": null, "name": "cPLA2 )."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Repression of farnesyltransferase (FNTA) by siRNA and the enzyme inhibitor ", "manumycin A", " caused elevation of ApoA-I secretion from hepatocytes and from transgenic mice expressing ", "hApoA-I", " and cholesterol ester transfer protein transgenes."], "h": {"pos": [1, 2], "type": null, "name": "manumycin A  caused elevation of ApoA-I secretion from hepatocytes and from transgenic mice expressing "}, "t": {"pos": [3, 4], "type": null, "name": "hApoA-I  and cholesterol ester transfer protein transgenes."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Phillyrin strongly inhibited high ", "glucose", "-induced ", "fatty acid synthase", " (FAS) expression by modulating sterol regulatory element-binding protein-1c (SREBP-1c) activation."], "h": {"pos": [1, 2], "type": null, "name": "glucose -induced "}, "t": {"pos": [3, 4], "type": null, "name": "fatty acid synthase  (FAS) expression by modulating sterol regulatory element-binding protein-1c (SREBP-1c) activation."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The lysosomal inhibitor ", "chloroquine", " significantly increased ", "RCAN1", " accumulation in +/+ cells, consistent with the hypothesis that higher lysosomal pH impairs RCAN1 degradation, leading to a higher RCAN1/NFATc1 ratio and consequently NFATc1 inhibition."], "h": {"pos": [1, 2], "type": null, "name": "chloroquine  significantly increased "}, "t": {"pos": [3, 4], "type": null, "name": "RCAN1  accumulation in +/+ cells, consistent with the hypothesis that higher lysosomal pH impairs RCAN1 degradation, leading to a higher RCAN1/NFATc1 ratio and consequently NFATc1 inhibition."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The results showed that ", "wogonoside", " promotes the expression of LC3-II and ", "Beclin-1", "."], "h": {"pos": [1, 2], "type": null, "name": "wogonoside  promotes the expression of LC3-II and "}, "t": {"pos": [3, 4], "type": null, "name": "Beclin-1 ."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["To determine whether H(2)S itself provoked inflammation in acinar cells, the cells were treated with H(2)S donor drug, sodium hydrosulphide (", "NaHS", "), (10, 50 and 100 muM), that resulted in a significant increase in SP concentration and expression of ", "PPT-A", " and NK1-R in acinar cells."], "h": {"pos": [1, 2], "type": null, "name": "NaHS ), (10, 50 and 100 muM), that resulted in a significant increase in SP concentration and expression of "}, "t": {"pos": [3, 4], "type": null, "name": "PPT-A  and NK1-R in acinar cells."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["In hippocampal dentate gyrus, ", "MPH", "-receiving rats showed a 51% decrease in NET-ir density and a 61% expanded distribution of the new-cell marker PSA-", "NCAM", " (polysialylated form of neural cell adhesion molecule)."], "h": {"pos": [1, 2], "type": null, "name": "MPH -receiving rats showed a 51% decrease in NET-ir density and a 61% expanded distribution of the new-cell marker PSA-"}, "t": {"pos": [3, 4], "type": null, "name": "NCAM  (polysialylated form of neural cell adhesion molecule)."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Isolated islets displayed improved ", "glucose", "-stimulated ", "insulin", " secretion after GRA treatment (0.061 +/- 0.007 vs 0.030 +/- 0.004 pmol islet(-1) h(-1) at 16.7 mmol/l glucose; p < 0.001), without affecting islet glucose oxidation."], "h": {"pos": [1, 2], "type": null, "name": "glucose -stimulated "}, "t": {"pos": [3, 4], "type": null, "name": "insulin  secretion after GRA treatment (0.061 +/- 0.007 vs 0.030 +/- 0.004 pmol islet(-1) h(-1) at 16.7 mmol/l glucose; p < 0.001), without affecting islet glucose oxidation."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "ALD", " increased ", "calpain", " expression and caspase-3 activity and promoted Bid cleavage."], "h": {"pos": [1, 2], "type": null, "name": "ALD  increased "}, "t": {"pos": [3, 4], "type": null, "name": "calpain  expression and caspase-3 activity and promoted Bid cleavage."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Sphingosine-1-phosphate", " promotes the nuclear translocation of \u03b2-catenin and thereby induces ", "osteoprotegerin", " gene expression in osteoblast-like cell lines."], "h": {"pos": [1, 2], "type": null, "name": "Sphingosine-1-phosphate  promotes the nuclear translocation of \u03b2-catenin and thereby induces "}, "t": {"pos": [3, 4], "type": null, "name": "osteoprotegerin  gene expression in osteoblast-like cell lines."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "CGP 12177A", " but not isoprenaline initiated arrhythmias at lower concentrations following ", "beta(1)-adrenoceptor", " overexpression."], "h": {"pos": [1, 2], "type": null, "name": "CGP 12177A  but not isoprenaline initiated arrhythmias at lower concentrations following "}, "t": {"pos": [3, 4], "type": null, "name": "beta(1)-adrenoceptor  overexpression."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["High-", "glucose", " environment enhanced oxidative stress and increased ", "interleukin-8", " secretion from keratinocytes: New insights on impaired diabetic wound healing."], "h": {"pos": [1, 2], "type": null, "name": "glucose  environment enhanced oxidative stress and increased "}, "t": {"pos": [3, 4], "type": null, "name": "interleukin-8  secretion from keratinocytes: New insights on impaired diabetic wound healing."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Upon treatment of isolated hepatocytes with Hb alone or in the presence of ", "TCDD", ", there was an increase in the ", "AhR", "-dependent luciferase activity."], "h": {"pos": [1, 2], "type": null, "name": "TCDD , there was an increase in the "}, "t": {"pos": [3, 4], "type": null, "name": "AhR -dependent luciferase activity."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The results showed that administration of ", "AlCl3", " resulted in a significant elevation in the levels of AchE activity, ", "CRP", ", NF-\u03baB, and MCP-1 accompanied with a significant depletion in the Ach level."], "h": {"pos": [1, 2], "type": null, "name": "AlCl3  resulted in a significant elevation in the levels of AchE activity, "}, "t": {"pos": [3, 4], "type": null, "name": "CRP , NF-\u03baB, and MCP-1 accompanied with a significant depletion in the Ach level."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["In addition to CYP2B6, ", "anisomycin", " co-treatment potentiated an increase in CYP2A7 and ", "CYP2C9", " mRNAs but not CYP3A4 or UDP-glucuronosyltransferase 1A1 mRNAs."], "h": {"pos": [1, 2], "type": null, "name": "anisomycin  co-treatment potentiated an increase in CYP2A7 and "}, "t": {"pos": [3, 4], "type": null, "name": "CYP2C9  mRNAs but not CYP3A4 or UDP-glucuronosyltransferase 1A1 mRNAs."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Mitiglinide", " (KAD-1229), a new anti-diabetic drug, is thought to stimulate ", "insulin", " secretion by closing the ATP-sensitive K+ (K(ATP)) channels in pancreatic beta-cells."], "h": {"pos": [1, 2], "type": null, "name": "Mitiglinide  (KAD-1229), a new anti-diabetic drug, is thought to stimulate "}, "t": {"pos": [3, 4], "type": null, "name": "insulin  secretion by closing the ATP-sensitive K+ (K(ATP)) channels in pancreatic beta-cells."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Although Bak and Bcl-2-associated X protein (Bax), another member of the Bcl-2 family, are generally thought to be functionally redundant, only Bak is necessary and sufficient for ", "VK2", "-induced ", "cytochrome c", " (cyt c) release and cell death."], "h": {"pos": [1, 2], "type": null, "name": "VK2 -induced "}, "t": {"pos": [3, 4], "type": null, "name": "cytochrome c  (cyt c) release and cell death."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The present results indicated that ", "N", "-BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing ", "Bim", " expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways."], "h": {"pos": [1, 2], "type": null, "name": "N -BPs induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, and enhancing "}, "t": {"pos": [3, 4], "type": null, "name": "Bim  expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Prolonged use of ", "tolvaptan", " leads to increased endogenous levels of ", "AVP", " and perhaps over-stimulation of V(1A) receptors."], "h": {"pos": [1, 2], "type": null, "name": "tolvaptan  leads to increased endogenous levels of "}, "t": {"pos": [3, 4], "type": null, "name": "AVP  and perhaps over-stimulation of V(1A) receptors."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "LTD4", " also induced expression of cysteinyl leukotriene receptor 1 (CysLT(1)R) and NF-\u03baB ", "p65", " in the hippocampus and cortex."], "h": {"pos": [1, 2], "type": null, "name": "LTD4  also induced expression of cysteinyl leukotriene receptor 1 (CysLT(1)R) and NF-\u03baB "}, "t": {"pos": [3, 4], "type": null, "name": "p65  in the hippocampus and cortex."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Phillyrin strongly inhibited high ", "glucose", "-induced fatty acid synthase (", "FAS", ") expression by modulating sterol regulatory element-binding protein-1c (SREBP-1c) activation."], "h": {"pos": [1, 2], "type": null, "name": "glucose -induced fatty acid synthase ("}, "t": {"pos": [3, 4], "type": null, "name": "FAS ) expression by modulating sterol regulatory element-binding protein-1c (SREBP-1c) activation."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Notably, ", "17-HDHA", " treatment reduced adipose tissue expression of inflammatory cytokines, increased adiponectin expression and improved glucose tolerance parallel to ", "insulin", " sensitivity in obese mice."], "h": {"pos": [1, 2], "type": null, "name": "17-HDHA  treatment reduced adipose tissue expression of inflammatory cytokines, increased adiponectin expression and improved glucose tolerance parallel to "}, "t": {"pos": [3, 4], "type": null, "name": "insulin  sensitivity in obese mice."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The treatment of U937 cells with NRF2 inducers including ", "sulforaphane", " effectively elevated the expression of ", "AKR1B1, 1B10, 1C1, 1C2, and 1C3", "."], "h": {"pos": [1, 2], "type": null, "name": "sulforaphane  effectively elevated the expression of "}, "t": {"pos": [3, 4], "type": null, "name": "AKR1B1, 1B10, 1C1, 1C2, and 1C3 ."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Re-feeding normal chow or a high ", "sucrose", " diet for 24 h after a 48-h fast increased both ACS1 and ", "ACS4", " protein expression 1.5-2.0-fold, consistent with inhibition studies."], "h": {"pos": [1, 2], "type": null, "name": "sucrose  diet for 24 h after a 48-h fast increased both ACS1 and "}, "t": {"pos": [3, 4], "type": null, "name": "ACS4  protein expression 1.5-2.0-fold, consistent with inhibition studies."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["We investigated the involvement of the farnesoid X receptor (FXR), a nuclear receptor for bile acids, in the chenodeoxycholic acid (", "CDCA", ")-induced expression of Cdx2 and ", "MUC2", " in normal rat gastric epithelial cells (RGM-1 cells)."], "h": {"pos": [1, 2], "type": null, "name": "CDCA )-induced expression of Cdx2 and "}, "t": {"pos": [3, 4], "type": null, "name": "MUC2  in normal rat gastric epithelial cells (RGM-1 cells)."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Conversely, AMPK inhibitor compound C or GSK3\u03b2 inhibitor SB216763 blocked the cleavages of ", "PARP", " and caspase 3 induced by ", "ursolic acid", " in HepG2 cells."], "h": {"pos": [1, 2], "type": null, "name": "PARP  and caspase 3 induced by "}, "t": {"pos": [3, 4], "type": null, "name": "ursolic acid  in HepG2 cells."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Pretreatment of human breast carcinoma MCF-7 cells for 24 h with the groundnut extract and soybean ", "isoflavone", " increased gene expression of heme oxygenase-1 (", "HO-1", "), a major antioxidative stress enzyme."], "h": {"pos": [1, 2], "type": null, "name": "isoflavone  increased gene expression of heme oxygenase-1 ("}, "t": {"pos": [3, 4], "type": null, "name": "HO-1 ), a major antioxidative stress enzyme."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Insulin", " secretion stimulated by both 200 \u03bcM ", "tolbutamide", " and 20 \u03bcM gliclazide, concentrations that had equivalent effects on membrane potential, was inhibited by thapsigargin (1 \u03bcM) or the L-type Ca(2+) channel blocker nicardipine (2 \u03bcM) and was potentiated by 8-pCPT-2'-O-Me-cAMP-AM at concentrations \u22652 \u03bcM in INS-1 cells."], "h": {"pos": [1, 2], "type": null, "name": "Insulin  secretion stimulated by both 200 \u03bcM "}, "t": {"pos": [3, 4], "type": null, "name": "tolbutamide  and 20 \u03bcM gliclazide, concentrations that had equivalent effects on membrane potential, was inhibited by thapsigargin (1 \u03bcM) or the L-type Ca(2+) channel blocker nicardipine (2 \u03bcM) and was potentiated by 8-pCPT-2'-O-Me-cAMP-AM at concentrations \u22652 \u03bcM in INS-1 cells."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Orlistat", " treatment also results in modest improvements in total cholesterol, low-density lipoprotein, blood pressure, and fasting glucose and ", "insulin", " concentrations."], "h": {"pos": [1, 2], "type": null, "name": "Orlistat  treatment also results in modest improvements in total cholesterol, low-density lipoprotein, blood pressure, and fasting glucose and "}, "t": {"pos": [3, 4], "type": null, "name": "insulin  concentrations."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Similarly, pelargonidin induced the expression of ", "CYP1A1", " mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM ", "2,3,7,8-tetrachlorodibenzodioxin", " (TCDD), the most potent activator of AhR."], "h": {"pos": [1, 2], "type": null, "name": "CYP1A1  mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM "}, "t": {"pos": [3, 4], "type": null, "name": "2,3,7,8-tetrachlorodibenzodioxin  (TCDD), the most potent activator of AhR."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Butein", " also increased ", "heme oxygenase-1", " (HO-1) protein expression and HO activity."], "h": {"pos": [1, 2], "type": null, "name": "Butein  also increased "}, "t": {"pos": [3, 4], "type": null, "name": "heme oxygenase-1  (HO-1) protein expression and HO activity."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Results: The administration of ", "prallethrin", " 1.6% w/w created significant increased changes in the levels of total WBC, lymphocytes, RBC, hemoglobin, packed cell volume, platelets, mean corpuscular volume, and mean corpuscular ", "hemoglobin", " in rats after 24, 48, and 72\u2009h of continuous inhalation; however, there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48\u2009h to return to normal after 72\u2009h."], "h": {"pos": [1, 2], "type": null, "name": "prallethrin  1.6% w/w created significant increased changes in the levels of total WBC, lymphocytes, RBC, hemoglobin, packed cell volume, platelets, mean corpuscular volume, and mean corpuscular "}, "t": {"pos": [3, 4], "type": null, "name": "hemoglobin  in rats after 24, 48, and 72\u2009h of continuous inhalation; however, there was a significant reduction in neutrophils at transient reduction in the monocytes after 24 and 48\u2009h to return to normal after 72\u2009h."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["In vitro, V(5+) decreased the ", "TCDD", "-mediated induction of ", "Cyp1a1", " mRNA, protein, and catalytic activity levels."], "h": {"pos": [1, 2], "type": null, "name": "TCDD -mediated induction of "}, "t": {"pos": [3, 4], "type": null, "name": "Cyp1a1  mRNA, protein, and catalytic activity levels."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["In addition to ", "CYP2B6", ", ", "anisomycin", " co-treatment potentiated an increase in CYP2A7 and CYP2C9 mRNAs but not CYP3A4 or UDP-glucuronosyltransferase 1A1 mRNAs."], "h": {"pos": [1, 2], "type": null, "name": "CYP2B6 , "}, "t": {"pos": [3, 4], "type": null, "name": "anisomycin  co-treatment potentiated an increase in CYP2A7 and CYP2C9 mRNAs but not CYP3A4 or UDP-glucuronosyltransferase 1A1 mRNAs."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Notably, ", "17-HDHA", " treatment reduced adipose tissue expression of inflammatory cytokines, increased ", "adiponectin", " expression and improved glucose tolerance parallel to insulin sensitivity in obese mice."], "h": {"pos": [1, 2], "type": null, "name": "17-HDHA  treatment reduced adipose tissue expression of inflammatory cytokines, increased "}, "t": {"pos": [3, 4], "type": null, "name": "adiponectin  expression and improved glucose tolerance parallel to insulin sensitivity in obese mice."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Culture of HepG2 cells with ", "griseofulvin", " has now been shown to induce both the formation of intracellular aggregates containing ", "K18", " as well as an increase in the abundance of K18 mRNA."], "h": {"pos": [1, 2], "type": null, "name": "griseofulvin  has now been shown to induce both the formation of intracellular aggregates containing "}, "t": {"pos": [3, 4], "type": null, "name": "K18  as well as an increase in the abundance of K18 mRNA."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Insulin", " secretion stimulated by both 200 \u03bcM tolbutamide and 20 \u03bcM ", "gliclazide", ", concentrations that had equivalent effects on membrane potential, was inhibited by thapsigargin (1 \u03bcM) or the L-type Ca(2+) channel blocker nicardipine (2 \u03bcM) and was potentiated by 8-pCPT-2'-O-Me-cAMP-AM at concentrations \u22652 \u03bcM in INS-1 cells."], "h": {"pos": [1, 2], "type": null, "name": "Insulin  secretion stimulated by both 200 \u03bcM tolbutamide and 20 \u03bcM "}, "t": {"pos": [3, 4], "type": null, "name": "gliclazide , concentrations that had equivalent effects on membrane potential, was inhibited by thapsigargin (1 \u03bcM) or the L-type Ca(2+) channel blocker nicardipine (2 \u03bcM) and was potentiated by 8-pCPT-2'-O-Me-cAMP-AM at concentrations \u22652 \u03bcM in INS-1 cells."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Furthermore, substance P (SP) concentration in the acini and expression of SP gene (", "preprotachykinin-A", ", PPT-A) and neurokinin-1 receptor (NK-1R), the primary receptor for SP, are increased in secretagogue ", "caerulein", "-treated acinar cells."], "h": {"pos": [1, 2], "type": null, "name": "preprotachykinin-A , PPT-A) and neurokinin-1 receptor (NK-1R), the primary receptor for SP, are increased in secretagogue "}, "t": {"pos": [3, 4], "type": null, "name": "caerulein -treated acinar cells."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The upregulation of ", "calpain", ", tBid and caspase-3 activity were further inhibited by treatment with EGTA in the presence of ", "ALD", "."], "h": {"pos": [1, 2], "type": null, "name": "calpain , tBid and caspase-3 activity were further inhibited by treatment with EGTA in the presence of "}, "t": {"pos": [3, 4], "type": null, "name": "ALD ."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Upon co-exposure to ", "V(5+)", " and TCDD, V(5+) significantly potentiated the TCDD-mediated induction of the Cyp1a1, Cyp1a2, and ", "Cyp1b1", " mRNA, protein, and catalytic activity levels at 24\u00a0h."], "h": {"pos": [1, 2], "type": null, "name": "V(5+)  and TCDD, V(5+) significantly potentiated the TCDD-mediated induction of the Cyp1a1, Cyp1a2, and "}, "t": {"pos": [3, 4], "type": null, "name": "Cyp1b1  mRNA, protein, and catalytic activity levels at 24\u00a0h."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Thiazolidinediones", " are a new class of anti-diabetic agents which increase insulin sensitivity by binding to the peroxisome proliferator-activated receptor gamma (PPAR(gamma)) and stimulating the expression of ", "insulin", "-responsive genes involved in glucose and lipid metabolism."], "h": {"pos": [1, 2], "type": null, "name": "Thiazolidinediones  are a new class of anti-diabetic agents which increase insulin sensitivity by binding to the peroxisome proliferator-activated receptor gamma (PPAR(gamma)) and stimulating the expression of "}, "t": {"pos": [3, 4], "type": null, "name": "insulin -responsive genes involved in glucose and lipid metabolism."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Phenobarbital", " (PB), a typical CAR activator, increased the gene expression of HIF-target genes in the livers of mice, including ", "erythropoietin", ", heme oxygenase-1 and vascular endothelial growth factor-a."], "h": {"pos": [1, 2], "type": null, "name": "Phenobarbital  (PB), a typical CAR activator, increased the gene expression of HIF-target genes in the livers of mice, including "}, "t": {"pos": [3, 4], "type": null, "name": "erythropoietin , heme oxygenase-1 and vascular endothelial growth factor-a."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Epi", " increased both WNT6/Wnt6 and ", "Cav1", " expression in human GC cells and within the tumor area of a murine model of GC (CEA424-SV40 TAg)."], "h": {"pos": [1, 2], "type": null, "name": "Epi  increased both WNT6/Wnt6 and "}, "t": {"pos": [3, 4], "type": null, "name": "Cav1  expression in human GC cells and within the tumor area of a murine model of GC (CEA424-SV40 TAg)."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Type I deiodinase, liver fatty-acid binding protein and cytochrome P450 (CYP) 3A37 mRNA levels were significantly induced by TCPP, while ", "TDCPP", " induced CYP3A37 and ", "CYP2H1", "."], "h": {"pos": [1, 2], "type": null, "name": "TDCPP  induced CYP3A37 and "}, "t": {"pos": [3, 4], "type": null, "name": "CYP2H1 ."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["Expression of L-type pyruvate kinase (", "L-PK", ") is upregulated in the liver by dietary ", "carbohydrate", "."], "h": {"pos": [1, 2], "type": null, "name": "L-PK ) is upregulated in the liver by dietary "}, "t": {"pos": [3, 4], "type": null, "name": "carbohydrate ."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["I3A induced a higher level of secretion of the inflammatory cytokine ", "interleukin 6", " compared with ", "PMA", " in the WEHI-231 cells and displayed a marked biphasic dose-response curve for the induction."], "h": {"pos": [1, 2], "type": null, "name": "interleukin 6  compared with "}, "t": {"pos": [3, 4], "type": null, "name": "PMA  in the WEHI-231 cells and displayed a marked biphasic dose-response curve for the induction."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["There was also an increase in ", "c-kit", ", Trio, Rho-A, Rac-3, EGFR, Notch-4, Dvl-2, Ezrin, beta catenin and mutant p53 protein expression in the ", "parathion", "-treated cells."], "h": {"pos": [1, 2], "type": null, "name": "c-kit , Trio, Rho-A, Rac-3, EGFR, Notch-4, Dvl-2, Ezrin, beta catenin and mutant p53 protein expression in the "}, "t": {"pos": [3, 4], "type": null, "name": "parathion -treated cells."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["", "Thiazolidinediones", " are a new class of anti-diabetic agents which increase ", "insulin", " sensitivity by binding to the peroxisome proliferator-activated receptor gamma (PPAR(gamma)) and stimulating the expression of insulin-responsive genes involved in glucose and lipid metabolism."], "h": {"pos": [1, 2], "type": null, "name": "Thiazolidinediones  are a new class of anti-diabetic agents which increase "}, "t": {"pos": [3, 4], "type": null, "name": "insulin  sensitivity by binding to the peroxisome proliferator-activated receptor gamma (PPAR(gamma)) and stimulating the expression of insulin-responsive genes involved in glucose and lipid metabolism."}}
{"relation": "INDIRECT-UPREGULATOR", "token": ["The ", "hemoglobin A1c", " (HbA1c) of all patients improved significantly from 8.1\u00b11.2% to 7.6\u00b11.1% after 12 weeks of add-on therapy with ", "sitagliptin", " (p<0.01), and the insulin dosage was reduced from 27.3\u00b115.8 U/day to 24.5\u00b116.5 U/day (p<0.001)."], "h": {"pos": [1, 2], "type": null, "name": "hemoglobin A1c  (HbA1c) of all patients improved significantly from 8.1\u00b11.2% to 7.6\u00b11.1% after 12 weeks of add-on therapy with "}, "t": {"pos": [3, 4], "type": null, "name": "sitagliptin  (p<0.01), and the insulin dosage was reduced from 27.3\u00b115.8 U/day to 24.5\u00b116.5 U/day (p<0.001)."}}
{"relation": "UPREGULATOR", "token": ["Moreover, BH(4) treatment of the fructose-fed rats markedly reduced the lipid peroxide content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors, ", "nuclear factor-kappaB", " and activating protein-1, which were increased in ", "fructose", "-fed rats."], "h": {"pos": [1, 2], "type": null, "name": "nuclear factor-kappaB  and activating protein-1, which were increased in "}, "t": {"pos": [3, 4], "type": null, "name": "fructose -fed rats."}}
{"relation": "UPREGULATOR", "token": ["Analysis of splice variants and site-directed mutants of the AMPA receptor GluR3 expressed in Xenopus oocytes has shown that lithium produces a large potentiation of the ", "GluR3 flop", " splice variant and suggested that ", "lithium", " might inhibit rapid desensitization, which is characteristic of this receptor (Karkanias, N. and Papke, R., Subtype-specific effects of lithium on glutamate receptor function. J. Neurophysiol., 81 (1999) 1506-1512)."], "h": {"pos": [1, 2], "type": null, "name": "GluR3 flop  splice variant and suggested that "}, "t": {"pos": [3, 4], "type": null, "name": "lithium  might inhibit rapid desensitization, which is characteristic of this receptor (Karkanias, N. and Papke, R., Subtype-specific effects of lithium on glutamate receptor function. J. Neurophysiol., 81 (1999) 1506-1512)."}}
{"relation": "UPREGULATOR", "token": ["Moreover, BH(4) treatment of the ", "fructose", "-fed rats markedly reduced the lipid peroxide content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors, nuclear factor-kappaB and ", "activating protein-1", ", which were increased in fructose-fed rats."], "h": {"pos": [1, 2], "type": null, "name": "fructose -fed rats markedly reduced the lipid peroxide content of both aortic and cardiac tissues and inhibited the activation of 2 redox-sensitive transcription factors, nuclear factor-kappaB and "}, "t": {"pos": [3, 4], "type": null, "name": "activating protein-1 , which were increased in fructose-fed rats."}}
{"relation": "UPREGULATOR", "token": ["Treatment of A549 and H1299 cells with ", "dioscin", " caused a dose-dependent increase in ERK1/2 and ", "JNK1/2", " activity, accompanied with a decreased PI3K expression and decreased phosphorylation of Akt and mTOR."], "h": {"pos": [1, 2], "type": null, "name": "dioscin  caused a dose-dependent increase in ERK1/2 and "}, "t": {"pos": [3, 4], "type": null, "name": "JNK1/2  activity, accompanied with a decreased PI3K expression and decreased phosphorylation of Akt and mTOR."}}
{"relation": "UPREGULATOR", "token": ["", "All-trans retinoic acid", " protects hepatocellular carcinoma cells against serum-starvation-induced cell death by upregulating ", "collagen 8A2", "."], "h": {"pos": [1, 2], "type": null, "name": "All-trans retinoic acid  protects hepatocellular carcinoma cells against serum-starvation-induced cell death by upregulating "}, "t": {"pos": [3, 4], "type": null, "name": "collagen 8A2 ."}}
{"relation": "UPREGULATOR", "token": ["Further, 5HHMF increased specific DNA-binding activity of Nrf2, and transient knockdown with ", "Nrf2", " siRNA subsequently reversed ", "5HHMF", "-induced NO inhibition, which was followed by suppression of HO-1 activity."], "h": {"pos": [1, 2], "type": null, "name": "Nrf2  siRNA subsequently reversed "}, "t": {"pos": [3, 4], "type": null, "name": "5HHMF -induced NO inhibition, which was followed by suppression of HO-1 activity."}}
{"relation": "UPREGULATOR", "token": ["", "CGP 12177A", " mediates cardiostimulation by activation of the 'putative' beta(4)-adrenoceptor; however, it has recently been reported that disruption of the ", "beta(1)-adrenoceptor", " gene abolishes this effect."], "h": {"pos": [1, 2], "type": null, "name": "CGP 12177A  mediates cardiostimulation by activation of the 'putative' beta(4)-adrenoceptor; however, it has recently been reported that disruption of the "}, "t": {"pos": [3, 4], "type": null, "name": "beta(1)-adrenoceptor  gene abolishes this effect."}}
{"relation": "UPREGULATOR", "token": ["The results showed that administration of ", "AlCl3", " resulted in a significant elevation in the levels of ", "AchE", " activity, CRP, NF-\u03baB, and MCP-1 accompanied with a significant depletion in the Ach level."], "h": {"pos": [1, 2], "type": null, "name": "AlCl3  resulted in a significant elevation in the levels of "}, "t": {"pos": [3, 4], "type": null, "name": "AchE  activity, CRP, NF-\u03baB, and MCP-1 accompanied with a significant depletion in the Ach level."}}
{"relation": "UPREGULATOR", "token": ["The results showed that (1) 15mg/kg body weight PhIP induced obvious histopathological changes in gastric mucosa; (2) ", "PhIP", " (10 and/or 15mg/kg) significantly decreased superoxide dismutase (SOD) and glutathioneperoxidase (GPx) activities, while increased catalase (", "CAT", ") activity compared with the control."], "h": {"pos": [1, 2], "type": null, "name": "PhIP  (10 and/or 15mg/kg) significantly decreased superoxide dismutase (SOD) and glutathioneperoxidase (GPx) activities, while increased catalase ("}, "t": {"pos": [3, 4], "type": null, "name": "CAT ) activity compared with the control."}}
{"relation": "UPREGULATOR", "token": ["Evidence has accumulated in the last few years that the expression of the ", "microsomal/peroxidase antigen", " (M/TPO-Ag) in thyroid cells is induced by TSH, through pathways which involve intracellular ", "cAMP", " accumulation and protein synthesis."], "h": {"pos": [1, 2], "type": null, "name": "microsomal/peroxidase antigen  (M/TPO-Ag) in thyroid cells is induced by TSH, through pathways which involve intracellular "}, "t": {"pos": [3, 4], "type": null, "name": "cAMP  accumulation and protein synthesis."}}
{"relation": "UPREGULATOR", "token": ["", "Ribonucleotide reductase", " activity was found to be strongly increased in the ", "gemcitabine", "-selected line and purine nucleoside phosphorylase was increased in the 2-chlorodeoxyadenosine-selected line."], "h": {"pos": [1, 2], "type": null, "name": "Ribonucleotide reductase  activity was found to be strongly increased in the "}, "t": {"pos": [3, 4], "type": null, "name": "gemcitabine -selected line and purine nucleoside phosphorylase was increased in the 2-chlorodeoxyadenosine-selected line."}}
{"relation": "UPREGULATOR", "token": ["Although the treatment with MSG increased IRS-1 tyrosine phosphorylation (", "pIRS-1", ") by 96\u00a0% (MSG, 17.02\u00a0\u00b1\u00a00.6; control, 8.7\u00a0\u00b1\u00a00.2\u00a0a.u.), exercise training also increased it in both groups (control, 13.6\u00a0\u00b1\u00a00.1; ", "MSG", ", 22.2\u00a0\u00b1\u00a01.1\u00a0a.u.)."], "h": {"pos": [1, 2], "type": null, "name": "pIRS-1 ) by 96\u00a0% (MSG, 17.02\u00a0\u00b1\u00a00.6; control, 8.7\u00a0\u00b1\u00a00.2\u00a0a.u.), exercise training also increased it in both groups (control, 13.6\u00a0\u00b1\u00a00.1; "}, "t": {"pos": [3, 4], "type": null, "name": "MSG , 22.2\u00a0\u00b1\u00a01.1\u00a0a.u.)."}}
{"relation": "UPREGULATOR", "token": ["Addition of ", "putrescine", " restored the induction of apoptosis as indicated by an increase in the number of detached cells and ", "caspase 3", " activity."], "h": {"pos": [1, 2], "type": null, "name": "putrescine  restored the induction of apoptosis as indicated by an increase in the number of detached cells and "}, "t": {"pos": [3, 4], "type": null, "name": "caspase 3  activity."}}
{"relation": "UPREGULATOR", "token": ["Differences in magnitude of Na(+)-dependent ", "l-alanine", " uptake through ASCT2 between WKY and SHR PTE cells correlated positively with differences in ", "ASCT2", " protein expression, this being more abundant in WKY PTE cells."], "h": {"pos": [1, 2], "type": null, "name": "l-alanine  uptake through ASCT2 between WKY and SHR PTE cells correlated positively with differences in "}, "t": {"pos": [3, 4], "type": null, "name": "ASCT2  protein expression, this being more abundant in WKY PTE cells."}}
{"relation": "UPREGULATOR", "token": ["Further, ", "5HHMF", " increased specific DNA-binding activity of Nrf2, and transient knockdown with ", "Nrf2", " siRNA subsequently reversed 5HHMF-induced NO inhibition, which was followed by suppression of HO-1 activity."], "h": {"pos": [1, 2], "type": null, "name": "5HHMF  increased specific DNA-binding activity of Nrf2, and transient knockdown with "}, "t": {"pos": [3, 4], "type": null, "name": "Nrf2  siRNA subsequently reversed 5HHMF-induced NO inhibition, which was followed by suppression of HO-1 activity."}}
{"relation": "UPREGULATOR", "token": ["Saturated ", "palmitic and stearic acids", " increased ceramides, up-regulated ", "PTP1B", ", and had AKt and PTP1B phosphorylation at Ser 50 impaired."], "h": {"pos": [1, 2], "type": null, "name": "palmitic and stearic acids  increased ceramides, up-regulated "}, "t": {"pos": [3, 4], "type": null, "name": "PTP1B , and had AKt and PTP1B phosphorylation at Ser 50 impaired."}}
{"relation": "UPREGULATOR", "token": ["Although the treatment with ", "MSG", " increased IRS-1 tyrosine phosphorylation (", "pIRS-1", ") by 96\u00a0% (MSG, 17.02\u00a0\u00b1\u00a00.6; control, 8.7\u00a0\u00b1\u00a00.2\u00a0a.u.), exercise training also increased it in both groups (control, 13.6\u00a0\u00b1\u00a00.1; MSG, 22.2\u00a0\u00b1\u00a01.1\u00a0a.u.)."], "h": {"pos": [1, 2], "type": null, "name": "MSG  increased IRS-1 tyrosine phosphorylation ("}, "t": {"pos": [3, 4], "type": null, "name": "pIRS-1 ) by 96\u00a0% (MSG, 17.02\u00a0\u00b1\u00a00.6; control, 8.7\u00a0\u00b1\u00a00.2\u00a0a.u.), exercise training also increased it in both groups (control, 13.6\u00a0\u00b1\u00a00.1; MSG, 22.2\u00a0\u00b1\u00a01.1\u00a0a.u.)."}}
{"relation": "UPREGULATOR", "token": ["Withdrawal from free-choice ", "ethanol", " consumption results in increased packing density of ", "glutamine synthetase", "-immunoreactive astrocytes in the prelimbic cortex of alcohol-preferring rats."], "h": {"pos": [1, 2], "type": null, "name": "ethanol  consumption results in increased packing density of "}, "t": {"pos": [3, 4], "type": null, "name": "glutamine synthetase -immunoreactive astrocytes in the prelimbic cortex of alcohol-preferring rats."}}
{"relation": "UPREGULATOR", "token": ["Upon co-exposure to V(5+) and ", "TCDD", ", V(5+) significantly potentiated the TCDD-mediated induction of the Cyp1a1, Cyp1a2, and ", "Cyp1b1", " mRNA, protein, and catalytic activity levels at 24\u00a0h."], "h": {"pos": [1, 2], "type": null, "name": "TCDD , V(5+) significantly potentiated the TCDD-mediated induction of the Cyp1a1, Cyp1a2, and "}, "t": {"pos": [3, 4], "type": null, "name": "Cyp1b1  mRNA, protein, and catalytic activity levels at 24\u00a0h."}}
{"relation": "UPREGULATOR", "token": ["The positive correlation between vitamin A and immunoglobulin A concentrations might be the result of the ", "vitamin A", " inductive effect during ", "immunoglobulins A", " synthesis."], "h": {"pos": [1, 2], "type": null, "name": "vitamin A  inductive effect during "}, "t": {"pos": [3, 4], "type": null, "name": "immunoglobulins A  synthesis."}}
{"relation": "UPREGULATOR", "token": ["db/db mice treated with ", "DRF 2655", " showed 5- and 3.6-fold inhibition in phosphoenolpyruvate carboxykinase and glucose 6-phosphatase activity and 651% and 77% increases in the beta-oxidation enzymes carnitine palmitoyltransferase and ", "carnitine acetyltransferase", ", respectively."], "h": {"pos": [1, 2], "type": null, "name": "DRF 2655  showed 5- and 3.6-fold inhibition in phosphoenolpyruvate carboxykinase and glucose 6-phosphatase activity and 651% and 77% increases in the beta-oxidation enzymes carnitine palmitoyltransferase and "}, "t": {"pos": [3, 4], "type": null, "name": "carnitine acetyltransferase , respectively."}}
{"relation": "UPREGULATOR", "token": ["", "Pinosylvin", " inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, c-Myc, and retinoblastoma protein (pRb), and the upregulation of p21(WAF1/CIP1) and ", "p53", "."], "h": {"pos": [1, 2], "type": null, "name": "Pinosylvin  inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, c-Myc, and retinoblastoma protein (pRb), and the upregulation of p21(WAF1/CIP1) and "}, "t": {"pos": [3, 4], "type": null, "name": "p53 ."}}
{"relation": "UPREGULATOR", "token": ["", "CYP1A1", " and CYP1A2 mRNAs were also increased by pelargonidin in three primary human hepatocytes cultures (approximately 5% of ", "TCDD", " potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme."], "h": {"pos": [1, 2], "type": null, "name": "CYP1A1  and CYP1A2 mRNAs were also increased by pelargonidin in three primary human hepatocytes cultures (approximately 5% of "}, "t": {"pos": [3, 4], "type": null, "name": "TCDD  potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme."}}
{"relation": "UPREGULATOR", "token": ["Pretreatment with dexamethasone significantly suppressed nasal allergy-like behaviors, up-regulation of histamine content, HDC activity and ", "HDC", " mRNA induced by TDI in ", "TDI", "-sensitized rats."], "h": {"pos": [1, 2], "type": null, "name": "HDC  mRNA induced by TDI in "}, "t": {"pos": [3, 4], "type": null, "name": "TDI -sensitized rats."}}
{"relation": "UPREGULATOR", "token": ["In conclusion, immortalized SHR and WKY PTE cells take up l-alanine mainly through a high-affinity ", "Na(+)", "-dependent amino acid transporter, with functional features of ", "ASCT2", " transport."], "h": {"pos": [1, 2], "type": null, "name": "Na(+) -dependent amino acid transporter, with functional features of "}, "t": {"pos": [3, 4], "type": null, "name": "ASCT2  transport."}}
{"relation": "UPREGULATOR", "token": ["Crocin (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of ", "Bax", "/Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by ", "DZN", "."], "h": {"pos": [1, 2], "type": null, "name": "Bax /Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by "}, "t": {"pos": [3, 4], "type": null, "name": "DZN ."}}
{"relation": "UPREGULATOR", "token": ["It has been reported that oligomeric ", "procyanidins", " of lotus seedpod (LSOPC) is effective in the alleviation of Alzheimer's disease and diabetes through its antioxidant and ", "insulin", "-potentiating activities."], "h": {"pos": [1, 2], "type": null, "name": "procyanidins  of lotus seedpod (LSOPC) is effective in the alleviation of Alzheimer's disease and diabetes through its antioxidant and "}, "t": {"pos": [3, 4], "type": null, "name": "insulin -potentiating activities."}}
{"relation": "UPREGULATOR", "token": ["Upon co-exposure to V(5+) and ", "TCDD", ", V(5+) significantly potentiated the TCDD-mediated induction of the Cyp1a1, ", "Cyp1a2", ", and Cyp1b1 mRNA, protein, and catalytic activity levels at 24\u00a0h."], "h": {"pos": [1, 2], "type": null, "name": "TCDD , V(5+) significantly potentiated the TCDD-mediated induction of the Cyp1a1, "}, "t": {"pos": [3, 4], "type": null, "name": "Cyp1a2 , and Cyp1b1 mRNA, protein, and catalytic activity levels at 24\u00a0h."}}
{"relation": "UPREGULATOR", "token": ["Ribonucleotide reductase activity was found to be strongly increased in the gemcitabine-selected line and ", "purine nucleoside phosphorylase", " was increased in the ", "2-chlorodeoxyadenosine", "-selected line."], "h": {"pos": [1, 2], "type": null, "name": "purine nucleoside phosphorylase  was increased in the "}, "t": {"pos": [3, 4], "type": null, "name": "2-chlorodeoxyadenosine -selected line."}}
{"relation": "UPREGULATOR", "token": ["", "Pinosylvin", " inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, c-Myc, and retinoblastoma protein (pRb), and the upregulation of ", "p21", "(WAF1/CIP1) and p53."], "h": {"pos": [1, 2], "type": null, "name": "Pinosylvin  inhibited the proliferation of HCT 116 cells by arresting transition of cell cycle from G1 to S phase along with the downregulation of cyclin D1, cyclin E, cyclin A, cyclin dependent kinase 2 (CDK2), CDK4, c-Myc, and retinoblastoma protein (pRb), and the upregulation of "}, "t": {"pos": [3, 4], "type": null, "name": "p21 (WAF1/CIP1) and p53."}}
{"relation": "UPREGULATOR", "token": ["G6pc2 deletion resulted in a leftward shift in the dose-response curve for ", "glucose", "-stimulated ", "insulin", " secretion (GSIS)."], "h": {"pos": [1, 2], "type": null, "name": "glucose -stimulated "}, "t": {"pos": [3, 4], "type": null, "name": "insulin  secretion (GSIS)."}}
{"relation": "UPREGULATOR", "token": ["CYP1A1 and CYP1A2 mRNAs were also increased by ", "pelargonidin", " in three primary human hepatocytes cultures (approximately 5% of TCDD potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of ", "CYP1A1", " enzyme."], "h": {"pos": [1, 2], "type": null, "name": "pelargonidin  in three primary human hepatocytes cultures (approximately 5% of TCDD potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of "}, "t": {"pos": [3, 4], "type": null, "name": "CYP1A1  enzyme."}}
{"relation": "UPREGULATOR", "token": ["db/db mice treated with ", "DRF 2655", " showed 5- and 3.6-fold inhibition in phosphoenolpyruvate carboxykinase and glucose 6-phosphatase activity and 651% and 77% increases in the beta-oxidation enzymes ", "carnitine palmitoyltransferase", " and carnitine acetyltransferase, respectively."], "h": {"pos": [1, 2], "type": null, "name": "DRF 2655  showed 5- and 3.6-fold inhibition in phosphoenolpyruvate carboxykinase and glucose 6-phosphatase activity and 651% and 77% increases in the beta-oxidation enzymes "}, "t": {"pos": [3, 4], "type": null, "name": "carnitine palmitoyltransferase  and carnitine acetyltransferase, respectively."}}
{"relation": "UPREGULATOR", "token": ["Evidence has accumulated in the last few years that the expression of the microsomal/peroxidase antigen (", "M/TPO-Ag", ") in thyroid cells is induced by TSH, through pathways which involve intracellular ", "cAMP", " accumulation and protein synthesis."], "h": {"pos": [1, 2], "type": null, "name": "M/TPO-Ag ) in thyroid cells is induced by TSH, through pathways which involve intracellular "}, "t": {"pos": [3, 4], "type": null, "name": "cAMP  accumulation and protein synthesis."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Genistin decreased myosin light chain kinase (MLCK) protein contents and MLCK mRNA expression in IJS, and inhibited both phosphorylation and Mg(2+)-ATPase activity of purified myosin, implicating that the decrease of ", "MLCK", " contents and inhibition of MLCK activity are involved in the ", "genistin", "-induced inhibitory effects."], "h": {"pos": [1, 2], "type": null, "name": "MLCK  contents and inhibition of MLCK activity are involved in the "}, "t": {"pos": [3, 4], "type": null, "name": "genistin -induced inhibitory effects."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Gemfibrozil", ", a lipid-lowering drug, inhibited cytokine-induced production of NO and the expression of inducible nitric-oxide synthase (", "iNOS", ") in human U373MG astroglial cells and primary astrocytes."], "h": {"pos": [1, 2], "type": null, "name": "Gemfibrozil , a lipid-lowering drug, inhibited cytokine-induced production of NO and the expression of inducible nitric-oxide synthase ("}, "t": {"pos": [3, 4], "type": null, "name": "iNOS ) in human U373MG astroglial cells and primary astrocytes."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In conclusion, we find that ", "sinapic acid", " exhibits hepatoprotective and antifibrotic effects against DMN-induced liver injury, most likely due to its antioxidant activities of scavenging radicals, its capacity to suppress ", "TGF-\u03b21", " and its ability to attenuate activation of hepatic stellate cells."], "h": {"pos": [1, 2], "type": null, "name": "sinapic acid  exhibits hepatoprotective and antifibrotic effects against DMN-induced liver injury, most likely due to its antioxidant activities of scavenging radicals, its capacity to suppress "}, "t": {"pos": [3, 4], "type": null, "name": "TGF-\u03b21  and its ability to attenuate activation of hepatic stellate cells."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Brain tissue analyses revealed that neonatal ", "quinpirole", " treatment produced a significant decrease in hippocampal NGF, ", "BDNF", " and ChAT that was eliminated by olanzapine treatment."], "h": {"pos": [1, 2], "type": null, "name": "quinpirole  treatment produced a significant decrease in hippocampal NGF, "}, "t": {"pos": [3, 4], "type": null, "name": "BDNF  and ChAT that was eliminated by olanzapine treatment."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Additionally, ", "AIF", " levels in the cytosol decreased due to ", "EGTA", " but not due to calpeptin."], "h": {"pos": [1, 2], "type": null, "name": "AIF  levels in the cytosol decreased due to "}, "t": {"pos": [3, 4], "type": null, "name": "EGTA  but not due to calpeptin."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Furthermore, treatment with ", "spironoclactone", " not only attenuated the pro-apoptotic effect of ALD but reversed the ALD-induced increase of ", "calpain", " and AIF levels."], "h": {"pos": [1, 2], "type": null, "name": "spironoclactone  not only attenuated the pro-apoptotic effect of ALD but reversed the ALD-induced increase of "}, "t": {"pos": [3, 4], "type": null, "name": "calpain  and AIF levels."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Conversely, AMPK inhibitor ", "compound C", " or GSK3\u03b2 inhibitor SB216763 blocked the cleavages of PARP and ", "caspase 3", " induced by ursolic acid in HepG2 cells."], "h": {"pos": [1, 2], "type": null, "name": "compound C  or GSK3\u03b2 inhibitor SB216763 blocked the cleavages of PARP and "}, "t": {"pos": [3, 4], "type": null, "name": "caspase 3  induced by ursolic acid in HepG2 cells."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Subsequently, ", "pinosylvin", " suppressed the nuclear translocation of \u03b2-catenin, one of downstream molecules of PI3K/Akt/GSK-3\u03b2 signaling, and these events led to the sequential downregulation of \u03b2-catenin-mediated transcription of target genes including BMP4, ID2, ", "survivin", ", cyclin D1, MMP7, and c-Myc."], "h": {"pos": [1, 2], "type": null, "name": "pinosylvin  suppressed the nuclear translocation of \u03b2-catenin, one of downstream molecules of PI3K/Akt/GSK-3\u03b2 signaling, and these events led to the sequential downregulation of \u03b2-catenin-mediated transcription of target genes including BMP4, ID2, "}, "t": {"pos": [3, 4], "type": null, "name": "survivin , cyclin D1, MMP7, and c-Myc."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Curcumin", " improves TNBS-induced colitis in rats by inhibiting ", "IL-27", " expression via the TLR4/NF-\u03baB signaling pathway."], "h": {"pos": [1, 2], "type": null, "name": "Curcumin  improves TNBS-induced colitis in rats by inhibiting "}, "t": {"pos": [3, 4], "type": null, "name": "IL-27  expression via the TLR4/NF-\u03baB signaling pathway."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Subsequently, ", "pinosylvin", " suppressed the nuclear translocation of \u03b2-catenin, one of downstream molecules of PI3K/Akt/GSK-3\u03b2 signaling, and these events led to the sequential downregulation of \u03b2-catenin-mediated transcription of target genes including ", "BMP4", ", ID2, survivin, cyclin D1, MMP7, and c-Myc."], "h": {"pos": [1, 2], "type": null, "name": "pinosylvin  suppressed the nuclear translocation of \u03b2-catenin, one of downstream molecules of PI3K/Akt/GSK-3\u03b2 signaling, and these events led to the sequential downregulation of \u03b2-catenin-mediated transcription of target genes including "}, "t": {"pos": [3, 4], "type": null, "name": "BMP4 , ID2, survivin, cyclin D1, MMP7, and c-Myc."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Interestingly, two categories of clones were distinguished based on the effects of GCS on IL-2 production and IL-2R alpha expression and proliferation; 1) In low IL-2 producers ", "DEX", " blocked IL-2 production and decreased ", "IL-2R alpha", " expression and proliferation; 2) In high IL-2 producers DEX inhibited IL-2 production partially and enhanced IL-2R alpha expression and proliferation."], "h": {"pos": [1, 2], "type": null, "name": "DEX  blocked IL-2 production and decreased "}, "t": {"pos": [3, 4], "type": null, "name": "IL-2R alpha  expression and proliferation; 2) In high IL-2 producers DEX inhibited IL-2 production partially and enhanced IL-2R alpha expression and proliferation."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Inhibition of MCP-1 and ", "MIP-2", " transcription and translation by ", "mimosine", " in muscle tissue infected with the parasite Trichinella spiralis."], "h": {"pos": [1, 2], "type": null, "name": "MIP-2  transcription and translation by "}, "t": {"pos": [3, 4], "type": null, "name": "mimosine  in muscle tissue infected with the parasite Trichinella spiralis."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Western blot analysis revealed that ", "OMT", " decreased the expression of ", "Bax", " and repaired the balance of pro- and anti-apoptotic proteins."], "h": {"pos": [1, 2], "type": null, "name": "OMT  decreased the expression of "}, "t": {"pos": [3, 4], "type": null, "name": "Bax  and repaired the balance of pro- and anti-apoptotic proteins."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Interestingly, two categories of clones were distinguished based on the effects of GCS on IL-2 production and IL-2R alpha expression and proliferation; 1) In low IL-2 producers ", "DEX", " blocked ", "IL-2", " production and decreased IL-2R alpha expression and proliferation; 2) In high IL-2 producers DEX inhibited IL-2 production partially and enhanced IL-2R alpha expression and proliferation."], "h": {"pos": [1, 2], "type": null, "name": "DEX  blocked "}, "t": {"pos": [3, 4], "type": null, "name": "IL-2  production and decreased IL-2R alpha expression and proliferation; 2) In high IL-2 producers DEX inhibited IL-2 production partially and enhanced IL-2R alpha expression and proliferation."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In the in vitro assay, ", "kinsenoside", " (20 and 50\u03bcg/mL) markedly inhibited changes in various biochemical substances (nitric oxide (NO), lactic dehydrogenase (LDH), superoxide dismutase (SOD), and catalase (", "CAT", ")) in human umbilical vein endothelial cells (HUVECs) damaged by high glucose (35mM) and restored vascular endothelial structure by balancing the matrix metalloproteinases-the tissue inhibitors of matrix metalloproteinases (MMP-TIMP) system."], "h": {"pos": [1, 2], "type": null, "name": "kinsenoside  (20 and 50\u03bcg/mL) markedly inhibited changes in various biochemical substances (nitric oxide (NO), lactic dehydrogenase (LDH), superoxide dismutase (SOD), and catalase ("}, "t": {"pos": [3, 4], "type": null, "name": "CAT )) in human umbilical vein endothelial cells (HUVECs) damaged by high glucose (35mM) and restored vascular endothelial structure by balancing the matrix metalloproteinases-the tissue inhibitors of matrix metalloproteinases (MMP-TIMP) system."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Similar to gemfibrozil, ", "clofibrate", ", another fibrate drug, also inhibited the expression of ", "iNOS", "."], "h": {"pos": [1, 2], "type": null, "name": "clofibrate , another fibrate drug, also inhibited the expression of "}, "t": {"pos": [3, 4], "type": null, "name": "iNOS ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["These effects were fully counteracted by dietary ", "phenolics", " which inhibited ROS overproduction and GSH consumption, rendered the reactive transcription of glutathione-associated enzymes unnecessary and blocked the intracellular signals leading to the overexpression and rearrangement of ", "p66Shc", " signalling molecule."], "h": {"pos": [1, 2], "type": null, "name": "phenolics  which inhibited ROS overproduction and GSH consumption, rendered the reactive transcription of glutathione-associated enzymes unnecessary and blocked the intracellular signals leading to the overexpression and rearrangement of "}, "t": {"pos": [3, 4], "type": null, "name": "p66Shc  signalling molecule."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Our results demonstrated that ", "auranofin", " suppressed TLR4-mediated activation of transcription factors, NF-kappaB and IRF3, and expression of ", "COX-2", ", a pro-inflammatory enzyme."], "h": {"pos": [1, 2], "type": null, "name": "auranofin  suppressed TLR4-mediated activation of transcription factors, NF-kappaB and IRF3, and expression of "}, "t": {"pos": [3, 4], "type": null, "name": "COX-2 , a pro-inflammatory enzyme."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In conclusion, the production of IL-4 and ", "IL-5", " by T-cell clones (derived either from BAL or blood) was more sensitive to inhibition by ", "DEX", " than that of IFN-gamma, which may account for the therapeutic effects of glucocorticosteroids in patients with asthma."], "h": {"pos": [1, 2], "type": null, "name": "IL-5  by T-cell clones (derived either from BAL or blood) was more sensitive to inhibition by "}, "t": {"pos": [3, 4], "type": null, "name": "DEX  than that of IFN-gamma, which may account for the therapeutic effects of glucocorticosteroids in patients with asthma."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Disruption of contact inhibition, which was induced by toxic AhR ligands 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or ", "polycyclic aromatic hydrocarbons", " in epithelial WB-F344 cells, reduced ", "Cx43", " protein levels, possibly via enhanced proteasomal degradation, significantly decreased the amount of gap junction plaques and downregulated GJIC, in an AhR-dependent manner."], "h": {"pos": [1, 2], "type": null, "name": "polycyclic aromatic hydrocarbons  in epithelial WB-F344 cells, reduced "}, "t": {"pos": [3, 4], "type": null, "name": "Cx43  protein levels, possibly via enhanced proteasomal degradation, significantly decreased the amount of gap junction plaques and downregulated GJIC, in an AhR-dependent manner."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Disruption of contact inhibition, which was induced by toxic AhR ligands 2,3,7,8-tetrachlorodibenzo-p-dioxin (", "TCDD", ") or polycyclic aromatic hydrocarbons in epithelial WB-F344 cells, reduced ", "Cx43", " protein levels, possibly via enhanced proteasomal degradation, significantly decreased the amount of gap junction plaques and downregulated GJIC, in an AhR-dependent manner."], "h": {"pos": [1, 2], "type": null, "name": "TCDD ) or polycyclic aromatic hydrocarbons in epithelial WB-F344 cells, reduced "}, "t": {"pos": [3, 4], "type": null, "name": "Cx43  protein levels, possibly via enhanced proteasomal degradation, significantly decreased the amount of gap junction plaques and downregulated GJIC, in an AhR-dependent manner."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Compared with the untreated colitis group, the ", "curcumin", "-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-\u03baB mRNA, IL-27 mRNA, TLR4 protein, ", "NF-\u03baB", " p65 protein, and IL-27 p28 protein (p < 0.05)."], "h": {"pos": [1, 2], "type": null, "name": "curcumin -treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-\u03baB mRNA, IL-27 mRNA, TLR4 protein, "}, "t": {"pos": [3, 4], "type": null, "name": "NF-\u03baB  p65 protein, and IL-27 p28 protein (p < 0.05)."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["HbA1c level in DM12W group was higher than in DM4W group, ", "HbA1c", " level in ", "EtOH", "+DM8W group was lower than in DM8W group."], "h": {"pos": [1, 2], "type": null, "name": "HbA1c  level in "}, "t": {"pos": [3, 4], "type": null, "name": "EtOH +DM8W group was lower than in DM8W group."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Thus, ", "sorafenib", " may inhibit tumor growth by a dual mechanism, acting either directly on the tumor (through inhibition of Raf and ", "Kit", " signaling) and/or on tumor angiogenesis (through inhibition of VEGFR and PDGFR signaling)."], "h": {"pos": [1, 2], "type": null, "name": "sorafenib  may inhibit tumor growth by a dual mechanism, acting either directly on the tumor (through inhibition of Raf and "}, "t": {"pos": [3, 4], "type": null, "name": "Kit  signaling) and/or on tumor angiogenesis (through inhibition of VEGFR and PDGFR signaling)."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Results showed that neonatal quinpirole treatment induced ", "D2", " priming that was eliminated by ", "olanzapine", " treatment."], "h": {"pos": [1, 2], "type": null, "name": "D2  priming that was eliminated by "}, "t": {"pos": [3, 4], "type": null, "name": "olanzapine  treatment."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Inhibition > 90% of ", "IL-2", " secretion was observed at 1 microM BPB and 10 microM ", "AACOCF3", " compared to the respective vehicle control."], "h": {"pos": [1, 2], "type": null, "name": "IL-2  secretion was observed at 1 microM BPB and 10 microM "}, "t": {"pos": [3, 4], "type": null, "name": "AACOCF3  compared to the respective vehicle control."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Ginseng total saponins, ", "ginsenosides Rb2, Rg1 and Rd", " administered intraperitoneally attenuated the immobilization stress-induced increase in plasma ", "IL-6", " level."], "h": {"pos": [1, 2], "type": null, "name": "ginsenosides Rb2, Rg1 and Rd  administered intraperitoneally attenuated the immobilization stress-induced increase in plasma "}, "t": {"pos": [3, 4], "type": null, "name": "IL-6  level."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In support of the hypothesis that TCDD decreases canonical Wnt signaling, we identify inhibitory effects of TCDD on multiple components of the canonical Wnt signaling pathway in the UGS that temporally coincide with the inhibitory effect of ", "TCDD", " on prostatic bud formation: (1) expression of R-spondins (", "Rspo2", " and Rspo3) that promote canonical Wnt signaling is reduced; (2) expression of Lef1, Tcf1, and Wif1, established canonical Wnt target genes, is decreased; (3) expression of Lgr5, a RSPO receptor that activates canonical Wnt signaling, is reduced; and (4) expression of Dickkopfs (Dkks), inhibitors of canonical Wnt signaling, is not increased by TCDD."], "h": {"pos": [1, 2], "type": null, "name": "TCDD  on prostatic bud formation: (1) expression of R-spondins ("}, "t": {"pos": [3, 4], "type": null, "name": "Rspo2  and Rspo3) that promote canonical Wnt signaling is reduced; (2) expression of Lef1, Tcf1, and Wif1, established canonical Wnt target genes, is decreased; (3) expression of Lgr5, a RSPO receptor that activates canonical Wnt signaling, is reduced; and (4) expression of Dickkopfs (Dkks), inhibitors of canonical Wnt signaling, is not increased by TCDD."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The IC50 values for ", "Gli1", " mRNA inhibition in the tumor and skin by ", "TAK-441", " were estimated to be 0.0457 and 0.113 \u03bcg/ml, respectively."], "h": {"pos": [1, 2], "type": null, "name": "Gli1  mRNA inhibition in the tumor and skin by "}, "t": {"pos": [3, 4], "type": null, "name": "TAK-441  were estimated to be 0.0457 and 0.113 \u03bcg/ml, respectively."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The mRNA levels of microphthalmia-associated transcription factor (MITF) and its downstream genes ", "tyrosinase", ", tyrosinase-related protein (TRP)-1, and TRP-2 were reduced by ", "artemisinic acid", " treatment."], "h": {"pos": [1, 2], "type": null, "name": "tyrosinase , tyrosinase-related protein (TRP)-1, and TRP-2 were reduced by "}, "t": {"pos": [3, 4], "type": null, "name": "artemisinic acid  treatment."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Thalidomide", " reduced COX-2 expression accompanied by a decrease of bcl-2 protein, TNFalpha, ", "VEGF", ", GSH and an increased cytochrome c, but had no effect on that of COX-1, in MCF-7 and HL-60."], "h": {"pos": [1, 2], "type": null, "name": "Thalidomide  reduced COX-2 expression accompanied by a decrease of bcl-2 protein, TNFalpha, "}, "t": {"pos": [3, 4], "type": null, "name": "VEGF , GSH and an increased cytochrome c, but had no effect on that of COX-1, in MCF-7 and HL-60."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Moreover, attempts to elucidate a possible mechanism underlying the artemisinic acid-mediated effects revealed that ", "artemisinic acid", " regulated melanogenesis by inhibiting cholesterol synthesis through downregulation of the ", "hydroxymethylglutaryl CoA (HMG CoA) reductase", " gene, which was mediated through reduced expression of the CCAAT/enhancer-binding protein (C/EBP) \u03b1 gene."], "h": {"pos": [1, 2], "type": null, "name": "artemisinic acid  regulated melanogenesis by inhibiting cholesterol synthesis through downregulation of the "}, "t": {"pos": [3, 4], "type": null, "name": "hydroxymethylglutaryl CoA (HMG CoA) reductase  gene, which was mediated through reduced expression of the CCAAT/enhancer-binding protein (C/EBP) \u03b1 gene."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Sulindac sulfide", " inhibited ", "14-3-3epsilon proteins", " in HT-29 and DLD-1 cells in a time- and concentration-dependent manner."], "h": {"pos": [1, 2], "type": null, "name": "Sulindac sulfide  inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "14-3-3epsilon proteins  in HT-29 and DLD-1 cells in a time- and concentration-dependent manner."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "CP[c]Ph", " has, comparably to B[a]P, a potential to repress expression of ", "tumor suppressor p53", ", in the head kidney of rainbow trout."], "h": {"pos": [1, 2], "type": null, "name": "CP[c]Ph  has, comparably to B[a]P, a potential to repress expression of "}, "t": {"pos": [3, 4], "type": null, "name": "tumor suppressor p53 , in the head kidney of rainbow trout."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Transduction with constitutively active forms of GSK-3\u03b2 could protect against the downregulation of ", "p65", " and upregulation of cleaved-PARP that are induced by ", "cinobufagin", " treatment."], "h": {"pos": [1, 2], "type": null, "name": "p65  and upregulation of cleaved-PARP that are induced by "}, "t": {"pos": [3, 4], "type": null, "name": "cinobufagin  treatment."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The mRNA levels of microphthalmia-associated transcription factor (MITF) and its downstream genes tyrosinase, ", "tyrosinase-related protein (TRP)-1", ", and TRP-2 were reduced by ", "artemisinic acid", " treatment."], "h": {"pos": [1, 2], "type": null, "name": "tyrosinase-related protein (TRP)-1 , and TRP-2 were reduced by "}, "t": {"pos": [3, 4], "type": null, "name": "artemisinic acid  treatment."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The ability of ", "sulindac", " to block ", "ERK1/2", " signaling by the EGF receptor may account for at least part of its potent growth-inhibitory effects against cancer cells."], "h": {"pos": [1, 2], "type": null, "name": "sulindac  to block "}, "t": {"pos": [3, 4], "type": null, "name": "ERK1/2  signaling by the EGF receptor may account for at least part of its potent growth-inhibitory effects against cancer cells."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Taken together, these data demonstrated that PLA2 inhibitors BPB and ", "AACOCF3", " are robust inhibitors of ", "IL-2", " expression at both the mRNA and protein levels in murine splenocytes."], "h": {"pos": [1, 2], "type": null, "name": "AACOCF3  are robust inhibitors of "}, "t": {"pos": [3, 4], "type": null, "name": "IL-2  expression at both the mRNA and protein levels in murine splenocytes."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Pretreatment of the splenocytes with both BPB and ", "AACOCF3", " suppressed phorbol 12-myristate 13-acetate plus ionomycin-induced ", "IL-2", " secretion in a concentration-dependent manner."], "h": {"pos": [1, 2], "type": null, "name": "AACOCF3  suppressed phorbol 12-myristate 13-acetate plus ionomycin-induced "}, "t": {"pos": [3, 4], "type": null, "name": "IL-2  secretion in a concentration-dependent manner."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The selective PDE 4 inhibitors, and to a certain extent the PDE3 inhibitors ", "amrinone", " and milrinone, reduced the ", "GM-CSF", " release in a concentration dependent manner."], "h": {"pos": [1, 2], "type": null, "name": "amrinone  and milrinone, reduced the "}, "t": {"pos": [3, 4], "type": null, "name": "GM-CSF  release in a concentration dependent manner."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Inhibition of mTOR by low dose ", "rapamycin", " decreases HG-induced ", "Nox4", " and Nox1, NADPH oxidase activity and podocyte apoptosis."], "h": {"pos": [1, 2], "type": null, "name": "rapamycin  decreases HG-induced "}, "t": {"pos": [3, 4], "type": null, "name": "Nox4  and Nox1, NADPH oxidase activity and podocyte apoptosis."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Additionally, the expression of hepatic fibrosis-related factors such as \u03b1-smooth muscle actin and ", "transforming growth factor-\u03b21", " (TGF-\u03b21), were reduced in rats treated with ", "sinapic acid", "."], "h": {"pos": [1, 2], "type": null, "name": "transforming growth factor-\u03b21  (TGF-\u03b21), were reduced in rats treated with "}, "t": {"pos": [3, 4], "type": null, "name": "sinapic acid ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In human blood, the tested glucocorticoids ", "beclomethasone", ", dexamethasone and fluticasone inhibited the LPS induced ", "TNF", " release potently in a concentration dependent manner, whereas in dispersed human nasal polyp cells, the effect of the glucocorticoids on allergically induced TNF release, with the exception of dexamethasone, was much less pronounced."], "h": {"pos": [1, 2], "type": null, "name": "beclomethasone , dexamethasone and fluticasone inhibited the LPS induced "}, "t": {"pos": [3, 4], "type": null, "name": "TNF  release potently in a concentration dependent manner, whereas in dispersed human nasal polyp cells, the effect of the glucocorticoids on allergically induced TNF release, with the exception of dexamethasone, was much less pronounced."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In conclusion, the production of ", "IL-4", " and IL-5 by T-cell clones (derived either from BAL or blood) was more sensitive to inhibition by ", "DEX", " than that of IFN-gamma, which may account for the therapeutic effects of glucocorticosteroids in patients with asthma."], "h": {"pos": [1, 2], "type": null, "name": "IL-4  and IL-5 by T-cell clones (derived either from BAL or blood) was more sensitive to inhibition by "}, "t": {"pos": [3, 4], "type": null, "name": "DEX  than that of IFN-gamma, which may account for the therapeutic effects of glucocorticosteroids in patients with asthma."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Also, ", "SB365", " showed anti-angiogenic activity by decreasing the expression of HIF-1\u03b1 and ", "VEGF", "."], "h": {"pos": [1, 2], "type": null, "name": "SB365  showed anti-angiogenic activity by decreasing the expression of HIF-1\u03b1 and "}, "t": {"pos": [3, 4], "type": null, "name": "VEGF ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["We found that ", "PSE", " inhibits ", "interleukin-2", " (IL-2) and tumor necrosis factor (TNF) alpha-gene transcription in stimulated Jurkat cells, a human T-cell leukemia cell line."], "h": {"pos": [1, 2], "type": null, "name": "PSE  inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "interleukin-2  (IL-2) and tumor necrosis factor (TNF) alpha-gene transcription in stimulated Jurkat cells, a human T-cell leukemia cell line."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In support of the hypothesis that TCDD decreases canonical Wnt signaling, we identify inhibitory effects of TCDD on multiple components of the canonical Wnt signaling pathway in the UGS that temporally coincide with the inhibitory effect of ", "TCDD", " on prostatic bud formation: (1) expression of R-spondins (Rspo2 and Rspo3) that promote canonical Wnt signaling is reduced; (2) expression of Lef1, ", "Tcf1", ", and Wif1, established canonical Wnt target genes, is decreased; (3) expression of Lgr5, a RSPO receptor that activates canonical Wnt signaling, is reduced; and (4) expression of Dickkopfs (Dkks), inhibitors of canonical Wnt signaling, is not increased by TCDD."], "h": {"pos": [1, 2], "type": null, "name": "TCDD  on prostatic bud formation: (1) expression of R-spondins (Rspo2 and Rspo3) that promote canonical Wnt signaling is reduced; (2) expression of Lef1, "}, "t": {"pos": [3, 4], "type": null, "name": "Tcf1 , and Wif1, established canonical Wnt target genes, is decreased; (3) expression of Lgr5, a RSPO receptor that activates canonical Wnt signaling, is reduced; and (4) expression of Dickkopfs (Dkks), inhibitors of canonical Wnt signaling, is not increased by TCDD."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Inhibition of p95ErbB2, p185ErbB2, and EGFR phosphorylation by ", "GW572016", " resulted in the inhibition of downstream phospho-", "Erk1/2", ", phospho-AKT, and cyclin D steady-state protein levels."], "h": {"pos": [1, 2], "type": null, "name": "GW572016  resulted in the inhibition of downstream phospho-"}, "t": {"pos": [3, 4], "type": null, "name": "Erk1/2 , phospho-AKT, and cyclin D steady-state protein levels."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Likewise, ", "IL-2", " steady-state mRNA expression was inhibited by both PLA2 inhibitors in a concentration-dependent fashion with > 90% inhibition at 1 microM BPB and 20 microM ", "AACOCF3", "."], "h": {"pos": [1, 2], "type": null, "name": "IL-2  steady-state mRNA expression was inhibited by both PLA2 inhibitors in a concentration-dependent fashion with > 90% inhibition at 1 microM BPB and 20 microM "}, "t": {"pos": [3, 4], "type": null, "name": "AACOCF3 ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["FCEO significantly inhibited nitric oxide (", "NO", ") and prostaglandin E2 (PGE2) by suppressing the protein expression of ", "inducible nitric oxide synthase", " (iNOS) and cyclooxygenase (COX)-2, respectively."], "h": {"pos": [1, 2], "type": null, "name": "NO ) and prostaglandin E2 (PGE2) by suppressing the protein expression of "}, "t": {"pos": [3, 4], "type": null, "name": "inducible nitric oxide synthase  (iNOS) and cyclooxygenase (COX)-2, respectively."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Pinosylvin", " was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and ", "phosphoinositide 3-kinase", " (PI3K)/Akt/ glycogen synthase kinase 3\u03b2 (GSK-3\u03b2) signaling pathway."], "h": {"pos": [1, 2], "type": null, "name": "Pinosylvin  was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and "}, "t": {"pos": [3, 4], "type": null, "name": "phosphoinositide 3-kinase  (PI3K)/Akt/ glycogen synthase kinase 3\u03b2 (GSK-3\u03b2) signaling pathway."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Crocin", " (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of ", "Bax", "/Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN."], "h": {"pos": [1, 2], "type": null, "name": "Crocin  (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of "}, "t": {"pos": [3, 4], "type": null, "name": "Bax /Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The inhibition of ", "UG", " synthesis and PR down-regulation by ", "5 alpha-NET", " and 3 beta,5 alpha-NET indicates that these NET metabolites possess antiprogestational properties."], "h": {"pos": [1, 2], "type": null, "name": "UG  synthesis and PR down-regulation by "}, "t": {"pos": [3, 4], "type": null, "name": "5 alpha-NET  and 3 beta,5 alpha-NET indicates that these NET metabolites possess antiprogestational properties."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Inhibition of SIRT1 significantly increased vascular superoxide production, enhanced ", "NADPH oxidase", " activity, and mRNA expression of its subunits p22(phox) and NOX4, which were prevented by ", "resveratrol", "."], "h": {"pos": [1, 2], "type": null, "name": "NADPH oxidase  activity, and mRNA expression of its subunits p22(phox) and NOX4, which were prevented by "}, "t": {"pos": [3, 4], "type": null, "name": "resveratrol ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Furthermore, treatment with ", "spironoclactone", " not only attenuated the pro-apoptotic effect of ALD but reversed the ALD-induced increase of calpain and ", "AIF", " levels."], "h": {"pos": [1, 2], "type": null, "name": "spironoclactone  not only attenuated the pro-apoptotic effect of ALD but reversed the ALD-induced increase of calpain and "}, "t": {"pos": [3, 4], "type": null, "name": "AIF  levels."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Genistin", " decreased myosin light chain kinase (", "MLCK", ") protein contents and MLCK mRNA expression in IJS, and inhibited both phosphorylation and Mg(2+)-ATPase activity of purified myosin, implicating that the decrease of MLCK contents and inhibition of MLCK activity are involved in the genistin-induced inhibitory effects."], "h": {"pos": [1, 2], "type": null, "name": "Genistin  decreased myosin light chain kinase ("}, "t": {"pos": [3, 4], "type": null, "name": "MLCK ) protein contents and MLCK mRNA expression in IJS, and inhibited both phosphorylation and Mg(2+)-ATPase activity of purified myosin, implicating that the decrease of MLCK contents and inhibition of MLCK activity are involved in the genistin-induced inhibitory effects."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Selective precipitation of cytosol receptors with 36% ", "(NH4)2SO4", " reduced ", "CBG", " concentrations to negligible levels."], "h": {"pos": [1, 2], "type": null, "name": "(NH4)2SO4  reduced "}, "t": {"pos": [3, 4], "type": null, "name": "CBG  concentrations to negligible levels."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["FCEO significantly inhibited nitric oxide (NO) and prostaglandin E2 (", "PGE2", ") by suppressing the protein expression of inducible nitric oxide synthase (iNOS) and ", "cyclooxygenase (COX)-2", ", respectively."], "h": {"pos": [1, 2], "type": null, "name": "PGE2 ) by suppressing the protein expression of inducible nitric oxide synthase (iNOS) and "}, "t": {"pos": [3, 4], "type": null, "name": "cyclooxygenase (COX)-2 , respectively."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In support of the hypothesis that TCDD decreases canonical Wnt signaling, we identify inhibitory effects of TCDD on multiple components of the canonical Wnt signaling pathway in the UGS that temporally coincide with the inhibitory effect of ", "TCDD", " on prostatic bud formation: (1) expression of ", "R-spondins", " (Rspo2 and Rspo3) that promote canonical Wnt signaling is reduced; (2) expression of Lef1, Tcf1, and Wif1, established canonical Wnt target genes, is decreased; (3) expression of Lgr5, a RSPO receptor that activates canonical Wnt signaling, is reduced; and (4) expression of Dickkopfs (Dkks), inhibitors of canonical Wnt signaling, is not increased by TCDD."], "h": {"pos": [1, 2], "type": null, "name": "TCDD  on prostatic bud formation: (1) expression of "}, "t": {"pos": [3, 4], "type": null, "name": "R-spondins  (Rspo2 and Rspo3) that promote canonical Wnt signaling is reduced; (2) expression of Lef1, Tcf1, and Wif1, established canonical Wnt target genes, is decreased; (3) expression of Lgr5, a RSPO receptor that activates canonical Wnt signaling, is reduced; and (4) expression of Dickkopfs (Dkks), inhibitors of canonical Wnt signaling, is not increased by TCDD."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Sulindac sulfide", " inhibited PPARdelta protein expression and ", "PPARdelta", " transcriptional activity."], "h": {"pos": [1, 2], "type": null, "name": "Sulindac sulfide  inhibited PPARdelta protein expression and "}, "t": {"pos": [3, 4], "type": null, "name": "PPARdelta  transcriptional activity."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Both ", "BB-94", " and captopril also prevented substrate degradation by ", "gelatinase A and B", " released in conditioned medium by cultured cells."], "h": {"pos": [1, 2], "type": null, "name": "BB-94  and captopril also prevented substrate degradation by "}, "t": {"pos": [3, 4], "type": null, "name": "gelatinase A and B  released in conditioned medium by cultured cells."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Inhibition of SIRT1 significantly increased vascular superoxide production, enhanced NADPH oxidase activity, and mRNA expression of its subunits ", "p22(phox)", " and NOX4, which were prevented by ", "resveratrol", "."], "h": {"pos": [1, 2], "type": null, "name": "p22(phox)  and NOX4, which were prevented by "}, "t": {"pos": [3, 4], "type": null, "name": "resveratrol ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In addition to this evidence (for the involvement of EP2 receptors), evidence for the involvement of EP1 receptors in the PGE1 mediated stimulation of ", "Na,K-ATPase beta", " subunit gene transcription includes the stimulatory effect of 17-phenyl trinor PGE2, as well as the inhibitory effects of ", "SC-51089", "."], "h": {"pos": [1, 2], "type": null, "name": "Na,K-ATPase beta  subunit gene transcription includes the stimulatory effect of 17-phenyl trinor PGE2, as well as the inhibitory effects of "}, "t": {"pos": [3, 4], "type": null, "name": "SC-51089 ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In addition, ", "BGG", "-mediated inhibition of AR prevented LPS-induced activation of JNK and ", "p38", " and lowered ROS levels, which could inhibit LPS-induced apoptosis."], "h": {"pos": [1, 2], "type": null, "name": "BGG -mediated inhibition of AR prevented LPS-induced activation of JNK and "}, "t": {"pos": [3, 4], "type": null, "name": "p38  and lowered ROS levels, which could inhibit LPS-induced apoptosis."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In muscle and liver, ", "TCDD", " (10 ng/kg/day) induced increases in methylation and decreases in mRNA expression of ", "Igf2r", "."], "h": {"pos": [1, 2], "type": null, "name": "TCDD  (10 ng/kg/day) induced increases in methylation and decreases in mRNA expression of "}, "t": {"pos": [3, 4], "type": null, "name": "Igf2r ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Moreover, protein and mRNA levels of DSS-induced proinflammatory cytokines in colon, including TNF-\u03b1, IL-1\u03b2, IL-18, ", "IL-17A", " and IFN-\u03b3, were markedly suppressed by ", "Fc11a-2", "."], "h": {"pos": [1, 2], "type": null, "name": "IL-17A  and IFN-\u03b3, were markedly suppressed by "}, "t": {"pos": [3, 4], "type": null, "name": "Fc11a-2 ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Prostacyclin", " analogues inhibit ", "tissue factor", " expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism."], "h": {"pos": [1, 2], "type": null, "name": "Prostacyclin  analogues inhibit "}, "t": {"pos": [3, 4], "type": null, "name": "tissue factor  expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Phospholipase A2 inhibitors ", "p-bromophenacyl bromide", " and arachidonyl trifluoromethyl ketone suppressed ", "interleukin-2", " (IL-2) expression in murine primary splenocytes."], "h": {"pos": [1, 2], "type": null, "name": "p-bromophenacyl bromide  and arachidonyl trifluoromethyl ketone suppressed "}, "t": {"pos": [3, 4], "type": null, "name": "interleukin-2  (IL-2) expression in murine primary splenocytes."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The inhibition of UG synthesis and ", "PR", " down-regulation by 5 alpha-NET and ", "3 beta,5 alpha-NET", " indicates that these NET metabolites possess antiprogestational properties."], "h": {"pos": [1, 2], "type": null, "name": "PR  down-regulation by 5 alpha-NET and "}, "t": {"pos": [3, 4], "type": null, "name": "3 beta,5 alpha-NET  indicates that these NET metabolites possess antiprogestational properties."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Dexamethasone", " (DXM) decreased the expression of ", "CXCL-8", ", VEGF, and iNOS induced by reIL-4, while 1400W dihydrochloride (1400W), a selective inhibitor of iNOS, decreased the expression of E-selectin, VEGF, and iNOS."], "h": {"pos": [1, 2], "type": null, "name": "Dexamethasone  (DXM) decreased the expression of "}, "t": {"pos": [3, 4], "type": null, "name": "CXCL-8 , VEGF, and iNOS induced by reIL-4, while 1400W dihydrochloride (1400W), a selective inhibitor of iNOS, decreased the expression of E-selectin, VEGF, and iNOS."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In contrast to adrenaline and ", "somatostatin", ", galanin, another inhibitor of ", "insulin", " secretion, reduced Ca2+ currents by about 40% in a pertussis toxin-insensitive manner."], "h": {"pos": [1, 2], "type": null, "name": "somatostatin , galanin, another inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "insulin  secretion, reduced Ca2+ currents by about 40% in a pertussis toxin-insensitive manner."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Dexamethasone (DXM) decreased the expression of CXCL-8, VEGF, and iNOS induced by reIL-4, while 1400W dihydrochloride (", "1400W", "), a selective inhibitor of iNOS, decreased the expression of ", "E-selectin", ", VEGF, and iNOS."], "h": {"pos": [1, 2], "type": null, "name": "1400W ), a selective inhibitor of iNOS, decreased the expression of "}, "t": {"pos": [3, 4], "type": null, "name": "E-selectin , VEGF, and iNOS."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Moreover, attempts to elucidate a possible mechanism underlying the artemisinic acid-mediated effects revealed that ", "artemisinic acid", " regulated melanogenesis by inhibiting cholesterol synthesis through downregulation of the hydroxymethylglutaryl CoA (HMG CoA) reductase gene, which was mediated through reduced expression of the ", "CCAAT/enhancer-binding protein (C/EBP) \u03b1", " gene."], "h": {"pos": [1, 2], "type": null, "name": "artemisinic acid  regulated melanogenesis by inhibiting cholesterol synthesis through downregulation of the hydroxymethylglutaryl CoA (HMG CoA) reductase gene, which was mediated through reduced expression of the "}, "t": {"pos": [3, 4], "type": null, "name": "CCAAT/enhancer-binding protein (C/EBP) \u03b1  gene."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["These results indicate that ", "phillyrin", " prevents lipid accumulation in HepG2 cells by blocking the expression of ", "SREBP-1c", " and FAS through LKB1/AMPK activation, suggesting that phillyrin is a novel AMPK activator with a role in the prevention and treatment of obesity."], "h": {"pos": [1, 2], "type": null, "name": "phillyrin  prevents lipid accumulation in HepG2 cells by blocking the expression of "}, "t": {"pos": [3, 4], "type": null, "name": "SREBP-1c  and FAS through LKB1/AMPK activation, suggesting that phillyrin is a novel AMPK activator with a role in the prevention and treatment of obesity."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Pinosylvin", " was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/", "extracellular signal-regulated kinase", " (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/Akt/ glycogen synthase kinase 3\u03b2 (GSK-3\u03b2) signaling pathway."], "h": {"pos": [1, 2], "type": null, "name": "Pinosylvin  was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/"}, "t": {"pos": [3, 4], "type": null, "name": "extracellular signal-regulated kinase  (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/Akt/ glycogen synthase kinase 3\u03b2 (GSK-3\u03b2) signaling pathway."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "HSYA", " suppressed the expression of TLR-4, Myd88, ICAM-1, TNF\u03b1, ", "IL-1\u03b2", " and IL-6 at the mRNA and protein level, and inhibited the adhesion of leukocytes to A549 cells."], "h": {"pos": [1, 2], "type": null, "name": "HSYA  suppressed the expression of TLR-4, Myd88, ICAM-1, TNF\u03b1, "}, "t": {"pos": [3, 4], "type": null, "name": "IL-1\u03b2  and IL-6 at the mRNA and protein level, and inhibited the adhesion of leukocytes to A549 cells."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "TCDD", " decreased the expression of the glucose transporter, ", "SLC2A1", ", and most of the glycolytic transcripts, followed by decreases in glycolytic intermediates, including pyruvate."], "h": {"pos": [1, 2], "type": null, "name": "TCDD  decreased the expression of the glucose transporter, "}, "t": {"pos": [3, 4], "type": null, "name": "SLC2A1 , and most of the glycolytic transcripts, followed by decreases in glycolytic intermediates, including pyruvate."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Sulindac sulfide", " inhibited ", "PPARdelta", " protein expression and PPARdelta transcriptional activity."], "h": {"pos": [1, 2], "type": null, "name": "Sulindac sulfide  inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "PPARdelta  protein expression and PPARdelta transcriptional activity."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Additionally, the mRNA levels of melanogenesis-related genes (c-KIT, ", "stem cell factor", " (SCF), and macrophage migration inhibitory factor (MIF)) were down-regulated by ", "artemisinic acid", "."], "h": {"pos": [1, 2], "type": null, "name": "stem cell factor  (SCF), and macrophage migration inhibitory factor (MIF)) were down-regulated by "}, "t": {"pos": [3, 4], "type": null, "name": "artemisinic acid ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Compared with the untreated colitis group, the ", "curcumin", "-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-\u03baB mRNA, ", "IL-27", " mRNA, TLR4 protein, NF-\u03baB p65 protein, and IL-27 p28 protein (p < 0.05)."], "h": {"pos": [1, 2], "type": null, "name": "curcumin -treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-\u03baB mRNA, "}, "t": {"pos": [3, 4], "type": null, "name": "IL-27  mRNA, TLR4 protein, NF-\u03baB p65 protein, and IL-27 p28 protein (p < 0.05)."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Western blotting demonstrated that ", "DMBT", " effectively suppressed the expression of VEGF, p-VEGFR-2, p-EGFR, and ", "p-Akt", "."], "h": {"pos": [1, 2], "type": null, "name": "DMBT  effectively suppressed the expression of VEGF, p-VEGFR-2, p-EGFR, and "}, "t": {"pos": [3, 4], "type": null, "name": "p-Akt ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The selective PDE 4 inhibitors, and to a certain extent the PDE3 inhibitors amrinone and ", "milrinone", ", reduced the ", "GM-CSF", " release in a concentration dependent manner."], "h": {"pos": [1, 2], "type": null, "name": "milrinone , reduced the "}, "t": {"pos": [3, 4], "type": null, "name": "GM-CSF  release in a concentration dependent manner."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["IRF3 activation induced by MyD88-independent signaling components, ", "TRIF", " and TBK1, was also downregulated by ", "auranofin", "."], "h": {"pos": [1, 2], "type": null, "name": "TRIF  and TBK1, was also downregulated by "}, "t": {"pos": [3, 4], "type": null, "name": "auranofin ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Thus, the ", "TCDD", "-induced reduction in canonical ", "Wnt", " signaling is associated with a decrease in activators (Rspo2 and Rspo3) rather than an increase in inhibitors (Dkk1 and Dkk2) of the pathway."], "h": {"pos": [1, 2], "type": null, "name": "TCDD -induced reduction in canonical "}, "t": {"pos": [3, 4], "type": null, "name": "Wnt  signaling is associated with a decrease in activators (Rspo2 and Rspo3) rather than an increase in inhibitors (Dkk1 and Dkk2) of the pathway."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["As add-on therapy in patients with suboptimal glycaemic control despite oral antihyperglycaemic treatment, sitagliptin improved ", "HbA(1c)", " to a significantly greater extent than placebo when added to metformin or pioglitazone and was noninferior to glipizide when added to ", "metformin", "."], "h": {"pos": [1, 2], "type": null, "name": "HbA(1c)  to a significantly greater extent than placebo when added to metformin or pioglitazone and was noninferior to glipizide when added to "}, "t": {"pos": [3, 4], "type": null, "name": "metformin ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Inhibition of mTOR by low dose ", "rapamycin", " decreases HG-induced Nox4 and ", "Nox1", ", NADPH oxidase activity and podocyte apoptosis."], "h": {"pos": [1, 2], "type": null, "name": "rapamycin  decreases HG-induced Nox4 and "}, "t": {"pos": [3, 4], "type": null, "name": "Nox1 , NADPH oxidase activity and podocyte apoptosis."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Moreover, recent in vitro studies suggest that ", "memantine", " abrogates beta-amyloid (Abeta) toxicity and possibly inhibits ", "Abeta", " production."], "h": {"pos": [1, 2], "type": null, "name": "memantine  abrogates beta-amyloid (Abeta) toxicity and possibly inhibits "}, "t": {"pos": [3, 4], "type": null, "name": "Abeta  production."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Pinosylvin", " was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/", "Akt", "/ glycogen synthase kinase 3\u03b2 (GSK-3\u03b2) signaling pathway."], "h": {"pos": [1, 2], "type": null, "name": "Pinosylvin  was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (PI3K)/"}, "t": {"pos": [3, 4], "type": null, "name": "Akt / glycogen synthase kinase 3\u03b2 (GSK-3\u03b2) signaling pathway."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Moreover, protein and mRNA levels of DSS-induced proinflammatory ", "cytokines", " in colon, including TNF-\u03b1, IL-1\u03b2, IL-18, IL-17A and IFN-\u03b3, were markedly suppressed by ", "Fc11a-2", "."], "h": {"pos": [1, 2], "type": null, "name": "cytokines  in colon, including TNF-\u03b1, IL-1\u03b2, IL-18, IL-17A and IFN-\u03b3, were markedly suppressed by "}, "t": {"pos": [3, 4], "type": null, "name": "Fc11a-2 ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Cotreatment with U0126 and YC-1 synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of ", "sulindac", " treatment on ERK1/2, JNK, and ", "beta-catenin", "."], "h": {"pos": [1, 2], "type": null, "name": "sulindac  treatment on ERK1/2, JNK, and "}, "t": {"pos": [3, 4], "type": null, "name": "beta-catenin ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "TAS-102", " is a novel drug containing trifluorothymidine, which is phosphorylated by TK-1 to its active monophosphated form, that in turn can inhibit ", "TS", "."], "h": {"pos": [1, 2], "type": null, "name": "TAS-102  is a novel drug containing trifluorothymidine, which is phosphorylated by TK-1 to its active monophosphated form, that in turn can inhibit "}, "t": {"pos": [3, 4], "type": null, "name": "TS ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Fisetin", " treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), NF-kB ", "p65", " unit (in pancreas) and IL-1\u03b2 (plasma), serum nitric oxide (NO) with an elevation in plasma insulin."], "h": {"pos": [1, 2], "type": null, "name": "Fisetin  treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), NF-kB "}, "t": {"pos": [3, 4], "type": null, "name": "p65  unit (in pancreas) and IL-1\u03b2 (plasma), serum nitric oxide (NO) with an elevation in plasma insulin."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Genistin", " decreased ", "myosin light chain kinase", " (MLCK) protein contents and MLCK mRNA expression in IJS, and inhibited both phosphorylation and Mg(2+)-ATPase activity of purified myosin, implicating that the decrease of MLCK contents and inhibition of MLCK activity are involved in the genistin-induced inhibitory effects."], "h": {"pos": [1, 2], "type": null, "name": "Genistin  decreased "}, "t": {"pos": [3, 4], "type": null, "name": "myosin light chain kinase  (MLCK) protein contents and MLCK mRNA expression in IJS, and inhibited both phosphorylation and Mg(2+)-ATPase activity of purified myosin, implicating that the decrease of MLCK contents and inhibition of MLCK activity are involved in the genistin-induced inhibitory effects."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Subsequently, ", "pinosylvin", " suppressed the nuclear translocation of \u03b2-catenin, one of downstream molecules of PI3K/Akt/GSK-3\u03b2 signaling, and these events led to the sequential downregulation of \u03b2-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, ", "MMP7", ", and c-Myc."], "h": {"pos": [1, 2], "type": null, "name": "pinosylvin  suppressed the nuclear translocation of \u03b2-catenin, one of downstream molecules of PI3K/Akt/GSK-3\u03b2 signaling, and these events led to the sequential downregulation of \u03b2-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, "}, "t": {"pos": [3, 4], "type": null, "name": "MMP7 , and c-Myc."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Additionally, ", "MPTP", " significantly down-regulated ", "Bcl-2", " expression in the mitochondria of dopaminergic cells in the SN, followed by an increase in Bax expression, cytochrome C translocation to the cytosol, andcleaved-caspase-3 expression, whereas these were inhibited by CRE or EB treatment."], "h": {"pos": [1, 2], "type": null, "name": "MPTP  significantly down-regulated "}, "t": {"pos": [3, 4], "type": null, "name": "Bcl-2  expression in the mitochondria of dopaminergic cells in the SN, followed by an increase in Bax expression, cytochrome C translocation to the cytosol, andcleaved-caspase-3 expression, whereas these were inhibited by CRE or EB treatment."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "TCDD", " decreased the expression of the ", "glucose transporter", ", SLC2A1, and most of the glycolytic transcripts, followed by decreases in glycolytic intermediates, including pyruvate."], "h": {"pos": [1, 2], "type": null, "name": "TCDD  decreased the expression of the "}, "t": {"pos": [3, 4], "type": null, "name": "glucose transporter , SLC2A1, and most of the glycolytic transcripts, followed by decreases in glycolytic intermediates, including pyruvate."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In the in vitro assay, ", "kinsenoside", " (20 and 50\u03bcg/mL) markedly inhibited changes in various biochemical substances (nitric oxide (NO), ", "lactic dehydrogenase", " (LDH), superoxide dismutase (SOD), and catalase (CAT)) in human umbilical vein endothelial cells (HUVECs) damaged by high glucose (35mM) and restored vascular endothelial structure by balancing the matrix metalloproteinases-the tissue inhibitors of matrix metalloproteinases (MMP-TIMP) system."], "h": {"pos": [1, 2], "type": null, "name": "kinsenoside  (20 and 50\u03bcg/mL) markedly inhibited changes in various biochemical substances (nitric oxide (NO), "}, "t": {"pos": [3, 4], "type": null, "name": "lactic dehydrogenase  (LDH), superoxide dismutase (SOD), and catalase (CAT)) in human umbilical vein endothelial cells (HUVECs) damaged by high glucose (35mM) and restored vascular endothelial structure by balancing the matrix metalloproteinases-the tissue inhibitors of matrix metalloproteinases (MMP-TIMP) system."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Catalpol", " also suppressed AGE-induced phosphorylation of mitogen activated protein (MAP) kinases, degradation of ", "I\u03baB\u03b1", " and the nuclear localization of NF-\u03baB."], "h": {"pos": [1, 2], "type": null, "name": "Catalpol  also suppressed AGE-induced phosphorylation of mitogen activated protein (MAP) kinases, degradation of "}, "t": {"pos": [3, 4], "type": null, "name": "I\u03baB\u03b1  and the nuclear localization of NF-\u03baB."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Also, ", "SB365", " showed anti-angiogenic activity by decreasing the expression of ", "HIF-1\u03b1", " and VEGF."], "h": {"pos": [1, 2], "type": null, "name": "SB365  showed anti-angiogenic activity by decreasing the expression of "}, "t": {"pos": [3, 4], "type": null, "name": "HIF-1\u03b1  and VEGF."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Thalidomide", " reduced COX-2 expression accompanied by a decrease of bcl-2 protein, ", "TNFalpha", ", VEGF, GSH and an increased cytochrome c, but had no effect on that of COX-1, in MCF-7 and HL-60."], "h": {"pos": [1, 2], "type": null, "name": "Thalidomide  reduced COX-2 expression accompanied by a decrease of bcl-2 protein, "}, "t": {"pos": [3, 4], "type": null, "name": "TNFalpha , VEGF, GSH and an increased cytochrome c, but had no effect on that of COX-1, in MCF-7 and HL-60."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In addition, we found that ", "neoechinulin A", " significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor-\u03b1 (TNF-\u03b1), interleukin-1\u03b2 (IL-1\u03b2), ", "interleukin-6", " (IL-6), and prostaglandin E2 (PGE2) in activated BV-2 cells."], "h": {"pos": [1, 2], "type": null, "name": "neoechinulin A  significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor-\u03b1 (TNF-\u03b1), interleukin-1\u03b2 (IL-1\u03b2), "}, "t": {"pos": [3, 4], "type": null, "name": "interleukin-6  (IL-6), and prostaglandin E2 (PGE2) in activated BV-2 cells."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In addition, we found that ", "neoechinulin A", " significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor-\u03b1 (TNF-\u03b1), interleukin-1\u03b2 (", "IL-1\u03b2", "), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) in activated BV-2 cells."], "h": {"pos": [1, 2], "type": null, "name": "neoechinulin A  significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor-\u03b1 (TNF-\u03b1), interleukin-1\u03b2 ("}, "t": {"pos": [3, 4], "type": null, "name": "IL-1\u03b2 ), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) in activated BV-2 cells."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Epididymal tissue from wild-type mice responded in vitro to ", "noradrenaline", " and isoprenaline with increased glycerol release, reduced ", "IL-6", " release, and increased cAMP accumulation."], "h": {"pos": [1, 2], "type": null, "name": "noradrenaline  and isoprenaline with increased glycerol release, reduced "}, "t": {"pos": [3, 4], "type": null, "name": "IL-6  release, and increased cAMP accumulation."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Treatment with ", "carvedilol", " reversed both protein and mRNA of HIF-1alpha, ", "VEGF", ", BNP, and NGF-beta to the baseline values."], "h": {"pos": [1, 2], "type": null, "name": "carvedilol  reversed both protein and mRNA of HIF-1alpha, "}, "t": {"pos": [3, 4], "type": null, "name": "VEGF , BNP, and NGF-beta to the baseline values."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Sumatriptan", " and LY 344864 decreased the number of capsaicin-induced ", "c-fos", "-like immunoreactive cells within trigeminal nucleus caudalis (ID50 = 0.04 and 0.6 mg kg(-1))."], "h": {"pos": [1, 2], "type": null, "name": "Sumatriptan  and LY 344864 decreased the number of capsaicin-induced "}, "t": {"pos": [3, 4], "type": null, "name": "c-fos -like immunoreactive cells within trigeminal nucleus caudalis (ID50 = 0.04 and 0.6 mg kg(-1))."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In activated microglia, ", "15d-PGJ2", " suppressed iNOS promoter activity, ", "iNOS", " mRNA, and protein levels."], "h": {"pos": [1, 2], "type": null, "name": "15d-PGJ2  suppressed iNOS promoter activity, "}, "t": {"pos": [3, 4], "type": null, "name": "iNOS  mRNA, and protein levels."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Crocin (25 and 50mg/kg) or ", "vitamin E", " improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/", "Bcl2", " ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN."], "h": {"pos": [1, 2], "type": null, "name": "vitamin E  improved histopathological damages, decreased MDA and CK-MB, increased GSH content and attenuated the increase of Bax/"}, "t": {"pos": [3, 4], "type": null, "name": "Bcl2  ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Moreover, LTD4-induced increases in ", "CysLT(1)R", " and NF-\u03baB p65 in the brain were also attenuated by ", "pranlukast", "."], "h": {"pos": [1, 2], "type": null, "name": "CysLT(1)R  and NF-\u03baB p65 in the brain were also attenuated by "}, "t": {"pos": [3, 4], "type": null, "name": "pranlukast ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In this study, we found that 5-hydroxy-3,6,7,8,3'4'-hexamethoxyflavone (", "5HHMF", ") from Hizikia fusiforme considerably inhibits lipopolysaccharide (LPS)-stimulated NO production by suppressing the expression of inducible NO synthase (", "iNOS", ") in BV2 microglia."], "h": {"pos": [1, 2], "type": null, "name": "5HHMF ) from Hizikia fusiforme considerably inhibits lipopolysaccharide (LPS)-stimulated NO production by suppressing the expression of inducible NO synthase ("}, "t": {"pos": [3, 4], "type": null, "name": "iNOS ) in BV2 microglia."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Cotreatment with ", "U0126", " and YC-1 synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of sulindac treatment on ERK1/2, JNK, and ", "beta-catenin", "."], "h": {"pos": [1, 2], "type": null, "name": "U0126  and YC-1 synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of sulindac treatment on ERK1/2, JNK, and "}, "t": {"pos": [3, 4], "type": null, "name": "beta-catenin ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Compared with aripiprazole, which significantly inhibited the firing activity of VTA DA neurons, ", "brexpiprazole", " displayed less efficacy at ", "D2 receptors", "."], "h": {"pos": [1, 2], "type": null, "name": "brexpiprazole  displayed less efficacy at "}, "t": {"pos": [3, 4], "type": null, "name": "D2 receptors ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The inhibition of UG synthesis and ", "PR", " down-regulation by 5 alpha-NET and 3 beta,5 alpha-NET indicates that these ", "NET", " metabolites possess antiprogestational properties."], "h": {"pos": [1, 2], "type": null, "name": "PR  down-regulation by 5 alpha-NET and 3 beta,5 alpha-NET indicates that these "}, "t": {"pos": [3, 4], "type": null, "name": "NET  metabolites possess antiprogestational properties."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Cells were also evaluated in the presence of ", "wortmannin", ", an inhibitor of phosphatidylinositol 3-kinases and thus ", "AKt", " (0-100 nM)."], "h": {"pos": [1, 2], "type": null, "name": "wortmannin , an inhibitor of phosphatidylinositol 3-kinases and thus "}, "t": {"pos": [3, 4], "type": null, "name": "AKt  (0-100 nM)."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "DXM", " and 1400W attenuated the mRNA expression of E-selectin and ", "iNOS", " induced by the costimulation of reIL-4, reTNF-alpha, and LPS."], "h": {"pos": [1, 2], "type": null, "name": "DXM  and 1400W attenuated the mRNA expression of E-selectin and "}, "t": {"pos": [3, 4], "type": null, "name": "iNOS  induced by the costimulation of reIL-4, reTNF-alpha, and LPS."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["This study explored whether ", "curcumin", " improves colonic inflammation in a rat colitis model through inhibition of the TLR4/NF-\u03baB signaling pathway and ", "IL-27", " expression."], "h": {"pos": [1, 2], "type": null, "name": "curcumin  improves colonic inflammation in a rat colitis model through inhibition of the TLR4/NF-\u03baB signaling pathway and "}, "t": {"pos": [3, 4], "type": null, "name": "IL-27  expression."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The obtained results showed that pioglitazone improved the renal function, structural changes, renal malondialdehyde (MDA), tumor necrosis factor alpha (TNF-\u03b1), nuclear factor kappa B (", "NF-\u03baB", ") genes expression in ", "cisplatin", " injected rats."], "h": {"pos": [1, 2], "type": null, "name": "NF-\u03baB ) genes expression in "}, "t": {"pos": [3, 4], "type": null, "name": "cisplatin  injected rats."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Allicin", " treatment showed reduced production of pro-inflammatory ", "cytokines", " and NO and increased HO-1 activity."], "h": {"pos": [1, 2], "type": null, "name": "Allicin  treatment showed reduced production of pro-inflammatory "}, "t": {"pos": [3, 4], "type": null, "name": "cytokines  and NO and increased HO-1 activity."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The obtained results showed that pioglitazone improved the renal function, structural changes, renal malondialdehyde (MDA), ", "tumor necrosis factor alpha", " (TNF-\u03b1), nuclear factor kappa B (NF-\u03baB) genes expression in ", "cisplatin", " injected rats."], "h": {"pos": [1, 2], "type": null, "name": "tumor necrosis factor alpha  (TNF-\u03b1), nuclear factor kappa B (NF-\u03baB) genes expression in "}, "t": {"pos": [3, 4], "type": null, "name": "cisplatin  injected rats."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Preincubation for 30 minutes with ", "iloprost", ", ciprostene, and carbacyclin led to a dose-dependent inhibition of ", "tissue factor", " expression induced by all three challenging agents."], "h": {"pos": [1, 2], "type": null, "name": "iloprost , ciprostene, and carbacyclin led to a dose-dependent inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "tissue factor  expression induced by all three challenging agents."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Artemisinic acid", " inhibits melanogenesis through downregulation of C/EBP \u03b1-dependent expression of ", "HMG-CoA reductase", " gene."], "h": {"pos": [1, 2], "type": null, "name": "Artemisinic acid  inhibits melanogenesis through downregulation of C/EBP \u03b1-dependent expression of "}, "t": {"pos": [3, 4], "type": null, "name": "HMG-CoA reductase  gene."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "HSYA", " suppressed the expression of TLR-4, Myd88, ", "ICAM-1", ", TNF\u03b1, IL-1\u03b2 and IL-6 at the mRNA and protein level, and inhibited the adhesion of leukocytes to A549 cells."], "h": {"pos": [1, 2], "type": null, "name": "HSYA  suppressed the expression of TLR-4, Myd88, "}, "t": {"pos": [3, 4], "type": null, "name": "ICAM-1 , TNF\u03b1, IL-1\u03b2 and IL-6 at the mRNA and protein level, and inhibited the adhesion of leukocytes to A549 cells."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["These G-proteins are likely to be involved in the adrenaline-induced inhibition of dihydropyridine-sensitive Ca2+ currents and in other signal transduction pathways contributing to the ", "adrenaline", "-induced inhibition of ", "insulin", " secretion."], "h": {"pos": [1, 2], "type": null, "name": "adrenaline -induced inhibition of "}, "t": {"pos": [3, 4], "type": null, "name": "insulin  secretion."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In addition, ", "BGG", "-mediated inhibition of AR prevented LPS-induced activation of ", "JNK", " and p38 and lowered ROS levels, which could inhibit LPS-induced apoptosis."], "h": {"pos": [1, 2], "type": null, "name": "BGG -mediated inhibition of AR prevented LPS-induced activation of "}, "t": {"pos": [3, 4], "type": null, "name": "JNK  and p38 and lowered ROS levels, which could inhibit LPS-induced apoptosis."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In the in vitro assay, ", "kinsenoside", " (20 and 50\u03bcg/mL) markedly inhibited changes in various biochemical substances (nitric oxide (NO), lactic dehydrogenase (LDH), superoxide dismutase (", "SOD", "), and catalase (CAT)) in human umbilical vein endothelial cells (HUVECs) damaged by high glucose (35mM) and restored vascular endothelial structure by balancing the matrix metalloproteinases-the tissue inhibitors of matrix metalloproteinases (MMP-TIMP) system."], "h": {"pos": [1, 2], "type": null, "name": "kinsenoside  (20 and 50\u03bcg/mL) markedly inhibited changes in various biochemical substances (nitric oxide (NO), lactic dehydrogenase (LDH), superoxide dismutase ("}, "t": {"pos": [3, 4], "type": null, "name": "SOD ), and catalase (CAT)) in human umbilical vein endothelial cells (HUVECs) damaged by high glucose (35mM) and restored vascular endothelial structure by balancing the matrix metalloproteinases-the tissue inhibitors of matrix metalloproteinases (MMP-TIMP) system."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Compared with the untreated colitis group, the ", "curcumin", "-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-\u03baB mRNA, IL-27 mRNA, TLR4 protein, NF-\u03baB ", "p65", " protein, and IL-27 p28 protein (p < 0.05)."], "h": {"pos": [1, 2], "type": null, "name": "curcumin -treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of NF-\u03baB mRNA, IL-27 mRNA, TLR4 protein, NF-\u03baB "}, "t": {"pos": [3, 4], "type": null, "name": "p65  protein, and IL-27 p28 protein (p < 0.05)."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Gene expression profiling (GEP) of GIST-S, GIST-R cells and two IM resistant GIST patients demonstrated that ", "KIT", " is downregulated implying a major role in ", "IM", " resistance."], "h": {"pos": [1, 2], "type": null, "name": "KIT  is downregulated implying a major role in "}, "t": {"pos": [3, 4], "type": null, "name": "IM  resistance."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Interestingly, two categories of clones were distinguished based on the effects of GCS on IL-2 production and IL-2R alpha expression and proliferation; 1) In low IL-2 producers DEX blocked IL-2 production and decreased IL-2R alpha expression and proliferation; 2) In high IL-2 producers ", "DEX", " inhibited ", "IL-2", " production partially and enhanced IL-2R alpha expression and proliferation."], "h": {"pos": [1, 2], "type": null, "name": "DEX  inhibited "}, "t": {"pos": [3, 4], "type": null, "name": "IL-2  production partially and enhanced IL-2R alpha expression and proliferation."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The obtained results showed that pioglitazone improved the renal function, structural changes, renal malondialdehyde (MDA), tumor necrosis factor alpha (TNF-\u03b1), ", "nuclear factor kappa B", " (NF-\u03baB) genes expression in ", "cisplatin", " injected rats."], "h": {"pos": [1, 2], "type": null, "name": "nuclear factor kappa B  (NF-\u03baB) genes expression in "}, "t": {"pos": [3, 4], "type": null, "name": "cisplatin  injected rats."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Fisetin", " treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (", "HbA1c", "), NF-kB p65 unit (in pancreas) and IL-1\u03b2 (plasma), serum nitric oxide (NO) with an elevation in plasma insulin."], "h": {"pos": [1, 2], "type": null, "name": "Fisetin  treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin ("}, "t": {"pos": [3, 4], "type": null, "name": "HbA1c ), NF-kB p65 unit (in pancreas) and IL-1\u03b2 (plasma), serum nitric oxide (NO) with an elevation in plasma insulin."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Taken together, these findings indicate that the inhibition of melanogenesis by ", "artemisinic acid", " occurs through reduced expression of the ", "HMG CoA reductase", " gene, which is mediated by C/EBP \u03b1 inhibition and suggest that artemisinic acid may be useful as a hyperpigmentation inhibitor."], "h": {"pos": [1, 2], "type": null, "name": "artemisinic acid  occurs through reduced expression of the "}, "t": {"pos": [3, 4], "type": null, "name": "HMG CoA reductase  gene, which is mediated by C/EBP \u03b1 inhibition and suggest that artemisinic acid may be useful as a hyperpigmentation inhibitor."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["There was no significant difference in ", "TLR4", ", NF-\u03baB, and IL-27 mRNA and proteins between ", "curcumin", "-treated and sulfasalazine-treated groups."], "h": {"pos": [1, 2], "type": null, "name": "TLR4 , NF-\u03baB, and IL-27 mRNA and proteins between "}, "t": {"pos": [3, 4], "type": null, "name": "curcumin -treated and sulfasalazine-treated groups."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Dexamethasone", " (DEX) inhibited the anti-CD3-induced production of IL-4, ", "IL-5", " and IFN-gamma in all 20 clones tested."], "h": {"pos": [1, 2], "type": null, "name": "Dexamethasone  (DEX) inhibited the anti-CD3-induced production of IL-4, "}, "t": {"pos": [3, 4], "type": null, "name": "IL-5  and IFN-gamma in all 20 clones tested."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The mechanism of action of ", "Fc11a-2", " was related to the inhibition of the cleavage of pro-caspase-1, ", "pro-IL-1\u03b2", " and pro-IL-18 which in turn suppressed the activation of NLRP3 inflammasome."], "h": {"pos": [1, 2], "type": null, "name": "Fc11a-2  was related to the inhibition of the cleavage of pro-caspase-1, "}, "t": {"pos": [3, 4], "type": null, "name": "pro-IL-1\u03b2  and pro-IL-18 which in turn suppressed the activation of NLRP3 inflammasome."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Dexamethasone (DXM) decreased the expression of CXCL-8, VEGF, and iNOS induced by reIL-4, while 1400W dihydrochloride (", "1400W", "), a selective inhibitor of iNOS, decreased the expression of E-selectin, ", "VEGF", ", and iNOS."], "h": {"pos": [1, 2], "type": null, "name": "1400W ), a selective inhibitor of iNOS, decreased the expression of E-selectin, "}, "t": {"pos": [3, 4], "type": null, "name": "VEGF , and iNOS."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Thalidomide", " reduced COX-2 expression accompanied by a decrease of ", "bcl-2", " protein, TNFalpha, VEGF, GSH and an increased cytochrome c, but had no effect on that of COX-1, in MCF-7 and HL-60."], "h": {"pos": [1, 2], "type": null, "name": "Thalidomide  reduced COX-2 expression accompanied by a decrease of "}, "t": {"pos": [3, 4], "type": null, "name": "bcl-2  protein, TNFalpha, VEGF, GSH and an increased cytochrome c, but had no effect on that of COX-1, in MCF-7 and HL-60."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Catalpol", " reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-\u03b1 (TNF-\u03b1), ", "inducible NO synthase", " (iNOS), and receptor for AGE (RAGE)."], "h": {"pos": [1, 2], "type": null, "name": "Catalpol  reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-\u03b1 (TNF-\u03b1), "}, "t": {"pos": [3, 4], "type": null, "name": "inducible NO synthase  (iNOS), and receptor for AGE (RAGE)."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Moreover, LTD4-induced increases in CysLT(1)R and NF-\u03baB ", "p65", " in the brain were also attenuated by ", "pranlukast", "."], "h": {"pos": [1, 2], "type": null, "name": "p65  in the brain were also attenuated by "}, "t": {"pos": [3, 4], "type": null, "name": "pranlukast ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "GCS", " therapy results in reduced mRNA expression of interleukin-4 (", "IL-4", ") and IL-5 in cells from bronchoalveolar lavage (BAL) but not of IFN-gamma."], "h": {"pos": [1, 2], "type": null, "name": "GCS  therapy results in reduced mRNA expression of interleukin-4 ("}, "t": {"pos": [3, 4], "type": null, "name": "IL-4 ) and IL-5 in cells from bronchoalveolar lavage (BAL) but not of IFN-gamma."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Subsequently, ", "pinosylvin", " suppressed the nuclear translocation of \u03b2-catenin, one of downstream molecules of PI3K/Akt/GSK-3\u03b2 signaling, and these events led to the sequential downregulation of \u03b2-catenin-mediated transcription of target genes including BMP4, ", "ID2", ", survivin, cyclin D1, MMP7, and c-Myc."], "h": {"pos": [1, 2], "type": null, "name": "pinosylvin  suppressed the nuclear translocation of \u03b2-catenin, one of downstream molecules of PI3K/Akt/GSK-3\u03b2 signaling, and these events led to the sequential downregulation of \u03b2-catenin-mediated transcription of target genes including BMP4, "}, "t": {"pos": [3, 4], "type": null, "name": "ID2 , survivin, cyclin D1, MMP7, and c-Myc."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Additionally, the expression of hepatic fibrosis-related factors such as \u03b1-smooth muscle actin and transforming growth factor-\u03b21 (", "TGF-\u03b21", "), were reduced in rats treated with ", "sinapic acid", "."], "h": {"pos": [1, 2], "type": null, "name": "TGF-\u03b21 ), were reduced in rats treated with "}, "t": {"pos": [3, 4], "type": null, "name": "sinapic acid ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Catalpol", " reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 (", "MCP-1", "), tumor necrosis factor-\u03b1 (TNF-\u03b1), inducible NO synthase (iNOS), and receptor for AGE (RAGE)."], "h": {"pos": [1, 2], "type": null, "name": "Catalpol  reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 ("}, "t": {"pos": [3, 4], "type": null, "name": "MCP-1 ), tumor necrosis factor-\u03b1 (TNF-\u03b1), inducible NO synthase (iNOS), and receptor for AGE (RAGE)."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The mRNA levels of ", "microphthalmia-associated transcription factor", " (MITF) and its downstream genes tyrosinase, tyrosinase-related protein (TRP)-1, and TRP-2 were reduced by ", "artemisinic acid", " treatment."], "h": {"pos": [1, 2], "type": null, "name": "microphthalmia-associated transcription factor  (MITF) and its downstream genes tyrosinase, tyrosinase-related protein (TRP)-1, and TRP-2 were reduced by "}, "t": {"pos": [3, 4], "type": null, "name": "artemisinic acid  treatment."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "DBDCT", " up-regulated the expression of Bax, down-regulated the expression of ", "Bcl-2", ", and significantly increased the ratio of Bax/Bcl-2."], "h": {"pos": [1, 2], "type": null, "name": "DBDCT  up-regulated the expression of Bax, down-regulated the expression of "}, "t": {"pos": [3, 4], "type": null, "name": "Bcl-2 , and significantly increased the ratio of Bax/Bcl-2."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Western blots showed a decrease in nuclear ", "p65", " protein expression after exposure to different concentrations of ", "cinobufagin", ", while the phosphorylation of GSK-3\u03b2 was simultaneously increased."], "h": {"pos": [1, 2], "type": null, "name": "p65  protein expression after exposure to different concentrations of "}, "t": {"pos": [3, 4], "type": null, "name": "cinobufagin , while the phosphorylation of GSK-3\u03b2 was simultaneously increased."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Separate 5-aza-2'-deoxycytidine pretreatment or in combination with ", "trichostatin A", " reduced (m)CpG and specific small interference RNAs targeting ", "Mecp2", " and Creb1 separately or together depleting Mecp2 and/or Creb1 binding of glut3-(m)CpGs reduced glut3 expression in HT22 cells."], "h": {"pos": [1, 2], "type": null, "name": "trichostatin A  reduced (m)CpG and specific small interference RNAs targeting "}, "t": {"pos": [3, 4], "type": null, "name": "Mecp2  and Creb1 separately or together depleting Mecp2 and/or Creb1 binding of glut3-(m)CpGs reduced glut3 expression in HT22 cells."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "GCS", " therapy results in reduced mRNA expression of ", "interleukin-4", " (IL-4) and IL-5 in cells from bronchoalveolar lavage (BAL) but not of IFN-gamma."], "h": {"pos": [1, 2], "type": null, "name": "GCS  therapy results in reduced mRNA expression of "}, "t": {"pos": [3, 4], "type": null, "name": "interleukin-4  (IL-4) and IL-5 in cells from bronchoalveolar lavage (BAL) but not of IFN-gamma."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In addition, we found that ", "neoechinulin A", " significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor-\u03b1 (TNF-\u03b1), interleukin-1\u03b2 (IL-1\u03b2), interleukin-6 (", "IL-6", "), and prostaglandin E2 (PGE2) in activated BV-2 cells."], "h": {"pos": [1, 2], "type": null, "name": "neoechinulin A  significantly suppressed the production of neurotoxic inflammatory mediator tumour necrosis factor-\u03b1 (TNF-\u03b1), interleukin-1\u03b2 (IL-1\u03b2), interleukin-6 ("}, "t": {"pos": [3, 4], "type": null, "name": "IL-6 ), and prostaglandin E2 (PGE2) in activated BV-2 cells."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The present studies were undertaken to determine whether stable analogues of ", "prostacyclin", ", a potent endothelium-derived platelet inhibitor and vasodilator, could inhibit ", "tissue factor", " expression by human monocytic cells."], "h": {"pos": [1, 2], "type": null, "name": "prostacyclin , a potent endothelium-derived platelet inhibitor and vasodilator, could inhibit "}, "t": {"pos": [3, 4], "type": null, "name": "tissue factor  expression by human monocytic cells."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Docetaxel", " is a semisynthetic taxane that inhibit tumor growth by induction of microtubule stabilization and promotion of ", "bcl-2", " inactivation, which induce apoptosis."], "h": {"pos": [1, 2], "type": null, "name": "Docetaxel  is a semisynthetic taxane that inhibit tumor growth by induction of microtubule stabilization and promotion of "}, "t": {"pos": [3, 4], "type": null, "name": "bcl-2  inactivation, which induce apoptosis."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Pyrrolidine dithiocarbamate (PDTC), a specific NF-\u03baB inhibitor, along with 20S proteasome inhibitor (PSI) significantly inhibited LPS-induced iNOS expression, which indirectly suggested that ", "5HHMF", " downregulated ", "iNOS", " expression by suppressing NF-\u03baB activity."], "h": {"pos": [1, 2], "type": null, "name": "5HHMF  downregulated "}, "t": {"pos": [3, 4], "type": null, "name": "iNOS  expression by suppressing NF-\u03baB activity."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Genistin", " decreased myosin light chain kinase (MLCK) protein contents and ", "MLCK", " mRNA expression in IJS, and inhibited both phosphorylation and Mg(2+)-ATPase activity of purified myosin, implicating that the decrease of MLCK contents and inhibition of MLCK activity are involved in the genistin-induced inhibitory effects."], "h": {"pos": [1, 2], "type": null, "name": "Genistin  decreased myosin light chain kinase (MLCK) protein contents and "}, "t": {"pos": [3, 4], "type": null, "name": "MLCK  mRNA expression in IJS, and inhibited both phosphorylation and Mg(2+)-ATPase activity of purified myosin, implicating that the decrease of MLCK contents and inhibition of MLCK activity are involved in the genistin-induced inhibitory effects."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["These actions are consistent with a pre-junctional inhibition of neuropeptide release from perivascular afferents of the trigeminal nerve, as confirmed by independent studies showing that ", "zolmitriptan", " blocks elevations of ", "calcitonin-gene-related peptide", " in jugular venous blood during electrical stimulation of the trigeminal ganglion."], "h": {"pos": [1, 2], "type": null, "name": "zolmitriptan  blocks elevations of "}, "t": {"pos": [3, 4], "type": null, "name": "calcitonin-gene-related peptide  in jugular venous blood during electrical stimulation of the trigeminal ganglion."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Consistent with these results, ", "prunetin", " significantly reduced serum levels of inflammatory ", "cytokines", " and mortality in mice challenged with lipopolysaccharide."], "h": {"pos": [1, 2], "type": null, "name": "prunetin  significantly reduced serum levels of inflammatory "}, "t": {"pos": [3, 4], "type": null, "name": "cytokines  and mortality in mice challenged with lipopolysaccharide."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Catalpol", " reduced the expression of pro-inflammatory mediates, such as ", "monocyte chemotactic protein-1", " (MCP-1), tumor necrosis factor-\u03b1 (TNF-\u03b1), inducible NO synthase (iNOS), and receptor for AGE (RAGE)."], "h": {"pos": [1, 2], "type": null, "name": "Catalpol  reduced the expression of pro-inflammatory mediates, such as "}, "t": {"pos": [3, 4], "type": null, "name": "monocyte chemotactic protein-1  (MCP-1), tumor necrosis factor-\u03b1 (TNF-\u03b1), inducible NO synthase (iNOS), and receptor for AGE (RAGE)."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["As revealed by glucose oxidase (GOD) and radioimmunoassay (RIA), both ", "dimethyldiguanide", " (DC, 0.6gkg(-1)d(-1)) and CPS (0.3, 0.6, 1.2gkg(-1)d(-1)) treatments significantly resulted in down-regulation of blood glucose and ", "insulin", " levels in serum, while the levels of oxidative stress markers were markedly lowered through ELISA assay."], "h": {"pos": [1, 2], "type": null, "name": "dimethyldiguanide  (DC, 0.6gkg(-1)d(-1)) and CPS (0.3, 0.6, 1.2gkg(-1)d(-1)) treatments significantly resulted in down-regulation of blood glucose and "}, "t": {"pos": [3, 4], "type": null, "name": "insulin  levels in serum, while the levels of oxidative stress markers were markedly lowered through ELISA assay."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Thus, ", "sorafenib", " may inhibit tumor growth by a dual mechanism, acting either directly on the tumor (through inhibition of Raf and Kit signaling) and/or on tumor angiogenesis (through inhibition of VEGFR and ", "PDGFR", " signaling)."], "h": {"pos": [1, 2], "type": null, "name": "sorafenib  may inhibit tumor growth by a dual mechanism, acting either directly on the tumor (through inhibition of Raf and Kit signaling) and/or on tumor angiogenesis (through inhibition of VEGFR and "}, "t": {"pos": [3, 4], "type": null, "name": "PDGFR  signaling)."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Moreover, we found that ", "juglone", " significantly inhibited the expression levels of androgen receptor (AR) and prostate-specific antigen (", "PSA", ") in a dose-dependent manner, as well as abrogated up-regulation of AR and PSA genes with and/or without dihydrotestosterone (DHT)."], "h": {"pos": [1, 2], "type": null, "name": "juglone  significantly inhibited the expression levels of androgen receptor (AR) and prostate-specific antigen ("}, "t": {"pos": [3, 4], "type": null, "name": "PSA ) in a dose-dependent manner, as well as abrogated up-regulation of AR and PSA genes with and/or without dihydrotestosterone (DHT)."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Cotreatment with U0126 and ", "YC-1", " synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of sulindac treatment on ERK1/2, JNK, and ", "beta-catenin", "."], "h": {"pos": [1, 2], "type": null, "name": "YC-1  synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of sulindac treatment on ERK1/2, JNK, and "}, "t": {"pos": [3, 4], "type": null, "name": "beta-catenin ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The failure of the myometrium to respond to ", "ritodrine", " (desensitization) was associated with significant reductions in agonist-induced cyclic adenosine monophosphate production and ", "beta 2-adrenergic receptor", " concentration in myometrial tissue collected from these animals compared with the saline solution-treated controls."], "h": {"pos": [1, 2], "type": null, "name": "ritodrine  (desensitization) was associated with significant reductions in agonist-induced cyclic adenosine monophosphate production and "}, "t": {"pos": [3, 4], "type": null, "name": "beta 2-adrenergic receptor  concentration in myometrial tissue collected from these animals compared with the saline solution-treated controls."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Gemfibrozil", ", a lipid-lowering drug, inhibited cytokine-induced production of NO and the expression of ", "inducible nitric-oxide synthase", " (iNOS) in human U373MG astroglial cells and primary astrocytes."], "h": {"pos": [1, 2], "type": null, "name": "Gemfibrozil , a lipid-lowering drug, inhibited cytokine-induced production of NO and the expression of "}, "t": {"pos": [3, 4], "type": null, "name": "inducible nitric-oxide synthase  (iNOS) in human U373MG astroglial cells and primary astrocytes."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Moreover, co-treatment with ", "antofine", " and a specific PKC\u03b2 inhibitor prevented endocytosis of gap junctions, downregulation of ", "Cx43", ", and inhibition of GJIC."], "h": {"pos": [1, 2], "type": null, "name": "antofine  and a specific PKC\u03b2 inhibitor prevented endocytosis of gap junctions, downregulation of "}, "t": {"pos": [3, 4], "type": null, "name": "Cx43 , and inhibition of GJIC."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Dexamethasone (", "DEX", ") inhibited the anti-CD3-induced production of IL-4, IL-5 and ", "IFN-gamma", " in all 20 clones tested."], "h": {"pos": [1, 2], "type": null, "name": "DEX ) inhibited the anti-CD3-induced production of IL-4, IL-5 and "}, "t": {"pos": [3, 4], "type": null, "name": "IFN-gamma  in all 20 clones tested."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In conclusion, the production of IL-4 and IL-5 by T-cell clones (derived either from BAL or blood) was more sensitive to inhibition by ", "DEX", " than that of ", "IFN-gamma", ", which may account for the therapeutic effects of glucocorticosteroids in patients with asthma."], "h": {"pos": [1, 2], "type": null, "name": "DEX  than that of "}, "t": {"pos": [3, 4], "type": null, "name": "IFN-gamma , which may account for the therapeutic effects of glucocorticosteroids in patients with asthma."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Subsequently, ", "pinosylvin", " suppressed the nuclear translocation of \u03b2-catenin, one of downstream molecules of PI3K/Akt/GSK-3\u03b2 signaling, and these events led to the sequential downregulation of \u03b2-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and ", "c-Myc", "."], "h": {"pos": [1, 2], "type": null, "name": "pinosylvin  suppressed the nuclear translocation of \u03b2-catenin, one of downstream molecules of PI3K/Akt/GSK-3\u03b2 signaling, and these events led to the sequential downregulation of \u03b2-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and "}, "t": {"pos": [3, 4], "type": null, "name": "c-Myc ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In the ", "IB-MECA", " group, ", "\u03b1-amylase", " activity was decreased with statistically high significance compared to group I."], "h": {"pos": [1, 2], "type": null, "name": "IB-MECA  group, "}, "t": {"pos": [3, 4], "type": null, "name": "\u03b1-amylase  activity was decreased with statistically high significance compared to group I."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["These results suggest that ", "prostacyclin", " may play a role in downregulating ", "tissue factor", " expression in monocytes, at least in part via elevation of intracellular levels of cyclic AMP."], "h": {"pos": [1, 2], "type": null, "name": "prostacyclin  may play a role in downregulating "}, "t": {"pos": [3, 4], "type": null, "name": "tissue factor  expression in monocytes, at least in part via elevation of intracellular levels of cyclic AMP."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Moreover, protein and mRNA levels of DSS-induced proinflammatory cytokines in colon, including TNF-\u03b1, IL-1\u03b2, ", "IL-18", ", IL-17A and IFN-\u03b3, were markedly suppressed by ", "Fc11a-2", "."], "h": {"pos": [1, 2], "type": null, "name": "IL-18 , IL-17A and IFN-\u03b3, were markedly suppressed by "}, "t": {"pos": [3, 4], "type": null, "name": "Fc11a-2 ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Carvedilol", " reduced mortality and heart failure in patients with higher pre-treatment plasma ", "N-BNP", " and adrenomedullin."], "h": {"pos": [1, 2], "type": null, "name": "Carvedilol  reduced mortality and heart failure in patients with higher pre-treatment plasma "}, "t": {"pos": [3, 4], "type": null, "name": "N-BNP  and adrenomedullin."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["There was no significant difference in TLR4, ", "NF-\u03baB", ", and IL-27 mRNA and proteins between ", "curcumin", "-treated and sulfasalazine-treated groups."], "h": {"pos": [1, 2], "type": null, "name": "NF-\u03baB , and IL-27 mRNA and proteins between "}, "t": {"pos": [3, 4], "type": null, "name": "curcumin -treated and sulfasalazine-treated groups."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Dexamethasone (DXM) decreased the expression of CXCL-8, VEGF, and iNOS induced by reIL-4, while ", "1400W dihydrochloride", " (1400W), a selective inhibitor of iNOS, decreased the expression of E-selectin, ", "VEGF", ", and iNOS."], "h": {"pos": [1, 2], "type": null, "name": "1400W dihydrochloride  (1400W), a selective inhibitor of iNOS, decreased the expression of E-selectin, "}, "t": {"pos": [3, 4], "type": null, "name": "VEGF , and iNOS."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Sulindac", " metabolites simultaneously (a) increase cellular cyclic GMP and subsequently activate cyclic GMP-dependent protein kinase (PKG); (b) activate c-jun NH2-terminal kinase (JNK); (c) inhibit extracellular signal-regulated kinase 1/2 (ERK1/2); and (d) decrease ", "beta-catenin", " protein expression at times and doses consistent with apoptosis."], "h": {"pos": [1, 2], "type": null, "name": "Sulindac  metabolites simultaneously (a) increase cellular cyclic GMP and subsequently activate cyclic GMP-dependent protein kinase (PKG); (b) activate c-jun NH2-terminal kinase (JNK); (c) inhibit extracellular signal-regulated kinase 1/2 (ERK1/2); and (d) decrease "}, "t": {"pos": [3, 4], "type": null, "name": "beta-catenin  protein expression at times and doses consistent with apoptosis."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "GCS", " therapy results in reduced mRNA expression of interleukin-4 (IL-4) and ", "IL-5", " in cells from bronchoalveolar lavage (BAL) but not of IFN-gamma."], "h": {"pos": [1, 2], "type": null, "name": "GCS  therapy results in reduced mRNA expression of interleukin-4 (IL-4) and "}, "t": {"pos": [3, 4], "type": null, "name": "IL-5  in cells from bronchoalveolar lavage (BAL) but not of IFN-gamma."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The inhibition of ", "UG", " synthesis and PR down-regulation by 5 alpha-NET and 3 beta,5 alpha-NET indicates that these ", "NET", " metabolites possess antiprogestational properties."], "h": {"pos": [1, 2], "type": null, "name": "UG  synthesis and PR down-regulation by 5 alpha-NET and 3 beta,5 alpha-NET indicates that these "}, "t": {"pos": [3, 4], "type": null, "name": "NET  metabolites possess antiprogestational properties."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["There was no significant difference in TLR4, NF-\u03baB, and ", "IL-27", " mRNA and proteins between curcumin-treated and ", "sulfasalazine", "-treated groups."], "h": {"pos": [1, 2], "type": null, "name": "IL-27  mRNA and proteins between curcumin-treated and "}, "t": {"pos": [3, 4], "type": null, "name": "sulfasalazine -treated groups."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Gene expression profiling (GEP) of GIST-S, GIST-R cells and two ", "IM", " resistant GIST patients demonstrated that ", "KIT", " is downregulated implying a major role in IM resistance."], "h": {"pos": [1, 2], "type": null, "name": "IM  resistant GIST patients demonstrated that "}, "t": {"pos": [3, 4], "type": null, "name": "KIT  is downregulated implying a major role in IM resistance."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Increased immunohistochemical labeling of ", "HIF-1alpha", ", VEGF, and BNP in the ventricular myocardium was observed in the shunt group and ", "carvedilol", " again normalized the labeling."], "h": {"pos": [1, 2], "type": null, "name": "HIF-1alpha , VEGF, and BNP in the ventricular myocardium was observed in the shunt group and "}, "t": {"pos": [3, 4], "type": null, "name": "carvedilol  again normalized the labeling."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The mechanism of action of ", "Fc11a-2", " was related to the inhibition of the cleavage of ", "pro-caspase-1", ", pro-IL-1\u03b2 and pro-IL-18 which in turn suppressed the activation of NLRP3 inflammasome."], "h": {"pos": [1, 2], "type": null, "name": "Fc11a-2  was related to the inhibition of the cleavage of "}, "t": {"pos": [3, 4], "type": null, "name": "pro-caspase-1 , pro-IL-1\u03b2 and pro-IL-18 which in turn suppressed the activation of NLRP3 inflammasome."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Increased immunohistochemical labeling of HIF-1alpha, ", "VEGF", ", and BNP in the ventricular myocardium was observed in the shunt group and ", "carvedilol", " again normalized the labeling."], "h": {"pos": [1, 2], "type": null, "name": "VEGF , and BNP in the ventricular myocardium was observed in the shunt group and "}, "t": {"pos": [3, 4], "type": null, "name": "carvedilol  again normalized the labeling."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Disruption of contact inhibition, which was induced by toxic AhR ligands ", "2,3,7,8-tetrachlorodibenzo-p-dioxin", " (TCDD) or polycyclic aromatic hydrocarbons in epithelial WB-F344 cells, reduced ", "Cx43", " protein levels, possibly via enhanced proteasomal degradation, significantly decreased the amount of gap junction plaques and downregulated GJIC, in an AhR-dependent manner."], "h": {"pos": [1, 2], "type": null, "name": "2,3,7,8-tetrachlorodibenzo-p-dioxin  (TCDD) or polycyclic aromatic hydrocarbons in epithelial WB-F344 cells, reduced "}, "t": {"pos": [3, 4], "type": null, "name": "Cx43  protein levels, possibly via enhanced proteasomal degradation, significantly decreased the amount of gap junction plaques and downregulated GJIC, in an AhR-dependent manner."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["RESULTS: Pretreatment of lung tissues with ", "pranlukast", " alone significantly decreased the amount of ", "IL-5", " protein in the culture medium by 40%."], "h": {"pos": [1, 2], "type": null, "name": "pranlukast  alone significantly decreased the amount of "}, "t": {"pos": [3, 4], "type": null, "name": "IL-5  protein in the culture medium by 40%."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In addition, ", "5HHMF", " blocked LPS-induced phosphorylation of I\u03baB, resulting in suppression of the nuclear translocation of ", "nuclear factor-\u03baB", " (NF-\u03baB) subunits, namely p65 and p50, which are important molecules involved in the regulation of iNOS expression."], "h": {"pos": [1, 2], "type": null, "name": "5HHMF  blocked LPS-induced phosphorylation of I\u03baB, resulting in suppression of the nuclear translocation of "}, "t": {"pos": [3, 4], "type": null, "name": "nuclear factor-\u03baB  (NF-\u03baB) subunits, namely p65 and p50, which are important molecules involved in the regulation of iNOS expression."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Colonic ", "cyclooxygenase-2", " and interkeukin-1beta mRNA and spinal c-FOS mRNA expression were significantly down-regulated by ", "ATB-429", ", but not by mesalamine."], "h": {"pos": [1, 2], "type": null, "name": "cyclooxygenase-2  and interkeukin-1beta mRNA and spinal c-FOS mRNA expression were significantly down-regulated by "}, "t": {"pos": [3, 4], "type": null, "name": "ATB-429 , but not by mesalamine."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In addition, we found that ", "MCP-1", " transcription and translation was completely inhibited by ", "mimosine", ", while MIP-2 transcription and translation was partially inhibited at 30 and 40 days; yet it was totally inhibited after 10 and 20 days in encysted diaphragm tissue infected by T. spiralis."], "h": {"pos": [1, 2], "type": null, "name": "MCP-1  transcription and translation was completely inhibited by "}, "t": {"pos": [3, 4], "type": null, "name": "mimosine , while MIP-2 transcription and translation was partially inhibited at 30 and 40 days; yet it was totally inhibited after 10 and 20 days in encysted diaphragm tissue infected by T. spiralis."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Inhibition of p95ErbB2, p185ErbB2, and EGFR phosphorylation by ", "GW572016", " resulted in the inhibition of downstream phospho-Erk1/2, phospho-", "AKT", ", and cyclin D steady-state protein levels."], "h": {"pos": [1, 2], "type": null, "name": "GW572016  resulted in the inhibition of downstream phospho-Erk1/2, phospho-"}, "t": {"pos": [3, 4], "type": null, "name": "AKT , and cyclin D steady-state protein levels."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["One of the mechanism of ", "mifepristone", " action on decreasing leiomyomata volume may be related to suppression on expression of ", "PR gene", "."], "h": {"pos": [1, 2], "type": null, "name": "mifepristone  action on decreasing leiomyomata volume may be related to suppression on expression of "}, "t": {"pos": [3, 4], "type": null, "name": "PR gene ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["On the other hand, in patients with a mean serum carvedilol level (Cmin) of less than 2.5 nmol/l up to 2 weeks after the start of", "carvedilol", " therapy, the degree of reduction in the ", "BNP", " value after the 3rd month was significantly larger, relative to the patient group with Cmin over 2.5 nmol/l."], "h": {"pos": [1, 2], "type": null, "name": "carvedilol  therapy, the degree of reduction in the "}, "t": {"pos": [3, 4], "type": null, "name": "BNP  value after the 3rd month was significantly larger, relative to the patient group with Cmin over 2.5 nmol/l."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Inhibition of ", "MCP-1", " and MIP-2 transcription and translation by ", "mimosine", " in muscle tissue infected with the parasite Trichinella spiralis."], "h": {"pos": [1, 2], "type": null, "name": "MCP-1  and MIP-2 transcription and translation by "}, "t": {"pos": [3, 4], "type": null, "name": "mimosine  in muscle tissue infected with the parasite Trichinella spiralis."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The molecular mechanism studies suggested that ", "neoechinulin A", " may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-\u03baB (NF-\u03baB) p65 and ", "p50", " subunits."], "h": {"pos": [1, 2], "type": null, "name": "neoechinulin A  may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-\u03baB (NF-\u03baB) p65 and "}, "t": {"pos": [3, 4], "type": null, "name": "p50  subunits."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In addition, we found that MCP-1 transcription and translation was completely inhibited by ", "mimosine", ", while ", "MIP-2", " transcription and translation was partially inhibited at 30 and 40 days; yet it was totally inhibited after 10 and 20 days in encysted diaphragm tissue infected by T. spiralis."], "h": {"pos": [1, 2], "type": null, "name": "mimosine , while "}, "t": {"pos": [3, 4], "type": null, "name": "MIP-2  transcription and translation was partially inhibited at 30 and 40 days; yet it was totally inhibited after 10 and 20 days in encysted diaphragm tissue infected by T. spiralis."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Compared with the untreated colitis group, the ", "curcumin", "-treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of ", "NF-\u03baB", " mRNA, IL-27 mRNA, TLR4 protein, NF-\u03baB p65 protein, and IL-27 p28 protein (p < 0.05)."], "h": {"pos": [1, 2], "type": null, "name": "curcumin -treated group showed significant decreases in the disease activity index, colonic mucosa damage index, histological score, myeloperoxidase activity, and expressions of "}, "t": {"pos": [3, 4], "type": null, "name": "NF-\u03baB  mRNA, IL-27 mRNA, TLR4 protein, NF-\u03baB p65 protein, and IL-27 p28 protein (p < 0.05)."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["DXM and ", "1400W", " attenuated the mRNA expression of E-selectin and ", "iNOS", " induced by the costimulation of reIL-4, reTNF-alpha, and LPS."], "h": {"pos": [1, 2], "type": null, "name": "1400W  attenuated the mRNA expression of E-selectin and "}, "t": {"pos": [3, 4], "type": null, "name": "iNOS  induced by the costimulation of reIL-4, reTNF-alpha, and LPS."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In hippocampal dentate gyrus, ", "MPH", "-receiving rats showed a 51% decrease in ", "NET", "-ir density and a 61% expanded distribution of the new-cell marker PSA-NCAM (polysialylated form of neural cell adhesion molecule)."], "h": {"pos": [1, 2], "type": null, "name": "MPH -receiving rats showed a 51% decrease in "}, "t": {"pos": [3, 4], "type": null, "name": "NET -ir density and a 61% expanded distribution of the new-cell marker PSA-NCAM (polysialylated form of neural cell adhesion molecule)."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Overall, higher alcohol production was reduced by ", "ammonium", " supplementation, and this can be correlated with a general downregulation of genes encoding decarboxylases and ", "dehydrogenases", " of the Ehrlich pathway."], "h": {"pos": [1, 2], "type": null, "name": "ammonium  supplementation, and this can be correlated with a general downregulation of genes encoding decarboxylases and "}, "t": {"pos": [3, 4], "type": null, "name": "dehydrogenases  of the Ehrlich pathway."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Pinosylvin", " was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase (", "PI3K", ")/Akt/ glycogen synthase kinase 3\u03b2 (GSK-3\u03b2) signaling pathway."], "h": {"pos": [1, 2], "type": null, "name": "Pinosylvin  was also found to attenuate the activation of proteins involved in focal adhesion kinase (FAK)/c-Src/extracellular signal-regulated kinase (ERK) signaling, and phosphoinositide 3-kinase ("}, "t": {"pos": [3, 4], "type": null, "name": "PI3K )/Akt/ glycogen synthase kinase 3\u03b2 (GSK-3\u03b2) signaling pathway."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Minocycline", " showed more potent inhibition on ", "MMP-9", " mRNA expression, starting at 1 (P<0.005) and further at more than 30 (P<0.001) mg/kg/day."], "h": {"pos": [1, 2], "type": null, "name": "Minocycline  showed more potent inhibition on "}, "t": {"pos": [3, 4], "type": null, "name": "MMP-9  mRNA expression, starting at 1 (P<0.005) and further at more than 30 (P<0.001) mg/kg/day."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Subsequently, ", "pinosylvin", " suppressed the nuclear translocation of \u03b2-catenin, one of downstream molecules of PI3K/Akt/", "GSK-3\u03b2", " signaling, and these events led to the sequential downregulation of \u03b2-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and c-Myc."], "h": {"pos": [1, 2], "type": null, "name": "pinosylvin  suppressed the nuclear translocation of \u03b2-catenin, one of downstream molecules of PI3K/Akt/"}, "t": {"pos": [3, 4], "type": null, "name": "GSK-3\u03b2  signaling, and these events led to the sequential downregulation of \u03b2-catenin-mediated transcription of target genes including BMP4, ID2, survivin, cyclin D1, MMP7, and c-Myc."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "HSYA", " suppressed the expression of ", "TLR-4", ", Myd88, ICAM-1, TNF\u03b1, IL-1\u03b2 and IL-6 at the mRNA and protein level, and inhibited the adhesion of leukocytes to A549 cells."], "h": {"pos": [1, 2], "type": null, "name": "HSYA  suppressed the expression of "}, "t": {"pos": [3, 4], "type": null, "name": "TLR-4 , Myd88, ICAM-1, TNF\u03b1, IL-1\u03b2 and IL-6 at the mRNA and protein level, and inhibited the adhesion of leukocytes to A549 cells."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In contrast to ", "adrenaline", " and somatostatin, galanin, another inhibitor of ", "insulin", " secretion, reduced Ca2+ currents by about 40% in a pertussis toxin-insensitive manner."], "h": {"pos": [1, 2], "type": null, "name": "adrenaline  and somatostatin, galanin, another inhibitor of "}, "t": {"pos": [3, 4], "type": null, "name": "insulin  secretion, reduced Ca2+ currents by about 40% in a pertussis toxin-insensitive manner."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In the long term, ", "orlistat", " has been shown to be more effective than placebo in reducing body weight and serum total and ", "low-density lipoprotein", " cholesterol levels."], "h": {"pos": [1, 2], "type": null, "name": "orlistat  has been shown to be more effective than placebo in reducing body weight and serum total and "}, "t": {"pos": [3, 4], "type": null, "name": "low-density lipoprotein  cholesterol levels."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The molecular mechanism studies suggested that ", "neoechinulin A", " may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of ", "nuclear factor-\u03baB", " (NF-\u03baB) p65 and p50 subunits."], "h": {"pos": [1, 2], "type": null, "name": "neoechinulin A  may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of "}, "t": {"pos": [3, 4], "type": null, "name": "nuclear factor-\u03baB  (NF-\u03baB) p65 and p50 subunits."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Pyrrolidine dithiocarbamate", " (PDTC), a specific NF-\u03baB inhibitor, along with 20S proteasome inhibitor (PSI) significantly inhibited LPS-induced ", "iNOS", " expression, which indirectly suggested that 5HHMF downregulated iNOS expression by suppressing NF-\u03baB activity."], "h": {"pos": [1, 2], "type": null, "name": "Pyrrolidine dithiocarbamate  (PDTC), a specific NF-\u03baB inhibitor, along with 20S proteasome inhibitor (PSI) significantly inhibited LPS-induced "}, "t": {"pos": [3, 4], "type": null, "name": "iNOS  expression, which indirectly suggested that 5HHMF downregulated iNOS expression by suppressing NF-\u03baB activity."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Treatment with ", "carvedilol", " reversed both protein and mRNA of HIF-1alpha, VEGF, ", "BNP", ", and NGF-beta to the baseline values."], "h": {"pos": [1, 2], "type": null, "name": "carvedilol  reversed both protein and mRNA of HIF-1alpha, VEGF, "}, "t": {"pos": [3, 4], "type": null, "name": "BNP , and NGF-beta to the baseline values."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Similar to gemfibrozil, clofibrate, another ", "fibrate", " drug, also inhibited the expression of ", "iNOS", "."], "h": {"pos": [1, 2], "type": null, "name": "fibrate  drug, also inhibited the expression of "}, "t": {"pos": [3, 4], "type": null, "name": "iNOS ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Furthermore, we validated the inhibition of GSK-3\u03b2/", "NF-\u03baB", " signaling following ", "cinobufagin", " treatment."], "h": {"pos": [1, 2], "type": null, "name": "NF-\u03baB  signaling following "}, "t": {"pos": [3, 4], "type": null, "name": "cinobufagin  treatment."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In the in vitro assay, ", "kinsenoside", " (20 and 50\u03bcg/mL) markedly inhibited changes in various biochemical substances (nitric oxide (NO), lactic dehydrogenase (LDH), ", "superoxide dismutase", " (SOD), and catalase (CAT)) in human umbilical vein endothelial cells (HUVECs) damaged by high glucose (35mM) and restored vascular endothelial structure by balancing the matrix metalloproteinases-the tissue inhibitors of matrix metalloproteinases (MMP-TIMP) system."], "h": {"pos": [1, 2], "type": null, "name": "kinsenoside  (20 and 50\u03bcg/mL) markedly inhibited changes in various biochemical substances (nitric oxide (NO), lactic dehydrogenase (LDH), "}, "t": {"pos": [3, 4], "type": null, "name": "superoxide dismutase  (SOD), and catalase (CAT)) in human umbilical vein endothelial cells (HUVECs) damaged by high glucose (35mM) and restored vascular endothelial structure by balancing the matrix metalloproteinases-the tissue inhibitors of matrix metalloproteinases (MMP-TIMP) system."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Furthermore, proteosomal inhibitor MG132 suppressed AMPK activation, GSK3\u03b2 phosphorylation, cleaved PARP and deceased ", "AEG-1", " induced by ", "ursolic acid", " in HepG2 cells."], "h": {"pos": [1, 2], "type": null, "name": "AEG-1  induced by "}, "t": {"pos": [3, 4], "type": null, "name": "ursolic acid  in HepG2 cells."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In cultured vascular smooth muscle cells (VSMCs), rAAV-mediated CYP2J2 overexpression and ", "EETs", " markedly suppressed Ang II-induced inflammatory ", "cytokine", " expression."], "h": {"pos": [1, 2], "type": null, "name": "EETs  markedly suppressed Ang II-induced inflammatory "}, "t": {"pos": [3, 4], "type": null, "name": "cytokine  expression."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In healthy rats, ", "ATB-429", " dose dependently (25, 50, or 100 mg/kg) attenuated CRD-induced hypersensitivity and significantly inhibited CRD-induced overexpression of spinal ", "c-FOS", " mRNA, whereas mesalamine had no effect."], "h": {"pos": [1, 2], "type": null, "name": "ATB-429  dose dependently (25, 50, or 100 mg/kg) attenuated CRD-induced hypersensitivity and significantly inhibited CRD-induced overexpression of spinal "}, "t": {"pos": [3, 4], "type": null, "name": "c-FOS  mRNA, whereas mesalamine had no effect."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Brain tissue analyses revealed that neonatal ", "quinpirole", " treatment produced a significant decrease in hippocampal NGF, BDNF and ", "ChAT", " that was eliminated by olanzapine treatment."], "h": {"pos": [1, 2], "type": null, "name": "quinpirole  treatment produced a significant decrease in hippocampal NGF, BDNF and "}, "t": {"pos": [3, 4], "type": null, "name": "ChAT  that was eliminated by olanzapine treatment."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In addition, we found that ", "neoechinulin A", " significantly suppressed the production of neurotoxic inflammatory mediator ", "tumour necrosis factor-\u03b1", " (TNF-\u03b1), interleukin-1\u03b2 (IL-1\u03b2), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) in activated BV-2 cells."], "h": {"pos": [1, 2], "type": null, "name": "neoechinulin A  significantly suppressed the production of neurotoxic inflammatory mediator "}, "t": {"pos": [3, 4], "type": null, "name": "tumour necrosis factor-\u03b1  (TNF-\u03b1), interleukin-1\u03b2 (IL-1\u03b2), interleukin-6 (IL-6), and prostaglandin E2 (PGE2) in activated BV-2 cells."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In vitro, ", "V(5+)", " decreased the TCDD-mediated induction of ", "Cyp1a1", " mRNA, protein, and catalytic activity levels."], "h": {"pos": [1, 2], "type": null, "name": "V(5+)  decreased the TCDD-mediated induction of "}, "t": {"pos": [3, 4], "type": null, "name": "Cyp1a1  mRNA, protein, and catalytic activity levels."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Dexamethasone (", "DXM", ") decreased the expression of ", "CXCL-8", ", VEGF, and iNOS induced by reIL-4, while 1400W dihydrochloride (1400W), a selective inhibitor of iNOS, decreased the expression of E-selectin, VEGF, and iNOS."], "h": {"pos": [1, 2], "type": null, "name": "DXM ) decreased the expression of "}, "t": {"pos": [3, 4], "type": null, "name": "CXCL-8 , VEGF, and iNOS induced by reIL-4, while 1400W dihydrochloride (1400W), a selective inhibitor of iNOS, decreased the expression of E-selectin, VEGF, and iNOS."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Fisetin", " treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), ", "NF-kB", " p65 unit (in pancreas) and IL-1\u03b2 (plasma), serum nitric oxide (NO) with an elevation in plasma insulin."], "h": {"pos": [1, 2], "type": null, "name": "Fisetin  treatment showed a significant decline in the levels of blood glucose, glycosylated hemoglobin (HbA1c), "}, "t": {"pos": [3, 4], "type": null, "name": "NF-kB  p65 unit (in pancreas) and IL-1\u03b2 (plasma), serum nitric oxide (NO) with an elevation in plasma insulin."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Separate ", "5-aza-2'-deoxycytidine", " pretreatment or in combination with trichostatin A reduced (m)CpG and specific small interference RNAs targeting ", "Mecp2", " and Creb1 separately or together depleting Mecp2 and/or Creb1 binding of glut3-(m)CpGs reduced glut3 expression in HT22 cells."], "h": {"pos": [1, 2], "type": null, "name": "5-aza-2'-deoxycytidine  pretreatment or in combination with trichostatin A reduced (m)CpG and specific small interference RNAs targeting "}, "t": {"pos": [3, 4], "type": null, "name": "Mecp2  and Creb1 separately or together depleting Mecp2 and/or Creb1 binding of glut3-(m)CpGs reduced glut3 expression in HT22 cells."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Crocin", " (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and ", "CK-MB", ", increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN."], "h": {"pos": [1, 2], "type": null, "name": "Crocin  (25 and 50mg/kg) or vitamin E improved histopathological damages, decreased MDA and "}, "t": {"pos": [3, 4], "type": null, "name": "CK-MB , increased GSH content and attenuated the increase of Bax/Bcl2 ratio, activation of caspase 3 and release of cytochrome c to the cytosol induced by DZN."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Neonatal ", "quinpirole", " treatment produced a significant decrease in ", "BDNF", " and ChAT in the frontal cortex that was unaffected by olanzapine treatment."], "h": {"pos": [1, 2], "type": null, "name": "quinpirole  treatment produced a significant decrease in "}, "t": {"pos": [3, 4], "type": null, "name": "BDNF  and ChAT in the frontal cortex that was unaffected by olanzapine treatment."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "NaAsO(2)", " increased the mRNA levels of the light and medium subunits of neurofilament and decreased the mRNA levels of ", "tau", " and tubulin in a dose-dependent manner; no significant effect was found in the mRNA levels of the heavy subunit of neurofilament, microtubule-associated protein 2, or actin."], "h": {"pos": [1, 2], "type": null, "name": "NaAsO(2)  increased the mRNA levels of the light and medium subunits of neurofilament and decreased the mRNA levels of "}, "t": {"pos": [3, 4], "type": null, "name": "tau  and tubulin in a dose-dependent manner; no significant effect was found in the mRNA levels of the heavy subunit of neurofilament, microtubule-associated protein 2, or actin."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Moreover, protein and mRNA levels of DSS-induced proinflammatory cytokines in colon, including TNF-\u03b1, ", "IL-1\u03b2", ", IL-18, IL-17A and IFN-\u03b3, were markedly suppressed by ", "Fc11a-2", "."], "h": {"pos": [1, 2], "type": null, "name": "IL-1\u03b2 , IL-18, IL-17A and IFN-\u03b3, were markedly suppressed by "}, "t": {"pos": [3, 4], "type": null, "name": "Fc11a-2 ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Pasireotide (", "Signifor", "(\u00ae)) is a new subcutaneous somatostatin analogue that acts via somatostatin receptors to inhibit the secretion of ", "corticotropin", " from the pituitary adenoma in patients with Cushing's disease."], "h": {"pos": [1, 2], "type": null, "name": "Signifor (\u00ae)) is a new subcutaneous somatostatin analogue that acts via somatostatin receptors to inhibit the secretion of "}, "t": {"pos": [3, 4], "type": null, "name": "corticotropin  from the pituitary adenoma in patients with Cushing's disease."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Subsequently, ", "pinosylvin", " suppressed the nuclear translocation of \u03b2-catenin, one of downstream molecules of PI3K/Akt/GSK-3\u03b2 signaling, and these events led to the sequential downregulation of \u03b2-catenin-mediated transcription of target genes including BMP4, ID2, survivin, ", "cyclin D1", ", MMP7, and c-Myc."], "h": {"pos": [1, 2], "type": null, "name": "pinosylvin  suppressed the nuclear translocation of \u03b2-catenin, one of downstream molecules of PI3K/Akt/GSK-3\u03b2 signaling, and these events led to the sequential downregulation of \u03b2-catenin-mediated transcription of target genes including BMP4, ID2, survivin, "}, "t": {"pos": [3, 4], "type": null, "name": "cyclin D1 , MMP7, and c-Myc."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Levels of ", "Cx43", " protein were also decreased in a dose- and time-dependent manner following ", "antofine", " treatment."], "h": {"pos": [1, 2], "type": null, "name": "Cx43  protein were also decreased in a dose- and time-dependent manner following "}, "t": {"pos": [3, 4], "type": null, "name": "antofine  treatment."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The molecular mechanism studies suggested that ", "neoechinulin A", " may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-\u03baB (", "NF-\u03baB", ") p65 and p50 subunits."], "h": {"pos": [1, 2], "type": null, "name": "neoechinulin A  may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regulating kinase 1 (ASK-1) and nuclear translocation of nuclear factor-\u03baB ("}, "t": {"pos": [3, 4], "type": null, "name": "NF-\u03baB ) p65 and p50 subunits."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The mechanism of action of ", "Fc11a-2", " was related to the inhibition of the cleavage of pro-caspase-1, pro-IL-1\u03b2 and ", "pro-IL-18", " which in turn suppressed the activation of NLRP3 inflammasome."], "h": {"pos": [1, 2], "type": null, "name": "Fc11a-2  was related to the inhibition of the cleavage of pro-caspase-1, pro-IL-1\u03b2 and "}, "t": {"pos": [3, 4], "type": null, "name": "pro-IL-18  which in turn suppressed the activation of NLRP3 inflammasome."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Licofelone", " reduced intima/media ratio in injured arteries, the macrophages infiltration in the neointimal area, monocyte chemoattractant protein-1 (MCP-1) gene expression, and the activation of ", "nuclear factor-kappaB", " in rabbit atheroma."], "h": {"pos": [1, 2], "type": null, "name": "Licofelone  reduced intima/media ratio in injured arteries, the macrophages infiltration in the neointimal area, monocyte chemoattractant protein-1 (MCP-1) gene expression, and the activation of "}, "t": {"pos": [3, 4], "type": null, "name": "nuclear factor-kappaB  in rabbit atheroma."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In addition, ", "5HHMF", " blocked LPS-induced phosphorylation of I\u03baB, resulting in suppression of the nuclear translocation of nuclear factor-\u03baB (NF-\u03baB) subunits, namely ", "p65", " and p50, which are important molecules involved in the regulation of iNOS expression."], "h": {"pos": [1, 2], "type": null, "name": "5HHMF  blocked LPS-induced phosphorylation of I\u03baB, resulting in suppression of the nuclear translocation of nuclear factor-\u03baB (NF-\u03baB) subunits, namely "}, "t": {"pos": [3, 4], "type": null, "name": "p65  and p50, which are important molecules involved in the regulation of iNOS expression."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Only FFAs that increased ", "ceramides", " caused impairment of ", "AKt", " and PTP1B phosphorylation at Ser 50."], "h": {"pos": [1, 2], "type": null, "name": "ceramides  caused impairment of "}, "t": {"pos": [3, 4], "type": null, "name": "AKt  and PTP1B phosphorylation at Ser 50."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["To explore the molecular basis for CPT hypersensitivity in Top2\u03b2-deficient cells, we found that upon ", "CPT", " exposure, the ", "RNA polymerase II large subunit", " (RNAP LS) became progressively depleted, followed by recovery to nearly the original level in wild-type MEFs, whereas RNAP LS remained depleted without recovery in Top2\u03b2-deficient cells."], "h": {"pos": [1, 2], "type": null, "name": "CPT  exposure, the "}, "t": {"pos": [3, 4], "type": null, "name": "RNA polymerase II large subunit  (RNAP LS) became progressively depleted, followed by recovery to nearly the original level in wild-type MEFs, whereas RNAP LS remained depleted without recovery in Top2\u03b2-deficient cells."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "PTE", " also down-regulated the expression of STAT3 target genes, including the anti-apoptotic proteins ", "Bcl-xL", " and Mcl-1, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, Bak, cytosolic Cytochrome c, and cleaved Caspase3) and cyclin-dependent kinase inhibitors such as p21 and p27."], "h": {"pos": [1, 2], "type": null, "name": "PTE  also down-regulated the expression of STAT3 target genes, including the anti-apoptotic proteins "}, "t": {"pos": [3, 4], "type": null, "name": "Bcl-xL  and Mcl-1, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, Bak, cytosolic Cytochrome c, and cleaved Caspase3) and cyclin-dependent kinase inhibitors such as p21 and p27."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Results of RT-PCR analysis showed decrease of ", "p53", " mRNA level and no significant difference in Bcl-2 and Bax mRNA expressions in ", "DEX", "-treated rats."], "h": {"pos": [1, 2], "type": null, "name": "p53  mRNA level and no significant difference in Bcl-2 and Bax mRNA expressions in "}, "t": {"pos": [3, 4], "type": null, "name": "DEX -treated rats."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Moreover, protein and mRNA levels of DSS-induced proinflammatory cytokines in colon, including ", "TNF-\u03b1", ", IL-1\u03b2, IL-18, IL-17A and IFN-\u03b3, were markedly suppressed by ", "Fc11a-2", "."], "h": {"pos": [1, 2], "type": null, "name": "TNF-\u03b1 , IL-1\u03b2, IL-18, IL-17A and IFN-\u03b3, were markedly suppressed by "}, "t": {"pos": [3, 4], "type": null, "name": "Fc11a-2 ."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Brain tissue analyses revealed that neonatal ", "quinpirole", " treatment produced a significant decrease in hippocampal ", "NGF", ", BDNF and ChAT that was eliminated by olanzapine treatment."], "h": {"pos": [1, 2], "type": null, "name": "quinpirole  treatment produced a significant decrease in hippocampal "}, "t": {"pos": [3, 4], "type": null, "name": "NGF , BDNF and ChAT that was eliminated by olanzapine treatment."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Catalpol", " reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-\u03b1 (TNF-\u03b1), inducible NO synthase (iNOS), and ", "receptor for AGE", " (RAGE)."], "h": {"pos": [1, 2], "type": null, "name": "Catalpol  reduced the expression of pro-inflammatory mediates, such as monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-\u03b1 (TNF-\u03b1), inducible NO synthase (iNOS), and "}, "t": {"pos": [3, 4], "type": null, "name": "receptor for AGE  (RAGE)."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Western blotting demonstrated that ", "DMBT", " effectively suppressed the expression of VEGF, p-VEGFR-2, ", "p-EGFR", ", and p-Akt."], "h": {"pos": [1, 2], "type": null, "name": "DMBT  effectively suppressed the expression of VEGF, p-VEGFR-2, "}, "t": {"pos": [3, 4], "type": null, "name": "p-EGFR , and p-Akt."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Furthermore, ", "N", "-BPs decreased the levels of phosphorylated extracellular signal-regulated kinase (ERK) and ", "mTOR", " via suppression of Ras prenylation and enhanced Bim expression."], "h": {"pos": [1, 2], "type": null, "name": "N -BPs decreased the levels of phosphorylated extracellular signal-regulated kinase (ERK) and "}, "t": {"pos": [3, 4], "type": null, "name": "mTOR  via suppression of Ras prenylation and enhanced Bim expression."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Promoter assay revealed that ", "prunetin", " inhibits LPS-induced nitric oxide and prostaglandin E2 production through the suppression of ", "iNOS", " and COX-2 at the transcriptional level."], "h": {"pos": [1, 2], "type": null, "name": "prunetin  inhibits LPS-induced nitric oxide and prostaglandin E2 production through the suppression of "}, "t": {"pos": [3, 4], "type": null, "name": "iNOS  and COX-2 at the transcriptional level."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Colonic cyclooxygenase-2 and ", "interkeukin-1beta", " mRNA and spinal c-FOS mRNA expression were significantly down-regulated by ", "ATB-429", ", but not by mesalamine."], "h": {"pos": [1, 2], "type": null, "name": "interkeukin-1beta  mRNA and spinal c-FOS mRNA expression were significantly down-regulated by "}, "t": {"pos": [3, 4], "type": null, "name": "ATB-429 , but not by mesalamine."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In support of the hypothesis that TCDD decreases canonical Wnt signaling, we identify inhibitory effects of TCDD on multiple components of the canonical Wnt signaling pathway in the UGS that temporally coincide with the inhibitory effect of ", "TCDD", " on prostatic bud formation: (1) expression of R-spondins (Rspo2 and ", "Rspo3", ") that promote canonical Wnt signaling is reduced; (2) expression of Lef1, Tcf1, and Wif1, established canonical Wnt target genes, is decreased; (3) expression of Lgr5, a RSPO receptor that activates canonical Wnt signaling, is reduced; and (4) expression of Dickkopfs (Dkks), inhibitors of canonical Wnt signaling, is not increased by TCDD."], "h": {"pos": [1, 2], "type": null, "name": "TCDD  on prostatic bud formation: (1) expression of R-spondins (Rspo2 and "}, "t": {"pos": [3, 4], "type": null, "name": "Rspo3 ) that promote canonical Wnt signaling is reduced; (2) expression of Lef1, Tcf1, and Wif1, established canonical Wnt target genes, is decreased; (3) expression of Lgr5, a RSPO receptor that activates canonical Wnt signaling, is reduced; and (4) expression of Dickkopfs (Dkks), inhibitors of canonical Wnt signaling, is not increased by TCDD."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of thymidylate synthase by ", "Tomudex", " and kilobase DNA fragmentation may correlate with the reduction of ", "p27(kip1)", " expression and the increase in cyclin E and cdk2 kinase activities."], "h": {"pos": [1, 2], "type": null, "name": "Tomudex  and kilobase DNA fragmentation may correlate with the reduction of "}, "t": {"pos": [3, 4], "type": null, "name": "p27(kip1)  expression and the increase in cyclin E and cdk2 kinase activities."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["The anti-inflammatory actions of ", "curcumin", " on colitis may involve inhibition of the TLR4/NF-\u03baB signaling pathway and of ", "IL-27", " expression."], "h": {"pos": [1, 2], "type": null, "name": "curcumin  on colitis may involve inhibition of the TLR4/NF-\u03baB signaling pathway and of "}, "t": {"pos": [3, 4], "type": null, "name": "IL-27  expression."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["In all patients ", "loperamide", " induced a significant fall in plasma ", "ACTH", " levels."], "h": {"pos": [1, 2], "type": null, "name": "loperamide  induced a significant fall in plasma "}, "t": {"pos": [3, 4], "type": null, "name": "ACTH  levels."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "Rg1", " attenuated the A\u03b225-35-associated mitochondrial apoptotic events, accompanied by inhibiting ", "HIF-1\u03b1", " expression followed by intracellular reactive nitrogen species generation, and protein nitrotyrosination."], "h": {"pos": [1, 2], "type": null, "name": "Rg1  attenuated the A\u03b225-35-associated mitochondrial apoptotic events, accompanied by inhibiting "}, "t": {"pos": [3, 4], "type": null, "name": "HIF-1\u03b1  expression followed by intracellular reactive nitrogen species generation, and protein nitrotyrosination."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Increased immunohistochemical labeling of HIF-1alpha, VEGF, and ", "BNP", " in the ventricular myocardium was observed in the shunt group and ", "carvedilol", " again normalized the labeling."], "h": {"pos": [1, 2], "type": null, "name": "BNP  in the ventricular myocardium was observed in the shunt group and "}, "t": {"pos": [3, 4], "type": null, "name": "carvedilol  again normalized the labeling."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["", "PTE", " also down-regulated the expression of ", "STAT3", " target genes, including the anti-apoptotic proteins Bcl-xL and Mcl-1, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, Bak, cytosolic Cytochrome c, and cleaved Caspase3) and cyclin-dependent kinase inhibitors such as p21 and p27."], "h": {"pos": [1, 2], "type": null, "name": "PTE  also down-regulated the expression of "}, "t": {"pos": [3, 4], "type": null, "name": "STAT3  target genes, including the anti-apoptotic proteins Bcl-xL and Mcl-1, leading to the up-regulation of mitochondrial apoptosis pathway-related proteins (Bax, Bak, cytosolic Cytochrome c, and cleaved Caspase3) and cyclin-dependent kinase inhibitors such as p21 and p27."}}
{"relation": "INDIRECT-DOWNREGULATOR", "token": ["Dexamethasone (DXM) decreased the expression of CXCL-8, VEGF, and iNOS induced by reIL-4, while 1400W dihydrochloride (", "1400W", "), a selective inhibitor of iNOS, decreased the expression of E-selectin, VEGF, and ", "iNOS", "."], "h": {"pos": [1, 2], "type": null, "name": "1400W ), a selective inhibitor of iNOS, decreased the expression of E-selectin, VEGF, and "}, "t": {"pos": [3, 4], "type": null, "name": "iNOS ."}}
{"relation": "ACTIVATOR", "token": ["Upon co-exposure to V(5+) and ", "TCDD", ", V(5+) significantly potentiated the TCDD-mediated induction of the ", "Cyp1a1", ", Cyp1a2, and Cyp1b1 mRNA, protein, and catalytic activity levels at 24\u00a0h."], "h": {"pos": [1, 2], "type": null, "name": "TCDD , V(5+) significantly potentiated the TCDD-mediated induction of the "}, "t": {"pos": [3, 4], "type": null, "name": "Cyp1a1 , Cyp1a2, and Cyp1b1 mRNA, protein, and catalytic activity levels at 24\u00a0h."}}
{"relation": "ACTIVATOR", "token": ["Exposure of cells to 4mM ", "NaF", " for 24h induced ", "caspase-3", " activation, ultrastructural alterations, and resulted in the translocation of Bax to the mitochondria and the release of cytochrome c from the mitochondrial inter-membrane space into the cytosol, indicating that fluoride-mediated apoptosis is mitochondria-dependent."], "h": {"pos": [1, 2], "type": null, "name": "NaF  for 24h induced "}, "t": {"pos": [3, 4], "type": null, "name": "caspase-3  activation, ultrastructural alterations, and resulted in the translocation of Bax to the mitochondria and the release of cytochrome c from the mitochondrial inter-membrane space into the cytosol, indicating that fluoride-mediated apoptosis is mitochondria-dependent."}}
{"relation": "ACTIVATOR", "token": ["", "CCl(4)", " administration triggered inflammatory response in mice livers by activating nuclear factor-kappaB (NF-\u03baB), which coincided with the induction of tumor necrosis factor-alpha (", "TNF-\u03b1", ") and cyclooxygenase-2 (COX-2)."], "h": {"pos": [1, 2], "type": null, "name": "CCl(4)  administration triggered inflammatory response in mice livers by activating nuclear factor-kappaB (NF-\u03baB), which coincided with the induction of tumor necrosis factor-alpha ("}, "t": {"pos": [3, 4], "type": null, "name": "TNF-\u03b1 ) and cyclooxygenase-2 (COX-2)."}}
{"relation": "ACTIVATOR", "token": ["Our results showed that ", "2-hydroxy-3-methylanthraquinone", " decreased phosphorylation-ERK1/2 (p-ERK1/2), and increased ", "p-p38MAPK", ", but did not affect expressions of p-JNK1/2 in U937 cells."], "h": {"pos": [1, 2], "type": null, "name": "2-hydroxy-3-methylanthraquinone  decreased phosphorylation-ERK1/2 (p-ERK1/2), and increased "}, "t": {"pos": [3, 4], "type": null, "name": "p-p38MAPK , but did not affect expressions of p-JNK1/2 in U937 cells."}}
{"relation": "ACTIVATOR", "token": ["Upon co-exposure to V(5+) and ", "TCDD", ", V(5+) significantly potentiated the TCDD-mediated induction of the Cyp1a1, ", "Cyp1a2", ", and Cyp1b1 mRNA, protein, and catalytic activity levels at 24\u00a0h."], "h": {"pos": [1, 2], "type": null, "name": "TCDD , V(5+) significantly potentiated the TCDD-mediated induction of the Cyp1a1, "}, "t": {"pos": [3, 4], "type": null, "name": "Cyp1a2 , and Cyp1b1 mRNA, protein, and catalytic activity levels at 24\u00a0h."}}
{"relation": "ACTIVATOR", "token": ["These results indicate that phillyrin prevents lipid accumulation in HepG2 cells by blocking the expression of SREBP-1c and FAS through LKB1/AMPK activation, suggesting that ", "phillyrin", " is a novel ", "AMPK", " activator with a role in the prevention and treatment of obesity."], "h": {"pos": [1, 2], "type": null, "name": "phillyrin  is a novel "}, "t": {"pos": [3, 4], "type": null, "name": "AMPK  activator with a role in the prevention and treatment of obesity."}}
{"relation": "ACTIVATOR", "token": ["", "Epi", " increased the activity of the human WNT6 promoter through Cav1-dependent binding of \u03b2-catenin to the proximal ", "WNT6 promoter", "."], "h": {"pos": [1, 2], "type": null, "name": "Epi  increased the activity of the human WNT6 promoter through Cav1-dependent binding of \u03b2-catenin to the proximal "}, "t": {"pos": [3, 4], "type": null, "name": "WNT6 promoter ."}}
{"relation": "ACTIVATOR", "token": ["In the CCl4 hepatotoxicity model, pre-treatment with PSM or silymarin resulted in significantly increased activities of ethylmorphine-N-demethylase and aniline 4-hydroxylase activity and ", "cytochrome P450", ", compared to the ", "CCl4", " only group."], "h": {"pos": [1, 2], "type": null, "name": "cytochrome P450 , compared to the "}, "t": {"pos": [3, 4], "type": null, "name": "CCl4  only group."}}
{"relation": "ACTIVATOR", "token": ["The in vitro kinase activity of ", "PKC-alpha", " induced by I3A was lower than that induced by ", "PMA", "."], "h": {"pos": [1, 2], "type": null, "name": "PKC-alpha  induced by I3A was lower than that induced by "}, "t": {"pos": [3, 4], "type": null, "name": "PMA ."}}
{"relation": "ACTIVATOR", "token": ["The protein exhibited modest ", "H(2)O(2)", "-dependent ", "peroxidase", " activities with guaiacol, potassium iodide, and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS)."], "h": {"pos": [1, 2], "type": null, "name": "H(2)O(2) -dependent "}, "t": {"pos": [3, 4], "type": null, "name": "peroxidase  activities with guaiacol, potassium iodide, and 2,2(')-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS)."}}
{"relation": "ACTIVATOR", "token": ["", "Tomudex", " treatment resulted in the decrease in p27(kip1) expression, with an increase in cyclin E and cdk2 protein expression and ", "kinase", " activities 24 h after a 2-h exposure."], "h": {"pos": [1, 2], "type": null, "name": "Tomudex  treatment resulted in the decrease in p27(kip1) expression, with an increase in cyclin E and cdk2 protein expression and "}, "t": {"pos": [3, 4], "type": null, "name": "kinase  activities 24 h after a 2-h exposure."}}
{"relation": "ACTIVATOR", "token": ["Sulfhydration of sulfonylurea receptor 2B (", "SUR2B", ") was induced by ", "NaHS", " and colonic inflammation."], "h": {"pos": [1, 2], "type": null, "name": "SUR2B ) was induced by "}, "t": {"pos": [3, 4], "type": null, "name": "NaHS  and colonic inflammation."}}
{"relation": "ACTIVATOR", "token": ["", "2-Deoxyglucose", " increased phosphorylation of tuberous sclerosis complex 2 (TSC2) on AMPK consensus sites but did not change the amount of TSC1 bound to ", "TSC2", "."], "h": {"pos": [1, 2], "type": null, "name": "2-Deoxyglucose  increased phosphorylation of tuberous sclerosis complex 2 (TSC2) on AMPK consensus sites but did not change the amount of TSC1 bound to "}, "t": {"pos": [3, 4], "type": null, "name": "TSC2 ."}}
{"relation": "ACTIVATOR", "token": ["", "KCNK1", ", a member of the family of two-pore K(+) ion channels, is specifically induced in the livers of male mice after ", "phenobarbital", " treatment."], "h": {"pos": [1, 2], "type": null, "name": "KCNK1 , a member of the family of two-pore K(+) ion channels, is specifically induced in the livers of male mice after "}, "t": {"pos": [3, 4], "type": null, "name": "phenobarbital  treatment."}}
{"relation": "ACTIVATOR", "token": ["Overall, our findings suggest that ", "ursolic acid", " induced apoptosis in HepG2 cells via AMPK activation and ", "GSK3\u03b2", " phosphorylation as a potent chemopreventive agent."], "h": {"pos": [1, 2], "type": null, "name": "ursolic acid  induced apoptosis in HepG2 cells via AMPK activation and "}, "t": {"pos": [3, 4], "type": null, "name": "GSK3\u03b2  phosphorylation as a potent chemopreventive agent."}}
{"relation": "ACTIVATOR", "token": ["The current U.S. military and civilian oxime countermeasure, 2-[(hydroxyimino)methyl]-1-methylpyridin-1-ium chloride (2-PAM), is under consideration for replacement with a more effective ", "acetylcholinesterase", " reactivator, ", "1,1'-methylenebis{4-hydroxyiminomethyl}pyridinium dimethanesulfonate", " (MMB-4)."], "h": {"pos": [1, 2], "type": null, "name": "acetylcholinesterase  reactivator, "}, "t": {"pos": [3, 4], "type": null, "name": "1,1'-methylenebis{4-hydroxyiminomethyl}pyridinium dimethanesulfonate  (MMB-4)."}}
{"relation": "ACTIVATOR", "token": ["Liver ", "BHMT", " activity was 1.3-fold higher in rats fed the Met deficient diet containing ", "choline", ", which was reflected in corresponding increases in mRNA content and immunodetectable protein."], "h": {"pos": [1, 2], "type": null, "name": "BHMT  activity was 1.3-fold higher in rats fed the Met deficient diet containing "}, "t": {"pos": [3, 4], "type": null, "name": "choline , which was reflected in corresponding increases in mRNA content and immunodetectable protein."}}
{"relation": "ACTIVATOR", "token": ["Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to ", "NRF2", " inducers (", "sulforaphane", ", tert-butylhydroquinone, cinnamic aldehyde, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments."], "h": {"pos": [1, 2], "type": null, "name": "NRF2  inducers ("}, "t": {"pos": [3, 4], "type": null, "name": "sulforaphane , tert-butylhydroquinone, cinnamic aldehyde, and hydrogen peroxide) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments."}}
{"relation": "ACTIVATOR", "token": ["", "CCl(4)", " administration triggered inflammatory response in mice livers by activating nuclear factor-kappaB (NF-\u03baB), which coincided with the induction of tumor necrosis factor-alpha (TNF-\u03b1) and ", "cyclooxygenase-2", " (COX-2)."], "h": {"pos": [1, 2], "type": null, "name": "CCl(4)  administration triggered inflammatory response in mice livers by activating nuclear factor-kappaB (NF-\u03baB), which coincided with the induction of tumor necrosis factor-alpha (TNF-\u03b1) and "}, "t": {"pos": [3, 4], "type": null, "name": "cyclooxygenase-2  (COX-2)."}}
{"relation": "ACTIVATOR", "token": ["In conclusion, ", "fenoterol", "-induced constitutive ", "beta(2)-adrenoceptor", " activity reduces muscarinic receptor agonist- and histamine-induced contractions of bovine tracheal smooth muscle, which can be reversed by the inverse agonist timolol."], "h": {"pos": [1, 2], "type": null, "name": "fenoterol -induced constitutive "}, "t": {"pos": [3, 4], "type": null, "name": "beta(2)-adrenoceptor  activity reduces muscarinic receptor agonist- and histamine-induced contractions of bovine tracheal smooth muscle, which can be reversed by the inverse agonist timolol."}}
{"relation": "ACTIVATOR", "token": ["In PFC, ", "DEX", " caused activation of ", "AKT", ", augmentation of pro-survival Bcl-2 protein and enhanced Bcl-2/Bax protein ratio, as well Bcl-2 translocation to mitochondria."], "h": {"pos": [1, 2], "type": null, "name": "DEX  caused activation of "}, "t": {"pos": [3, 4], "type": null, "name": "AKT , augmentation of pro-survival Bcl-2 protein and enhanced Bcl-2/Bax protein ratio, as well Bcl-2 translocation to mitochondria."}}
{"relation": "ACTIVATOR", "token": ["Firstly, in the normal human renal epithelial HK-2 cells, the measurement of the expression of 30 previously reported NRF2 target genes in response to ", "NRF2", " inducers (sulforaphane, tert-butylhydroquinone, cinnamic aldehyde, and ", "hydrogen peroxide", ") showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments."], "h": {"pos": [1, 2], "type": null, "name": "NRF2  inducers (sulforaphane, tert-butylhydroquinone, cinnamic aldehyde, and "}, "t": {"pos": [3, 4], "type": null, "name": "hydrogen peroxide ) showed that the aldo-keto reductase (AKR) 1C1 is highly inducible by all treatments."}}
{"relation": "ACTIVATOR", "token": ["In general, rifampicin can act on a pattern: ", "rifampicin", " activates the ", "nuclear pregnane X receptor", " that in turn affects cytochromes P450, glucuronosyltransferases and p-glycoprotein activities."], "h": {"pos": [1, 2], "type": null, "name": "rifampicin  activates the "}, "t": {"pos": [3, 4], "type": null, "name": "nuclear pregnane X receptor  that in turn affects cytochromes P450, glucuronosyltransferases and p-glycoprotein activities."}}
{"relation": "ACTIVATOR", "token": ["Exogenous ", "C2-ceramide", " activates ", "c-fos serum response element", " via Rac-dependent signalling pathway."], "h": {"pos": [1, 2], "type": null, "name": "C2-ceramide  activates "}, "t": {"pos": [3, 4], "type": null, "name": "c-fos serum response element  via Rac-dependent signalling pathway."}}
{"relation": "ACTIVATOR", "token": ["", "Phenobarbital", " (PB), a typical ", "CAR", " activator, increased the gene expression of HIF-target genes in the livers of mice, including erythropoietin, heme oxygenase-1 and vascular endothelial growth factor-a."], "h": {"pos": [1, 2], "type": null, "name": "Phenobarbital  (PB), a typical "}, "t": {"pos": [3, 4], "type": null, "name": "CAR  activator, increased the gene expression of HIF-target genes in the livers of mice, including erythropoietin, heme oxygenase-1 and vascular endothelial growth factor-a."}}
{"relation": "ACTIVATOR", "token": ["In concert with these results, we highlighted that the secretion of pro-inflammatory cytokine and ", "NF-\u03baB", " activation induced by ", "TCDD", " can be mediated by elevation of [Ca(2+)]i in HAPI microglial cells."], "h": {"pos": [1, 2], "type": null, "name": "NF-\u03baB  activation induced by "}, "t": {"pos": [3, 4], "type": null, "name": "TCDD  can be mediated by elevation of [Ca(2+)]i in HAPI microglial cells."}}
{"relation": "ACTIVATOR", "token": ["In addition, PSE inhibited the transcriptional activity of NFAT without interfering with the ", "calcium", "-induced ", "NFAT", " dephosphorylation event, which represents the major signaling pathway for its activation."], "h": {"pos": [1, 2], "type": null, "name": "calcium -induced "}, "t": {"pos": [3, 4], "type": null, "name": "NFAT  dephosphorylation event, which represents the major signaling pathway for its activation."}}
{"relation": "ACTIVATOR", "token": ["The TXM peptides were effective in inhibiting ", "AuF", "-induced MAPK, ", "JNK", " and p38(MAPK) phosphorylation, in correlation with preventing caspase-3 cleavage and thereby PARP-1 dissociation."], "h": {"pos": [1, 2], "type": null, "name": "AuF -induced MAPK, "}, "t": {"pos": [3, 4], "type": null, "name": "JNK  and p38(MAPK) phosphorylation, in correlation with preventing caspase-3 cleavage and thereby PARP-1 dissociation."}}
{"relation": "ACTIVATOR", "token": ["Subsequent analysis revealed that ", "cucurbitacin I", " strongly activates RhoA and the ", "Rho", " effector Rho kinase (ROCK) in breast cancer cells and induces the formation of stress fibers."], "h": {"pos": [1, 2], "type": null, "name": "cucurbitacin I  strongly activates RhoA and the "}, "t": {"pos": [3, 4], "type": null, "name": "Rho  effector Rho kinase (ROCK) in breast cancer cells and induces the formation of stress fibers."}}
{"relation": "ACTIVATOR", "token": ["Interestingly, ", "ursolic acid", " increased the phosphorylation of ", "AMPK", " and coenzyme A carboxylase and also enhanced phosphorylation of GSK3\u03b2 at inactive form serine 9, whereas ursolic acid attenuated the phosphorylation of AKT and mTOR in HepG2 cells."], "h": {"pos": [1, 2], "type": null, "name": "ursolic acid  increased the phosphorylation of "}, "t": {"pos": [3, 4], "type": null, "name": "AMPK  and coenzyme A carboxylase and also enhanced phosphorylation of GSK3\u03b2 at inactive form serine 9, whereas ursolic acid attenuated the phosphorylation of AKT and mTOR in HepG2 cells."}}
{"relation": "ACTIVATOR", "token": ["Here, translocation studies using the human androgen receptor (hAR) and the human glucocorticoid receptor (hGR) were performed to aid in identifying the mechanism by which anabolic-androgenic ", "steroids", " (AAS) were activating ", "hAR", " and potentially interacting with hGR and how glucocorticoid ligands were interacting with the hGR and hAR."], "h": {"pos": [1, 2], "type": null, "name": "steroids  (AAS) were activating "}, "t": {"pos": [3, 4], "type": null, "name": "hAR  and potentially interacting with hGR and how glucocorticoid ligands were interacting with the hGR and hAR."}}
{"relation": "ACTIVATOR", "token": ["Specifically, ", "aniracetam", ", which potentiates wild-type ", "AMPA receptors", ", is ineffective on the non-desensitizing GluR3(L507Y) mutant, but has synergistic effects with lithium on wild-type receptors."], "h": {"pos": [1, 2], "type": null, "name": "aniracetam , which potentiates wild-type "}, "t": {"pos": [3, 4], "type": null, "name": "AMPA receptors , is ineffective on the non-desensitizing GluR3(L507Y) mutant, but has synergistic effects with lithium on wild-type receptors."}}
{"relation": "ACTIVATOR", "token": ["Treatment of Rat-2 fibroblast cells with ", "C2-ceramide", " caused the stimulation of ", "c-fos SRE", "-dependent reporter gene activity in a dose- and time-dependent manner by transient transfection analysis."], "h": {"pos": [1, 2], "type": null, "name": "C2-ceramide  caused the stimulation of "}, "t": {"pos": [3, 4], "type": null, "name": "c-fos SRE -dependent reporter gene activity in a dose- and time-dependent manner by transient transfection analysis."}}
{"relation": "ACTIVATOR", "token": ["", "Amprenavir", " efficiently activated ", "PXR", " and induced PXR target gene expression in vitro and in vivo."], "h": {"pos": [1, 2], "type": null, "name": "Amprenavir  efficiently activated "}, "t": {"pos": [3, 4], "type": null, "name": "PXR  and induced PXR target gene expression in vitro and in vivo."}}
{"relation": "ACTIVATOR", "token": ["Activation of ", "alpha 2B-adrenoceptors", " mediates the cardiovascular effects of ", "etomidate", "."], "h": {"pos": [1, 2], "type": null, "name": "alpha 2B-adrenoceptors  mediates the cardiovascular effects of "}, "t": {"pos": [3, 4], "type": null, "name": "etomidate ."}}
{"relation": "ACTIVATOR", "token": ["", "Pelargonidin", " activates the ", "AhR", " and induces CYP1A1 in primary human hepatocytes and human cancer cell lines HepG2 and LS174T."], "h": {"pos": [1, 2], "type": null, "name": "Pelargonidin  activates the "}, "t": {"pos": [3, 4], "type": null, "name": "AhR  and induces CYP1A1 in primary human hepatocytes and human cancer cell lines HepG2 and LS174T."}}
{"relation": "ACTIVATOR", "token": ["The results reinforce previous assumptions that ", "dopamine", " may interact with eicosanoid metabolism by means of ", "D(2) receptor", " activation, and implicate an involvement of cPLA(2) and COX-2 in this effect."], "h": {"pos": [1, 2], "type": null, "name": "dopamine  may interact with eicosanoid metabolism by means of "}, "t": {"pos": [3, 4], "type": null, "name": "D(2) receptor  activation, and implicate an involvement of cPLA(2) and COX-2 in this effect."}}
{"relation": "ACTIVATOR", "token": ["Also, ", "vinblastine", " enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, ", "inhibitor of kappaB\u03b1", " (I\u03baB\u03b1) kinase, and inositol requiring enzyme 1\u03b1."], "h": {"pos": [1, 2], "type": null, "name": "vinblastine  enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, "}, "t": {"pos": [3, 4], "type": null, "name": "inhibitor of kappaB\u03b1  (I\u03baB\u03b1) kinase, and inositol requiring enzyme 1\u03b1."}}
{"relation": "ACTIVATOR", "token": ["Both ", "BRL", " and SAL produced a significant increase in postural finger tremor in keeping with ", "beta 2-adrenoceptor", " stimulation, and this response was totally abolished by pretreatment with N20."], "h": {"pos": [1, 2], "type": null, "name": "BRL  and SAL produced a significant increase in postural finger tremor in keeping with "}, "t": {"pos": [3, 4], "type": null, "name": "beta 2-adrenoceptor  stimulation, and this response was totally abolished by pretreatment with N20."}}
{"relation": "ACTIVATOR", "token": ["", "NCFP", " binds to the CPPHA site on mGlu5 and potentiates ", "mGlu5", "-mediated responses in both recombinant and native systems."], "h": {"pos": [1, 2], "type": null, "name": "NCFP  binds to the CPPHA site on mGlu5 and potentiates "}, "t": {"pos": [3, 4], "type": null, "name": "mGlu5 -mediated responses in both recombinant and native systems."}}
{"relation": "ACTIVATOR", "token": ["CONCLUSIONS: Our results show that ", "indomethacin", ", a known cyclooxygenase (COX) inhibitor, is also an activator of ", "CA", "."], "h": {"pos": [1, 2], "type": null, "name": "indomethacin , a known cyclooxygenase (COX) inhibitor, is also an activator of "}, "t": {"pos": [3, 4], "type": null, "name": "CA ."}}
{"relation": "ACTIVATOR", "token": ["", "Cortisol", " and IFNT stimulated endometrial HSD11B1 expression and activity, increased endometrial ", "PTGS2", " activity and the amount of PG in the uterine lumen, and up-regulated many conceptus elongation-related genes in the endometrium."], "h": {"pos": [1, 2], "type": null, "name": "Cortisol  and IFNT stimulated endometrial HSD11B1 expression and activity, increased endometrial "}, "t": {"pos": [3, 4], "type": null, "name": "PTGS2  activity and the amount of PG in the uterine lumen, and up-regulated many conceptus elongation-related genes in the endometrium."}}
{"relation": "ACTIVATOR", "token": ["These results suggest that ", "epinastine", ", although identified as a 5-HT antagonist, acts as a 5-HT1 agonist and that it inhibits the noncholinergic contraction in guinea-pig airways through stimulation of a prejunctional ", "5-HT1-like receptor", ", located to sensory nerves."], "h": {"pos": [1, 2], "type": null, "name": "epinastine , although identified as a 5-HT antagonist, acts as a 5-HT1 agonist and that it inhibits the noncholinergic contraction in guinea-pig airways through stimulation of a prejunctional "}, "t": {"pos": [3, 4], "type": null, "name": "5-HT1-like receptor , located to sensory nerves."}}
{"relation": "ACTIVATOR", "token": ["In addition, ", "vinblastine", " induces the DNA-binding activities of the transcription factor ", "NF-\u03baB", ", HSF1, AP-1, and ATF-2, together with the expression of HSP70 and Bax proteins."], "h": {"pos": [1, 2], "type": null, "name": "vinblastine  induces the DNA-binding activities of the transcription factor "}, "t": {"pos": [3, 4], "type": null, "name": "NF-\u03baB , HSF1, AP-1, and ATF-2, together with the expression of HSP70 and Bax proteins."}}
{"relation": "ACTIVATOR", "token": ["Acetylcholinesterase (", "AChE", ") inhibited by the organophosphate soman (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by ", "oximes", " due to dealkylation of the soman-enzyme complex."], "h": {"pos": [1, 2], "type": null, "name": "AChE ) inhibited by the organophosphate soman (1,2,2-trimethyl-propylmethylphosphonofluoridate) rapidly becomes resistant to reactivation by "}, "t": {"pos": [3, 4], "type": null, "name": "oximes  due to dealkylation of the soman-enzyme complex."}}
{"relation": "ACTIVATOR", "token": ["The treatment of mice with ", "Fe-NTA", " alone enhances ", "ornithine decarboxylase", " activity to 4.6 folds, protein carbonyl formation increased up to 2.9 folds and DNA synthesis expressed in terms of [(3)H] thymidine incorporation increased to 3.2 folds, and antioxidants and antioxidant enzymes decreased to 1.8-2.5 folds, compared with the corresponding saline-treated controls."], "h": {"pos": [1, 2], "type": null, "name": "Fe-NTA  alone enhances "}, "t": {"pos": [3, 4], "type": null, "name": "ornithine decarboxylase  activity to 4.6 folds, protein carbonyl formation increased up to 2.9 folds and DNA synthesis expressed in terms of [(3)H] thymidine incorporation increased to 3.2 folds, and antioxidants and antioxidant enzymes decreased to 1.8-2.5 folds, compared with the corresponding saline-treated controls."}}
{"relation": "ACTIVATOR", "token": ["The ROS scavenger ", "N-acetyl l-cysteine", " and the mitochondrial antioxidant Mito-TEMPO rescued the inhibitory effect of cucurbitacin I on ", "Rac1", " activation."], "h": {"pos": [1, 2], "type": null, "name": "N-acetyl l-cysteine  and the mitochondrial antioxidant Mito-TEMPO rescued the inhibitory effect of cucurbitacin I on "}, "t": {"pos": [3, 4], "type": null, "name": "Rac1  activation."}}
{"relation": "ACTIVATOR", "token": ["Interestingly, ", "ursolic acid", " increased the phosphorylation of AMPK and coenzyme A carboxylase and also enhanced phosphorylation of ", "GSK3\u03b2", " at inactive form serine 9, whereas ursolic acid attenuated the phosphorylation of AKT and mTOR in HepG2 cells."], "h": {"pos": [1, 2], "type": null, "name": "ursolic acid  increased the phosphorylation of AMPK and coenzyme A carboxylase and also enhanced phosphorylation of "}, "t": {"pos": [3, 4], "type": null, "name": "GSK3\u03b2  at inactive form serine 9, whereas ursolic acid attenuated the phosphorylation of AKT and mTOR in HepG2 cells."}}
{"relation": "ACTIVATOR", "token": ["These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of thymidylate synthase by ", "Tomudex", " and kilobase DNA fragmentation may correlate with the reduction of p27(kip1) expression and the increase in ", "cyclin E", " and cdk2 kinase activities."], "h": {"pos": [1, 2], "type": null, "name": "Tomudex  and kilobase DNA fragmentation may correlate with the reduction of p27(kip1) expression and the increase in "}, "t": {"pos": [3, 4], "type": null, "name": "cyclin E  and cdk2 kinase activities."}}
{"relation": "ACTIVATOR", "token": ["", "5-Hydroxy-3,6,7,8,3'4'-hexamethoxyflavone", " inhibits nitric oxide production in lipopolysaccharide-stimulated BV2 microglia via NF-\u03baB suppression and ", "Nrf-2", "-dependent heme oxygenase-1 induction."], "h": {"pos": [1, 2], "type": null, "name": "5-Hydroxy-3,6,7,8,3'4'-hexamethoxyflavone  inhibits nitric oxide production in lipopolysaccharide-stimulated BV2 microglia via NF-\u03baB suppression and "}, "t": {"pos": [3, 4], "type": null, "name": "Nrf-2 -dependent heme oxygenase-1 induction."}}
{"relation": "ACTIVATOR", "token": ["Chronic consumption of ", "alcohol", " also stimulated abrupt increases in pro-inflammatory cytokines such as ", "nuclear factor (NF)-\u03baB", ", tumor necrosis factor (TNF)-\u03b1 and interleukin (IL)-1\u03b2 in liver otherwise co-administration of CNF effectively suppressed production of these cytokines dose-dependently."], "h": {"pos": [1, 2], "type": null, "name": "alcohol  also stimulated abrupt increases in pro-inflammatory cytokines such as "}, "t": {"pos": [3, 4], "type": null, "name": "nuclear factor (NF)-\u03baB , tumor necrosis factor (TNF)-\u03b1 and interleukin (IL)-1\u03b2 in liver otherwise co-administration of CNF effectively suppressed production of these cytokines dose-dependently."}}
{"relation": "ACTIVATOR", "token": ["In contrast to parenteral delivery of rBChE, which currently requires posttranslational modification for good plasma stability, an unmodified aer-rBChE pretreatment given 1-40h prior to >1 LD50 of aer-", "paraoxon", " (Px) was able to prevent inhibition of circulating ", "cholinesterase", " in a dose-dependent manner."], "h": {"pos": [1, 2], "type": null, "name": "paraoxon  (Px) was able to prevent inhibition of circulating "}, "t": {"pos": [3, 4], "type": null, "name": "cholinesterase  in a dose-dependent manner."}}
{"relation": "ACTIVATOR", "token": ["", "Aldosterone", " also induces the rapid phosphorylation of Protein Kinase D1 (", "PKD1", ")."], "h": {"pos": [1, 2], "type": null, "name": "Aldosterone  also induces the rapid phosphorylation of Protein Kinase D1 ("}, "t": {"pos": [3, 4], "type": null, "name": "PKD1 )."}}
{"relation": "ACTIVATOR", "token": ["In fact, we demonstrated a significant stimulation of ", "Nox4", " activity by 4 quinone derivatives (", "AA-861", ", tBuBHQ, tBuBQ, and duroquinone) observed in 3 different cellular models, HEK293E, T-REx\u2122, and chondrocyte cell lines."], "h": {"pos": [1, 2], "type": null, "name": "Nox4  activity by 4 quinone derivatives ("}, "t": {"pos": [3, 4], "type": null, "name": "AA-861 , tBuBHQ, tBuBQ, and duroquinone) observed in 3 different cellular models, HEK293E, T-REx\u2122, and chondrocyte cell lines."}}
{"relation": "ACTIVATOR", "token": ["The concentration response to levcromakalim (", "LEVC", "), a ", "K(ATP) channel", " opener, was significantly shifted to the left in the inflamed smooth-muscle cells."], "h": {"pos": [1, 2], "type": null, "name": "LEVC ), a "}, "t": {"pos": [3, 4], "type": null, "name": "K(ATP) channel  opener, was significantly shifted to the left in the inflamed smooth-muscle cells."}}
{"relation": "ACTIVATOR", "token": ["Histamine content, ", "HDC", " activity and HDC mRNA expression in nasal mucosa were also significantly increased after ", "TDI", " provocation."], "h": {"pos": [1, 2], "type": null, "name": "HDC  activity and HDC mRNA expression in nasal mucosa were also significantly increased after "}, "t": {"pos": [3, 4], "type": null, "name": "TDI  provocation."}}
{"relation": "ACTIVATOR", "token": ["Also, ", "vinblastine", " enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, inhibitor of kappaB\u03b1 (I\u03baB\u03b1) ", "kinase", ", and inositol requiring enzyme 1\u03b1."], "h": {"pos": [1, 2], "type": null, "name": "vinblastine  enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, inhibitor of kappaB\u03b1 (I\u03baB\u03b1) "}, "t": {"pos": [3, 4], "type": null, "name": "kinase , and inositol requiring enzyme 1\u03b1."}}
{"relation": "ACTIVATOR", "token": ["Furthermore, proteosomal inhibitor MG132 suppressed AMPK activation, ", "GSK3\u03b2", " phosphorylation, cleaved PARP and deceased AEG-1 induced by ", "ursolic acid", " in HepG2 cells."], "h": {"pos": [1, 2], "type": null, "name": "GSK3\u03b2  phosphorylation, cleaved PARP and deceased AEG-1 induced by "}, "t": {"pos": [3, 4], "type": null, "name": "ursolic acid  in HepG2 cells."}}
{"relation": "ACTIVATOR", "token": ["Also, ", "vinblastine", " enhances the phosphorylation of ", "Ras homologous protein A", ", the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, inhibitor of kappaB\u03b1 (I\u03baB\u03b1) kinase, and inositol requiring enzyme 1\u03b1."], "h": {"pos": [1, 2], "type": null, "name": "vinblastine  enhances the phosphorylation of "}, "t": {"pos": [3, 4], "type": null, "name": "Ras homologous protein A , the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, inhibitor of kappaB\u03b1 (I\u03baB\u03b1) kinase, and inositol requiring enzyme 1\u03b1."}}
{"relation": "ACTIVATOR", "token": ["Galanin attenuates cyclic AMP regulatory element-binding protein (", "CREB", ") phosphorylation induced by chronic ", "morphine", " and naloxone challenge in Cath.a cells and primary striatal cultures."], "h": {"pos": [1, 2], "type": null, "name": "CREB ) phosphorylation induced by chronic "}, "t": {"pos": [3, 4], "type": null, "name": "morphine  and naloxone challenge in Cath.a cells and primary striatal cultures."}}
{"relation": "ACTIVATOR", "token": ["Treatment with diclofenac resulted in nuclear condensation (a morphological change due to apoptosis of NSCs) 24hr after the treatment and activated caspase-3 after 6 hr, indicating that ", "diclofenac", " may cause apoptosis of neuronal cells via activation of the ", "caspase", " cascade."], "h": {"pos": [1, 2], "type": null, "name": "diclofenac  may cause apoptosis of neuronal cells via activation of the "}, "t": {"pos": [3, 4], "type": null, "name": "caspase  cascade."}}
{"relation": "ACTIVATOR", "token": ["3.\u2002", "CYP3A", " induction in the liver increased depending on the dose of DEX-P, whereas that in intestine showed a mild increase, but the induction level was almost constant regardless of the dose of ", "DEX-P", "."], "h": {"pos": [1, 2], "type": null, "name": "CYP3A  induction in the liver increased depending on the dose of DEX-P, whereas that in intestine showed a mild increase, but the induction level was almost constant regardless of the dose of "}, "t": {"pos": [3, 4], "type": null, "name": "DEX-P ."}}
{"relation": "ACTIVATOR", "token": ["The present results indicated that N-", "BPs", " induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of ", "caspase-9", " and caspase-3, and enhancing Bim expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways."], "h": {"pos": [1, 2], "type": null, "name": "BPs  induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of "}, "t": {"pos": [3, 4], "type": null, "name": "caspase-9  and caspase-3, and enhancing Bim expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways."}}
{"relation": "ACTIVATOR", "token": ["The current U.S. military and civilian oxime countermeasure, 2-[(hydroxyimino)methyl]-1-methylpyridin-1-ium chloride (2-PAM), is under consideration for replacement with a more effective ", "acetylcholinesterase", " reactivator, 1,1'-methylenebis{4-hydroxyiminomethyl}pyridinium dimethanesulfonate (", "MMB-4", ")."], "h": {"pos": [1, 2], "type": null, "name": "acetylcholinesterase  reactivator, 1,1'-methylenebis{4-hydroxyiminomethyl}pyridinium dimethanesulfonate ("}, "t": {"pos": [3, 4], "type": null, "name": "MMB-4 )."}}
{"relation": "ACTIVATOR", "token": ["Galanin attenuates ", "cyclic AMP regulatory element-binding protein", " (CREB) phosphorylation induced by chronic morphine and ", "naloxone", " challenge in Cath.a cells and primary striatal cultures."], "h": {"pos": [1, 2], "type": null, "name": "cyclic AMP regulatory element-binding protein  (CREB) phosphorylation induced by chronic morphine and "}, "t": {"pos": [3, 4], "type": null, "name": "naloxone  challenge in Cath.a cells and primary striatal cultures."}}
{"relation": "ACTIVATOR", "token": ["The results of this study suggest that ", "noradrenaline", " predominantly, but not exclusively, mediates contraction of rat aorta through the activation of an ", "alphalD-adrenoceptor", "."], "h": {"pos": [1, 2], "type": null, "name": "noradrenaline  predominantly, but not exclusively, mediates contraction of rat aorta through the activation of an "}, "t": {"pos": [3, 4], "type": null, "name": "alphalD-adrenoceptor ."}}
{"relation": "ACTIVATOR", "token": ["", "Indomethacin", " activates ", "carbonic anhydrase", " and antagonizes the effect of the specific carbonic anhydrase inhibitor acetazolamide, by a direct mechanism of action."], "h": {"pos": [1, 2], "type": null, "name": "Indomethacin  activates "}, "t": {"pos": [3, 4], "type": null, "name": "carbonic anhydrase  and antagonizes the effect of the specific carbonic anhydrase inhibitor acetazolamide, by a direct mechanism of action."}}
{"relation": "ACTIVATOR", "token": ["Finally, we found that liver kinase B1 (LKB1) phosphorylation is required for the ", "phillyrin", "-enhanced activation of ", "AMPK", " in HepG2 hepatocytes."], "h": {"pos": [1, 2], "type": null, "name": "phillyrin -enhanced activation of "}, "t": {"pos": [3, 4], "type": null, "name": "AMPK  in HepG2 hepatocytes."}}
{"relation": "ACTIVATOR", "token": ["Under isotonic conditions, ", "N-ethylmaleimide", " (NEM) produced ", "KCC", " activation and transient cell shrinkage."], "h": {"pos": [1, 2], "type": null, "name": "N-ethylmaleimide  (NEM) produced "}, "t": {"pos": [3, 4], "type": null, "name": "KCC  activation and transient cell shrinkage."}}
{"relation": "ACTIVATOR", "token": ["Also, ", "vinblastine", " enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, ", "c-jun-N-terminal kinase", ", p38, inhibitor of kappaB\u03b1 (I\u03baB\u03b1) kinase, and inositol requiring enzyme 1\u03b1."], "h": {"pos": [1, 2], "type": null, "name": "vinblastine  enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, "}, "t": {"pos": [3, 4], "type": null, "name": "c-jun-N-terminal kinase , p38, inhibitor of kappaB\u03b1 (I\u03baB\u03b1) kinase, and inositol requiring enzyme 1\u03b1."}}
{"relation": "ACTIVATOR", "token": ["The reactivation of brain ", "AChE", " inhibited with tabun demonstrated better activity of new compound BT-07-4M, ", "TMB-4", " and obidoxime from symmetric oximes, and BT-05 and BT-03 possessing asymmetric structure."], "h": {"pos": [1, 2], "type": null, "name": "AChE  inhibited with tabun demonstrated better activity of new compound BT-07-4M, "}, "t": {"pos": [3, 4], "type": null, "name": "TMB-4  and obidoxime from symmetric oximes, and BT-05 and BT-03 possessing asymmetric structure."}}
{"relation": "ACTIVATOR", "token": ["Abstract 1.\u2002We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal ", "cytochrome P450 3A", " (CYP3A) in rats using ", "dexamethasone 21-phosphate", " (DEX-P) and midazolam (MDZ) as an inducer and a substrate to CYP3A, respectively."], "h": {"pos": [1, 2], "type": null, "name": "cytochrome P450 3A  (CYP3A) in rats using "}, "t": {"pos": [3, 4], "type": null, "name": "dexamethasone 21-phosphate  (DEX-P) and midazolam (MDZ) as an inducer and a substrate to CYP3A, respectively."}}
{"relation": "ACTIVATOR", "token": ["It is concluded that ", "D-1997", " contracts the canine basilar artery by stimulating 5-HT1-like receptors unrelated to either the 5-HT1A or ", "5-HT1B", " receptor subtypes."], "h": {"pos": [1, 2], "type": null, "name": "D-1997  contracts the canine basilar artery by stimulating 5-HT1-like receptors unrelated to either the 5-HT1A or "}, "t": {"pos": [3, 4], "type": null, "name": "5-HT1B  receptor subtypes."}}
{"relation": "ACTIVATOR", "token": ["Taken together, our findings indicate that ", "5HHMF", " suppresses NO production through modulation of iNOS, consequently suppressing NF-\u03baB activity and induction of Nrf2-dependent ", "HO-1", " activity."], "h": {"pos": [1, 2], "type": null, "name": "5HHMF  suppresses NO production through modulation of iNOS, consequently suppressing NF-\u03baB activity and induction of Nrf2-dependent "}, "t": {"pos": [3, 4], "type": null, "name": "HO-1  activity."}}
{"relation": "ACTIVATOR", "token": ["Specifically, aniracetam, which potentiates wild-type AMPA receptors, is ineffective on the non-desensitizing GluR3(", "L507Y", ") mutant, but has synergistic effects with ", "lithium", " on wild-type receptors."], "h": {"pos": [1, 2], "type": null, "name": "L507Y ) mutant, but has synergistic effects with "}, "t": {"pos": [3, 4], "type": null, "name": "lithium  on wild-type receptors."}}
{"relation": "ACTIVATOR", "token": ["", "EROD", " activity induction in peripheral blood lymphocytes, liver and brain tissues of rats orally exposed to ", "polycyclic aromatic hydrocarbons", "."], "h": {"pos": [1, 2], "type": null, "name": "EROD  activity induction in peripheral blood lymphocytes, liver and brain tissues of rats orally exposed to "}, "t": {"pos": [3, 4], "type": null, "name": "polycyclic aromatic hydrocarbons ."}}
{"relation": "ACTIVATOR", "token": ["Also, ", "vinblastine", " enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, inhibitor of kappaB\u03b1 (I\u03baB\u03b1) kinase, and ", "inositol requiring enzyme 1\u03b1", "."], "h": {"pos": [1, 2], "type": null, "name": "vinblastine  enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of apoptosis signal-regulating kinase 1, c-jun-N-terminal kinase, p38, inhibitor of kappaB\u03b1 (I\u03baB\u03b1) kinase, and "}, "t": {"pos": [3, 4], "type": null, "name": "inositol requiring enzyme 1\u03b1 ."}}
{"relation": "ACTIVATOR", "token": ["The TXM peptides were effective in inhibiting ", "AuF", "-induced MAPK, JNK and p38(", "MAPK", ") phosphorylation, in correlation with preventing caspase-3 cleavage and thereby PARP-1 dissociation."], "h": {"pos": [1, 2], "type": null, "name": "AuF -induced MAPK, JNK and p38("}, "t": {"pos": [3, 4], "type": null, "name": "MAPK ) phosphorylation, in correlation with preventing caspase-3 cleavage and thereby PARP-1 dissociation."}}
{"relation": "ACTIVATOR", "token": ["Chronic consumption of ", "alcohol", " also stimulated abrupt increases in pro-inflammatory cytokines such as nuclear factor (NF)-\u03baB, tumor necrosis factor (TNF)-\u03b1 and ", "interleukin (IL)-1\u03b2", " in liver otherwise co-administration of CNF effectively suppressed production of these cytokines dose-dependently."], "h": {"pos": [1, 2], "type": null, "name": "alcohol  also stimulated abrupt increases in pro-inflammatory cytokines such as nuclear factor (NF)-\u03baB, tumor necrosis factor (TNF)-\u03b1 and "}, "t": {"pos": [3, 4], "type": null, "name": "interleukin (IL)-1\u03b2  in liver otherwise co-administration of CNF effectively suppressed production of these cytokines dose-dependently."}}
{"relation": "ACTIVATOR", "token": ["", "Indomethacin", " treatment led to an increase in lipid peroxidation, glutathione peroxidase and ", "glucose-6-phosphate dehydrogenase", " activities and to a decrease in catalase activity and glutathione levels in gastric mucosa."], "h": {"pos": [1, 2], "type": null, "name": "Indomethacin  treatment led to an increase in lipid peroxidation, glutathione peroxidase and "}, "t": {"pos": [3, 4], "type": null, "name": "glucose-6-phosphate dehydrogenase  activities and to a decrease in catalase activity and glutathione levels in gastric mucosa."}}
{"relation": "ACTIVATOR", "token": ["In the CCl4 hepatotoxicity model, pre-treatment with PSM or ", "silymarin", " resulted in significantly increased activities of ethylmorphine-N-demethylase and aniline 4-hydroxylase activity and ", "cytochrome P450", ", compared to the CCl4 only group."], "h": {"pos": [1, 2], "type": null, "name": "silymarin  resulted in significantly increased activities of ethylmorphine-N-demethylase and aniline 4-hydroxylase activity and "}, "t": {"pos": [3, 4], "type": null, "name": "cytochrome P450 , compared to the CCl4 only group."}}
{"relation": "ACTIVATOR", "token": ["The enzyme requires PLP and divalent cations such as Ca(2+), Mg(2+), or Mn(2+), but not ATP, whereas mammalian ", "serine racemase", " activity is increased by ", "ATP", "."], "h": {"pos": [1, 2], "type": null, "name": "serine racemase  activity is increased by "}, "t": {"pos": [3, 4], "type": null, "name": "ATP ."}}
{"relation": "ACTIVATOR", "token": ["", "Indomethacin", " abolished the inhibitory effect of acetazolamide on CA I and ", "CA II", "."], "h": {"pos": [1, 2], "type": null, "name": "Indomethacin  abolished the inhibitory effect of acetazolamide on CA I and "}, "t": {"pos": [3, 4], "type": null, "name": "CA II ."}}
{"relation": "ACTIVATOR", "token": ["These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of thymidylate synthase by ", "Tomudex", " and kilobase DNA fragmentation may correlate with the reduction of p27(kip1) expression and the increase in cyclin E and ", "cdk2", " kinase activities."], "h": {"pos": [1, 2], "type": null, "name": "Tomudex  and kilobase DNA fragmentation may correlate with the reduction of p27(kip1) expression and the increase in cyclin E and "}, "t": {"pos": [3, 4], "type": null, "name": "cdk2  kinase activities."}}
{"relation": "ACTIVATOR", "token": ["Thus, we found that ", "5HHMF", " enhances heme oxygenase-1 (HO-1) expression via nuclear factor-erythroid 2-related factor 2 (", "Nrf2", ") activation."], "h": {"pos": [1, 2], "type": null, "name": "5HHMF  enhances heme oxygenase-1 (HO-1) expression via nuclear factor-erythroid 2-related factor 2 ("}, "t": {"pos": [3, 4], "type": null, "name": "Nrf2 ) activation."}}
{"relation": "ACTIVATOR", "token": ["Activation of ", "AMP-activated Protein Kinase", " and Phosphorylation of Glycogen Synthase Kinase3 \u03b2 Mediate ", "Ursolic Acid", " Induced Apoptosis in HepG2 Liver Cancer Cells."], "h": {"pos": [1, 2], "type": null, "name": "AMP-activated Protein Kinase  and Phosphorylation of Glycogen Synthase Kinase3 \u03b2 Mediate "}, "t": {"pos": [3, 4], "type": null, "name": "Ursolic Acid  Induced Apoptosis in HepG2 Liver Cancer Cells."}}
{"relation": "ACTIVATOR", "token": ["Polymorphisms in dopamine transporter (", "SLC6A3", ") are associated with stimulant effects of ", "D-amphetamine", ": an exploratory pharmacogenetic study using healthy volunteers."], "h": {"pos": [1, 2], "type": null, "name": "SLC6A3 ) are associated with stimulant effects of "}, "t": {"pos": [3, 4], "type": null, "name": "D-amphetamine : an exploratory pharmacogenetic study using healthy volunteers."}}
{"relation": "ACTIVATOR", "token": ["Pretreatment with dexamethasone significantly suppressed nasal allergy-like behaviors, up-regulation of histamine content, ", "HDC", " activity and HDC mRNA induced by ", "TDI", " in TDI-sensitized rats."], "h": {"pos": [1, 2], "type": null, "name": "HDC  activity and HDC mRNA induced by "}, "t": {"pos": [3, 4], "type": null, "name": "TDI  in TDI-sensitized rats."}}
{"relation": "ACTIVATOR", "token": ["Upon activation by ", "phenobarbital", ", nuclear receptor ", "CAR", " binds the 97-bp response element (-2441/-2345) within the Kcnk1 promoter."], "h": {"pos": [1, 2], "type": null, "name": "phenobarbital , nuclear receptor "}, "t": {"pos": [3, 4], "type": null, "name": "CAR  binds the 97-bp response element (-2441/-2345) within the Kcnk1 promoter."}}
{"relation": "ACTIVATOR", "token": ["Upon activation by ", "phenobarbital", ", ", "nuclear receptor", " CAR binds the 97-bp response element (-2441/-2345) within the Kcnk1 promoter."], "h": {"pos": [1, 2], "type": null, "name": "phenobarbital , "}, "t": {"pos": [3, 4], "type": null, "name": "nuclear receptor  CAR binds the 97-bp response element (-2441/-2345) within the Kcnk1 promoter."}}
{"relation": "ACTIVATOR", "token": ["In the CCl4 hepatotoxicity model, pre-treatment with PSM or ", "silymarin", " resulted in significantly increased activities of ethylmorphine-N-demethylase and ", "aniline 4-hydroxylase", " activity and cytochrome P450, compared to the CCl4 only group."], "h": {"pos": [1, 2], "type": null, "name": "silymarin  resulted in significantly increased activities of ethylmorphine-N-demethylase and "}, "t": {"pos": [3, 4], "type": null, "name": "aniline 4-hydroxylase  activity and cytochrome P450, compared to the CCl4 only group."}}
{"relation": "ACTIVATOR", "token": ["Activation of endogenous somatostatin receptor subtype 2 (sst2) by somatostatin-14 or activation of transiently transfected rat D2 dopamine receptors (", "rD2", "(long)) by ", "quinpirole", " had no effect."], "h": {"pos": [1, 2], "type": null, "name": "rD2 (long)) by "}, "t": {"pos": [3, 4], "type": null, "name": "quinpirole  had no effect."}}
{"relation": "ACTIVATOR", "token": ["", "Amitriptyline", ", but not any other tricyclic or selective serotonin reuptake inhibitor antidepressants, promotes ", "TrkA", " autophosphorylation in primary neurons and induces neurite outgrowth in PC12 cells."], "h": {"pos": [1, 2], "type": null, "name": "Amitriptyline , but not any other tricyclic or selective serotonin reuptake inhibitor antidepressants, promotes "}, "t": {"pos": [3, 4], "type": null, "name": "TrkA  autophosphorylation in primary neurons and induces neurite outgrowth in PC12 cells."}}
{"relation": "ACTIVATOR", "token": ["Cotreatment with U0126 and YC-1 synergistically increases apoptosis in colorectal cancer cells and recapitulates the effects of ", "sulindac", " treatment on ERK1/2, ", "JNK", ", and beta-catenin."], "h": {"pos": [1, 2], "type": null, "name": "sulindac  treatment on ERK1/2, "}, "t": {"pos": [3, 4], "type": null, "name": "JNK , and beta-catenin."}}
{"relation": "ACTIVATOR", "token": ["The reactivation of brain ", "AChE", " inhibited with tabun demonstrated better activity of new compound BT-07-4M, TMB-4 and obidoxime from symmetric oximes, and BT-05 and ", "BT-03", " possessing asymmetric structure."], "h": {"pos": [1, 2], "type": null, "name": "AChE  inhibited with tabun demonstrated better activity of new compound BT-07-4M, TMB-4 and obidoxime from symmetric oximes, and BT-05 and "}, "t": {"pos": [3, 4], "type": null, "name": "BT-03  possessing asymmetric structure."}}
{"relation": "ACTIVATOR", "token": ["", "Nitrogen", "-containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of Ras signaling pathways and ", "Bim", "-mediated activation of the intrinsic apoptotic pathway."], "h": {"pos": [1, 2], "type": null, "name": "Nitrogen -containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of Ras signaling pathways and "}, "t": {"pos": [3, 4], "type": null, "name": "Bim -mediated activation of the intrinsic apoptotic pathway."}}
{"relation": "ACTIVATOR", "token": ["Moreover, treatment of U937 cells with ", "2-hydroxy-3-methylanthraquinone", " resulted in activation of ", "caspase-3", "."], "h": {"pos": [1, 2], "type": null, "name": "2-hydroxy-3-methylanthraquinone  resulted in activation of "}, "t": {"pos": [3, 4], "type": null, "name": "caspase-3 ."}}
{"relation": "ACTIVATOR", "token": ["In fact, we demonstrated a significant stimulation of ", "Nox4", " activity by 4 quinone derivatives (AA-861, ", "tBuBHQ", ", tBuBQ, and duroquinone) observed in 3 different cellular models, HEK293E, T-REx\u2122, and chondrocyte cell lines."], "h": {"pos": [1, 2], "type": null, "name": "Nox4  activity by 4 quinone derivatives (AA-861, "}, "t": {"pos": [3, 4], "type": null, "name": "tBuBHQ , tBuBQ, and duroquinone) observed in 3 different cellular models, HEK293E, T-REx\u2122, and chondrocyte cell lines."}}
{"relation": "ACTIVATOR", "token": ["Abstract 1.\u2002We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (", "CYP3A", ") in rats using dexamethasone 21-phosphate (", "DEX-P", ") and midazolam (MDZ) as an inducer and a substrate to CYP3A, respectively."], "h": {"pos": [1, 2], "type": null, "name": "CYP3A ) in rats using dexamethasone 21-phosphate ("}, "t": {"pos": [3, 4], "type": null, "name": "DEX-P ) and midazolam (MDZ) as an inducer and a substrate to CYP3A, respectively."}}
{"relation": "ACTIVATOR", "token": ["The data indicated that ", "PhIP", " could cause stomach injury, oxidative stress in rat stomachs as well as the activation of ", "c-fos", " and c-jun and inactivation of p16, which may play a role in the pathogenesis of PhIP-associated stomach cancer."], "h": {"pos": [1, 2], "type": null, "name": "PhIP  could cause stomach injury, oxidative stress in rat stomachs as well as the activation of "}, "t": {"pos": [3, 4], "type": null, "name": "c-fos  and c-jun and inactivation of p16, which may play a role in the pathogenesis of PhIP-associated stomach cancer."}}
{"relation": "ACTIVATOR", "token": ["Assays examining the ability of TFP to block S100A4-mediated disassembly of myosin-IIA filaments demonstrate that significant inhibition of S100A4 function occurs only at ", "TFP", " concentrations that promote ", "S100A4", " oligomerization."], "h": {"pos": [1, 2], "type": null, "name": "TFP  concentrations that promote "}, "t": {"pos": [3, 4], "type": null, "name": "S100A4  oligomerization."}}
{"relation": "ACTIVATOR", "token": ["RESULTS: ", "Indomethacin", ", in vitro and in vivo. induces an increase in erythorcyte ", "CA I", " and CA II activity."], "h": {"pos": [1, 2], "type": null, "name": "Indomethacin , in vitro and in vivo. induces an increase in erythorcyte "}, "t": {"pos": [3, 4], "type": null, "name": "CA I  and CA II activity."}}
{"relation": "ACTIVATOR", "token": ["Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM ", "2,3,7,8-tetrachlorodibenzodioxin", " (TCDD), the most potent activator of ", "AhR", "."], "h": {"pos": [1, 2], "type": null, "name": "2,3,7,8-tetrachlorodibenzodioxin  (TCDD), the most potent activator of "}, "t": {"pos": [3, 4], "type": null, "name": "AhR ."}}
{"relation": "ACTIVATOR", "token": ["Activation of AMP-activated Protein Kinase and Phosphorylation of ", "Glycogen Synthase Kinase3 \u03b2", " Mediate ", "Ursolic Acid", " Induced Apoptosis in HepG2 Liver Cancer Cells."], "h": {"pos": [1, 2], "type": null, "name": "Glycogen Synthase Kinase3 \u03b2  Mediate "}, "t": {"pos": [3, 4], "type": null, "name": "Ursolic Acid  Induced Apoptosis in HepG2 Liver Cancer Cells."}}
{"relation": "ACTIVATOR", "token": ["These results suggest that the megabase DNA fragmentation is induced as a consequence of inhibition of thymidylate synthase by ", "Tomudex", " and kilobase DNA fragmentation may correlate with the reduction of p27(kip1) expression and the increase in cyclin E and cdk2 ", "kinase", " activities."], "h": {"pos": [1, 2], "type": null, "name": "Tomudex  and kilobase DNA fragmentation may correlate with the reduction of p27(kip1) expression and the increase in cyclin E and cdk2 "}, "t": {"pos": [3, 4], "type": null, "name": "kinase  activities."}}
{"relation": "ACTIVATOR", "token": ["Abstract 1.\u2002We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (CYP3A) in rats using dexamethasone 21-phosphate (DEX-P) and ", "midazolam", " (MDZ) as an inducer and a substrate to ", "CYP3A", ", respectively."], "h": {"pos": [1, 2], "type": null, "name": "midazolam  (MDZ) as an inducer and a substrate to "}, "t": {"pos": [3, 4], "type": null, "name": "CYP3A , respectively."}}
{"relation": "ACTIVATOR", "token": ["Since ", "gemfibrozil", " is known to activate ", "peroxisome proliferator-activated receptor-alpha", " (PPAR-alpha), we investigated the role of PPAR-alpha in gemfibrozil-mediated inhibition of iNOS."], "h": {"pos": [1, 2], "type": null, "name": "gemfibrozil  is known to activate "}, "t": {"pos": [3, 4], "type": null, "name": "peroxisome proliferator-activated receptor-alpha  (PPAR-alpha), we investigated the role of PPAR-alpha in gemfibrozil-mediated inhibition of iNOS."}}
{"relation": "ACTIVATOR", "token": ["The present results indicated that N-", "BPs", " induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and ", "caspase-3", ", and enhancing Bim expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways."], "h": {"pos": [1, 2], "type": null, "name": "BPs  induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and "}, "t": {"pos": [3, 4], "type": null, "name": "caspase-3 , and enhancing Bim expression through inhibition of the Ras/MEK/ERK and Ras/mTOR pathways."}}
{"relation": "ACTIVATOR", "token": ["Functional and biochemical studies indicated that ", "TES", " signaling involved activity of the phosphoinositide 3 (PI3) kinase-protein kinase B (Akt) cascade initiated by activation of the ", "androgen receptor", " and culminated in enhanced production of cGMP and microvascular vasodilation."], "h": {"pos": [1, 2], "type": null, "name": "TES  signaling involved activity of the phosphoinositide 3 (PI3) kinase-protein kinase B (Akt) cascade initiated by activation of the "}, "t": {"pos": [3, 4], "type": null, "name": "androgen receptor  and culminated in enhanced production of cGMP and microvascular vasodilation."}}
{"relation": "ACTIVATOR", "token": ["In addition, cobalt protoporphyrin (", "CoPP", "), a specific ", "HO-1", " inducer, predominantly suppressed LPS-induced NO production."], "h": {"pos": [1, 2], "type": null, "name": "CoPP ), a specific "}, "t": {"pos": [3, 4], "type": null, "name": "HO-1  inducer, predominantly suppressed LPS-induced NO production."}}
{"relation": "ACTIVATOR", "token": ["", "Indomethacin", " completely antagonizes CA activity, i.e. abolishes the inhibitory effect of acetazolamide on ", "CA", "."], "h": {"pos": [1, 2], "type": null, "name": "Indomethacin  completely antagonizes CA activity, i.e. abolishes the inhibitory effect of acetazolamide on "}, "t": {"pos": [3, 4], "type": null, "name": "CA ."}}
{"relation": "ACTIVATOR", "token": ["", "2-Deoxyglucose", " increased phosphorylation of ", "tuberous sclerosis complex 2", " (TSC2) on AMPK consensus sites but did not change the amount of TSC1 bound to TSC2."], "h": {"pos": [1, 2], "type": null, "name": "2-Deoxyglucose  increased phosphorylation of "}, "t": {"pos": [3, 4], "type": null, "name": "tuberous sclerosis complex 2  (TSC2) on AMPK consensus sites but did not change the amount of TSC1 bound to TSC2."}}
{"relation": "ACTIVATOR", "token": ["Taken together, these findings indicate that ", "antofine", " induces Cx43 gap junction disassembly by the ", "PKC\u03b2", " signaling pathway."], "h": {"pos": [1, 2], "type": null, "name": "antofine  induces Cx43 gap junction disassembly by the "}, "t": {"pos": [3, 4], "type": null, "name": "PKC\u03b2  signaling pathway."}}
{"relation": "ACTIVATOR", "token": ["In fact, we demonstrated a significant stimulation of ", "Nox4", " activity by 4 ", "quinone", " derivatives (AA-861, tBuBHQ, tBuBQ, and duroquinone) observed in 3 different cellular models, HEK293E, T-REx\u2122, and chondrocyte cell lines."], "h": {"pos": [1, 2], "type": null, "name": "Nox4  activity by 4 "}, "t": {"pos": [3, 4], "type": null, "name": "quinone  derivatives (AA-861, tBuBHQ, tBuBQ, and duroquinone) observed in 3 different cellular models, HEK293E, T-REx\u2122, and chondrocyte cell lines."}}
{"relation": "ACTIVATOR", "token": ["", "2-Deoxyglucose", " increased phosphorylation of tuberous sclerosis complex 2 (", "TSC2", ") on AMPK consensus sites but did not change the amount of TSC1 bound to TSC2."], "h": {"pos": [1, 2], "type": null, "name": "2-Deoxyglucose  increased phosphorylation of tuberous sclerosis complex 2 ("}, "t": {"pos": [3, 4], "type": null, "name": "TSC2 ) on AMPK consensus sites but did not change the amount of TSC1 bound to TSC2."}}
{"relation": "ACTIVATOR", "token": ["Activation of endogenous ", "somatostatin receptor subtype 2", " (sst2) by ", "somatostatin-14", " or activation of transiently transfected rat D2 dopamine receptors (rD2(long)) by quinpirole had no effect."], "h": {"pos": [1, 2], "type": null, "name": "somatostatin receptor subtype 2  (sst2) by "}, "t": {"pos": [3, 4], "type": null, "name": "somatostatin-14  or activation of transiently transfected rat D2 dopamine receptors (rD2(long)) by quinpirole had no effect."}}
{"relation": "ACTIVATOR", "token": ["Since gemfibrozil is known to activate peroxisome proliferator-activated receptor-alpha (PPAR-alpha), we investigated the role of ", "PPAR-alpha", " in ", "gemfibrozil", "-mediated inhibition of iNOS."], "h": {"pos": [1, 2], "type": null, "name": "PPAR-alpha  in "}, "t": {"pos": [3, 4], "type": null, "name": "gemfibrozil -mediated inhibition of iNOS."}}
{"relation": "ACTIVATOR", "token": ["Prolonged use of ", "tolvaptan", " leads to increased endogenous levels of AVP and perhaps over-stimulation of ", "V(1A) receptors", "."], "h": {"pos": [1, 2], "type": null, "name": "tolvaptan  leads to increased endogenous levels of AVP and perhaps over-stimulation of "}, "t": {"pos": [3, 4], "type": null, "name": "V(1A) receptors ."}}
{"relation": "ACTIVATOR", "token": ["Together, our findings suggest the critical role of 'Rac and subsequent activation of ", "phospholipase A2", "' in ", "ceramide", "-signalling to nucleus."], "h": {"pos": [1, 2], "type": null, "name": "phospholipase A2 ' in "}, "t": {"pos": [3, 4], "type": null, "name": "ceramide -signalling to nucleus."}}
{"relation": "ACTIVATOR", "token": ["Also, ", "vinblastine", " enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of ", "apoptosis signal-regulating kinase 1", ", c-jun-N-terminal kinase, p38, inhibitor of kappaB\u03b1 (I\u03baB\u03b1) kinase, and inositol requiring enzyme 1\u03b1."], "h": {"pos": [1, 2], "type": null, "name": "vinblastine  enhances the phosphorylation of Ras homologous protein A, the accumulation of reactive oxygen species, the release of intracellular Ca(2+), as well as the activation of "}, "t": {"pos": [3, 4], "type": null, "name": "apoptosis signal-regulating kinase 1 , c-jun-N-terminal kinase, p38, inhibitor of kappaB\u03b1 (I\u03baB\u03b1) kinase, and inositol requiring enzyme 1\u03b1."}}
{"relation": "ACTIVATOR", "token": ["Galanin attenuates ", "cyclic AMP regulatory element-binding protein", " (CREB) phosphorylation induced by chronic ", "morphine", " and naloxone challenge in Cath.a cells and primary striatal cultures."], "h": {"pos": [1, 2], "type": null, "name": "cyclic AMP regulatory element-binding protein  (CREB) phosphorylation induced by chronic "}, "t": {"pos": [3, 4], "type": null, "name": "morphine  and naloxone challenge in Cath.a cells and primary striatal cultures."}}
{"relation": "ACTIVATOR", "token": ["", "cAspAT", " activity, as well as the incorporation of [(14)C]aspartate into the neutral lipid fraction of 3T3-F442A adipocytes was stimulated by the thiazolidinedione (TZD) ", "rosiglitazone", "."], "h": {"pos": [1, 2], "type": null, "name": "cAspAT  activity, as well as the incorporation of [(14)C]aspartate into the neutral lipid fraction of 3T3-F442A adipocytes was stimulated by the thiazolidinedione (TZD) "}, "t": {"pos": [3, 4], "type": null, "name": "rosiglitazone ."}}
{"relation": "ACTIVATOR", "token": ["Activating ", "glucocorticoid receptor", "-ERK signaling pathway contributes to ", "ginsenoside Rg1", " protection against \u03b2-amyloid peptide-induced human endothelial cells apoptosis."], "h": {"pos": [1, 2], "type": null, "name": "glucocorticoid receptor -ERK signaling pathway contributes to "}, "t": {"pos": [3, 4], "type": null, "name": "ginsenoside Rg1  protection against \u03b2-amyloid peptide-induced human endothelial cells apoptosis."}}
{"relation": "ACTIVATOR", "token": ["Analysis of splice variants and site-directed mutants of the AMPA receptor GluR3 expressed in Xenopus oocytes has shown that ", "lithium", " produces a large potentiation of the ", "GluR3 flop", " splice variant and suggested that lithium might inhibit rapid desensitization, which is characteristic of this receptor (Karkanias, N. and Papke, R., Subtype-specific effects of lithium on glutamate receptor function. J. Neurophysiol., 81 (1999) 1506-1512)."], "h": {"pos": [1, 2], "type": null, "name": "lithium  produces a large potentiation of the "}, "t": {"pos": [3, 4], "type": null, "name": "GluR3 flop  splice variant and suggested that lithium might inhibit rapid desensitization, which is characteristic of this receptor (Karkanias, N. and Papke, R., Subtype-specific effects of lithium on glutamate receptor function. J. Neurophysiol., 81 (1999) 1506-1512)."}}
{"relation": "ACTIVATOR", "token": ["", "Fluoride", " treatment also increased phosphorylation of JNK and ", "ERK", ", but not p38, and apoptosis induced by fluoride was notably or partly suppressed by treatment with JNK or ERK inhibitors, respectively."], "h": {"pos": [1, 2], "type": null, "name": "Fluoride  treatment also increased phosphorylation of JNK and "}, "t": {"pos": [3, 4], "type": null, "name": "ERK , but not p38, and apoptosis induced by fluoride was notably or partly suppressed by treatment with JNK or ERK inhibitors, respectively."}}
{"relation": "ACTIVATOR", "token": ["In addition, ", "vinblastine", " induces the DNA-binding activities of the transcription factor NF-\u03baB, HSF1, ", "AP-1", ", and ATF-2, together with the expression of HSP70 and Bax proteins."], "h": {"pos": [1, 2], "type": null, "name": "vinblastine  induces the DNA-binding activities of the transcription factor NF-\u03baB, HSF1, "}, "t": {"pos": [3, 4], "type": null, "name": "AP-1 , and ATF-2, together with the expression of HSP70 and Bax proteins."}}
{"relation": "ACTIVATOR", "token": ["Phosphorylation of ", "AMPK", " at Thr172 increased by 1.4-fold within 5 min, and remained elevated throughout a 30-min time course, in response to ", "2-deoxyglucose", "."], "h": {"pos": [1, 2], "type": null, "name": "AMPK  at Thr172 increased by 1.4-fold within 5 min, and remained elevated throughout a 30-min time course, in response to "}, "t": {"pos": [3, 4], "type": null, "name": "2-deoxyglucose ."}}
{"relation": "ACTIVATOR", "token": ["", "Fluoride", " treatment also increased phosphorylation of ", "JNK", " and ERK, but not p38, and apoptosis induced by fluoride was notably or partly suppressed by treatment with JNK or ERK inhibitors, respectively."], "h": {"pos": [1, 2], "type": null, "name": "Fluoride  treatment also increased phosphorylation of "}, "t": {"pos": [3, 4], "type": null, "name": "JNK  and ERK, but not p38, and apoptosis induced by fluoride was notably or partly suppressed by treatment with JNK or ERK inhibitors, respectively."}}
{"relation": "ACTIVATOR", "token": ["In the CCl4 hepatotoxicity model, pre-treatment with PSM or ", "silymarin", " resulted in significantly increased activities of ", "ethylmorphine-N-demethylase", " and aniline 4-hydroxylase activity and cytochrome P450, compared to the CCl4 only group."], "h": {"pos": [1, 2], "type": null, "name": "silymarin  resulted in significantly increased activities of "}, "t": {"pos": [3, 4], "type": null, "name": "ethylmorphine-N-demethylase  and aniline 4-hydroxylase activity and cytochrome P450, compared to the CCl4 only group."}}
{"relation": "ACTIVATOR", "token": ["The reactivation of brain ", "AChE", " inhibited with tabun demonstrated better activity of new compound BT-07-4M, TMB-4 and obidoxime from symmetric oximes, and ", "BT-05", " and BT-03 possessing asymmetric structure."], "h": {"pos": [1, 2], "type": null, "name": "AChE  inhibited with tabun demonstrated better activity of new compound BT-07-4M, TMB-4 and obidoxime from symmetric oximes, and "}, "t": {"pos": [3, 4], "type": null, "name": "BT-05  and BT-03 possessing asymmetric structure."}}
{"relation": "ACTIVATOR", "token": ["Thus, in 158N cells, the ability of ", "oxysterols", " to trigger a mode of cell death by apoptosis involving GSK-3 and ", "caspase-3", " activation is independent of the increase in the Ca(2+) level and of their accumulation in lipid raft microdomains."], "h": {"pos": [1, 2], "type": null, "name": "oxysterols  to trigger a mode of cell death by apoptosis involving GSK-3 and "}, "t": {"pos": [3, 4], "type": null, "name": "caspase-3  activation is independent of the increase in the Ca(2+) level and of their accumulation in lipid raft microdomains."}}
{"relation": "ACTIVATOR", "token": ["High ", "glucose", " (HG) induces apoptosis of podocytes, inhibits AMPK activation, inactivates tuberin and activates ", "mTOR", "."], "h": {"pos": [1, 2], "type": null, "name": "glucose  (HG) induces apoptosis of podocytes, inhibits AMPK activation, inactivates tuberin and activates "}, "t": {"pos": [3, 4], "type": null, "name": "mTOR ."}}
{"relation": "ACTIVATOR", "token": ["", "Phospholipase A2", " inhibitors ", "p-bromophenacyl bromide", " and arachidonyl trifluoromethyl ketone suppressed interleukin-2 (IL-2) expression in murine primary splenocytes."], "h": {"pos": [1, 2], "type": null, "name": "Phospholipase A2  inhibitors "}, "t": {"pos": [3, 4], "type": null, "name": "p-bromophenacyl bromide  and arachidonyl trifluoromethyl ketone suppressed interleukin-2 (IL-2) expression in murine primary splenocytes."}}
{"relation": "ACTIVATOR", "token": ["", "Methylphenidate", " increased ", "DAT", " Vmax in SHR mPFC and decreased DAT Vmax in WKY OFC."], "h": {"pos": [1, 2], "type": null, "name": "Methylphenidate  increased "}, "t": {"pos": [3, 4], "type": null, "name": "DAT  Vmax in SHR mPFC and decreased DAT Vmax in WKY OFC."}}
{"relation": "ACTIVATOR", "token": ["Recently, it has been shown that the activation of particular ", "T2R", " bitter taste receptors is partially involved with the bitter aftertaste sensation of ", "saccharin", " and acesulfame-K."], "h": {"pos": [1, 2], "type": null, "name": "T2R  bitter taste receptors is partially involved with the bitter aftertaste sensation of "}, "t": {"pos": [3, 4], "type": null, "name": "saccharin  and acesulfame-K."}}
{"relation": "ACTIVATOR", "token": ["Such model of ", "Nox4", " activity regulation could provide new insight into the understanding of the molecular mechanism of the electron transfer through the enzyme, i.e., its potential redox regulation, and could also define new therapeutic targets in diseases in which ", "quinones", " and Nox4 are implicated."], "h": {"pos": [1, 2], "type": null, "name": "Nox4  activity regulation could provide new insight into the understanding of the molecular mechanism of the electron transfer through the enzyme, i.e., its potential redox regulation, and could also define new therapeutic targets in diseases in which "}, "t": {"pos": [3, 4], "type": null, "name": "quinones  and Nox4 are implicated."}}
{"relation": "ACTIVATOR", "token": ["Moreover, GCs have a synergistic effect on ", "GW4064", "-induced ", "FXR", " activation, whereas chenodeoxycholate and GW4064 have an additive effect."], "h": {"pos": [1, 2], "type": null, "name": "GW4064 -induced "}, "t": {"pos": [3, 4], "type": null, "name": "FXR  activation, whereas chenodeoxycholate and GW4064 have an additive effect."}}
{"relation": "ACTIVATOR", "token": ["3.\u2002", "CYP3A", " induction in the liver increased depending on the dose of ", "DEX-P", ", whereas that in intestine showed a mild increase, but the induction level was almost constant regardless of the dose of DEX-P."], "h": {"pos": [1, 2], "type": null, "name": "CYP3A  induction in the liver increased depending on the dose of "}, "t": {"pos": [3, 4], "type": null, "name": "DEX-P , whereas that in intestine showed a mild increase, but the induction level was almost constant regardless of the dose of DEX-P."}}
{"relation": "ACTIVATOR", "token": ["Combined treatment of ", "Mn", " and DA further augments cell toxicity, ROS production and ", "JNK", " phosphorylation in LRRK2 deficient cells compared to controls."], "h": {"pos": [1, 2], "type": null, "name": "Mn  and DA further augments cell toxicity, ROS production and "}, "t": {"pos": [3, 4], "type": null, "name": "JNK  phosphorylation in LRRK2 deficient cells compared to controls."}}
{"relation": "ACTIVATOR", "token": ["Here, we have determined the molecular mechanism of this male-specific activation of the Kcnk1 gene and characterized ", "KCNK1", " as a ", "phenobarbital", "-inducible antihyperplasia factor."], "h": {"pos": [1, 2], "type": null, "name": "KCNK1  as a "}, "t": {"pos": [3, 4], "type": null, "name": "phenobarbital -inducible antihyperplasia factor."}}
{"relation": "ACTIVATOR", "token": ["", "AMPK", " activators ", "metformin", " and AICAR partly prevented the cell cycle block, oxidative stress and apoptosis induced by compound C."], "h": {"pos": [1, 2], "type": null, "name": "AMPK  activators "}, "t": {"pos": [3, 4], "type": null, "name": "metformin  and AICAR partly prevented the cell cycle block, oxidative stress and apoptosis induced by compound C."}}
{"relation": "ACTIVATOR", "token": ["In fact, we demonstrated a significant stimulation of ", "Nox4", " activity by 4 quinone derivatives (AA-861, tBuBHQ, ", "tBuBQ", ", and duroquinone) observed in 3 different cellular models, HEK293E, T-REx\u2122, and chondrocyte cell lines."], "h": {"pos": [1, 2], "type": null, "name": "Nox4  activity by 4 quinone derivatives (AA-861, tBuBHQ, "}, "t": {"pos": [3, 4], "type": null, "name": "tBuBQ , and duroquinone) observed in 3 different cellular models, HEK293E, T-REx\u2122, and chondrocyte cell lines."}}
{"relation": "ACTIVATOR", "token": ["Phosphorylation of ER-stress marker ", "eIF2\u03b1", " was also increased but only at 30 min of ", "2-deoxyglucose", " exposure."], "h": {"pos": [1, 2], "type": null, "name": "eIF2\u03b1  was also increased but only at 30 min of "}, "t": {"pos": [3, 4], "type": null, "name": "2-deoxyglucose  exposure."}}
{"relation": "ACTIVATOR", "token": ["", "Cortisol", " and IFNT stimulated endometrial ", "HSD11B1", " expression and activity, increased endometrial PTGS2 activity and the amount of PG in the uterine lumen, and up-regulated many conceptus elongation-related genes in the endometrium."], "h": {"pos": [1, 2], "type": null, "name": "Cortisol  and IFNT stimulated endometrial "}, "t": {"pos": [3, 4], "type": null, "name": "HSD11B1  expression and activity, increased endometrial PTGS2 activity and the amount of PG in the uterine lumen, and up-regulated many conceptus elongation-related genes in the endometrium."}}
{"relation": "ACTIVATOR", "token": ["Specifically, aniracetam, which potentiates wild-type AMPA receptors, is ineffective on the non-desensitizing ", "GluR3", "(L507Y) mutant, but has synergistic effects with ", "lithium", " on wild-type receptors."], "h": {"pos": [1, 2], "type": null, "name": "GluR3 (L507Y) mutant, but has synergistic effects with "}, "t": {"pos": [3, 4], "type": null, "name": "lithium  on wild-type receptors."}}
{"relation": "ACTIVATOR", "token": ["", "2-Deoxyglucose", " increased phosphorylation of tuberous sclerosis complex 2 (TSC2) on ", "AMPK", " consensus sites but did not change the amount of TSC1 bound to TSC2."], "h": {"pos": [1, 2], "type": null, "name": "2-Deoxyglucose  increased phosphorylation of tuberous sclerosis complex 2 (TSC2) on "}, "t": {"pos": [3, 4], "type": null, "name": "AMPK  consensus sites but did not change the amount of TSC1 bound to TSC2."}}
{"relation": "ACTIVATOR", "token": ["Subsequent analysis revealed that ", "cucurbitacin I", " strongly activates RhoA and the Rho effector ", "Rho kinase", " (ROCK) in breast cancer cells and induces the formation of stress fibers."], "h": {"pos": [1, 2], "type": null, "name": "cucurbitacin I  strongly activates RhoA and the Rho effector "}, "t": {"pos": [3, 4], "type": null, "name": "Rho kinase  (ROCK) in breast cancer cells and induces the formation of stress fibers."}}
{"relation": "ACTIVATOR", "token": ["The ", "BH(4)", " treatment was associated with a 2-fold increase in ", "eNOS", " activity as well as a 70% reduction in endothelial O(2)(-) production compared with those in fructose-fed rats."], "h": {"pos": [1, 2], "type": null, "name": "BH(4)  treatment was associated with a 2-fold increase in "}, "t": {"pos": [3, 4], "type": null, "name": "eNOS  activity as well as a 70% reduction in endothelial O(2)(-) production compared with those in fructose-fed rats."}}
{"relation": "ACTIVATOR", "token": ["", "Phillyrin", " attenuates high glucose-induced lipid accumulation in human HepG2 hepatocytes through the activation of ", "LKB1", "/AMP-activated protein kinase-dependent signalling."], "h": {"pos": [1, 2], "type": null, "name": "Phillyrin  attenuates high glucose-induced lipid accumulation in human HepG2 hepatocytes through the activation of "}, "t": {"pos": [3, 4], "type": null, "name": "LKB1 /AMP-activated protein kinase-dependent signalling."}}
{"relation": "ACTIVATOR", "token": ["", "Indomethacin", " activates carbonic anhydrase and antagonizes the effect of the specific ", "carbonic anhydrase", " inhibitor acetazolamide, by a direct mechanism of action."], "h": {"pos": [1, 2], "type": null, "name": "Indomethacin  activates carbonic anhydrase and antagonizes the effect of the specific "}, "t": {"pos": [3, 4], "type": null, "name": "carbonic anhydrase  inhibitor acetazolamide, by a direct mechanism of action."}}
{"relation": "ACTIVATOR", "token": ["", "DBDCT", " also caused the phosphorylation of JNK and p38(", "MAPK", ")."], "h": {"pos": [1, 2], "type": null, "name": "DBDCT  also caused the phosphorylation of JNK and p38("}, "t": {"pos": [3, 4], "type": null, "name": "MAPK )."}}
{"relation": "ACTIVATOR", "token": ["", "cAspAT", " activity, as well as the incorporation of [(14)C]aspartate into the neutral lipid fraction of 3T3-F442A adipocytes was stimulated by the thiazolidinedione (", "TZD", ") rosiglitazone."], "h": {"pos": [1, 2], "type": null, "name": "cAspAT  activity, as well as the incorporation of [(14)C]aspartate into the neutral lipid fraction of 3T3-F442A adipocytes was stimulated by the thiazolidinedione ("}, "t": {"pos": [3, 4], "type": null, "name": "TZD ) rosiglitazone."}}
{"relation": "ACTIVATOR", "token": ["Extracellular ", "L-arginine", " also dose-dependently increased NO release and ", "arginase", " activity."], "h": {"pos": [1, 2], "type": null, "name": "L-arginine  also dose-dependently increased NO release and "}, "t": {"pos": [3, 4], "type": null, "name": "arginase  activity."}}
{"relation": "ACTIVATOR", "token": ["Abstract 1.\u2002We investigated the effects of the dose of and the number of times an inducer was administered and the duration of induction of hepatic and intestinal cytochrome P450 3A (CYP3A) in rats using ", "dexamethasone 21-phosphate", " (DEX-P) and midazolam (MDZ) as an inducer and a substrate to ", "CYP3A", ", respectively."], "h": {"pos": [1, 2], "type": null, "name": "dexamethasone 21-phosphate  (DEX-P) and midazolam (MDZ) as an inducer and a substrate to "}, "t": {"pos": [3, 4], "type": null, "name": "CYP3A , respectively."}}
{"relation": "ACTIVATOR", "token": ["Peroxisome proliferator-activated receptor-\u03b1 (PPAR\u03b1) activation mimicked the effects of ", "resveratrol", " while PPAR\u03b1 inhibition prevented the effects of this ", "SIRT1", " activator."], "h": {"pos": [1, 2], "type": null, "name": "resveratrol  while PPAR\u03b1 inhibition prevented the effects of this "}, "t": {"pos": [3, 4], "type": null, "name": "SIRT1  activator."}}
{"relation": "ACTIVATOR", "token": ["When HUVECs were stimulated by thrombin without extracellular L-arginine, ", "Nor-NOHA", " dose-dependently increased the ", "NOS", " activity and the NO release with maximal effects at 20 microM."], "h": {"pos": [1, 2], "type": null, "name": "Nor-NOHA  dose-dependently increased the "}, "t": {"pos": [3, 4], "type": null, "name": "NOS  activity and the NO release with maximal effects at 20 microM."}}
{"relation": "ACTIVATOR", "token": ["In addition, ", "vinblastine", " induces the DNA-binding activities of the transcription factor NF-\u03baB, ", "HSF1", ", AP-1, and ATF-2, together with the expression of HSP70 and Bax proteins."], "h": {"pos": [1, 2], "type": null, "name": "vinblastine  induces the DNA-binding activities of the transcription factor NF-\u03baB, "}, "t": {"pos": [3, 4], "type": null, "name": "HSF1 , AP-1, and ATF-2, together with the expression of HSP70 and Bax proteins."}}
{"relation": "ACTIVATOR", "token": ["It was concluded that ", "PGE1", " selectively reduces both N- and R-type Ca2+ currents by activating a ", "G-protein", " probably through the EP3 receptor in paratracheal ganglion cells."], "h": {"pos": [1, 2], "type": null, "name": "PGE1  selectively reduces both N- and R-type Ca2+ currents by activating a "}, "t": {"pos": [3, 4], "type": null, "name": "G-protein  probably through the EP3 receptor in paratracheal ganglion cells."}}
{"relation": "ACTIVATOR", "token": ["", "Indomethacin", " completely antagonizes ", "CA", " activity, i.e. abolishes the inhibitory effect of acetazolamide on CA."], "h": {"pos": [1, 2], "type": null, "name": "Indomethacin  completely antagonizes "}, "t": {"pos": [3, 4], "type": null, "name": "CA  activity, i.e. abolishes the inhibitory effect of acetazolamide on CA."}}
{"relation": "ACTIVATOR", "token": ["However, Ca(2+) blockers also obviously attenuated ", "NF-\u03baB", " activation and transnuclear transport induced by ", "TCDD", "."], "h": {"pos": [1, 2], "type": null, "name": "NF-\u03baB  activation and transnuclear transport induced by "}, "t": {"pos": [3, 4], "type": null, "name": "TCDD ."}}
{"relation": "ACTIVATOR", "token": ["In the CCl4 hepatotoxicity model, pre-treatment with PSM or silymarin resulted in significantly increased activities of ", "ethylmorphine-N-demethylase", " and aniline 4-hydroxylase activity and cytochrome P450, compared to the ", "CCl4", " only group."], "h": {"pos": [1, 2], "type": null, "name": "ethylmorphine-N-demethylase  and aniline 4-hydroxylase activity and cytochrome P450, compared to the "}, "t": {"pos": [3, 4], "type": null, "name": "CCl4  only group."}}
{"relation": "ACTIVATOR", "token": ["The CYP3A4 activity could be induced 2-fold by ", "rifampicin", ", whereas ", "CYP2C9", " activity remained equally high."], "h": {"pos": [1, 2], "type": null, "name": "rifampicin , whereas "}, "t": {"pos": [3, 4], "type": null, "name": "CYP2C9  activity remained equally high."}}
{"relation": "AGONIST-ACTIVATOR", "token": ["The results suggested that both the EtOAc extract and berberine were able to activate ", "PPAR\u03b1/\u03b2/\u03b3", ", and Rhizoma Coptis contains potential natural agonists of PPARs besides ", "berberine", "."], "h": {"pos": [1, 2], "type": null, "name": "PPAR\u03b1/\u03b2/\u03b3 , and Rhizoma Coptis contains potential natural agonists of PPARs besides "}, "t": {"pos": [3, 4], "type": null, "name": "berberine ."}}
{"relation": "AGONIST-ACTIVATOR", "token": ["RESULTS: ", "DRF 2655", " showed concentration-dependent transactivation of ", "PPARalpha", " and PPARgamma."], "h": {"pos": [1, 2], "type": null, "name": "DRF 2655  showed concentration-dependent transactivation of "}, "t": {"pos": [3, 4], "type": null, "name": "PPARalpha  and PPARgamma."}}
{"relation": "AGONIST-ACTIVATOR", "token": ["The results suggested that both the ", "EtOAc", " extract and berberine were able to activate ", "PPAR\u03b1/\u03b2/\u03b3", ", and Rhizoma Coptis contains potential natural agonists of PPARs besides berberine."], "h": {"pos": [1, 2], "type": null, "name": "EtOAc  extract and berberine were able to activate "}, "t": {"pos": [3, 4], "type": null, "name": "PPAR\u03b1/\u03b2/\u03b3 , and Rhizoma Coptis contains potential natural agonists of PPARs besides berberine."}}
{"relation": "AGONIST-ACTIVATOR", "token": ["The results suggested that both the EtOAc extract and ", "berberine", " were able to activate ", "PPAR\u03b1/\u03b2/\u03b3", ", and Rhizoma Coptis contains potential natural agonists of PPARs besides berberine."], "h": {"pos": [1, 2], "type": null, "name": "berberine  were able to activate "}, "t": {"pos": [3, 4], "type": null, "name": "PPAR\u03b1/\u03b2/\u03b3 , and Rhizoma Coptis contains potential natural agonists of PPARs besides berberine."}}
{"relation": "AGONIST-ACTIVATOR", "token": ["RESULTS: ", "DRF 2655", " showed concentration-dependent transactivation of PPARalpha and ", "PPARgamma", "."], "h": {"pos": [1, 2], "type": null, "name": "DRF 2655  showed concentration-dependent transactivation of PPARalpha and "}, "t": {"pos": [3, 4], "type": null, "name": "PPARgamma ."}}
{"relation": "AGONIST-INHIBITOR", "token": ["Pretreatment of the tissues with combined ", "5-HT1", "/5-HT2 antagonists, methysergide (1 microM) or methiothepin (0.1 microM), significantly attenuated the inhibitory effect of ", "epinastine", " on the noncholinergic contraction."], "h": {"pos": [1, 2], "type": null, "name": "5-HT1 /5-HT2 antagonists, methysergide (1 microM) or methiothepin (0.1 microM), significantly attenuated the inhibitory effect of "}, "t": {"pos": [3, 4], "type": null, "name": "epinastine  on the noncholinergic contraction."}}
{"relation": "AGONIST-INHIBITOR", "token": ["Pretreatment of the tissues with combined 5-HT1/", "5-HT2", " antagonists, methysergide (1 microM) or methiothepin (0.1 microM), significantly attenuated the inhibitory effect of ", "epinastine", " on the noncholinergic contraction."], "h": {"pos": [1, 2], "type": null, "name": "5-HT2  antagonists, methysergide (1 microM) or methiothepin (0.1 microM), significantly attenuated the inhibitory effect of "}, "t": {"pos": [3, 4], "type": null, "name": "epinastine  on the noncholinergic contraction."}}
{"relation": "SUBSTRATE_PRODUCT-OF", "token": ["One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (", "KATI", "), also catalyses the reversible transamination of ", "glutamine", " to oxoglutaramic acid (GTK, EC 2.6.1.15)."], "h": {"pos": [1, 2], "type": null, "name": "KATI ), also catalyses the reversible transamination of "}, "t": {"pos": [3, 4], "type": null, "name": "glutamine  to oxoglutaramic acid (GTK, EC 2.6.1.15)."}}
{"relation": "SUBSTRATE_PRODUCT-OF", "token": ["", "Carnitine acetyltransferases", " (CrAT) catalyze the reversible conversion of acetyl-CoA and carnitine to ", "acetylcarnitine", " and free CoA."], "h": {"pos": [1, 2], "type": null, "name": "Carnitine acetyltransferases  (CrAT) catalyze the reversible conversion of acetyl-CoA and carnitine to "}, "t": {"pos": [3, 4], "type": null, "name": "acetylcarnitine  and free CoA."}}
{"relation": "SUBSTRATE_PRODUCT-OF", "token": ["One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of ", "glutamine", " to oxoglutaramic acid (", "GTK", ", EC 2.6.1.15)."], "h": {"pos": [1, 2], "type": null, "name": "glutamine  to oxoglutaramic acid ("}, "t": {"pos": [3, 4], "type": null, "name": "GTK , EC 2.6.1.15)."}}
{"relation": "SUBSTRATE_PRODUCT-OF", "token": ["One of the enzymes responsible for the production of KA, kynurenine aminotransferase I (KATI), also catalyses the reversible transamination of glutamine to ", "oxoglutaramic acid", " (", "GTK", ", EC 2.6.1.15)."], "h": {"pos": [1, 2], "type": null, "name": "oxoglutaramic acid  ("}, "t": {"pos": [3, 4], "type": null, "name": "GTK , EC 2.6.1.15)."}}
{"relation": "SUBSTRATE_PRODUCT-OF", "token": ["", "Type 2 11\u03b2-hydroxysteroid dehydrogenase", " encoded by the HSD11B2 gene converts ", "cortisol", " to inactive cortisone, and alteration in this enzymatic activity might affect glucose homeostasis by affecting circulating levels or tissue availability of glucocorticoids."], "h": {"pos": [1, 2], "type": null, "name": "Type 2 11\u03b2-hydroxysteroid dehydrogenase  encoded by the HSD11B2 gene converts "}, "t": {"pos": [3, 4], "type": null, "name": "cortisol  to inactive cortisone, and alteration in this enzymatic activity might affect glucose homeostasis by affecting circulating levels or tissue availability of glucocorticoids."}}
{"relation": "SUBSTRATE_PRODUCT-OF", "token": ["", "Type 2 11\u03b2-hydroxysteroid dehydrogenase", " encoded by the HSD11B2 gene converts cortisol to inactive ", "cortisone", ", and alteration in this enzymatic activity might affect glucose homeostasis by affecting circulating levels or tissue availability of glucocorticoids."], "h": {"pos": [1, 2], "type": null, "name": "Type 2 11\u03b2-hydroxysteroid dehydrogenase  encoded by the HSD11B2 gene converts cortisol to inactive "}, "t": {"pos": [3, 4], "type": null, "name": "cortisone , and alteration in this enzymatic activity might affect glucose homeostasis by affecting circulating levels or tissue availability of glucocorticoids."}}
{"relation": "SUBSTRATE_PRODUCT-OF", "token": ["One of the enzymes responsible for the production of KA, ", "kynurenine aminotransferase I", " (KATI), also catalyses the reversible transamination of glutamine to ", "oxoglutaramic acid", " (GTK, EC 2.6.1.15)."], "h": {"pos": [1, 2], "type": null, "name": "kynurenine aminotransferase I  (KATI), also catalyses the reversible transamination of glutamine to "}, "t": {"pos": [3, 4], "type": null, "name": "oxoglutaramic acid  (GTK, EC 2.6.1.15)."}}
